#AlleleID	Type	Name	GeneID	GeneSymbol	HGNC_ID	ClinicalSignificance	ClinSigSimple	LastEvaluated	RS# (dbSNP)	nsv/esv (dbVar)	RCVaccession	PhenotypeIDS	PhenotypeList	Origin	OriginSimple	Assembly	ChromosomeAccession	Chromosome	Start	Stop	ReferenceAllele	AlternateAllele	Cytogenetic	ReviewStatus	NumberSubmitters	Guidelines	TestedInGTR	OtherIDs	SubmitterCategories	VariationID	chr	pos	REF	ALT	AlleleID	variant_str	submitter_clinical_significance	submitter_date_last_evaluated	submitter_description	submitted_phenotype_info	reported_phenotype_info	clarification_unspecified_reported_phenotype	Correct_phenotype	Why_incorrect_phenotype	submitter_review_status	submitter_collection_method	submitter_origin_counts	submitter	submitterSCV			submitted_gene_symbol	ExplanationOfInterpretation	Traits	last_evaluated	n_called	n_not_called	AC	AF	n_het	submitterSCV23175	single nucleotide variant	NM_015869.4(PPARG):c.1484C>T (p.Pro495Leu)	5468	PPARG	HGNC:9236	Conflicting interpretations of pathogenicity	1	14-Jun-16	121909244	-	RCV000288354;RCV000343316;RCV000008612;RCV000382908	"MedGen:C4016738;MedGen:C0271694,Orphanet:ORPHA98306,SNOMED CT:49292002;MedGen:C1720861,OMIM:604367,Orphanet:ORPHA79083;Human Phenotype Ontology:HP:0001513,MedGen:C0028754,OMIM:601665,Orphanet:ORPHA71529,SNOMED CT:414916001"	"Diabetes Mellitus, Noninsulin-Dependent, with Acanthosis Nigricans and Hypertension;Familial partial lipodystrophy;Familial partial lipodystrophy 3;Obesity"	germline	germline	GRCh37	NC_000003.11	3	12475610	12475610	C	T	3p25	"criteria provided, conflicting interpretations"	2	NA	N	"OMIM Allelic Variant:601487.0007,UniProtKB (protein):P37231#VAR_010728"	3	8136	3	12475610	C	T	23175	3:12475610:C:T	Pathogenic	4/1/03	-	"LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 3"	C1720861:Familial partial lipodystrophy 3	NA	TRUE	NA	no assertion criteria provided	literature only	germline:na	OMIM	SCV000028820.2	SCV000028820		PPARG	-	"Lipodystrophy, MonogenicDM_all"	6/14/16	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV00002882023176	single nucleotide variant	NM_138712.3(PPARG):c.868G>A (p.Val290Met)	5468	PPARG	HGNC:9236	Pathogenic	1	1-Apr-03	72551362	-	RCV000008613	"MedGen:C1720861,OMIM:604367,Orphanet:ORPHA79083"	Familial partial lipodystrophy 3	germline	germline	GRCh37	NC_000003.11	3	12458335	12458335	G	A	3p25	no assertion criteria provided	1	NA	N	OMIM Allelic Variant:601487.0008	1	8137	3	12458335	G	A	23176	3:12458335:G:A	Pathogenic	4/1/03	-	"LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 3"	C1720861:Familial partial lipodystrophy 3	NA	TRUE	NA	no assertion criteria provided	literature only	germline:na	OMIM	SCV000028821.2	SCV000028821		PPARG	-	"Lipodystrophy, MonogenicDM_all"	4/1/03	46962	1	1	"[0.9999893530939908,1.0646906009113752E-5]"	1	SCV00002882123716	single nucleotide variant	NM_000525.3(KCNJ11):c.776A>G (p.His259Arg)	3767	KCNJ11	HGNC:6257	Pathogenic	1	1-Sep-05	104894248	-	RCV000009213	"MedGen:C2931833,OMIM:601820,SNOMED CT:42681006"	Islet cell hyperplasia	germline	germline	GRCh37	NC_000011.9	11	17408863	17408863	T	C	11p15.1	no assertion criteria provided	1	NA	N	OMIM Allelic Variant:600937.0013	1	8677	11	17408863	T	C	23716	11:17408863:T:C	Pathogenic	9/1/05	-	"HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 2"	C2931833:Islet cell hyperplasia	NA	FALSE	Not trait of interest	no assertion criteria provided	literature only	germline:na	OMIM	SCV000029431.2	SCV000029431		KCNJ11	-	"MODY Extended, MonogenicDM_all, Neonatal Diabetes"	9/1/05	46963	0	21	"[0.9997764197346848,2.2358026531524818E-4]"	21	SCV00002943123722	single nucleotide variant	NM_000525.3(KCNJ11):c.902G>A (p.Arg301His)	3767	KCNJ11	HGNC:6257	Likely pathogenic	1	11-Dec-17	74339576	-	RCV000009220;RCV000671339;RCV000671339;RCV000671339	"MedGen:C2931833,OMIM:601820,SNOMED CT:42681006;MedGen:C2931833,OMIM:601820,SNOMED CT:42681006;MedGen:C1833104,OMIM:606176,Orphanet:ORPHA99885;MedGen:C1864623,OMIM:610582"	Islet cell hyperplasia;Islet cell hyperplasia;Permanent neonatal diabetes mellitus;Transient neonatal diabetes mellitus 3	germline;unknown	germline	GRCh37	NC_000011.9	11	17408737	17408737	C	T	11p15.1	"criteria provided, single submitter"	2	NA	N	OMIM Allelic Variant:600937.0019	3	8683	11	17408737	C	T	23722	11:17408737:C:T	Pathogenic	2/1/05	-	"HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 2"	C2931833:Islet cell hyperplasia	NA	FALSE	Not trait of interest	no assertion criteria provided	literature only	germline:na	OMIM	SCV000029438.1	SCV000029438		KCNJ11	-	"MODY Extended, MonogenicDM_all, Neonatal Diabetes"	12/11/17	46963	0	2	"[0.9999787066413985,2.1293358601452207E-5]"	2	SCV00002943823725	single nucleotide variant	NM_000525.3(KCNJ11):c.844G>A (p.Glu282Lys)	3767	KCNJ11	HGNC:6257	Pathogenic/Likely pathogenic	1	31-Oct-18	267607196	-	RCV000763231;RCV000009223;RCV000763231;RCV000763231;RCV000763231;RCV000763231	"Human Phenotype Ontology:HP:0005978,MedGen:C0011860,OMIM:125853,Orphanet:ORPHA181376,SNOMED CT:44054006;MedGen:C2931833,OMIM:601820,SNOMED CT:42681006;MedGen:C2931833,OMIM:601820,SNOMED CT:42681006;MedGen:C4225365,OMIM:616329;MedGen:C1833104,OMIM:606176,Orphanet:ORPHA99885;MedGen:C1864623,OMIM:610582"	"Diabetes mellitus type 2;Islet cell hyperplasia;Islet cell hyperplasia;Maturity-onset diabetes of the young, type 13;Permanent neonatal diabetes mellitus;Transient neonatal diabetes mellitus 3"	germline;unknown	germline	GRCh37	NC_000011.9	11	17408795	17408795	C	T	11p15.1	"criteria provided, multiple submitters, no conflicts"	3	NA	N	OMIM Allelic Variant:600937.0022	3	8686	11	17408795	C	T	23725	11:17408795:C:T	Pathogenic	7/1/09	-	"HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 2"	C2931833:Islet cell hyperplasia	NA	FALSE	Not trait of interest	no assertion criteria provided	literature only	germline:na	OMIM	SCV000029441.2	SCV000029441		KCNJ11	-	"MODY Extended, MonogenicDM_all, Neonatal Diabetes"	10/31/18	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV00002944124073	single nucleotide variant	NM_002052.4(GATA4):c.1273G>A (p.Asp425Asn)	2626	GATA4	HGNC:4173	Conflicting interpretations of pathogenicity	1	8-Dec-17	56208331	-	RCV000009600;RCV000549514;RCV000190715;RCV000626818;RCV000626818;RCV000009601;RCV000626818;RCV000431077	"MedGen:C1842778,OMIM:607941;MedGen:C3280781,OMIM:614430;MeSH:D030342,MedGen:C0950123;Human Phenotype Ontology:HP:0010882,MedGen:CN116616;Human Phenotype Ontology:HP:0001642,MedGen:C1956257,OMIM:265500;Human Phenotype Ontology:HP:0001636,MedGen:C0039685,OMIM:187500,Orphanet:ORPHA3303,SNOMED CT:86299006;Human Phenotype Ontology:HP:0005180,MedGen:C0040961;MedGen:CN517202"	Atrial septal defect 2;Atrioventricular septal defect 4;Inborn genetic diseases;Pulmonary valve atresia;Pulmonic stenosis;Tetralogy of Fallot;Tricuspid regurgitation;not provided	germline;unknown	germline	GRCh37	NC_000008.10	8	11615928	11615928	G	A	8p23.1	"criteria provided, conflicting interpretations"	5	NA	N	"OMIM Allelic Variant:600576.0005,UniProtKB (protein):P43694#VAR_067621"	3	9034	8	11615928	G	A	24073	8:11615928:G:A	Pathogenic	12/1/07	-	ATRIAL SEPTAL DEFECT 2	C1842778:Atrial septal defect 2	NA	FALSE	Not trait of interest	no assertion criteria provided	literature only	germline:na	OMIM	SCV000029818.2	SCV000029818		GATA4	-	"MonogenicDM_all, Neonatal Diabetes"	12/8/17	46963	0	221	"[0.9976470838745395,0.002352916125460469]"	217	SCV00002981824073	single nucleotide variant	NM_002052.4(GATA4):c.1273G>A (p.Asp425Asn)	2626	GATA4	HGNC:4173	Conflicting interpretations of pathogenicity	1	8-Dec-17	56208331	-	RCV000009600;RCV000549514;RCV000190715;RCV000626818;RCV000626818;RCV000009601;RCV000626818;RCV000431077	"MedGen:C1842778,OMIM:607941;MedGen:C3280781,OMIM:614430;MeSH:D030342,MedGen:C0950123;Human Phenotype Ontology:HP:0010882,MedGen:CN116616;Human Phenotype Ontology:HP:0001642,MedGen:C1956257,OMIM:265500;Human Phenotype Ontology:HP:0001636,MedGen:C0039685,OMIM:187500,Orphanet:ORPHA3303,SNOMED CT:86299006;Human Phenotype Ontology:HP:0005180,MedGen:C0040961;MedGen:CN517202"	Atrial septal defect 2;Atrioventricular septal defect 4;Inborn genetic diseases;Pulmonary valve atresia;Pulmonic stenosis;Tetralogy of Fallot;Tricuspid regurgitation;not provided	germline;unknown	germline	GRCh37	NC_000008.10	8	11615928	11615928	G	A	8p23.1	"criteria provided, conflicting interpretations"	5	NA	N	"OMIM Allelic Variant:600576.0005,UniProtKB (protein):P43694#VAR_067621"	3	9034	8	11615928	G	A	24073	8:11615928:G:A	Pathogenic	12/1/07	-	TETRALOGY OF FALLOT	C0039685:Tetralogy of Fallot	NA	FALSE	Not trait of interest	no assertion criteria provided	literature only	germline:na	OMIM	SCV000029819.2	SCV000029819		GATA4	-	"MonogenicDM_all, Neonatal Diabetes"	12/8/17	46963	0	221	"[0.9976470838745395,0.002352916125460469]"	217	SCV00002981924127	single nucleotide variant	NM_001287174.1(ABCC8):c.3992-9G>A	6833	ABCC8	HGNC:59	Pathogenic	1	5-Jun-17	151344623	-	RCV000590487;RCV000009656;RCV000144995	"MedGen:C3888018,Orphanet:ORPHA276525;MedGen:C2931832,OMIM:256450,SNOMED CT:360339005;MedGen:CN517202"	Familial hyperinsulinism;Persistent hyperinsulinemic hypoglycemia of infancy;not provided	germline;unknown	germline	GRCh37	NC_000011.9	11	17418602	17418602	C	T	11p15.1	"criteria provided, multiple submitters, no conflicts"	7	NA	N	OMIM Allelic Variant:600509.0002	3	9088	11	17418602	C	T	24127	11:17418602:C:T	Pathogenic	1/1/99	-	"HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 1"	C2931832:Persistent hyperinsulinemic hypoglycemia of infancy	NA	FALSE	Not trait of interest	no assertion criteria provided	literature only	germline:na	OMIM	SCV000029874.1	SCV000029874		ABCC8	-	"MODY Extended, MonogenicDM_all, Neonatal Diabetes"	6/5/17	46963	0	15	"[0.9998402998104892,1.5970018951089155E-4]"	15	SCV00002987424135	single nucleotide variant	NM_000352.4(ABCC8):c.4477C>T (p.Arg1493Trp)	6833	ABCC8	HGNC:59	Pathogenic/Likely pathogenic	1	29-Aug-17	28936371	-	RCV000009664;RCV000710390	"MedGen:C2931832,OMIM:256450,SNOMED CT:360339005;MedGen:CN517202"	Persistent hyperinsulinemic hypoglycemia of infancy;not provided	germline;unknown	germline	GRCh37	NC_000011.9	11	17415881	17415881	G	A	11p15.1	"criteria provided, multiple submitters, no conflicts"	3	NA	N	"OMIM Allelic Variant:600509.0010,UniProtKB (protein):Q09428#VAR_008540"	3	9096	11	17415881	G	A	24135	11:17415881:G:A	Pathogenic	10/1/98	-	"HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 1"	C2931832:Persistent hyperinsulinemic hypoglycemia of infancy	NA	FALSE	Not trait of interest	no assertion criteria provided	literature only	germline:na	OMIM	SCV000029882.1	SCV000029882		ABCC8	-	"MODY Extended, MonogenicDM_all, Neonatal Diabetes"	8/29/17	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV00002988224137	single nucleotide variant	NM_001287174.1(ABCC8):c.4058G>A (p.Arg1353His)	6833	ABCC8	HGNC:59	Pathogenic	1	1-Sep-04	28936370	-	RCV000009666	"MedGen:C0271714,OMIM:240800,SNOMED CT:62151007"	Leucine-induced hypoglycemia	germline	germline	GRCh37	NC_000011.9	11	17418527	17418527	C	T	11p15.1	no assertion criteria provided	1	NA	N	OMIM Allelic Variant:600509.0012	1	9098	11	17418527	C	T	24137	11:17418527:C:T	Pathogenic	9/1/04	-	LEUCINE-SENSITIVE HYPOGLYCEMIA OF INFANCY	C0271714:Leucine-induced hypoglycemia	NA	FALSE	Not trait of interest	no assertion criteria provided	literature only	germline:na	OMIM	SCV000029884.1	SCV000029884		ABCC8	-	"MODY Extended, MonogenicDM_all, Neonatal Diabetes"	9/1/04	46963	0	2	"[0.9999787066413985,2.1293358601452207E-5]"	2	SCV00002988424138	single nucleotide variant	NM_000352.4(ABCC8):c.560T>A (p.Val187Asp)	6833	ABCC8	HGNC:59	Pathogenic	1	19-Feb-16	137852672	-	RCV000009667;RCV000723825	"MedGen:C2931832,OMIM:256450,SNOMED CT:360339005;MedGen:CN517202"	Persistent hyperinsulinemic hypoglycemia of infancy;not provided	germline;unknown	germline	GRCh37	NC_000011.9	11	17485004	17485004	A	T	11p15.1	"criteria provided, multiple submitters, no conflicts"	3	NA	N	"OMIM Allelic Variant:600509.0013,UniProtKB (protein):Q09428#VAR_008641"	3	9099	11	17485004	A	T	24138	11:17485004:A:T	Pathogenic	2/1/99	-	"HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 1"	C2931832:Persistent hyperinsulinemic hypoglycemia of infancy	NA	FALSE	Not trait of interest	no assertion criteria provided	literature only	germline:na	OMIM	SCV000029885.1	SCV000029885		ABCC8	-	"MODY Extended, MonogenicDM_all, Neonatal Diabetes"	2/19/16	46927	36	7	"[0.9999254160717711,7.458392822895134E-5]"	7	SCV00002988524144	single nucleotide variant	NM_000352.4(ABCC8):c.4135C>T (p.Arg1379Cys)	6833	ABCC8	HGNC:59	Pathogenic	1	1-Mar-16	137852673	-	RCV000009674;RCV000502425;RCV000009673	"Human Phenotype Ontology:HP:0005978,MedGen:C0011860,OMIM:125853,Orphanet:ORPHA181376,SNOMED CT:44054006;MedGen:C1833104,OMIM:606176,Orphanet:ORPHA99885;MedGen:C1835887,OMIM:610374"	Diabetes mellitus type 2;Permanent neonatal diabetes mellitus;Transient neonatal diabetes mellitus 2	germline	germline	GRCh37	NC_000011.9	11	17417462	17417462	G	A	11p15.1	"criteria provided, single submitter"	2	NA	N	OMIM Allelic Variant:600509.0019	3	9105	11	17417462	G	A	24144	11:17417462:G:A	Pathogenic	11/27/07	-	"DIABETES MELLITUS, TRANSIENT NEONATAL, 2"	C1835887:Transient neonatal diabetes mellitus 2	NA	TRUE	NA	no assertion criteria provided	literature only	germline:na	OMIM	SCV000029891.1	SCV000029891		ABCC8	-	"MODY Extended, MonogenicDM_all, Neonatal Diabetes"	3/1/16	46515	448	1	"[0.9999892507793186,1.0749220681500592E-5]"	1	SCV00002989124144	single nucleotide variant	NM_000352.4(ABCC8):c.4135C>T (p.Arg1379Cys)	6833	ABCC8	HGNC:59	Pathogenic	1	1-Mar-16	137852673	-	RCV000009674;RCV000502425;RCV000009673	"Human Phenotype Ontology:HP:0005978,MedGen:C0011860,OMIM:125853,Orphanet:ORPHA181376,SNOMED CT:44054006;MedGen:C1833104,OMIM:606176,Orphanet:ORPHA99885;MedGen:C1835887,OMIM:610374"	Diabetes mellitus type 2;Permanent neonatal diabetes mellitus;Transient neonatal diabetes mellitus 2	germline	germline	GRCh37	NC_000011.9	11	17417462	17417462	G	A	11p15.1	"criteria provided, single submitter"	2	NA	N	OMIM Allelic Variant:600509.0019	3	9105	11	17417462	G	A	24144	11:17417462:G:A	Pathogenic	11/27/07	-	"DIABETES MELLITUS, NONINSULIN-DEPENDENT"	C0011860:Diabetes mellitus type 2	NA	FALSE	Not trait of interest	no assertion criteria provided	literature only	germline:na	OMIM	SCV000029892.1	SCV000029892		ABCC8	-	"MODY Extended, MonogenicDM_all, Neonatal Diabetes"	3/1/16	46515	448	1	"[0.9999892507793186,1.0749220681500592E-5]"	1	SCV00002989227680	single nucleotide variant	NM_000458.3(HNF1B):c.1395C>G (p.Ser465Arg)	6928	HNF1B	HGNC:11630	Pathogenic	1	1-Aug-02	121918673	-	RCV000013476	"Human Phenotype Ontology:HP:0005978,MedGen:C0011860,OMIM:125853,Orphanet:ORPHA181376,SNOMED CT:44054006"	Diabetes mellitus type 2	germline	germline	GRCh37	NC_000017.10	17	36061127	36061127	G	C	17q12	no assertion criteria provided	1	NA	N	"OMIM Allelic Variant:189907.0007,UniProtKB (protein):P35680#VAR_017665"	1	12641	17	36061127	G	C	27680	17:36061127:G:C	Pathogenic	8/1/02	-	"DIABETES MELLITUS, NONINSULIN-DEPENDENT"	C0011860:Diabetes mellitus type 2	NA	FALSE	Not trait of interest	no assertion criteria provided	literature only	germline:na	OMIM	SCV000033723.1	SCV000033723		HNF1B	-	"MODY, MODY Extended, MonogenicDM_all, Neonatal Diabetes"	8/1/02	45112	1851	1	"[0.9999889164745522,1.1083525447774428E-5]"	1	SCV00003372328419	single nucleotide variant	NM_000207.2(INS):c.266G>A (p.Arg89His)	3630	INS	HGNC:6081	Pathogenic	1	1-Jun-98	28933985	-	RCV000014310	"MedGen:C0342283,OMIM:616214"	Hyperproinsulinemia	germline	germline	GRCh37	NC_000011.9	11	2181149	2181149	C	T	11p15.5	no assertion criteria provided	1	NA	N	"OMIM Allelic Variant:176730.0004,UniProtKB (protein):P01308#VAR_003974"	1	13380	11	2181149	C	T	28419	11:2181149:C:T	Pathogenic	6/1/98	-	HYPERPROINSULINEMIA	C0342283:Hyperproinsulinemia	NA	FALSE	Not trait of interest	no assertion criteria provided	literature only	germline:na	OMIM	SCV000034559.2	SCV000034559		INS	-	"MODY Extended, MonogenicDM_all, Neonatal Diabetes"	6/1/98	46590	373	1	"[0.9999892680832797,1.0731916720326251E-5]"	1	SCV00003455928429	single nucleotide variant	NM_000207.2(INS):c.16C>T (p.Arg6Cys)	3630	INS	HGNC:6081	Pathogenic	1	1-Apr-08	121908278	-	RCV000014322	"MedGen:C3150617,OMIM:613370"	"Maturity-onset diabetes of the young, type 10"	germline	germline	GRCh37	NC_000011.9	11	2182186	2182186	G	A	11p15.5	no assertion criteria provided	2	NA	N	"OMIM Allelic Variant:176730.0014,UniProtKB (protein):P01308#VAR_063721,UniProtKB (variants):VAR_063721"	1	13390	11	2182186	G	A	28429	11:2182186:G:A	Pathogenic	4/1/08	-	"MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 10"	"C3150617:Maturity-onset diabetes of the young, type 10"	NA	TRUE	NA	no assertion criteria provided	literature only	germline:na	OMIM	SCV000034571.1	SCV000034571		INS	-	"MODY Extended, MonogenicDM_all, Neonatal Diabetes"	4/1/08	46941	22	1	"[0.9999893483308835,1.0651669116550563E-5]"	1	SCV00003457129524	single nucleotide variant	NM_005572.3(LMNA):c.1711C>A (p.Arg571Ser)	4000	LMNA	HGNC:6636	Uncertain significance	1	1-Feb-18	80338938	-	RCV000705473;RCV000015574;RCV000057044	"MedGen:C0270914,Orphanet:ORPHA64746;MedGen:C1449563,OMIM:115200,Orphanet:ORPHA300751;MedGen:CN517202"	"Charcot-Marie-Tooth disease, type 2;Dilated cardiomyopathy 1A;not provided"	germline	germline	GRCh37	NC_000001.10	1	156107547	156107547	C	A	1q22	"criteria provided, single submitter"	4	"ACMG2013,ACMG2016"	N	OMIM Allelic Variant:150330.0009	3	14485	1	156107547	C	A	29524	1:156107547:C:A	Pathogenic	12/2/99	-	"CARDIOMYOPATHY, DILATED, 1A"	C1449563:Dilated cardiomyopathy 1A	NA	FALSE	Incorrect phenotype	no assertion criteria provided	literature only	germline:na	OMIM	SCV000035839.1	SCV000035839		LMNA	-	"Lipodystrophy, MonogenicDM_all"	2/1/18	37533	9430	2	"[0.9999733567793675,2.6643220632510057E-5]"	2	SCV00003583929525	single nucleotide variant	NM_170707.3(LMNA):c.1445G>A (p.Arg482Gln)	4000	LMNA	HGNC:6636	Pathogenic	1	31-Oct-18	11575937	-	RCV000763258;RCV000763258;RCV000459624;RCV000763258;RCV000763258;RCV000763258;RCV000190399;RCV000763258;RCV000015575;RCV000763258;RCV000763258;RCV000763258;RCV000041318;RCV000763258;RCV000763258;RCV000754814;RCV000148600;RCV000057299	"MedGen:C0410190,OMIM:181350,Orphanet:ORPHA98853,SNOMED CT:240072005;MedGen:C1854154,OMIM:605588,Orphanet:ORPHA98856;MedGen:C0270914,Orphanet:ORPHA64746;MedGen:C2750785,OMIM:613205,Orphanet:ORPHA157973;MedGen:C1449563,OMIM:115200,Orphanet:ORPHA300751;MedGen:C0796031,OMIM:212112,Orphanet:ORPHA2229;MedGen:C2750035,OMIM:616516,Orphanet:ORPHA98855;MedGen:C2750035,OMIM:616516,Orphanet:ORPHA98855;MedGen:C1720860,OMIM:151660,Orphanet:ORPHA2348;MedGen:C1720860,OMIM:151660,Orphanet:ORPHA2348;MedGen:C1857829,OMIM:610140,Orphanet:ORPHA168796;MedGen:C0033300,OMIM:176670,Orphanet:ORPHA740,SNOMED CT:238870004;MedGen:CN236383,Orphanet:ORPHA98301;MedGen:C0406585,OMIM:275210,Orphanet:ORPHA1662,SNOMED CT:400128006;MedGen:C0432291,OMIM:248370,Orphanet:ORPHA2457,SNOMED CT:109419009;MedGen:C3888631;MedGen:CN221589;MedGen:CN517202"	"Benign scapuloperoneal muscular dystrophy with cardiomyopathy;Charcot-Marie-Tooth disease type 2B1;Charcot-Marie-Tooth disease, type 2;Congenital muscular dystrophy, LMNA-related;Dilated cardiomyopathy 1A;Dilated cardiomyopathy-hypergonadotropic hypogonadism syndrome;Emery-Dreifuss muscular dystrophy 3, autosomal recessive;Emery-Dreifuss muscular dystrophy 3, autosomal recessive;Familial partial lipodystrophy 2;Familial partial lipodystrophy 2;Heart-hand syndrome, Slovenian type;Hutchinson-Gilford syndrome;Laminopathy;Lethal tight skin contracture syndrome;Mandibuloacral dysostosis;Monogenic diabetes;Partial lipodystrophy, Dunnigan;not provided"	de novo;germline;unknown	germline	GRCh37	NC_000001.10	1	156106776	156106776	G	A	1q22	"criteria provided, multiple submitters, no conflicts"	10	"ACMG2013,ACMG2016"	N	"OMIM Allelic Variant:150330.0010,UniProtKB (protein):P02545#VAR_009992"	3	14486	1	156106776	G	A	29525	1:156106776:G:A	Pathogenic	3/1/13	-	"LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 2"	C1720860:Familial partial lipodystrophy 2	NA	TRUE	NA	no assertion criteria provided	literature only	germline:na	OMIM	SCV000035840.3	SCV000035840		LMNA	-	"Lipodystrophy, MonogenicDM_all"	10/31/18	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV00003584029526	single nucleotide variant	NM_170707.3(LMNA):c.1579C>T (p.Arg527Cys)	4000	LMNA	HGNC:6636	Pathogenic	1	16-Nov-15	57318642	-	RCV000192240;RCV000192011;RCV000015576;RCV000057324	"MedGen:C0007959,Orphanet:ORPHA166,SNOMED CT:50548001;MedGen:C0033300,OMIM:176670,Orphanet:ORPHA740,SNOMED CT:238870004;MedGen:C0432291,OMIM:248370,Orphanet:ORPHA2457,SNOMED CT:109419009;MedGen:CN517202"	Charcot-Marie-Tooth disease;Hutchinson-Gilford syndrome;Mandibuloacral dysostosis;not provided	germline	germline	GRCh37	NC_000001.10	1	156106994	156106994	C	T	1q22	"criteria provided, single submitter"	4	"ACMG2013,ACMG2016"	N	"OMIM Allelic Variant:150330.0026,UniProtKB (protein):P02545#VAR_017663"	3	14487	1	156106994	C	T	29526	1:156106994:C:T	Pathogenic	1/1/03	-	MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY	C0432291:Mandibuloacral dysostosis	NA	FALSE	AR	no assertion criteria provided	literature only	germline:na	OMIM	SCV000035841.4	SCV000035841		LMNA	-	"Lipodystrophy, MonogenicDM_all"	11/16/15	46874	89	3	"[0.9999679993173187,3.2000682681230535E-5]"	3	SCV00003584129533	single nucleotide variant	NM_170707.3(LMNA):c.1745G>A (p.Arg582His)	4000	LMNA	HGNC:6636	Pathogenic	1	1-Jan-01	57830985	-	RCV000015585;RCV000057353	"MedGen:C1720860,OMIM:151660,Orphanet:ORPHA2348;MedGen:CN517202"	Familial partial lipodystrophy 2;not provided	germline	germline	GRCh37	NC_000001.10	1	156108325	156108325	G	A	1q22	no assertion criteria provided	2	"ACMG2013,ACMG2016"	N	"OMIM Allelic Variant:150330.0016,UniProtKB (protein):P02545#VAR_009998"	3	14494	1	156108325	G	A	29533	1:156108325:G:A	Pathogenic	1/1/01	-	"LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 2"	C1720860:Familial partial lipodystrophy 2	NA	TRUE	NA	no assertion criteria provided	literature only	germline:na	OMIM	SCV000035850.2	SCV000035850		LMNA	-	"Lipodystrophy, MonogenicDM_all"	1/1/01	46899	64	1	"[0.9999893387918719,1.0661208128105077E-5]"	1	SCV00003585029537	single nucleotide variant	NM_170707.3(LMNA):c.892C>T (p.Arg298Cys)	4000	LMNA	HGNC:6636	Pathogenic	1	8-Jun-18	59885338	-	RCV000192238;RCV000015590;RCV000653885;RCV000057479	"MedGen:C0007959,Orphanet:ORPHA166,SNOMED CT:50548001;MedGen:C1854154,OMIM:605588,Orphanet:ORPHA98856;MedGen:C0270914,Orphanet:ORPHA64746;MedGen:CN517202"	"Charcot-Marie-Tooth disease;Charcot-Marie-Tooth disease type 2B1;Charcot-Marie-Tooth disease, type 2;not provided"	germline	germline	GRCh37	NC_000001.10	1	156105059	156105059	C	T	1q22	"criteria provided, multiple submitters, no conflicts"	5	"ACMG2013,ACMG2016"	N	"OMIM Allelic Variant:150330.0020,UniProtKB (protein):P02545#VAR_017661"	3	14498	1	156105059	C	T	29537	1:156105059:C:T	Pathogenic	12/1/07	-	"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B1"	C1854154:Charcot-Marie-Tooth disease type 2B1	NA	FALSE	Incorrect phenotype	no assertion criteria provided	literature only	germline:na	OMIM	SCV000035855.3	SCV000035855		LMNA	-	"Lipodystrophy, MonogenicDM_all"	6/8/18	46953	10	2	"[0.9999787021063616,2.129789363831917E-5]"	2	SCV00003585529538	single nucleotide variant	NM_170707.3(LMNA):c.1580G>A (p.Arg527His)	4000	LMNA	HGNC:6636	Pathogenic	1	2-Jul-18	57520892	-	RCV000555364;RCV000015591;RCV000148607;RCV000015592;RCV000057326	"MedGen:C0270914,Orphanet:ORPHA64746;MedGen:C0432291,OMIM:248370,Orphanet:ORPHA2457,SNOMED CT:109419009;MedGen:CN118835;MedGen:CN043412;MedGen:CN517202"	"Charcot-Marie-Tooth disease, type 2;Mandibuloacral dysostosis;Mandibuloacral dysplasia;Mandibuloacral dysplasia with type A lipodystrophy, atypical;not provided"	germline	germline	GRCh37	NC_000001.10	1	156106995	156106995	G	A	1q22	"criteria provided, multiple submitters, no conflicts"	6	"ACMG2013,ACMG2016"	N	"OMIM Allelic Variant:150330.0021,UniProtKB (protein):P02545#VAR_018727"	3	14499	1	156106995	G	A	29538	1:156106995:G:A	Pathogenic	10/1/09	-	MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY	C0432291:Mandibuloacral dysostosis	NA	FALSE	AR	no assertion criteria provided	literature only	germline:na	OMIM	SCV000035856.3	SCV000035856		LMNA	-	"Lipodystrophy, MonogenicDM_all"	7/2/18	46868	95	8	"[0.9999146539216524,8.534607834769993E-5]"	8	SCV00003585629538	single nucleotide variant	NM_170707.3(LMNA):c.1580G>A (p.Arg527His)	4000	LMNA	HGNC:6636	Pathogenic	1	2-Jul-18	57520892	-	RCV000555364;RCV000015591;RCV000148607;RCV000015592;RCV000057326	"MedGen:C0270914,Orphanet:ORPHA64746;MedGen:C0432291,OMIM:248370,Orphanet:ORPHA2457,SNOMED CT:109419009;MedGen:CN118835;MedGen:CN043412;MedGen:CN517202"	"Charcot-Marie-Tooth disease, type 2;Mandibuloacral dysostosis;Mandibuloacral dysplasia;Mandibuloacral dysplasia with type A lipodystrophy, atypical;not provided"	germline	germline	GRCh37	NC_000001.10	1	156106995	156106995	G	A	1q22	"criteria provided, multiple submitters, no conflicts"	6	"ACMG2013,ACMG2016"	N	"OMIM Allelic Variant:150330.0021,UniProtKB (protein):P02545#VAR_018727"	3	14499	1	156106995	G	A	29538	1:156106995:G:A	Pathogenic	10/1/09	-	"MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY, ATYPICAL"	"CN043412:Mandibuloacral dysplasia with type A lipodystrophy, atypical"	NA	FALSE	AR	no assertion criteria provided	literature only	germline:na	OMIM	SCV000035857.3	SCV000035857		LMNA	-	"Lipodystrophy, MonogenicDM_all"	7/2/18	46868	95	8	"[0.9999146539216524,8.534607834769993E-5]"	8	SCV00003585729556	single nucleotide variant	NM_170707.3(LMNA):c.1718C>T (p.Ser573Leu)	4000	LMNA	HGNC:6636	Conflicting interpretations of pathogenicity	1	21-Dec-17	60890628	-	RCV000617932;RCV000653881;RCV000015612;RCV000015614;RCV000015613;RCV000057351;RCV000041329	"MedGen:CN230736;MedGen:C0270914,Orphanet:ORPHA64746;MedGen:C1449563,OMIM:115200,Orphanet:ORPHA300751;MedGen:C1720860,OMIM:151660,Orphanet:ORPHA2348;MedGen:CN043412;MedGen:CN517202;MedGen:CN169374"	"Cardiovascular phenotype;Charcot-Marie-Tooth disease, type 2;Dilated cardiomyopathy 1A;Familial partial lipodystrophy 2;Mandibuloacral dysplasia with type A lipodystrophy, atypical;not provided;not specified"	germline	germline	GRCh37	NC_000001.10	1	156108298	156108298	C	T	1q22	"criteria provided, conflicting interpretations"	7	"ACMG2013,ACMG2016"	N	"OMIM Allelic Variant:150330.0041,UniProtKB (protein):P02545#VAR_039789"	3	14517	1	156108298	C	T	29556	1:156108298:C:T	Pathogenic	2/1/07	-	"CARDIOMYOPATHY, DILATED, 1A"	C1449563:Dilated cardiomyopathy 1A	NA	FALSE	Incorrect phenotype	no assertion criteria provided	literature only	germline:na	OMIM	SCV000035877.3	SCV000035877		LMNA	-	"Lipodystrophy, MonogenicDM_all"	12/21/17	46812	151	16	"[0.9998291036486371,1.708963513628984E-4]"	16	SCV00003587729556	single nucleotide variant	NM_170707.3(LMNA):c.1718C>T (p.Ser573Leu)	4000	LMNA	HGNC:6636	Conflicting interpretations of pathogenicity	1	21-Dec-17	60890628	-	RCV000617932;RCV000653881;RCV000015612;RCV000015614;RCV000015613;RCV000057351;RCV000041329	"MedGen:CN230736;MedGen:C0270914,Orphanet:ORPHA64746;MedGen:C1449563,OMIM:115200,Orphanet:ORPHA300751;MedGen:C1720860,OMIM:151660,Orphanet:ORPHA2348;MedGen:CN043412;MedGen:CN517202;MedGen:CN169374"	"Cardiovascular phenotype;Charcot-Marie-Tooth disease, type 2;Dilated cardiomyopathy 1A;Familial partial lipodystrophy 2;Mandibuloacral dysplasia with type A lipodystrophy, atypical;not provided;not specified"	germline	germline	GRCh37	NC_000001.10	1	156108298	156108298	C	T	1q22	"criteria provided, conflicting interpretations"	7	"ACMG2013,ACMG2016"	N	"OMIM Allelic Variant:150330.0041,UniProtKB (protein):P02545#VAR_039789"	3	14517	1	156108298	C	T	29556	1:156108298:C:T	Pathogenic	2/1/07	-	"MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY, ATYPICAL"	"CN043412:Mandibuloacral dysplasia with type A lipodystrophy, atypical"	NA	FALSE	AR	no assertion criteria provided	literature only	germline:na	OMIM	SCV000035878.3	SCV000035878		LMNA	-	"Lipodystrophy, MonogenicDM_all"	12/21/17	46812	151	16	"[0.9998291036486371,1.708963513628984E-4]"	16	SCV00003587829556	single nucleotide variant	NM_170707.3(LMNA):c.1718C>T (p.Ser573Leu)	4000	LMNA	HGNC:6636	Conflicting interpretations of pathogenicity	1	21-Dec-17	60890628	-	RCV000617932;RCV000653881;RCV000015612;RCV000015614;RCV000015613;RCV000057351;RCV000041329	"MedGen:CN230736;MedGen:C0270914,Orphanet:ORPHA64746;MedGen:C1449563,OMIM:115200,Orphanet:ORPHA300751;MedGen:C1720860,OMIM:151660,Orphanet:ORPHA2348;MedGen:CN043412;MedGen:CN517202;MedGen:CN169374"	"Cardiovascular phenotype;Charcot-Marie-Tooth disease, type 2;Dilated cardiomyopathy 1A;Familial partial lipodystrophy 2;Mandibuloacral dysplasia with type A lipodystrophy, atypical;not provided;not specified"	germline	germline	GRCh37	NC_000001.10	1	156108298	156108298	C	T	1q22	"criteria provided, conflicting interpretations"	7	"ACMG2013,ACMG2016"	N	"OMIM Allelic Variant:150330.0041,UniProtKB (protein):P02545#VAR_039789"	3	14517	1	156108298	C	T	29556	1:156108298:C:T	Pathogenic	2/1/07	-	"LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 2"	C1720860:Familial partial lipodystrophy 2	NA	TRUE	NA	no assertion criteria provided	literature only	germline:na	OMIM	SCV000035879.3	SCV000035879		LMNA	-	"Lipodystrophy, MonogenicDM_all"	12/21/17	46812	151	16	"[0.9998291036486371,1.708963513628984E-4]"	16	SCV00003587929558	single nucleotide variant	NM_170707.3(LMNA):c.1195C>T (p.Arg399Cys)	4000	LMNA	HGNC:6636	Uncertain significance	1	15-Nov-17	58672172	-	RCV000653937;RCV000015616;RCV000057255;RCV000212505	"MedGen:C0270914,Orphanet:ORPHA64746;MedGen:C1720860,OMIM:151660,Orphanet:ORPHA2348;MedGen:CN517202;MedGen:CN169374"	"Charcot-Marie-Tooth disease, type 2;Familial partial lipodystrophy 2;not provided;not specified"	germline	germline	GRCh37	NC_000001.10	1	156106042	156106042	C	T	1q22	"criteria provided, multiple submitters, no conflicts"	4	"ACMG2013,ACMG2016"	N	"OMIM Allelic Variant:150330.0043,UniProtKB (protein):P02545#VAR_039778"	3	14519	1	156106042	C	T	29558	1:156106042:C:T	Pathogenic	2/1/07	-	"LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 2"	C1720860:Familial partial lipodystrophy 2	NA	TRUE	NA	no assertion criteria provided	literature only	germline:na	OMIM	SCV000035881.3	SCV000035881		LMNA	-	"Lipodystrophy, MonogenicDM_all"	11/15/17	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV00003588129566	single nucleotide variant	NM_170707.3(LMNA):c.1930C>T (p.Arg644Cys)	4000	LMNA	HGNC:6636	Conflicting interpretations of pathogenicity	1	21-Nov-18	142000963	-	RCV000245284;RCV000144868;RCV000471403;RCV000755679;RCV000148602;RCV000015626;RCV000057374;RCV000041340	"MedGen:CN230736;MedGen:C0007959,Orphanet:ORPHA166,SNOMED CT:50548001;MedGen:C0270914,Orphanet:ORPHA64746;MedGen:C1449563,OMIM:115200,Orphanet:ORPHA300751;EFO:EFO_0000407,Human Phenotype Ontology:HP:0001644,MedGen:C0007193,Orphanet:ORPHA217604,SNOMED CT:195021004;na;MedGen:CN517202;MedGen:CN169374"	"Cardiovascular phenotype;Charcot-Marie-Tooth disease;Charcot-Marie-Tooth disease, type 2;Dilated cardiomyopathy 1A;Primary dilated cardiomyopathy;Variant of unknown significance;not provided;not specified"	germline;tested-inconclusive;unknown	germline	GRCh37	NC_000001.10	1	156108510	156108510	C	T	1q22	"criteria provided, conflicting interpretations"	13	"ACMG2013,ACMG2016"	N	"OMIM Allelic Variant:150330.0051,UniProtKB (protein):P02545#VAR_039792"	3	14527	1	156108510	C	T	29566	1:156108510:C:T	Uncertain significance	11/1/09	-	VARIANT OF UNKNOWN SIGNIFICANCE	na:Variant of unknown significance	No Information	FALSE	No Information	no assertion criteria provided	literature only	germline:na	OMIM	SCV000035891.4	SCV000035891		LMNA	-	"Lipodystrophy, MonogenicDM_all"	11/21/18	46954	9	67	"[0.9992865357584019,7.134642415981599E-4]"	65	SCV00003589129524	single nucleotide variant	NM_005572.3(LMNA):c.1711C>A (p.Arg571Ser)	4000	LMNA	HGNC:6636	Uncertain significance	1	1-Feb-18	80338938	-	RCV000705473;RCV000015574;RCV000057044	"MedGen:C0270914,Orphanet:ORPHA64746;MedGen:C1449563,OMIM:115200,Orphanet:ORPHA300751;MedGen:CN517202"	"Charcot-Marie-Tooth disease, type 2;Dilated cardiomyopathy 1A;not provided"	germline	germline	GRCh37	NC_000001.10	1	156107547	156107547	C	A	1q22	"criteria provided, single submitter"	4	"ACMG2013,ACMG2016"	N	OMIM Allelic Variant:150330.0009	3	14485	1	156107547	C	A	29524	1:156107547:C:A	Pathogenic	4/5/11	-	LMNA-Related Dilated Cardiomyopathy	C1449563:Dilated cardiomyopathy 1A	NA	FALSE	Incorrect phenotype	no assertion criteria provided	curation	not provided:na	GeneReviews	SCV000041153.1	SCV000041153		-	-	"Lipodystrophy, MonogenicDM_all"	2/1/18	37533	9430	2	"[0.9999733567793675,2.6643220632510057E-5]"	2	SCV00004115339054	single nucleotide variant	NM_002052.4(GATA4):c.487C>T (p.Pro163Ser)	2626	GATA4	HGNC:4173	Conflicting interpretations of pathogenicity	1	9-Jan-18	387906769	-	RCV000023002;RCV000023004;RCV000023003	"MedGen:C3280781,OMIM:614430;Human Phenotype Ontology:HP:0001636,MedGen:C0039685,OMIM:187500,Orphanet:ORPHA3303,SNOMED CT:86299006;MedGen:C3280777,OMIM:614429"	Atrioventricular septal defect 4;Tetralogy of Fallot;Ventricular septal defect 1	germline;inherited	germline	GRCh37	NC_000008.10	8	11566308	11566308	C	T	8p23.1	"criteria provided, conflicting interpretations"	3	NA	N	"OMIM Allelic Variant:600576.0007,UniProtKB (protein):P43694#VAR_067610"	3	30099	8	11566308	C	T	39054	8:11566308:C:T	Pathogenic	12/1/10	-	ATRIOVENTRICULAR SEPTAL DEFECT 4	C3280781:Atrioventricular septal defect 4	NA	FALSE	Not trait of interest	no assertion criteria provided	literature only	germline:na	OMIM	SCV000044293.2	SCV000044293		GATA4	-	"MonogenicDM_all, Neonatal Diabetes"	1/9/18	25928	21035	2	"[0.999961431656896,3.856834310398025E-5]"	2	SCV00004429339054	single nucleotide variant	NM_002052.4(GATA4):c.487C>T (p.Pro163Ser)	2626	GATA4	HGNC:4173	Conflicting interpretations of pathogenicity	1	9-Jan-18	387906769	-	RCV000023002;RCV000023004;RCV000023003	"MedGen:C3280781,OMIM:614430;Human Phenotype Ontology:HP:0001636,MedGen:C0039685,OMIM:187500,Orphanet:ORPHA3303,SNOMED CT:86299006;MedGen:C3280777,OMIM:614429"	Atrioventricular septal defect 4;Tetralogy of Fallot;Ventricular septal defect 1	germline;inherited	germline	GRCh37	NC_000008.10	8	11566308	11566308	C	T	8p23.1	"criteria provided, conflicting interpretations"	3	NA	N	"OMIM Allelic Variant:600576.0007,UniProtKB (protein):P43694#VAR_067610"	3	30099	8	11566308	C	T	39054	8:11566308:C:T	Pathogenic	12/1/10	-	VENTRICULAR SEPTAL DEFECT 1	C3280777:Ventricular septal defect 1	NA	FALSE	Not trait of interest	no assertion criteria provided	literature only	germline:na	OMIM	SCV000044294.2	SCV000044294		GATA4	-	"MonogenicDM_all, Neonatal Diabetes"	1/9/18	25928	21035	2	"[0.999961431656896,3.856834310398025E-5]"	2	SCV00004429439054	single nucleotide variant	NM_002052.4(GATA4):c.487C>T (p.Pro163Ser)	2626	GATA4	HGNC:4173	Conflicting interpretations of pathogenicity	1	9-Jan-18	387906769	-	RCV000023002;RCV000023004;RCV000023003	"MedGen:C3280781,OMIM:614430;Human Phenotype Ontology:HP:0001636,MedGen:C0039685,OMIM:187500,Orphanet:ORPHA3303,SNOMED CT:86299006;MedGen:C3280777,OMIM:614429"	Atrioventricular septal defect 4;Tetralogy of Fallot;Ventricular septal defect 1	germline;inherited	germline	GRCh37	NC_000008.10	8	11566308	11566308	C	T	8p23.1	"criteria provided, conflicting interpretations"	3	NA	N	"OMIM Allelic Variant:600576.0007,UniProtKB (protein):P43694#VAR_067610"	3	30099	8	11566308	C	T	39054	8:11566308:C:T	Pathogenic	12/1/10	-	TETRALOGY OF FALLOT	C0039685:Tetralogy of Fallot	NA	FALSE	Not trait of interest	no assertion criteria provided	literature only	germline:na	OMIM	SCV000044295.2	SCV000044295		GATA4	-	"MonogenicDM_all, Neonatal Diabetes"	1/9/18	25928	21035	2	"[0.999961431656896,3.856834310398025E-5]"	2	SCV00004429539055	single nucleotide variant	NM_002052.4(GATA4):c.1037C>T (p.Ala346Val)	2626	GATA4	HGNC:4173	Conflicting interpretations of pathogenicity	1	19-Dec-17	115372595	-	RCV000023005;RCV000617346;RCV000503266	"MedGen:C3280781,OMIM:614430;MedGen:CN230736;MedGen:CN169374"	Atrioventricular septal defect 4;Cardiovascular phenotype;not specified	germline	germline	GRCh37	NC_000008.10	8	11614483	11614483	C	T	8p23.1	"criteria provided, conflicting interpretations"	4	NA	N	"OMIM Allelic Variant:600576.0008,UniProtKB (protein):P43694#VAR_067616"	3	30100	8	11614483	C	T	39055	8:11614483:C:T	Pathogenic	12/1/07	-	ATRIOVENTRICULAR SEPTAL DEFECT 4	C3280781:Atrioventricular septal defect 4	NA	FALSE	Not trait of interest	no assertion criteria provided	literature only	germline:na	OMIM	SCV000044296.2	SCV000044296		GATA4	-	"MonogenicDM_all, Neonatal Diabetes"	12/19/17	46963	0	104	"[0.9988927453527244,0.0011072546472755147]"	104	SCV00004429639056	single nucleotide variant	NM_002052.4(GATA4):c.1075G>A (p.Glu359Lys)	2626	GATA4	HGNC:4173	Pathogenic	1	1-Nov-08	368489876	-	RCV000023006	"MedGen:C3280777,OMIM:614429"	Ventricular septal defect 1	germline	germline	GRCh37	NC_000008.10	8	11614521	11614521	G	A	8p23.1	no assertion criteria provided	1	NA	N	"OMIM Allelic Variant:600576.0009,UniProtKB (protein):P43694#VAR_067617"	1	30101	8	11614521	G	A	39056	8:11614521:G:A	Pathogenic	11/1/08	-	VENTRICULAR SEPTAL DEFECT 1	C3280777:Ventricular septal defect 1	NA	FALSE	Not trait of interest	no assertion criteria provided	literature only	germline:na	OMIM	SCV000044297.2	SCV000044297		GATA4	-	"MonogenicDM_all, Neonatal Diabetes"	11/1/08	46963	0	3	"[0.9999680599620978,3.194003790217831E-5]"	3	SCV00004429739057	single nucleotide variant	NM_002052.4(GATA4):c.1325C>T (p.Ala442Val)	2626	GATA4	HGNC:4173	Pathogenic	1	1-Nov-08	146017816	-	RCV000023007	"MedGen:C3280777,OMIM:614429"	Ventricular septal defect 1	germline	germline	GRCh37	NC_000008.10	8	11615980	11615980	C	T	8p23.1	no assertion criteria provided	1	NA	N	"OMIM Allelic Variant:600576.0010,UniProtKB (protein):P43694#VAR_067623"	1	30102	8	11615980	C	T	39057	8:11615980:C:T	Pathogenic	11/1/08	-	VENTRICULAR SEPTAL DEFECT 1	C3280777:Ventricular septal defect 1	NA	FALSE	Not trait of interest	no assertion criteria provided	literature only	germline:na	OMIM	SCV000044298.2	SCV000044298		GATA4	-	"MonogenicDM_all, Neonatal Diabetes"	11/1/08	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV00004429839058	single nucleotide variant	NM_002052.4(GATA4):c.1220C>A (p.Pro407Gln)	2626	GATA4	HGNC:4173	Conflicting interpretations of pathogenicity	1	21-Mar-17	115099192	-	RCV000490358;RCV000490358;RCV000526826;RCV000023008;RCV000030949;RCV000490358	"MedGen:C1842778,OMIM:607941;MedGen:C3280781,OMIM:614430;MedGen:C3280781,OMIM:614430;Human Phenotype Ontology:HP:0001636,MedGen:C0039685,OMIM:187500,Orphanet:ORPHA3303,SNOMED CT:86299006;MedGen:C3280777,OMIM:614429;MedGen:C3280777,OMIM:614429"	Atrial septal defect 2;Atrioventricular septal defect 4;Atrioventricular septal defect 4;Tetralogy of Fallot;Ventricular septal defect 1;Ventricular septal defect 1	germline	germline	GRCh37	NC_000008.10	8	11615875	11615875	C	A	8p23.1	"criteria provided, conflicting interpretations"	3	NA	N	"OMIM Allelic Variant:600576.0011,OMIM Allelic Variant:600576.0013,UniProtKB (protein):P43694#VAR_067619"	3	30103	8	11615875	C	A	39058	8:11615875:C:A	Pathogenic	11/1/08	-	TETRALOGY OF FALLOT	C0039685:Tetralogy of Fallot	NA	FALSE	Not trait of interest	no assertion criteria provided	literature only	germline:na	OMIM	SCV000044299.2	SCV000044299		GATA4	-	"MonogenicDM_all, Neonatal Diabetes"	3/21/17	46963	0	85	"[0.9990950322594383,9.049677405617188E-4]"	85	SCV00004429939058	single nucleotide variant	NM_002052.4(GATA4):c.1220C>A (p.Pro407Gln)	2626	GATA4	HGNC:4173	Conflicting interpretations of pathogenicity	1	21-Mar-17	115099192	-	RCV000490358;RCV000490358;RCV000526826;RCV000023008;RCV000030949;RCV000490358	"MedGen:C1842778,OMIM:607941;MedGen:C3280781,OMIM:614430;MedGen:C3280781,OMIM:614430;Human Phenotype Ontology:HP:0001636,MedGen:C0039685,OMIM:187500,Orphanet:ORPHA3303,SNOMED CT:86299006;MedGen:C3280777,OMIM:614429;MedGen:C3280777,OMIM:614429"	Atrial septal defect 2;Atrioventricular septal defect 4;Atrioventricular septal defect 4;Tetralogy of Fallot;Ventricular septal defect 1;Ventricular septal defect 1	germline	germline	GRCh37	NC_000008.10	8	11615875	11615875	C	A	8p23.1	"criteria provided, conflicting interpretations"	3	NA	N	"OMIM Allelic Variant:600576.0011,OMIM Allelic Variant:600576.0013,UniProtKB (protein):P43694#VAR_067619"	3	30103	8	11615875	C	A	39058	8:11615875:C:A	Pathogenic	12/1/10	-	VENTRICULAR SEPTAL DEFECT 1	C3280777:Ventricular septal defect 1	NA	FALSE	Not trait of interest	no assertion criteria provided	literature only	germline:na	OMIM	SCV000044301.2	SCV000044301		GATA4	-	"MonogenicDM_all, Neonatal Diabetes"	3/21/17	46963	0	85	"[0.9990950322594383,9.049677405617188E-4]"	85	SCV00004430139165	single nucleotide variant	NM_005257.5(GATA6):c.533C>T (p.Ala178Val)	2627	GATA6	HGNC:4174	Pathogenic	1	1-Oct-10	387906815	-	RCV000023130	"MedGen:C3280939,OMIM:614474"	Atrioventricular septal defect 5	germline	germline	GRCh37	NC_000018.9	18	19751638	19751638	C	T	18q11.2	no assertion criteria provided	1	NA	N	"OMIM Allelic Variant:601656.0004,UniProtKB (protein):Q92908#VAR_067381"	1	30209	18	19751638	C	T	39165	18:19751638:C:T	Pathogenic	10/1/10	-	ATRIOVENTRICULAR SEPTAL DEFECT 5	C3280939:Atrioventricular septal defect 5	NA	FALSE	Not trait of interest	no assertion criteria provided	literature only	germline:na	OMIM	SCV000044421.1	SCV000044421		GATA6	-	"MonogenicDM_all, Neonatal Diabetes"	10/1/10	35385	11578	14	"[0.9998021760633037,1.9782393669634025E-4]"	10	SCV00004442139166	single nucleotide variant	NM_005257.5(GATA6):c.551G>A (p.Ser184Asn)	2627	GATA6	HGNC:4174	Pathogenic	1	1-Oct-10	387906816	-	RCV000023131;RCV000023132	"MedGen:C3280943,OMIM:614475;Human Phenotype Ontology:HP:0001636,MedGen:C0039685,OMIM:187500,Orphanet:ORPHA3303,SNOMED CT:86299006"	Atrial septal defect 9;Tetralogy of Fallot	germline	germline	GRCh37	NC_000018.9	18	19751656	19751656	G	A	18q11.2	no assertion criteria provided	1	NA	N	"OMIM Allelic Variant:601656.0005,UniProtKB (protein):Q92908#VAR_067382"	1	30210	18	19751656	G	A	39166	18:19751656:G:A	Pathogenic	10/1/10	-	ATRIAL SEPTAL DEFECT 9	C3280943:Atrial septal defect 9	NA	FALSE	Not trait of interest	no assertion criteria provided	literature only	germline:na	OMIM	SCV000044422.1	SCV000044422		GATA6	-	"MonogenicDM_all, Neonatal Diabetes"	10/1/10	27178	19785	58	"[0.9989329604827434,0.0010670395172566046]"	56	SCV00004442239166	single nucleotide variant	NM_005257.5(GATA6):c.551G>A (p.Ser184Asn)	2627	GATA6	HGNC:4174	Pathogenic	1	1-Oct-10	387906816	-	RCV000023131;RCV000023132	"MedGen:C3280943,OMIM:614475;Human Phenotype Ontology:HP:0001636,MedGen:C0039685,OMIM:187500,Orphanet:ORPHA3303,SNOMED CT:86299006"	Atrial septal defect 9;Tetralogy of Fallot	germline	germline	GRCh37	NC_000018.9	18	19751656	19751656	G	A	18q11.2	no assertion criteria provided	1	NA	N	"OMIM Allelic Variant:601656.0005,UniProtKB (protein):Q92908#VAR_067382"	1	30210	18	19751656	G	A	39166	18:19751656:G:A	Pathogenic	10/1/10	-	TETRALOGY OF FALLOT	C0039685:Tetralogy of Fallot	NA	FALSE	Not trait of interest	no assertion criteria provided	literature only	germline:na	OMIM	SCV000044423.1	SCV000044423		GATA6	-	"MonogenicDM_all, Neonatal Diabetes"	10/1/10	27178	19785	58	"[0.9989329604827434,0.0010670395172566046]"	56	SCV00004442329566	single nucleotide variant	NM_170707.3(LMNA):c.1930C>T (p.Arg644Cys)	4000	LMNA	HGNC:6636	Conflicting interpretations of pathogenicity	1	21-Nov-18	142000963	-	RCV000245284;RCV000144868;RCV000471403;RCV000755679;RCV000148602;RCV000015626;RCV000057374;RCV000041340	"MedGen:CN230736;MedGen:C0007959,Orphanet:ORPHA166,SNOMED CT:50548001;MedGen:C0270914,Orphanet:ORPHA64746;MedGen:C1449563,OMIM:115200,Orphanet:ORPHA300751;EFO:EFO_0000407,Human Phenotype Ontology:HP:0001644,MedGen:C0007193,Orphanet:ORPHA217604,SNOMED CT:195021004;na;MedGen:CN517202;MedGen:CN169374"	"Cardiovascular phenotype;Charcot-Marie-Tooth disease;Charcot-Marie-Tooth disease, type 2;Dilated cardiomyopathy 1A;Primary dilated cardiomyopathy;Variant of unknown significance;not provided;not specified"	germline;tested-inconclusive;unknown	germline	GRCh37	NC_000001.10	1	156108510	156108510	C	T	1q22	"criteria provided, conflicting interpretations"	13	"ACMG2013,ACMG2016"	N	"OMIM Allelic Variant:150330.0051,UniProtKB (protein):P02545#VAR_039792"	3	14527	1	156108510	C	T	29566	1:156108510:C:T	Likely benign	6/24/13	-	Not provided	CN517202:not provided	cardiomyopathy - from pubmed articles	FALSE	Incorrect phenotype	"criteria provided, single submitter"	research	unknown:1	"Biesecker Lab/Human Development Section,National Institutes of Health"	SCV000051400.1	SCV000051400		LMNA	-	"Lipodystrophy, MonogenicDM_all"	11/21/18	46954	9	67	"[0.9992865357584019,7.134642415981599E-4]"	65	SCV00005140044274	single nucleotide variant	NM_000352.4(ABCC8):c.3517G>A (p.Val1173Met)	6833	ABCC8	HGNC:59	Likely pathogenic	1	1-Jan-17	141322087	-	RCV000626670;RCV000626670;RCV000626670;RCV000626670;RCV000626670;RCV000626670;RCV000626670;RCV000626670;RCV000626670;RCV000029255;RCV000626670;RCV000626670;RCV000626670	"Human Phenotype Ontology:HP:0001631,MedGen:C0018817,Orphanet:ORPHA1478;Human Phenotype Ontology:HP:0001693,MedGen:C0232180;Human Phenotype Ontology:HP:0001635,MedGen:C0018802;Human Phenotype Ontology:HP:0011968,MedGen:C0232466;Human Phenotype Ontology:HP:0002020,MedGen:C4317146;Human Phenotype Ontology:HP:0001510,MedGen:C0456070;Human Phenotype Ontology:HP:0001943,MedGen:C0020615;Human Phenotype Ontology:HP:0000256,MedGen:C2243051;Human Phenotype Ontology:HP:0000400,MedGen:C0152421;MedGen:C0158981,Orphanet:ORPHA224,SNOMED CT:49817004;Human Phenotype Ontology:HP:0002643,MedGen:C4281993;Human Phenotype Ontology:HP:0004322,MedGen:C0349588;Human Phenotype Ontology:HP:0001518,MedGen:C0235991"	Atrial septal defect;Cardiac shunt;Congestive heart failure;Feeding difficulties;Gastroesophageal reflux;Growth delay;Hypoglycemia;Macrocephalus;Macrotia;Neonatal diabetes mellitus;Neonatal respiratory distress;Short stature;Small for gestational age	germline;unknown	germline	GRCh37	NC_000011.9	11	17426099	17426099	C	T	11p15.1	"criteria provided, multiple submitters, no conflicts"	2	NA	N	-	2	35609	11	17426099	C	T	44274	11:17426099:C:T	Likely pathogenic	8/18/11	-	Neonatal Diabetes Mellitus	C0158981:Neonatal diabetes mellitus	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing;curation	germline:2	Integrated Genetics/Laboratory Corporation of America	SCV000051901.1	SCV000051901		ABCC8	-	"MODY Extended, MonogenicDM_all, Neonatal Diabetes"	1/1/17	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV00005190144279	single nucleotide variant	NM_000352.4(ABCC8):c.4135C>A (p.Arg1379Ser)	6833	ABCC8	HGNC:59	Conflicting interpretations of pathogenicity	1	9-May-18	137852673	-	RCV000029261;RCV000675131	"MedGen:C0158981,Orphanet:ORPHA224,SNOMED CT:49817004;MedGen:C2931832,OMIM:256450,SNOMED CT:360339005"	Neonatal diabetes mellitus;Persistent hyperinsulinemic hypoglycemia of infancy	germline;unknown	germline	GRCh37	NC_000011.9	11	17417462	17417462	G	T	11p15.1	"criteria provided, conflicting interpretations"	2	NA	N	-	2	35614	11	17417462	G	T	44279	11:17417462:G:T	Likely pathogenic	8/18/11	-	Neonatal Diabetes Mellitus	C0158981:Neonatal diabetes mellitus	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing;curation	germline:2	Integrated Genetics/Laboratory Corporation of America	SCV000051907.1	SCV000051907		ABCC8	-	"MODY Extended, MonogenicDM_all, Neonatal Diabetes"	5/9/18	46517	446	3	"[0.9999677537244448,3.2246275555173374E-5]"	3	SCV00005190744289	single nucleotide variant	NM_000352.4(ABCC8):c.886G>A (p.Gly296Arg)	6833	ABCC8	HGNC:59	Conflicting interpretations of pathogenicity	1	9-Nov-17	148529020	-	RCV000029271;RCV000675093	"MedGen:C0158981,Orphanet:ORPHA224,SNOMED CT:49817004;MedGen:C2931832,OMIM:256450,SNOMED CT:360339005"	Neonatal diabetes mellitus;Persistent hyperinsulinemic hypoglycemia of infancy	germline;unknown	germline	GRCh37	NC_000011.9	11	17482160	17482160	C	T	11p15.1	"criteria provided, conflicting interpretations"	2	NA	N	-	2	35624	11	17482160	C	T	44289	11:17482160:C:T	Likely pathogenic	8/18/11	-	Neonatal Diabetes Mellitus	C0158981:Neonatal diabetes mellitus	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing;curation	germline:2	Integrated Genetics/Laboratory Corporation of America	SCV000051917.1	SCV000051917		ABCC8	-	"MODY Extended, MonogenicDM_all, Neonatal Diabetes"	11/9/17	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV00005191744479	deletion	NM_001807.4(CEL):c.1785delC (p.Val596Cysfs)	1056	CEL	HGNC:1848	Likely pathogenic	1	18-Aug-11	193922638	-	RCV000029467	"MedGen:C1853297,OMIM:609812"	"Maturity-onset diabetes of the young, type 8"	germline	germline	GRCh37	NC_000009.11	9	135946665	135946665	C	-	9q34.2	"criteria provided, single submitter"	1	NA	N	-	2	35815	9	135946657	GC	G	44479	9:135946657:GC:G	Likely pathogenic	8/18/11	-	MODY8	"C1853297:Maturity-onset diabetes of the young, type 8"	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing;curation	germline:4	Integrated Genetics/Laboratory Corporation of America	SCV000052117.1	SCV000052117		CEL	-	"MODY Extended, MonogenicDM_all"	8/18/11	41404	5559	1	"[0.9999879238720897,1.2076127910346827E-5]"	1	SCV00005211744846	single nucleotide variant	NM_000162.3(GCK):c.1160C>T (p.Ala387Val)	2645	GCK	HGNC:4195	Likely pathogenic	1	3-Dec-15	193921338	-	RCV000029845;RCV000493278	"MedGen:C1841962,OMIM:125851;MedGen:CN517202"	"Maturity-onset diabetes of the young,  type 2;not provided"	germline	germline	GRCh37	NC_000007.13	7	44185189	44185189	G	A	7p13	"criteria provided, multiple submitters, no conflicts"	2	NA	N	-	2	36182	7	44185189	G	A	44846	7:44185189:G:A	Likely pathogenic	8/18/11	-	MODY2	"C1841962:Maturity-onset diabetes of the young, type 2"	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing;curation	germline:3	Integrated Genetics/Laboratory Corporation of America	SCV000052500.1	SCV000052500		GCK	-	"MODY, MODY Extended, MonogenicDM_all"	12/3/15	46297	666	1	"[0.9999892001641575,1.0799835842495194E-5]"	1	SCV00005250044852	single nucleotide variant	NM_000162.3(GCK):c.1240A>G (p.Lys414Glu)	2645	GCK	HGNC:4195	Likely pathogenic	1	22-May-18	193922272	-	RCV000029851;RCV000711759	"MedGen:C1841962,OMIM:125851;MedGen:CN517202"	"Maturity-onset diabetes of the young,  type 2;not provided"	germline	germline	GRCh37	NC_000007.13	7	44185109	44185109	T	C	7p13	"criteria provided, multiple submitters, no conflicts"	2	NA	N	UniProtKB (protein):P35557#VAR_003714	2	36188	7	44185109	T	C	44852	7:44185109:T:C	Likely pathogenic	8/18/11	-	MODY2	"C1841962:Maturity-onset diabetes of the young, type 2"	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing;curation	germline:4	Integrated Genetics/Laboratory Corporation of America	SCV000052506.1	SCV000052506		GCK	-	"MODY, MODY Extended, MonogenicDM_all"	5/22/18	46861	102	1	"[0.9999893301466037,1.0669853396214336E-5]"	1	SCV00005250644873	single nucleotide variant	NM_000162.3(GCK):c.214G>A (p.Gly72Arg)	2645	GCK	HGNC:4195	Pathogenic	1	12-Jul-18	193922289	-	RCV000029872;RCV000255585	"MedGen:C1841962,OMIM:125851;MedGen:CN517202"	"Maturity-onset diabetes of the young,  type 2;not provided"	germline	germline	GRCh37	NC_000007.13	7	44192019	44192019	C	T	7p13	"criteria provided, multiple submitters, no conflicts"	3	NA	N	-	2	36209	7	44192019	C	T	44873	7:44192019:C:T	Pathogenic	8/18/11	-	MODY2	"C1841962:Maturity-onset diabetes of the young, type 2"	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing;curation	germline:8	Integrated Genetics/Laboratory Corporation of America	SCV000052527.1	SCV000052527		GCK	-	"MODY, MODY Extended, MonogenicDM_all"	7/12/18	46963	0	2	"[0.9999787066413985,2.1293358601452207E-5]"	2	SCV00005252744881	single nucleotide variant	NM_000162.3(GCK):c.440G>A (p.Gly147Asp)	2645	GCK	HGNC:4195	Likely pathogenic	1	18-Aug-11	193922296	-	RCV000029880	"MedGen:C1841962,OMIM:125851"	"Maturity-onset diabetes of the young,  type 2"	germline	germline	GRCh37	NC_000007.13	7	44190598	44190598	C	T	7p13	"criteria provided, single submitter"	1	NA	N	-	2	36217	7	44190598	C	T	44881	7:44190598:C:T	Likely pathogenic	8/18/11	-	MODY2	"C1841962:Maturity-onset diabetes of the young, type 2"	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing;curation	germline:2	Integrated Genetics/Laboratory Corporation of America	SCV000052535.1	SCV000052535		GCK	-	"MODY, MODY Extended, MonogenicDM_all"	8/18/11	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV00005253544907	single nucleotide variant	NM_000162.5(GCK):c.676G>A (p.Val226Met)	2645	GCK	HGNC:4195	Pathogenic/Likely pathogenic	1	31-Oct-18	148311934	-	RCV000763584;RCV000763584;RCV000029906;RCV000763584;RCV000763584;RCV000255932	"Human Phenotype Ontology:HP:0005978,MedGen:C0011860,OMIM:125853,Orphanet:ORPHA181376,SNOMED CT:44054006;MedGen:C1865290,OMIM:602485,Orphanet:ORPHA79299;MedGen:C1841962,OMIM:125851;MedGen:C1841962,OMIM:125851;MedGen:C1833104,OMIM:606176,Orphanet:ORPHA99885;MedGen:CN517202"	"Diabetes mellitus type 2;Hyperinsulinemic hypoglycemia familial 3;Maturity-onset diabetes of the young,  type 2;Maturity-onset diabetes of the young,  type 2;Permanent neonatal diabetes mellitus;not provided"	germline;unknown	germline	GRCh37	NC_000007.13	7	44189362	44189362	C	T	7p13	"criteria provided, multiple submitters, no conflicts"	6	NA	N	UniProtKB (protein):P35557#VAR_003703	2	36243	7	44189362	C	T	44907	7:44189362:C:T	Pathogenic	8/18/11	-	MODY2	"C1841962:Maturity-onset diabetes of the young, type 2"	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing;curation	germline:25	Integrated Genetics/Laboratory Corporation of America	SCV000052561.1	SCV000052561		GCK	-	"MODY, MODY Extended, MonogenicDM_all"	10/31/18	46963	0	2	"[0.9999787066413985,2.1293358601452207E-5]"	2	SCV00005256145013	single nucleotide variant	NM_000457.4(HNF4A):c.427A>G (p.Ser143Gly)	3172	HNF4A	HGNC:5024	Conflicting interpretations of pathogenicity	1	20-Mar-17	193922472	-	RCV000030019;RCV000484752	"MedGen:C1852093,OMIM:125850;MedGen:CN169374"	"Maturity-onset diabetes of the young,  type 1;not specified"	germline	germline	GRCh37	NC_000020.10	20	43042375	43042375	A	G	20q13.1	"criteria provided, conflicting interpretations"	2	NA	N	-	2	36349	20	43042375	A	G	45013	20:43042375:A:G	Likely pathogenic	8/18/11	-	MODY1	"C1852093:Maturity-onset diabetes of the young, type 1"	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing;curation	germline:2	Integrated Genetics/Laboratory Corporation of America	SCV000052674.1	SCV000052674		HNF4A	-	"MODY, MODY Extended, MonogenicDM_all"	3/20/17	46962	1	1	"[0.9999893530939908,1.0646906009113752E-5]"	1	SCV00005267445024	single nucleotide variant	NM_000457.4(HNF4A):c.834G>C (p.Glu278Asp)	3172	HNF4A	HGNC:5024	Likely pathogenic	1	18-Aug-11	193922477	-	RCV000030030	"MedGen:C1852093,OMIM:125850"	"Maturity-onset diabetes of the young,  type 1"	germline	germline	GRCh37	NC_000020.10	20	43048458	43048458	G	C	20q13.1	"criteria provided, single submitter"	1	NA	N	-	2	36360	20	43048458	G	C	45024	20:43048458:G:C	Likely pathogenic	8/18/11	-	MODY1	"C1852093:Maturity-onset diabetes of the young, type 1"	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing;curation	germline:2	Integrated Genetics/Laboratory Corporation of America	SCV000052685.1	SCV000052685		HNF4A	-	"MODY, MODY Extended, MonogenicDM_all"	8/18/11	46963	0	2	"[0.9999787066413985,2.1293358601452207E-5]"	2	SCV00005268545028	single nucleotide variant	NM_000457.4(HNF4A):c.991C>T (p.Arg331Cys)	3172	HNF4A	HGNC:5024	Conflicting interpretations of pathogenicity	1	21-Dec-16	193922479	-	RCV000193933;RCV000030034;RCV000517103	"Human Phenotype Ontology:HP:0000842,MedGen:C0020459;MedGen:C1852093,OMIM:125850;MedGen:CN169374"	"Hyperinsulinemia;Maturity-onset diabetes of the young,  type 1;not specified"	germline	germline	GRCh37	NC_000020.10	20	43052756	43052756	C	T	20q13.1	"criteria provided, conflicting interpretations"	3	NA	N	-	2	36364	20	43052756	C	T	45028	20:43052756:C:T	Likely pathogenic	8/18/11	-	MODY1	"C1852093:Maturity-onset diabetes of the young, type 1"	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing;curation	germline:3	Integrated Genetics/Laboratory Corporation of America	SCV000052689.1	SCV000052689		HNF4A	-	"MODY, MODY Extended, MonogenicDM_all"	12/21/16	46938	25	1	"[0.9999893476500916,1.065234990838979E-5]"	1	SCV00005268923898	single nucleotide variant	NM_000209.3(PDX1):c.226G>A (p.Asp76Asn)	3651	PDX1	HGNC:6107	"Conflicting interpretations of pathogenicity, risk factor"	1	5-Feb-18	137852783	-	RCV000009409;RCV000626294;RCV000030077;RCV000445407;RCV000246150	"Human Phenotype Ontology:HP:0005978,MedGen:C0011860,OMIM:125853,Orphanet:ORPHA181376,SNOMED CT:44054006;Human Phenotype Ontology:HP:0004904,MedGen:C0342276,OMIM:606391,Orphanet:ORPHA552,SNOMED CT:28453007;MedGen:C1833382,OMIM:606392;MedGen:C3888631;MedGen:CN169374"	"Diabetes mellitus type 2;Maturity onset diabetes mellitus in young;Maturity-onset diabetes of the young, type 4;Monogenic diabetes;not specified"	germline;inherited;unknown	germline	GRCh37	NC_000013.10	13	28494501	28494501	G	A	13q12.2	"criteria provided, conflicting interpretations"	6	NA	N	"OMIM Allelic Variant:600733.0002,UniProtKB (protein):P52945#VAR_009311"	3	8859	13	28494501	G	A	23898	13:28494501:G:A	not provided	8/18/11	-	"Maturity-onset diabetes of the young, type 4"	"C1833382:Maturity-onset diabetes of the young, type 4"	NA	TRUE	NA	no assertion provided	clinical testing	germline:na	Integrated Genetics/Laboratory Corporation of America	SCV000052732.2	SCV000052732		PDX1	-	"MODY, MODY Extended, MonogenicDM_all"	2/5/18	42422	4541	98	"[0.998844938946773,0.0011550610532270991]"	98	SCV00005273245074	single nucleotide variant	NM_000209.3(PDX1):c.725C>T (p.Pro242Leu)	3651	PDX1	HGNC:6107	Conflicting interpretations of pathogenicity	1	28-Mar-16	193922358	-	RCV000030083;RCV000455258	"MedGen:C1833382,OMIM:606392;MedGen:CN169374"	"Maturity-onset diabetes of the young, type 4;not specified"	germline	germline	GRCh37	NC_000013.10	13	28498711	28498711	C	T	13q12.2	"criteria provided, conflicting interpretations"	2	NA	N	-	2	36411	13	28498711	C	T	45074	13:28498711:C:T	Likely pathogenic	8/18/11	-	MODY4	"C1833382:Maturity-onset diabetes of the young, type 4"	NA	NA	NA	"criteria provided, single submitter"	clinical testing	germline:8	Integrated Genetics/Laboratory Corporation of America	SCV000052738.1	SCV000052738		IPF1	-	"MODY, MODY Extended, MonogenicDM_all"	3/28/16	41198	5765	24	"[0.9997087237244526,2.9127627554735667E-4]"	24	SCV00005273845077	single nucleotide variant	NM_000209.3(PDX1):c.97C>A (p.Pro33Thr)	3651	PDX1	HGNC:6107	Conflicting interpretations of pathogenicity	1	10-Jun-16	192902098	-	RCV000030086;RCV000414508	"MedGen:C1833382,OMIM:606392;MedGen:CN517202"	"Maturity-onset diabetes of the young, type 4;not provided"	germline	germline	GRCh37	NC_000013.10	13	28494372	28494372	C	A	13q12.2	"criteria provided, conflicting interpretations"	2	NA	N	-	2	36414	13	28494372	C	A	45077	13:28494372:C:A	Uncertain significance	8/18/11	-	MODY4	"C1833382:Maturity-onset diabetes of the young, type 4"	NA	NA	NA	"criteria provided, single submitter"	clinical testing;curation	germline:13	Integrated Genetics/Laboratory Corporation of America	SCV000052741.1	SCV000052741		IPF1	-	"MODY, MODY Extended, MonogenicDM_all"	6/10/16	38775	8188	96	"[0.998762088974855,0.0012379110251450676]"	96	SCV00005274145113	single nucleotide variant	NM_000527.4(LDLR):c.1055G>A (p.Cys352Tyr)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	31-Oct-18	193922566	-	RCV000030122;RCV000722113;RCV000413322	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:CN517202"	Familial hypercholesterolemia;Familial hypercholesterolemias;not provided	germline;unknown	germline	GRCh37	NC_000019.9	19	11221442	11221442	G	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	9	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_001339,UniProtKB (protein):P01130#VAR_005369"	2	36450	19	11221442	G	A	45113	19:11221442:G:A	Pathogenic	9/17/18	"Variant summary: LDLR c.1055G>A (p.Cys352Tyr) results in a non-conservative amino acid change located in the EGF-like domain and EGF-like calcium-binding domain of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 8.1e-06 in 245700 control chromosomes. c.1055G>A has been reported in the literature in multiple individuals affected with Familial Hypercholesterolemia. In one family, a severely affected proband was homozygous for the variant, while the father and paternal grandmother who were heterozygous carriers were unaffected, suggesting incomplete penetrance of the variant (Magana Torres_2014). However, several variants at the same codon have been associated with FH (C352R, C352F, C352S, C352W), as well as the immediately adjacent codons, suggesting the locus is important for gene function. Overall, these data indicate that the variant is very likely to be associated with disease. At least one publication reports experimental evidence evaluating an impact on LDL receptor function, which showed the variant resulted in <10% of normal activity (Kolansky_2008). Six clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. All laboratories classified the variant as pathogenic/likely pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic."	MedGen:CN118841	C0020445:Familial hypercholesterolemias	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Integrated Genetics/Laboratory Corporation of America	SCV000052777.2	SCV000052777		LDLR	-	High LDL	10/31/18	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV00005277745114	single nucleotide variant	NM_000527.4(LDLR):c.1061-8T>C	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	31-May-18	72658861	-	RCV000030123;RCV000759074;RCV000245346	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202;MedGen:CN169374"	Familial hypercholesterolemia;not provided;not specified	germline;unknown	germline	GRCh37	NC_000019.9	19	11222182	11222182	T	C	19p13.2	"criteria provided, conflicting interpretations"	15	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000154	2	36451	19	11222182	T	C	45114	19:11222182:T:C	Uncertain significance	8/18/11	-	Familial Hypercholesterolemia	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing;curation	germline:56	Integrated Genetics/Laboratory Corporation of America	SCV000052778.1	SCV000052778		LDLR	-	High LDL	5/31/18	46960	3	426	"[0.9954642248722317,0.004535775127768314]"	420	SCV00005277845115	single nucleotide variant	NM_000527.4(LDLR):c.1085A>C (p.Asp362Ala)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	25-Mar-16	138315511	-	RCV000030124;RCV000148563	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443"	Familial hypercholesterolemia;Hypercholesterolaemia	germline	germline	GRCh37	NC_000019.9	19	11222214	11222214	A	C	19p13.2	"criteria provided, conflicting interpretations"	6	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000792	2	36452	19	11222214	A	C	45115	19:11222214:A:C	Likely pathogenic	8/18/11	-	Familial Hypercholesterolemia	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing;curation	germline:9	Integrated Genetics/Laboratory Corporation of America	SCV000052779.1	SCV000052779		LDLR	-	High LDL	3/25/16	46963	0	6	"[0.9999361199241956,6.388007580435663E-5]"	6	SCV00005277945116	single nucleotide variant	NM_000527.4(LDLR):c.1222G>A (p.Glu408Lys)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	23-Jan-18	137943601	-	RCV000030125;RCV000148564	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443"	Familial hypercholesterolemia;Hypercholesterolaemia	germline;unknown	germline	GRCh37	NC_000019.9	19	11223989	11223989	G	A	19p13.2	"criteria provided, conflicting interpretations"	12	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_001379,UniProtKB (protein):P01130#VAR_005378"	2	36453	19	11223989	G	A	45116	19:11223989:G:A	Pathogenic	8/18/11	-	Familial Hypercholesterolemia	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing;curation	germline:14	Integrated Genetics/Laboratory Corporation of America	SCV000052780.1	SCV000052780		LDLR	-	High LDL	1/23/18	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV00005278045119	single nucleotide variant	NM_000527.4(LDLR):c.1381G>A (p.Gly461Ser)	3949	LDLR	HGNC:6547	Likely pathogenic	1	18-Aug-11	193922568	-	RCV000030128	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline	germline	GRCh37	NC_000019.9	19	11224233	11224233	G	A	19p13.2	"criteria provided, single submitter"	1	"ACMG2013,ACMG2016"	N	-	2	36456	19	11224233	G	A	45119	19:11224233:G:A	Likely pathogenic	8/18/11	-	Familial Hypercholesterolemia	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing;curation	germline:2	Integrated Genetics/Laboratory Corporation of America	SCV000052783.1	SCV000052783		LDLR	-	High LDL	8/18/11	46963	0	2	"[0.9999787066413985,2.1293358601452207E-5]"	2	SCV00005278345123	single nucleotide variant	NM_000527.4(LDLR):c.2140+5G>A	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	26-Jan-18	72658867	-	RCV000030133;RCV000614028	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN169374"	Familial hypercholesterolemia;not specified	germline	germline	GRCh37	NC_000019.9	19	11231203	11231203	G	A	19p13.2	"criteria provided, conflicting interpretations"	13	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000283	2	36460	19	11231203	G	A	45123	19:11231203:G:A	Uncertain significance	8/18/11	-	Familial Hypercholesterolemia	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing;curation	germline:9	Integrated Genetics/Laboratory Corporation of America	SCV000052788.1	SCV000052788		LDLR	-	High LDL	1/26/18	46942	21	472	"[0.9949725192791103,0.005027480720889608]"	464	SCV00005278845125	single nucleotide variant	NM_000527.4(LDLR):c.2479G>A (p.Val827Ile)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	2-Nov-17	137853964	-	RCV000030135;RCV000148585;RCV000058923;RCV000436469	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202;MedGen:CN169374"	Familial hypercholesterolemia;Hypercholesterolaemia;not provided;not specified	germline;inherited;not applicable;unknown	germline	GRCh37	NC_000019.9	19	11240278	11240278	G	A	19p13.2	"criteria provided, conflicting interpretations"	16	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_001657,UniProtKB (protein):P01130#VAR_005418"	2	36462	19	11240278	G	A	45125	19:11240278:G:A	Uncertain significance	10/29/15	-	Familial Hypercholesterolemia	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	no assertion criteria provided	clinical testing	germline:na	Integrated Genetics/Laboratory Corporation of America	SCV000052790.2	SCV000052790		LDLR	-	High LDL	11/2/17	46963	0	74	"[0.9992121457317462,7.878542682537317E-4]"	74	SCV00005279029357	single nucleotide variant	NM_005912.2(MC4R):c.105C>A (p.Tyr35Ter)	4160	MC4R	HGNC:6932	Pathogenic	1	14-Aug-18	13447324	-	RCV000015394;RCV000202583;RCV000255005	"Human Phenotype Ontology:HP:0001513,MedGen:C0028754,OMIM:601665,Orphanet:ORPHA71529,SNOMED CT:414916001;Human Phenotype Ontology:HP:0100753,MedGen:C0036341,OMIM:181500,SNOMED CT:58214004;MedGen:CN517202"	Obesity;Schizophrenia;not provided	germline	germline	GRCh37	NC_000018.9	18	58039478	58039478	G	T	18q21.3	"criteria provided, multiple submitters, no conflicts"	8	NA	N	OMIM Allelic Variant:155541.0003	3	14318	18	58039478	G	T	29357	18:58039478:G:T	Pathogenic	8/18/11	-	Early Onset Obesity	C0028754:Obesity	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing;curation	germline:26	Integrated Genetics/Laboratory Corporation of America	SCV000052811.1	SCV000052811		MC4R	-	Obesity	8/14/18	46963	0	6	"[0.9999361199241956,6.388007580435663E-5]"	6	SCV00005281145148	single nucleotide variant	NM_005912.2(MC4R):c.806T>A (p.Ile269Asn)	4160	MC4R	HGNC:6932	Conflicting interpretations of pathogenicity	1	14-Mar-17	79783591	-	RCV000030158;RCV000499660	"Human Phenotype Ontology:HP:0001513,MedGen:C0028754,OMIM:601665,Orphanet:ORPHA71529,SNOMED CT:414916001;MedGen:CN169374"	Obesity;not specified	germline	germline	GRCh37	NC_000018.9	18	58038777	58038777	A	T	18q21.3	"criteria provided, conflicting interpretations"	3	NA	N	-	2	36486	18	58038777	A	T	45148	18:58038777:A:T	Likely pathogenic	8/18/11	-	Early Onset Obesity	C0028754:Obesity	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing;curation	germline:5	Integrated Genetics/Laboratory Corporation of America	SCV000052816.1	SCV000052816		MC4R	-	Obesity	3/14/17	46963	0	241	"[0.997434150288525,0.002565849711474991]"	237	SCV00005281645150	single nucleotide variant	NM_005912.2(MC4R):c.896C>A (p.Pro299His)	4160	MC4R	HGNC:6932	Pathogenic	1	18-Aug-11	52804924	-	RCV000030160	"Human Phenotype Ontology:HP:0001513,MedGen:C0028754,OMIM:601665,Orphanet:ORPHA71529,SNOMED CT:414916001"	Obesity	germline	germline	GRCh37	NC_000018.9	18	58038687	58038687	G	T	18q21.3	"criteria provided, single submitter"	1	NA	N	-	2	36488	18	58038687	G	T	45150	18:58038687:G:T	Pathogenic	8/18/11	-	Early Onset Obesity	C0028754:Obesity	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing;curation	germline:13	Integrated Genetics/Laboratory Corporation of America	SCV000052818.1	SCV000052818		MC4R	-	Obesity	8/18/11	46963	0	3	"[0.9999680599620978,3.194003790217831E-5]"	3	SCV00005281845462	single nucleotide variant	NM_000545.6(HNF1A):c.1424C>T (p.Pro475Leu)	6927	HNF1A	HGNC:11621	Likely pathogenic	1	18-Aug-11	193922580	-	RCV000030481	"MedGen:C1838100,OMIM:600496"	"Maturity-onset diabetes of the young, type 3"	germline	germline	GRCh37	NC_000012.11	12	121435391	121435391	C	T	12q24.31	"criteria provided, single submitter"	1	NA	N	-	2	36801	12	121435391	C	T	45462	12:121435391:C:T	Likely pathogenic	8/18/11	-	MODY3	"C1838100:Maturity-onset diabetes of the young, type 3"	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing;curation	germline:2	Integrated Genetics/Laboratory Corporation of America	SCV000053151.1	SCV000053151		TCF1	-	"MODY, MODY Extended, MonogenicDM_all"	8/18/11	46951	12	2	"[0.9999787011991225,2.1298800877510595E-5]"	2	SCV00005315145472	single nucleotide variant	NM_000545.6(HNF1A):c.1745A>G (p.His582Arg)	6927	HNF1A	HGNC:11621	Likely pathogenic	1	18-Aug-11	193922589	-	RCV000030491	"MedGen:C1838100,OMIM:600496"	"Maturity-onset diabetes of the young, type 3"	germline	germline	GRCh37	NC_000012.11	12	121437407	121437407	A	G	12q24.31	"criteria provided, single submitter"	1	NA	N	-	2	36811	12	121437407	A	G	45472	12:121437407:A:G	Likely pathogenic	8/18/11	-	MODY3	"C1838100:Maturity-onset diabetes of the young, type 3"	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing;curation	germline:2	Integrated Genetics/Laboratory Corporation of America	SCV000053161.1	SCV000053161		TCF1	-	"MODY, MODY Extended, MonogenicDM_all"	8/18/11	46865	98	4	"[0.9999573242291689,4.267577083111064E-5]"	4	SCV00005316145483	single nucleotide variant	NM_000545.6(HNF1A):c.467C>T (p.Thr156Met)	6927	HNF1A	HGNC:11621	Likely pathogenic	1	18-Aug-11	150513055	-	RCV000030503	"MedGen:C1838100,OMIM:600496"	"Maturity-onset diabetes of the young, type 3"	germline	germline	GRCh37	NC_000012.11	12	121426776	121426776	C	T	12q24.31	"criteria provided, single submitter"	1	NA	N	-	2	36822	12	121426776	C	T	45483	12:121426776:C:T	Likely pathogenic	8/18/11	-	MODY3	"C1838100:Maturity-onset diabetes of the young, type 3"	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing;curation	germline:2	Integrated Genetics/Laboratory Corporation of America	SCV000053174.1	SCV000053174		TCF1	-	"MODY, MODY Extended, MonogenicDM_all"	8/18/11	46962	1	7	"[0.9999254716579362,7.452834206379626E-5]"	7	SCV00005317445493	single nucleotide variant	NM_000545.6(HNF1A):c.827C>G (p.Ala276Gly)	6927	HNF1A	HGNC:11621	Likely pathogenic	1	26-Oct-16	137853245	-	RCV000030513;RCV000441328	"MedGen:C1838100,OMIM:600496;MedGen:CN517202"	"Maturity-onset diabetes of the young, type 3;not provided"	germline	germline	GRCh37	NC_000012.11	12	121432080	121432080	C	G	12q24.31	"criteria provided, multiple submitters, no conflicts"	2	NA	N	-	2	36832	12	121432080	C	G	45493	12:121432080:C:G	Likely pathogenic	8/18/11	-	MODY3	"C1838100:Maturity-onset diabetes of the young, type 3"	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing;curation	germline:5	Integrated Genetics/Laboratory Corporation of America	SCV000053184.1	SCV000053184		TCF1	-	"MODY, MODY Extended, MonogenicDM_all"	10/26/16	46946	17	1	"[0.9999893494653431,1.0650534656839773E-5]"	1	SCV00005318445494	single nucleotide variant	NM_000545.6(HNF1A):c.872C>G (p.Pro291Arg)	6927	HNF1A	HGNC:11621	Likely pathogenic	1	18-Aug-11	193922606	-	RCV000030514	"MedGen:C1838100,OMIM:600496"	"Maturity-onset diabetes of the young, type 3"	germline	germline	GRCh37	NC_000012.11	12	121432125	121432125	C	G	12q24.31	"criteria provided, single submitter"	1	NA	N	-	2	36833	12	121432125	C	G	45494	12:121432125:C:G	Likely pathogenic	8/18/11	-	MODY3	"C1838100:Maturity-onset diabetes of the young, type 3"	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing;curation	germline:3	Integrated Genetics/Laboratory Corporation of America	SCV000053185.1	SCV000053185		TCF1	-	"MODY, MODY Extended, MonogenicDM_all"	8/18/11	46829	134	5	"[0.9999466142774777,5.338572252236862E-5]"	5	SCV00005318545498	single nucleotide variant	NM_000458.3(HNF1B):c.1006C>T (p.His336Tyr)	6928	HNF1B	HGNC:11630	Likely pathogenic	1	18-Aug-11	138986885	-	RCV000030518	"MedGen:C0431693,OMIM:137920,SNOMED CT:253864004"	"Familial hypoplastic, glomerulocystic kidney"	germline	germline	GRCh37	NC_000017.10	17	36091625	36091625	G	A	17q12	"criteria provided, single submitter"	1	NA	N	-	2	36837	17	36091625	G	A	45498	17:36091625:G:A	Likely pathogenic	8/18/11	-	MODY5	"C0431693:Familial hypoplastic, glomerulocystic kidney"	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing;curation	germline:2	Integrated Genetics/Laboratory Corporation of America	SCV000053189.1	SCV000053189		TCF2	-	"MODY, MODY Extended, MonogenicDM_all, Neonatal Diabetes"	8/18/11	46962	1	3	"[0.9999680592819726,3.1940718027341254E-5]"	3	SCV00005318945501	single nucleotide variant	NM_000458.3(HNF1B):c.140C>T (p.Pro47Leu)	6928	HNF1B	HGNC:11630	Conflicting interpretations of pathogenicity	1	27-Nov-17	193922483	-	RCV000030521;RCV000730643	"MedGen:C0431693,OMIM:137920,SNOMED CT:253864004;MedGen:CN517202"	"Familial hypoplastic, glomerulocystic kidney;not provided"	germline	germline	GRCh37	NC_000017.10	17	36104736	36104736	G	A	17q12	"criteria provided, conflicting interpretations"	2	NA	N	-	2	36840	17	36104736	G	A	45501	17:36104736:G:A	Likely pathogenic	8/18/11	-	MODY5	"C0431693:Familial hypoplastic, glomerulocystic kidney"	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing;curation	germline:2	Integrated Genetics/Laboratory Corporation of America	SCV000053192.1	SCV000053192		TCF2	-	"MODY, MODY Extended, MonogenicDM_all, Neonatal Diabetes"	11/27/17	46962	1	6	"[0.9999361185639453,6.388143605468251E-5]"	6	SCV00005319245515	single nucleotide variant	NM_000458.3(HNF1B):c.949G>T (p.Ala317Ser)	6928	HNF1B	HGNC:11630	Likely pathogenic	1	18-Aug-11	193922492	-	RCV000030535	"MedGen:C0431693,OMIM:137920,SNOMED CT:253864004"	"Familial hypoplastic, glomerulocystic kidney"	germline	germline	GRCh37	NC_000017.10	17	36091682	36091682	C	A	17q12	"criteria provided, single submitter"	1	NA	N	-	2	36854	17	36091682	C	A	45515	17:36091682:C:A	Likely pathogenic	8/18/11	-	MODY5	"C0431693:Familial hypoplastic, glomerulocystic kidney"	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing;curation	germline:2	Integrated Genetics/Laboratory Corporation of America	SCV000053206.1	SCV000053206		TCF2	-	"MODY, MODY Extended, MonogenicDM_all, Neonatal Diabetes"	8/18/11	46963	0	3	"[0.9999680599620978,3.194003790217831E-5]"	3	SCV00005320657199	single nucleotide variant	NM_005572.3(LMNA):c.1201C>T (p.Arg401Cys)	4000	LMNA	HGNC:6636	Conflicting interpretations of pathogenicity	1	17-May-18	61094188	-	RCV000157295;RCV000528639;RCV000172002;RCV000627127;RCV000057258;RCV000041313	"MedGen:C4053736,OMIM:604772;MedGen:C0270914,Orphanet:ORPHA64746;MedGen:C0410189,Orphanet:ORPHA261,SNOMED CT:111508004;MedGen:C0340427,Orphanet:ORPHA217607;MedGen:CN517202;MedGen:CN169374"	"Catecholaminergic polymorphic ventricular tachycardia type 1;Charcot-Marie-Tooth disease, type 2;Emery-Dreifuss muscular dystrophy;Familial dilated cardiomyopathy;not provided;not specified"	germline;unknown	germline	GRCh37	NC_000001.10	1	156106048	156106048	C	T	1q22	"criteria provided, conflicting interpretations"	8	"ACMG2013,ACMG2016"	N	UniProtKB (protein):P02545#VAR_072818	2	48035	1	156106048	C	T	57199	1:156106048:C:T	Uncertain significance	6/24/13	-	"Muscular dystrophy, Emery Dreifuss"	C0410189:Emery-Dreifuss muscular dystrophy	NA	FALSE	Incorrect phenotype	"criteria provided, single submitter"	research	unknown:1	"Biesecker Lab/Human Development Section,National Institutes of Health"	SCV000054719.2	SCV000054719		LMNA	-	"Lipodystrophy, MonogenicDM_all"	5/17/18	46962	1	6	"[0.9999361185639453,6.388143605468251E-5]"	6	SCV00005471953501	single nucleotide variant	NM_002052.4(GATA4):c.1129A>G (p.Ser377Gly)	2626	GATA4	HGNC:4173	Benign	1	13-Dec-16	3729856	-	RCV000620305;RCV000128527;RCV000037322	MedGen:CN230736;MedGen:CN517202;MedGen:CN169374	Cardiovascular phenotype;not provided;not specified	germline	germline	GRCh37	NC_000008.10	8	11614575	11614575	A	G	8p23.1	"criteria provided, multiple submitters, no conflicts"	3	NA	N	UniProtKB (protein):P43694#VAR_038196	2	44334	8	11614575	A	G	53501	8:11614575:A:G	Benign	12/13/16	"p.Ser377Gly in exon 6 of GATA4: This variant is not expected to have clinical significance because it is not located within the splice consensus sequence. It has been identified in 14% (927/6596) of European chromosomes, including 67 homozygotes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs3729856)."	not specified	CN169374:not specified	No Information	FALSE	No Information	"criteria provided, single submitter"	clinical testing	germline:26	"Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine"	SCV000060979.5	SCV000060979		GATA4	-	"MonogenicDM_all, Neonatal Diabetes"	12/13/16	46919	44	5733	"[0.9389053475138004,0.06109465248619962]"	5145	SCV00006097957199	single nucleotide variant	NM_005572.3(LMNA):c.1201C>T (p.Arg401Cys)	4000	LMNA	HGNC:6636	Conflicting interpretations of pathogenicity	1	17-May-18	61094188	-	RCV000157295;RCV000528639;RCV000172002;RCV000627127;RCV000057258;RCV000041313	"MedGen:C4053736,OMIM:604772;MedGen:C0270914,Orphanet:ORPHA64746;MedGen:C0410189,Orphanet:ORPHA261,SNOMED CT:111508004;MedGen:C0340427,Orphanet:ORPHA217607;MedGen:CN517202;MedGen:CN169374"	"Catecholaminergic polymorphic ventricular tachycardia type 1;Charcot-Marie-Tooth disease, type 2;Emery-Dreifuss muscular dystrophy;Familial dilated cardiomyopathy;not provided;not specified"	germline;unknown	germline	GRCh37	NC_000001.10	1	156106048	156106048	C	T	1q22	"criteria provided, conflicting interpretations"	8	"ACMG2013,ACMG2016"	N	UniProtKB (protein):P02545#VAR_072818	2	48035	1	156106048	C	T	57199	1:156106048:C:T	Uncertain significance	5/23/17	"The p.Arg401Cys variant in LMNA has been reported in 1 individual with Emery Dreifuss muscular dystrophy who carried a second LMNA variant (p.Thr150fs), which was also present in the father who suffered sudden cardiac death. The p.Arg401Cys variant was also identified in the reportedly unaffected mother and sister (Hanisch 2002, Vytopil 2002, Muchir 2004, Emerson 2009). This variant was also identified in 2 individuals with DCM (one with neonatal onset), segregated with disease in 1 affected relative (Chami 2014, LMM data) and has also been reported in ClinVar (Variation ID 48035). It has been identified in 6/34400 of Latino chromosomes and 11/126264 of European chromosomes by the Genome Aggregation Consortium (gnomAD, http://gnomad.broadinstitute.org; dbSNP rs61094188). Computational prediction tools and conservation analysis do not provide strong support for or against an impact to the protein. In summary, the clinical significance of the p.Arg401Cys variant is uncertain."	not specified	CN169374:not specified	Emery-Dreifuss muscular dystrophy and DCM	FALSE	Incorrect phenotype	"criteria provided, single submitter"	clinical testing	germline:5	"Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine"	SCV000065005.5	SCV000065005		LMNA	-	"Lipodystrophy, MonogenicDM_all"	5/17/18	46962	1	6	"[0.9999361185639453,6.388143605468251E-5]"	6	SCV00006500529525	single nucleotide variant	NM_170707.3(LMNA):c.1445G>A (p.Arg482Gln)	4000	LMNA	HGNC:6636	Pathogenic	1	31-Oct-18	11575937	-	RCV000763258;RCV000763258;RCV000459624;RCV000763258;RCV000763258;RCV000763258;RCV000190399;RCV000763258;RCV000015575;RCV000763258;RCV000763258;RCV000763258;RCV000041318;RCV000763258;RCV000763258;RCV000754814;RCV000148600;RCV000057299	"MedGen:C0410190,OMIM:181350,Orphanet:ORPHA98853,SNOMED CT:240072005;MedGen:C1854154,OMIM:605588,Orphanet:ORPHA98856;MedGen:C0270914,Orphanet:ORPHA64746;MedGen:C2750785,OMIM:613205,Orphanet:ORPHA157973;MedGen:C1449563,OMIM:115200,Orphanet:ORPHA300751;MedGen:C0796031,OMIM:212112,Orphanet:ORPHA2229;MedGen:C2750035,OMIM:616516,Orphanet:ORPHA98855;MedGen:C2750035,OMIM:616516,Orphanet:ORPHA98855;MedGen:C1720860,OMIM:151660,Orphanet:ORPHA2348;MedGen:C1720860,OMIM:151660,Orphanet:ORPHA2348;MedGen:C1857829,OMIM:610140,Orphanet:ORPHA168796;MedGen:C0033300,OMIM:176670,Orphanet:ORPHA740,SNOMED CT:238870004;MedGen:CN236383,Orphanet:ORPHA98301;MedGen:C0406585,OMIM:275210,Orphanet:ORPHA1662,SNOMED CT:400128006;MedGen:C0432291,OMIM:248370,Orphanet:ORPHA2457,SNOMED CT:109419009;MedGen:C3888631;MedGen:CN221589;MedGen:CN517202"	"Benign scapuloperoneal muscular dystrophy with cardiomyopathy;Charcot-Marie-Tooth disease type 2B1;Charcot-Marie-Tooth disease, type 2;Congenital muscular dystrophy, LMNA-related;Dilated cardiomyopathy 1A;Dilated cardiomyopathy-hypergonadotropic hypogonadism syndrome;Emery-Dreifuss muscular dystrophy 3, autosomal recessive;Emery-Dreifuss muscular dystrophy 3, autosomal recessive;Familial partial lipodystrophy 2;Familial partial lipodystrophy 2;Heart-hand syndrome, Slovenian type;Hutchinson-Gilford syndrome;Laminopathy;Lethal tight skin contracture syndrome;Mandibuloacral dysostosis;Monogenic diabetes;Partial lipodystrophy, Dunnigan;not provided"	de novo;germline;unknown	germline	GRCh37	NC_000001.10	1	156106776	156106776	G	A	1q22	"criteria provided, multiple submitters, no conflicts"	10	"ACMG2013,ACMG2016"	N	"OMIM Allelic Variant:150330.0010,UniProtKB (protein):P02545#VAR_009992"	3	14486	1	156106776	G	A	29525	1:156106776:G:A	Pathogenic	12/1/17	"The p.Arg482Gln variant in LMNA has been reported in at least 20 individuals with Dunnigan-type familial partial lipodystrophy (FPLD) and segregated with disease in more than 40 affected family members from at least 8 families (Cao 2000, Hegel 2000, Speckman 2000, Vigouroux 2000, Ludtke 2005, Gambineri 2008, Mory 2012, Wiltshire 2013, Lewandowski 2015). Other clinical laboratories have reported this variant in ClinVar (Variation ID 14486). This variant has also been identified in 1/111632 European chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP rs11575937). Please note that for diseases with clinical variability, reduced penetrance, or recessive inheritance, pathogenic variants may be present at a low frequency in the general population. Transgenic mice with the p.Arg482Gln variant of LMNA have a phenotype consistent FPLD (Wojtanik 2009). In summary, this variant meets our criteria to be classified as pathogenic for FPLD in an autosomal dominant manner based on presence in multiple affected individuals, segregation studies, low frequency in the general population and in vivo functional studies. ACMG/AMP Criteria applied: PS4, PP1_strong, PM2, PS3_moderate (Richards 2015)."	Orphanet:ORPHA98301	CN236383:Laminopathy	NA	TRUE	description from lab says lipodystrophy	"criteria provided, single submitter"	clinical testing	germline:13	"Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine"	SCV000065011.5	SCV000065011		LMNA	-	"Lipodystrophy, MonogenicDM_all"	10/31/18	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV00006501157209	single nucleotide variant	NM_170707.3(LMNA):c.1567G>A (p.Gly523Arg)	4000	LMNA	HGNC:6636	Conflicting interpretations of pathogenicity	1	16-Aug-18	201583907	-	RCV000245950;RCV000474372;RCV000678714;RCV000057323;RCV000041324	"MedGen:CN230736;MedGen:C0270914,Orphanet:ORPHA64746;Human Phenotype Ontology:HP:0030682,MedGen:C1960469,Orphanet:ORPHA54260,SNOMED CT:427608000;MedGen:CN517202;MedGen:CN169374"	"Cardiovascular phenotype;Charcot-Marie-Tooth disease, type 2;Left ventricular noncompaction;not provided;not specified"	germline	germline	GRCh37	NC_000001.10	1	156106982	156106982	G	A	1q22	"criteria provided, conflicting interpretations"	7	"ACMG2013,ACMG2016"	N	UniProtKB (protein):P02545#VAR_067258	2	48045	1	156106982	G	A	57209	1:156106982:G:A	Uncertain significance	11/25/14	"The p.Gly523Arg variant in LMNA has been detected in 7/39252 European chromosomes screened by the Broad Institute (http://exac.broadinstitute.org/). It has also been detected in individuals with features commonly caused by LMNA variants. These include 1 individual with DCM (Millat 2009) as well as two siblings presenting with features of COL6A2 related myopathy as well as EDMD (Chapon 2008, conference abstract only). In the family described by Chapon et al, the myopathy present in both sibs was believed to be due recessively inherited Col2A6 variants. The LMNA variant was present in one of the sibs as well as the father, who was clinically normal but showed dystrophic changes as well as mild deficit of collagen 6 fibers. Our laboratory has identified this variant in 1 Caucasian individual with LVNC, conduction system disease and muscle weakness and 2 Caucasian individuals with DCM, both of whom carried an additional, likely pathogenic variant (Pugh 2014). Computational prediction tools and conservation analysis suggest that the p.Gly523Arg variant may impact the protein, though this information is not predictive enough to determine pathogenicity. In summary, the available evidence for this variant is ambiguous and its clinical significance is uncertain."	not specified	CN169374:not specified	"DCM, COL6A2 related myopathy, EDMD"	FALSE	Incorrect phenotype	"criteria provided, single submitter"	clinical testing	germline:12	"Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine"	SCV000065017.5	SCV000065017		LMNA	-	"Lipodystrophy, MonogenicDM_all"	8/16/18	46878	85	4	"[0.9999573360638252,4.2663936174751484E-5]"	4	SCV00006501729556	single nucleotide variant	NM_170707.3(LMNA):c.1718C>T (p.Ser573Leu)	4000	LMNA	HGNC:6636	Conflicting interpretations of pathogenicity	1	21-Dec-17	60890628	-	RCV000617932;RCV000653881;RCV000015612;RCV000015614;RCV000015613;RCV000057351;RCV000041329	"MedGen:CN230736;MedGen:C0270914,Orphanet:ORPHA64746;MedGen:C1449563,OMIM:115200,Orphanet:ORPHA300751;MedGen:C1720860,OMIM:151660,Orphanet:ORPHA2348;MedGen:CN043412;MedGen:CN517202;MedGen:CN169374"	"Cardiovascular phenotype;Charcot-Marie-Tooth disease, type 2;Dilated cardiomyopathy 1A;Familial partial lipodystrophy 2;Mandibuloacral dysplasia with type A lipodystrophy, atypical;not provided;not specified"	germline	germline	GRCh37	NC_000001.10	1	156108298	156108298	C	T	1q22	"criteria provided, conflicting interpretations"	7	"ACMG2013,ACMG2016"	N	"OMIM Allelic Variant:150330.0041,UniProtKB (protein):P02545#VAR_039789"	3	14517	1	156108298	C	T	29556	1:156108298:C:T	Uncertain significance	1/24/17	"Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Classified in Jul 2015 and no new evidence: The p.Ser573Leu variant in LMNA has been reported as homozygous in 1 individual with arthropathy, tendinous calcinosis, and progeroid features (Van Esch 2006) and as heterozygous in 1 individual with LGMD (Benedetti 2007), 1 individual with familial partial lipodystrophy (Lanktree 2007), and 3 individuals with DCM as well as 1 affected family member (Taylor 2003, Pasotti 2008). The p.Ser573Leu variant has also been identified by our laboratory in 1 teenager with infantile DCM and 1 adult with HCM; however, the teenager also carried a likely pathogenic variant in another gene (LMM unpublished data). It has also been identified in 9/57438 European chromosomes by the Exome Aggregation consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs60890628). Computational prediction tools and conservation analysis do not provide strong support for or against an impact to the protein. Although the presence in affected individuals and low frequency in the general population suggests that this variant could play a role in disease, the clinical significance of the p.Ser573Leu variant is classified as uncertain since it is unclear if one variant could result in such a wide spectrum of phenotypes."	not specified	CN169374:not specified	infantile DCM and 1 adult with HCM	FALSE	Incorrect phenotype	"criteria provided, single submitter"	clinical testing	germline:8	"Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine"	SCV000065022.5	SCV000065022		LMNA	-	"Lipodystrophy, MonogenicDM_all"	12/21/17	46812	151	16	"[0.9998291036486371,1.708963513628984E-4]"	16	SCV00006502229566	single nucleotide variant	NM_170707.3(LMNA):c.1930C>T (p.Arg644Cys)	4000	LMNA	HGNC:6636	Conflicting interpretations of pathogenicity	1	21-Nov-18	142000963	-	RCV000245284;RCV000144868;RCV000471403;RCV000755679;RCV000148602;RCV000015626;RCV000057374;RCV000041340	"MedGen:CN230736;MedGen:C0007959,Orphanet:ORPHA166,SNOMED CT:50548001;MedGen:C0270914,Orphanet:ORPHA64746;MedGen:C1449563,OMIM:115200,Orphanet:ORPHA300751;EFO:EFO_0000407,Human Phenotype Ontology:HP:0001644,MedGen:C0007193,Orphanet:ORPHA217604,SNOMED CT:195021004;na;MedGen:CN517202;MedGen:CN169374"	"Cardiovascular phenotype;Charcot-Marie-Tooth disease;Charcot-Marie-Tooth disease, type 2;Dilated cardiomyopathy 1A;Primary dilated cardiomyopathy;Variant of unknown significance;not provided;not specified"	germline;tested-inconclusive;unknown	germline	GRCh37	NC_000001.10	1	156108510	156108510	C	T	1q22	"criteria provided, conflicting interpretations"	13	"ACMG2013,ACMG2016"	N	"OMIM Allelic Variant:150330.0051,UniProtKB (protein):P02545#VAR_039792"	3	14527	1	156108510	C	T	29566	1:156108510:C:T	Likely benign	8/6/17	"The p.Arg644Cys variant in LMNA has been detected by our laboratory in 7 individuals with cardiomyopathy (2 with DCM, 1 with LVNC, 2 with HCM, 1 with an unspecified cardiomyopathy, and 1 with VFib and a T-wave inversion). Four of these patients had a very early age at onset (range birth to 7 years) and no family history, which is atypical for LMNA variants. The p.Arg644Cys variant has also been identified in a large number of individuals (>20) with a diverse range of clinical features consistent with laminopathy, isolated cardiomyopathy (DCM, ARVC, HCM) or Hallermann-Streiff syndrome, a rare genetic disorder with clinical overlap with some laminopathies (Speckman 2000, Genschel 2001, Csoka 2004, Mercuri 2005, Muntoni 2006, Rankin 2008, Pasotti 2008, Perrot 2009, MÃ¸ller 2009, Larsen 2011, Kortum 2011, Scharner 2011, Quarta 2012, Vasli 2012, Hoyer 2014). In addition, one study reported non-segregation with disease in 2 families (Mercuri 2005). This variant has also been identified in 0.2% (106/63724) of European chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; rs142000963) and in gnomAD at 0.2% (242 alleles). Computational prediction tools and conservation analyses do not provide strong support for or against an impact to the protein; however, in vitro functional studies indicate the variant may affect nuclear morphology (Csoka 2004). In summary, the lack of segregation with disease, its population frequency, and the wide-spectrum of observed phenotypes reduces the likelihood that the p.Arg644Cys variant can cause disease when present in isolation."	not specified	CN169374:not specified	"2 with DCM, 1 with LVNC, 2 with HCM, 1 with an unspecified cardiomyopathy, and 1 with VFib and a T-wave inversion"	FALSE	Incorrect phenotype	"criteria provided, single submitter"	clinical testing	germline:20	"Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine"	SCV000065033.5	SCV000065033		LMNA	-	"Lipodystrophy, MonogenicDM_all"	11/21/18	46954	9	67	"[0.9992865357584019,7.134642415981599E-4]"	65	SCV00006503357227	single nucleotide variant	NM_170707.3(LMNA):c.350A>G (p.Lys117Arg)	4000	LMNA	HGNC:6636	Conflicting interpretations of pathogenicity	1	15-Jun-18	397517901	-	RCV000653882;RCV000324940;RCV000041346	"MedGen:C0270914,Orphanet:ORPHA64746;MedGen:CN517202;MedGen:CN169374"	"Charcot-Marie-Tooth disease, type 2;not provided;not specified"	germline	germline	GRCh37	NC_000001.10	1	156085059	156085059	A	G	1q22	"criteria provided, conflicting interpretations"	3	"ACMG2013,ACMG2016"	N	-	2	48063	1	156085059	A	G	57227	1:156085059:A:G	Uncertain significance	3/27/17	"The p.Lys117Arg variant in LMNA has been previously reported in 1 individual with DCM, 1 individual with LVNC, and in 2 individuals with unspecified cardiomyopathy and was found to segregate with disease in 2 affected family members with LVNC from 1 family (Botto 2011, Rijsingen 2013, Fontana 2013). This variant was also identified in the homozygous state in 1 individual with DCM and an arthrogryposis presentation (Bayram 2016). This variant has also been identified by our laboratory in 1 Caucasian adult with DCM who carried another pathogenic LMNA variant and in a Hispanic child with DCM and LVNC. It has been identified in 4/13594 South Asian chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org/; dbSNP rs397517901). Computational prediction tools and conservation analysis do not provide strong support for or against an impact to the protein. In summary, in the presence of conflicting data, the clinical significance of the p.Lys117Arg variant is uncertain."	not specified	CN169374:not specified	"DCM,  LVNC, unspecified cardiomyopathy"	FALSE	Incorrect phenotype	"criteria provided, single submitter"	clinical testing	germline:6	"Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine"	SCV000065039.5	SCV000065039		LMNA	-	"Lipodystrophy, MonogenicDM_all"	6/15/18	46729	234	3	"[0.99996790001926,3.2099980740011554E-5]"	3	SCV00006503957261	single nucleotide variant	NM_170707.3(LMNA):c.976T>A (p.Ser326Thr)	4000	LMNA	HGNC:6636	Conflicting interpretations of pathogenicity	1	21-Nov-18	56851164	-	RCV000621488;RCV000544253;RCV000755678;RCV000208012;RCV000057494;RCV000212504	"MedGen:CN230736;MedGen:C0270914,Orphanet:ORPHA64746;MedGen:C1449563,OMIM:115200,Orphanet:ORPHA300751;MedGen:C0949658,Orphanet:ORPHA155,SNOMED CT:83978005;MedGen:CN517202;MedGen:CN169374"	"Cardiovascular phenotype;Charcot-Marie-Tooth disease, type 2;Dilated cardiomyopathy 1A;Primary familial hypertrophic cardiomyopathy;not provided;not specified"	germline;unknown	germline	GRCh37	NC_000001.10	1	156105731	156105731	T	A	1q22	"criteria provided, conflicting interpretations"	8	"ACMG2013,ACMG2016"	N	-	2	48097	1	156105731	T	A	57261	1:156105731:T:A	Uncertain significance	2/16/17	"Variant classified as Uncertain Significance - Favor Pathogenic. The Ser326Thr variant in LMNA has been reported in 5 individuals with a range of cardio-muscular manifestations (Muntoni 2006, Meune 2006). This variant has been identified in 7/64452 European chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs56851164). Muntoni 2006 report 2 individuals with DCM and conduction system disease (CSD) and 1 with late-onset scapular myopathy and CSD though no details are provided. This study also reported 1 family with X-linked EDMD and a pathogenic EMD variant that segregated with disease. One family member had a more severe/early onset presentation (including EDMD, CSD and DCM) and had the LMNA Ser326Thr (de novo) in addition to the EMD variant. The LMNA variant may explain the more severe disease in this individual but the available data are insufficient to conclusively establish whether it can cause disease on is own. Additional data call a role in disease into question: In vitro functional studies provide some evidence that the p.Ser326Thr variant may not impact protein function (Gangemi 2013). However, these types of assays may not accurately represent biological function. In addition, serine (Ser) at position 326 is not conserved in evolution with 6 species carrying a threonine (Thr), suggesting that this change may be tolerated. In summary, while there is some suspicion for a pathogenic role, the clinical significance of the p.Ser326Thr variant is uncertain."	not specified	CN169374:not specified	cardio-muscular manifestations	FALSE	Incorrect phenotype	"criteria provided, single submitter"	clinical testing	germline:5	"Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine"	SCV000065076.5	SCV000065076		LMNA	-	"Lipodystrophy, MonogenicDM_all"	11/21/18	46959	4	3	"[0.9999680572414233,3.1942758576630676E-5]"	3	SCV00006507657262	single nucleotide variant	NM_170707.3(LMNA):c.992G>A (p.Arg331Gln)	4000	LMNA	HGNC:6636	Conflicting interpretations of pathogenicity	1	28-Jul-17	59301204	-	RCV000182367;RCV000593819	MedGen:CN517202;MedGen:CN169374	not provided;not specified	germline	germline	GRCh37	NC_000001.10	1	156105747	156105747	G	A	1q22	"criteria provided, conflicting interpretations"	3	"ACMG2013,ACMG2016"	N	-	2	48098	1	156105747	G	A	57262	1:156105747:G:A	Uncertain significance	7/7/17	"The p.Arg331Gln variant in LMNA has been reported in 1 individual with Limb-Girdle Muscular Dystrophy and 6 individuals with dilated cardiomyopathy (Benedetti 2007, Moller 2009, van Spaendonck-Zwarts 2013, Hazebroek 2015, Pugh 2014, GeneDx case referenced in ClinVar SCV000234690.8 ). However, in at least 2 of these individuals, a distinct LMNA pathogenic variant was sufficient to explain disease (p.Arg541Cys in Pugh 2014 and Arg627Cys in Hazebroek 2015). It has been identified in 1/16488 South Asian and 1/64850 European chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs59301204). Computational prediction tools and conservation analysis do not provide strong support for or against an impact to the protein. In summary, the clinical significance of the p.Arg331Gln variant is uncertain."	not specified	CN169374:not specified	Limb-Girdle Muscular Dystrophy and dilated cardiomyopathy	FALSE	Incorrect phenotype	"criteria provided, single submitter"	clinical testing	germline:4	"Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine"	SCV000065077.5	SCV000065077		LMNA	-	"Lipodystrophy, MonogenicDM_all"	7/28/17	46951	12	1	"[0.9999893505995613,1.0649400438755298E-5]"	1	SCV00006507776489	single nucleotide variant	NM_000207.2(INS):c.*59A>G	3630	INS	HGNC:6081	Pathogenic	1	5-Jul-11	397515519	-	RCV000055785	"MedGen:C1833104,OMIM:606176,Orphanet:ORPHA99885"	Permanent neonatal diabetes mellitus	not provided	not provided	GRCh37	NC_000011.9	11	2181023	2181023	T	C	11p15.5	no assertion criteria provided	1	NA	N	-	1	65581	11	2181023	T	C	76489	11:2181023:T:C	Pathogenic	7/5/11	-	Permanent Neonatal Diabetes Mellitus	C1833104:Permanent neonatal diabetes mellitus	NA	TRUE	NA	no assertion criteria provided	curation	not provided:na	GeneReviews	SCV000086751.1	SCV000086751		-	-	"MODY Extended, MonogenicDM_all, Neonatal Diabetes"	7/5/11	46566	397	1	"[0.9999892625520767,1.0737447923377572E-5]"	1	SCV00008675129537	single nucleotide variant	NM_170707.3(LMNA):c.892C>T (p.Arg298Cys)	4000	LMNA	HGNC:6636	Pathogenic	1	8-Jun-18	59885338	-	RCV000192238;RCV000015590;RCV000653885;RCV000057479	"MedGen:C0007959,Orphanet:ORPHA166,SNOMED CT:50548001;MedGen:C1854154,OMIM:605588,Orphanet:ORPHA98856;MedGen:C0270914,Orphanet:ORPHA64746;MedGen:CN517202"	"Charcot-Marie-Tooth disease;Charcot-Marie-Tooth disease type 2B1;Charcot-Marie-Tooth disease, type 2;not provided"	germline	germline	GRCh37	NC_000001.10	1	156105059	156105059	C	T	1q22	"criteria provided, multiple submitters, no conflicts"	5	"ACMG2013,ACMG2016"	N	"OMIM Allelic Variant:150330.0020,UniProtKB (protein):P02545#VAR_017661"	3	14498	1	156105059	C	T	29537	1:156105059:C:T	Pathogenic	7/5/12	-	Charcot-Marie-Tooth Neuropathy Type 2	C1854154:Charcot-Marie-Tooth disease type 2B1	NA	FALSE	Incorrect phenotype	no assertion criteria provided	curation	not provided:na	GeneReviews	SCV000087058.1	SCV000087058		-	-	"Lipodystrophy, MonogenicDM_all"	6/8/18	46953	10	2	"[0.9999787021063616,2.129789363831917E-5]"	2	SCV00008705829524	single nucleotide variant	NM_005572.3(LMNA):c.1711C>A (p.Arg571Ser)	4000	LMNA	HGNC:6636	Uncertain significance	1	1-Feb-18	80338938	-	RCV000705473;RCV000015574;RCV000057044	"MedGen:C0270914,Orphanet:ORPHA64746;MedGen:C1449563,OMIM:115200,Orphanet:ORPHA300751;MedGen:CN517202"	"Charcot-Marie-Tooth disease, type 2;Dilated cardiomyopathy 1A;not provided"	germline	germline	GRCh37	NC_000001.10	1	156107547	156107547	C	A	1q22	"criteria provided, single submitter"	4	"ACMG2013,ACMG2016"	N	OMIM Allelic Variant:150330.0009	3	14485	1	156107547	C	A	29524	1:156107547:C:A	not provided	NA	-	not provided	CN517202:not provided	No Information	FALSE	No Information	no assertion provided	literature only	not provided:na	"Epithelial Biology; Institute of Medical Biology, Singapore"	SCV000088157.1	SCV000088157		-	-	"Lipodystrophy, MonogenicDM_all"	2/1/18	37533	9430	2	"[0.9999733567793675,2.6643220632510057E-5]"	2	SCV00008815729558	single nucleotide variant	NM_170707.3(LMNA):c.1195C>T (p.Arg399Cys)	4000	LMNA	HGNC:6636	Uncertain significance	1	15-Nov-17	58672172	-	RCV000653937;RCV000015616;RCV000057255;RCV000212505	"MedGen:C0270914,Orphanet:ORPHA64746;MedGen:C1720860,OMIM:151660,Orphanet:ORPHA2348;MedGen:CN517202;MedGen:CN169374"	"Charcot-Marie-Tooth disease, type 2;Familial partial lipodystrophy 2;not provided;not specified"	germline	germline	GRCh37	NC_000001.10	1	156106042	156106042	C	T	1q22	"criteria provided, multiple submitters, no conflicts"	4	"ACMG2013,ACMG2016"	N	"OMIM Allelic Variant:150330.0043,UniProtKB (protein):P02545#VAR_039778"	3	14519	1	156106042	C	T	29558	1:156106042:C:T	not provided	NA	-	not provided	CN517202:not provided	No Information	FALSE	No Information	no assertion provided	literature only	not provided:na	"Epithelial Biology; Institute of Medical Biology, Singapore"	SCV000088368.1	SCV000088368		-	-	"Lipodystrophy, MonogenicDM_all"	11/15/17	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV00008836857199	single nucleotide variant	NM_005572.3(LMNA):c.1201C>T (p.Arg401Cys)	4000	LMNA	HGNC:6636	Conflicting interpretations of pathogenicity	1	17-May-18	61094188	-	RCV000157295;RCV000528639;RCV000172002;RCV000627127;RCV000057258;RCV000041313	"MedGen:C4053736,OMIM:604772;MedGen:C0270914,Orphanet:ORPHA64746;MedGen:C0410189,Orphanet:ORPHA261,SNOMED CT:111508004;MedGen:C0340427,Orphanet:ORPHA217607;MedGen:CN517202;MedGen:CN169374"	"Catecholaminergic polymorphic ventricular tachycardia type 1;Charcot-Marie-Tooth disease, type 2;Emery-Dreifuss muscular dystrophy;Familial dilated cardiomyopathy;not provided;not specified"	germline;unknown	germline	GRCh37	NC_000001.10	1	156106048	156106048	C	T	1q22	"criteria provided, conflicting interpretations"	8	"ACMG2013,ACMG2016"	N	UniProtKB (protein):P02545#VAR_072818	2	48035	1	156106048	C	T	57199	1:156106048:C:T	not provided	NA	-	not provided	CN517202:not provided	No Information	FALSE	No Information	no assertion provided	literature only	not provided:na	"Epithelial Biology; Institute of Medical Biology, Singapore"	SCV000088371.1	SCV000088371		-	-	"Lipodystrophy, MonogenicDM_all"	5/17/18	46962	1	6	"[0.9999361185639453,6.388143605468251E-5]"	6	SCV00008837177699	single nucleotide variant	NM_170707.3(LMNA):c.1303C>T (p.Arg435Cys)	4000	LMNA	HGNC:6636	Conflicting interpretations of pathogenicity	1	12-Nov-17	150840924	-	RCV000653929;RCV000150953;RCV000148606;RCV000057265	"MedGen:C0270914,Orphanet:ORPHA64746;MedGen:C0033300,OMIM:176670,Orphanet:ORPHA740,SNOMED CT:238870004;EFO:EFO_0000407,Human Phenotype Ontology:HP:0001644,MedGen:C0007193,Orphanet:ORPHA217604,SNOMED CT:195021004;MedGen:CN517202"	"Charcot-Marie-Tooth disease, type 2;Hutchinson-Gilford syndrome;Primary dilated cardiomyopathy;not provided"	germline	germline	GRCh37	NC_000001.10	1	156106150	156106150	C	T	1q22	"criteria provided, conflicting interpretations"	5	"ACMG2013,ACMG2016"	N	UniProtKB (protein):P02545#VAR_039779	3	66802	1	156106150	C	T	77699	1:156106150:C:T	not provided	NA	-	not provided	CN517202:not provided	No Information	FALSE	No Information	no assertion provided	literature only	not provided:na	"Epithelial Biology; Institute of Medical Biology, Singapore"	SCV000088378.1	SCV000088378		-	-	"Lipodystrophy, MonogenicDM_all"	11/12/17	46956	7	1	"[0.9999893517335378,1.064826646221995E-5]"	1	SCV00008837829525	single nucleotide variant	NM_170707.3(LMNA):c.1445G>A (p.Arg482Gln)	4000	LMNA	HGNC:6636	Pathogenic	1	31-Oct-18	11575937	-	RCV000763258;RCV000763258;RCV000459624;RCV000763258;RCV000763258;RCV000763258;RCV000190399;RCV000763258;RCV000015575;RCV000763258;RCV000763258;RCV000763258;RCV000041318;RCV000763258;RCV000763258;RCV000754814;RCV000148600;RCV000057299	"MedGen:C0410190,OMIM:181350,Orphanet:ORPHA98853,SNOMED CT:240072005;MedGen:C1854154,OMIM:605588,Orphanet:ORPHA98856;MedGen:C0270914,Orphanet:ORPHA64746;MedGen:C2750785,OMIM:613205,Orphanet:ORPHA157973;MedGen:C1449563,OMIM:115200,Orphanet:ORPHA300751;MedGen:C0796031,OMIM:212112,Orphanet:ORPHA2229;MedGen:C2750035,OMIM:616516,Orphanet:ORPHA98855;MedGen:C2750035,OMIM:616516,Orphanet:ORPHA98855;MedGen:C1720860,OMIM:151660,Orphanet:ORPHA2348;MedGen:C1720860,OMIM:151660,Orphanet:ORPHA2348;MedGen:C1857829,OMIM:610140,Orphanet:ORPHA168796;MedGen:C0033300,OMIM:176670,Orphanet:ORPHA740,SNOMED CT:238870004;MedGen:CN236383,Orphanet:ORPHA98301;MedGen:C0406585,OMIM:275210,Orphanet:ORPHA1662,SNOMED CT:400128006;MedGen:C0432291,OMIM:248370,Orphanet:ORPHA2457,SNOMED CT:109419009;MedGen:C3888631;MedGen:CN221589;MedGen:CN517202"	"Benign scapuloperoneal muscular dystrophy with cardiomyopathy;Charcot-Marie-Tooth disease type 2B1;Charcot-Marie-Tooth disease, type 2;Congenital muscular dystrophy, LMNA-related;Dilated cardiomyopathy 1A;Dilated cardiomyopathy-hypergonadotropic hypogonadism syndrome;Emery-Dreifuss muscular dystrophy 3, autosomal recessive;Emery-Dreifuss muscular dystrophy 3, autosomal recessive;Familial partial lipodystrophy 2;Familial partial lipodystrophy 2;Heart-hand syndrome, Slovenian type;Hutchinson-Gilford syndrome;Laminopathy;Lethal tight skin contracture syndrome;Mandibuloacral dysostosis;Monogenic diabetes;Partial lipodystrophy, Dunnigan;not provided"	de novo;germline;unknown	germline	GRCh37	NC_000001.10	1	156106776	156106776	G	A	1q22	"criteria provided, multiple submitters, no conflicts"	10	"ACMG2013,ACMG2016"	N	"OMIM Allelic Variant:150330.0010,UniProtKB (protein):P02545#VAR_009992"	3	14486	1	156106776	G	A	29525	1:156106776:G:A	not provided	NA	-	not provided	CN517202:not provided	No Information	FALSE	No Information	no assertion provided	literature only	not provided:na	"Epithelial Biology; Institute of Medical Biology, Singapore"	SCV000088412.1	SCV000088412		-	-	"Lipodystrophy, MonogenicDM_all"	10/31/18	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV00008841257209	single nucleotide variant	NM_170707.3(LMNA):c.1567G>A (p.Gly523Arg)	4000	LMNA	HGNC:6636	Conflicting interpretations of pathogenicity	1	16-Aug-18	201583907	-	RCV000245950;RCV000474372;RCV000678714;RCV000057323;RCV000041324	"MedGen:CN230736;MedGen:C0270914,Orphanet:ORPHA64746;Human Phenotype Ontology:HP:0030682,MedGen:C1960469,Orphanet:ORPHA54260,SNOMED CT:427608000;MedGen:CN517202;MedGen:CN169374"	"Cardiovascular phenotype;Charcot-Marie-Tooth disease, type 2;Left ventricular noncompaction;not provided;not specified"	germline	germline	GRCh37	NC_000001.10	1	156106982	156106982	G	A	1q22	"criteria provided, conflicting interpretations"	7	"ACMG2013,ACMG2016"	N	UniProtKB (protein):P02545#VAR_067258	2	48045	1	156106982	G	A	57209	1:156106982:G:A	not provided	NA	-	not provided	CN517202:not provided	No Information	FALSE	No Information	no assertion provided	literature only	not provided:na	"Epithelial Biology; Institute of Medical Biology, Singapore"	SCV000088436.1	SCV000088436		-	-	"Lipodystrophy, MonogenicDM_all"	8/16/18	46878	85	4	"[0.9999573360638252,4.2663936174751484E-5]"	4	SCV00008843629526	single nucleotide variant	NM_170707.3(LMNA):c.1579C>T (p.Arg527Cys)	4000	LMNA	HGNC:6636	Pathogenic	1	16-Nov-15	57318642	-	RCV000192240;RCV000192011;RCV000015576;RCV000057324	"MedGen:C0007959,Orphanet:ORPHA166,SNOMED CT:50548001;MedGen:C0033300,OMIM:176670,Orphanet:ORPHA740,SNOMED CT:238870004;MedGen:C0432291,OMIM:248370,Orphanet:ORPHA2457,SNOMED CT:109419009;MedGen:CN517202"	Charcot-Marie-Tooth disease;Hutchinson-Gilford syndrome;Mandibuloacral dysostosis;not provided	germline	germline	GRCh37	NC_000001.10	1	156106994	156106994	C	T	1q22	"criteria provided, single submitter"	4	"ACMG2013,ACMG2016"	N	"OMIM Allelic Variant:150330.0026,UniProtKB (protein):P02545#VAR_017663"	3	14487	1	156106994	C	T	29526	1:156106994:C:T	not provided	NA	-	not provided	CN517202:not provided	No Information	FALSE	No Information	no assertion provided	literature only	not provided:na	"Epithelial Biology; Institute of Medical Biology, Singapore"	SCV000088437.1	SCV000088437		-	-	"Lipodystrophy, MonogenicDM_all"	11/16/15	46874	89	3	"[0.9999679993173187,3.2000682681230535E-5]"	3	SCV00008843729538	single nucleotide variant	NM_170707.3(LMNA):c.1580G>A (p.Arg527His)	4000	LMNA	HGNC:6636	Pathogenic	1	2-Jul-18	57520892	-	RCV000555364;RCV000015591;RCV000148607;RCV000015592;RCV000057326	"MedGen:C0270914,Orphanet:ORPHA64746;MedGen:C0432291,OMIM:248370,Orphanet:ORPHA2457,SNOMED CT:109419009;MedGen:CN118835;MedGen:CN043412;MedGen:CN517202"	"Charcot-Marie-Tooth disease, type 2;Mandibuloacral dysostosis;Mandibuloacral dysplasia;Mandibuloacral dysplasia with type A lipodystrophy, atypical;not provided"	germline	germline	GRCh37	NC_000001.10	1	156106995	156106995	G	A	1q22	"criteria provided, multiple submitters, no conflicts"	6	"ACMG2013,ACMG2016"	N	"OMIM Allelic Variant:150330.0021,UniProtKB (protein):P02545#VAR_018727"	3	14499	1	156106995	G	A	29538	1:156106995:G:A	not provided	NA	-	not provided	CN517202:not provided	No Information	FALSE	No Information	no assertion provided	literature only	not provided:na	"Epithelial Biology; Institute of Medical Biology, Singapore"	SCV000088439.1	SCV000088439		-	-	"Lipodystrophy, MonogenicDM_all"	7/2/18	46868	95	8	"[0.9999146539216524,8.534607834769993E-5]"	8	SCV00008843929556	single nucleotide variant	NM_170707.3(LMNA):c.1718C>T (p.Ser573Leu)	4000	LMNA	HGNC:6636	Conflicting interpretations of pathogenicity	1	21-Dec-17	60890628	-	RCV000617932;RCV000653881;RCV000015612;RCV000015614;RCV000015613;RCV000057351;RCV000041329	"MedGen:CN230736;MedGen:C0270914,Orphanet:ORPHA64746;MedGen:C1449563,OMIM:115200,Orphanet:ORPHA300751;MedGen:C1720860,OMIM:151660,Orphanet:ORPHA2348;MedGen:CN043412;MedGen:CN517202;MedGen:CN169374"	"Cardiovascular phenotype;Charcot-Marie-Tooth disease, type 2;Dilated cardiomyopathy 1A;Familial partial lipodystrophy 2;Mandibuloacral dysplasia with type A lipodystrophy, atypical;not provided;not specified"	germline	germline	GRCh37	NC_000001.10	1	156108298	156108298	C	T	1q22	"criteria provided, conflicting interpretations"	7	"ACMG2013,ACMG2016"	N	"OMIM Allelic Variant:150330.0041,UniProtKB (protein):P02545#VAR_039789"	3	14517	1	156108298	C	T	29556	1:156108298:C:T	not provided	NA	-	not provided	CN517202:not provided	No Information	FALSE	No Information	no assertion provided	literature only	not provided:na	"Epithelial Biology; Institute of Medical Biology, Singapore"	SCV000088464.1	SCV000088464		-	-	"Lipodystrophy, MonogenicDM_all"	12/21/17	46812	151	16	"[0.9998291036486371,1.708963513628984E-4]"	16	SCV00008846429533	single nucleotide variant	NM_170707.3(LMNA):c.1745G>A (p.Arg582His)	4000	LMNA	HGNC:6636	Pathogenic	1	1-Jan-01	57830985	-	RCV000015585;RCV000057353	"MedGen:C1720860,OMIM:151660,Orphanet:ORPHA2348;MedGen:CN517202"	Familial partial lipodystrophy 2;not provided	germline	germline	GRCh37	NC_000001.10	1	156108325	156108325	G	A	1q22	no assertion criteria provided	2	"ACMG2013,ACMG2016"	N	"OMIM Allelic Variant:150330.0016,UniProtKB (protein):P02545#VAR_009998"	3	14494	1	156108325	G	A	29533	1:156108325:G:A	not provided	NA	-	not provided	CN517202:not provided	No Information	FALSE	No Information	no assertion provided	literature only	not provided:na	"Epithelial Biology; Institute of Medical Biology, Singapore"	SCV000088466.1	SCV000088466		-	-	"Lipodystrophy, MonogenicDM_all"	1/1/01	46899	64	1	"[0.9999893387918719,1.0661208128105077E-5]"	1	SCV00008846677772	single nucleotide variant	NM_170707.3(LMNA):c.1908C>T (p.Ser636=)	4000	LMNA	HGNC:6636	Pathogenic	1	30-Apr-15	80356814	-	RCV000192236;RCV000057372	"MedGen:C0007959,Orphanet:ORPHA166,SNOMED CT:50548001;MedGen:CN517202"	Charcot-Marie-Tooth disease;not provided	germline	germline	GRCh37	NC_000001.10	1	156108488	156108488	C	T	1q22	no assertion criteria provided	2	"ACMG2013,ACMG2016"	N	-	3	66875	1	156108488	C	T	77772	1:156108488:C:T	not provided	NA	-	not provided	CN517202:not provided	No Information	FALSE	No Information	no assertion provided	literature only	not provided:na	"Epithelial Biology; Institute of Medical Biology, Singapore"	SCV000088485.1	SCV000088485		-	-	"Lipodystrophy, MonogenicDM_all"	4/30/15	46948	15	2	"[0.9999786998381188,2.1300161881230296E-5]"	2	SCV00008848529566	single nucleotide variant	NM_170707.3(LMNA):c.1930C>T (p.Arg644Cys)	4000	LMNA	HGNC:6636	Conflicting interpretations of pathogenicity	1	21-Nov-18	142000963	-	RCV000245284;RCV000144868;RCV000471403;RCV000755679;RCV000148602;RCV000015626;RCV000057374;RCV000041340	"MedGen:CN230736;MedGen:C0007959,Orphanet:ORPHA166,SNOMED CT:50548001;MedGen:C0270914,Orphanet:ORPHA64746;MedGen:C1449563,OMIM:115200,Orphanet:ORPHA300751;EFO:EFO_0000407,Human Phenotype Ontology:HP:0001644,MedGen:C0007193,Orphanet:ORPHA217604,SNOMED CT:195021004;na;MedGen:CN517202;MedGen:CN169374"	"Cardiovascular phenotype;Charcot-Marie-Tooth disease;Charcot-Marie-Tooth disease, type 2;Dilated cardiomyopathy 1A;Primary dilated cardiomyopathy;Variant of unknown significance;not provided;not specified"	germline;tested-inconclusive;unknown	germline	GRCh37	NC_000001.10	1	156108510	156108510	C	T	1q22	"criteria provided, conflicting interpretations"	13	"ACMG2013,ACMG2016"	N	"OMIM Allelic Variant:150330.0051,UniProtKB (protein):P02545#VAR_039792"	3	14527	1	156108510	C	T	29566	1:156108510:C:T	not provided	NA	-	not provided	CN517202:not provided	No Information	FALSE	No Information	no assertion provided	literature only	not provided:na	"Epithelial Biology; Institute of Medical Biology, Singapore"	SCV000088487.1	SCV000088487		-	-	"Lipodystrophy, MonogenicDM_all"	11/21/18	46954	9	67	"[0.9992865357584019,7.134642415981599E-4]"	65	SCV00008848729537	single nucleotide variant	NM_170707.3(LMNA):c.892C>T (p.Arg298Cys)	4000	LMNA	HGNC:6636	Pathogenic	1	8-Jun-18	59885338	-	RCV000192238;RCV000015590;RCV000653885;RCV000057479	"MedGen:C0007959,Orphanet:ORPHA166,SNOMED CT:50548001;MedGen:C1854154,OMIM:605588,Orphanet:ORPHA98856;MedGen:C0270914,Orphanet:ORPHA64746;MedGen:CN517202"	"Charcot-Marie-Tooth disease;Charcot-Marie-Tooth disease type 2B1;Charcot-Marie-Tooth disease, type 2;not provided"	germline	germline	GRCh37	NC_000001.10	1	156105059	156105059	C	T	1q22	"criteria provided, multiple submitters, no conflicts"	5	"ACMG2013,ACMG2016"	N	"OMIM Allelic Variant:150330.0020,UniProtKB (protein):P02545#VAR_017661"	3	14498	1	156105059	C	T	29537	1:156105059:C:T	not provided	NA	-	not provided	CN517202:not provided	No Information	FALSE	No Information	no assertion provided	literature only	not provided:na	"Epithelial Biology; Institute of Medical Biology, Singapore"	SCV000088593.1	SCV000088593		-	-	"Lipodystrophy, MonogenicDM_all"	6/8/18	46953	10	2	"[0.9999787021063616,2.129789363831917E-5]"	2	SCV00008859357261	single nucleotide variant	NM_170707.3(LMNA):c.976T>A (p.Ser326Thr)	4000	LMNA	HGNC:6636	Conflicting interpretations of pathogenicity	1	21-Nov-18	56851164	-	RCV000621488;RCV000544253;RCV000755678;RCV000208012;RCV000057494;RCV000212504	"MedGen:CN230736;MedGen:C0270914,Orphanet:ORPHA64746;MedGen:C1449563,OMIM:115200,Orphanet:ORPHA300751;MedGen:C0949658,Orphanet:ORPHA155,SNOMED CT:83978005;MedGen:CN517202;MedGen:CN169374"	"Cardiovascular phenotype;Charcot-Marie-Tooth disease, type 2;Dilated cardiomyopathy 1A;Primary familial hypertrophic cardiomyopathy;not provided;not specified"	germline;unknown	germline	GRCh37	NC_000001.10	1	156105731	156105731	T	A	1q22	"criteria provided, conflicting interpretations"	8	"ACMG2013,ACMG2016"	N	-	2	48097	1	156105731	T	A	57261	1:156105731:T:A	not provided	NA	-	not provided	CN517202:not provided	No Information	FALSE	No Information	no assertion provided	literature only	not provided:na	"Epithelial Biology; Institute of Medical Biology, Singapore"	SCV000088608.1	SCV000088608		-	-	"Lipodystrophy, MonogenicDM_all"	11/21/18	46959	4	3	"[0.9999680572414233,3.1942758576630676E-5]"	3	SCV00008860828429	single nucleotide variant	NM_000207.2(INS):c.16C>T (p.Arg6Cys)	3630	INS	HGNC:6081	Pathogenic	1	1-Apr-08	121908278	-	RCV000014322	"MedGen:C3150617,OMIM:613370"	"Maturity-onset diabetes of the young, type 10"	germline	germline	GRCh37	NC_000011.9	11	2182186	2182186	G	A	11p15.5	no assertion criteria provided	2	NA	N	"OMIM Allelic Variant:176730.0014,UniProtKB (protein):P01308#VAR_063721,UniProtKB (variants):VAR_063721"	1	13390	11	2182186	G	A	28429	11:2182186:G:A	not provided	NA	-	"Maturity-onset diabetes of the young, type 10"	"C3150617:Maturity-onset diabetes of the young, type 10"	NA	TRUE	NA	no assertion provided	literature only	not provided:na	UniProtKB/Swiss-Prot	SCV000091154.1	SCV000091154		-	-	"MODY Extended, MonogenicDM_all, Neonatal Diabetes"	4/1/08	46941	22	1	"[0.9999893483308835,1.0651669116550563E-5]"	1	SCV00009115429966	duplication	NM_000545.6(HNF1A):c.872dupC (p.Gly292Argfs)	6927	HNF1A	HGNC:11621	Pathogenic	1	6-Nov-17	587776825	-	RCV000016063;RCV000117225;RCV000016064;RCV000022617;RCV000016062;RCV000490055	"Human Phenotype Ontology:HP:0006770,MedGen:C0279702,Orphanet:ORPHA319276,SNOMED CT:188251003,SNOMED CT:254915003;MedGen:C0011854,OMIM:222100,Orphanet:ORPHA181371,SNOMED CT:46635009;MedGen:C2675866,OMIM:612520;MedGen:C1840646,OMIM:142330;MedGen:C1838100,OMIM:600496;MedGen:CN517202"	"Clear cell carcinoma of kidney;Diabetes mellitus type 1;Diabetes mellitus, insulin-dependent, 20;Hepatic adenomas, familial;Maturity-onset diabetes of the young, type 3;not provided"	germline;somatic	germline/somatic	GRCh37	NC_000012.11	12	121432125	121432125	C	CC	12q24.31	"criteria provided, multiple submitters, no conflicts"	4	NA	N	OMIM Allelic Variant:142410.0001	3	14927	12	121432117	G	GC	29966	12:121432117:G:GC	Pathogenic	5/3/13	-	"Diabetes mellitus, insulin-dependent"	C0011854:Diabetes mellitus type 1	NA	FALSE	Not trait of interest	"criteria provided, single submitter"	clinical testing	germline:na	"Genetic Services Laboratory, University of Chicago"	SCV000151398.1	SCV000151398		HNF1A	-	"MODY, MODY Extended, MonogenicDM_all"	11/6/17	46549	414	17	"[0.9998173967217341,1.8260327826591334E-4]"	17	SCV00015139829566	single nucleotide variant	NM_170707.3(LMNA):c.1930C>T (p.Arg644Cys)	4000	LMNA	HGNC:6636	Conflicting interpretations of pathogenicity	1	21-Nov-18	142000963	-	RCV000245284;RCV000144868;RCV000471403;RCV000755679;RCV000148602;RCV000015626;RCV000057374;RCV000041340	"MedGen:CN230736;MedGen:C0007959,Orphanet:ORPHA166,SNOMED CT:50548001;MedGen:C0270914,Orphanet:ORPHA64746;MedGen:C1449563,OMIM:115200,Orphanet:ORPHA300751;EFO:EFO_0000407,Human Phenotype Ontology:HP:0001644,MedGen:C0007193,Orphanet:ORPHA217604,SNOMED CT:195021004;na;MedGen:CN517202;MedGen:CN169374"	"Cardiovascular phenotype;Charcot-Marie-Tooth disease;Charcot-Marie-Tooth disease, type 2;Dilated cardiomyopathy 1A;Primary dilated cardiomyopathy;Variant of unknown significance;not provided;not specified"	germline;tested-inconclusive;unknown	germline	GRCh37	NC_000001.10	1	156108510	156108510	C	T	1q22	"criteria provided, conflicting interpretations"	13	"ACMG2013,ACMG2016"	N	"OMIM Allelic Variant:150330.0051,UniProtKB (protein):P02545#VAR_039792"	3	14527	1	156108510	C	T	29566	1:156108510:C:T	Likely pathogenic	11/1/13	Observed in two induviduals from two different families.	Charcot-Marie-Tooth disease	C0007959:Charcot-Marie-Tooth disease	NA	FALSE	Incorrect phenotype	no assertion criteria provided	research	tested-inconclusive:na	"Dept. of Medical Genetics, Telemark Hospital Trust"	SCV000172139.1	SCV000172139		LMNA	-	"Lipodystrophy, MonogenicDM_all"	11/21/18	46954	9	67	"[0.9992865357584019,7.134642415981599E-4]"	65	SCV00017213953501	single nucleotide variant	NM_002052.4(GATA4):c.1129A>G (p.Ser377Gly)	2626	GATA4	HGNC:4173	Benign	1	13-Dec-16	3729856	-	RCV000620305;RCV000128527;RCV000037322	MedGen:CN230736;MedGen:CN517202;MedGen:CN169374	Cardiovascular phenotype;not provided;not specified	germline	germline	GRCh37	NC_000008.10	8	11614575	11614575	A	G	8p23.1	"criteria provided, multiple submitters, no conflicts"	3	NA	N	UniProtKB (protein):P43694#VAR_038196	2	44334	8	11614575	A	G	53501	8:11614575:A:G	Likely pathogenic	NA	-	not provided	CN517202:not provided	No Information	FALSE	No Information	no assertion criteria provided	literature only	not provided:na	"Molecular Genetics and Enzymology, National Research Centre"	SCV000172172.1	SCV000172172		-	-	"MonogenicDM_all, Neonatal Diabetes"	12/13/16	46919	44	5733	"[0.9389053475138004,0.06109465248619962]"	5145	SCV000172172143220	single nucleotide variant	NM_002052.4(GATA4):c.909+25G>A	2626	GATA4	HGNC:4173	Conflicting interpretations of pathogenicity	1	7-Jan-17	147860174	-	RCV000498033;RCV000128536	"MedGen:C0152021,SNOMED CT:13213009;MedGen:CN517202"	Congenital heart disease;not provided	unknown	unknown	GRCh37	NC_000008.10	8	11607770	11607770	G	A	8p23.1	no assertion criteria provided	2	NA	N	-	2	139595	8	11607770	G	A	143220	8:11607770:G:A	Uncertain significance	NA	-	not provided	CN517202:not provided	No Information	FALSE	No Information	no assertion criteria provided	literature only	not provided:na	"Molecular Genetics and Enzymology, National Research Centre"	SCV000172173.1	SCV000172173		-	-	"MonogenicDM_all, Neonatal Diabetes"	1/7/17	46958	5	334	"[0.9964436304782998,0.0035563695217002427]"	330	SCV00017217329525	single nucleotide variant	NM_170707.3(LMNA):c.1445G>A (p.Arg482Gln)	4000	LMNA	HGNC:6636	Pathogenic	1	31-Oct-18	11575937	-	RCV000763258;RCV000763258;RCV000459624;RCV000763258;RCV000763258;RCV000763258;RCV000190399;RCV000763258;RCV000015575;RCV000763258;RCV000763258;RCV000763258;RCV000041318;RCV000763258;RCV000763258;RCV000754814;RCV000148600;RCV000057299	"MedGen:C0410190,OMIM:181350,Orphanet:ORPHA98853,SNOMED CT:240072005;MedGen:C1854154,OMIM:605588,Orphanet:ORPHA98856;MedGen:C0270914,Orphanet:ORPHA64746;MedGen:C2750785,OMIM:613205,Orphanet:ORPHA157973;MedGen:C1449563,OMIM:115200,Orphanet:ORPHA300751;MedGen:C0796031,OMIM:212112,Orphanet:ORPHA2229;MedGen:C2750035,OMIM:616516,Orphanet:ORPHA98855;MedGen:C2750035,OMIM:616516,Orphanet:ORPHA98855;MedGen:C1720860,OMIM:151660,Orphanet:ORPHA2348;MedGen:C1720860,OMIM:151660,Orphanet:ORPHA2348;MedGen:C1857829,OMIM:610140,Orphanet:ORPHA168796;MedGen:C0033300,OMIM:176670,Orphanet:ORPHA740,SNOMED CT:238870004;MedGen:CN236383,Orphanet:ORPHA98301;MedGen:C0406585,OMIM:275210,Orphanet:ORPHA1662,SNOMED CT:400128006;MedGen:C0432291,OMIM:248370,Orphanet:ORPHA2457,SNOMED CT:109419009;MedGen:C3888631;MedGen:CN221589;MedGen:CN517202"	"Benign scapuloperoneal muscular dystrophy with cardiomyopathy;Charcot-Marie-Tooth disease type 2B1;Charcot-Marie-Tooth disease, type 2;Congenital muscular dystrophy, LMNA-related;Dilated cardiomyopathy 1A;Dilated cardiomyopathy-hypergonadotropic hypogonadism syndrome;Emery-Dreifuss muscular dystrophy 3, autosomal recessive;Emery-Dreifuss muscular dystrophy 3, autosomal recessive;Familial partial lipodystrophy 2;Familial partial lipodystrophy 2;Heart-hand syndrome, Slovenian type;Hutchinson-Gilford syndrome;Laminopathy;Lethal tight skin contracture syndrome;Mandibuloacral dysostosis;Monogenic diabetes;Partial lipodystrophy, Dunnigan;not provided"	de novo;germline;unknown	germline	GRCh37	NC_000001.10	1	156106776	156106776	G	A	1q22	"criteria provided, multiple submitters, no conflicts"	10	"ACMG2013,ACMG2016"	N	"OMIM Allelic Variant:150330.0010,UniProtKB (protein):P02545#VAR_009992"	3	14486	1	156106776	G	A	29525	1:156106776:G:A	Pathogenic	6/1/14	-	"Partial lipodystrophy, Dunnigan"	"CN221589:Partial lipodystrophy, Dunnigan"	NA	TRUE	NA	no assertion criteria provided	research	germline:na	CSER_CC_NCGL; University of Washington Medical Center	SCV000190315.1	SCV000190315		LMNA	-	"Lipodystrophy, MonogenicDM_all"	10/31/18	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV00019031529566	single nucleotide variant	NM_170707.3(LMNA):c.1930C>T (p.Arg644Cys)	4000	LMNA	HGNC:6636	Conflicting interpretations of pathogenicity	1	21-Nov-18	142000963	-	RCV000245284;RCV000144868;RCV000471403;RCV000755679;RCV000148602;RCV000015626;RCV000057374;RCV000041340	"MedGen:CN230736;MedGen:C0007959,Orphanet:ORPHA166,SNOMED CT:50548001;MedGen:C0270914,Orphanet:ORPHA64746;MedGen:C1449563,OMIM:115200,Orphanet:ORPHA300751;EFO:EFO_0000407,Human Phenotype Ontology:HP:0001644,MedGen:C0007193,Orphanet:ORPHA217604,SNOMED CT:195021004;na;MedGen:CN517202;MedGen:CN169374"	"Cardiovascular phenotype;Charcot-Marie-Tooth disease;Charcot-Marie-Tooth disease, type 2;Dilated cardiomyopathy 1A;Primary dilated cardiomyopathy;Variant of unknown significance;not provided;not specified"	germline;tested-inconclusive;unknown	germline	GRCh37	NC_000001.10	1	156108510	156108510	C	T	1q22	"criteria provided, conflicting interpretations"	13	"ACMG2013,ACMG2016"	N	"OMIM Allelic Variant:150330.0051,UniProtKB (protein):P02545#VAR_039792"	3	14527	1	156108510	C	T	29566	1:156108510:C:T	Uncertain significance	6/1/14	-	"Cardiomyopathy, dilated"	C0007193:Primary dilated cardiomyopathy	NA	FALSE	Incorrect phenotype	no assertion criteria provided	research	germline:na	CSER_CC_NCGL; University of Washington Medical Center	SCV000190317.1	SCV000190317		LMNA	-	"Lipodystrophy, MonogenicDM_all"	11/21/18	46954	9	67	"[0.9992865357584019,7.134642415981599E-4]"	65	SCV00019031777699	single nucleotide variant	NM_170707.3(LMNA):c.1303C>T (p.Arg435Cys)	4000	LMNA	HGNC:6636	Conflicting interpretations of pathogenicity	1	12-Nov-17	150840924	-	RCV000653929;RCV000150953;RCV000148606;RCV000057265	"MedGen:C0270914,Orphanet:ORPHA64746;MedGen:C0033300,OMIM:176670,Orphanet:ORPHA740,SNOMED CT:238870004;EFO:EFO_0000407,Human Phenotype Ontology:HP:0001644,MedGen:C0007193,Orphanet:ORPHA217604,SNOMED CT:195021004;MedGen:CN517202"	"Charcot-Marie-Tooth disease, type 2;Hutchinson-Gilford syndrome;Primary dilated cardiomyopathy;not provided"	germline	germline	GRCh37	NC_000001.10	1	156106150	156106150	C	T	1q22	"criteria provided, conflicting interpretations"	5	"ACMG2013,ACMG2016"	N	UniProtKB (protein):P02545#VAR_039779	3	66802	1	156106150	C	T	77699	1:156106150:C:T	Uncertain significance	6/1/14	-	"Cardiomyopathy, dilated"	C0007193:Primary dilated cardiomyopathy	NA	FALSE	Incorrect phenotype	no assertion criteria provided	research	germline:na	CSER_CC_NCGL; University of Washington Medical Center	SCV000190321.1	SCV000190321		LMNA	-	"Lipodystrophy, MonogenicDM_all"	11/12/17	46956	7	1	"[0.9999893517335378,1.064826646221995E-5]"	1	SCV00019032129538	single nucleotide variant	NM_170707.3(LMNA):c.1580G>A (p.Arg527His)	4000	LMNA	HGNC:6636	Pathogenic	1	2-Jul-18	57520892	-	RCV000555364;RCV000015591;RCV000148607;RCV000015592;RCV000057326	"MedGen:C0270914,Orphanet:ORPHA64746;MedGen:C0432291,OMIM:248370,Orphanet:ORPHA2457,SNOMED CT:109419009;MedGen:CN118835;MedGen:CN043412;MedGen:CN517202"	"Charcot-Marie-Tooth disease, type 2;Mandibuloacral dysostosis;Mandibuloacral dysplasia;Mandibuloacral dysplasia with type A lipodystrophy, atypical;not provided"	germline	germline	GRCh37	NC_000001.10	1	156106995	156106995	G	A	1q22	"criteria provided, multiple submitters, no conflicts"	6	"ACMG2013,ACMG2016"	N	"OMIM Allelic Variant:150330.0021,UniProtKB (protein):P02545#VAR_018727"	3	14499	1	156106995	G	A	29538	1:156106995:G:A	Uncertain significance	6/1/14	-	Mandibuloacral dysplasia	CN118835:Mandibuloacral dysplasia	NA	FALSE	AR	no assertion criteria provided	research	germline:na	CSER_CC_NCGL; University of Washington Medical Center	SCV000190322.1	SCV000190322		LMNA	-	"Lipodystrophy, MonogenicDM_all"	7/2/18	46868	95	8	"[0.9999146539216524,8.534607834769993E-5]"	8	SCV000190322167531	single nucleotide variant	NM_000352.4(ABCC8):c.1562G>A (p.Arg521Gln)	6833	ABCC8	HGNC:59	Conflicting interpretations of pathogenicity	1	1-Jan-17	368114790	-	RCV000144978;RCV000722048	"Human Phenotype Ontology:HP:0000819,MedGen:C0011849,SNOMED CT:73211009;MedGen:C3888018,Orphanet:ORPHA276525"	Diabetes mellitus;Familial hyperinsulinism	germline	germline	GRCh37	NC_000011.9	11	17464335	17464335	C	T	11p15.1	"criteria provided, conflicting interpretations"	2	NA	N	-	2	157683	11	17464335	C	T	167531	11:17464335:C:T	Uncertain significance	7/12/13	-	Diabetes mellitus	C0011849:Diabetes mellitus				"criteria provided, single submitter"	clinical testing	germline:na	"Genetic Services Laboratory, University of Chicago"	SCV000192014.1	SCV000192014		ABCC8	-	"MODY Extended, MonogenicDM_all, Neonatal Diabetes"	1/1/17	46963	0	4	"[0.9999574132827971,4.2586717202904415E-5]"	4	SCV00019201424127	single nucleotide variant	NM_001287174.1(ABCC8):c.3992-9G>A	6833	ABCC8	HGNC:59	Pathogenic	1	5-Jun-17	151344623	-	RCV000590487;RCV000009656;RCV000144995	"MedGen:C3888018,Orphanet:ORPHA276525;MedGen:C2931832,OMIM:256450,SNOMED CT:360339005;MedGen:CN517202"	Familial hyperinsulinism;Persistent hyperinsulinemic hypoglycemia of infancy;not provided	germline;unknown	germline	GRCh37	NC_000011.9	11	17418602	17418602	C	T	11p15.1	"criteria provided, multiple submitters, no conflicts"	7	NA	N	OMIM Allelic Variant:600509.0002	3	9088	11	17418602	C	T	24127	11:17418602:C:T	Pathogenic	7/23/13	-	not provided	CN517202:not provided	No Information	FALSE	No Information	"criteria provided, single submitter"	clinical testing	germline:na	"Genetic Services Laboratory, University of Chicago"	SCV000192031.1	SCV000192031		ABCC8	-	"MODY Extended, MonogenicDM_all, Neonatal Diabetes"	6/5/17	46963	0	15	"[0.9998402998104892,1.5970018951089155E-4]"	15	SCV000192031168869	single nucleotide variant	NM_000525.3(KCNJ11):c.679G>A (p.Glu227Lys)	3767	KCNJ11	HGNC:6257	Pathogenic	1	23-Jul-13	587783672	-	RCV000146115;RCV000170299	"Human Phenotype Ontology:HP:0000819,MedGen:C0011849,SNOMED CT:73211009;MedGen:C4225365,OMIM:616329"	"Diabetes mellitus;Maturity-onset diabetes of the young, type 13"	germline	germline	GRCh37	NC_000011.9	11	17408960	17408960	C	T	11p15.1	"criteria provided, single submitter"	2	NA	N	OMIM Allelic Variant:600937.0024	3	158682	11	17408960	C	T	168869	11:17408960:C:T	Pathogenic	7/23/13	-	Diabetes mellitus	C0011849:Diabetes mellitus	NA	FALSE	Not trait of interest	"criteria provided, single submitter"	clinical testing	germline:na	"Genetic Services Laboratory, University of Chicago"	SCV000193332.1	SCV000193332		KCNJ11	-	"MODY Extended, MonogenicDM_all, Neonatal Diabetes"	7/23/13	46961	2	1	"[0.9999893528672729,1.0647132727156576E-5]"	1	SCV00019333277699	single nucleotide variant	NM_170707.3(LMNA):c.1303C>T (p.Arg435Cys)	4000	LMNA	HGNC:6636	Conflicting interpretations of pathogenicity	1	12-Nov-17	150840924	-	RCV000653929;RCV000150953;RCV000148606;RCV000057265	"MedGen:C0270914,Orphanet:ORPHA64746;MedGen:C0033300,OMIM:176670,Orphanet:ORPHA740,SNOMED CT:238870004;EFO:EFO_0000407,Human Phenotype Ontology:HP:0001644,MedGen:C0007193,Orphanet:ORPHA217604,SNOMED CT:195021004;MedGen:CN517202"	"Charcot-Marie-Tooth disease, type 2;Hutchinson-Gilford syndrome;Primary dilated cardiomyopathy;not provided"	germline	germline	GRCh37	NC_000001.10	1	156106150	156106150	C	T	1q22	"criteria provided, conflicting interpretations"	5	"ACMG2013,ACMG2016"	N	UniProtKB (protein):P02545#VAR_039779	3	66802	1	156106150	C	T	77699	1:156106150:C:T	Pathogenic	1/8/15	-	Hutchinson-Gilford syndrome	C0033300:Hutchinson-Gilford syndrome	NA	FALSE	Incorrect phenotype	no assertion criteria provided	literature only	germline:na	GeneReviews	SCV000196613.1	SCV000196613		LMNA	-	"Lipodystrophy, MonogenicDM_all"	11/12/17	46956	7	1	"[0.9999893517335378,1.064826646221995E-5]"	1	SCV00019661329526	single nucleotide variant	NM_170707.3(LMNA):c.1579C>T (p.Arg527Cys)	4000	LMNA	HGNC:6636	Pathogenic	1	16-Nov-15	57318642	-	RCV000192240;RCV000192011;RCV000015576;RCV000057324	"MedGen:C0007959,Orphanet:ORPHA166,SNOMED CT:50548001;MedGen:C0033300,OMIM:176670,Orphanet:ORPHA740,SNOMED CT:238870004;MedGen:C0432291,OMIM:248370,Orphanet:ORPHA2457,SNOMED CT:109419009;MedGen:CN517202"	Charcot-Marie-Tooth disease;Hutchinson-Gilford syndrome;Mandibuloacral dysostosis;not provided	germline	germline	GRCh37	NC_000001.10	1	156106994	156106994	C	T	1q22	"criteria provided, single submitter"	4	"ACMG2013,ACMG2016"	N	"OMIM Allelic Variant:150330.0026,UniProtKB (protein):P02545#VAR_017663"	3	14487	1	156106994	C	T	29526	1:156106994:C:T	Pathogenic	1/8/15	-	Hutchinson-Gilford syndrome	C0033300:Hutchinson-Gilford syndrome	NA	FALSE	Incorrect phenotype	no assertion criteria provided	literature only	germline:na	GeneReviews	SCV000196614.1	SCV000196614		LMNA	-	"Lipodystrophy, MonogenicDM_all"	11/16/15	46874	89	3	"[0.9999679993173187,3.2000682681230535E-5]"	3	SCV00019661477699	single nucleotide variant	NM_170707.3(LMNA):c.1303C>T (p.Arg435Cys)	4000	LMNA	HGNC:6636	Conflicting interpretations of pathogenicity	1	12-Nov-17	150840924	-	RCV000653929;RCV000150953;RCV000148606;RCV000057265	"MedGen:C0270914,Orphanet:ORPHA64746;MedGen:C0033300,OMIM:176670,Orphanet:ORPHA740,SNOMED CT:238870004;EFO:EFO_0000407,Human Phenotype Ontology:HP:0001644,MedGen:C0007193,Orphanet:ORPHA217604,SNOMED CT:195021004;MedGen:CN517202"	"Charcot-Marie-Tooth disease, type 2;Hutchinson-Gilford syndrome;Primary dilated cardiomyopathy;not provided"	germline	germline	GRCh37	NC_000001.10	1	156106150	156106150	C	T	1q22	"criteria provided, conflicting interpretations"	5	"ACMG2013,ACMG2016"	N	UniProtKB (protein):P02545#VAR_039779	3	66802	1	156106150	C	T	77699	1:156106150:C:T	Uncertain significance	5/23/17	"The p.Arg435Cys variant in LMNA has been reported in the heterozygous state in 1 adult with DCM and subtle myopic findings (Vytopil 2003) and in the homozygous state in 3 infants with a progeroid syndrome and restrictive dermopathy/skin abnormalities (Madej-Pilarczyk 2009, Youn 2010, Starke 2013). The 3 infants did not have any cardiovascular features nor did any nor did any of the heterozygous relatives who were tested except one family member had mild signs of hypertensive cardiac disease that was most likely age related. Western blot and tissue immuno-staining analyses revealed the Arg435Cys variant led to progressive loss of LMNA over time associated with increasing DNA double strand breaks and decreased recruitment of P53 binding protein 1 (53BP1) to DNA-damage sites, suggesting delayed DNA repair (Madej-Pilarczyk 2009, Starke 2013). This variant has also been identified in 2/111156 of European chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP rs150840924). Computational prediction tools and conservation analysis do not provide strong support for or against an impact to the protein. In summary, while there is some suspicion for a pathogenic role in progeroid syndrome and/or dermatological abnormalities when present in homozygosity, the clinical significance of this variant is uncertain. In addition, there is limited information available to assess if this variant is disease-causing for cardiomyopathy when present in heterozygosity and therefore the clinical significance of this variant for cardiomyopathy is uncertain."	Orphanet:ORPHA217604	C0007193:Primary dilated cardiomyopathy	NA	FALSE	Incorrect phenotype	"criteria provided, single submitter"	clinical testing	germline:2	"Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine"	SCV000198614.4	SCV000198614		LMNA	-	"Lipodystrophy, MonogenicDM_all"	11/12/17	46956	7	1	"[0.9999893517335378,1.064826646221995E-5]"	1	SCV00019861477699	single nucleotide variant	NM_170707.3(LMNA):c.1303C>T (p.Arg435Cys)	4000	LMNA	HGNC:6636	Conflicting interpretations of pathogenicity	1	12-Nov-17	150840924	-	RCV000653929;RCV000150953;RCV000148606;RCV000057265	"MedGen:C0270914,Orphanet:ORPHA64746;MedGen:C0033300,OMIM:176670,Orphanet:ORPHA740,SNOMED CT:238870004;EFO:EFO_0000407,Human Phenotype Ontology:HP:0001644,MedGen:C0007193,Orphanet:ORPHA217604,SNOMED CT:195021004;MedGen:CN517202"	"Charcot-Marie-Tooth disease, type 2;Hutchinson-Gilford syndrome;Primary dilated cardiomyopathy;not provided"	germline	germline	GRCh37	NC_000001.10	1	156106150	156106150	C	T	1q22	"criteria provided, conflicting interpretations"	5	"ACMG2013,ACMG2016"	N	UniProtKB (protein):P02545#VAR_039779	3	66802	1	156106150	C	T	77699	1:156106150:C:T	Uncertain significance	5/23/17	"Variant classified as Uncertain Significance - Favor Pathogenic. The p.Arg435Cys variant in LMNA has been reported in the heterozygous state in 1 adult with DCM and subtle myopic findings (Vytopil 2003) and in the homozygous state in 3 infants with a progeroid syndrome and restrictive dermopathy/skin abnormalities (Madej-Pilarczyk 2009, Youn 2010, Starke 2013). The 3 infants did not have any cardiovascular features nor did any nor did any of the heterozygous relatives who were tested except one family member had mild signs of hypertensive cardiac disease that was most likely age related. Western blot and tissue immuno-staining analyses revealed the Arg435Cys variant led to progressive loss of LMNA over time associated with increasing DNA double strand breaks and decreased recruitment of P53 binding protein 1 (53BP1) to DNA-damage sites, suggesting delayed DNA repair (Madej-Pilarczyk 2009, Starke 2013). This variant has also been identified in 2/111156 of European chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP rs150840924). Computational prediction tools and conservation analysis do not provide strong support for or against an impact to the protein. In summary, while there is some suspicion for a pathogenic role in progeroid syndrome and/or dermatological abnormalities when present in homozygosity, the clinical significance of this variant is uncertain. In addition, there is limited information available to assess if this variant is disease-causing for cardiomyopathy when present in heterozygosity and therefore the clinical significance of this variant for cardiomyopathy is uncertain."	Orphanet:ORPHA740	C0033300:Hutchinson-Gilford syndrome	NA	FALSE	Incorrect phenotype	"criteria provided, single submitter"	clinical testing	germline:2	"Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine"	SCV000198615.4	SCV000198615		LMNA	-	"Lipodystrophy, MonogenicDM_all"	11/12/17	46956	7	1	"[0.9999893517335378,1.064826646221995E-5]"	1	SCV000198615172489	single nucleotide variant	NM_170707.3(LMNA):c.1634G>A (p.Arg545His)	4000	LMNA	HGNC:6636	Conflicting interpretations of pathogenicity	1	23-Apr-18	142191737	-	RCV000621850;RCV000468904;RCV000491650;RCV000449630;RCV000505801;RCV000150955	"MedGen:CN230736;MedGen:C0270914,Orphanet:ORPHA64746;MedGen:C1834481,OMIM:613426;Human Phenotype Ontology:HP:0009830,MedGen:C0031117,Orphanet:ORPHA98496;MedGen:CN517202;MedGen:CN169374"	"Cardiovascular phenotype;Charcot-Marie-Tooth disease, type 2;Dilated cardiomyopathy 1S;Peripheral neuropathy;not provided;not specified"	germline;maternal	germline	GRCh37	NC_000001.10	1	156107470	156107470	G	A	1q22	"criteria provided, conflicting interpretations"	7	"ACMG2013,ACMG2016"	N	-	2	163878	1	156107470	G	A	172489	1:156107470:G:A	Uncertain significance	8/6/17	"The Arg545His variant in LMNA has been reported in 1 individual with clinical features consistent with a laminopathy (specific phenotype not described, van Rijsingen 2013). In addition, This variant has been identified in 0.05% (38/75898) European chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org/; dbSNP rs142191737). Computational prediction tools and conservation analysis do not provide strong support for or against an impact to the protein. In summary, the clinical significance of the Arg545His variant is uncertain."	not specified	CN169374:not specified	No Information	FALSE	phenotype unclear from reported paper	"criteria provided, single submitter"	clinical testing	germline:2	"Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine"	SCV000198618.4	SCV000198618		LMNA	-	"Lipodystrophy, MonogenicDM_all"	4/23/18	44851	2112	4	"[0.9999554079061782,4.45920938217654E-5]"	4	SCV00019861857199	single nucleotide variant	NM_005572.3(LMNA):c.1201C>T (p.Arg401Cys)	4000	LMNA	HGNC:6636	Conflicting interpretations of pathogenicity	1	17-May-18	61094188	-	RCV000157295;RCV000528639;RCV000172002;RCV000627127;RCV000057258;RCV000041313	"MedGen:C4053736,OMIM:604772;MedGen:C0270914,Orphanet:ORPHA64746;MedGen:C0410189,Orphanet:ORPHA261,SNOMED CT:111508004;MedGen:C0340427,Orphanet:ORPHA217607;MedGen:CN517202;MedGen:CN169374"	"Catecholaminergic polymorphic ventricular tachycardia type 1;Charcot-Marie-Tooth disease, type 2;Emery-Dreifuss muscular dystrophy;Familial dilated cardiomyopathy;not provided;not specified"	germline;unknown	germline	GRCh37	NC_000001.10	1	156106048	156106048	C	T	1q22	"criteria provided, conflicting interpretations"	8	"ACMG2013,ACMG2016"	N	UniProtKB (protein):P02545#VAR_072818	2	48035	1	156106048	C	T	57199	1:156106048:C:T	Uncertain significance	8/19/14	-	Catecholaminergic polymorphic ventricular tachycardia	C4053736:Catecholaminergic polymorphic ventricular tachycardia type 1	NA	FALSE	Incorrect phenotype	no assertion criteria provided	clinical testing	germline:1	"Blueprint Genetics,"	SCV000207027.1	SCV000207027		LMNA	-	"Lipodystrophy, MonogenicDM_all"	5/17/18	46962	1	6	"[0.9999361185639453,6.388143605468251E-5]"	6	SCV00020702724135	single nucleotide variant	NM_000352.4(ABCC8):c.4477C>T (p.Arg1493Trp)	6833	ABCC8	HGNC:59	Pathogenic/Likely pathogenic	1	29-Aug-17	28936371	-	RCV000009664;RCV000710390	"MedGen:C2931832,OMIM:256450,SNOMED CT:360339005;MedGen:CN517202"	Persistent hyperinsulinemic hypoglycemia of infancy;not provided	germline;unknown	germline	GRCh37	NC_000011.9	11	17415881	17415881	G	A	11p15.1	"criteria provided, multiple submitters, no conflicts"	3	NA	N	"OMIM Allelic Variant:600509.0010,UniProtKB (protein):Q09428#VAR_008540"	3	9096	11	17415881	G	A	24135	11:17415881:G:A	Likely pathogenic	3/24/14	-	Persistent hyperinsulinemic hypoglycemia of infancy	C2931832:Persistent hyperinsulinemic hypoglycemia of infancy	NA	FALSE	Not trait of interest	"criteria provided, single submitter"	literature only	unknown:na	Counsyl	SCV000220188.1	SCV000220188		ABCC8	-	"MODY Extended, MonogenicDM_all, Neonatal Diabetes"	8/29/17	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV000220188186811	single nucleotide variant	NM_000352.4(ABCC8):c.4628T>C (p.Leu1543Pro)	6833	ABCC8	HGNC:59	Likely pathogenic	1	9-Nov-15	72559713	-	RCV000169185	"MedGen:C2931832,OMIM:256450,SNOMED CT:360339005"	Persistent hyperinsulinemic hypoglycemia of infancy	germline;unknown	germline	GRCh37	NC_000011.9	11	17414656	17414656	A	G	11p15.1	"criteria provided, multiple submitters, no conflicts"	2	NA	N	UniProtKB (protein):Q09428#VAR_015010	2	188836	11	17414656	A	G	186811	11:17414656:A:G	Likely pathogenic	6/19/14	-	Persistent hyperinsulinemic hypoglycemia of infancy	C2931832:Persistent hyperinsulinemic hypoglycemia of infancy	NA	FALSE	Not trait of interest	"criteria provided, single submitter"	literature only	unknown:na	Counsyl	SCV000220427.1	SCV000220427		ABCC8	-	"MODY Extended, MonogenicDM_all, Neonatal Diabetes"	11/9/15	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV000220427186816	single nucleotide variant	NM_001287174.1(ABCC8):c.2509C>T (p.Arg837Ter)	6833	ABCC8	HGNC:59	Pathogenic/Likely pathogenic	1	31-Oct-18	72559722	-	RCV000763234;RCV000763234;RCV000763234;RCV000169276;RCV000763234;RCV000763234;RCV000201895	"Human Phenotype Ontology:HP:0005978,MedGen:C0011860,OMIM:125853,Orphanet:ORPHA181376,SNOMED CT:44054006;MedGen:C0271714,OMIM:240800,SNOMED CT:62151007;MedGen:C1833104,OMIM:606176,Orphanet:ORPHA99885;MedGen:C2931832,OMIM:256450,SNOMED CT:360339005;MedGen:C2931832,OMIM:256450,SNOMED CT:360339005;MedGen:C1835887,OMIM:610374;MedGen:CN517202"	Diabetes mellitus type 2;Leucine-induced hypoglycemia;Permanent neonatal diabetes mellitus;Persistent hyperinsulinemic hypoglycemia of infancy;Persistent hyperinsulinemic hypoglycemia of infancy;Transient neonatal diabetes mellitus 2;not provided	germline;unknown	germline	GRCh37	NC_000011.9	11	17434263	17434263	G	A	11p15.1	"criteria provided, multiple submitters, no conflicts"	5	NA	N	-	2	188915	11	17434263	G	A	186816	11:17434263:G:A	Likely pathogenic	8/9/14	-	Persistent hyperinsulinemic hypoglycemia of infancy	C2931832:Persistent hyperinsulinemic hypoglycemia of infancy	NA	FALSE	Not trait of interest	"criteria provided, single submitter"	literature only	unknown:na	Counsyl	SCV000220582.1	SCV000220582		ABCC8	-	"MODY Extended, MonogenicDM_all, Neonatal Diabetes"	10/31/18	46955	8	12	"[0.9998722180811416,1.2778191885848153E-4]"	12	SCV000220582186812	single nucleotide variant	NM_000352.4(ABCC8):c.4411G>A (p.Asp1471Asn)	6833	ABCC8	HGNC:59	Pathogenic/Likely pathogenic	1	17-Feb-16	72559716	-	RCV000586940;RCV000169299	"MedGen:C3888018,Orphanet:ORPHA276525;MedGen:C2931832,OMIM:256450,SNOMED CT:360339005"	Familial hyperinsulinism;Persistent hyperinsulinemic hypoglycemia of infancy	germline;unknown	germline	GRCh37	NC_000011.9	11	17416719	17416719	C	T	11p15.1	"criteria provided, multiple submitters, no conflicts"	2	NA	N	-	2	188931	11	17416719	C	T	186812	11:17416719:C:T	Likely pathogenic	8/21/14	-	Persistent hyperinsulinemic hypoglycemia of infancy	C2931832:Persistent hyperinsulinemic hypoglycemia of infancy	NA	FALSE	Not trait of interest	"criteria provided, single submitter"	literature only	unknown:na	Counsyl	SCV000220618.1	SCV000220618		ABCC8	-	"MODY Extended, MonogenicDM_all, Neonatal Diabetes"	2/17/16	46775	188	2	"[0.9999786210582576,2.1378941742383753E-5]"	2	SCV000220618168869	single nucleotide variant	NM_000525.3(KCNJ11):c.679G>A (p.Glu227Lys)	3767	KCNJ11	HGNC:6257	Pathogenic	1	23-Jul-13	587783672	-	RCV000146115;RCV000170299	"Human Phenotype Ontology:HP:0000819,MedGen:C0011849,SNOMED CT:73211009;MedGen:C4225365,OMIM:616329"	"Diabetes mellitus;Maturity-onset diabetes of the young, type 13"	germline	germline	GRCh37	NC_000011.9	11	17408960	17408960	C	T	11p15.1	"criteria provided, single submitter"	2	NA	N	OMIM Allelic Variant:600937.0024	3	158682	11	17408960	C	T	168869	11:17408960:C:T	Pathogenic	1/1/12	-	"MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 13"	"C4225365:Maturity-onset diabetes of the young, type 13"	NA	TRUE	NA	no assertion criteria provided	literature only	germline:na	OMIM	SCV000222635.2	SCV000222635		KCNJ11	-	"MODY Extended, MonogenicDM_all, Neonatal Diabetes"	7/23/13	46961	2	1	"[0.9999893528672729,1.0647132727156576E-5]"	1	SCV00022263524127	single nucleotide variant	NM_001287174.1(ABCC8):c.3992-9G>A	6833	ABCC8	HGNC:59	Pathogenic	1	5-Jun-17	151344623	-	RCV000590487;RCV000009656;RCV000144995	"MedGen:C3888018,Orphanet:ORPHA276525;MedGen:C2931832,OMIM:256450,SNOMED CT:360339005;MedGen:CN517202"	Familial hyperinsulinism;Persistent hyperinsulinemic hypoglycemia of infancy;not provided	germline;unknown	germline	GRCh37	NC_000011.9	11	17418602	17418602	C	T	11p15.1	"criteria provided, multiple submitters, no conflicts"	7	NA	N	OMIM Allelic Variant:600509.0002	3	9088	11	17418602	C	T	24127	11:17418602:C:T	Pathogenic	6/13/14	-	not provided	CN517202:not provided	NA	FALSE	Not trait of interest	"criteria provided, single submitter"	clinical testing	germline:2	"EGL Genetic Diagnostics,Eurofins Clinical Diagnostics"	SCV000229594.5	SCV000229594		ABCC8	-	"MODY Extended, MonogenicDM_all, Neonatal Diabetes"	6/5/17	46963	0	15	"[0.9998402998104892,1.5970018951089155E-4]"	15	SCV00022959424138	single nucleotide variant	NM_000352.4(ABCC8):c.560T>A (p.Val187Asp)	6833	ABCC8	HGNC:59	Pathogenic	1	19-Feb-16	137852672	-	RCV000009667;RCV000723825	"MedGen:C2931832,OMIM:256450,SNOMED CT:360339005;MedGen:CN517202"	Persistent hyperinsulinemic hypoglycemia of infancy;not provided	germline;unknown	germline	GRCh37	NC_000011.9	11	17485004	17485004	A	T	11p15.1	"criteria provided, multiple submitters, no conflicts"	3	NA	N	"OMIM Allelic Variant:600509.0013,UniProtKB (protein):Q09428#VAR_008641"	3	9099	11	17485004	A	T	24138	11:17485004:A:T	Pathogenic	6/13/14	-	not provided	CN517202:not provided	NA	FALSE	Not trait of interest	"criteria provided, single submitter"	clinical testing	germline:na	"EGL Genetic Diagnostics,Eurofins Clinical Diagnostics"	SCV000230073.5	SCV000230073		ABCC8	-	"MODY Extended, MonogenicDM_all, Neonatal Diabetes"	2/19/16	46927	36	7	"[0.9999254160717711,7.458392822895134E-5]"	7	SCV00023007329538	single nucleotide variant	NM_170707.3(LMNA):c.1580G>A (p.Arg527His)	4000	LMNA	HGNC:6636	Pathogenic	1	2-Jul-18	57520892	-	RCV000555364;RCV000015591;RCV000148607;RCV000015592;RCV000057326	"MedGen:C0270914,Orphanet:ORPHA64746;MedGen:C0432291,OMIM:248370,Orphanet:ORPHA2457,SNOMED CT:109419009;MedGen:CN118835;MedGen:CN043412;MedGen:CN517202"	"Charcot-Marie-Tooth disease, type 2;Mandibuloacral dysostosis;Mandibuloacral dysplasia;Mandibuloacral dysplasia with type A lipodystrophy, atypical;not provided"	germline	germline	GRCh37	NC_000001.10	1	156106995	156106995	G	A	1q22	"criteria provided, multiple submitters, no conflicts"	6	"ACMG2013,ACMG2016"	N	"OMIM Allelic Variant:150330.0021,UniProtKB (protein):P02545#VAR_018727"	3	14499	1	156106995	G	A	29538	1:156106995:G:A	Pathogenic	6/19/14	-	not provided	CN517202:not provided	NA	FALSE	AR	"criteria provided, single submitter"	clinical testing	germline:1	"EGL Genetic Diagnostics,Eurofins Clinical Diagnostics"	SCV000233098.5	SCV000233098		LMNA	-	"Lipodystrophy, MonogenicDM_all"	7/2/18	46868	95	8	"[0.9999146539216524,8.534607834769993E-5]"	8	SCV000233098198013	single nucleotide variant	NM_000527.4(LDLR):c.718G>A (p.Glu240Lys)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	22-May-18	768563000	-	RCV000211564;RCV000586018;RCV000182341	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:CN517202"	Familial hypercholesterolemia;Familial hypercholesterolemias;not provided	germline	germline	GRCh37	NC_000019.9	19	11217264	11217264	G	A	19p13.2	"criteria provided, conflicting interpretations"	9	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_001828,UniProtKB (protein):P01130#VAR_005343"	2	200920	19	11217264	G	A	198013	19:11217264:G:A	Pathogenic	9/1/15	"The E240K mutation in the LDLR gene has been published previously as a disease-causing mutation (reported as E219K in Hobbs et al. due to alternate nomenclature) associated with autosomal dominant hypercholesterolemia (Hobbs et al., 1992; Bertolini et al., 2013). Based on the ACMG recommendations, E240K is interpreted as a known pathogenic sequence change."	Not Provided	CN517202:not provided	Familial hypercholesterolemia	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	GeneDx	SCV000234645.10	SCV000234645		LDLR	-	High LDL	5/22/18	46963	0	3	"[0.9999680599620978,3.194003790217831E-5]"	3	SCV000234645171201	single nucleotide variant	NM_000527.4(LDLR):c.798T>A (p.Asp266Glu)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	17-May-18	139043155	-	RCV000172959;RCV000148594;RCV000162020	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202"	Familial hypercholesterolemia;Hypercholesterolaemia;not provided	germline;inherited;not applicable;unknown	germline	GRCh37	NC_000019.9	19	11217344	11217344	T	A	19p13.2	"criteria provided, conflicting interpretations"	16	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000117,UniProtKB (protein):P01130#VAR_005347"	2	161287	19	11217344	T	A	171201	19:11217344:T:A	Pathogenic	9/11/17	"The D266E pathogenic variant in the LDLR gene has been published previously, as D245E using alternative nomenclature, in association with FH (Hobbs et al., 1992; Kuhrova et al., 2001; Muller et al., 2004; Chmara et al., 2010; Amhad et al., 2012; Tichy et al., 2012; Stein et al., 2013; Kusters et al., 2013; Lange et al., 2014; Sharifi et al., 2016; Gabcova et al., 2016). Functional studies by Hobbs et al. (1992) demonstrate LDL receptor activity is 15-30% in patients with the D266E variant. The D266E variant results in a conservative amino acid substitution at a position that is conserved across most species. Finally, the D266E variant is not observed in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server)."	Not Provided	CN517202:not provided	Familial hypercholesterolemia	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	GeneDx	SCV000234646.4	SCV000234646		LDLR	-	High LDL	5/17/18	46963	0	2	"[0.9999787066413985,2.1293358601452207E-5]"	2	SCV000234646198015	single nucleotide variant	NM_000527.4(LDLR):c.1747C>T (p.His583Tyr)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	23-Jan-18	730882109	-	RCV000211604;RCV000182342	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202"	Familial hypercholesterolemia;not provided	germline;not applicable;unknown	germline	GRCh37	NC_000019.9	19	11227576	11227576	C	T	19p13.2	"criteria provided, conflicting interpretations"	10	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000234	2	200921	19	11227576	C	T	198015	19:11227576:C:T	Pathogenic	3/19/15	"The H583Y c.1747CAC>TAC mutation in the LDLR gene has been published previously as a disease-causing mutation using alternate nomenclature (reported as H562Y) (Sun et al., 1994; Van Hoof et al., 2005). Based on the ACMG recommendations, H583Y is interpreted as a known pathogenic sequence change. The variant is found in ,LDLR panel(s)."	Not Provided	CN517202:not provided	Familial hypercholesterolemia	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	GeneDx	SCV000234652.11	SCV000234652		LDLR	-	High LDL	1/23/18	46963	0	14	"[0.9998509464897898,1.4905351021016544E-4]"	14	SCV000234652196476	single nucleotide variant	NM_170707.3(LMNA):c.1057C>T (p.Gln353Ter)	4000	LMNA	HGNC:6636	Pathogenic	1	11-Apr-18	267607623	-	RCV000247014;RCV000229718;RCV000182362	"MedGen:CN230736;MedGen:C0270914,Orphanet:ORPHA64746;MedGen:CN517202"	"Cardiovascular phenotype;Charcot-Marie-Tooth disease, type 2;not provided"	germline	germline	GRCh37	NC_000001.10	1	156105812	156105812	C	T	1q22	"criteria provided, multiple submitters, no conflicts"	3	"ACMG2013,ACMG2016"	N	-	2	200939	1	156105812	C	T	196476	1:156105812:C:T	Pathogenic	8/16/17	"The Q353X pathogenic variant in the LMNA gene has previously been reported in a Japanese malewith a diagnosis of spinal muscular atrophy type 3 and AV block (Iwahara et al., 2015). His familyhistory was remarkable for gait disturbances and AV block in multiple relatives (Iwahara et al., 2015).This variant is predicted to cause loss of normal protein function either due to the production of anabnormal, truncated protein product, or loss of protein from this allele due to nonsense-mediatedmRNA decay. Other downstream nonsense variants in the LMNA gene have been reported in HGMDin association with dilated cardiomyopathy (DCM) or laminopathy (Stenson et al., 2014).Furthermore, the Q353X variant has not been observed in approximately 6,500 individuals ofEuropean and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is nota common, benign variant in these populations."	Not Provided	CN517202:not provided	spinal muscular atrophy type 3 and AV block	FALSE	Incorrect phenotype	"criteria provided, single submitter"	clinical testing	germline:na	GeneDx	SCV000234681.12	SCV000234681		LMNA	-	"Lipodystrophy, MonogenicDM_all"	4/11/18	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV00023468157261	single nucleotide variant	NM_170707.3(LMNA):c.976T>A (p.Ser326Thr)	4000	LMNA	HGNC:6636	Conflicting interpretations of pathogenicity	1	21-Nov-18	56851164	-	RCV000621488;RCV000544253;RCV000755678;RCV000208012;RCV000057494;RCV000212504	"MedGen:CN230736;MedGen:C0270914,Orphanet:ORPHA64746;MedGen:C1449563,OMIM:115200,Orphanet:ORPHA300751;MedGen:C0949658,Orphanet:ORPHA155,SNOMED CT:83978005;MedGen:CN517202;MedGen:CN169374"	"Cardiovascular phenotype;Charcot-Marie-Tooth disease, type 2;Dilated cardiomyopathy 1A;Primary familial hypertrophic cardiomyopathy;not provided;not specified"	germline;unknown	germline	GRCh37	NC_000001.10	1	156105731	156105731	T	A	1q22	"criteria provided, conflicting interpretations"	8	"ACMG2013,ACMG2016"	N	-	2	48097	1	156105731	T	A	57261	1:156105731:T:A	Uncertain significance	5/13/14	"p.Ser326Thr (TCA>ACA): c.976 T>A in exon 6 of the LMNA gene (NM_170707.2). The S326T variant in LMNA gene has been reported previously in association with Emery Dreifuss muscular dystrophy (EDMD) and was absent from 100 healthy controls (Muntoni F et al., 2006). This individuals family history was positive for molecularly confirmed X-linked EDMD, however as the proband was severely affected additional studies identified a de novo S326T sequence change in LMNA gene. The authors hypothezised that separate mutations in related proteins that interact or are involved in the same pathway, may contribute to disease severity in EDMD (Muntoni F et al., 2006). On the other hand, a simulation model used for structural and thermodynamic characterization of LMNA mutations showed that S326T did not affect noticeably the coil 2B dimerization of lamin A/C (Gangemi F et al., 2012). The S326T variant was not observed in approximately 6500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. Missense mutations in nearby residues (E317K, A318T, R331Q, R331P, S334N, R335Q, R335W, R336Q) have been reported in association with LMNA-related disorder, supporting the functional importance of this region of the protein. However, the S326T variant is a conservative amino acid substitution, which is not likely to impact secondary protein structure as these residues share similar properties. This substitution occurs at a position that is not well conserved across species. In silico analysis predicts this variant likely does not alter the protein structure/function. Therefore, based on the currently available information, it is unclear whether this variant is a pathogenic mutation or a rare benign variant. The variant is found in DCM-CRDM panel(s)."	not specified	CN169374:not specified	Emery Dreifuss muscular dystrophy (EDMD)	FALSE	Incorrect phenotype	"criteria provided, single submitter"	clinical testing	germline:na	GeneDx	SCV000234689.9	SCV000234689		LMNA	-	"Lipodystrophy, MonogenicDM_all"	11/21/18	46959	4	3	"[0.9999680572414233,3.1942758576630676E-5]"	3	SCV00023468957262	single nucleotide variant	NM_170707.3(LMNA):c.992G>A (p.Arg331Gln)	4000	LMNA	HGNC:6636	Conflicting interpretations of pathogenicity	1	28-Jul-17	59301204	-	RCV000182367;RCV000593819	MedGen:CN517202;MedGen:CN169374	not provided;not specified	germline	germline	GRCh37	NC_000001.10	1	156105747	156105747	G	A	1q22	"criteria provided, conflicting interpretations"	3	"ACMG2013,ACMG2016"	N	-	2	48098	1	156105747	G	A	57262	1:156105747:G:A	Pathogenic	7/28/17	"The R331Q pathogenic variant in the LMNA gene has been reported previously in multiple unrelated individuals with DCM (Benedetti et al., 2007; Moller et al., 2009; van Spaendonck-Zwarts et al., 2013; Pugh et al., 2014; Hazebroek et al., 2015; Dalin et al., 2017). The R331Q variant has also been observed in two other individuals referred for cardiomyopathy genetic testing at GeneDx. R331Q is not observed at a significant frequency in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). The R331Q variant is a semi-conservative amino acid substitution, which may impact secondary protein structure as these residues differ in some properties. In addition, this substitution occurs at a position that is conserved across species, and in silico analysis predicts this variant is probably damaging to the protein structure/function. Functional studies have shown that the R331Q variant, which is located in the coil 2B domain and participates in an interchain salt bridge, results in decreased lamina stability (Gangemi et al., 2013). Finally, a missense variant at the same residue (R331P), and multiple missense variants in nearby residues (S326T, S334N, R335W, R336Q), have been reported in HGMD in association with DCM or laminopathy (Stenson et al., 2014)."	Not Provided	CN517202:not provided	DCM	FALSE	Incorrect phenotype	"criteria provided, single submitter"	clinical testing	germline:na	GeneDx	SCV000234690.10	SCV000234690		LMNA	-	"Lipodystrophy, MonogenicDM_all"	7/28/17	46951	12	1	"[0.9999893505995613,1.0649400438755298E-5]"	1	SCV00023469029558	single nucleotide variant	NM_170707.3(LMNA):c.1195C>T (p.Arg399Cys)	4000	LMNA	HGNC:6636	Uncertain significance	1	15-Nov-17	58672172	-	RCV000653937;RCV000015616;RCV000057255;RCV000212505	"MedGen:C0270914,Orphanet:ORPHA64746;MedGen:C1720860,OMIM:151660,Orphanet:ORPHA2348;MedGen:CN517202;MedGen:CN169374"	"Charcot-Marie-Tooth disease, type 2;Familial partial lipodystrophy 2;not provided;not specified"	germline	germline	GRCh37	NC_000001.10	1	156106042	156106042	C	T	1q22	"criteria provided, multiple submitters, no conflicts"	4	"ACMG2013,ACMG2016"	N	"OMIM Allelic Variant:150330.0043,UniProtKB (protein):P02545#VAR_039778"	3	14519	1	156106042	C	T	29558	1:156106042:C:T	Uncertain significance	7/7/15	"The R399C variant in the LMNA gene has been reported previously in one individual with familial partial lipodystrophy, however no segregation data was reported (Lanktree M et al., 2007). The R399C variant in the LMNA gene has also been identified in one individual with DCM, however testing of additional family members showed that this variant did not co-segregate with disease (Parks S et al., 2008). In addition, functional studies have shown that the R399C mutation shows nuclear morphology similar to wild type (Cowan J et al., 2010). The R399C mutation was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The R331Q variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is conserved in mammals. Furthermore, a missense mutation in this residue (R399H) and mutations in nearby residues (S395L, R397C, R401C) have been reported in HGMD in association with cardiomyopathy, metabolic laminopathy and muscular dystrophy (Stenson P et al., 2014), further supporting the functional importance of this residue and region of the protein. Nevertheless, in silico analysisis inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function.Therefore, based on the currently available information, it is unclear whether this variant is a pathogenic mutation or a rare benign variant."	not specified	CN169374:not specified	No Information	FALSE	No Information	"criteria provided, single submitter"	clinical testing	germline:na	GeneDx	SCV000234695.12	SCV000234695		LMNA	-	"Lipodystrophy, MonogenicDM_all"	11/15/17	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV00023469557199	single nucleotide variant	NM_005572.3(LMNA):c.1201C>T (p.Arg401Cys)	4000	LMNA	HGNC:6636	Conflicting interpretations of pathogenicity	1	17-May-18	61094188	-	RCV000157295;RCV000528639;RCV000172002;RCV000627127;RCV000057258;RCV000041313	"MedGen:C4053736,OMIM:604772;MedGen:C0270914,Orphanet:ORPHA64746;MedGen:C0410189,Orphanet:ORPHA261,SNOMED CT:111508004;MedGen:C0340427,Orphanet:ORPHA217607;MedGen:CN517202;MedGen:CN169374"	"Catecholaminergic polymorphic ventricular tachycardia type 1;Charcot-Marie-Tooth disease, type 2;Emery-Dreifuss muscular dystrophy;Familial dilated cardiomyopathy;not provided;not specified"	germline;unknown	germline	GRCh37	NC_000001.10	1	156106048	156106048	C	T	1q22	"criteria provided, conflicting interpretations"	8	"ACMG2013,ACMG2016"	N	UniProtKB (protein):P02545#VAR_072818	2	48035	1	156106048	C	T	57199	1:156106048:C:T	Uncertain significance	6/22/17	"The R401C variant in the LMNA gene has been reported as a heterozygous variant in an individual with Emery-Dreifuss muscular dystrophy (EDMD), as well as in the individual's unaffected mother and sister (Vytopil et al., 2002). R401C was also observed in trans with another LMNA variant (c.447insC) in a different individual with EDMD and was found to be inherited from a parent without neuromuscular disease (Emerson, et al., 2009). Additionally, the R401C variant was observed in two siblings with dilated cardiomyopathy who may or may not have had additional variants in other cardiomyopathy-related genes (Chami et al., 2014). Nevertheless, this variant is observed in 2 /11,536 alleles (0.02%) from individuals of Latino ancestry in large population cohorts (Lek et al., 2016) and in multiple unaffected individuals referred for genetic testing at GeneDx. The R401C variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution alters a highly conserved position within the Tail region of the LMNA protein. Furthermore, in silico analysis predicts this variant is probably damaging to the protein structure/function."	not specified	CN169374:not specified	Emery-Dreifuss muscular dystrophy and DCM	FALSE	Incorrect phenotype	"criteria provided, single submitter"	clinical testing	germline:na	GeneDx	SCV000234697.4	SCV000234697		LMNA	-	"Lipodystrophy, MonogenicDM_all"	5/17/18	46962	1	6	"[0.9999361185639453,6.388143605468251E-5]"	6	SCV00023469757209	single nucleotide variant	NM_170707.3(LMNA):c.1567G>A (p.Gly523Arg)	4000	LMNA	HGNC:6636	Conflicting interpretations of pathogenicity	1	16-Aug-18	201583907	-	RCV000245950;RCV000474372;RCV000678714;RCV000057323;RCV000041324	"MedGen:CN230736;MedGen:C0270914,Orphanet:ORPHA64746;Human Phenotype Ontology:HP:0030682,MedGen:C1960469,Orphanet:ORPHA54260,SNOMED CT:427608000;MedGen:CN517202;MedGen:CN169374"	"Cardiovascular phenotype;Charcot-Marie-Tooth disease, type 2;Left ventricular noncompaction;not provided;not specified"	germline	germline	GRCh37	NC_000001.10	1	156106982	156106982	G	A	1q22	"criteria provided, conflicting interpretations"	7	"ACMG2013,ACMG2016"	N	UniProtKB (protein):P02545#VAR_067258	2	48045	1	156106982	G	A	57209	1:156106982:G:A	Uncertain significance	8/3/17	"The G523R variant in the LMNA gene has been previously reported in association with dilated cardiomyopathy (DCM) and Limb Girdle Muscular Dystrophy (LGMD); however, additional clinical information and familial segregation studies were not provided (Millat et al., 2009; Pugh et al., 2014; Haas et al., 2015; Magri et al., 2015). The G523R variant is observed in 7/38,488 alleles (0.02%) from individuals of non-Finnish European background in the ExAC dataset with no homozygous controls reported (Lek et al., 2016). The G523R variant results in a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. In addition, this substitution occurs at a position that is conserved across species, and in silico analysis predicts this variant is probably damaging to the protein structure/function. A study of protein interaction found that G523R altered the ability of LMNA to interact with 5% of its targets, though the clinical validity of this observation was not established (Dittmer et al., 2014). Missense variants in nearby residues (W520R, W520G, W520S, R527C, R527P, R527L, and R527H) have been reported in the Human Gene Mutation Database in association with LMNA-related disorders (Stenson et al., 2014), supporting the functional importance of this region of the protein. Nonetheless, the G523R variant has been classified as a variant of uncertain significance by other clinical laboratories in ClinVar, one of which reports this variant was observed in two individuals with DCM who also harbored an additional likely pathogenic variant (SCV000065017.4, SCV000320458.1, SCV000336479.1; Landrum et al., 2016). In summary, this variant lacks observation in a sufficient number of affected individuals, segregation data, and functional evidence, all of which would further clarify pathogenicity. We therefore interpret G523R as a variant of uncertain significance."	not specified	CN169374:not specified	dilated cardiomyopathy (DCM) and Limb Girdle Muscular Dystrophy (LGMD)	FALSE	Incorrect phenotype	"criteria provided, single submitter"	clinical testing	germline:na	GeneDx	SCV000234703.6	SCV000234703		LMNA	-	"Lipodystrophy, MonogenicDM_all"	8/16/18	46878	85	4	"[0.9999573360638252,4.2663936174751484E-5]"	4	SCV00023470329538	single nucleotide variant	NM_170707.3(LMNA):c.1580G>A (p.Arg527His)	4000	LMNA	HGNC:6636	Pathogenic	1	2-Jul-18	57520892	-	RCV000555364;RCV000015591;RCV000148607;RCV000015592;RCV000057326	"MedGen:C0270914,Orphanet:ORPHA64746;MedGen:C0432291,OMIM:248370,Orphanet:ORPHA2457,SNOMED CT:109419009;MedGen:CN118835;MedGen:CN043412;MedGen:CN517202"	"Charcot-Marie-Tooth disease, type 2;Mandibuloacral dysostosis;Mandibuloacral dysplasia;Mandibuloacral dysplasia with type A lipodystrophy, atypical;not provided"	germline	germline	GRCh37	NC_000001.10	1	156106995	156106995	G	A	1q22	"criteria provided, multiple submitters, no conflicts"	6	"ACMG2013,ACMG2016"	N	"OMIM Allelic Variant:150330.0021,UniProtKB (protein):P02545#VAR_018727"	3	14499	1	156106995	G	A	29538	1:156106995:G:A	Pathogenic	4/17/18	"The R527H pathogenic variant in the LMNA gene has been reported multiple times in association with autosomal recessive mandibuloacral dysplasia (MAD) (Novelli et al., 2002; Shen et al., 2003; Simha et al., 2003; Lombardi et al., 2007; Garavelli et al., 2009). R527H has not been reported in association with a cardiomyopathy phenotype to our knowledge, and to date, heterozygous carriers of the R527H variant have not been reported to exhibit disease phenotype. However, R527H has been observed at GeneDx in the heterozygous state, in the absence of other pathogenic variants, in one individual diagnosed with dilated cardiomyopathy. The R527H variant is observed in 6/30986 (0.02%) alleles from individuals of Latino ancestry in large population cohorts (Lek et al., 2016). The R527H variant is a conservative amino acid substitution, which is not likely to impact secondary protein structure as these residues share similar properties. Functional studies using fibroblasts from homozygous R527H MAD patients demonstrated that R527H results in an accumulation of unprocessed prelamin A, alters distribution of the lamin B receptor, and destabilizes two heterochromatin-associated proteins (Filesi et al., 2005). Finally, several missense variants in the same residue (R527C, R527L, R527P) have been reported in association with laminopathies (Cao et al., 2003; Scharner et al., 2013; Zwerger et al., 2013), supporting the functional importance of this region of the protein. In summary, R527H in the LMNA gene is interpreted as a pathogenic variant."	Not Provided	CN517202:not provided	dilated cardiomyopathy	FALSE	Incorrect phenotype	"criteria provided, single submitter"	clinical testing	germline:na	GeneDx	SCV000234705.13	SCV000234705		LMNA	-	"Lipodystrophy, MonogenicDM_all"	7/2/18	46868	95	8	"[0.9999146539216524,8.534607834769993E-5]"	8	SCV000234705172489	single nucleotide variant	NM_170707.3(LMNA):c.1634G>A (p.Arg545His)	4000	LMNA	HGNC:6636	Conflicting interpretations of pathogenicity	1	23-Apr-18	142191737	-	RCV000621850;RCV000468904;RCV000491650;RCV000449630;RCV000505801;RCV000150955	"MedGen:CN230736;MedGen:C0270914,Orphanet:ORPHA64746;MedGen:C1834481,OMIM:613426;Human Phenotype Ontology:HP:0009830,MedGen:C0031117,Orphanet:ORPHA98496;MedGen:CN517202;MedGen:CN169374"	"Cardiovascular phenotype;Charcot-Marie-Tooth disease, type 2;Dilated cardiomyopathy 1S;Peripheral neuropathy;not provided;not specified"	germline;maternal	germline	GRCh37	NC_000001.10	1	156107470	156107470	G	A	1q22	"criteria provided, conflicting interpretations"	7	"ACMG2013,ACMG2016"	N	-	2	163878	1	156107470	G	A	172489	1:156107470:G:A	Likely pathogenic	10/17/17	"A R545H variant that is likely pathogenic has been identified in the LMNA gene. The R545H variant in the LMNA gene was previously identified in one patient in a cohort of LMNA variant carriers who had known cardiac involvement or a family history of cardiac involvement (van Rijsingen et al., 2013). This variant has also been reported in a patient with lipodystrophy (Chan et al., 2016). Additionally, this variant has been reported in several individuals at GeneDx with various levels of cardiac involvement. The R545H variant is observed in 38/75898 (0.05%) alleles from individuals of European (non-Finnish) ancestry in large population cohorts (Lek et al., 2016). The R545H variant is a conservative amino acid substitution, and in silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. Nevertheless, this substitution occurs at a position that is conserved among mammals and is located within the C-terminal tail domain. A variant in the same residue (R545C) has been reported in association with muscular dystrophy (Kandert et al., 2009). Additionally, missense variants in nearby residues (R541C, R541H, R541G) have been reported in the Human Gene Mutation Database in association with LMNA-related disorders (Stenson et al., 2014), further supporting the functional importance of this region of the protein."	Not Provided	CN517202:not provided	cardiac involvement and a patient with lipodystrophy	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	GeneDx	SCV000234709.3	SCV000234709		LMNA	-	"Lipodystrophy, MonogenicDM_all"	4/23/18	44851	2112	4	"[0.9999554079061782,4.45920938217654E-5]"	4	SCV00023470929566	single nucleotide variant	NM_170707.3(LMNA):c.1930C>T (p.Arg644Cys)	4000	LMNA	HGNC:6636	Conflicting interpretations of pathogenicity	1	21-Nov-18	142000963	-	RCV000245284;RCV000144868;RCV000471403;RCV000755679;RCV000148602;RCV000015626;RCV000057374;RCV000041340	"MedGen:CN230736;MedGen:C0007959,Orphanet:ORPHA166,SNOMED CT:50548001;MedGen:C0270914,Orphanet:ORPHA64746;MedGen:C1449563,OMIM:115200,Orphanet:ORPHA300751;EFO:EFO_0000407,Human Phenotype Ontology:HP:0001644,MedGen:C0007193,Orphanet:ORPHA217604,SNOMED CT:195021004;na;MedGen:CN517202;MedGen:CN169374"	"Cardiovascular phenotype;Charcot-Marie-Tooth disease;Charcot-Marie-Tooth disease, type 2;Dilated cardiomyopathy 1A;Primary dilated cardiomyopathy;Variant of unknown significance;not provided;not specified"	germline;tested-inconclusive;unknown	germline	GRCh37	NC_000001.10	1	156108510	156108510	C	T	1q22	"criteria provided, conflicting interpretations"	13	"ACMG2013,ACMG2016"	N	"OMIM Allelic Variant:150330.0051,UniProtKB (protein):P02545#VAR_039792"	3	14527	1	156108510	C	T	29566	1:156108510:C:T	Uncertain significance	8/25/17	"The R644C variant of uncertain significance in the LMNA gene has been reported multiple times in association with LMNA-related disorders, and demonstrates a wide phenotypic spectrum, variable severity, incomplete penetrance, and non-segregation (Genschel et al., 2001; Csoka et al., 2004; Mercuri et al., 2005; Muntoni et al., 2006; Rankin et al., 2008; Pasotti et al., 2008; Moller et al., 2009; Perrot et al., 2009; Scharner et al., 2011; Quarta et al., 2012; Vasli et al., 2012; Larsen et al., 2012; Hoyer et al., 2014; Cann et al., 2016). The R644C variant has been identified in individuals with isolated cardiomyopathy, laminopathies, Hallermann-Streiff syndrome, or Hutchinson-Gilford progeria syndrome, and also in asymptomatic relatives. Additionally, two studies reported that the R644C variant did not segregate with disease in two unrelated families (Mercuri et al., 2005; Muntoni et al., 2006). The Exome Aggregation Consortium (ExAC) reports R644C was observed in 106/63,724 alleles from individuals of Non-Finnish European and 27/16,410 alleles from individuals of South Asian ancestry, including one homozygote, indicating it may be a rare benign variant in these populations (Lek et al., 2016). It has been suggested that the extreme phenotypic variability caused by this pleiotropic LMNA variant could be due to either an altered methylation pattern or abnormal post-translational processing of prelamin A because R644C is located at the C-terminal end of lamin A/C close to the endoproteolytic cleavage site (Perrot et al., 2009; Capell et al., 2006). The R644C variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. Additionally, this substitution occurs at a position that is conserved in mammals. Nevertheless, in silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function."	not specified	CN169374:not specified	No Information	FALSE	No Information	"criteria provided, single submitter"	clinical testing	germline:na	GeneDx	SCV000234713.8	SCV000234713		LMNA	-	"Lipodystrophy, MonogenicDM_all"	11/21/18	46954	9	67	"[0.9992865357584019,7.134642415981599E-4]"	65	SCV000234713196756	single nucleotide variant	NM_174936.3(PCSK9):c.1405C>T (p.Arg469Trp)	255738	PCSK9	HGNC:20001	Conflicting interpretations of pathogenicity	1	7-Dec-17	141502002	-	RCV000408878;RCV000228895;RCV000182576	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C1863551,OMIM:603776;MedGen:CN169374"	"Familial hypercholesterolemia;Hypercholesterolemia, autosomal dominant, 3;not specified"	germline	germline	GRCh37	NC_000001.10	1	55524222	55524222	C	T	1p32.3	"criteria provided, conflicting interpretations"	5	"ACMG2013,ACMG2016"	N	UniProtKB (protein):Q8NBP7#VAR_025456	2	201128	1	55524222	C	T	196756	1:55524222:C:T	Uncertain significance	3/21/17	"The R469W variant has been reported in one individual with severe hypercholesterolemia, who was also heterozygous for a variant in the LDLR gene (Allard et al., 2005). Subsequently, an individual with elevated LDL-C was found to harbor this variant in isolation (Wang et al., 2016). The R469W variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. Nevertheless, this substitution occurs at a position that is not conserved across species, where W469 is wild-type in at least one mammalian species. Additionally, the majority of in silico analyses (2 out of 3) predict this variant likely does not alter the protein structure/function. Though R469W was presumed to be a gain-of-function variant by Hampton et al. (2007), in vitro functional analysis showed no effect on the ability of the PCSK9-encoded protein to bind Annexin A2, a protein responsible for inhibiting PCSK9-endoded protein activity (Ly et al,. 2014). Therefore, the mechanism by which this variant may result in disease is unclear. Furthermore, the Exome Aggregation Consortium reports R469W was observed in 80/10392 (0.8%) alleles from individuals of African background, including two individuals of African background who were homozygous for the variant. Of note, this variant has been reported in individuals of African descent with high LDL, though the association was not statistically significant (Kotowski et al., 2006). It has also been identified in two individuals of African Canadian descent from the general population who also harbored other PCSK9 variants (Mayne et al., 2013). Ultimately, the possibility that this variant may have a mild clinical effect and/or function as a genetic modifier for disease can not be excluded, at this time."	not specified	CN169374:not specified	severe hypercholesterolemia	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	GeneDx	SCV000234926.12	SCV000234926		PCSK9	-	Low LDL	12/7/17	46960	3	122	"[0.9987010221465077,0.0012989778534923339]"	122	SCV00023492677772	single nucleotide variant	NM_170707.3(LMNA):c.1908C>T (p.Ser636=)	4000	LMNA	HGNC:6636	Pathogenic	1	30-Apr-15	80356814	-	RCV000192236;RCV000057372	"MedGen:C0007959,Orphanet:ORPHA166,SNOMED CT:50548001;MedGen:CN517202"	Charcot-Marie-Tooth disease;not provided	germline	germline	GRCh37	NC_000001.10	1	156108488	156108488	C	T	1q22	no assertion criteria provided	2	"ACMG2013,ACMG2016"	N	-	3	66875	1	156108488	C	T	77772	1:156108488:C:T	Pathogenic	4/30/15	-	Charcot-Marie-Tooth disease	C0007959:Charcot-Marie-Tooth disease	NA	FALSE	Incorrect phenotype	no assertion criteria provided	literature only	germline:na	GeneReviews	SCV000239884.1	SCV000239884		LMNA	-	"Lipodystrophy, MonogenicDM_all"	4/30/15	46948	15	2	"[0.9999786998381188,2.1300161881230296E-5]"	2	SCV00023988429537	single nucleotide variant	NM_170707.3(LMNA):c.892C>T (p.Arg298Cys)	4000	LMNA	HGNC:6636	Pathogenic	1	8-Jun-18	59885338	-	RCV000192238;RCV000015590;RCV000653885;RCV000057479	"MedGen:C0007959,Orphanet:ORPHA166,SNOMED CT:50548001;MedGen:C1854154,OMIM:605588,Orphanet:ORPHA98856;MedGen:C0270914,Orphanet:ORPHA64746;MedGen:CN517202"	"Charcot-Marie-Tooth disease;Charcot-Marie-Tooth disease type 2B1;Charcot-Marie-Tooth disease, type 2;not provided"	germline	germline	GRCh37	NC_000001.10	1	156105059	156105059	C	T	1q22	"criteria provided, multiple submitters, no conflicts"	5	"ACMG2013,ACMG2016"	N	"OMIM Allelic Variant:150330.0020,UniProtKB (protein):P02545#VAR_017661"	3	14498	1	156105059	C	T	29537	1:156105059:C:T	Pathogenic	4/30/15	-	Charcot-Marie-Tooth disease	C0007959:Charcot-Marie-Tooth disease	NA	FALSE	Incorrect phenotype	no assertion criteria provided	literature only	germline:na	GeneReviews	SCV000239886.1	SCV000239886		LMNA	-	"Lipodystrophy, MonogenicDM_all"	6/8/18	46953	10	2	"[0.9999787021063616,2.129789363831917E-5]"	2	SCV00023988629526	single nucleotide variant	NM_170707.3(LMNA):c.1579C>T (p.Arg527Cys)	4000	LMNA	HGNC:6636	Pathogenic	1	16-Nov-15	57318642	-	RCV000192240;RCV000192011;RCV000015576;RCV000057324	"MedGen:C0007959,Orphanet:ORPHA166,SNOMED CT:50548001;MedGen:C0033300,OMIM:176670,Orphanet:ORPHA740,SNOMED CT:238870004;MedGen:C0432291,OMIM:248370,Orphanet:ORPHA2457,SNOMED CT:109419009;MedGen:CN517202"	Charcot-Marie-Tooth disease;Hutchinson-Gilford syndrome;Mandibuloacral dysostosis;not provided	germline	germline	GRCh37	NC_000001.10	1	156106994	156106994	C	T	1q22	"criteria provided, single submitter"	4	"ACMG2013,ACMG2016"	N	"OMIM Allelic Variant:150330.0026,UniProtKB (protein):P02545#VAR_017663"	3	14487	1	156106994	C	T	29526	1:156106994:C:T	Pathogenic	4/30/15	-	Charcot-Marie-Tooth disease	C0007959:Charcot-Marie-Tooth disease	NA	FALSE	Incorrect phenotype	no assertion criteria provided	literature only	germline:na	GeneReviews	SCV000239888.1	SCV000239888		LMNA	-	"Lipodystrophy, MonogenicDM_all"	11/16/15	46874	89	3	"[0.9999679993173187,3.2000682681230535E-5]"	3	SCV00023988829525	single nucleotide variant	NM_170707.3(LMNA):c.1445G>A (p.Arg482Gln)	4000	LMNA	HGNC:6636	Pathogenic	1	31-Oct-18	11575937	-	RCV000763258;RCV000763258;RCV000459624;RCV000763258;RCV000763258;RCV000763258;RCV000190399;RCV000763258;RCV000015575;RCV000763258;RCV000763258;RCV000763258;RCV000041318;RCV000763258;RCV000763258;RCV000754814;RCV000148600;RCV000057299	"MedGen:C0410190,OMIM:181350,Orphanet:ORPHA98853,SNOMED CT:240072005;MedGen:C1854154,OMIM:605588,Orphanet:ORPHA98856;MedGen:C0270914,Orphanet:ORPHA64746;MedGen:C2750785,OMIM:613205,Orphanet:ORPHA157973;MedGen:C1449563,OMIM:115200,Orphanet:ORPHA300751;MedGen:C0796031,OMIM:212112,Orphanet:ORPHA2229;MedGen:C2750035,OMIM:616516,Orphanet:ORPHA98855;MedGen:C2750035,OMIM:616516,Orphanet:ORPHA98855;MedGen:C1720860,OMIM:151660,Orphanet:ORPHA2348;MedGen:C1720860,OMIM:151660,Orphanet:ORPHA2348;MedGen:C1857829,OMIM:610140,Orphanet:ORPHA168796;MedGen:C0033300,OMIM:176670,Orphanet:ORPHA740,SNOMED CT:238870004;MedGen:CN236383,Orphanet:ORPHA98301;MedGen:C0406585,OMIM:275210,Orphanet:ORPHA1662,SNOMED CT:400128006;MedGen:C0432291,OMIM:248370,Orphanet:ORPHA2457,SNOMED CT:109419009;MedGen:C3888631;MedGen:CN221589;MedGen:CN517202"	"Benign scapuloperoneal muscular dystrophy with cardiomyopathy;Charcot-Marie-Tooth disease type 2B1;Charcot-Marie-Tooth disease, type 2;Congenital muscular dystrophy, LMNA-related;Dilated cardiomyopathy 1A;Dilated cardiomyopathy-hypergonadotropic hypogonadism syndrome;Emery-Dreifuss muscular dystrophy 3, autosomal recessive;Emery-Dreifuss muscular dystrophy 3, autosomal recessive;Familial partial lipodystrophy 2;Familial partial lipodystrophy 2;Heart-hand syndrome, Slovenian type;Hutchinson-Gilford syndrome;Laminopathy;Lethal tight skin contracture syndrome;Mandibuloacral dysostosis;Monogenic diabetes;Partial lipodystrophy, Dunnigan;not provided"	de novo;germline;unknown	germline	GRCh37	NC_000001.10	1	156106776	156106776	G	A	1q22	"criteria provided, multiple submitters, no conflicts"	10	"ACMG2013,ACMG2016"	N	"OMIM Allelic Variant:150330.0010,UniProtKB (protein):P02545#VAR_009992"	3	14486	1	156106776	G	A	29525	1:156106776:G:A	Pathogenic	3/1/13	-	"EMERY-DREIFUSS MUSCULAR DYSTROPHY 3, AUTOSOMAL RECESSIVE"	"C2750035:Emery-Dreifuss muscular dystrophy 3, autosomal recessive"	NA	FALSE	Incorrect phenotype	no assertion criteria provided	literature only	germline:na	OMIM	SCV000243941.2	SCV000243941		LMNA	-	"Lipodystrophy, MonogenicDM_all"	10/31/18	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV00024394124073	single nucleotide variant	NM_002052.4(GATA4):c.1273G>A (p.Asp425Asn)	2626	GATA4	HGNC:4173	Conflicting interpretations of pathogenicity	1	8-Dec-17	56208331	-	RCV000009600;RCV000549514;RCV000190715;RCV000626818;RCV000626818;RCV000009601;RCV000626818;RCV000431077	"MedGen:C1842778,OMIM:607941;MedGen:C3280781,OMIM:614430;MeSH:D030342,MedGen:C0950123;Human Phenotype Ontology:HP:0010882,MedGen:CN116616;Human Phenotype Ontology:HP:0001642,MedGen:C1956257,OMIM:265500;Human Phenotype Ontology:HP:0001636,MedGen:C0039685,OMIM:187500,Orphanet:ORPHA3303,SNOMED CT:86299006;Human Phenotype Ontology:HP:0005180,MedGen:C0040961;MedGen:CN517202"	Atrial septal defect 2;Atrioventricular septal defect 4;Inborn genetic diseases;Pulmonary valve atresia;Pulmonic stenosis;Tetralogy of Fallot;Tricuspid regurgitation;not provided	germline;unknown	germline	GRCh37	NC_000008.10	8	11615928	11615928	G	A	8p23.1	"criteria provided, conflicting interpretations"	5	NA	N	"OMIM Allelic Variant:600576.0005,UniProtKB (protein):P43694#VAR_067621"	3	9034	8	11615928	G	A	24073	8:11615928:G:A	Uncertain significance	7/1/13	-	Inborn genetic diseases	C0950123:Inborn genetic diseases	NA	FALSE	Not trait of interest	"criteria provided, single submitter"	clinical testing	germline:1	Ambry Genetics	SCV000244156.4	SCV000244156		GATA4	-	"MonogenicDM_all, Neonatal Diabetes"	12/8/17	46963	0	221	"[0.9976470838745395,0.002352916125460469]"	217	SCV000244156207484	single nucleotide variant	NM_000162.3(GCK):c.370G>A (p.Asp124Asn)	2645	GCK	HGNC:4195	Conflicting interpretations of pathogenicity	1	1-Jun-17	759072800	-	RCV000193215;RCV000518229	"MedGen:C1841962,OMIM:125851;MedGen:CN169374"	"Maturity-onset diabetes of the young,  type 2;not specified"	germline	germline	GRCh37	NC_000007.13	7	44190668	44190668	C	T	7p13	"criteria provided, conflicting interpretations"	2	NA	N	-	2	211073	7	44190668	C	T	207484	7:44190668:C:T	Likely pathogenic	1/21/15	-	"MODY, type II"	"C1841962:Maturity-onset diabetes of the young, type 2"	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	"Genetic Services Laboratory, University of Chicago"	SCV000247467.1	SCV000247467		GCK	-	"MODY, MODY Extended, MonogenicDM_all"	6/1/17	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV00024746745028	single nucleotide variant	NM_000457.4(HNF4A):c.991C>T (p.Arg331Cys)	3172	HNF4A	HGNC:5024	Conflicting interpretations of pathogenicity	1	21-Dec-16	193922479	-	RCV000193933;RCV000030034;RCV000517103	"Human Phenotype Ontology:HP:0000842,MedGen:C0020459;MedGen:C1852093,OMIM:125850;MedGen:CN169374"	"Hyperinsulinemia;Maturity-onset diabetes of the young,  type 1;not specified"	germline	germline	GRCh37	NC_000020.10	20	43052756	43052756	C	T	20q13.1	"criteria provided, conflicting interpretations"	3	NA	N	-	2	36364	20	43052756	C	T	45028	20:43052756:C:T	Likely pathogenic	6/1/15	-	Hyperinsulinemia	C0020459:Hyperinsulinemia	NA	FALSE	Not trait of interest	"criteria provided, single submitter"	clinical testing	germline:na	"Genetic Services Laboratory, University of Chicago"	SCV000247565.1	SCV000247565		HNF4A	-	"MODY, MODY Extended, MonogenicDM_all"	12/21/16	46938	25	1	"[0.9999893476500916,1.065234990838979E-5]"	1	SCV000247565207840	single nucleotide variant	NM_000525.3(KCNJ11):c.79C>T (p.Arg27Cys)	3767	KCNJ11	HGNC:6257	Conflicting interpretations of pathogenicity	1	26-May-17	752507753	-	RCV000193401;RCV000675066;RCV000675066;RCV000675066	"MedGen:C2931833,OMIM:601820,SNOMED CT:42681006;MedGen:C2931833,OMIM:601820,SNOMED CT:42681006;MedGen:C1833104,OMIM:606176,Orphanet:ORPHA99885;MedGen:C1864623,OMIM:610582"	Islet cell hyperplasia;Islet cell hyperplasia;Permanent neonatal diabetes mellitus;Transient neonatal diabetes mellitus 3	germline;unknown	germline	GRCh37	NC_000011.9	11	17409560	17409560	G	A	11p15.1	"criteria provided, conflicting interpretations"	2	NA	N	-	2	211226	11	17409560	G	A	207840	11:17409560:G:A	Likely pathogenic	2/24/15	-	"Hyperinsulinemic hypoglycemia, familial, 2"	C2931833:Islet cell hyperplasia	NA	FALSE	Not trait of interest	"criteria provided, single submitter"	clinical testing	germline:na	"Genetic Services Laboratory, University of Chicago"	SCV000247653.1	SCV000247653		KCNJ11	-	"MODY Extended, MonogenicDM_all, Neonatal Diabetes"	5/26/17	46963	0	2	"[0.9999787066413985,2.1293358601452207E-5]"	2	SCV00024765323725	single nucleotide variant	NM_000525.3(KCNJ11):c.844G>A (p.Glu282Lys)	3767	KCNJ11	HGNC:6257	Pathogenic/Likely pathogenic	1	31-Oct-18	267607196	-	RCV000763231;RCV000009223;RCV000763231;RCV000763231;RCV000763231;RCV000763231	"Human Phenotype Ontology:HP:0005978,MedGen:C0011860,OMIM:125853,Orphanet:ORPHA181376,SNOMED CT:44054006;MedGen:C2931833,OMIM:601820,SNOMED CT:42681006;MedGen:C2931833,OMIM:601820,SNOMED CT:42681006;MedGen:C4225365,OMIM:616329;MedGen:C1833104,OMIM:606176,Orphanet:ORPHA99885;MedGen:C1864623,OMIM:610582"	"Diabetes mellitus type 2;Islet cell hyperplasia;Islet cell hyperplasia;Maturity-onset diabetes of the young, type 13;Permanent neonatal diabetes mellitus;Transient neonatal diabetes mellitus 3"	germline;unknown	germline	GRCh37	NC_000011.9	11	17408795	17408795	C	T	11p15.1	"criteria provided, multiple submitters, no conflicts"	3	NA	N	OMIM Allelic Variant:600937.0022	3	8686	11	17408795	C	T	23725	11:17408795:C:T	Pathogenic	1/5/15	-	"Hyperinsulinemic hypoglycemia, familial, 2"	C2931833:Islet cell hyperplasia	NA	FALSE	Not trait of interest	"criteria provided, single submitter"	clinical testing	germline:na	"Genetic Services Laboratory, University of Chicago"	SCV000247655.1	SCV000247655		KCNJ11	-	"MODY Extended, MonogenicDM_all, Neonatal Diabetes"	10/31/18	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV000247655207832	single nucleotide variant	NM_000525.3(KCNJ11):c.881C>T (p.Thr294Met)	3767	KCNJ11	HGNC:6257	Pathogenic/Likely pathogenic	1	18-Aug-17	780957825	-	RCV000192330;RCV000668887;RCV000668887;RCV000668887	"MedGen:C2931833,OMIM:601820,SNOMED CT:42681006;MedGen:C2931833,OMIM:601820,SNOMED CT:42681006;MedGen:C1833104,OMIM:606176,Orphanet:ORPHA99885;MedGen:C1864623,OMIM:610582"	Islet cell hyperplasia;Islet cell hyperplasia;Permanent neonatal diabetes mellitus;Transient neonatal diabetes mellitus 3	germline;unknown	germline	GRCh37	NC_000011.9	11	17408758	17408758	G	A	11p15.1	"criteria provided, multiple submitters, no conflicts"	2	NA	N	-	2	211230	11	17408758	G	A	207832	11:17408758:G:A	Pathogenic	5/18/15	-	"Hyperinsulinemic hypoglycemia, familial, 2"	C2931833:Islet cell hyperplasia	NA	FALSE	Not trait of interest	"criteria provided, single submitter"	clinical testing	germline:na	"Genetic Services Laboratory, University of Chicago"	SCV000247658.1	SCV000247658		KCNJ11	-	"MODY Extended, MonogenicDM_all, Neonatal Diabetes"	8/18/17	46963	0	7	"[0.9999254732448949,7.452675510508272E-5]"	7	SCV00024765829537	single nucleotide variant	NM_170707.3(LMNA):c.892C>T (p.Arg298Cys)	4000	LMNA	HGNC:6636	Pathogenic	1	8-Jun-18	59885338	-	RCV000192238;RCV000015590;RCV000653885;RCV000057479	"MedGen:C0007959,Orphanet:ORPHA166,SNOMED CT:50548001;MedGen:C1854154,OMIM:605588,Orphanet:ORPHA98856;MedGen:C0270914,Orphanet:ORPHA64746;MedGen:CN517202"	"Charcot-Marie-Tooth disease;Charcot-Marie-Tooth disease type 2B1;Charcot-Marie-Tooth disease, type 2;not provided"	germline	germline	GRCh37	NC_000001.10	1	156105059	156105059	C	T	1q22	"criteria provided, multiple submitters, no conflicts"	5	"ACMG2013,ACMG2016"	N	"OMIM Allelic Variant:150330.0020,UniProtKB (protein):P02545#VAR_017661"	3	14498	1	156105059	C	T	29537	1:156105059:C:T	Pathogenic	11/18/14	-	Charcot-Marie-Tooth disease type 2B1	C1854154:Charcot-Marie-Tooth disease type 2B1	NA	FALSE	Incorrect phenotype	"criteria provided, single submitter"	clinical testing	germline:na	Athena Diagnostics Inc	SCV000255789.2	SCV000255789		LMNA	-	"Lipodystrophy, MonogenicDM_all"	6/8/18	46953	10	2	"[0.9999787021063616,2.129789363831917E-5]"	2	SCV00025578924127	single nucleotide variant	NM_001287174.1(ABCC8):c.3992-9G>A	6833	ABCC8	HGNC:59	Pathogenic	1	5-Jun-17	151344623	-	RCV000590487;RCV000009656;RCV000144995	"MedGen:C3888018,Orphanet:ORPHA276525;MedGen:C2931832,OMIM:256450,SNOMED CT:360339005;MedGen:CN517202"	Familial hyperinsulinism;Persistent hyperinsulinemic hypoglycemia of infancy;not provided	germline;unknown	germline	GRCh37	NC_000011.9	11	17418602	17418602	C	T	11p15.1	"criteria provided, multiple submitters, no conflicts"	7	NA	N	OMIM Allelic Variant:600509.0002	3	9088	11	17418602	C	T	24127	11:17418602:C:T	Pathogenic	10/7/15	-	Not provided	CN517202:not provided	No Information	FALSE	No Information	no assertion criteria provided	clinical testing	germline:15	"Division of Genomic Diagnostics,The Children's Hospital of Philadelphia"	SCV000256803.1	SCV000256803		ABCC8	-	"MODY Extended, MonogenicDM_all, Neonatal Diabetes"	6/5/17	46963	0	15	"[0.9998402998104892,1.5970018951089155E-4]"	15	SCV000256803214505	single nucleotide variant	NM_001287174.1(ABCC8):c.72C>A (p.Asn24Lys)	6833	ABCC8	HGNC:59	Pathogenic	1	27-Oct-15	771075821	-	RCV000201893	MedGen:CN517202	not provided	germline	germline	GRCh37	NC_000011.9	11	17498252	17498252	G	T	11p15.1	no assertion criteria provided	1	NA	N	-	2	217847	11	17498252	G	T	214505	11:17498252:G:T	Pathogenic	10/27/15	-	Not provided	CN517202:not provided	No Information	FALSE	No Information	no assertion criteria provided	clinical testing	germline:1	"Division of Genomic Diagnostics,The Children's Hospital of Philadelphia"	SCV000256807.1	SCV000256807		ABCC8	-	"MODY Extended, MonogenicDM_all, Neonatal Diabetes"	10/27/15	46903	60	1	"[0.9999893397010852,1.0660298914781571E-5]"	1	SCV000256807186816	single nucleotide variant	NM_001287174.1(ABCC8):c.2509C>T (p.Arg837Ter)	6833	ABCC8	HGNC:59	Pathogenic/Likely pathogenic	1	31-Oct-18	72559722	-	RCV000763234;RCV000763234;RCV000763234;RCV000169276;RCV000763234;RCV000763234;RCV000201895	"Human Phenotype Ontology:HP:0005978,MedGen:C0011860,OMIM:125853,Orphanet:ORPHA181376,SNOMED CT:44054006;MedGen:C0271714,OMIM:240800,SNOMED CT:62151007;MedGen:C1833104,OMIM:606176,Orphanet:ORPHA99885;MedGen:C2931832,OMIM:256450,SNOMED CT:360339005;MedGen:C2931832,OMIM:256450,SNOMED CT:360339005;MedGen:C1835887,OMIM:610374;MedGen:CN517202"	Diabetes mellitus type 2;Leucine-induced hypoglycemia;Permanent neonatal diabetes mellitus;Persistent hyperinsulinemic hypoglycemia of infancy;Persistent hyperinsulinemic hypoglycemia of infancy;Transient neonatal diabetes mellitus 2;not provided	germline;unknown	germline	GRCh37	NC_000011.9	11	17434263	17434263	G	A	11p15.1	"criteria provided, multiple submitters, no conflicts"	5	NA	N	-	2	188915	11	17434263	G	A	186816	11:17434263:G:A	Pathogenic	10/7/15	-	Not provided	CN517202:not provided	No Information	FALSE	No Information	no assertion criteria provided	clinical testing	germline:1	"Division of Genomic Diagnostics,The Children's Hospital of Philadelphia"	SCV000256810.1	SCV000256810		ABCC8	-	"MODY Extended, MonogenicDM_all, Neonatal Diabetes"	10/31/18	46955	8	12	"[0.9998722180811416,1.2778191885848153E-4]"	12	SCV00025681045114	single nucleotide variant	NM_000527.4(LDLR):c.1061-8T>C	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	31-May-18	72658861	-	RCV000030123;RCV000759074;RCV000245346	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202;MedGen:CN169374"	Familial hypercholesterolemia;not provided;not specified	germline;unknown	germline	GRCh37	NC_000019.9	19	11222182	11222182	T	C	19p13.2	"criteria provided, conflicting interpretations"	15	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000154	2	36451	19	11222182	T	C	45114	19:11222182:T:C	Likely benign	6/17/15	-	Familial hypercholesterolemia	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	unknown:na	"Division of Genomic Diagnostics,The Children's Hospital of Philadelphia"	SCV000257699.2	SCV000257699		LDLR	-	High LDL	5/31/18	46960	3	426	"[0.9954642248722317,0.004535775127768314]"	420	SCV000257699226972	single nucleotide variant	NM_000527.4(LDLR):c.190+4A>T	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	23-Oct-17	769446356	-	RCV000211667;RCV000210581;RCV000523458	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MeSH:D030342,MedGen:C0950123;MedGen:CN517202"	Familial hypercholesterolemia;Inborn genetic diseases;not provided	germline;not applicable	germline	GRCh37	NC_000019.9	19	11211025	11211025	A	T	19p13.2	"criteria provided, conflicting interpretations"	8	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000028	2	225097	19	11211025	A	T	226972	19:11211025:A:T	Uncertain significance	6/25/14	Lines of evidence used in support of classification: POSITIVE: Relevant Alteration(s) Detected	MeSH:D030342	C0950123:Inborn genetic diseases	Familial Hypercholesterolemia	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:1	Ambry Genetics	SCV000263003.4	SCV000263003		LDLR	-	High LDL	10/23/17	46963	0	2	"[0.9999787066413985,2.1293358601452207E-5]"	2	SCV00026300318734	single nucleotide variant	NM_000527.4(LDLR):c.1291G>A (p.Ala431Thr)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	30-Mar-17	28942079	-	RCV000003883	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline;unknown	germline	GRCh37	NC_000019.9	19	11224058	11224058	G	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	13	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000184,OMIM Allelic Variant:606945.0010,UniProtKB (protein):P01130#VAR_005384"	3	3695	19	11224058	G	A	18734	19:11224058:G:A	Likely pathogenic	9/17/15	-	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:1	"Blueprint Genetics,"	SCV000264001.2	SCV000264001		LDLR	-	High LDL	3/30/17	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV00026400118738	single nucleotide variant	NM_000527.4(LDLR):c.2043C>A (p.Cys681Ter)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	31-Oct-18	121908031	-	RCV000003887;RCV000590806;RCV000481771	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:CN517202"	Familial hypercholesterolemia;Familial hypercholesterolemias;not provided	germline;unknown	germline	GRCh37	NC_000019.9	19	11231101	11231101	C	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	18	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_001592,OMIM Allelic Variant:606945.0016"	3	3699	19	11231101	C	A	18738	19:11231101:C:A	Pathogenic	11/2/15	-	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:1	"Blueprint Genetics,"	SCV000264002.2	SCV000264002		LDLR	-	High LDL	10/31/18	46958	5	1	"[0.9999893521870608,1.0647812939222283E-5]"	1	SCV00026400257261	single nucleotide variant	NM_170707.3(LMNA):c.976T>A (p.Ser326Thr)	4000	LMNA	HGNC:6636	Conflicting interpretations of pathogenicity	1	21-Nov-18	56851164	-	RCV000621488;RCV000544253;RCV000755678;RCV000208012;RCV000057494;RCV000212504	"MedGen:CN230736;MedGen:C0270914,Orphanet:ORPHA64746;MedGen:C1449563,OMIM:115200,Orphanet:ORPHA300751;MedGen:C0949658,Orphanet:ORPHA155,SNOMED CT:83978005;MedGen:CN517202;MedGen:CN169374"	"Cardiovascular phenotype;Charcot-Marie-Tooth disease, type 2;Dilated cardiomyopathy 1A;Primary familial hypertrophic cardiomyopathy;not provided;not specified"	germline;unknown	germline	GRCh37	NC_000001.10	1	156105731	156105731	T	A	1q22	"criteria provided, conflicting interpretations"	8	"ACMG2013,ACMG2016"	N	-	2	48097	1	156105731	T	A	57261	1:156105731:T:A	Likely pathogenic	9/14/15	-	MedGen:C0949658	C0949658:Primary familial hypertrophic cardiomyopathy	NA	FALSE	Incorrect phenotype	"criteria provided, single submitter"	clinical testing	germline:1	"Blueprint Genetics,"	SCV000264011.2	SCV000264011		LMNA	-	"Lipodystrophy, MonogenicDM_all"	11/21/18	46959	4	3	"[0.9999680572414233,3.1942758576630676E-5]"	3	SCV00026401139058	single nucleotide variant	NM_002052.4(GATA4):c.1220C>A (p.Pro407Gln)	2626	GATA4	HGNC:4173	Conflicting interpretations of pathogenicity	1	21-Mar-17	115099192	-	RCV000490358;RCV000490358;RCV000526826;RCV000023008;RCV000030949;RCV000490358	"MedGen:C1842778,OMIM:607941;MedGen:C3280781,OMIM:614430;MedGen:C3280781,OMIM:614430;Human Phenotype Ontology:HP:0001636,MedGen:C0039685,OMIM:187500,Orphanet:ORPHA3303,SNOMED CT:86299006;MedGen:C3280777,OMIM:614429;MedGen:C3280777,OMIM:614429"	Atrial septal defect 2;Atrioventricular septal defect 4;Atrioventricular septal defect 4;Tetralogy of Fallot;Ventricular septal defect 1;Ventricular septal defect 1	germline	germline	GRCh37	NC_000008.10	8	11615875	11615875	C	A	8p23.1	"criteria provided, conflicting interpretations"	3	NA	N	"OMIM Allelic Variant:600576.0011,OMIM Allelic Variant:600576.0013,UniProtKB (protein):P43694#VAR_067619"	3	30103	8	11615875	C	A	39058	8:11615875:C:A	Uncertain significance	3/18/16	-	OMIM:607941;OMIM:614429;OMIM:614430	C1842778:Atrial septal defect 2;C3280777:Ventricular septal defect 1;C3280781:Atrioventricular septal defect 4	NA	FALSE	Not trait of interest	"criteria provided, single submitter"	reference population	germline:3	"Soonchunhyang University Bucheon Hospital,Soonchunhyang University Medical Center"	SCV000267333.1	SCV000267333		GATA4	-	"MonogenicDM_all, Neonatal Diabetes"	3/21/17	46963	0	85	"[0.9990950322594383,9.049677405617188E-4]"	85	SCV00026733318780	single nucleotide variant	NM_000527.4(LDLR):c.131G>A (p.Trp44Ter)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	14-Nov-17	267607213	-	RCV000003939	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline;inherited	germline	GRCh37	NC_000019.9	19	11210962	11210962	G	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	13	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000019,OMIM Allelic Variant:606945.0060"	3	3741	19	11210962	G	A	18780	19:11210962:G:A	Pathogenic	7/22/08	-	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	no assertion criteria provided	clinical testing	germline:1	"Cardiovascular Genetics Laboratory,PathWest Laboratory Medicine WA - Fiona Stanley Hospital"	SCV000268535.1	SCV000268535		LDLR	-	High LDL	11/14/17	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV000268535226972	single nucleotide variant	NM_000527.4(LDLR):c.190+4A>T	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	23-Oct-17	769446356	-	RCV000211667;RCV000210581;RCV000523458	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MeSH:D030342,MedGen:C0950123;MedGen:CN517202"	Familial hypercholesterolemia;Inborn genetic diseases;not provided	germline;not applicable	germline	GRCh37	NC_000019.9	19	11211025	11211025	A	T	19p13.2	"criteria provided, conflicting interpretations"	8	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000028	2	225097	19	11211025	A	T	226972	19:11211025:A:T	Pathogenic	3/18/10	-	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	no assertion criteria provided	clinical testing	germline:3	"Cardiovascular Genetics Laboratory,PathWest Laboratory Medicine WA - Fiona Stanley Hospital"	SCV000268537.1	SCV000268537		LDLR	-	High LDL	10/23/17	46963	0	2	"[0.9999787066413985,2.1293358601452207E-5]"	2	SCV000268537228117	single nucleotide variant	NM_000527.4(LDLR):c.81C>G (p.Cys27Trp)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	30-Mar-17	2228671	-	RCV000211569;RCV000588365	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445"	Familial hypercholesterolemia;Familial hypercholesterolemias	germline;unknown	germline	GRCh37	NC_000019.9	19	11210912	11210912	C	G	19p13.2	"criteria provided, conflicting interpretations"	10	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000352,UniProtKB (protein):P01130#VAR_005304"	2	226304	19	11210912	C	G	228117	19:11210912:C:G	Pathogenic	4/16/12	-	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	no assertion criteria provided	clinical testing	germline:1	"Cardiovascular Genetics Laboratory,PathWest Laboratory Medicine WA - Fiona Stanley Hospital"	SCV000268538.1	SCV000268538		LDLR	-	High LDL	3/30/17	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV00026853818724	single nucleotide variant	NM_000527.4(LDLR):c.259T>G (p.Trp87Gly)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	8-Jun-18	121908025	-	RCV000003870;RCV000622852	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202"	Familial hypercholesterolemia;not provided	germline;inherited	germline	GRCh37	NC_000019.9	19	11213408	11213408	T	G	19p13.2	"criteria provided, multiple submitters, no conflicts"	11	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_001671,OMIM Allelic Variant:606945.0003,UniProtKB (protein):P01130#VAR_005308"	3	3685	19	11213408	T	G	18724	19:11213408:T:G	Pathogenic	12/18/08	-	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	no assertion criteria provided	clinical testing	germline:6	"Cardiovascular Genetics Laboratory,PathWest Laboratory Medicine WA - Fiona Stanley Hospital"	SCV000268547.1	SCV000268547		LDLR	-	High LDL	6/8/18	46963	0	3	"[0.9999680599620978,3.194003790217831E-5]"	3	SCV000268547171199	single nucleotide variant	NM_000527.4(LDLR):c.301G>A (p.Glu101Lys)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	31-Oct-18	144172724	-	RCV000211583;RCV000148571;RCV000162016	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202"	Familial hypercholesterolemia;Hypercholesterolaemia;not provided	germline;not applicable;unknown	germline	GRCh37	NC_000019.9	19	11213450	11213450	G	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	15	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000044,UniProtKB (protein):P01130#VAR_005315"	2	161266	19	11213450	G	A	171199	19:11213450:G:A	Pathogenic	6/5/08	-	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	no assertion criteria provided	clinical testing	germline:7	"Cardiovascular Genetics Laboratory,PathWest Laboratory Medicine WA - Fiona Stanley Hospital"	SCV000268550.1	SCV000268550		LDLR	-	High LDL	10/31/18	46963	0	3	"[0.9999680599620978,3.194003790217831E-5]"	3	SCV000268550228138	single nucleotide variant	NM_000527.4(LDLR):c.429C>A (p.Cys143Ter)	3949	LDLR	HGNC:6547	Pathogenic	1	5-Dec-17	199774121	-	RCV000211567	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline	germline	GRCh37	NC_000019.9	19	11216011	11216011	C	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	7	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_001734	2	226325	19	11216011	C	A	228138	19:11216011:C:A	Pathogenic	2/18/16	-	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	no assertion criteria provided	clinical testing	germline:1	"Cardiovascular Genetics Laboratory,PathWest Laboratory Medicine WA - Fiona Stanley Hospital"	SCV000268564.1	SCV000268564		LDLR	-	High LDL	12/5/17	46963	0	2	"[0.9999787066413985,2.1293358601452207E-5]"	2	SCV000268564181228	single nucleotide variant	NM_000527.4(LDLR):c.502G>A (p.Asp168Asn)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	28-Jun-18	200727689	-	RCV000211669;RCV000162017	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202"	Familial hypercholesterolemia;not provided	germline;not applicable;unknown	germline	GRCh37	NC_000019.9	19	11216084	11216084	G	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	7	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_001749,UniProtKB (protein):P01130#VAR_005322"	2	183136	19	11216084	G	A	181228	19:11216084:G:A	Pathogenic	4/4/14	-	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	no assertion criteria provided	clinical testing	germline:1	"Cardiovascular Genetics Laboratory,PathWest Laboratory Medicine WA - Fiona Stanley Hospital"	SCV000268566.1	SCV000268566		LDLR	-	High LDL	6/28/18	46963	0	2	"[0.9999787066413985,2.1293358601452207E-5]"	2	SCV00026856618765	single nucleotide variant	NM_000527.4(LDLR):c.523G>A (p.Asp175Asn)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	2-Jan-18	121908033	-	RCV000003924	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline	germline	GRCh37	NC_000019.9	19	11216105	11216105	G	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	7	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_001755,OMIM Allelic Variant:606945.0044,UniProtKB (protein):P01130#VAR_005326"	3	3726	19	11216105	G	A	18765	19:11216105:G:A	Pathogenic	1/9/15	-	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	no assertion criteria provided	clinical testing	germline:1	"Cardiovascular Genetics Laboratory,PathWest Laboratory Medicine WA - Fiona Stanley Hospital"	SCV000268568.1	SCV000268568		LDLR	-	High LDL	1/2/18	46963	0	2	"[0.9999787066413985,2.1293358601452207E-5]"	2	SCV000268568228142	deletion	NM_000527.4(LDLR):c.654_656delTGG (p.Gly219del)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	25-Jun-18	121908027	-	RCV000211647;RCV000589051;RCV000489033	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:CN517202"	Familial hypercholesterolemia;Familial hypercholesterolemias;not provided	germline;inherited;not applicable	germline	GRCh37	NC_000019.9	19	11216236	11216238	TGG	-	19p13.2	"criteria provided, multiple submitters, no conflicts"	14	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000094,OMIM Allelic Variant:606945.0005"	3	226329	19	11216232	ATGG	A	228142	19:11216232:ATGG:A	Pathogenic	2/12/09	-	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	no assertion criteria provided	clinical testing	germline:1	"Cardiovascular Genetics Laboratory,PathWest Laboratory Medicine WA - Fiona Stanley Hospital"	SCV000268574.1	SCV000268574		LDLR	-	High LDL	6/25/18	46962	1	1	"[0.9999893530939908,1.0646906009113752E-5]"	1	SCV000268574181233	single nucleotide variant	NM_000527.4(LDLR):c.662A>G (p.Asp221Gly)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	3-Apr-17	373822756	-	RCV000211655;RCV000161962	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202"	Familial hypercholesterolemia;not provided	germline;inherited;not applicable	germline	GRCh37	NC_000019.9	19	11216244	11216244	A	G	19p13.2	"criteria provided, multiple submitters, no conflicts"	14	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000096,UniProtKB (protein):P01130#VAR_005332"	2	183092	19	11216244	A	G	181233	19:11216244:A:G	Pathogenic	12/12/09	-	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	no assertion criteria provided	clinical testing	germline:3	"Cardiovascular Genetics Laboratory,PathWest Laboratory Medicine WA - Fiona Stanley Hospital"	SCV000268577.1	SCV000268577		LDLR	-	High LDL	4/3/17	46959	4	1	"[0.9999893524138078,1.0647586192210225E-5]"	1	SCV00026857718729	single nucleotide variant	NM_000527.4(LDLR):c.681C>G (p.Asp227Glu)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	30-Jun-17	121908028	-	RCV000003876	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline;not applicable	germline	GRCh37	NC_000019.9	19	11216263	11216263	C	G	19p13.2	"criteria provided, multiple submitters, no conflicts"	10	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_001815,OMIM Allelic Variant:606945.0006,UniProtKB (protein):P01130#VAR_005338"	3	3690	19	11216263	C	G	18729	19:11216263:C:G	Pathogenic	6/25/08	-	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	no assertion criteria provided	clinical testing	germline:14	"Cardiovascular Genetics Laboratory,PathWest Laboratory Medicine WA - Fiona Stanley Hospital"	SCV000268580.1	SCV000268580		LDLR	-	High LDL	6/30/17	46946	17	1	"[0.9999893494653431,1.0650534656839773E-5]"	1	SCV00026858018730	single nucleotide variant	NM_000527.4(LDLR):c.682G>A (p.Glu228Lys)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	31-Oct-18	121908029	-	RCV000735406;RCV000735406;RCV000735406;RCV000003878;RCV000735406;RCV000735406;RCV000623885	"Human Phenotype Ontology:HP:0002647,MedGen:C0340643;Human Phenotype Ontology:HP:0012158,MedGen:C0338585;Human Phenotype Ontology:HP:0012474,MedGen:C0265101;MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;Human Phenotype Ontology:HP:0012159,MedGen:C0751815;Human Phenotype Ontology:HP:0001297,MedGen:C0038454;MedGen:CN517202"	Aortic dissection;Carotid artery dissection;Carotid artery occlusion;Familial hypercholesterolemia;Internal carotid artery dissection;Stroke;not provided	germline;unknown	germline	GRCh37	NC_000019.9	19	11216264	11216264	G	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	19	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000105,OMIM Allelic Variant:606945.0007,UniProtKB (protein):P01130#VAR_005341"	3	3691	19	11216264	G	A	18730	19:11216264:G:A	Pathogenic	7/20/12	-	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	no assertion criteria provided	clinical testing	germline:1	"Cardiovascular Genetics Laboratory,PathWest Laboratory Medicine WA - Fiona Stanley Hospital"	SCV000268581.1	SCV000268581		LDLR	-	High LDL	10/31/18	46944	19	2	"[0.9999786980231765,2.1301976823449217E-5]"	2	SCV000268581228146	single nucleotide variant	NM_000527.4(LDLR):c.682G>T (p.Glu228Ter)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	31-Oct-18	121908029	-	RCV000211631;RCV000589867;RCV000518828	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:CN517202"	Familial hypercholesterolemia;Familial hypercholesterolemias;not provided	germline;not applicable;unknown	germline	GRCh37	NC_000019.9	19	11216264	11216264	G	T	19p13.2	"criteria provided, multiple submitters, no conflicts"	12	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_001818	2	226333	19	11216264	G	T	228146	19:11216264:G:T	Pathogenic	8/11/11	-	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	no assertion criteria provided	clinical testing	germline:5	"Cardiovascular Genetics Laboratory,PathWest Laboratory Medicine WA - Fiona Stanley Hospital"	SCV000268582.1	SCV000268582		LDLR	-	High LDL	10/31/18	46944	19	1	"[0.9999893490115883,1.0650988411724608E-5]"	1	SCV000268582198013	single nucleotide variant	NM_000527.4(LDLR):c.718G>A (p.Glu240Lys)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	22-May-18	768563000	-	RCV000211564;RCV000586018;RCV000182341	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:CN517202"	Familial hypercholesterolemia;Familial hypercholesterolemias;not provided	germline	germline	GRCh37	NC_000019.9	19	11217264	11217264	G	A	19p13.2	"criteria provided, conflicting interpretations"	9	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_001828,UniProtKB (protein):P01130#VAR_005343"	2	200920	19	11217264	G	A	198013	19:11217264:G:A	Pathogenic	3/1/12	-	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	no assertion criteria provided	clinical testing	germline:1	"Cardiovascular Genetics Laboratory,PathWest Laboratory Medicine WA - Fiona Stanley Hospital"	SCV000268584.1	SCV000268584		LDLR	-	High LDL	5/22/18	46963	0	3	"[0.9999680599620978,3.194003790217831E-5]"	3	SCV000268584228147	single nucleotide variant	NM_000527.4(LDLR):c.796G>A (p.Asp266Asn)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	19-Sep-17	875989907	-	RCV000211615	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline;inherited	germline	GRCh37	NC_000019.9	19	11217342	11217342	G	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	8	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000469	2	226334	19	11217342	G	A	228147	19:11217342:G:A	Pathogenic	2/26/13	-	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	no assertion criteria provided	clinical testing	germline:1	"Cardiovascular Genetics Laboratory,PathWest Laboratory Medicine WA - Fiona Stanley Hospital"	SCV000268585.1	SCV000268585		LDLR	-	High LDL	9/19/17	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV000268585171201	single nucleotide variant	NM_000527.4(LDLR):c.798T>A (p.Asp266Glu)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	17-May-18	139043155	-	RCV000172959;RCV000148594;RCV000162020	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202"	Familial hypercholesterolemia;Hypercholesterolaemia;not provided	germline;inherited;not applicable;unknown	germline	GRCh37	NC_000019.9	19	11217344	11217344	T	A	19p13.2	"criteria provided, conflicting interpretations"	16	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000117,UniProtKB (protein):P01130#VAR_005347"	2	161287	19	11217344	T	A	171201	19:11217344:T:A	Pathogenic	7/9/08	-	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	no assertion criteria provided	clinical testing	germline:2	"Cardiovascular Genetics Laboratory,PathWest Laboratory Medicine WA - Fiona Stanley Hospital"	SCV000268586.1	SCV000268586		LDLR	-	High LDL	5/17/18	46963	0	2	"[0.9999787066413985,2.1293358601452207E-5]"	2	SCV000268586181247	single nucleotide variant	NM_000527.4(LDLR):c.1027G>A (p.Gly343Ser)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	5-Jul-18	730882096	-	RCV000211596;RCV000587327;RCV000161977	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:CN517202"	Familial hypercholesterolemia;Familial hypercholesterolemias;not provided	germline;not applicable	germline	GRCh37	NC_000019.9	19	11221414	11221414	G	A	19p13.2	"criteria provided, conflicting interpretations"	15	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_001328,UniProtKB (protein):P01130#VAR_005367"	2	183106	19	11221414	G	A	181247	19:11221414:G:A	Pathogenic	6/9/08	-	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	no assertion criteria provided	clinical testing	germline:1	"Cardiovascular Genetics Laboratory,PathWest Laboratory Medicine WA - Fiona Stanley Hospital"	SCV000268593.1	SCV000268593		LDLR	-	High LDL	7/5/18	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV000268593228156	single nucleotide variant	NM_000527.4(LDLR):c.1048C>T (p.Arg350Ter)	3949	LDLR	HGNC:6547	Pathogenic	1	8-May-18	769737896	-	RCV000211692;RCV000520229	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202"	Familial hypercholesterolemia;not provided	germline;inherited	germline	GRCh37	NC_000019.9	19	11221435	11221435	C	T	19p13.2	"criteria provided, multiple submitters, no conflicts"	11	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000147	2	226342	19	11221435	C	T	228156	19:11221435:C:T	Pathogenic	6/5/08	-	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	no assertion criteria provided	clinical testing	germline:8	"Cardiovascular Genetics Laboratory,PathWest Laboratory Medicine WA - Fiona Stanley Hospital"	SCV000268595.1	SCV000268595		LDLR	-	High LDL	5/8/18	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV000268595228154	single nucleotide variant	NM_000527.4(LDLR):c.986G>A (p.Cys329Tyr)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	16-Dec-16	761954844	-	RCV000211666	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline;not applicable;unknown	germline	GRCh37	NC_000019.9	19	11221373	11221373	G	A	19p13.2	"criteria provided, conflicting interpretations"	7	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000150,UniProtKB (protein):P01130#VAR_005362"	2	226344	19	11221373	G	A	228154	19:11221373:G:A	Pathogenic	11/17/08	-	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	no assertion criteria provided	clinical testing	germline:4	"Cardiovascular Genetics Laboratory,PathWest Laboratory Medicine WA - Fiona Stanley Hospital"	SCV000268597.1	SCV000268597		LDLR	-	High LDL	12/16/16	46963	0	4	"[0.9999574132827971,4.2586717202904415E-5]"	4	SCV000268597228162	single nucleotide variant	NM_000527.4(LDLR):c.1187-10G>A	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	30-Mar-17	765696008	-	RCV000211627;RCV000588170	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445"	Familial hypercholesterolemia;Familial hypercholesterolemias	germline	germline	GRCh37	NC_000019.9	19	11223944	11223944	G	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	10	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000172	2	226349	19	11223944	G	A	228162	19:11223944:G:A	Pathogenic	6/5/08	-	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	no assertion criteria provided	clinical testing	germline:5	"Cardiovascular Genetics Laboratory,PathWest Laboratory Medicine WA - Fiona Stanley Hospital"	SCV000268602.1	SCV000268602		LDLR	-	High LDL	3/30/17	46963	0	4	"[0.9999574132827971,4.2586717202904415E-5]"	4	SCV000268602228164	single nucleotide variant	NM_000527.4(LDLR):c.1216C>T (p.Arg406Trp)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	30-Mar-17	121908043	-	RCV000211575	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline	germline	GRCh37	NC_000019.9	19	11223983	11223983	C	T	19p13.2	"criteria provided, multiple submitters, no conflicts"	9	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000177,UniProtKB (protein):P01130#VAR_072847"	2	226351	19	11223983	C	T	228164	19:11223983:C:T	Pathogenic	7/4/12	-	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	no assertion criteria provided	clinical testing	germline:1	"Cardiovascular Genetics Laboratory,PathWest Laboratory Medicine WA - Fiona Stanley Hospital"	SCV000268604.1	SCV000268604		LDLR	-	High LDL	3/30/17	46963	0	2	"[0.9999787066413985,2.1293358601452207E-5]"	2	SCV00026860445116	single nucleotide variant	NM_000527.4(LDLR):c.1222G>A (p.Glu408Lys)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	23-Jan-18	137943601	-	RCV000030125;RCV000148564	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443"	Familial hypercholesterolemia;Hypercholesterolaemia	germline;unknown	germline	GRCh37	NC_000019.9	19	11223989	11223989	G	A	19p13.2	"criteria provided, conflicting interpretations"	12	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_001379,UniProtKB (protein):P01130#VAR_005378"	2	36453	19	11223989	G	A	45116	19:11223989:G:A	Pathogenic	8/25/11	-	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	no assertion criteria provided	clinical testing	germline:1	"Cardiovascular Genetics Laboratory,PathWest Laboratory Medicine WA - Fiona Stanley Hospital"	SCV000268606.1	SCV000268606		LDLR	-	High LDL	1/23/18	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV000268606171212	single nucleotide variant	NM_000527.4(LDLR):c.1238C>T (p.Thr413Met)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	23-Oct-17	368562025	-	RCV000211581;RCV000148582;RCV000519267	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202"	Familial hypercholesterolemia;Hypercholesterolaemia;not provided	germline;unknown	germline	GRCh37	NC_000019.9	19	11224005	11224005	C	T	19p13.2	"criteria provided, conflicting interpretations"	9	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000967	2	161276	19	11224005	C	T	171212	19:11224005:C:T	Pathogenic	6/5/08	-	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	no assertion criteria provided	clinical testing	germline:2	"Cardiovascular Genetics Laboratory,PathWest Laboratory Medicine WA - Fiona Stanley Hospital"	SCV000268607.1	SCV000268607		LDLR	-	High LDL	10/23/17	46963	0	3	"[0.9999680599620978,3.194003790217831E-5]"	3	SCV00026860718733	single nucleotide variant	NM_000527.4(LDLR):c.1285G>A (p.Val429Met)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	31-Oct-18	28942078	-	RCV000003882	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline;inherited;unknown	germline	GRCh37	NC_000019.9	19	11224052	11224052	G	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	14	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_001387,OMIM Allelic Variant:606945.0009,UniProtKB (protein):P01130#VAR_005383"	3	3694	19	11224052	G	A	18733	19:11224052:G:A	Pathogenic	11/7/11	-	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	no assertion criteria provided	clinical testing	germline:7	"Cardiovascular Genetics Laboratory,PathWest Laboratory Medicine WA - Fiona Stanley Hospital"	SCV000268609.1	SCV000268609		LDLR	-	High LDL	10/31/18	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV000268609172183	single nucleotide variant	NM_000527.4(LDLR):c.1359-1G>A	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	16-Jan-18	139617694	-	RCV000172962;RCV000149884	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443"	Familial hypercholesterolemia;Hypercholesterolaemia	germline	germline	GRCh37	NC_000019.9	19	11224210	11224210	G	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	12	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_001405	2	162499	19	11224210	G	A	172183	19:11224210:G:A	Pathogenic	3/17/14	-	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	no assertion criteria provided	clinical testing	germline:1	"Cardiovascular Genetics Laboratory,PathWest Laboratory Medicine WA - Fiona Stanley Hospital"	SCV000268613.1	SCV000268613		LDLR	-	High LDL	1/16/18	46961	2	1	"[0.9999893528672729,1.0647132727156576E-5]"	1	SCV000268613171213	single nucleotide variant	NM_000527.4(LDLR):c.1432G>A (p.Gly478Arg)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	26-Apr-18	144614838	-	RCV000211688;RCV000148583	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443"	Familial hypercholesterolemia;Hypercholesterolaemia	germline;unknown	germline	GRCh37	NC_000019.9	19	11224284	11224284	G	A	19p13.2	"criteria provided, conflicting interpretations"	13	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000198,UniProtKB (protein):P01130#VAR_005390"	2	161277	19	11224284	G	A	171213	19:11224284:G:A	Pathogenic	6/27/08	-	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	no assertion criteria provided	clinical testing	germline:6	"Cardiovascular Genetics Laboratory,PathWest Laboratory Medicine WA - Fiona Stanley Hospital"	SCV000268615.1	SCV000268615		LDLR	-	High LDL	4/26/18	46961	2	3	"[0.9999680586018185,3.194139818146973E-5]"	3	SCV000268615171214	single nucleotide variant	NM_000527.4(LDLR):c.1444G>A (p.Asp482Asn)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	11-May-17	139624145	-	RCV000172963;RCV000148591;RCV000414235	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202"	Familial hypercholesterolemia;Hypercholesterolaemia;not provided	germline;inherited	germline	GRCh37	NC_000019.9	19	11224296	11224296	G	A	19p13.2	"criteria provided, conflicting interpretations"	13	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_001428	2	161284	19	11224296	G	A	171214	19:11224296:G:A	Pathogenic	7/22/08	-	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	no assertion criteria provided	clinical testing	germline:4	"Cardiovascular Genetics Laboratory,PathWest Laboratory Medicine WA - Fiona Stanley Hospital"	SCV000268616.1	SCV000268616		LDLR	-	High LDL	5/11/17	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV000268616198015	single nucleotide variant	NM_000527.4(LDLR):c.1747C>T (p.His583Tyr)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	23-Jan-18	730882109	-	RCV000211604;RCV000182342	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202"	Familial hypercholesterolemia;not provided	germline;not applicable;unknown	germline	GRCh37	NC_000019.9	19	11227576	11227576	C	T	19p13.2	"criteria provided, conflicting interpretations"	10	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000234	2	200921	19	11227576	C	T	198015	19:11227576:C:T	Pathogenic	10/19/10	-	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	no assertion criteria provided	clinical testing	germline:3	"Cardiovascular Genetics Laboratory,PathWest Laboratory Medicine WA - Fiona Stanley Hospital"	SCV000268636.1	SCV000268636		LDLR	-	High LDL	1/23/18	46963	0	14	"[0.9998509464897898,1.4905351021016544E-4]"	14	SCV000268636171217	single nucleotide variant	NM_000527.4(LDLR):c.1775G>A (p.Gly592Glu)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	31-Oct-18	137929307	-	RCV000172964;RCV000587007;RCV000148576;RCV000162001	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:C0020443;MedGen:CN517202"	Familial hypercholesterolemia;Familial hypercholesterolemias;Hypercholesterolaemia;not provided	germline;inherited;not applicable;unknown	germline	GRCh37	NC_000019.9	19	11227604	11227604	G	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	22	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000237,UniProtKB (protein):P01130#VAR_005403"	2	161271	19	11227604	G	A	171217	19:11227604:G:A	Pathogenic	9/7/10	-	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	no assertion criteria provided	clinical testing	germline:3	"Cardiovascular Genetics Laboratory,PathWest Laboratory Medicine WA - Fiona Stanley Hospital"	SCV000268637.1	SCV000268637		LDLR	-	High LDL	10/31/18	46963	0	3	"[0.9999680599620978,3.194003790217831E-5]"	3	SCV000268637181268	single nucleotide variant	NM_000527.4(LDLR):c.1784G>A (p.Arg595Gln)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	11-Apr-18	201102492	-	RCV000211609;RCV000162002	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202"	Familial hypercholesterolemia;not provided	germline;not applicable;unknown	germline	GRCh37	NC_000019.9	19	11227613	11227613	G	A	19p13.2	"criteria provided, conflicting interpretations"	8	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000563	2	183126	19	11227613	G	A	181268	19:11227613:G:A	Pathogenic	9/24/10	-	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	no assertion criteria provided	clinical testing	germline:1	"Cardiovascular Genetics Laboratory,PathWest Laboratory Medicine WA - Fiona Stanley Hospital"	SCV000268639.1	SCV000268639		LDLR	-	High LDL	4/11/18	46963	0	5	"[0.9999467666034964,5.323339650363052E-5]"	5	SCV000268639171219	single nucleotide variant	NM_000527.4(LDLR):c.1816G>T (p.Ala606Ser)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	25-Oct-17	72658865	-	RCV000211562;RCV000148567;RCV000162003	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202"	Familial hypercholesterolemia;Hypercholesterolaemia;not provided	germline;not applicable	germline	GRCh37	NC_000019.9	19	11227645	11227645	G	T	19p13.2	"criteria provided, conflicting interpretations"	9	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000566	2	161264	19	11227645	G	T	171219	19:11227645:G:T	Uncertain significance	8/7/12	-	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	no assertion criteria provided	clinical testing	germline:3	"Cardiovascular Genetics Laboratory,PathWest Laboratory Medicine WA - Fiona Stanley Hospital"	SCV000268641.1	SCV000268641		LDLR	-	High LDL	10/25/17	46963	0	5	"[0.9999467666034964,5.323339650363052E-5]"	5	SCV000268641181269	single nucleotide variant	NM_000527.4(LDLR):c.1876G>A (p.Glu626Lys)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	27-Sep-17	139791325	-	RCV000211563;RCV000162004;RCV000454999	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202;MedGen:CN169374"	Familial hypercholesterolemia;not provided;not specified	germline;not applicable;unknown	germline	GRCh37	NC_000019.9	19	11230798	11230798	G	A	19p13.2	"criteria provided, conflicting interpretations"	9	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000258	2	183127	19	11230798	G	A	181269	19:11230798:G:A	Pathogenic	5/25/11	-	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	no assertion criteria provided	clinical testing	germline:1	"Cardiovascular Genetics Laboratory,PathWest Laboratory Medicine WA - Fiona Stanley Hospital"	SCV000268644.1	SCV000268644		LDLR	-	High LDL	9/27/17	46963	0	19	"[0.9997977130932862,2.0228690671379596E-4]"	19	SCV000268644228193	single nucleotide variant	NM_000527.4(LDLR):c.1898G>A (p.Arg633His)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	28-Nov-17	754536745	-	RCV000211621	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline	germline	GRCh37	NC_000019.9	19	11230820	11230820	G	A	19p13.2	"criteria provided, conflicting interpretations"	7	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_001073	2	226380	19	11230820	G	A	228193	19:11230820:G:A	Pathogenic	10/30/13	-	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	no assertion criteria provided	clinical testing	germline:1	"Cardiovascular Genetics Laboratory,PathWest Laboratory Medicine WA - Fiona Stanley Hospital"	SCV000268649.1	SCV000268649		LDLR	-	High LDL	11/28/17	46963	0	2	"[0.9999787066413985,2.1293358601452207E-5]"	2	SCV000268649228195	single nucleotide variant	NM_000527.4(LDLR):c.1955T>C (p.Met652Thr)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	28-Mar-18	875989936	-	RCV000211590	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline	germline	GRCh37	NC_000019.9	19	11230877	11230877	T	C	19p13.2	"criteria provided, conflicting interpretations"	5	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000266	2	226382	19	11230877	T	C	228195	19:11230877:T:C	Pathogenic	6/25/08	-	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	no assertion criteria provided	clinical testing	germline:1	"Cardiovascular Genetics Laboratory,PathWest Laboratory Medicine WA - Fiona Stanley Hospital"	SCV000268651.1	SCV000268651		LDLR	-	High LDL	3/28/18	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV000268651228198	single nucleotide variant	NM_000527.4(LDLR):c.2030G>T (p.Cys677Phe)	3949	LDLR	HGNC:6547	Likely pathogenic	1	25-Mar-16	875989938	-	RCV000211595	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline	germline	GRCh37	NC_000019.9	19	11231088	11231088	G	T	19p13.2	"criteria provided, single submitter"	2	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000659	2	226385	19	11231088	G	T	228198	19:11231088:G:T	Pathogenic	11/3/08	-	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	no assertion criteria provided	clinical testing	germline:1	"Cardiovascular Genetics Laboratory,PathWest Laboratory Medicine WA - Fiona Stanley Hospital"	SCV000268654.1	SCV000268654		LDLR	-	High LDL	3/25/16	46956	7	1	"[0.9999893517335378,1.064826646221995E-5]"	1	SCV00026865418738	single nucleotide variant	NM_000527.4(LDLR):c.2043C>A (p.Cys681Ter)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	31-Oct-18	121908031	-	RCV000003887;RCV000590806;RCV000481771	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:CN517202"	Familial hypercholesterolemia;Familial hypercholesterolemias;not provided	germline;unknown	germline	GRCh37	NC_000019.9	19	11231101	11231101	C	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	18	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_001592,OMIM Allelic Variant:606945.0016"	3	3699	19	11231101	C	A	18738	19:11231101:C:A	Pathogenic	5/4/12	-	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	no assertion criteria provided	clinical testing	germline:5	"Cardiovascular Genetics Laboratory,PathWest Laboratory Medicine WA - Fiona Stanley Hospital"	SCV000268655.1	SCV000268655		LDLR	-	High LDL	10/31/18	46958	5	1	"[0.9999893521870608,1.0647812939222283E-5]"	1	SCV00026865518741	single nucleotide variant	NM_000527.4(LDLR):c.2054C>T (p.Pro685Leu)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	31-Oct-18	28942084	-	RCV000003891;RCV000162007	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202"	Familial hypercholesterolemia;not provided	germline;inherited;not applicable;unknown	germline	GRCh37	NC_000019.9	19	11231112	11231112	C	T	19p13.2	"criteria provided, multiple submitters, no conflicts"	16	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000276,OMIM Allelic Variant:606945.0017,UniProtKB (protein):P01130#VAR_005410"	3	3702	19	11231112	C	T	18741	19:11231112:C:T	Pathogenic	4/13/10	-	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	no assertion criteria provided	clinical testing	germline:6	"Cardiovascular Genetics Laboratory,PathWest Laboratory Medicine WA - Fiona Stanley Hospital"	SCV000268656.1	SCV000268656		LDLR	-	High LDL	10/31/18	46963	0	3	"[0.9999680599620978,3.194003790217831E-5]"	3	SCV00026865618783	single nucleotide variant	NM_000527.4(LDLR):c.2140+1G>A	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	11-Jun-18	145787161	-	RCV000003942	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline	germline	GRCh37	NC_000019.9	19	11231199	11231199	G	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	8	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000282,OMIM Allelic Variant:606945.0063"	3	3744	19	11231199	G	A	18783	19:11231199:G:A	Pathogenic	6/10/08	-	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	no assertion criteria provided	clinical testing	germline:1	"Cardiovascular Genetics Laboratory,PathWest Laboratory Medicine WA - Fiona Stanley Hospital"	SCV000268658.1	SCV000268658		LDLR	-	High LDL	6/11/18	46962	1	1	"[0.9999893530939908,1.0646906009113752E-5]"	1	SCV000268658228201	deletion	NM_000527.4(LDLR):c.2271delT (p.Leu759Serfs)	3949	LDLR	HGNC:6547	Pathogenic	1	11-May-17	875989940	-	RCV000211650;RCV000493493	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202"	Familial hypercholesterolemia;not provided	germline	germline	GRCh37	NC_000019.9	19	11233980	11233980	T	-	19p13.2	"criteria provided, multiple submitters, no conflicts"	6	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000890	2	226388	19	11233979	CT	C	228201	19:11233979:CT:C	Pathogenic	3/26/10	-	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	no assertion criteria provided	clinical testing	germline:1	"Cardiovascular Genetics Laboratory,PathWest Laboratory Medicine WA - Fiona Stanley Hospital"	SCV000268661.1	SCV000268661		LDLR	-	High LDL	5/11/17	46963	0	2	"[0.9999787066413985,2.1293358601452207E-5]"	2	SCV00026866132929	single nucleotide variant	NM_000384.2(APOB):c.10580G>A (p.Arg3527Gln)	338	APOB	HGNC:603	Conflicting interpretations of pathogenicity	1	11-Jul-18	5742904	-	RCV000019479;RCV000284412;RCV000412515;RCV000627797;RCV000499833;RCV000627797;RCV000254882	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C1862596,Orphanet:ORPHA426,SNOMED CT:60193003;MedGen:C1704417,OMIM:144010;MedGen:C1704417,OMIM:144010;MedGen:C0020597,Orphanet:ORPHA31154;MedGen:C4551990,OMIM:615558;MedGen:CN517202"	"Familial hypercholesterolemia;Familial hypobetalipoproteinemia;Hypercholesterolemia, autosomal dominant, type B;Hypercholesterolemia, autosomal dominant, type B;Hypobetalipoproteinemia;Hypobetalipoproteinemia, familial, 1;not provided"	germline;maternal;unknown	germline	GRCh37	NC_000002.11	2	21229160	21229160	C	T	2p24	"criteria provided, conflicting interpretations"	18	"ACMG2013,ACMG2016"	Y	OMIM Allelic Variant:107730.0009	3	17890	2	21229160	C	T	32929	2:21229160:C:T	Pathogenic	1/11/18	"The p.Arg3527Gln variant in APOB is a well-established pathogenic variant that is mainly found in individuals of European descent. It has been previously reported in >500 individuals with familial hypercholesterolemia (FH) and segregated with disease in >50 affected relatives (Soria 1989, MÃ¤rz 1993, Leren 1997, Ludwig 1990, Bednarska-Makaruk 2001, Horvath 2001, Kalina 2001). This variant has also been reported by other clinical laboratories in ClinVar (Variation ID 17890). It has been identified in 53/126056 of European chromosomes, including 1 homozygote, by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org/; dbSNP rs5742904). This frequency is low enough to be consistent with the frequency of FH in the general population. In summary, this variant meets criteria to be classified as pathogenic for autosomal dominant familial hypercholesterolemia based upon presence in multiple affected individuals and segregation studies. Please note that pathogenic variants in APOB can have reduced penetrance and a less severe phenotype than disease-causing LDLR or PCSK9 variants (Youngblom and Knowles, GeneReviews). ACMG/AMP Criteria applied: PS4_strong, PP1_Strong (Richards 2015)."	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:71	"Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine"	SCV000271309.2	SCV000271309		APOB	-	Low LDL	7/11/18	46963	0	12	"[0.9998722398483912,1.2776015160871325E-4]"	12	SCV00027130918780	single nucleotide variant	NM_000527.4(LDLR):c.131G>A (p.Trp44Ter)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	14-Nov-17	267607213	-	RCV000003939	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline;inherited	germline	GRCh37	NC_000019.9	19	11210962	11210962	G	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	13	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000019,OMIM Allelic Variant:606945.0060"	3	3741	19	11210962	G	A	18780	19:11210962:G:A	Pathogenic	3/23/15	"The p.Trp44X variant in LDLR has been reported in a large number (>500) of individuals with hypercholesterolemia (Hobbs 1992, Huijgen 2010, Chmara 2010, DuÅ¡kovÃ¡ 2011, Fouchier 2015). It was absent from large population studies. This nonsense variant leads to a premature termination codon at position 44, which is predicted to lead to a truncated or absent protein. Heterozygous loss of LDLR function is an established disease mechanism in familial hypercholesterolemia. In summary, this variant meets our criteria to be classified as pathogenic for hypercholesterolemia in an autosomal dominant manner (http://www.partners.org/personalizedmedicince/LMM) based upon the predicted impact to the protein, its presence in a large number of affected individuals, and absence from controls."	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:2	"Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine"	SCV000271381.2	SCV000271381		LDLR	-	High LDL	11/14/17	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV000271381172183	single nucleotide variant	NM_000527.4(LDLR):c.1359-1G>A	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	16-Jan-18	139617694	-	RCV000172962;RCV000149884	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443"	Familial hypercholesterolemia;Hypercholesterolaemia	germline	germline	GRCh37	NC_000019.9	19	11224210	11224210	G	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	12	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_001405	2	162499	19	11224210	G	A	172183	19:11224210:G:A	Pathogenic	2/9/16	"The c.1359-1G>A variant in LDLR has been reported in >80 individuals with familial hypercholesterolemia (FH), segregated with disease in 8 affected relatives from 3 families (Peeters 1995, Lombarid 1995 and 2000, Garcia-Garcia 2001, Braenne 2015), and has been identified in 1/8600 European American chromosomes by the NHLBI Exome Sequencing Project (http://evs.gs.washington.edu/EVS/; dbSNP rs139617694). This variant occurs in the invariant region (+/- 1,2) of the splice consensus sequence and is predicted to cause altered splicing leading to an abnormal or absent protein. Heterozygous loss of LDLR function is an established disease mechanism in familial hypercholesterolemia. In summary, this variant meets our criteria to be classified as pathogenic for familial hypercholesterolemia in an autosomal dominant manner."	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:2	"Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine"	SCV000271383.2	SCV000271383		LDLR	-	High LDL	1/16/18	46961	2	1	"[0.9999893528672729,1.0647132727156576E-5]"	1	SCV000271383171217	single nucleotide variant	NM_000527.4(LDLR):c.1775G>A (p.Gly592Glu)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	31-Oct-18	137929307	-	RCV000172964;RCV000587007;RCV000148576;RCV000162001	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:C0020443;MedGen:CN517202"	Familial hypercholesterolemia;Familial hypercholesterolemias;Hypercholesterolaemia;not provided	germline;inherited;not applicable;unknown	germline	GRCh37	NC_000019.9	19	11227604	11227604	G	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	22	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000237,UniProtKB (protein):P01130#VAR_005403"	2	161271	19	11227604	G	A	171217	19:11227604:G:A	Pathogenic	12/19/17	"The p.Gly592Glu variant in LDLR has been reported in >200 Caucasian individuals with familial hypercholesterolemia (FH) and segregated with disease in >30 affected relatives from >3 families (Gorski 1998, Miltiadous 2001, Kuhrova 2002, Kublaska 2008, Bourbon 2008, Chmara 2010, Diakou 2011, Tichy 2012, Bertolini 2013, Do 2015, Medeiros 2015, Jannes 2015, Braenne 2015). This variant has also been identified in 15/126710 European chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP rs137929307). However, this frequency is low enough to be consistent with the frequency of FH in the general population. Furthermore, in vitro functional studies provide some evidence that the p.Gly592Glu variant may impact protein function (Romano 2011). In summary, this variant meets criteria to be classified as pathogenic for familial hypercholesterolemia in an autosomal dominant manner based upon presence in multiple affected individuals and segregation studies. ACMG/AMP Criteria applied: PS4_Strong, PP1_Strong (Richards 2015)."	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:16	"Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine"	SCV000271385.2	SCV000271385		LDLR	-	High LDL	10/31/18	46963	0	3	"[0.9999680599620978,3.194003790217831E-5]"	3	SCV00027138518741	single nucleotide variant	NM_000527.4(LDLR):c.2054C>T (p.Pro685Leu)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	31-Oct-18	28942084	-	RCV000003891;RCV000162007	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202"	Familial hypercholesterolemia;not provided	germline;inherited;not applicable;unknown	germline	GRCh37	NC_000019.9	19	11231112	11231112	C	T	19p13.2	"criteria provided, multiple submitters, no conflicts"	16	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000276,OMIM Allelic Variant:606945.0017,UniProtKB (protein):P01130#VAR_005410"	3	3702	19	11231112	C	T	18741	19:11231112:C:T	Pathogenic	1/11/16	"The p.Pro685Leu variant in LDLR has been reported in >40 individuals with familial hypercholesterolemia (FH), segregated with disease in >40 affected relatives from at least 4 families, and was identified in the homozygous state in at least 10 individuals with FH (Bertolini 2013, Sharifi 2016, Medeiros 2010,Rubinsztein 1992, Soutar 1989, Soutar 1991, Thormaehlen 2015, Van Der Graaf 2011). This variant has also been identified in 7/66600 European chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs28942084). However, this frequency is low enough to be consistent with the frequency of FH in the general population. In vitro functional studies provide some evidence that the p.Pro685Leu variant may impact protein function (Knight 1989, Rubinsztein 1992, Thormaehlen 2015). In summary, this variant meets our criteria to be classified as pathogenic for familial hypercholesterolemia in an autosomal dominant manner."	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:2	"Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine"	SCV000271386.2	SCV000271386		LDLR	-	High LDL	10/31/18	46963	0	3	"[0.9999680599620978,3.194003790217831E-5]"	3	SCV00027138618724	single nucleotide variant	NM_000527.4(LDLR):c.259T>G (p.Trp87Gly)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	8-Jun-18	121908025	-	RCV000003870;RCV000622852	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202"	Familial hypercholesterolemia;not provided	germline;inherited	germline	GRCh37	NC_000019.9	19	11213408	11213408	T	G	19p13.2	"criteria provided, multiple submitters, no conflicts"	11	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_001671,OMIM Allelic Variant:606945.0003,UniProtKB (protein):P01130#VAR_005308"	3	3685	19	11213408	T	G	18724	19:11213408:T:G	Pathogenic	1/11/16	"The p.Trp87Gly variant in LDLR is a well-established pathogenic variant for familial hypercholesterolemia (Leitersdorf 1990, Jensen 1996, Vohl 1997, Tybjaerg-Hansen 2005, Futema 2013), and is a known founder mutation in the French Canadian population where it has been reported in >400 individuals with FH, including >15 homozygous individuals (Vohl 1997). It has also been identified in 5/66740 European chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs121908025); however, this frequency is low enough to be consistent with the frequency of FH in the general population. Additionally, in vitro functional studies provide some evidence that the p.Trp87Gly variant may impact protein function (Leitersdorf 1990). In summary, this variant meets our criteria to be classified as pathogenic for FH in an autosomal dominant manner based upon its identification in a large number of affected individuals and low frequency in controls."	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:2	"Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine"	SCV000271387.2	SCV000271387		LDLR	-	High LDL	6/8/18	46963	0	3	"[0.9999680599620978,3.194003790217831E-5]"	3	SCV000271387230981	single nucleotide variant	NM_000527.4(LDLR):c.1217G>A (p.Arg406Gln)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	30-Mar-17	552422789	-	RCV000238261;RCV000223047	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN169374"	Familial hypercholesterolemia;not specified	germline	germline	GRCh37	NC_000019.9	19	11223984	11223984	G	A	19p13.2	"criteria provided, conflicting interpretations"	6	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000650,UniProtKB (protein):P01130#VAR_013954"	2	228798	19	11223984	G	A	230981	19:11223984:G:A	Uncertain significance	12/21/15	"Variant classified as Uncertain Significance - Favor Pathogenic. The p.Arg406Gln variant in LDLR has been reported in 2 individuals with familial hypercholesterolemia (Tosi 2007, Thiart 2000) and has been identified in 1/10248 African chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs552422789). Computational prediction tools and conservation analysis suggest that the p.Arg406Gln variant may impact the protein. In addition, splicing prediction tools predict this variant results in the generation of a novel 3' splice site. However, the results of these computational tools are not predictive enough to determine pathogenicity. In summary, while there is some suspicion for a pathogenic role, the clinical significance of the p.Arg406Gln variant is uncertain."	not specified	CN169374:not specified	familial hypercholesterolemia	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:2	"Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine"	SCV000271917.2	SCV000271917		LDLR	-	High LDL	3/30/17	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV000271917237314	single nucleotide variant	NM_000352.4(ABCC8):c.3640C>T (p.Arg1214Trp)	6833	ABCC8	HGNC:59	Pathogenic/Likely pathogenic	1	21-Mar-17	139964066	-	RCV000588494;RCV000666191;RCV000223959	"MedGen:C3888018,Orphanet:ORPHA276525;MedGen:C2931832,OMIM:256450,SNOMED CT:360339005;MedGen:CN517202"	Familial hyperinsulinism;Persistent hyperinsulinemic hypoglycemia of infancy;not provided	germline;unknown	germline	GRCh37	NC_000011.9	11	17424218	17424218	G	A	11p15.1	"criteria provided, multiple submitters, no conflicts"	3	NA	N	UniProtKB (protein):Q09428#VAR_031373	2	235633	11	17424218	G	A	237314	11:17424218:G:A	Pathogenic	8/27/14	-	not provided	CN517202:not provided	No Information	FALSE	No Information	"criteria provided, single submitter"	clinical testing	germline:na	"Center for Pediatric Genomic Medicine,Children's Mercy Hospital and Clinics"	SCV000281360.2	SCV000281360		-	-	"MODY Extended, MonogenicDM_all, Neonatal Diabetes"	3/21/17	46963	0	5	"[0.9999467666034964,5.323339650363052E-5]"	5	SCV00028136048709	single nucleotide variant	NM_000384.2(APOB):c.10579C>T (p.Arg3527Trp)	338	APOB	HGNC:603	Conflicting interpretations of pathogenicity	1	3-Jul-18	144467873	-	RCV000408839;RCV000231844;RCV000627798;RCV000627798;RCV000494148	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C1704417,OMIM:144010;MedGen:C1704417,OMIM:144010;MedGen:C4551990,OMIM:615558;MedGen:CN517202"	"Familial hypercholesterolemia;Hypercholesterolemia, autosomal dominant, type B;Hypercholesterolemia, autosomal dominant, type B;Hypobetalipoproteinemia, familial, 1;not provided"	germline	germline	GRCh37	NC_000002.11	2	21229161	21229161	G	A	2p24	"criteria provided, conflicting interpretations"	8	"ACMG2013,ACMG2016"	Y	-	3	40223	2	21229161	G	A	48709	2:21229161:G:A	Pathogenic	7/3/18	"This sequence change replaces arginine with tryptophan at codon 3527 of the APOB protein (p.Arg3527Trp). The arginine residue is moderately conserved and there is a moderate physicochemical difference between arginine and tryptophan. This variant is present in population databases (rs144467873, ExAC 0.1%). This variant has been reported in individuals and families affected with hyperlipidemia and apolipoprotein B deficiency (PMID: 7627691, 9191540, 9702952, 22294733, 21376320, 16250003, 11238294). This variant is a common cause of hyperlipidemia in individuals of East Asian ancestry (PMID: 9702952, 27206935), but has also been reported in individuals of other ancestries (PMID: 23936638, 16250003, 23375686, 26415676) This variant is also known as R3500W in the literature. Experimental studies have shown that this sequence change has been shown to affect protein function (PMID: 11238294, 10388479). In addition, Â¬â€ A different missense substitution at this codon (p.Arg3527Gln) is reported to be deleterious (PMID: 24234650, 2563166). This indicates that the arginine residue is important for APOB protein function. In summary, this missense variant has been reported in affected individuals and affects a residue which is important for APOB protein function. For these reasons it has been classified as Pathogenic."	MedGen:C1704417;MedGen:CN182502	"C1704417:Hypercholesterolemia, autosomal dominant, type B;C4551990:Hypobetalipoproteinemia, familial, 1"	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Invitae	SCV000284754.4	SCV000284754		APOB	-	Low LDL	7/3/18	46963	0	14	"[0.9998509464897898,1.4905351021016544E-4]"	14	SCV000284754243266	single nucleotide variant	NM_000527.4(LDLR):c.12G>A (p.Trp4Ter)	3949	LDLR	HGNC:6547	Pathogenic	1	30-Mar-17	756039188	-	RCV000227275	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline	germline	GRCh37	NC_000019.9	19	11200236	11200236	G	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	5	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000357	2	237860	19	11200236	G	A	243266	19:11200236:G:A	Pathogenic	12/20/15	"This sequence change creates a premature translational stop signal at codon 4 (p.Trp4*). It is expected to result in an absent or disrupted protein product. Truncating variants in LDLR are known to be pathogenic. This particular truncation has been reported in the literature in individuals affected with hypercholesterolemia (PMID: 7903864, 16314194, 20428891, 21376320, 21868016). This variant is also known as W-18X in the literature. For these reasons, this variant has been classified as Pathogenic."	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Invitae	SCV000285010.2	SCV000285010		LDLR	-	High LDL	3/30/17	46919	44	1	"[0.9999893433363882,1.0656663611756432E-5]"	1	SCV00028501045116	single nucleotide variant	NM_000527.4(LDLR):c.1222G>A (p.Glu408Lys)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	23-Jan-18	137943601	-	RCV000030125;RCV000148564	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443"	Familial hypercholesterolemia;Hypercholesterolaemia	germline;unknown	germline	GRCh37	NC_000019.9	19	11223989	11223989	G	A	19p13.2	"criteria provided, conflicting interpretations"	12	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_001379,UniProtKB (protein):P01130#VAR_005378"	2	36453	19	11223989	G	A	45116	19:11223989:G:A	Pathogenic	8/8/16	"This sequence change replaces glutamic acid with lysine at codon 408 of the LDLR protein (p.Glu408Lys). The glutamic acid residue is highly conserved and there is a small physicochemical difference between glutamic acid and lysine. This variant is present in population databases (rs137943601, ExAC 0.002%). This variant has been reported in multiple unrelated individuals and families affected with hypercholesterolemia (PMID: 1301956, 14974088, 17347910, 19843101, 20236128). This variant is also known as FH Algeria-1 or E387K in the literature. ClinVar contains an entry for this variant (Variation ID: 36453). Experimental studies have shown that this missense change is a recycling-defective allele (PMID: 1301956, 21531209). In summary, this variant is rare in population databases, has been observed in many patients with hypercholesterolemia, and has been shown to have a deleterious effect on protein function. For these reasons, this variant has been classified as Pathogenic."	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Invitae	SCV000285013.3	SCV000285013		LDLR	-	High LDL	1/23/18	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV000285013243273	single nucleotide variant	NM_000527.4(LDLR):c.1586G>A (p.Gly529Asp)	3949	LDLR	HGNC:6547	Likely pathogenic	1	25-Mar-16	878854025	-	RCV000231049	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline	germline	GRCh37	NC_000019.9	19	11224438	11224438	G	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	3	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_001464	2	237863	19	11224438	G	A	243273	19:11224438:G:A	Likely pathogenic	12/8/15	"This sequence change replaces glycine with aspartic acid at codon 529 of the LDLR protein (p.Gly529Asp). The glycine residue is highly conserved and there is a moderate physicochemical difference between glycine and aspartic acid. It also falls at the last nucleotide of exon 10 of the LDLR coding sequence. This variant is not present in population databases (ExAC no frequency). This variant has been reported in individuals affected with familial hypercholesterolemia (PMID: 21722902, 22998978). Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: ""Tolerated""; PolyPhen-2: ""Probably Damaging""; Align-GVGD: ""Class C0""). Nucleotide substitutions at the last nucleotide of the exon are relatively common causes of aberrant splicing (PMID: 17576681). Algorithms developed to predict the effect of nucleotide changes on mRNA splicing suggest that this variant may alter mRNA splicing, but this prediction has not been confirmed by published transcriptional studies. In summary, this is a rare missense change that has been reported in affected individuals and has been predicted to have an impact on mRNA splicing. For these reasons, this variant has been classified as Likely Pathogenic."	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Invitae	SCV000285014.2	SCV000285014		LDLR	-	High LDL	3/25/16	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV000285014243275	single nucleotide variant	NM_000527.4(LDLR):c.1721G>T (p.Arg574Leu)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	5-Nov-16	777188764	-	RCV000228158	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline;inherited	germline	GRCh37	NC_000019.9	19	11227550	11227550	G	T	19p13.2	"criteria provided, conflicting interpretations"	3	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_001502	2	237867	19	11227550	G	T	243275	19:11227550:G:T	Uncertain significance	1/29/16	"This sequence change replaces arginine with leucine at codon 574 of the LDLR protein (p.Arg574Leu). The arginine residue is highly conserved and there is a moderate physicochemical difference between arginine and leucine. This variant is present in population databases (rs777188764, ExAC 0.02%). This variant has been reported in an individual affected with hypercholesterolemia. Currently there is insufficient evidence to conclude whether this variant segregates with disease or not (PMID: 22698793). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive, but these predictions have not been confirmed by published functional studies. In summary, this is a novel missense change with uncertain impact on protein function that has been reported in one patient. However, the clinical significance of this finding is still unknown. Therefore, it has been classified as a Variant of Uncertain Significance."	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Invitae	SCV000285019.2	SCV000285019		LDLR	-	High LDL	11/5/16	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV000285019243276	single nucleotide variant	NM_000527.4(LDLR):c.1887C>T (p.Phe629=)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	8-Jan-18	751234870	-	RCV000225826	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline	germline	GRCh37	NC_000019.9	19	11230809	11230809	C	T	19p13.2	"criteria provided, conflicting interpretations"	2	"ACMG2013,ACMG2016"	N	-	2	237868	19	11230809	C	T	243276	19:11230809:C:T	Benign	1/8/18	-	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Invitae	SCV000285021.3	SCV000285021		LDLR	-	High LDL	1/8/18	46963	0	149	"[0.9984136447841918,0.0015863552158081895]"	147	SCV000285021228193	single nucleotide variant	NM_000527.4(LDLR):c.1898G>A (p.Arg633His)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	28-Nov-17	754536745	-	RCV000211621	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline	germline	GRCh37	NC_000019.9	19	11230820	11230820	G	A	19p13.2	"criteria provided, conflicting interpretations"	7	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_001073	2	226380	19	11230820	G	A	228193	19:11230820:G:A	Likely pathogenic	2/25/16	"This sequence change replaces arginine with histidine at codon 633 of the LDLR protein (p.Arg633His). The arginine residue is highly conserved and there is a small physicochemical difference between arginine and histidine. This variant is present in population databases (rs754536745, ExAC 0.01%). This variant has been reported in the literature in three patients affected with hypercholesterolemia (PMID: 16250003, 19843101, 15823288). This variant is also known in the literature as R612H. Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: ""Deleterious""; PolyPhen-2: ""Probably Damaging""; Align-GVGD: ""Class C0""). A different missense substitution at this codon (p.Arg633Cys) is reported to be deleterious (PMID: 9259195, 15241806, 23375686). This variant is also known in the literature as R612C. This indicates that the arginine residue is important for LDLR protein function. In summary, this is a rare missense change that has been reported in patients affected with hypercholesterolemia and is located in a residue important for LDLR protein function. For these reasons, it has been classified as Likely Pathogenic."	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Invitae	SCV000285022.2	SCV000285022		LDLR	-	High LDL	11/28/17	46963	0	2	"[0.9999787066413985,2.1293358601452207E-5]"	2	SCV00028502218738	single nucleotide variant	NM_000527.4(LDLR):c.2043C>A (p.Cys681Ter)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	31-Oct-18	121908031	-	RCV000003887;RCV000590806;RCV000481771	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:CN517202"	Familial hypercholesterolemia;Familial hypercholesterolemias;not provided	germline;unknown	germline	GRCh37	NC_000019.9	19	11231101	11231101	C	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	18	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_001592,OMIM Allelic Variant:606945.0016"	3	3699	19	11231101	C	A	18738	19:11231101:C:A	Pathogenic	4/28/18	"This sequence change creates a premature translational stop signal at codon 681 (p.Cys681*) of the LDLR gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in LDLR are known to be pathogenic. This particular variant is a known common cause of familial hypercholesterolemia in the Lebanese population (PMID: 19319977, 21145767), although it has been observed in individuals from other ethnicities (PMID: 11668627, 25461735). This variant is also known as p.Cys660* in the literature. For these reasons, this variant has been classified as Pathogenic."	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Invitae	SCV000285024.5	SCV000285024		LDLR	-	High LDL	10/31/18	46958	5	1	"[0.9999893521870608,1.0647812939222283E-5]"	1	SCV00028502418724	single nucleotide variant	NM_000527.4(LDLR):c.259T>G (p.Trp87Gly)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	8-Jun-18	121908025	-	RCV000003870;RCV000622852	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202"	Familial hypercholesterolemia;not provided	germline;inherited	germline	GRCh37	NC_000019.9	19	11213408	11213408	T	G	19p13.2	"criteria provided, multiple submitters, no conflicts"	11	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_001671,OMIM Allelic Variant:606945.0003,UniProtKB (protein):P01130#VAR_005308"	3	3685	19	11213408	T	G	18724	19:11213408:T:G	Pathogenic	6/8/18	"This sequence change replaces tryptophan with glycine at codon 87 of the LDLR protein (p.Trp87Gly). The tryptophan residue is highly conserved and there is a large physicochemical difference between tryptophan and glycine. This variant is clearly defined as a familial hypercholesterolemia causative allele (PMID: 2318961, 12553167, 16542394). It is a founder mutation in the Dutch population, and is common in individuals of European ancestry. This variant is also known as p.W66G in the literature. ClinVar contains an entry for this variant (Variation ID: 3685). Experimental studies have shown that this missense change leads to an LDL receptor protein that is unable to properly bind LDL (PMID: 8098448). For these reasons, this variant has been classified as Pathogenic."	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Invitae	SCV000285027.5	SCV000285027		LDLR	-	High LDL	6/8/18	46963	0	3	"[0.9999680599620978,3.194003790217831E-5]"	3	SCV000285027171199	single nucleotide variant	NM_000527.4(LDLR):c.301G>A (p.Glu101Lys)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	31-Oct-18	144172724	-	RCV000211583;RCV000148571;RCV000162016	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202"	Familial hypercholesterolemia;Hypercholesterolaemia;not provided	germline;not applicable;unknown	germline	GRCh37	NC_000019.9	19	11213450	11213450	G	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	15	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000044,UniProtKB (protein):P01130#VAR_005315"	2	161266	19	11213450	G	A	171199	19:11213450:G:A	Pathogenic	7/11/17	"This sequence change replaces glutamic acid with lysine at codon 101 of the LDLR protein (p.Glu101Lys). The glutamic acid residue is highly conserved and there is a small physicochemical difference between glutamic acid and lysine. This variant is present in population databases (rs144172724, ExAC <0.01%). This variant has been reported in the literature to segregate with disease in two families (PMID: 1301940, 1352322) and also present in multiple individuals affected with hypercholesterolemia (PMID: 1352322, 11668627, 23669246, 18718593, 19843101, 15241806, 20236128, 17142622, 16314194, 11668640). This variant is also known in the literature as E80K. ClinVar contains an entry for this variant (Variation ID: 161266). One experimental study has shown that this missense variant inhibited LDL uptake in Hel-Kyoto cells (PMID: 25647241). In summary, this variant is present at a very low frequency in the general population, has been reported to segregate with disease and is present in multiple individuals with hypercholesterolemia, and has been shown to affected protein function in vitro. For these reasons, it has been classified as Pathogenic."	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Invitae	SCV000285028.3	SCV000285028		LDLR	-	High LDL	10/31/18	46963	0	3	"[0.9999680599620978,3.194003790217831E-5]"	3	SCV000285028243268	single nucleotide variant	NM_000527.4(LDLR):c.337G>A (p.Glu113Lys)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	8-Feb-18	769383881	-	RCV000232879	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline	germline	GRCh37	NC_000019.9	19	11215919	11215919	G	A	19p13.2	"criteria provided, conflicting interpretations"	4	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_001704	2	237872	19	11215919	G	A	243268	19:11215919:G:A	Likely pathogenic	2/8/18	"This sequence change replaces glutamic acid with lysine at codon 113 of the LDLR protein (p.Glu113Lys). The glutamic acid residue is highly conserved and there is a small physicochemical difference between glutamic acid and lysine. This variant is present in population databases (rs769383881, ExAC <0.01%). This variant has been reported to segregate with elevated LDL levels in a single family (PMID: 10807540). It has also been reported in several unrelated individuals affected with hypercholesterolemia (PMID: 16250003, 17539906, Invitae). This variant is also known as E92K in the literature. ClinVar contains an entry for this variant (Variation ID: 237872). Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: ""Deleterious""; PolyPhen-2: ""Possibly Damaging""; Align-GVGD: ""Class C0""). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic."	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Invitae	SCV000285029.3	SCV000285029		LDLR	-	High LDL	2/8/18	46961	2	2	"[0.9999787057345457,2.1294265454313153E-5]"	2	SCV000285029228142	deletion	NM_000527.4(LDLR):c.654_656delTGG (p.Gly219del)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	25-Jun-18	121908027	-	RCV000211647;RCV000589051;RCV000489033	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:CN517202"	Familial hypercholesterolemia;Familial hypercholesterolemias;not provided	germline;inherited;not applicable	germline	GRCh37	NC_000019.9	19	11216236	11216238	TGG	-	19p13.2	"criteria provided, multiple submitters, no conflicts"	14	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000094,OMIM Allelic Variant:606945.0005"	3	226329	19	11216232	ATGG	A	228142	19:11216232:ATGG:A	Pathogenic	6/25/18	"This sequence change deletes 3 nucleotides from exon 4 of the LDLR mRNA (c.654_656delTGG). This leads to the deletion of 1 amino acid residue in the LDLR protein (p.Gly219del) but otherwise preserves the integrity of the reading frame. This variant is present in population databases (rs758036807, ExAC 0.008%). This variant is a known common cause of familial hypercholesterolemia in Ashkenazi Jewish population from Eastern Europe (PMID:Â¬â€ 9744476,Â¬â€ 11309683,Â¬â€ 1867200), although it has been observed in individuals from other ethnicities (PMID: 17539906, 18096825, 22698793,Â¬â€ 28104544). This variant is also known as p.G197del and p.Gly218del in the literature. Experimental studies and prediction algorithms are not available for this variant, and the functional significance of the deleted amino acid is currently unknown. For these reasons, this variant has been classified as Pathogenic."	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Invitae	SCV000285032.3	SCV000285032		LDLR	-	High LDL	6/25/18	46962	1	1	"[0.9999893530939908,1.0646906009113752E-5]"	1	SCV000285032181238	single nucleotide variant	NM_000527.4(LDLR):c.829G>A (p.Glu277Lys)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	29-Dec-17	148698650	-	RCV000210246;RCV000495914;RCV000161968;RCV000610848	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202;MedGen:CN169374"	Familial hypercholesterolemia;Familial hypercholesterolemia;not provided;not specified	germline;not applicable;unknown	germline	GRCh37	NC_000019.9	19	11218079	11218079	G	A	19p13.2	"criteria provided, conflicting interpretations"	12	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_001845,UniProtKB (protein):P01130#VAR_005350"	2	183097	19	11218079	G	A	181238	19:11218079:G:A	Benign	4/24/17	-	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Invitae	SCV000285034.2	SCV000285034		LDLR	-	High LDL	12/29/17	46963	0	61	"[0.9993505525626557,6.494474373442923E-4]"	61	SCV000285034171204	single nucleotide variant	NM_000527.4(LDLR):c.862G>A (p.Glu288Lys)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	1-May-18	368657165	-	RCV000234348;RCV000148573	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443"	Familial hypercholesterolemia;Hypercholesterolaemia	germline	germline	GRCh37	NC_000019.9	19	11218112	11218112	G	A	19p13.2	"criteria provided, conflicting interpretations"	11	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000509,UniProtKB (protein):P01130#VAR_007983"	2	161268	19	11218112	G	A	171204	19:11218112:G:A	Likely pathogenic	5/1/18	"This sequence change replaces glutamic acid with lysine at codon 288 of the LDLR protein (p.Glu288Lys). The glutamic acid residue is highly conserved and there is a small physicochemical difference between glutamic acid and lysine. This variant is present in population databases (rs368657165, ExAC 0.02%). This variant has been reported in multiple individuals affected with hypercholesterolemia (PMID: 10090484, 11810272, 11857755, 17765246,Â¬â€ 23375686). Experimental studies have shown that this missense change reduces the protein LDL-binding capacity and decreases LDL internalization (PMID: 21990180). For these reasons, this variant has been classified as Likely Pathogenic."	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Invitae	SCV000285035.3	SCV000285035		LDLR	-	High LDL	5/1/18	46963	0	8	"[0.9999148265655942,8.517343440580883E-5]"	8	SCV00028503539055	single nucleotide variant	NM_002052.4(GATA4):c.1037C>T (p.Ala346Val)	2626	GATA4	HGNC:4173	Conflicting interpretations of pathogenicity	1	19-Dec-17	115372595	-	RCV000023005;RCV000617346;RCV000503266	"MedGen:C3280781,OMIM:614430;MedGen:CN230736;MedGen:CN169374"	Atrioventricular septal defect 4;Cardiovascular phenotype;not specified	germline	germline	GRCh37	NC_000008.10	8	11614483	11614483	C	T	8p23.1	"criteria provided, conflicting interpretations"	4	NA	N	"OMIM Allelic Variant:600576.0008,UniProtKB (protein):P43694#VAR_067616"	3	30100	8	11614483	C	T	39055	8:11614483:C:T	Likely benign	12/19/17	-	MedGen:C3280781	C3280781:Atrioventricular septal defect 4	NA	FALSE	Not trait of interest	"criteria provided, single submitter"	clinical testing	germline:na	Invitae	SCV000287293.4	SCV000287293		GATA4	-	"MonogenicDM_all, Neonatal Diabetes"	12/19/17	46963	0	104	"[0.9988927453527244,0.0011072546472755147]"	104	SCV000287293196476	single nucleotide variant	NM_170707.3(LMNA):c.1057C>T (p.Gln353Ter)	4000	LMNA	HGNC:6636	Pathogenic	1	11-Apr-18	267607623	-	RCV000247014;RCV000229718;RCV000182362	"MedGen:CN230736;MedGen:C0270914,Orphanet:ORPHA64746;MedGen:CN517202"	"Cardiovascular phenotype;Charcot-Marie-Tooth disease, type 2;not provided"	germline	germline	GRCh37	NC_000001.10	1	156105812	156105812	C	T	1q22	"criteria provided, multiple submitters, no conflicts"	3	"ACMG2013,ACMG2016"	N	-	2	200939	1	156105812	C	T	196476	1:156105812:C:T	Pathogenic	2/5/16	"This sequence change creates a premature translational stop signal at codon 353 (p.Gln353*) of the LMNA gene. It is expected to result in an absent or disrupted protein product. Truncating variants in LMNA are known to be pathogenic (PMID: 23183350). This particular truncation has been reported in the literature in an individual affected with an LMNA-related disorder (PMID: 25886484). For these reasons, this variant has been classified as Pathogenic."	MedGen:CN043576	"C0270914:Charcot-Marie-Tooth disease, type 2"	NA	FALSE	Incorrect phenotype	"criteria provided, single submitter"	clinical testing	germline:na	Invitae	SCV000291542.2	SCV000291542		LMNA	-	"Lipodystrophy, MonogenicDM_all"	4/11/18	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV000291542196756	single nucleotide variant	NM_174936.3(PCSK9):c.1405C>T (p.Arg469Trp)	255738	PCSK9	HGNC:20001	Conflicting interpretations of pathogenicity	1	7-Dec-17	141502002	-	RCV000408878;RCV000228895;RCV000182576	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C1863551,OMIM:603776;MedGen:CN169374"	"Familial hypercholesterolemia;Hypercholesterolemia, autosomal dominant, 3;not specified"	germline	germline	GRCh37	NC_000001.10	1	55524222	55524222	C	T	1p32.3	"criteria provided, conflicting interpretations"	5	"ACMG2013,ACMG2016"	N	UniProtKB (protein):Q8NBP7#VAR_025456	2	201128	1	55524222	C	T	196756	1:55524222:C:T	Benign	12/7/17	-	MedGen:C1863551	"C1863551:Hypercholesterolemia, autosomal dominant, 3"	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Invitae	SCV000291596.3	SCV000291596		PCSK9	-	Low LDL	12/7/17	46960	3	122	"[0.9987010221465077,0.0012989778534923339]"	122	SCV000291596181269	single nucleotide variant	NM_000527.4(LDLR):c.1876G>A (p.Glu626Lys)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	27-Sep-17	139791325	-	RCV000211563;RCV000162004;RCV000454999	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202;MedGen:CN169374"	Familial hypercholesterolemia;not provided;not specified	germline;not applicable;unknown	germline	GRCh37	NC_000019.9	19	11230798	11230798	G	A	19p13.2	"criteria provided, conflicting interpretations"	9	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000258	2	183127	19	11230798	G	A	181269	19:11230798:G:A	Uncertain significance	7/30/15	-	Familial hypercholesterolemia	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	unknown:na	"Division of Genomic Diagnostics,The Children's Hospital of Philadelphia"	SCV000296926.2	SCV000296926		LDLR	-	High LDL	9/27/17	46963	0	19	"[0.9997977130932862,2.0228690671379596E-4]"	19	SCV000296926226399	single nucleotide variant	NM_000527.4(LDLR):c.941-4G>A	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	12-Jan-18	116405216	-	RCV000210248;RCV000736080	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN169374"	Familial hypercholesterolemia;not specified	germline;unknown	germline	GRCh37	NC_000019.9	19	11221324	11221324	G	A	19p13.2	"criteria provided, conflicting interpretations"	10	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000515	2	224619	19	11221324	G	A	226399	19:11221324:G:A	Likely benign	11/30/15	-	Familial hypercholesterolemia	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	unknown:na	"Division of Genomic Diagnostics,The Children's Hospital of Philadelphia"	SCV000296929.2	SCV000296929		LDLR	-	High LDL	1/12/18	46963	0	399	"[0.9957519749590102,0.004248025040989715]"	389	SCV000296929172489	single nucleotide variant	NM_170707.3(LMNA):c.1634G>A (p.Arg545His)	4000	LMNA	HGNC:6636	Conflicting interpretations of pathogenicity	1	23-Apr-18	142191737	-	RCV000621850;RCV000468904;RCV000491650;RCV000449630;RCV000505801;RCV000150955	"MedGen:CN230736;MedGen:C0270914,Orphanet:ORPHA64746;MedGen:C1834481,OMIM:613426;Human Phenotype Ontology:HP:0009830,MedGen:C0031117,Orphanet:ORPHA98496;MedGen:CN517202;MedGen:CN169374"	"Cardiovascular phenotype;Charcot-Marie-Tooth disease, type 2;Dilated cardiomyopathy 1S;Peripheral neuropathy;not provided;not specified"	germline;maternal	germline	GRCh37	NC_000001.10	1	156107470	156107470	G	A	1q22	"criteria provided, conflicting interpretations"	7	"ACMG2013,ACMG2016"	N	-	2	163878	1	156107470	G	A	172489	1:156107470:G:A	Likely pathogenic	5/1/16	-	OMIM:613426	C1834481:Dilated cardiomyopathy 1S	NA	FALSE	Incorrect phenotype	no assertion criteria provided	clinical testing	germline:1	"Erich and Hanna Klessmann Institute for Cardiovascular Research and Development,Heart and Diabetes Center North Rhine-Westphalia"	SCV000298120.1	SCV000298120		LMNA	-	"Lipodystrophy, MonogenicDM_all"	4/23/18	44851	2112	4	"[0.9999554079061782,4.45920938217654E-5]"	4	SCV00029812023898	single nucleotide variant	NM_000209.3(PDX1):c.226G>A (p.Asp76Asn)	3651	PDX1	HGNC:6107	"Conflicting interpretations of pathogenicity, risk factor"	1	5-Feb-18	137852783	-	RCV000009409;RCV000626294;RCV000030077;RCV000445407;RCV000246150	"Human Phenotype Ontology:HP:0005978,MedGen:C0011860,OMIM:125853,Orphanet:ORPHA181376,SNOMED CT:44054006;Human Phenotype Ontology:HP:0004904,MedGen:C0342276,OMIM:606391,Orphanet:ORPHA552,SNOMED CT:28453007;MedGen:C1833382,OMIM:606392;MedGen:C3888631;MedGen:CN169374"	"Diabetes mellitus type 2;Maturity onset diabetes mellitus in young;Maturity-onset diabetes of the young, type 4;Monogenic diabetes;not specified"	germline;inherited;unknown	germline	GRCh37	NC_000013.10	13	28494501	28494501	G	A	13q12.2	"criteria provided, conflicting interpretations"	6	NA	N	"OMIM Allelic Variant:600733.0002,UniProtKB (protein):P52945#VAR_009311"	3	8859	13	28494501	G	A	23898	13:28494501:G:A	Benign	NA	-	NOT SPECIFIED	CN169374:not specified	No Information	FALSE	No Information	"criteria provided, single submitter"	clinical testing	germline:na	"PreventionGenetics,PreventionGenetics"	SCV000302992.1	SCV000302992		-	-	"MODY, MODY Extended, MonogenicDM_all"	2/5/18	42422	4541	98	"[0.998844938946773,0.0011550610532270991]"	98	SCV00030299245114	single nucleotide variant	NM_000527.4(LDLR):c.1061-8T>C	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	31-May-18	72658861	-	RCV000030123;RCV000759074;RCV000245346	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202;MedGen:CN169374"	Familial hypercholesterolemia;not provided;not specified	germline;unknown	germline	GRCh37	NC_000019.9	19	11222182	11222182	T	C	19p13.2	"criteria provided, conflicting interpretations"	15	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000154	2	36451	19	11222182	T	C	45114	19:11222182:T:C	Benign	NA	-	NOT SPECIFIED	CN169374:not specified	No Information	FALSE	No Information	"criteria provided, single submitter"	clinical testing	germline:na	"PreventionGenetics,PreventionGenetics"	SCV000304681.1	SCV000304681		-	-	High LDL	5/31/18	46960	3	426	"[0.9954642248722317,0.004535775127768314]"	420	SCV000304681256754	single nucleotide variant	NM_000527.4(LDLR):c.1167G>A (p.Thr389=)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	30-Mar-17	139066906	-	RCV000495926;RCV000249917	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN169374"	Familial hypercholesterolemia;not specified	germline	germline	GRCh37	NC_000019.9	19	11222296	11222296	G	A	19p13.2	"criteria provided, conflicting interpretations"	2	"ACMG2013,ACMG2016"	N	-	2	256365	19	11222296	G	A	256754	19:11222296:G:A	Likely benign	NA	-	NOT SPECIFIED	CN169374:not specified	No Information	FALSE	No Information	"criteria provided, single submitter"	clinical testing	germline:na	"PreventionGenetics,PreventionGenetics"	SCV000304682.1	SCV000304682		-	-	High LDL	3/30/17	46963	0	19	"[0.9997977130932862,2.0228690671379596E-4]"	19	SCV000304682181250	single nucleotide variant	NM_000527.4(LDLR):c.1171G>A (p.Ala391Thr)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	18-Aug-17	11669576	-	RCV000237576;RCV000162023;RCV000241875	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202;MedGen:CN169374"	Familial hypercholesterolemia;not provided;not specified	germline;not applicable;unknown	germline	GRCh37	NC_000019.9	19	11222300	11222300	G	A	19p13.2	"criteria provided, conflicting interpretations"	15	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_001369,UniProtKB (protein):P01130#VAR_024519"	2	183138	19	11222300	G	A	181250	19:11222300:G:A	Benign	NA	-	NOT SPECIFIED	CN169374:not specified	No Information	FALSE	No Information	"criteria provided, single submitter"	clinical testing	germline:na	"PreventionGenetics,PreventionGenetics"	SCV000304683.1	SCV000304683		-	-	High LDL	8/18/17	46928	35	4469	"[0.9523845039209001,0.0476154960790999]"	3889	SCV000304683196476	single nucleotide variant	NM_170707.3(LMNA):c.1057C>T (p.Gln353Ter)	4000	LMNA	HGNC:6636	Pathogenic	1	11-Apr-18	267607623	-	RCV000247014;RCV000229718;RCV000182362	"MedGen:CN230736;MedGen:C0270914,Orphanet:ORPHA64746;MedGen:CN517202"	"Cardiovascular phenotype;Charcot-Marie-Tooth disease, type 2;not provided"	germline	germline	GRCh37	NC_000001.10	1	156105812	156105812	C	T	1q22	"criteria provided, multiple submitters, no conflicts"	3	"ACMG2013,ACMG2016"	N	-	2	200939	1	156105812	C	T	196476	1:156105812:C:T	Pathogenic	4/11/18	"Lines of evidence used in support of classification: Alterations resulting in premature truncation (e.g.reading frame shift, nonsense),Rarity in general population databases (dbsnp, esp, 1000 genomes)"	cardiovascular phenotype	CN230736:Cardiovascular phenotype	NA	FALSE	Incorrect phenotype	"criteria provided, single submitter"	clinical testing	germline:1	Ambry Genetics	SCV000319073.4	SCV000319073		LMNA	-	"Lipodystrophy, MonogenicDM_all"	4/11/18	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV00031907329566	single nucleotide variant	NM_170707.3(LMNA):c.1930C>T (p.Arg644Cys)	4000	LMNA	HGNC:6636	Conflicting interpretations of pathogenicity	1	21-Nov-18	142000963	-	RCV000245284;RCV000144868;RCV000471403;RCV000755679;RCV000148602;RCV000015626;RCV000057374;RCV000041340	"MedGen:CN230736;MedGen:C0007959,Orphanet:ORPHA166,SNOMED CT:50548001;MedGen:C0270914,Orphanet:ORPHA64746;MedGen:C1449563,OMIM:115200,Orphanet:ORPHA300751;EFO:EFO_0000407,Human Phenotype Ontology:HP:0001644,MedGen:C0007193,Orphanet:ORPHA217604,SNOMED CT:195021004;na;MedGen:CN517202;MedGen:CN169374"	"Cardiovascular phenotype;Charcot-Marie-Tooth disease;Charcot-Marie-Tooth disease, type 2;Dilated cardiomyopathy 1A;Primary dilated cardiomyopathy;Variant of unknown significance;not provided;not specified"	germline;tested-inconclusive;unknown	germline	GRCh37	NC_000001.10	1	156108510	156108510	C	T	1q22	"criteria provided, conflicting interpretations"	13	"ACMG2013,ACMG2016"	N	"OMIM Allelic Variant:150330.0051,UniProtKB (protein):P02545#VAR_039792"	3	14527	1	156108510	C	T	29566	1:156108510:C:T	Uncertain significance	12/22/17	Lines of evidence used in support of classification: Insufficient evidence	cardiovascular phenotype	CN230736:Cardiovascular phenotype	NA	FALSE	Incorrect phenotype	"criteria provided, single submitter"	clinical testing	germline:1	Ambry Genetics	SCV000319734.4	SCV000319734		LMNA	-	"Lipodystrophy, MonogenicDM_all"	11/21/18	46954	9	67	"[0.9992865357584019,7.134642415981599E-4]"	65	SCV00031973457209	single nucleotide variant	NM_170707.3(LMNA):c.1567G>A (p.Gly523Arg)	4000	LMNA	HGNC:6636	Conflicting interpretations of pathogenicity	1	16-Aug-18	201583907	-	RCV000245950;RCV000474372;RCV000678714;RCV000057323;RCV000041324	"MedGen:CN230736;MedGen:C0270914,Orphanet:ORPHA64746;Human Phenotype Ontology:HP:0030682,MedGen:C1960469,Orphanet:ORPHA54260,SNOMED CT:427608000;MedGen:CN517202;MedGen:CN169374"	"Cardiovascular phenotype;Charcot-Marie-Tooth disease, type 2;Left ventricular noncompaction;not provided;not specified"	germline	germline	GRCh37	NC_000001.10	1	156106982	156106982	G	A	1q22	"criteria provided, conflicting interpretations"	7	"ACMG2013,ACMG2016"	N	UniProtKB (protein):P02545#VAR_067258	2	48045	1	156106982	G	A	57209	1:156106982:G:A	Uncertain significance	11/12/15	"Lines of evidence used in support of classification: Rarity in general population databases (dbsnp, esp, 1000 genomes),In silico models in agreement (deleterious) and/or completely conserved position in appropriate species,Detected in individual satisfying established diagnostic critera for classic disease without a clear mutation,Insufficient or conflicting evidence"	cardiovascular phenotype	CN230736:Cardiovascular phenotype	NA	FALSE	Incorrect phenotype	"criteria provided, single submitter"	clinical testing	germline:1	Ambry Genetics	SCV000320458.4	SCV000320458		LMNA	-	"Lipodystrophy, MonogenicDM_all"	8/16/18	46878	85	4	"[0.9999573360638252,4.2663936174751484E-5]"	4	SCV00032045844873	single nucleotide variant	NM_000162.3(GCK):c.214G>A (p.Gly72Arg)	2645	GCK	HGNC:4195	Pathogenic	1	12-Jul-18	193922289	-	RCV000029872;RCV000255585	"MedGen:C1841962,OMIM:125851;MedGen:CN517202"	"Maturity-onset diabetes of the young,  type 2;not provided"	germline	germline	GRCh37	NC_000007.13	7	44192019	44192019	C	T	7p13	"criteria provided, multiple submitters, no conflicts"	3	NA	N	-	2	36209	7	44192019	C	T	44873	7:44192019:C:T	Pathogenic	4/4/16	"The G72R variant has been published previously in association with MODY2 (Lehto et al., 1999; Raimondo et al., 2014; Flanagan et al., 2014). The variant was not observed at any significant frequency in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. G72R is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position within a connecting region that is conserved across species, and which is critical for glucokinase interaction (Zelent et al., 2011). In silico analysis predicts this variant is probably damaging to the protein structure/function. Additionally, functional studies have shown that G72R results in increased activity compared to wild type, as well as decreased thermal stability of the protein (Sagen et al., 2006; Raimondo et al., 2014). Missense variants in nearby residues (E70K/D, V71I, D73G, S76C/Y/F) have been reported in the Human Gene Mutation Database in association with MODY (Stenson et al., 2014), supporting the functional importance of this region of the protein. Therefore, this variant is pathogenic."	Not Provided	CN517202:not provided	MODY	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	GeneDx	SCV000321712.6	SCV000321712		GCK	-	"MODY, MODY Extended, MonogenicDM_all"	7/12/18	46963	0	2	"[0.9999787066413985,2.1293358601452207E-5]"	2	SCV00032171229357	single nucleotide variant	NM_005912.2(MC4R):c.105C>A (p.Tyr35Ter)	4160	MC4R	HGNC:6932	Pathogenic	1	14-Aug-18	13447324	-	RCV000015394;RCV000202583;RCV000255005	"Human Phenotype Ontology:HP:0001513,MedGen:C0028754,OMIM:601665,Orphanet:ORPHA71529,SNOMED CT:414916001;Human Phenotype Ontology:HP:0100753,MedGen:C0036341,OMIM:181500,SNOMED CT:58214004;MedGen:CN517202"	Obesity;Schizophrenia;not provided	germline	germline	GRCh37	NC_000018.9	18	58039478	58039478	G	T	18q21.3	"criteria provided, multiple submitters, no conflicts"	8	NA	N	OMIM Allelic Variant:155541.0003	3	14318	18	58039478	G	T	29357	18:58039478:G:T	Pathogenic	5/27/16	"The Y35X pathogenic variant in the MC4R gene has been reported multiple times in association with obesity, seen on the same allele (in cis) with the D37V variant, which will not be translated since it is downstream of the premature stop codon created by Y35X (Hinney et al., 1999; Hinney et al., 2003; Larsen et al., 2005). Functional studies show Y35X leads to impaired cAMP responses and absent binding of NDP-alphaMSH (Hinney et al., 2003; Larsen et al., 2005). The Y35X variant was not observed at any significant frequency in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. We interpret Y35X as a pathogenic variant."	Not Provided	CN517202:not provided	Obesity	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	GeneDx	SCV000321871.6	SCV000321871		MC4R	-	Obesity	8/14/18	46963	0	6	"[0.9999361199241956,6.388007580435663E-5]"	6	SCV00032187132929	single nucleotide variant	NM_000384.2(APOB):c.10580G>A (p.Arg3527Gln)	338	APOB	HGNC:603	Conflicting interpretations of pathogenicity	1	11-Jul-18	5742904	-	RCV000019479;RCV000284412;RCV000412515;RCV000627797;RCV000499833;RCV000627797;RCV000254882	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C1862596,Orphanet:ORPHA426,SNOMED CT:60193003;MedGen:C1704417,OMIM:144010;MedGen:C1704417,OMIM:144010;MedGen:C0020597,Orphanet:ORPHA31154;MedGen:C4551990,OMIM:615558;MedGen:CN517202"	"Familial hypercholesterolemia;Familial hypobetalipoproteinemia;Hypercholesterolemia, autosomal dominant, type B;Hypercholesterolemia, autosomal dominant, type B;Hypobetalipoproteinemia;Hypobetalipoproteinemia, familial, 1;not provided"	germline;maternal;unknown	germline	GRCh37	NC_000002.11	2	21229160	21229160	C	T	2p24	"criteria provided, conflicting interpretations"	18	"ACMG2013,ACMG2016"	Y	OMIM Allelic Variant:107730.0009	3	17890	2	21229160	C	T	32929	2:21229160:C:T	Pathogenic	11/7/17	"The R3527Q pathogenic variant in the APOB gene, also denoted as R3500Q due to the use of alternate nomenclature, has been previously reported in association with apolipoprotein B deficiency and hypercholesterolemia (Soria et al., 1989; Tybjaerg-Hansen et al.,1998; Fisher et al., 1999; Bertolini et al., 2013; Norsworthy et al., 2014; Radovica-Splavina et al., 2015; Braenne et al., 2016). This variant has been shown to segregate with disease in multiple affected relatives from multiple families (Soria et al., 1989; Loux et al., 1993; Chatzistefanidis et al., 2013). Additionally, R3527Q has been reported as a founder mutation in the Old Order Amish population (Shen et al., 2010). This variant is observed in 73/126,056 alleles from individuals of Non-Finnish European ancestry in large population cohorts (Lek et al., 2016). The R3527Q variant is a semi-conservative amino acid substitution, which occurs at a position that is conserved across mammalian species. Moreover, functional studies indicate that the R3527Q variant causes decreased binding of the APOB protein to the LDL receptor (Fisher et al., 1999). Furthermore, a pathogenic missense variant at the same residue (R3527W, also denoted as R3500W due to the use of alternate nomenclature) has also been reported in association with FH (Gaffney et al., 1995; Fisher et al., 1999)."	Not Provided	CN517202:not provided	hypercholesterolemia	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	GeneDx	SCV000322134.6	SCV000322134		APOB	-	Low LDL	7/11/18	46963	0	12	"[0.9998722398483912,1.2776015160871325E-4]"	12	SCV000322134171211	single nucleotide variant	NM_000527.4(LDLR):c.1201C>G (p.Leu401Val)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	11-May-18	146200173	-	RCV000238417;RCV000586642;RCV000148572;RCV000255176	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:C0020443;MedGen:CN517202"	Familial hypercholesterolemia;Familial hypercholesterolemias;Hypercholesterolaemia;not provided	germline	germline	GRCh37	NC_000019.9	19	11223968	11223968	C	G	19p13.2	"criteria provided, conflicting interpretations"	10	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000535,UniProtKB (protein):P01130#VAR_007987"	2	161267	19	11223968	C	G	171211	19:11223968:C:G	Pathogenic	8/25/16	"The L401V variant in the LDLR gene has been reported previously in the heterozygous state in multiple individuals with familial hypercholesterolemia (Leren et al., 1997; Vaca et al., 2011; Jannes et al., 2015). Note that Leren et al. described L401V using alternate nomenclature L380V (1997). The L401V variant was not observed at any significant frequency in approximately 6500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The L401V variant is a conservative amino acid substitution, which is not likely to impact secondary protein structure as these residues share similar properties. However, this substitution occurs at a position that is conserved across species, and in silico analysis predicts this variant is probably damaging to the protein structure/function. A missense variant in the same residue, L401H, was previously reported, using alternate nomenclature L308H and referred to as FH-Pori, in four unrelated individuals of Finnish descent with heterozygous familial hypercholesterolemia (Koivisto et al., 1995), supporting the functional importance of this region of the protein. Therefore, we interpret L401V as a known pathogenic variant."	Not Provided	CN517202:not provided	Familial hypercholesterolemia	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	GeneDx	SCV000322301.6	SCV000322301		LDLR	-	High LDL	5/11/18	46963	0	3	"[0.9999680599620978,3.194003790217831E-5]"	3	SCV000322301260011	single nucleotide variant	NM_000545.6(HNF1A):c.779C>T (p.Thr260Met)	6927	HNF1A	HGNC:11621	Pathogenic	1	16-Feb-18	886039544	-	RCV000255526	MedGen:CN517202	not provided	germline	germline	GRCh37	NC_000012.11	12	121432032	121432032	C	T	12q24.31	"criteria provided, multiple submitters, no conflicts"	2	NA	N	-	2	265436	12	121432032	C	T	260011	12:121432032:C:T	Pathogenic	2/23/16	"The T260M pathogenic variant in the HNF1A gene has been published previously in association with MODY (Lehto et al., 1997; Awa et al., 2011; Yorifuji et al., 2012). The variant was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. T260M is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is conserved across species, and in silico analysis predicts this variant is probably damaging to the protein structure/function. Additionally, transfection studies have shown that T260M significantly inhibits the normal regulatory effects of HNF1A, and causes increased bile acid synthesis (Ekholm et al., 2013). Missense variants in nearby residues (N257T, V259D/F, E261K, R263C/H/L) have been reported in the Human Gene Mutation Database in association with MODY (Stenson et al., 2014), supporting the functional importance of this region of the protein. Therefore, this variant is pathogenic."	Not Provided	CN517202:not provided	MODY	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	GeneDx	SCV000322330.6	SCV000322330		HNF1A	-	"MODY, MODY Extended, MonogenicDM_all"	2/16/18	46957	6	1	"[0.9999893519603041,1.0648039695891987E-5]"	1	SCV00032233044907	single nucleotide variant	NM_000162.5(GCK):c.676G>A (p.Val226Met)	2645	GCK	HGNC:4195	Pathogenic/Likely pathogenic	1	31-Oct-18	148311934	-	RCV000763584;RCV000763584;RCV000029906;RCV000763584;RCV000763584;RCV000255932	"Human Phenotype Ontology:HP:0005978,MedGen:C0011860,OMIM:125853,Orphanet:ORPHA181376,SNOMED CT:44054006;MedGen:C1865290,OMIM:602485,Orphanet:ORPHA79299;MedGen:C1841962,OMIM:125851;MedGen:C1841962,OMIM:125851;MedGen:C1833104,OMIM:606176,Orphanet:ORPHA99885;MedGen:CN517202"	"Diabetes mellitus type 2;Hyperinsulinemic hypoglycemia familial 3;Maturity-onset diabetes of the young,  type 2;Maturity-onset diabetes of the young,  type 2;Permanent neonatal diabetes mellitus;not provided"	germline;unknown	germline	GRCh37	NC_000007.13	7	44189362	44189362	C	T	7p13	"criteria provided, multiple submitters, no conflicts"	6	NA	N	UniProtKB (protein):P35557#VAR_003703	2	36243	7	44189362	C	T	44907	7:44189362:C:T	Pathogenic	10/11/17	"The V226M missense variant in the GCK gene has been reported previously in association with MODY (Velho et al., 1997; Pruhova et al., 2010; Vits et al., 2006). This variant has been shown to segregate with disease in many affected individuals from several families in published literature (Henderson et al., 2007) or referred for genetic testing at GeneDx. The V226M variant is observed in 2/111,690 (0.0018%) alleles from individuals of non-Finnish European background in the gnomAD dataset (Lek et al., 2016). This substitution occurs at a position in the hexokinase subdomain that is conserved across species, and functional studies have shown that V226M leads to decreased enzyme activity of the glucokinase protein (Davis et al., 1999). However, another functional study theorized V226M may lead to a milder phenotype in comparison to other GCK pathogenic variants, as it leads to increased stability of the glucokinase protein while simltaneously decreasing its activity (Raimondo et al., 2014). Missense variants in the same codon (V226L/E) have been reported in association with MODY (Borowiec et al., 2012; Pruhova et al., 2010), as have missense variants in nearby residues (M224R/T, I225F/M, G227R/S/C, T228A/M/R/K) in the Human Gene Mutation Database (Stenson et al., 2014), supporting the functional importance of this region of the protein. The V226M variant is reported as pathogenic in ClinVar but additional evidence is not available (Landrum et al., 2016; SCV000594954.1). We interpret V226M as a pathogenic variant."	Not Provided	CN517202:not provided	MODY	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	GeneDx	SCV000322348.6	SCV000322348		GCK	-	"MODY, MODY Extended, MonogenicDM_all"	10/31/18	46963	0	2	"[0.9999787066413985,2.1293358601452207E-5]"	2	SCV000322348264506	single nucleotide variant	NM_000352.4(ABCC8):c.4308-2A>G	6833	ABCC8	HGNC:59	Pathogenic	1	13-Jul-17	886041391	-	RCV000334836	MedGen:CN517202	not provided	germline	germline	GRCh37	NC_000011.9	11	17416824	17416824	T	C	11p15.1	"criteria provided, single submitter"	1	NA	N	-	2	280114	11	17416824	T	C	264506	11:17416824:T:C	Pathogenic	7/13/17	"The c.4308-2A>G pathogenic variant in the ABCC8 gene has been reported previously (as c.4311-2A>G due to the use of alternative nomenclature) in association with congenital hyperinsulinism in one individual who also harbored a nonsense variant in trans (Kapoor et al., 2013). This splice site variant destroys the canonical splice acceptor site in intron 35. It is predicted to cause abnormal gene splicing, either leading to an abnormal message that is subject to nonsense-mediated mRNA decay, or to an abnormal protein product if the message is used for protein translation. The c.4308-2A>G variant was not observed in approximately 6500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. We interpret c.4308-2A>G as a pathogenic variant."	Not Provided	CN517202:not provided	congenital hyperinsulinism	FALSE	Not trait of interest	"criteria provided, single submitter"	clinical testing	germline:na	GeneDx	SCV000329971.5	SCV000329971		ABCC8	-	"MODY Extended, MonogenicDM_all, Neonatal Diabetes"	7/13/17	46811	152	1	"[0.9999893187498665,1.0681250133515627E-5]"	1	SCV00032997129566	single nucleotide variant	NM_170707.3(LMNA):c.1930C>T (p.Arg644Cys)	4000	LMNA	HGNC:6636	Conflicting interpretations of pathogenicity	1	21-Nov-18	142000963	-	RCV000245284;RCV000144868;RCV000471403;RCV000755679;RCV000148602;RCV000015626;RCV000057374;RCV000041340	"MedGen:CN230736;MedGen:C0007959,Orphanet:ORPHA166,SNOMED CT:50548001;MedGen:C0270914,Orphanet:ORPHA64746;MedGen:C1449563,OMIM:115200,Orphanet:ORPHA300751;EFO:EFO_0000407,Human Phenotype Ontology:HP:0001644,MedGen:C0007193,Orphanet:ORPHA217604,SNOMED CT:195021004;na;MedGen:CN517202;MedGen:CN169374"	"Cardiovascular phenotype;Charcot-Marie-Tooth disease;Charcot-Marie-Tooth disease, type 2;Dilated cardiomyopathy 1A;Primary dilated cardiomyopathy;Variant of unknown significance;not provided;not specified"	germline;tested-inconclusive;unknown	germline	GRCh37	NC_000001.10	1	156108510	156108510	C	T	1q22	"criteria provided, conflicting interpretations"	13	"ACMG2013,ACMG2016"	N	"OMIM Allelic Variant:150330.0051,UniProtKB (protein):P02545#VAR_039792"	3	14527	1	156108510	C	T	29566	1:156108510:C:T	Likely benign	1/26/16	-	not specified	CN169374:not specified	No Information	FALSE	No Information	"criteria provided, single submitter"	clinical testing	germline:10	"EGL Genetic Diagnostics,Eurofins Clinical Diagnostics"	SCV000332002.4	SCV000332002		LMNA	-	"Lipodystrophy, MonogenicDM_all"	11/21/18	46954	9	67	"[0.9992865357584019,7.134642415981599E-4]"	65	SCV00033200257209	single nucleotide variant	NM_170707.3(LMNA):c.1567G>A (p.Gly523Arg)	4000	LMNA	HGNC:6636	Conflicting interpretations of pathogenicity	1	16-Aug-18	201583907	-	RCV000245950;RCV000474372;RCV000678714;RCV000057323;RCV000041324	"MedGen:CN230736;MedGen:C0270914,Orphanet:ORPHA64746;Human Phenotype Ontology:HP:0030682,MedGen:C1960469,Orphanet:ORPHA54260,SNOMED CT:427608000;MedGen:CN517202;MedGen:CN169374"	"Cardiovascular phenotype;Charcot-Marie-Tooth disease, type 2;Left ventricular noncompaction;not provided;not specified"	germline	germline	GRCh37	NC_000001.10	1	156106982	156106982	G	A	1q22	"criteria provided, conflicting interpretations"	7	"ACMG2013,ACMG2016"	N	UniProtKB (protein):P02545#VAR_067258	2	48045	1	156106982	G	A	57209	1:156106982:G:A	Uncertain significance	8/16/18	-	not provided	CN517202:not provided	No Information	FALSE	No Information	"criteria provided, single submitter"	clinical testing	germline:3	"EGL Genetic Diagnostics,Eurofins Clinical Diagnostics"	SCV000336479.4	SCV000336479		LMNA	-	"Lipodystrophy, MonogenicDM_all"	8/16/18	46878	85	4	"[0.9999573360638252,4.2663936174751484E-5]"	4	SCV00033647929526	single nucleotide variant	NM_170707.3(LMNA):c.1579C>T (p.Arg527Cys)	4000	LMNA	HGNC:6636	Pathogenic	1	16-Nov-15	57318642	-	RCV000192240;RCV000192011;RCV000015576;RCV000057324	"MedGen:C0007959,Orphanet:ORPHA166,SNOMED CT:50548001;MedGen:C0033300,OMIM:176670,Orphanet:ORPHA740,SNOMED CT:238870004;MedGen:C0432291,OMIM:248370,Orphanet:ORPHA2457,SNOMED CT:109419009;MedGen:CN517202"	Charcot-Marie-Tooth disease;Hutchinson-Gilford syndrome;Mandibuloacral dysostosis;not provided	germline	germline	GRCh37	NC_000001.10	1	156106994	156106994	C	T	1q22	"criteria provided, single submitter"	4	"ACMG2013,ACMG2016"	N	"OMIM Allelic Variant:150330.0026,UniProtKB (protein):P02545#VAR_017663"	3	14487	1	156106994	C	T	29526	1:156106994:C:T	Pathogenic	11/16/15	-	not provided	CN517202:not provided	NA	FALSE	Incorrect phenotype	"criteria provided, single submitter"	clinical testing	germline:1	"EGL Genetic Diagnostics,Eurofins Clinical Diagnostics"	SCV000337575.4	SCV000337575		LMNA	-	"Lipodystrophy, MonogenicDM_all"	11/16/15	46874	89	3	"[0.9999679993173187,3.2000682681230535E-5]"	3	SCV00033757529526	single nucleotide variant	NM_170707.3(LMNA):c.1579C>T (p.Arg527Cys)	4000	LMNA	HGNC:6636	Pathogenic	1	16-Nov-15	57318642	-	RCV000192240;RCV000192011;RCV000015576;RCV000057324	"MedGen:C0007959,Orphanet:ORPHA166,SNOMED CT:50548001;MedGen:C0033300,OMIM:176670,Orphanet:ORPHA740,SNOMED CT:238870004;MedGen:C0432291,OMIM:248370,Orphanet:ORPHA2457,SNOMED CT:109419009;MedGen:CN517202"	Charcot-Marie-Tooth disease;Hutchinson-Gilford syndrome;Mandibuloacral dysostosis;not provided	germline	germline	GRCh37	NC_000001.10	1	156106994	156106994	C	T	1q22	"criteria provided, single submitter"	4	"ACMG2013,ACMG2016"	N	"OMIM Allelic Variant:150330.0026,UniProtKB (protein):P02545#VAR_017663"	3	14487	1	156106994	C	T	29526	1:156106994:C:T	Pathogenic	11/16/15	-	OMIM:248370	C0432291:Mandibuloacral dysostosis	NA	FALSE	AR	"criteria provided, single submitter"	clinical testing	germline:1	"EGL Genetic Diagnostics,Eurofins Clinical Diagnostics"	SCV000337576.3	SCV000337576		LMNA	-	"Lipodystrophy, MonogenicDM_all"	11/16/15	46874	89	3	"[0.9999679993173187,3.2000682681230535E-5]"	3	SCV00033757657199	single nucleotide variant	NM_005572.3(LMNA):c.1201C>T (p.Arg401Cys)	4000	LMNA	HGNC:6636	Conflicting interpretations of pathogenicity	1	17-May-18	61094188	-	RCV000157295;RCV000528639;RCV000172002;RCV000627127;RCV000057258;RCV000041313	"MedGen:C4053736,OMIM:604772;MedGen:C0270914,Orphanet:ORPHA64746;MedGen:C0410189,Orphanet:ORPHA261,SNOMED CT:111508004;MedGen:C0340427,Orphanet:ORPHA217607;MedGen:CN517202;MedGen:CN169374"	"Catecholaminergic polymorphic ventricular tachycardia type 1;Charcot-Marie-Tooth disease, type 2;Emery-Dreifuss muscular dystrophy;Familial dilated cardiomyopathy;not provided;not specified"	germline;unknown	germline	GRCh37	NC_000001.10	1	156106048	156106048	C	T	1q22	"criteria provided, conflicting interpretations"	8	"ACMG2013,ACMG2016"	N	UniProtKB (protein):P02545#VAR_072818	2	48035	1	156106048	C	T	57199	1:156106048:C:T	Uncertain significance	5/17/18	-	not provided	CN517202:not provided	No Information	FALSE	No Information	"criteria provided, single submitter"	clinical testing	germline:4	"EGL Genetic Diagnostics,Eurofins Clinical Diagnostics"	SCV000337619.4	SCV000337619		LMNA	-	"Lipodystrophy, MonogenicDM_all"	5/17/18	46962	1	6	"[0.9999361185639453,6.388143605468251E-5]"	6	SCV00033761957261	single nucleotide variant	NM_170707.3(LMNA):c.976T>A (p.Ser326Thr)	4000	LMNA	HGNC:6636	Conflicting interpretations of pathogenicity	1	21-Nov-18	56851164	-	RCV000621488;RCV000544253;RCV000755678;RCV000208012;RCV000057494;RCV000212504	"MedGen:CN230736;MedGen:C0270914,Orphanet:ORPHA64746;MedGen:C1449563,OMIM:115200,Orphanet:ORPHA300751;MedGen:C0949658,Orphanet:ORPHA155,SNOMED CT:83978005;MedGen:CN517202;MedGen:CN169374"	"Cardiovascular phenotype;Charcot-Marie-Tooth disease, type 2;Dilated cardiomyopathy 1A;Primary familial hypertrophic cardiomyopathy;not provided;not specified"	germline;unknown	germline	GRCh37	NC_000001.10	1	156105731	156105731	T	A	1q22	"criteria provided, conflicting interpretations"	8	"ACMG2013,ACMG2016"	N	-	2	48097	1	156105731	T	A	57261	1:156105731:T:A	Uncertain significance	12/8/15	-	not provided	CN517202:not provided	No Information	FALSE	No Information	"criteria provided, single submitter"	clinical testing	germline:3	"EGL Genetic Diagnostics,Eurofins Clinical Diagnostics"	SCV000337761.4	SCV000337761		LMNA	-	"Lipodystrophy, MonogenicDM_all"	11/21/18	46959	4	3	"[0.9999680572414233,3.1942758576630676E-5]"	3	SCV000337761172489	single nucleotide variant	NM_170707.3(LMNA):c.1634G>A (p.Arg545His)	4000	LMNA	HGNC:6636	Conflicting interpretations of pathogenicity	1	23-Apr-18	142191737	-	RCV000621850;RCV000468904;RCV000491650;RCV000449630;RCV000505801;RCV000150955	"MedGen:CN230736;MedGen:C0270914,Orphanet:ORPHA64746;MedGen:C1834481,OMIM:613426;Human Phenotype Ontology:HP:0009830,MedGen:C0031117,Orphanet:ORPHA98496;MedGen:CN517202;MedGen:CN169374"	"Cardiovascular phenotype;Charcot-Marie-Tooth disease, type 2;Dilated cardiomyopathy 1S;Peripheral neuropathy;not provided;not specified"	germline;maternal	germline	GRCh37	NC_000001.10	1	156107470	156107470	G	A	1q22	"criteria provided, conflicting interpretations"	7	"ACMG2013,ACMG2016"	N	-	2	163878	1	156107470	G	A	172489	1:156107470:G:A	Uncertain significance	1/3/17	-	not provided	CN517202:not provided	No Information	FALSE	No Information	"criteria provided, single submitter"	clinical testing	germline:5	"EGL Genetic Diagnostics,Eurofins Clinical Diagnostics"	SCV000338870.3	SCV000338870		LMNA	-	"Lipodystrophy, MonogenicDM_all"	4/23/18	44851	2112	4	"[0.9999554079061782,4.45920938217654E-5]"	4	SCV00033887057227	single nucleotide variant	NM_170707.3(LMNA):c.350A>G (p.Lys117Arg)	4000	LMNA	HGNC:6636	Conflicting interpretations of pathogenicity	1	15-Jun-18	397517901	-	RCV000653882;RCV000324940;RCV000041346	"MedGen:C0270914,Orphanet:ORPHA64746;MedGen:CN517202;MedGen:CN169374"	"Charcot-Marie-Tooth disease, type 2;not provided;not specified"	germline	germline	GRCh37	NC_000001.10	1	156085059	156085059	A	G	1q22	"criteria provided, conflicting interpretations"	3	"ACMG2013,ACMG2016"	N	-	2	48063	1	156085059	A	G	57227	1:156085059:A:G	Likely pathogenic	9/14/16	-	not provided	CN517202:not provided	NA	FALSE	Incorrect phenotype	"criteria provided, single submitter"	clinical testing	germline:1	"EGL Genetic Diagnostics,Eurofins Clinical Diagnostics"	SCV000345189.4	SCV000345189		LMNA	-	"Lipodystrophy, MonogenicDM_all"	6/15/18	46729	234	3	"[0.99996790001926,3.2099980740011554E-5]"	3	SCV000345189275130	deletion	NM_001807.4(CEL):c.2181delT (p.Val728Cysfs)	1056	CEL	HGNC:1848	Likely pathogenic	1	26-Aug-16	780419796	-	RCV000365428	MedGen:CN517202	not provided	germline	germline	GRCh37	NC_000009.11	9	135947061	135947061	T	-	9q34.2	"criteria provided, single submitter"	1	NA	N	-	2	290893	9	135947060	CT	C	275130	9:135947060:CT:C	Likely pathogenic	8/26/16	-	not provided	CN517202:not provided	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:1	"EGL Genetic Diagnostics,Eurofins Clinical Diagnostics"	SCV000345559.4	SCV000345559		CEL	-	"MODY Extended, MonogenicDM_all"	8/26/16	46130	833	19	"[0.9997940602644699,2.0593973553002386E-4]"	17	SCV000345559281418	single nucleotide variant	NM_174936.3(PCSK9):c.94G>A (p.Glu32Lys)	255738	PCSK9	HGNC:20001	Conflicting interpretations of pathogenicity	1	14-Jun-16	564427867	-	RCV000331053;RCV000370400	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C1862596,Orphanet:ORPHA426,SNOMED CT:60193003"	Familial hypercholesterolemia;Familial hypobetalipoproteinemia	germline	germline	GRCh37	NC_000001.10	1	55505604	55505604	G	A	1p32.3	"criteria provided, conflicting interpretations"	3	"ACMG2013,ACMG2016"	N	-	2	297692	1	55505604	G	A	281418	1:55505604:G:A	Uncertain significance	6/14/16	-	Familial Hypobetalipoproteinemia	C1862596:Familial hypobetalipoproteinemia	NA	FALSE	Not trait of interest and AR	"criteria provided, single submitter"	clinical testing	germline:na	"Illumina Clinical Services Laboratory,Illumina"	SCV000358212.2	SCV000358212		PCSK9	-	Low LDL	6/14/16	45906	1057	3	"[0.9999673245327408,3.267546725918181E-5]"	3	SCV000358212281418	single nucleotide variant	NM_174936.3(PCSK9):c.94G>A (p.Glu32Lys)	255738	PCSK9	HGNC:20001	Conflicting interpretations of pathogenicity	1	14-Jun-16	564427867	-	RCV000331053;RCV000370400	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C1862596,Orphanet:ORPHA426,SNOMED CT:60193003"	Familial hypercholesterolemia;Familial hypobetalipoproteinemia	germline	germline	GRCh37	NC_000001.10	1	55505604	55505604	G	A	1p32.3	"criteria provided, conflicting interpretations"	3	"ACMG2013,ACMG2016"	N	-	2	297692	1	55505604	G	A	281418	1:55505604:G:A	Likely pathogenic	6/14/16	"Mabuchi et al. (2014) investigated a cohort of 1096 Japanese familial hypercholesterolemia patients and identified the c.94G>A (p.Glu32Lys) variant in two homozygotes and 62 heterozygotes, and in nine patients who were double heterozygotes for the p.Glu32Lys variant as well as a variant in the LDLR gene. The authors also reported that the levels of LDL-cholesterol in homozygotes and double heterozygotes of the p.Glu32Lys variant were significantly higher (p<0.001) than p.Glu32Lys heterozygotes, which were in turn significantly higher (p<0.001) than in unaffected family members. In addition, the variant was shown to segregate with a phenotype of elevated LDL-cholesterol levels by Mabuchi et al. (2014) and Noguchi et al. (2010) in unrelated families, although the phenotype was milder than that of heterozygotes with a mutation in the LDLR gene. Control data are unavailable for the p.Glu32Lys variant, which is reported at a frequency of 0.00155 in the East Asian population of the Exome Aggregation Consortium but this is based on two alleles only and hence the variant is presumed rare. Based on the evidence, the p.Glu32Lys variant is classified as likely pathogenic for familial hypercholesterolemia."	Familial Hypercholesterolemia	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	"Illumina Clinical Services Laboratory,Illumina"	SCV000358214.2	SCV000358214		PCSK9	-	Low LDL	6/14/16	45906	1057	3	"[0.9999673245327408,3.267546725918181E-5]"	3	SCV000358214347739	single nucleotide variant	NM_005912.2(MC4R):c.494G>A (p.Arg165Gln)	4160	MC4R	HGNC:6932	Likely pathogenic	1	14-Jun-16	747681609	-	RCV000332082	"Human Phenotype Ontology:HP:0001513,MedGen:C0028754,OMIM:601665,Orphanet:ORPHA71529,SNOMED CT:414916001"	Obesity	germline	germline	GRCh37	NC_000018.9	18	58039089	58039089	C	T	18q21.32	"criteria provided, single submitter"	1	NA	N	UniProtKB (protein):P32245#VAR_038644	2	327713	18	58039089	C	T	347739	18:58039089:C:T	Likely pathogenic	6/14/16	"The c.494G>A (p.Arg165Gln) variant has been reported in at least four studies in a heterozygous state in a total of 18 patients with severe early-onset obesity, severe obesity, or juvenile onset obesity (Farooqi et al. 2000; Farooqi et al. 2003; Ma et al. 2004; Larsen et al. 2005). In one family, the p.Arg165Gln variant was detected in both the affected father and affected son. The p.Arg165Gln variant was absent from 2,070 control alleles but is reported at a frequency of 0.00005 in the European (Non-Finnish) population of the Exome Aggregation Consortium. In vitro functional studies demonstrated that the p.Arg165Gln variant was expressed but defective in trafficking to the cell surface and was retained intracellularly. The variant was also shown to have impaired ligand-stimulated ERK 1/2 activation, a partial cAMP response when stimulated with alpha-MSH, and to exhibit a 17-fold decrease in affinity to NDP-MSH as a result of a markedly reduced ligand binding capacity (Nijenhuis et al. 2003; Yeo et al. 2003; He et al. 2014). The Arg165 residue is conserved across thirty species (StÃ¤ubert et al. 2007). Based on the evidence, the p.Arg165Gln variant is classified as likely pathogenic for obesity."	Obesity	C0028754:Obesity	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	"Illumina Clinical Services Laboratory,Illumina"	SCV000409977.2	SCV000409977		MC4R	-	Obesity	6/14/16	46963	0	2	"[0.9999787066413985,2.1293358601452207E-5]"	2	SCV00040997729375	single nucleotide variant	NM_005912.2(MC4R):c.380C>T (p.Ser127Leu)	4160	MC4R	HGNC:6932	Conflicting interpretations of pathogenicity	1	25-May-17	13447331	-	RCV000015412;RCV000414065	"Human Phenotype Ontology:HP:0001513,MedGen:C0028754,OMIM:601665,Orphanet:ORPHA71529,SNOMED CT:414916001;MedGen:CN517202"	Obesity;not provided	germline	germline	GRCh37	NC_000018.9	18	58039203	58039203	G	A	18q21.3	"criteria provided, conflicting interpretations"	6	NA	N	"OMIM Allelic Variant:155541.0021,UniProtKB (protein):P32245#VAR_038643"	3	14336	18	58039203	G	A	29375	18:58039203:G:A	Uncertain significance	6/14/16	"Across a selection of the available literature, the c.380C>T (p.Ser127Leu) variant has been identified in a total of 15 obese patients, including nine patients in a compound heterozygous state with a known MC4R polymorphism and six patients in a heterozygous state (Hinney et al. 2003; Valli-Jaakola et al. 2004; Hainerova et al. 2007; Calton et al. 2009; Santoro et al. 2009; Nowacka-Woszuk et al. 2011; Albuquerque et al. 2014; Rovite et al. 2014). The variant was also found in five unaffected individuals, including two that carried the variant in a compound heterozygous state with the common MC4R polymorphism (Nowacka-Woszuk et al. 2011; Rouskas et al. 2012; Stanikova et al. 2015). Control data are unavailable for the p.Ser127eu variant, which is reported at a frequency of 0.00052 in the Latino population of the Exome Aggregation Consortium. Functional studies for the p.Ser127Leu variant revealed a constituitively active receptor (Hinney et al. 2003; Srinivasan et al. 2007; Mo et al. 2013), which conflicts with functional studies showing decreased cell surface expression (Rovite et al. 2014), impaired signaling (Valli-Jaakola et al. 2004), and altered alpha-MSH activation of the receptor (Lubrano-Berthelier et al. 2003). Based on the conflicting evidence from the literature, the p.Ser127Leu variant is classified as a variant of unknown significance but suspicious for pathogenicity for obesity."	Obesity	C0028754:Obesity	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	"Illumina Clinical Services Laboratory,Illumina"	SCV000409978.2	SCV000409978		MC4R	-	Obesity	5/25/17	46963	0	18	"[0.999808359772587,1.9164022741306988E-4]"	18	SCV00040997829357	single nucleotide variant	NM_005912.2(MC4R):c.105C>A (p.Tyr35Ter)	4160	MC4R	HGNC:6932	Pathogenic	1	14-Aug-18	13447324	-	RCV000015394;RCV000202583;RCV000255005	"Human Phenotype Ontology:HP:0001513,MedGen:C0028754,OMIM:601665,Orphanet:ORPHA71529,SNOMED CT:414916001;Human Phenotype Ontology:HP:0100753,MedGen:C0036341,OMIM:181500,SNOMED CT:58214004;MedGen:CN517202"	Obesity;Schizophrenia;not provided	germline	germline	GRCh37	NC_000018.9	18	58039478	58039478	G	T	18q21.3	"criteria provided, multiple submitters, no conflicts"	8	NA	N	OMIM Allelic Variant:155541.0003	3	14318	18	58039478	G	T	29357	18:58039478:G:T	Pathogenic	6/14/16	"Across a selection of the available literature, the c.105C>A (p.Tyr35Ter) stop-gained variant has been identified in a heterozygous state in at least 38 individuals with obesity. In almost all of these reports, the variant was found in cis with another variant, p.Asp37Val (Hinney et al. 1999; Hinney et al. 2003; Farooqi et al. 2003; Stutzmann et al. 2008; Tan et al. 2009; Calton et al. 2009; Larsen et al. 2009; van den Berg et al. 2011). The p.Tyr35Ter variant was absent from over 4,000 controls and is reported at a frequency of 0.00009 in the European (Non-Finnish) population of the Exome Aggregation Consortium. Lubrano-Berthelier et al. (2006) demonstrated a complete lack of membrane expression of the p.Tyr35Ter variant protein as well as a significantly impaired basal receptor activity and reduced response to a receptor agonist, both to less than 10% of wild-type. It has been shown that the C-terminal tail of the receptor contains a signal for cell surface expression, hence any truncation of the protein upstream of this signal as is predicted for the p.Tyr35Ter variant would result in intracellular retention of the variant receptor (MacKenzie, 2006). Based on the collective evidence and the potential impact of stop-gained variants, the p.Tyr35Ter variant is classified as pathogenic for obesity."	Obesity	C0028754:Obesity	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	"Illumina Clinical Services Laboratory,Illumina"	SCV000409981.2	SCV000409981		MC4R	-	Obesity	8/14/18	46963	0	6	"[0.9999361199241956,6.388007580435663E-5]"	6	SCV000409981181250	single nucleotide variant	NM_000527.4(LDLR):c.1171G>A (p.Ala391Thr)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	18-Aug-17	11669576	-	RCV000237576;RCV000162023;RCV000241875	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202;MedGen:CN169374"	Familial hypercholesterolemia;not provided;not specified	germline;not applicable;unknown	germline	GRCh37	NC_000019.9	19	11222300	11222300	G	A	19p13.2	"criteria provided, conflicting interpretations"	15	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_001369,UniProtKB (protein):P01130#VAR_024519"	2	183138	19	11222300	G	A	181250	19:11222300:G:A	Likely benign	6/14/16	-	Familial Hypercholesterolemia	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	"Illumina Clinical Services Laboratory,Illumina"	SCV000410531.2	SCV000410531		LDLR	-	High LDL	8/18/17	46928	35	4469	"[0.9523845039209001,0.0476154960790999]"	3889	SCV000410531226402	single nucleotide variant	NM_000527.4(LDLR):c.1836C>T (p.Ala612=)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	27-Jun-17	143872778	-	RCV000210239;RCV000586569;RCV000456101	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202;MedGen:CN169374"	Familial hypercholesterolemia;not provided;not specified	germline	germline	GRCh37	NC_000019.9	19	11227665	11227665	C	T	19p13.2	"criteria provided, conflicting interpretations"	9	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000249	2	224618	19	11227665	C	T	226402	19:11227665:C:T	Uncertain significance	6/14/16	"The c.1836C>T (p.Ala612Ala) variant has been reported in two studies and is found in a total of eight familial hypercholesterolemia patients in a heterozygous state (Widhalm et al. 2007; Chmara et al. 2010). In silico analysis of this variant predicted no effect on consensus splice sites and overall non-pathogenicity (Chmara et al. 2010; Usifo et al. 2012). Control data are unavailable for this variant, which is reported at a frequency of 0.00034 in the European (Non-Finnish) population of the Exome Aggregation Consortium. The evidence for this variant is limited. The p.Ala612Ala variant is classified as a variant of unknown significance but suspicious for pathogenicity for familial hypercholesterolemia."	Familial Hypercholesterolemia	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	"Illumina Clinical Services Laboratory,Illumina"	SCV000410538.2	SCV000410538		LDLR	-	High LDL	6/27/17	46963	0	10	"[0.9998935332069927,1.0646679300726103E-4]"	10	SCV000410538181275	single nucleotide variant	NM_000527.4(LDLR):c.2242G>A (p.Asp748Asn)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	14-Jun-16	150104358	-	RCV000237615;RCV000162012	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202"	Familial hypercholesterolemia;not provided	germline;not applicable	germline	GRCh37	NC_000019.9	19	11233951	11233951	G	A	19p13.2	"criteria provided, conflicting interpretations"	5	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000290	2	183133	19	11233951	G	A	181275	19:11233951:G:A	Uncertain significance	6/14/16	-	Familial Hypercholesterolemia	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	"Illumina Clinical Services Laboratory,Illumina"	SCV000410544.2	SCV000410544		LDLR	-	High LDL	6/14/16	46963	0	11	"[0.999882886527692,1.1711347230798714E-4]"	11	SCV00041054432929	single nucleotide variant	NM_000384.2(APOB):c.10580G>A (p.Arg3527Gln)	338	APOB	HGNC:603	Conflicting interpretations of pathogenicity	1	11-Jul-18	5742904	-	RCV000019479;RCV000284412;RCV000412515;RCV000627797;RCV000499833;RCV000627797;RCV000254882	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C1862596,Orphanet:ORPHA426,SNOMED CT:60193003;MedGen:C1704417,OMIM:144010;MedGen:C1704417,OMIM:144010;MedGen:C0020597,Orphanet:ORPHA31154;MedGen:C4551990,OMIM:615558;MedGen:CN517202"	"Familial hypercholesterolemia;Familial hypobetalipoproteinemia;Hypercholesterolemia, autosomal dominant, type B;Hypercholesterolemia, autosomal dominant, type B;Hypobetalipoproteinemia;Hypobetalipoproteinemia, familial, 1;not provided"	germline;maternal;unknown	germline	GRCh37	NC_000002.11	2	21229160	21229160	C	T	2p24	"criteria provided, conflicting interpretations"	18	"ACMG2013,ACMG2016"	Y	OMIM Allelic Variant:107730.0009	3	17890	2	21229160	C	T	32929	2:21229160:C:T	Uncertain significance	6/14/16	-	Familial Hypobetalipoproteinemia	C1862596:Familial hypobetalipoproteinemia	NA	FALSE	Not trait of interest and AR	"criteria provided, single submitter"	clinical testing	germline:na	"Illumina Clinical Services Laboratory,Illumina"	SCV000426985.2	SCV000426985		APOB	-	Low LDL	7/11/18	46963	0	12	"[0.9998722398483912,1.2776015160871325E-4]"	12	SCV00042698532929	single nucleotide variant	NM_000384.2(APOB):c.10580G>A (p.Arg3527Gln)	338	APOB	HGNC:603	Conflicting interpretations of pathogenicity	1	11-Jul-18	5742904	-	RCV000019479;RCV000284412;RCV000412515;RCV000627797;RCV000499833;RCV000627797;RCV000254882	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C1862596,Orphanet:ORPHA426,SNOMED CT:60193003;MedGen:C1704417,OMIM:144010;MedGen:C1704417,OMIM:144010;MedGen:C0020597,Orphanet:ORPHA31154;MedGen:C4551990,OMIM:615558;MedGen:CN517202"	"Familial hypercholesterolemia;Familial hypobetalipoproteinemia;Hypercholesterolemia, autosomal dominant, type B;Hypercholesterolemia, autosomal dominant, type B;Hypobetalipoproteinemia;Hypobetalipoproteinemia, familial, 1;not provided"	germline;maternal;unknown	germline	GRCh37	NC_000002.11	2	21229160	21229160	C	T	2p24	"criteria provided, conflicting interpretations"	18	"ACMG2013,ACMG2016"	Y	OMIM Allelic Variant:107730.0009	3	17890	2	21229160	C	T	32929	2:21229160:C:T	Pathogenic	6/14/16	"The c.10580G>A (p.Arg3527Gln) variant, also reported as p.Arg3500Gln, is well described in the literature and reported as one of the two most common variants associated with familial hypercholesterolemia, particularly in individuals of European ancestry (Youngblom et al. 2014). Across a selection of the available literature, the p.Arg3527Gln variant has been found in a heterozygous state in 42 patients (Tybjaerg-Hansen et al. 1998; Soria et al. 1989; Saint-Jore et al. 2000; Bednarska-Makaruk et al. 2001; Horvath et al. 2001; Braenne et al. 2016). Four of the studies demonstrated segregation of the variant with disease (Soria et al. 1989; Horvath et al. 2001; Saint-Jore et al. 2000; Braenne et al. 2016). Control data are unavailable for this variant which is reported at a frequency of 0.00081 in the European American population of the Exome Sequencing Project. Functional studies in transgenic mice showed that the variant resulted in defective LDL receptor binding (Boren et al. 2001). Based on the collective evidence, the p.Arg3527Gln variant is classified as pathogenic for familial hypercholesterolemia."	Familial Hypercholesterolemia	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	"Illumina Clinical Services Laboratory,Illumina"	SCV000426986.2	SCV000426986		APOB	-	Low LDL	7/11/18	46963	0	12	"[0.9998722398483912,1.2776015160871325E-4]"	12	SCV00042698623175	single nucleotide variant	NM_015869.4(PPARG):c.1484C>T (p.Pro495Leu)	5468	PPARG	HGNC:9236	Conflicting interpretations of pathogenicity	1	14-Jun-16	121909244	-	RCV000288354;RCV000343316;RCV000008612;RCV000382908	"MedGen:C4016738;MedGen:C0271694,Orphanet:ORPHA98306,SNOMED CT:49292002;MedGen:C1720861,OMIM:604367,Orphanet:ORPHA79083;Human Phenotype Ontology:HP:0001513,MedGen:C0028754,OMIM:601665,Orphanet:ORPHA71529,SNOMED CT:414916001"	"Diabetes Mellitus, Noninsulin-Dependent, with Acanthosis Nigricans and Hypertension;Familial partial lipodystrophy;Familial partial lipodystrophy 3;Obesity"	germline	germline	GRCh37	NC_000003.11	3	12475610	12475610	C	T	3p25	"criteria provided, conflicting interpretations"	2	NA	N	"OMIM Allelic Variant:601487.0007,UniProtKB (protein):P37231#VAR_010728"	3	8136	3	12475610	C	T	23175	3:12475610:C:T	Uncertain significance	6/14/16	-	Obesity	C0028754:Obesity	NA	FALSE	Incorrect phenotype	"criteria provided, single submitter"	clinical testing	germline:na	"Illumina Clinical Services Laboratory,Illumina"	SCV000440529.2	SCV000440529		PPARG	-	"Lipodystrophy, MonogenicDM_all"	6/14/16	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV00044052923175	single nucleotide variant	NM_015869.4(PPARG):c.1484C>T (p.Pro495Leu)	5468	PPARG	HGNC:9236	Conflicting interpretations of pathogenicity	1	14-Jun-16	121909244	-	RCV000288354;RCV000343316;RCV000008612;RCV000382908	"MedGen:C4016738;MedGen:C0271694,Orphanet:ORPHA98306,SNOMED CT:49292002;MedGen:C1720861,OMIM:604367,Orphanet:ORPHA79083;Human Phenotype Ontology:HP:0001513,MedGen:C0028754,OMIM:601665,Orphanet:ORPHA71529,SNOMED CT:414916001"	"Diabetes Mellitus, Noninsulin-Dependent, with Acanthosis Nigricans and Hypertension;Familial partial lipodystrophy;Familial partial lipodystrophy 3;Obesity"	germline	germline	GRCh37	NC_000003.11	3	12475610	12475610	C	T	3p25	"criteria provided, conflicting interpretations"	2	NA	N	"OMIM Allelic Variant:601487.0007,UniProtKB (protein):P37231#VAR_010728"	3	8136	3	12475610	C	T	23175	3:12475610:C:T	Uncertain significance	6/14/16	-	"Diabetes Mellitus, Noninsulin-Dependent, with Acanthosis Nigricans and Hypertension"	"C4016738:Diabetes Mellitus, Noninsulin-Dependent, with Acanthosis Nigricans and Hypertension"	NA	FALSE	Incorrect phenotype	"criteria provided, single submitter"	clinical testing	germline:na	"Illumina Clinical Services Laboratory,Illumina"	SCV000440530.2	SCV000440530		PPARG	-	"Lipodystrophy, MonogenicDM_all"	6/14/16	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV00044053023175	single nucleotide variant	NM_015869.4(PPARG):c.1484C>T (p.Pro495Leu)	5468	PPARG	HGNC:9236	Conflicting interpretations of pathogenicity	1	14-Jun-16	121909244	-	RCV000288354;RCV000343316;RCV000008612;RCV000382908	"MedGen:C4016738;MedGen:C0271694,Orphanet:ORPHA98306,SNOMED CT:49292002;MedGen:C1720861,OMIM:604367,Orphanet:ORPHA79083;Human Phenotype Ontology:HP:0001513,MedGen:C0028754,OMIM:601665,Orphanet:ORPHA71529,SNOMED CT:414916001"	"Diabetes Mellitus, Noninsulin-Dependent, with Acanthosis Nigricans and Hypertension;Familial partial lipodystrophy;Familial partial lipodystrophy 3;Obesity"	germline	germline	GRCh37	NC_000003.11	3	12475610	12475610	C	T	3p25	"criteria provided, conflicting interpretations"	2	NA	N	"OMIM Allelic Variant:601487.0007,UniProtKB (protein):P37231#VAR_010728"	3	8136	3	12475610	C	T	23175	3:12475610:C:T	Likely pathogenic	6/14/16	"The c.1484C>T (p.Pro495Leu) variant, also known as p.Pro467Leu, is reported in a study by Barroso et al. (1999) in which it is found in a heterozygous state in one patient with familial partial lipodystrophy and her affected son. The variant was not found in any of the five unaffected family members tested, showing that the variant segregated with disease over two generations. The p.Pro495Leu variant was absent from 314 control chromosomes and is not found in the 1000 Genomes Project, the Exome Sequencing Project, or the Exome Aggregation Consortium. The p.Pro495Leu variant is located in the PPARG ligand binding domain. Functional studies showed that the variant protein had severely impaired ligand binding ability, abnormal activation profile and inhibited the function of the wild-type protein (Barroso et al. 1999). Majithia et al. (2014) describe an in vitro assay wherein the p.Pro495Leu variant had a significantly reduced ability to rescue differentiation of adipocytes when compared to wild type PPARG. Modrick et al. (2012) showed that mice with the p.Pro495Leu variant had vascular dysfunction not seen in the wild-type mice. Tsai et al. (2004) demonstrated that homozygosity for the variant is lethal in utero for mice establishing that the mutant protein is functionally null. Mice who were heterozygous for the variant showed abnormal fat distribution and hypertension but not insulin resistance. Based on the evidence, the p.Pro495Leu variant is classified to be likely pathogenic for familial partial lipodystrophy."	Familial Partial Lipodystrophy	C0271694:Familial partial lipodystrophy	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	"Illumina Clinical Services Laboratory,Illumina"	SCV000440531.2	SCV000440531		PPARG	-	"Lipodystrophy, MonogenicDM_all"	6/14/16	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV00044053116568	single nucleotide variant	NM_000237.3(LPL):c.662T>C (p.Ile221Thr)	4023	LPL	HGNC:6677	Pathogenic	1	14-Jun-16	118204061	-	RCV000001593	"MedGen:C0023817,OMIM:238600,Orphanet:ORPHA309015,SNOMED CT:238086005,SNOMED CT:275598004"	"Hyperlipoproteinemia, type I"	germline	germline	GRCh37	NC_000008.10	8	19811751	19811751	T	C	8p21.3	"criteria provided, single submitter"	2	NA	N	"OMIM Allelic Variant:609708.0010,UniProtKB (protein):P06858#VAR_004227"	3	1529	8	19811751	T	C	16568	8:19811751:T:C	Pathogenic	6/14/16	"Across nine studies, the c.662T>C (p.Ile221Thr) variant, which is also referred to as p.Ile194Thr, was identified in 18 subjects with familial lipoprotein lipase deficiency or severe hypertriglyceridemia, including four homozygotes, six compound heterozygotes, and eight heterozygotes in whom a second variant was not identified. The variant was also found in a heterozygous state in at least two unaffected family members of patients (Henderson et al. 1991; Dichek et al. 1991; Santer et al. 2005; Nierman et al. 2006; Wang et al. 2007; Ooi et al. 2011; Rabacchi et al. 2015; Rodrigues et al. 2016; Tani et al. 2016). The variant was absent from 522 controls but is reported at a frequency of 0.00012 in the European American population of the Exome Sequencing Project. This frequency is based on only one allele in a region of good coverage so the variant is presumed to be rare. Functional studies demonstrated that despite finding the variant protein in the culture medium, the variant protein had virtually no lipolytic activity. Further, the amount of intracellular variant LPL protein was found to be higher than wild-type and it is suggested that the variant protein may not be secreted appropriately (Henderson et al. 1991). These results were confirmed in studies by Dichek et al. (1991) and Fojo et al. (1992). Based on the collective evidence, the p.Ile221Thr variant is classified as pathogenic for familial lipoprotein lipase deficiency."	Familial Lipoprotein Lipase Deficiency	"C0023817:Hyperlipoproteinemia, type I"	NA	FALSE	AR	"criteria provided, single submitter"	clinical testing	germline:na	"Illumina Clinical Services Laboratory,Illumina"	SCV000472756.2	SCV000472756		LPL	-	High triglycerides	6/14/16	46963	0	3	"[0.9999680599620978,3.194003790217831E-5]"	3	SCV000472756171201	single nucleotide variant	NM_000527.4(LDLR):c.798T>A (p.Asp266Glu)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	17-May-18	139043155	-	RCV000172959;RCV000148594;RCV000162020	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202"	Familial hypercholesterolemia;Hypercholesterolaemia;not provided	germline;inherited;not applicable;unknown	germline	GRCh37	NC_000019.9	19	11217344	11217344	T	A	19p13.2	"criteria provided, conflicting interpretations"	16	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000117,UniProtKB (protein):P01130#VAR_005347"	2	161287	19	11217344	T	A	171201	19:11217344:T:A	Likely pathogenic	NA	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:1	"Robarts Research Institute,Western University"	SCV000484680.1	SCV000484680		LDLR	-	High LDL	5/17/18	46963	0	2	"[0.9999787066413985,2.1293358601452207E-5]"	2	SCV000484680171219	single nucleotide variant	NM_000527.4(LDLR):c.1816G>T (p.Ala606Ser)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	25-Oct-17	72658865	-	RCV000211562;RCV000148567;RCV000162003	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202"	Familial hypercholesterolemia;Hypercholesterolaemia;not provided	germline;not applicable	germline	GRCh37	NC_000019.9	19	11227645	11227645	G	T	19p13.2	"criteria provided, conflicting interpretations"	9	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000566	2	161264	19	11227645	G	T	171219	19:11227645:G:T	Likely pathogenic	NA	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:2	"Robarts Research Institute,Western University"	SCV000484684.1	SCV000484684		LDLR	-	High LDL	10/25/17	46963	0	5	"[0.9999467666034964,5.323339650363052E-5]"	5	SCV00048468445125	single nucleotide variant	NM_000527.4(LDLR):c.2479G>A (p.Val827Ile)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	2-Nov-17	137853964	-	RCV000030135;RCV000148585;RCV000058923;RCV000436469	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202;MedGen:CN169374"	Familial hypercholesterolemia;Hypercholesterolaemia;not provided;not specified	germline;inherited;not applicable;unknown	germline	GRCh37	NC_000019.9	19	11240278	11240278	G	A	19p13.2	"criteria provided, conflicting interpretations"	16	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_001657,UniProtKB (protein):P01130#VAR_005418"	2	36462	19	11240278	G	A	45125	19:11240278:G:A	Likely pathogenic	NA	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:2	"Robarts Research Institute,Western University"	SCV000484685.1	SCV000484685		LDLR	-	High LDL	11/2/17	46963	0	74	"[0.9992121457317462,7.878542682537317E-4]"	74	SCV00048468578990	single nucleotide variant	NM_000527.4(LDLR):c.148G>T (p.Ala50Ser)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	30-Nov-17	137853960	-	RCV000210234;RCV000148578;RCV000058916;RCV000455660	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202;MedGen:CN169374"	Familial hypercholesterolemia;Hypercholesterolaemia;not provided;not specified	germline;unknown	germline	GRCh37	NC_000019.9	19	11210979	11210979	G	T	19p13.2	"criteria provided, conflicting interpretations"	13	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000021,UniProtKB (protein):P01130#VAR_007979"	2	68099	19	11210979	G	T	78990	19:11210979:G:T	Likely pathogenic	NA	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:1	"Robarts Research Institute,Western University"	SCV000484686.1	SCV000484686		LDLR	-	High LDL	11/30/17	46963	0	43	"[0.9995421927900687,4.5780720993122243E-4]"	43	SCV000484686246378	single nucleotide variant	NM_000527.4(LDLR):c.1855T>C (p.Phe619Leu)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	16-Dec-16	747134711	-	RCV000237217	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline	germline	GRCh37	NC_000019.9	19	11230777	11230777	T	C	19p13.2	"criteria provided, conflicting interpretations"	4	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000570	2	252083	19	11230777	T	C	246378	19:11230777:T:C	Likely pathogenic	NA	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:1	"Robarts Research Institute,Western University"	SCV000484688.1	SCV000484688		LDLR	-	High LDL	12/16/16	46963	0	3	"[0.9999680599620978,3.194003790217831E-5]"	3	SCV00048468818741	single nucleotide variant	NM_000527.4(LDLR):c.2054C>T (p.Pro685Leu)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	31-Oct-18	28942084	-	RCV000003891;RCV000162007	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202"	Familial hypercholesterolemia;not provided	germline;inherited;not applicable;unknown	germline	GRCh37	NC_000019.9	19	11231112	11231112	C	T	19p13.2	"criteria provided, multiple submitters, no conflicts"	16	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000276,OMIM Allelic Variant:606945.0017,UniProtKB (protein):P01130#VAR_005410"	3	3702	19	11231112	C	T	18741	19:11231112:C:T	Likely pathogenic	NA	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:2	"Robarts Research Institute,Western University"	SCV000484689.1	SCV000484689		LDLR	-	High LDL	10/31/18	46963	0	3	"[0.9999680599620978,3.194003790217831E-5]"	3	SCV000484689181250	single nucleotide variant	NM_000527.4(LDLR):c.1171G>A (p.Ala391Thr)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	18-Aug-17	11669576	-	RCV000237576;RCV000162023;RCV000241875	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202;MedGen:CN169374"	Familial hypercholesterolemia;not provided;not specified	germline;not applicable;unknown	germline	GRCh37	NC_000019.9	19	11222300	11222300	G	A	19p13.2	"criteria provided, conflicting interpretations"	15	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_001369,UniProtKB (protein):P01130#VAR_024519"	2	183138	19	11222300	G	A	181250	19:11222300:G:A	Likely pathogenic	NA	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:1	"Robarts Research Institute,Western University"	SCV000484696.1	SCV000484696		LDLR	-	High LDL	8/18/17	46928	35	4469	"[0.9523845039209001,0.0476154960790999]"	3889	SCV00048469618780	single nucleotide variant	NM_000527.4(LDLR):c.131G>A (p.Trp44Ter)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	14-Nov-17	267607213	-	RCV000003939	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline;inherited	germline	GRCh37	NC_000019.9	19	11210962	11210962	G	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	13	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000019,OMIM Allelic Variant:606945.0060"	3	3741	19	11210962	G	A	18780	19:11210962:G:A	Likely pathogenic	NA	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:2	"Robarts Research Institute,Western University"	SCV000484698.1	SCV000484698		LDLR	-	High LDL	11/14/17	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV000484698171224	single nucleotide variant	NM_000527.4(LDLR):c.2475C>G (p.Asn825Lys)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	30-Mar-17	374045590	-	RCV000237920;RCV000148570	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443"	Familial hypercholesterolemia;Hypercholesterolaemia	germline	germline	GRCh37	NC_000019.9	19	11240274	11240274	C	G	19p13.2	"criteria provided, multiple submitters, no conflicts"	5	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_001654,UniProtKB (protein):P01130#VAR_072861"	2	161265	19	11240274	C	G	171224	19:11240274:C:G	Likely pathogenic	NA	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:2	"Robarts Research Institute,Western University"	SCV000484701.1	SCV000484701		LDLR	-	High LDL	3/30/17	46963	0	3	"[0.9999680599620978,3.194003790217831E-5]"	3	SCV00048470118734	single nucleotide variant	NM_000527.4(LDLR):c.1291G>A (p.Ala431Thr)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	30-Mar-17	28942079	-	RCV000003883	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline;unknown	germline	GRCh37	NC_000019.9	19	11224058	11224058	G	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	13	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000184,OMIM Allelic Variant:606945.0010,UniProtKB (protein):P01130#VAR_005384"	3	3695	19	11224058	G	A	18734	19:11224058:G:A	Likely pathogenic	NA	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:5	"Robarts Research Institute,Western University"	SCV000484702.1	SCV000484702		LDLR	-	High LDL	3/30/17	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV000484702171204	single nucleotide variant	NM_000527.4(LDLR):c.862G>A (p.Glu288Lys)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	1-May-18	368657165	-	RCV000234348;RCV000148573	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443"	Familial hypercholesterolemia;Hypercholesterolaemia	germline	germline	GRCh37	NC_000019.9	19	11218112	11218112	G	A	19p13.2	"criteria provided, conflicting interpretations"	11	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000509,UniProtKB (protein):P01130#VAR_007983"	2	161268	19	11218112	G	A	171204	19:11218112:G:A	Likely pathogenic	NA	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:4	"Robarts Research Institute,Western University"	SCV000484703.1	SCV000484703		LDLR	-	High LDL	5/1/18	46963	0	8	"[0.9999148265655942,8.517343440580883E-5]"	8	SCV000484703181268	single nucleotide variant	NM_000527.4(LDLR):c.1784G>A (p.Arg595Gln)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	11-Apr-18	201102492	-	RCV000211609;RCV000162002	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202"	Familial hypercholesterolemia;not provided	germline;not applicable;unknown	germline	GRCh37	NC_000019.9	19	11227613	11227613	G	A	19p13.2	"criteria provided, conflicting interpretations"	8	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000563	2	183126	19	11227613	G	A	181268	19:11227613:G:A	Likely pathogenic	NA	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:1	"Robarts Research Institute,Western University"	SCV000484704.1	SCV000484704		LDLR	-	High LDL	4/11/18	46963	0	5	"[0.9999467666034964,5.323339650363052E-5]"	5	SCV000484704198015	single nucleotide variant	NM_000527.4(LDLR):c.1747C>T (p.His583Tyr)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	23-Jan-18	730882109	-	RCV000211604;RCV000182342	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202"	Familial hypercholesterolemia;not provided	germline;not applicable;unknown	germline	GRCh37	NC_000019.9	19	11227576	11227576	C	T	19p13.2	"criteria provided, conflicting interpretations"	10	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000234	2	200921	19	11227576	C	T	198015	19:11227576:C:T	Likely pathogenic	NA	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:2	"Robarts Research Institute,Western University"	SCV000484707.1	SCV000484707		LDLR	-	High LDL	1/23/18	46963	0	14	"[0.9998509464897898,1.4905351021016544E-4]"	14	SCV000484707245448	single nucleotide variant	NM_000527.4(LDLR):c.268G>A (p.Asp90Asn)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	15-Jun-18	749038326	-	RCV000238573;RCV000494304	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202"	Familial hypercholesterolemia;not provided	germline;not applicable	germline	GRCh37	NC_000019.9	19	11213417	11213417	G	A	19p13.2	"criteria provided, conflicting interpretations"	8	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000041,UniProtKB (protein):P01130#VAR_005311"	2	251105	19	11213417	G	A	245448	19:11213417:G:A	Likely pathogenic	NA	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:3	"Robarts Research Institute,Western University"	SCV000484708.1	SCV000484708		LDLR	-	High LDL	6/15/18	46963	0	8	"[0.9999148265655942,8.517343440580883E-5]"	8	SCV000484708171215	single nucleotide variant	NM_000527.4(LDLR):c.1467C>G (p.Tyr489Ter)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	25-Mar-16	370777955	-	RCV000238307;RCV000148575	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443"	Familial hypercholesterolemia;Hypercholesterolaemia	germline	germline	GRCh37	NC_000019.9	19	11224319	11224319	C	G	19p13.2	"criteria provided, multiple submitters, no conflicts"	3	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000415	2	161270	19	11224319	C	G	171215	19:11224319:C:G	Likely pathogenic	NA	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:2	"Robarts Research Institute,Western University"	SCV000484710.1	SCV000484710		LDLR	-	High LDL	3/25/16	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV000484710228146	single nucleotide variant	NM_000527.4(LDLR):c.682G>T (p.Glu228Ter)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	31-Oct-18	121908029	-	RCV000211631;RCV000589867;RCV000518828	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:CN517202"	Familial hypercholesterolemia;Familial hypercholesterolemias;not provided	germline;not applicable;unknown	germline	GRCh37	NC_000019.9	19	11216264	11216264	G	T	19p13.2	"criteria provided, multiple submitters, no conflicts"	12	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_001818	2	226333	19	11216264	G	T	228146	19:11216264:G:T	Likely pathogenic	NA	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:1	"Robarts Research Institute,Western University"	SCV000484711.1	SCV000484711		LDLR	-	High LDL	10/31/18	46944	19	1	"[0.9999893490115883,1.0650988411724608E-5]"	1	SCV00048471118724	single nucleotide variant	NM_000527.4(LDLR):c.259T>G (p.Trp87Gly)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	8-Jun-18	121908025	-	RCV000003870;RCV000622852	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202"	Familial hypercholesterolemia;not provided	germline;inherited	germline	GRCh37	NC_000019.9	19	11213408	11213408	T	G	19p13.2	"criteria provided, multiple submitters, no conflicts"	11	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_001671,OMIM Allelic Variant:606945.0003,UniProtKB (protein):P01130#VAR_005308"	3	3685	19	11213408	T	G	18724	19:11213408:T:G	Likely pathogenic	NA	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:3	"Robarts Research Institute,Western University"	SCV000484716.1	SCV000484716		LDLR	-	High LDL	6/8/18	46963	0	3	"[0.9999680599620978,3.194003790217831E-5]"	3	SCV000484716171217	single nucleotide variant	NM_000527.4(LDLR):c.1775G>A (p.Gly592Glu)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	31-Oct-18	137929307	-	RCV000172964;RCV000587007;RCV000148576;RCV000162001	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:C0020443;MedGen:CN517202"	Familial hypercholesterolemia;Familial hypercholesterolemias;Hypercholesterolaemia;not provided	germline;inherited;not applicable;unknown	germline	GRCh37	NC_000019.9	19	11227604	11227604	G	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	22	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000237,UniProtKB (protein):P01130#VAR_005403"	2	161271	19	11227604	G	A	171217	19:11227604:G:A	Likely pathogenic	NA	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:4	"Robarts Research Institute,Western University"	SCV000484718.1	SCV000484718		LDLR	-	High LDL	10/31/18	46963	0	3	"[0.9999680599620978,3.194003790217831E-5]"	3	SCV000484718246576	single nucleotide variant	NM_000527.4(LDLR):c.2343G>T (p.Glu781Asp)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	25-Mar-16	761683856	-	RCV000237385	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline	germline	GRCh37	NC_000019.9	19	11238715	11238715	G	T	19p13.2	"criteria provided, conflicting interpretations"	2	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000981	2	252290	19	11238715	G	T	246576	19:11238715:G:T	Likely pathogenic	NA	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:1	"Robarts Research Institute,Western University"	SCV000484720.1	SCV000484720		LDLR	-	High LDL	3/25/16	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV000484720246089	single nucleotide variant	NM_000527.4(LDLR):c.1301C>T (p.Thr434Met)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	25-Mar-16	745343524	-	RCV000237891	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline	germline	GRCh37	NC_000019.9	19	11224068	11224068	C	T	19p13.2	"criteria provided, conflicting interpretations"	3	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000979	2	251775	19	11224068	C	T	246089	19:11224068:C:T	Likely pathogenic	NA	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:1	"Robarts Research Institute,Western University"	SCV000484722.1	SCV000484722		LDLR	-	High LDL	3/25/16	46963	0	2	"[0.9999787066413985,2.1293358601452207E-5]"	2	SCV000484722171199	single nucleotide variant	NM_000527.4(LDLR):c.301G>A (p.Glu101Lys)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	31-Oct-18	144172724	-	RCV000211583;RCV000148571;RCV000162016	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202"	Familial hypercholesterolemia;Hypercholesterolaemia;not provided	germline;not applicable;unknown	germline	GRCh37	NC_000019.9	19	11213450	11213450	G	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	15	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000044,UniProtKB (protein):P01130#VAR_005315"	2	161266	19	11213450	G	A	171199	19:11213450:G:A	Likely pathogenic	NA	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:4	"Robarts Research Institute,Western University"	SCV000484724.1	SCV000484724		LDLR	-	High LDL	10/31/18	46963	0	3	"[0.9999680599620978,3.194003790217831E-5]"	3	SCV00048472418733	single nucleotide variant	NM_000527.4(LDLR):c.1285G>A (p.Val429Met)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	31-Oct-18	28942078	-	RCV000003882	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline;inherited;unknown	germline	GRCh37	NC_000019.9	19	11224052	11224052	G	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	14	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_001387,OMIM Allelic Variant:606945.0009,UniProtKB (protein):P01130#VAR_005383"	3	3694	19	11224052	G	A	18733	19:11224052:G:A	Likely pathogenic	NA	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:3	"Robarts Research Institute,Western University"	SCV000484726.1	SCV000484726		LDLR	-	High LDL	10/31/18	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV00048472618738	single nucleotide variant	NM_000527.4(LDLR):c.2043C>A (p.Cys681Ter)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	31-Oct-18	121908031	-	RCV000003887;RCV000590806;RCV000481771	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:CN517202"	Familial hypercholesterolemia;Familial hypercholesterolemias;not provided	germline;unknown	germline	GRCh37	NC_000019.9	19	11231101	11231101	C	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	18	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_001592,OMIM Allelic Variant:606945.0016"	3	3699	19	11231101	C	A	18738	19:11231101:C:A	Likely pathogenic	NA	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:5	"Robarts Research Institute,Western University"	SCV000484730.1	SCV000484730		LDLR	-	High LDL	10/31/18	46958	5	1	"[0.9999893521870608,1.0647812939222283E-5]"	1	SCV000484730181233	single nucleotide variant	NM_000527.4(LDLR):c.662A>G (p.Asp221Gly)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	3-Apr-17	373822756	-	RCV000211655;RCV000161962	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202"	Familial hypercholesterolemia;not provided	germline;inherited;not applicable	germline	GRCh37	NC_000019.9	19	11216244	11216244	A	G	19p13.2	"criteria provided, multiple submitters, no conflicts"	14	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000096,UniProtKB (protein):P01130#VAR_005332"	2	183092	19	11216244	A	G	181233	19:11216244:A:G	Likely pathogenic	NA	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:1	"Robarts Research Institute,Western University"	SCV000484733.1	SCV000484733		LDLR	-	High LDL	4/3/17	46959	4	1	"[0.9999893524138078,1.0647586192210225E-5]"	1	SCV00048473318729	single nucleotide variant	NM_000527.4(LDLR):c.681C>G (p.Asp227Glu)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	30-Jun-17	121908028	-	RCV000003876	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline;not applicable	germline	GRCh37	NC_000019.9	19	11216263	11216263	C	G	19p13.2	"criteria provided, multiple submitters, no conflicts"	10	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_001815,OMIM Allelic Variant:606945.0006,UniProtKB (protein):P01130#VAR_005338"	3	3690	19	11216263	C	G	18729	19:11216263:C:G	Likely pathogenic	NA	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:2	"Robarts Research Institute,Western University"	SCV000484734.1	SCV000484734		LDLR	-	High LDL	6/30/17	46946	17	1	"[0.9999893494653431,1.0650534656839773E-5]"	1	SCV000484734228117	single nucleotide variant	NM_000527.4(LDLR):c.81C>G (p.Cys27Trp)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	30-Mar-17	2228671	-	RCV000211569;RCV000588365	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445"	Familial hypercholesterolemia;Familial hypercholesterolemias	germline;unknown	germline	GRCh37	NC_000019.9	19	11210912	11210912	C	G	19p13.2	"criteria provided, conflicting interpretations"	10	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000352,UniProtKB (protein):P01130#VAR_005304"	2	226304	19	11210912	C	G	228117	19:11210912:C:G	Likely pathogenic	NA	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:1	"Robarts Research Institute,Western University"	SCV000484735.1	SCV000484735		LDLR	-	High LDL	3/30/17	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV00048473518730	single nucleotide variant	NM_000527.4(LDLR):c.682G>A (p.Glu228Lys)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	31-Oct-18	121908029	-	RCV000735406;RCV000735406;RCV000735406;RCV000003878;RCV000735406;RCV000735406;RCV000623885	"Human Phenotype Ontology:HP:0002647,MedGen:C0340643;Human Phenotype Ontology:HP:0012158,MedGen:C0338585;Human Phenotype Ontology:HP:0012474,MedGen:C0265101;MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;Human Phenotype Ontology:HP:0012159,MedGen:C0751815;Human Phenotype Ontology:HP:0001297,MedGen:C0038454;MedGen:CN517202"	Aortic dissection;Carotid artery dissection;Carotid artery occlusion;Familial hypercholesterolemia;Internal carotid artery dissection;Stroke;not provided	germline;unknown	germline	GRCh37	NC_000019.9	19	11216264	11216264	G	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	19	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000105,OMIM Allelic Variant:606945.0007,UniProtKB (protein):P01130#VAR_005341"	3	3691	19	11216264	G	A	18730	19:11216264:G:A	Likely pathogenic	NA	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:1	"Robarts Research Institute,Western University"	SCV000484738.1	SCV000484738		LDLR	-	High LDL	10/31/18	46944	19	2	"[0.9999786980231765,2.1301976823449217E-5]"	2	SCV000484738246513	single nucleotide variant	NM_000527.4(LDLR):c.2096C>T (p.Pro699Leu)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	9-Oct-17	201573863	-	RCV000237906;RCV000589820	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445"	Familial hypercholesterolemia;Familial hypercholesterolemias	germline;unknown	germline	GRCh37	NC_000019.9	19	11231154	11231154	C	T	19p13.2	"criteria provided, conflicting interpretations"	10	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_001600,UniProtKB (protein):P01130#VAR_013955"	2	252219	19	11231154	C	T	246513	19:11231154:C:T	Likely pathogenic	NA	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:2	"Robarts Research Institute,Western University"	SCV000484739.1	SCV000484739		LDLR	-	High LDL	10/9/17	46962	1	6	"[0.9999361185639453,6.388143605468251E-5]"	6	SCV000484739245598	single nucleotide variant	NM_000527.4(LDLR):c.504C>A (p.Asp168Glu)	3949	LDLR	HGNC:6547	Likely pathogenic	1	25-Mar-16	777321035	-	RCV000238338	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline	germline	GRCh37	NC_000019.9	19	11216086	11216086	C	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	2	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_001133	2	251261	19	11216086	C	A	245598	19:11216086:C:A	Likely pathogenic	NA	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:1	"Robarts Research Institute,Western University"	SCV000484741.1	SCV000484741		LDLR	-	High LDL	3/25/16	46963	0	2	"[0.9999787066413985,2.1293358601452207E-5]"	2	SCV000484741246061	single nucleotide variant	NM_000527.4(LDLR):c.1241T>G (p.Leu414Arg)	3949	LDLR	HGNC:6547	Likely pathogenic	1	25-Mar-16	748554592	-	RCV000238583	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline	germline	GRCh37	NC_000019.9	19	11224008	11224008	T	G	19p13.2	"criteria provided, multiple submitters, no conflicts"	3	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000372,UniProtKB (protein):P01130#VAR_005379"	2	251747	19	11224008	T	G	246061	19:11224008:T:G	Likely pathogenic	NA	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:1	"Robarts Research Institute,Western University"	SCV000484747.1	SCV000484747		LDLR	-	High LDL	3/25/16	46963	0	3	"[0.9999680599620978,3.194003790217831E-5]"	3	SCV00048474745115	single nucleotide variant	NM_000527.4(LDLR):c.1085A>C (p.Asp362Ala)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	25-Mar-16	138315511	-	RCV000030124;RCV000148563	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443"	Familial hypercholesterolemia;Hypercholesterolaemia	germline	germline	GRCh37	NC_000019.9	19	11222214	11222214	A	C	19p13.2	"criteria provided, conflicting interpretations"	6	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000792	2	36452	19	11222214	A	C	45115	19:11222214:A:C	Likely pathogenic	NA	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:1	"Robarts Research Institute,Western University"	SCV000484750.1	SCV000484750		LDLR	-	High LDL	3/25/16	46963	0	6	"[0.9999361199241956,6.388007580435663E-5]"	6	SCV000484750228154	single nucleotide variant	NM_000527.4(LDLR):c.986G>A (p.Cys329Tyr)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	16-Dec-16	761954844	-	RCV000211666	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline;not applicable;unknown	germline	GRCh37	NC_000019.9	19	11221373	11221373	G	A	19p13.2	"criteria provided, conflicting interpretations"	7	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000150,UniProtKB (protein):P01130#VAR_005362"	2	226344	19	11221373	G	A	228154	19:11221373:G:A	Likely pathogenic	NA	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:1	"Robarts Research Institute,Western University"	SCV000484751.1	SCV000484751		LDLR	-	High LDL	12/16/16	46963	0	4	"[0.9999574132827971,4.2586717202904415E-5]"	4	SCV000484751181247	single nucleotide variant	NM_000527.4(LDLR):c.1027G>A (p.Gly343Ser)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	5-Jul-18	730882096	-	RCV000211596;RCV000587327;RCV000161977	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:CN517202"	Familial hypercholesterolemia;Familial hypercholesterolemias;not provided	germline;not applicable	germline	GRCh37	NC_000019.9	19	11221414	11221414	G	A	19p13.2	"criteria provided, conflicting interpretations"	15	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_001328,UniProtKB (protein):P01130#VAR_005367"	2	183106	19	11221414	G	A	181247	19:11221414:G:A	Likely pathogenic	NA	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:1	"Robarts Research Institute,Western University"	SCV000484753.1	SCV000484753		LDLR	-	High LDL	7/5/18	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV000484753171214	single nucleotide variant	NM_000527.4(LDLR):c.1444G>A (p.Asp482Asn)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	11-May-17	139624145	-	RCV000172963;RCV000148591;RCV000414235	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202"	Familial hypercholesterolemia;Hypercholesterolaemia;not provided	germline;inherited	germline	GRCh37	NC_000019.9	19	11224296	11224296	G	A	19p13.2	"criteria provided, conflicting interpretations"	13	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_001428	2	161284	19	11224296	G	A	171214	19:11224296:G:A	Likely pathogenic	NA	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:1	"Robarts Research Institute,Western University"	SCV000484754.1	SCV000484754		LDLR	-	High LDL	5/11/17	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV000484754181275	single nucleotide variant	NM_000527.4(LDLR):c.2242G>A (p.Asp748Asn)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	14-Jun-16	150104358	-	RCV000237615;RCV000162012	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202"	Familial hypercholesterolemia;not provided	germline;not applicable	germline	GRCh37	NC_000019.9	19	11233951	11233951	G	A	19p13.2	"criteria provided, conflicting interpretations"	5	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000290	2	183133	19	11233951	G	A	181275	19:11233951:G:A	Likely pathogenic	NA	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:1	"Robarts Research Institute,Western University"	SCV000484755.1	SCV000484755		LDLR	-	High LDL	6/14/16	46963	0	11	"[0.999882886527692,1.1711347230798714E-4]"	11	SCV000484755243276	single nucleotide variant	NM_000527.4(LDLR):c.1887C>T (p.Phe629=)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	8-Jan-18	751234870	-	RCV000225826	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline	germline	GRCh37	NC_000019.9	19	11230809	11230809	C	T	19p13.2	"criteria provided, conflicting interpretations"	2	"ACMG2013,ACMG2016"	N	-	2	237868	19	11230809	C	T	243276	19:11230809:C:T	Likely pathogenic	NA	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:1	"Robarts Research Institute,Western University"	SCV000484765.1	SCV000484765		LDLR	-	High LDL	1/8/18	46963	0	149	"[0.9984136447841918,0.0015863552158081895]"	147	SCV000484765354097	single nucleotide variant	NM_000527.4(LDLR):c.1868T>C (p.Ile623Thr)	3949	LDLR	HGNC:6547	Likely pathogenic	1	-	141155833	-	RCV000408811	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline	germline	GRCh37	NC_000019.9	19	11230790	11230790	T	C	19p13.2	"criteria provided, single submitter"	2	"ACMG2013,ACMG2016"	N	-	2	369855	19	11230790	T	C	354097	19:11230790:T:C	Likely pathogenic	NA	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:2	"Robarts Research Institute,Western University"	SCV000484770.1	SCV000484770		LDLR	-	High LDL	NA	46963	0	3	"[0.9999680599620978,3.194003790217831E-5]"	3	SCV000484770354078	single nucleotide variant	NM_000527.4(LDLR):c.165C>G (p.Gly55=)	3949	LDLR	HGNC:6547	Likely pathogenic	1	-	150644181	-	RCV000408777	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline	germline	GRCh37	NC_000019.9	19	11210996	11210996	C	G	19p13.2	"criteria provided, single submitter"	2	"ACMG2013,ACMG2016"	N	-	2	369857	19	11210996	C	G	354078	19:11210996:C:G	Likely pathogenic	NA	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:1	"Robarts Research Institute,Western University"	SCV000484772.1	SCV000484772		LDLR	-	High LDL	NA	46963	0	7	"[0.9999254732448949,7.452675510508272E-5]"	7	SCV000484772226972	single nucleotide variant	NM_000527.4(LDLR):c.190+4A>T	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	23-Oct-17	769446356	-	RCV000211667;RCV000210581;RCV000523458	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MeSH:D030342,MedGen:C0950123;MedGen:CN517202"	Familial hypercholesterolemia;Inborn genetic diseases;not provided	germline;not applicable	germline	GRCh37	NC_000019.9	19	11211025	11211025	A	T	19p13.2	"criteria provided, conflicting interpretations"	8	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000028	2	225097	19	11211025	A	T	226972	19:11211025:A:T	Likely pathogenic	NA	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:2	"Robarts Research Institute,Western University"	SCV000484775.1	SCV000484775		LDLR	-	High LDL	10/23/17	46963	0	2	"[0.9999787066413985,2.1293358601452207E-5]"	2	SCV000484775226399	single nucleotide variant	NM_000527.4(LDLR):c.941-4G>A	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	12-Jan-18	116405216	-	RCV000210248;RCV000736080	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN169374"	Familial hypercholesterolemia;not specified	germline;unknown	germline	GRCh37	NC_000019.9	19	11221324	11221324	G	A	19p13.2	"criteria provided, conflicting interpretations"	10	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000515	2	224619	19	11221324	G	A	226399	19:11221324:G:A	Likely pathogenic	NA	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:1	"Robarts Research Institute,Western University"	SCV000484780.1	SCV000484780		LDLR	-	High LDL	1/12/18	46963	0	399	"[0.9957519749590102,0.004248025040989715]"	389	SCV00048478045114	single nucleotide variant	NM_000527.4(LDLR):c.1061-8T>C	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	31-May-18	72658861	-	RCV000030123;RCV000759074;RCV000245346	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202;MedGen:CN169374"	Familial hypercholesterolemia;not provided;not specified	germline;unknown	germline	GRCh37	NC_000019.9	19	11222182	11222182	T	C	19p13.2	"criteria provided, conflicting interpretations"	15	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000154	2	36451	19	11222182	T	C	45114	19:11222182:T:C	Likely pathogenic	NA	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:1	"Robarts Research Institute,Western University"	SCV000484782.1	SCV000484782		LDLR	-	High LDL	5/31/18	46960	3	426	"[0.9954642248722317,0.004535775127768314]"	420	SCV000484782354091	single nucleotide variant	NM_000527.4(LDLR):c.1060+9C>T	3949	LDLR	HGNC:6547	Likely pathogenic	1	-	540073140	-	RCV000408891	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline	germline	GRCh37	NC_000019.9	19	11221456	11221456	C	T	19p13.2	"criteria provided, single submitter"	1	"ACMG2013,ACMG2016"	N	-	2	369861	19	11221456	C	T	354091	19:11221456:C:T	Likely pathogenic	NA	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:1	"Robarts Research Institute,Western University"	SCV000484783.1	SCV000484783		LDLR	-	High LDL	NA	46963	0	4	"[0.9999574132827971,4.2586717202904415E-5]"	4	SCV000484783228162	single nucleotide variant	NM_000527.4(LDLR):c.1187-10G>A	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	30-Mar-17	765696008	-	RCV000211627;RCV000588170	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445"	Familial hypercholesterolemia;Familial hypercholesterolemias	germline	germline	GRCh37	NC_000019.9	19	11223944	11223944	G	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	10	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000172	2	226349	19	11223944	G	A	228162	19:11223944:G:A	Likely pathogenic	NA	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:4	"Robarts Research Institute,Western University"	SCV000484784.1	SCV000484784		LDLR	-	High LDL	3/30/17	46963	0	4	"[0.9999574132827971,4.2586717202904415E-5]"	4	SCV000484784172183	single nucleotide variant	NM_000527.4(LDLR):c.1359-1G>A	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	16-Jan-18	139617694	-	RCV000172962;RCV000149884	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443"	Familial hypercholesterolemia;Hypercholesterolaemia	germline	germline	GRCh37	NC_000019.9	19	11224210	11224210	G	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	12	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_001405	2	162499	19	11224210	G	A	172183	19:11224210:G:A	Likely pathogenic	NA	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:1	"Robarts Research Institute,Western University"	SCV000484787.1	SCV000484787		LDLR	-	High LDL	1/16/18	46961	2	1	"[0.9999893528672729,1.0647132727156576E-5]"	1	SCV000484787246373	single nucleotide variant	NM_000527.4(LDLR):c.1846-10G>T	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	29-Aug-17	368243304	-	RCV000237306;RCV000599958	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN169374"	Familial hypercholesterolemia;not specified	germline	germline	GRCh37	NC_000019.9	19	11230758	11230758	G	T	19p13.2	"criteria provided, conflicting interpretations"	3	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000252	2	252072	19	11230758	G	T	246373	19:11230758:G:T	Likely pathogenic	NA	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:1	"Robarts Research Institute,Western University"	SCV000484791.1	SCV000484791		LDLR	-	High LDL	8/29/17	46963	0	3	"[0.9999680599620978,3.194003790217831E-5]"	3	SCV00048479145123	single nucleotide variant	NM_000527.4(LDLR):c.2140+5G>A	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	26-Jan-18	72658867	-	RCV000030133;RCV000614028	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN169374"	Familial hypercholesterolemia;not specified	germline	germline	GRCh37	NC_000019.9	19	11231203	11231203	G	A	19p13.2	"criteria provided, conflicting interpretations"	13	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000283	2	36460	19	11231203	G	A	45123	19:11231203:G:A	Likely pathogenic	NA	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:1	"Robarts Research Institute,Western University"	SCV000484792.1	SCV000484792		LDLR	-	High LDL	1/26/18	46942	21	472	"[0.9949725192791103,0.005027480720889608]"	464	SCV00048479218783	single nucleotide variant	NM_000527.4(LDLR):c.2140+1G>A	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	11-Jun-18	145787161	-	RCV000003942	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline	germline	GRCh37	NC_000019.9	19	11231199	11231199	G	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	8	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000282,OMIM Allelic Variant:606945.0063"	3	3744	19	11231199	G	A	18783	19:11231199:G:A	Likely pathogenic	NA	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:1	"Robarts Research Institute,Western University"	SCV000484793.1	SCV000484793		LDLR	-	High LDL	6/11/18	46962	1	1	"[0.9999893530939908,1.0646906009113752E-5]"	1	SCV000484793196756	single nucleotide variant	NM_174936.3(PCSK9):c.1405C>T (p.Arg469Trp)	255738	PCSK9	HGNC:20001	Conflicting interpretations of pathogenicity	1	7-Dec-17	141502002	-	RCV000408878;RCV000228895;RCV000182576	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C1863551,OMIM:603776;MedGen:CN169374"	"Familial hypercholesterolemia;Hypercholesterolemia, autosomal dominant, 3;not specified"	germline	germline	GRCh37	NC_000001.10	1	55524222	55524222	C	T	1p32.3	"criteria provided, conflicting interpretations"	5	"ACMG2013,ACMG2016"	N	UniProtKB (protein):Q8NBP7#VAR_025456	2	201128	1	55524222	C	T	196756	1:55524222:C:T	Likely pathogenic	NA	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:1	"Robarts Research Institute,Western University"	SCV000484814.1	SCV000484814		PCSK9	-	Low LDL	12/7/17	46960	3	122	"[0.9987010221465077,0.0012989778534923339]"	122	SCV000484814354066	single nucleotide variant	NM_174936.3(PCSK9):c.1251C>A (p.His417Gln)	255738	PCSK9	HGNC:20001	Conflicting interpretations of pathogenicity	1	16-Dec-16	143275858	-	RCV000408779;RCV000417285	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C1863551,OMIM:603776"	"Familial hypercholesterolemia;Hypercholesterolemia, autosomal dominant, 3"	germline	germline	GRCh37	NC_000001.10	1	55523779	55523779	C	A	1p32.3	"criteria provided, conflicting interpretations"	2	"ACMG2013,ACMG2016"	N	-	2	369875	1	55523779	C	A	354066	1:55523779:C:A	Likely pathogenic	NA	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:1	"Robarts Research Institute,Western University"	SCV000484815.1	SCV000484815		PCSK9	-	Low LDL	12/16/16	46963	0	36	"[0.9996167195451738,3.8328045482613975E-4]"	36	SCV000484815260609	single nucleotide variant	NM_174936.3(PCSK9):c.709C>T (p.Arg237Trp)	255738	PCSK9	HGNC:20001	Conflicting interpretations of pathogenicity	1	25-Jul-17	148195424	-	RCV000256274;RCV000417261	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C1863551,OMIM:603776"	"Familial hypercholesterolemia;Hypercholesterolemia, autosomal dominant, 3"	germline	germline	GRCh37	NC_000001.10	1	55518374	55518374	C	T	1p32.3	"criteria provided, conflicting interpretations"	5	"ACMG2013,ACMG2016"	N	UniProtKB (protein):Q8NBP7#VAR_025452	2	265933	1	55518374	C	T	260609	1:55518374:C:T	Likely pathogenic	NA	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:1	"Robarts Research Institute,Western University"	SCV000484816.1	SCV000484816		PCSK9	-	Low LDL	7/25/17	46949	14	63	"[0.9993290591918891,6.709408081109288E-4]"	63	SCV00048481632929	single nucleotide variant	NM_000384.2(APOB):c.10580G>A (p.Arg3527Gln)	338	APOB	HGNC:603	Conflicting interpretations of pathogenicity	1	11-Jul-18	5742904	-	RCV000019479;RCV000284412;RCV000412515;RCV000627797;RCV000499833;RCV000627797;RCV000254882	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C1862596,Orphanet:ORPHA426,SNOMED CT:60193003;MedGen:C1704417,OMIM:144010;MedGen:C1704417,OMIM:144010;MedGen:C0020597,Orphanet:ORPHA31154;MedGen:C4551990,OMIM:615558;MedGen:CN517202"	"Familial hypercholesterolemia;Familial hypobetalipoproteinemia;Hypercholesterolemia, autosomal dominant, type B;Hypercholesterolemia, autosomal dominant, type B;Hypobetalipoproteinemia;Hypobetalipoproteinemia, familial, 1;not provided"	germline;maternal;unknown	germline	GRCh37	NC_000002.11	2	21229160	21229160	C	T	2p24	"criteria provided, conflicting interpretations"	18	"ACMG2013,ACMG2016"	Y	OMIM Allelic Variant:107730.0009	3	17890	2	21229160	C	T	32929	2:21229160:C:T	Likely pathogenic	NA	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:20	"Robarts Research Institute,Western University"	SCV000484820.1	SCV000484820		APOB	-	Low LDL	7/11/18	46963	0	12	"[0.9998722398483912,1.2776015160871325E-4]"	12	SCV00048482048709	single nucleotide variant	NM_000384.2(APOB):c.10579C>T (p.Arg3527Trp)	338	APOB	HGNC:603	Conflicting interpretations of pathogenicity	1	3-Jul-18	144467873	-	RCV000408839;RCV000231844;RCV000627798;RCV000627798;RCV000494148	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C1704417,OMIM:144010;MedGen:C1704417,OMIM:144010;MedGen:C4551990,OMIM:615558;MedGen:CN517202"	"Familial hypercholesterolemia;Hypercholesterolemia, autosomal dominant, type B;Hypercholesterolemia, autosomal dominant, type B;Hypobetalipoproteinemia, familial, 1;not provided"	germline	germline	GRCh37	NC_000002.11	2	21229161	21229161	G	A	2p24	"criteria provided, conflicting interpretations"	8	"ACMG2013,ACMG2016"	Y	-	3	40223	2	21229161	G	A	48709	2:21229161:G:A	Likely pathogenic	NA	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:1	"Robarts Research Institute,Western University"	SCV000484822.1	SCV000484822		APOB	-	Low LDL	7/3/18	46963	0	14	"[0.9998509464897898,1.4905351021016544E-4]"	14	SCV00048482224138	single nucleotide variant	NM_000352.4(ABCC8):c.560T>A (p.Val187Asp)	6833	ABCC8	HGNC:59	Pathogenic	1	19-Feb-16	137852672	-	RCV000009667;RCV000723825	"MedGen:C2931832,OMIM:256450,SNOMED CT:360339005;MedGen:CN517202"	Persistent hyperinsulinemic hypoglycemia of infancy;not provided	germline;unknown	germline	GRCh37	NC_000011.9	11	17485004	17485004	A	T	11p15.1	"criteria provided, multiple submitters, no conflicts"	3	NA	N	"OMIM Allelic Variant:600509.0013,UniProtKB (protein):Q09428#VAR_008641"	3	9099	11	17485004	A	T	24138	11:17485004:A:T	Pathogenic	2/19/16	-	OMIM:256450	C2931832:Persistent hyperinsulinemic hypoglycemia of infancy	NA	FALSE	Not trait of interest	"criteria provided, single submitter"	clinical testing	unknown:na	Counsyl	SCV000485103.1	SCV000485103		ABCC8	-	"MODY Extended, MonogenicDM_all, Neonatal Diabetes"	2/19/16	46927	36	7	"[0.9999254160717711,7.458392822895134E-5]"	7	SCV00048510345077	single nucleotide variant	NM_000209.3(PDX1):c.97C>A (p.Pro33Thr)	3651	PDX1	HGNC:6107	Conflicting interpretations of pathogenicity	1	10-Jun-16	192902098	-	RCV000030086;RCV000414508	"MedGen:C1833382,OMIM:606392;MedGen:CN517202"	"Maturity-onset diabetes of the young, type 4;not provided"	germline	germline	GRCh37	NC_000013.10	13	28494372	28494372	C	A	13q12.2	"criteria provided, conflicting interpretations"	2	NA	N	-	2	36414	13	28494372	C	A	45077	13:28494372:C:A	Likely pathogenic	6/10/16	"The P33T variant in the PDX1 gene has been published previously in association with gestational diabetes, MODY, type 2 diabetes, and ketosis-prone diabetes (Gragnoli et al., 2005; Edghill et al., 2011; Haaland et al., 2009). However, the variant was also reported in multiple unaffected family members as well as unaffected controls in these studies. The P33T variant was not observed in approximately 5400 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The P33T variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is conserved across species. While functional studies have indicated that P33T impairs the normal function of the PDX1 protein, this impairment is not complete (Gragnoli et al., 2005). The P33T variant is a strong candidate for a pathogenic variant, however the possibility it may be a rare benign variant cannot be excluded."	Not Provided	CN517202:not provided	NA	NA	NA	"criteria provided, single submitter"	clinical testing	germline:na	GeneDx	SCV000490700.1	SCV000490700		PDX1	-	"MODY, MODY Extended, MonogenicDM_all"	6/10/16	38775	8188	96	"[0.998762088974855,0.0012379110251450676]"	96	SCV00049070029556	single nucleotide variant	NM_170707.3(LMNA):c.1718C>T (p.Ser573Leu)	4000	LMNA	HGNC:6636	Conflicting interpretations of pathogenicity	1	21-Dec-17	60890628	-	RCV000617932;RCV000653881;RCV000015612;RCV000015614;RCV000015613;RCV000057351;RCV000041329	"MedGen:CN230736;MedGen:C0270914,Orphanet:ORPHA64746;MedGen:C1449563,OMIM:115200,Orphanet:ORPHA300751;MedGen:C1720860,OMIM:151660,Orphanet:ORPHA2348;MedGen:CN043412;MedGen:CN517202;MedGen:CN169374"	"Cardiovascular phenotype;Charcot-Marie-Tooth disease, type 2;Dilated cardiomyopathy 1A;Familial partial lipodystrophy 2;Mandibuloacral dysplasia with type A lipodystrophy, atypical;not provided;not specified"	germline	germline	GRCh37	NC_000001.10	1	156108298	156108298	C	T	1q22	"criteria provided, conflicting interpretations"	7	"ACMG2013,ACMG2016"	N	"OMIM Allelic Variant:150330.0041,UniProtKB (protein):P02545#VAR_039789"	3	14517	1	156108298	C	T	29556	1:156108298:C:T	Likely pathogenic	7/29/16	"The S573L variant in the LMNA gene has been reported previously in the heterozygous state in individuals with dilated cardiomyopathy, ventricular tachycardia and ventricular ectopy, familial partial lipodystrophy subtype 2, and in a patient with a Limb-girdle muscular dystrophy phenotype with no cardiac involvement (Pasotti et al., 2008; Taylor et al., 2003; Lanktree et al., 2007; Benedetti et al., 2007). The S573L variant has also been reported in the homozygous state in an individual with progeroid features with no cardiac involvement (Van Esch et al., 2006). The S573L variant was not observed in approximately 6,400 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The S573L variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position where amino acids with similar properties to Serine are tolerated across species and is located within the LTD domain; in the Glubular caroxy-terminal tail . In silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. The S573L variant is a strong candidate for a pathogenic variant, however the possibility it may be a rare benign variant cannot be excluded."	Not Provided	CN517202:not provided	No Information	FALSE	No Information	"criteria provided, single submitter"	clinical testing	germline:na	GeneDx	SCV000491119.1	SCV000491119		LMNA	-	"Lipodystrophy, MonogenicDM_all"	12/21/17	46812	151	16	"[0.9998291036486371,1.708963513628984E-4]"	16	SCV00049111945113	single nucleotide variant	NM_000527.4(LDLR):c.1055G>A (p.Cys352Tyr)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	31-Oct-18	193922566	-	RCV000030122;RCV000722113;RCV000413322	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:CN517202"	Familial hypercholesterolemia;Familial hypercholesterolemias;not provided	germline;unknown	germline	GRCh37	NC_000019.9	19	11221442	11221442	G	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	9	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_001339,UniProtKB (protein):P01130#VAR_005369"	2	36450	19	11221442	G	A	45113	19:11221442:G:A	Likely pathogenic	12/12/16	"The C352Y likely pathogenic variant in the LDLR gene (also reported as C331Y due to alternate nomenclature) has been reported previously in association with FH (Hobbs et al., 1992; Kolansky et al., 2008; Alonso et al., 2009; Tichy et al., 2012; Magana Torres et al., 2014). Initially, the C352Y variant was reported in several Hispanic individuals with FH (Hobbs et al., 1992; Kolansky et al., 2008; Alonso et al., 2009) and was also subsequently reported in a Czech individual with FH (Tichy et al., 2012). Most recently, the C352Y variant was reported to be homozygous in one individual with severe homozygous FH (Magana Torres et al., 2014). This variant was reported to be heterozygous in both parents, siblings, and the paternal grandmother; however, reduced penetrance was noted as the father and paternal grandmother who were heterozygous for the variant were asymptomatic (Magana Torres et al., 2014). Additionally, the C352Y variant has been reported as a likely pathogenic variant associated with FH by one other clinical laboratory in ClinVar (ClinVar SCV000052777.1; Landrum et al., 2016). The C352Y variant was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project and was not observed with any significant frequency in the Exome Aggregation Consortium, indicating it is not a common benign variant in these populations. The C352Y variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. Additionally, this substitution occurs at a position that is conserved across species and is located in the EGF-like 1 domain. Furthermore, in silico analysis predicts this variant is probably damaging to the protein structure/function. Missense variants in the same residue (C352S, C352R, C352F, C352W) have been reported in the Human Gene Mutation Database in association with FH (Stenson et al., 2014); however, the pathogenicity of these variants has not been definitively determined.Therefore, this variant is likely pathogenic. In order to definitively determine its clinical significance, additional data is required."	Not Provided	CN517202:not provided	Familial hypercholesterolemia	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	GeneDx	SCV000491200.1	SCV000491200		LDLR	-	High LDL	10/31/18	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV000491200171214	single nucleotide variant	NM_000527.4(LDLR):c.1444G>A (p.Asp482Asn)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	11-May-17	139624145	-	RCV000172963;RCV000148591;RCV000414235	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202"	Familial hypercholesterolemia;Hypercholesterolaemia;not provided	germline;inherited	germline	GRCh37	NC_000019.9	19	11224296	11224296	G	A	19p13.2	"criteria provided, conflicting interpretations"	13	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_001428	2	161284	19	11224296	G	A	171214	19:11224296:G:A	Pathogenic	12/1/16	"The D482N variant in the LDLR gene has been reported previously in the heterozygous state in multiple individuals with familial hypercholesterolemia (Taylor et al., 2010; Graham et al., 2005; Laurie et al., 2004). The D482N variant was not observed with any significant frequency in approximately 6500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The D482N variant is a semi-conservative amino acid substitution, which may impact secondary protein structure as these residues differ in some properties. This substitution occurs at a position that is conserved across species. In silico analysis predicts this variant is probably damaging to the protein structure/function. Missense variants in the same residue (D482H, D482Y) have been reported previously in the heterozygous state in individuals with familial hypercholesterolemia (Meshkov et al., 2004; Day et al., 1997). Missense variants at nearby residues (D477N, G478R, L479P, A480V, V481M, W483R, F485R, H485Q, S486G, S486N) have been reported in the Human Gene Mutation Database in association with familial hypercholesterolemia (Stenson et al., 2014), supporting the functional importance of this region of the protein. Therefore, based on the ACMG recommendations, D482N is interpreted as a known pathogenic sequence change."	Not Provided	CN517202:not provided	Familial hypercholesterolemia	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	GeneDx	SCV000491201.1	SCV000491201		LDLR	-	High LDL	5/11/17	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV00049120129375	single nucleotide variant	NM_005912.2(MC4R):c.380C>T (p.Ser127Leu)	4160	MC4R	HGNC:6932	Conflicting interpretations of pathogenicity	1	25-May-17	13447331	-	RCV000015412;RCV000414065	"Human Phenotype Ontology:HP:0001513,MedGen:C0028754,OMIM:601665,Orphanet:ORPHA71529,SNOMED CT:414916001;MedGen:CN517202"	Obesity;not provided	germline	germline	GRCh37	NC_000018.9	18	58039203	58039203	G	A	18q21.3	"criteria provided, conflicting interpretations"	6	NA	N	"OMIM Allelic Variant:155541.0021,UniProtKB (protein):P32245#VAR_038643"	3	14336	18	58039203	G	A	29375	18:58039203:G:A	Likely pathogenic	1/7/16	"The S127L variant in the MC4R gene has been reported in individuals with obesity (Lubrano-Berthelier et al., 2003; Rovite et al., 2014). Functional assays showed S127L has decreased membrane trafficking and functional activity (Rovite et al., 2014). The S127L variant was not observed at any significant frequency in approximately 6500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The S127L variant is a non-conservative amino acid substitution, which occurs within the Transmembrane 3 domain at a position that is conserved across species. In silico analysis predicts this variant is probably damaging to the protein structure/function. A missense variant in a nearby residue (D126Y) has been reported in the Human Gene Mutation Database in association with obesity (Stenson et al., 2014), supporting the functional importance of this region of the protein. The S127L variant is a strong candidate for a pathogenic variant, however the possibility it may be a rare benign variant cannot be excluded."	Not Provided	CN517202:not provided	Obesity	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	GeneDx	SCV000491324.1	SCV000491324		MC4R	-	Obesity	5/25/17	46963	0	18	"[0.999808359772587,1.9164022741306988E-4]"	18	SCV000491324171218	single nucleotide variant	NM_000527.4(LDLR):c.1783C>T (p.Arg595Trp)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	24-Oct-17	373371572	-	RCV000237585;RCV000588105;RCV000148597;RCV000518174	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:C0020443;MedGen:CN517202"	Familial hypercholesterolemia;Familial hypercholesterolemias;Hypercholesterolaemia;not provided	germline	germline	GRCh37	NC_000019.9	19	11227612	11227612	C	T	19p13.2	"criteria provided, conflicting interpretations"	11	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000239,UniProtKB (protein):P01130#VAR_072856"	2	161290	19	11227612	C	T	171218	19:11227612:C:T	Pathogenic	3/30/17	-	Familial Hypercholesterolemia	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:5	"U4M - Lille University & CHRU Lille,Université Lille 2 - CHRU de Lille"	SCV000494601.2	SCV000494601		LDLR	-	High LDL	10/24/17	46963	0	2	"[0.9999787066413985,2.1293358601452207E-5]"	2	SCV000494601228117	single nucleotide variant	NM_000527.4(LDLR):c.81C>G (p.Cys27Trp)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	30-Mar-17	2228671	-	RCV000211569;RCV000588365	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445"	Familial hypercholesterolemia;Familial hypercholesterolemias	germline;unknown	germline	GRCh37	NC_000019.9	19	11210912	11210912	C	G	19p13.2	"criteria provided, conflicting interpretations"	10	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000352,UniProtKB (protein):P01130#VAR_005304"	2	226304	19	11210912	C	G	228117	19:11210912:C:G	Likely benign	12/16/16	subject mutated among 2600 FH index cases screened = 1 / Software predictions: Damaging	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:1	"Centre de Génétique Moléculaire et Chromosomique, Unité de génétique de l'Obésité et des Dyslipidémies,APHP, GH Hôpitaux Universitaires Pitié-Salpêtrière / Charles-Foix"	SCV000503098.1	SCV000503098		LDLR	-	High LDL	3/30/17	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV00050309818780	single nucleotide variant	NM_000527.4(LDLR):c.131G>A (p.Trp44Ter)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	14-Nov-17	267607213	-	RCV000003939	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline;inherited	germline	GRCh37	NC_000019.9	19	11210962	11210962	G	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	13	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000019,OMIM Allelic Variant:606945.0060"	3	3741	19	11210962	G	A	18780	19:11210962:G:A	Pathogenic	12/16/16	"subjects mutated among 2600 FH index cases screened = 10 , family members = 2 with co-segregation / FH-Cincinnati-5, 2 to 5% LDLR activity"	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:10	"Centre de Génétique Moléculaire et Chromosomique, Unité de génétique de l'Obésité et des Dyslipidémies,APHP, GH Hôpitaux Universitaires Pitié-Salpêtrière / Charles-Foix"	SCV000503103.1	SCV000503103		LDLR	-	High LDL	11/14/17	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV00050310378990	single nucleotide variant	NM_000527.4(LDLR):c.148G>T (p.Ala50Ser)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	30-Nov-17	137853960	-	RCV000210234;RCV000148578;RCV000058916;RCV000455660	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202;MedGen:CN169374"	Familial hypercholesterolemia;Hypercholesterolaemia;not provided;not specified	germline;unknown	germline	GRCh37	NC_000019.9	19	11210979	11210979	G	T	19p13.2	"criteria provided, conflicting interpretations"	13	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000021,UniProtKB (protein):P01130#VAR_007979"	2	68099	19	11210979	G	T	78990	19:11210979:G:T	Benign	12/16/16	"subjects mutated among 2600 FH index cases screened = 4 , 2 compound heterozygous / Software predictions: Benign"	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:4	"Centre de Génétique Moléculaire et Chromosomique, Unité de génétique de l'Obésité et des Dyslipidémies,APHP, GH Hôpitaux Universitaires Pitié-Salpêtrière / Charles-Foix"	SCV000503105.1	SCV000503105		LDLR	-	High LDL	11/30/17	46963	0	43	"[0.9995421927900687,4.5780720993122243E-4]"	43	SCV00050310518724	single nucleotide variant	NM_000527.4(LDLR):c.259T>G (p.Trp87Gly)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	8-Jun-18	121908025	-	RCV000003870;RCV000622852	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202"	Familial hypercholesterolemia;not provided	germline;inherited	germline	GRCh37	NC_000019.9	19	11213408	11213408	T	G	19p13.2	"criteria provided, multiple submitters, no conflicts"	11	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_001671,OMIM Allelic Variant:606945.0003,UniProtKB (protein):P01130#VAR_005308"	3	3685	19	11213408	T	G	18724	19:11213408:T:G	Likely pathogenic	12/16/16	"subjects mutated among 2600 FH index cases screened = 9 , family members = 7 with co-segregation / frequently associated with c.1975A>C, p.Thr659Pro (2 index cases), Subnormal LDLR activity / Software predictions: Damaging"	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:9	"Centre de Génétique Moléculaire et Chromosomique, Unité de génétique de l'Obésité et des Dyslipidémies,APHP, GH Hôpitaux Universitaires Pitié-Salpêtrière / Charles-Foix"	SCV000503120.1	SCV000503120		LDLR	-	High LDL	6/8/18	46963	0	3	"[0.9999680599620978,3.194003790217831E-5]"	3	SCV000503120245448	single nucleotide variant	NM_000527.4(LDLR):c.268G>A (p.Asp90Asn)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	15-Jun-18	749038326	-	RCV000238573;RCV000494304	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202"	Familial hypercholesterolemia;not provided	germline;not applicable	germline	GRCh37	NC_000019.9	19	11213417	11213417	G	A	19p13.2	"criteria provided, conflicting interpretations"	8	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000041,UniProtKB (protein):P01130#VAR_005311"	2	251105	19	11213417	G	A	245448	19:11213417:G:A	Likely benign	12/16/16	"subject mutated among 2600 FH index cases screened = 1 , family members = 2 with co-segregation / other mutations at same codon / Software predictions: Damaging"	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:1	"Centre de Génétique Moléculaire et Chromosomique, Unité de génétique de l'Obésité et des Dyslipidémies,APHP, GH Hôpitaux Universitaires Pitié-Salpêtrière / Charles-Foix"	SCV000503122.1	SCV000503122		LDLR	-	High LDL	6/15/18	46963	0	8	"[0.9999148265655942,8.517343440580883E-5]"	8	SCV000503122171199	single nucleotide variant	NM_000527.4(LDLR):c.301G>A (p.Glu101Lys)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	31-Oct-18	144172724	-	RCV000211583;RCV000148571;RCV000162016	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202"	Familial hypercholesterolemia;Hypercholesterolaemia;not provided	germline;not applicable;unknown	germline	GRCh37	NC_000019.9	19	11213450	11213450	G	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	15	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000044,UniProtKB (protein):P01130#VAR_005315"	2	161266	19	11213450	G	A	171199	19:11213450:G:A	Likely pathogenic	12/16/16	"subjects mutated among 2600 FH index cases screened = 8 , family members = 12 with co-segregation / FH-Lancashire"	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:8	"Centre de Génétique Moléculaire et Chromosomique, Unité de génétique de l'Obésité et des Dyslipidémies,APHP, GH Hôpitaux Universitaires Pitié-Salpêtrière / Charles-Foix"	SCV000503127.1	SCV000503127		LDLR	-	High LDL	10/31/18	46963	0	3	"[0.9999680599620978,3.194003790217831E-5]"	3	SCV000503127245500	single nucleotide variant	NM_000527.4(LDLR):c.343C>T (p.Arg115Cys)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	30-Mar-17	774723292	-	RCV000238127	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline	germline	GRCh37	NC_000019.9	19	11215925	11215925	C	T	19p13.2	"criteria provided, conflicting interpretations"	4	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_001036	2	251162	19	11215925	C	T	245500	19:11215925:C:T	Uncertain significance	12/16/16	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:2	"Centre de Génétique Moléculaire et Chromosomique, Unité de génétique de l'Obésité et des Dyslipidémies,APHP, GH Hôpitaux Universitaires Pitié-Salpêtrière / Charles-Foix"	SCV000503143.1	SCV000503143		LDLR	-	High LDL	3/30/17	46962	1	6	"[0.9999361185639453,6.388143605468251E-5]"	6	SCV000503143228138	single nucleotide variant	NM_000527.4(LDLR):c.429C>A (p.Cys143Ter)	3949	LDLR	HGNC:6547	Pathogenic	1	5-Dec-17	199774121	-	RCV000211567	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline	germline	GRCh37	NC_000019.9	19	11216011	11216011	C	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	7	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_001734	2	226325	19	11216011	C	A	228138	19:11216011:C:A	Pathogenic	12/16/16	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:7	"Centre de Génétique Moléculaire et Chromosomique, Unité de génétique de l'Obésité et des Dyslipidémies,APHP, GH Hôpitaux Universitaires Pitié-Salpêtrière / Charles-Foix"	SCV000503157.1	SCV000503157		LDLR	-	High LDL	12/5/17	46963	0	2	"[0.9999787066413985,2.1293358601452207E-5]"	2	SCV000503157181228	single nucleotide variant	NM_000527.4(LDLR):c.502G>A (p.Asp168Asn)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	28-Jun-18	200727689	-	RCV000211669;RCV000162017	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202"	Familial hypercholesterolemia;not provided	germline;not applicable;unknown	germline	GRCh37	NC_000019.9	19	11216084	11216084	G	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	7	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_001749,UniProtKB (protein):P01130#VAR_005322"	2	183136	19	11216084	G	A	181228	19:11216084:G:A	Likely pathogenic	12/16/16	"subjects mutated among 2600 FH index cases screened = 3 , family member = 1 with co-segregation / FH-Sephardic, 2 to 5% LDLR Activity / Software predictions: Conflicting"	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:3	"Centre de Génétique Moléculaire et Chromosomique, Unité de génétique de l'Obésité et des Dyslipidémies,APHP, GH Hôpitaux Universitaires Pitié-Salpêtrière / Charles-Foix"	SCV000503170.1	SCV000503170		LDLR	-	High LDL	6/28/18	46963	0	2	"[0.9999787066413985,2.1293358601452207E-5]"	2	SCV00050317018765	single nucleotide variant	NM_000527.4(LDLR):c.523G>A (p.Asp175Asn)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	2-Jan-18	121908033	-	RCV000003924	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline	germline	GRCh37	NC_000019.9	19	11216105	11216105	G	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	7	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_001755,OMIM Allelic Variant:606945.0044,UniProtKB (protein):P01130#VAR_005326"	3	3726	19	11216105	G	A	18765	19:11216105:G:A	Likely pathogenic	12/16/16	"subject mutated among 2600 FH index cases screened = 1, family member =1 /FH-Afrikaner-3 / Software predictions: Damaging"	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:1	"Centre de Génétique Moléculaire et Chromosomique, Unité de génétique de l'Obésité et des Dyslipidémies,APHP, GH Hôpitaux Universitaires Pitié-Salpêtrière / Charles-Foix"	SCV000503175.1	SCV000503175		LDLR	-	High LDL	1/2/18	46963	0	2	"[0.9999787066413985,2.1293358601452207E-5]"	2	SCV000503175228142	deletion	NM_000527.4(LDLR):c.654_656delTGG (p.Gly219del)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	25-Jun-18	121908027	-	RCV000211647;RCV000589051;RCV000489033	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:CN517202"	Familial hypercholesterolemia;Familial hypercholesterolemias;not provided	germline;inherited;not applicable	germline	GRCh37	NC_000019.9	19	11216236	11216238	TGG	-	19p13.2	"criteria provided, multiple submitters, no conflicts"	14	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000094,OMIM Allelic Variant:606945.0005"	3	226329	19	11216232	ATGG	A	228142	19:11216232:ATGG:A	Likely pathogenic	12/16/16	"subjects mutated among 2600 FH index cases screened = 3 , family members = 3 with co-segregation / FH-Lithuania, < 5% LDLR Activity"	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:3	"Centre de Génétique Moléculaire et Chromosomique, Unité de génétique de l'Obésité et des Dyslipidémies,APHP, GH Hôpitaux Universitaires Pitié-Salpêtrière / Charles-Foix"	SCV000503197.1	SCV000503197		LDLR	-	High LDL	6/25/18	46962	1	1	"[0.9999893530939908,1.0646906009113752E-5]"	1	SCV000503197181233	single nucleotide variant	NM_000527.4(LDLR):c.662A>G (p.Asp221Gly)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	3-Apr-17	373822756	-	RCV000211655;RCV000161962	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202"	Familial hypercholesterolemia;not provided	germline;inherited;not applicable	germline	GRCh37	NC_000019.9	19	11216244	11216244	A	G	19p13.2	"criteria provided, multiple submitters, no conflicts"	14	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000096,UniProtKB (protein):P01130#VAR_005332"	2	183092	19	11216244	A	G	181233	19:11216244:A:G	Likely pathogenic	12/16/16	"subjects mutated among 2600 FH index cases screened = 12 , family members = 7 with co-segregation / FH-Padua / Software predictions: Damaging"	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:12	"Centre de Génétique Moléculaire et Chromosomique, Unité de génétique de l'Obésité et des Dyslipidémies,APHP, GH Hôpitaux Universitaires Pitié-Salpêtrière / Charles-Foix"	SCV000503199.1	SCV000503199		LDLR	-	High LDL	4/3/17	46959	4	1	"[0.9999893524138078,1.0647586192210225E-5]"	1	SCV00050319918729	single nucleotide variant	NM_000527.4(LDLR):c.681C>G (p.Asp227Glu)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	30-Jun-17	121908028	-	RCV000003876	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline;not applicable	germline	GRCh37	NC_000019.9	19	11216263	11216263	C	G	19p13.2	"criteria provided, multiple submitters, no conflicts"	10	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_001815,OMIM Allelic Variant:606945.0006,UniProtKB (protein):P01130#VAR_005338"	3	3690	19	11216263	C	G	18729	19:11216263:C:G	Pathogenic	12/16/16	"subjects mutated among 2600 FH index cases screened = 6 , family members = 3 with co-segregation / FH-Afrikaner-1 / Software predictions: Damaging"	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:6	"Centre de Génétique Moléculaire et Chromosomique, Unité de génétique de l'Obésité et des Dyslipidémies,APHP, GH Hôpitaux Universitaires Pitié-Salpêtrière / Charles-Foix"	SCV000503215.1	SCV000503215		LDLR	-	High LDL	6/30/17	46946	17	1	"[0.9999893494653431,1.0650534656839773E-5]"	1	SCV000503215228146	single nucleotide variant	NM_000527.4(LDLR):c.682G>T (p.Glu228Ter)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	31-Oct-18	121908029	-	RCV000211631;RCV000589867;RCV000518828	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:CN517202"	Familial hypercholesterolemia;Familial hypercholesterolemias;not provided	germline;not applicable;unknown	germline	GRCh37	NC_000019.9	19	11216264	11216264	G	T	19p13.2	"criteria provided, multiple submitters, no conflicts"	12	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_001818	2	226333	19	11216264	G	T	228146	19:11216264:G:T	Pathogenic	12/16/16	"subjects mutated among 2600 FH index cases screened = 7 , family member = 1 with co-segregation / FH-Morocco, 2% LDLR Activity"	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:7	"Centre de Génétique Moléculaire et Chromosomique, Unité de génétique de l'Obésité et des Dyslipidémies,APHP, GH Hôpitaux Universitaires Pitié-Salpêtrière / Charles-Foix"	SCV000503219.1	SCV000503219		LDLR	-	High LDL	10/31/18	46944	19	1	"[0.9999893490115883,1.0650988411724608E-5]"	1	SCV00050321918730	single nucleotide variant	NM_000527.4(LDLR):c.682G>A (p.Glu228Lys)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	31-Oct-18	121908029	-	RCV000735406;RCV000735406;RCV000735406;RCV000003878;RCV000735406;RCV000735406;RCV000623885	"Human Phenotype Ontology:HP:0002647,MedGen:C0340643;Human Phenotype Ontology:HP:0012158,MedGen:C0338585;Human Phenotype Ontology:HP:0012474,MedGen:C0265101;MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;Human Phenotype Ontology:HP:0012159,MedGen:C0751815;Human Phenotype Ontology:HP:0001297,MedGen:C0038454;MedGen:CN517202"	Aortic dissection;Carotid artery dissection;Carotid artery occlusion;Familial hypercholesterolemia;Internal carotid artery dissection;Stroke;not provided	germline;unknown	germline	GRCh37	NC_000019.9	19	11216264	11216264	G	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	19	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000105,OMIM Allelic Variant:606945.0007,UniProtKB (protein):P01130#VAR_005341"	3	3691	19	11216264	G	A	18730	19:11216264:G:A	Pathogenic	12/16/16	"subjects mutated among 2600 FH index cases screened = 9 , family members = 3 with co-segregation / FH-Canada-3, < 2% LDLR Activity / Software predictions: Damaging"	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:9	"Centre de Génétique Moléculaire et Chromosomique, Unité de génétique de l'Obésité et des Dyslipidémies,APHP, GH Hôpitaux Universitaires Pitié-Salpêtrière / Charles-Foix"	SCV000503221.1	SCV000503221		LDLR	-	High LDL	10/31/18	46944	19	2	"[0.9999786980231765,2.1301976823449217E-5]"	2	SCV000503221198013	single nucleotide variant	NM_000527.4(LDLR):c.718G>A (p.Glu240Lys)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	22-May-18	768563000	-	RCV000211564;RCV000586018;RCV000182341	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:CN517202"	Familial hypercholesterolemia;Familial hypercholesterolemias;not provided	germline	germline	GRCh37	NC_000019.9	19	11217264	11217264	G	A	19p13.2	"criteria provided, conflicting interpretations"	9	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_001828,UniProtKB (protein):P01130#VAR_005343"	2	200920	19	11217264	G	A	198013	19:11217264:G:A	Likely benign	12/16/16	subject mutated among 2600 FH index cases screened = 1 / previously described in association with FH / Software predictions: Conflicting	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:1	"Centre de Génétique Moléculaire et Chromosomique, Unité de génétique de l'Obésité et des Dyslipidémies,APHP, GH Hôpitaux Universitaires Pitié-Salpêtrière / Charles-Foix"	SCV000503229.1	SCV000503229		LDLR	-	High LDL	5/22/18	46963	0	3	"[0.9999680599620978,3.194003790217831E-5]"	3	SCV000503229245782	single nucleotide variant	NM_000527.4(LDLR):c.769C>T (p.Arg257Trp)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	29-Jun-18	200990725	-	RCV000237953	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline	germline	GRCh37	NC_000019.9	19	11217315	11217315	C	T	19p13.2	"criteria provided, conflicting interpretations"	8	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000115,UniProtKB (protein):P01130#VAR_072836"	2	251446	19	11217315	C	T	245782	19:11217315:C:T	Likely benign	12/16/16	"subjects mutated among 2600 FH index cases screened = 2 / in association with c.1765G>A, p.Asp589Asn / Software predictions: Benign"	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:2	"Centre de Génétique Moléculaire et Chromosomique, Unité de génétique de l'Obésité et des Dyslipidémies,APHP, GH Hôpitaux Universitaires Pitié-Salpêtrière / Charles-Foix"	SCV000503232.1	SCV000503232		LDLR	-	High LDL	6/29/18	46963	0	14	"[0.9998509464897898,1.4905351021016544E-4]"	14	SCV000503232228147	single nucleotide variant	NM_000527.4(LDLR):c.796G>A (p.Asp266Asn)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	19-Sep-17	875989907	-	RCV000211615	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline;inherited	germline	GRCh37	NC_000019.9	19	11217342	11217342	G	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	8	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000469	2	226334	19	11217342	G	A	228147	19:11217342:G:A	Likely pathogenic	12/16/16	"subject mutated among 2600 FH index cases screened = 1 , family members = 2 with co-segregation / previously described in association with FH / Software predictions: Damaging"	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:1	"Centre de Génétique Moléculaire et Chromosomique, Unité de génétique de l'Obésité et des Dyslipidémies,APHP, GH Hôpitaux Universitaires Pitié-Salpêtrière / Charles-Foix"	SCV000503237.1	SCV000503237		LDLR	-	High LDL	9/19/17	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV000503237171201	single nucleotide variant	NM_000527.4(LDLR):c.798T>A (p.Asp266Glu)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	17-May-18	139043155	-	RCV000172959;RCV000148594;RCV000162020	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202"	Familial hypercholesterolemia;Hypercholesterolaemia;not provided	germline;inherited;not applicable;unknown	germline	GRCh37	NC_000019.9	19	11217344	11217344	T	A	19p13.2	"criteria provided, conflicting interpretations"	16	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000117,UniProtKB (protein):P01130#VAR_005347"	2	161287	19	11217344	T	A	171201	19:11217344:T:A	Likely pathogenic	12/16/16	"subjects mutated among 2600 FH index cases screened = 4 , family members = 11 with co-segregation / FH-Cincinnati-1, 15 to 30% LDLR activity / Software predictions: Damaging"	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:4	"Centre de Génétique Moléculaire et Chromosomique, Unité de génétique de l'Obésité et des Dyslipidémies,APHP, GH Hôpitaux Universitaires Pitié-Salpêtrière / Charles-Foix"	SCV000503238.1	SCV000503238		LDLR	-	High LDL	5/17/18	46963	0	2	"[0.9999787066413985,2.1293358601452207E-5]"	2	SCV000503238171202	single nucleotide variant	NM_000527.4(LDLR):c.806G>A (p.Gly269Asp)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	17-Oct-17	143992984	-	RCV000210247;RCV000148586;RCV000161966	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202"	Familial hypercholesterolemia;Hypercholesterolaemia;not provided	germline;not applicable	germline	GRCh37	NC_000019.9	19	11217352	11217352	G	A	19p13.2	"criteria provided, conflicting interpretations"	13	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000504	2	161279	19	11217352	G	A	171202	19:11217352:G:A	Likely benign	12/16/16	subjects mutated among 2600 FH index cases screened = 3 / FH-Rome-3 / Software predictions: Conflicting	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:3	"Centre de Génétique Moléculaire et Chromosomique, Unité de génétique de l'Obésité et des Dyslipidémies,APHP, GH Hôpitaux Universitaires Pitié-Salpêtrière / Charles-Foix"	SCV000503239.1	SCV000503239		LDLR	-	High LDL	10/17/17	46963	0	33	"[0.999648659583076,3.513404169239614E-4]"	33	SCV000503239181238	single nucleotide variant	NM_000527.4(LDLR):c.829G>A (p.Glu277Lys)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	29-Dec-17	148698650	-	RCV000210246;RCV000495914;RCV000161968;RCV000610848	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202;MedGen:CN169374"	Familial hypercholesterolemia;Familial hypercholesterolemia;not provided;not specified	germline;not applicable;unknown	germline	GRCh37	NC_000019.9	19	11218079	11218079	G	A	19p13.2	"criteria provided, conflicting interpretations"	12	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_001845,UniProtKB (protein):P01130#VAR_005350"	2	183097	19	11218079	G	A	181238	19:11218079:G:A	Benign	12/16/16	"subjects mutated among 2600 FH index cases screened = 15 , family members = 5 / for 14 index cases among 15 this variant is associated with c.1268T>C, p.Ile423Thr that seems to be more deleterious / Software predictions: Conflicting"	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:15	"Centre de Génétique Moléculaire et Chromosomique, Unité de génétique de l'Obésité et des Dyslipidémies,APHP, GH Hôpitaux Universitaires Pitié-Salpêtrière / Charles-Foix"	SCV000503243.1	SCV000503243		LDLR	-	High LDL	12/29/17	46963	0	61	"[0.9993505525626557,6.494474373442923E-4]"	61	SCV000503243171204	single nucleotide variant	NM_000527.4(LDLR):c.862G>A (p.Glu288Lys)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	1-May-18	368657165	-	RCV000234348;RCV000148573	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443"	Familial hypercholesterolemia;Hypercholesterolaemia	germline	germline	GRCh37	NC_000019.9	19	11218112	11218112	G	A	19p13.2	"criteria provided, conflicting interpretations"	11	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000509,UniProtKB (protein):P01130#VAR_007983"	2	161268	19	11218112	G	A	171204	19:11218112:G:A	Uncertain significance	12/16/16	subjects mutated among 2600 FH index cases screened = 2 / previously described in association with FH / Software predictions: Conflicting	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:2	"Centre de Génétique Moléculaire et Chromosomique, Unité de génétique de l'Obésité et des Dyslipidémies,APHP, GH Hôpitaux Universitaires Pitié-Salpêtrière / Charles-Foix"	SCV000503246.1	SCV000503246		LDLR	-	High LDL	5/1/18	46963	0	8	"[0.9999148265655942,8.517343440580883E-5]"	8	SCV000503246171206	single nucleotide variant	NM_000527.4(LDLR):c.967G>A (p.Gly323Ser)	3949	LDLR	HGNC:6547	Likely pathogenic	1	16-Dec-16	373869746	-	RCV000238216;RCV000148589	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443"	Familial hypercholesterolemia;Hypercholesterolaemia	germline	germline	GRCh37	NC_000019.9	19	11221354	11221354	G	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	3	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000623	2	161282	19	11221354	G	A	171206	19:11221354:G:A	Likely pathogenic	12/16/16	subject mutated among 2600 FH index cases screened = 1 / Software predictions: Damaging	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:1	"Centre de Génétique Moléculaire et Chromosomique, Unité de génétique de l'Obésité et des Dyslipidémies,APHP, GH Hôpitaux Universitaires Pitié-Salpêtrière / Charles-Foix"	SCV000503269.1	SCV000503269		LDLR	-	High LDL	12/16/16	46961	2	3	"[0.9999680586018185,3.194139818146973E-5]"	3	SCV000503269171207	single nucleotide variant	NM_000527.4(LDLR):c.970G>A (p.Gly324Ser)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	5-Oct-17	72658860	-	RCV000237236;RCV000148566;RCV000162021;RCV000455308	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202;MedGen:CN169374"	Familial hypercholesterolemia;Hypercholesterolaemia;not provided;not specified	germline;not applicable	germline	GRCh37	NC_000019.9	19	11221357	11221357	G	A	19p13.2	"criteria provided, conflicting interpretations"	11	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000640	2	161263	19	11221357	G	A	171207	19:11221357:G:A	Benign	12/16/16	subjects mutated among 2600 FH index cases screened = 2 / Software predictions: Damaging	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:2	"Centre de Génétique Moléculaire et Chromosomique, Unité de génétique de l'Obésité et des Dyslipidémies,APHP, GH Hôpitaux Universitaires Pitié-Salpêtrière / Charles-Foix"	SCV000503271.1	SCV000503271		LDLR	-	High LDL	10/5/17	46961	2	186	"[0.9980196333127489,0.001980366687251123]"	186	SCV000503271228154	single nucleotide variant	NM_000527.4(LDLR):c.986G>A (p.Cys329Tyr)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	16-Dec-16	761954844	-	RCV000211666	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline;not applicable;unknown	germline	GRCh37	NC_000019.9	19	11221373	11221373	G	A	19p13.2	"criteria provided, conflicting interpretations"	7	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000150,UniProtKB (protein):P01130#VAR_005362"	2	226344	19	11221373	G	A	228154	19:11221373:G:A	Likely benign	12/16/16	subject mutated among 2600 FH index cases screened = 1 / previously described in association with FH (linked to ethnicity ?) / Software predictions: Damaging	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:1	"Centre de Génétique Moléculaire et Chromosomique, Unité de génétique de l'Obésité et des Dyslipidémies,APHP, GH Hôpitaux Universitaires Pitié-Salpêtrière / Charles-Foix"	SCV000503275.1	SCV000503275		LDLR	-	High LDL	12/16/16	46963	0	4	"[0.9999574132827971,4.2586717202904415E-5]"	4	SCV000503275181247	single nucleotide variant	NM_000527.4(LDLR):c.1027G>A (p.Gly343Ser)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	5-Jul-18	730882096	-	RCV000211596;RCV000587327;RCV000161977	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:CN517202"	Familial hypercholesterolemia;Familial hypercholesterolemias;not provided	germline;not applicable	germline	GRCh37	NC_000019.9	19	11221414	11221414	G	A	19p13.2	"criteria provided, conflicting interpretations"	15	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_001328,UniProtKB (protein):P01130#VAR_005367"	2	183106	19	11221414	G	A	181247	19:11221414:G:A	Likely pathogenic	12/16/16	"subjects mutated among 2600 FH index cases screened = 7 , family members = 12 with co-segregation (1 homozygote in a family) / FH-Picardie, 15 to 30% LDLR activity / Software predictions: Damaging"	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:7	"Centre de Génétique Moléculaire et Chromosomique, Unité de génétique de l'Obésité et des Dyslipidémies,APHP, GH Hôpitaux Universitaires Pitié-Salpêtrière / Charles-Foix"	SCV000503283.1	SCV000503283		LDLR	-	High LDL	7/5/18	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV000503283245935	single nucleotide variant	NM_000527.4(LDLR):c.1045C>T (p.Gln349Ter)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	2-Jan-18	748300548	-	RCV000237544	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline	germline	GRCh37	NC_000019.9	19	11221432	11221432	C	T	19p13.2	"criteria provided, conflicting interpretations"	4	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000964	2	251611	19	11221432	C	T	245935	19:11221432:C:T	Pathogenic	12/16/16	"subject mutated among 2600 FH index cases screened = 1 , family member = 1 with co-segregation"	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:1	"Centre de Génétique Moléculaire et Chromosomique, Unité de génétique de l'Obésité et des Dyslipidémies,APHP, GH Hôpitaux Universitaires Pitié-Salpêtrière / Charles-Foix"	SCV000503285.1	SCV000503285		LDLR	-	High LDL	1/2/18	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV000503285228156	single nucleotide variant	NM_000527.4(LDLR):c.1048C>T (p.Arg350Ter)	3949	LDLR	HGNC:6547	Pathogenic	1	8-May-18	769737896	-	RCV000211692;RCV000520229	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202"	Familial hypercholesterolemia;not provided	germline;inherited	germline	GRCh37	NC_000019.9	19	11221435	11221435	C	T	19p13.2	"criteria provided, multiple submitters, no conflicts"	11	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000147	2	226342	19	11221435	C	T	228156	19:11221435:C:T	Pathogenic	12/16/16	"subjects mutated among 2600 FH index cases screened = 4 , family member = 3 with co-segregation / FH-Fossum"	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:4	"Centre de Génétique Moléculaire et Chromosomique, Unité de génétique de l'Obésité et des Dyslipidémies,APHP, GH Hôpitaux Universitaires Pitié-Salpêtrière / Charles-Foix"	SCV000503287.1	SCV000503287		LDLR	-	High LDL	5/8/18	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV000503287245949	single nucleotide variant	NM_000527.4(LDLR):c.1060+10G>A	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	2-Jan-18	12710260	-	RCV000238168	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline	germline	GRCh37	NC_000019.9	19	11221457	11221457	G	A	19p13.2	"criteria provided, conflicting interpretations"	5	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000880	2	251625	19	11221457	G	A	245949	19:11221457:G:A	Likely pathogenic	12/16/16	"subjects mutated among 2600 FH index cases screened = 6 , family member = 1"	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:6	"Centre de Génétique Moléculaire et Chromosomique, Unité de génétique de l'Obésité et des Dyslipidémies,APHP, GH Hôpitaux Universitaires Pitié-Salpêtrière / Charles-Foix"	SCV000503290.1	SCV000503290		LDLR	-	High LDL	1/2/18	46962	1	1	"[0.9999893530939908,1.0646906009113752E-5]"	1	SCV000503290245988	single nucleotide variant	NM_000527.4(LDLR):c.1103G>A (p.Cys368Tyr)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	5-Jun-18	768430352	-	RCV000237712	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline	germline	GRCh37	NC_000019.9	19	11222232	11222232	G	A	19p13.2	"criteria provided, conflicting interpretations"	8	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_001357,UniProtKB (protein):P01130#VAR_072844"	2	251665	19	11222232	G	A	245988	19:11222232:G:A	Likely pathogenic	12/16/16	"subjects mutated among 2600 FH index cases screened = 3 , family members = 3 with co-segregation / previously described in association with FH / Software predictions: Damaging"	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:3	"Centre de Génétique Moléculaire et Chromosomique, Unité de génétique de l'Obésité et des Dyslipidémies,APHP, GH Hôpitaux Universitaires Pitié-Salpêtrière / Charles-Foix"	SCV000503297.1	SCV000503297		LDLR	-	High LDL	6/5/18	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV000503297181250	single nucleotide variant	NM_000527.4(LDLR):c.1171G>A (p.Ala391Thr)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	18-Aug-17	11669576	-	RCV000237576;RCV000162023;RCV000241875	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202;MedGen:CN169374"	Familial hypercholesterolemia;not provided;not specified	germline;not applicable;unknown	germline	GRCh37	NC_000019.9	19	11222300	11222300	G	A	19p13.2	"criteria provided, conflicting interpretations"	15	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_001369,UniProtKB (protein):P01130#VAR_024519"	2	183138	19	11222300	G	A	181250	19:11222300:G:A	Benign	12/16/16	subjects mutated among 2600 FH index cases screened = 201 6 being homozygotes / Software predictions: Benign	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:201	"Centre de Génétique Moléculaire et Chromosomique, Unité de génétique de l'Obésité et des Dyslipidémies,APHP, GH Hôpitaux Universitaires Pitié-Salpêtrière / Charles-Foix"	SCV000503308.1	SCV000503308		LDLR	-	High LDL	8/18/17	46928	35	4469	"[0.9523845039209001,0.0476154960790999]"	3889	SCV000503308228162	single nucleotide variant	NM_000527.4(LDLR):c.1187-10G>A	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	30-Mar-17	765696008	-	RCV000211627;RCV000588170	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445"	Familial hypercholesterolemia;Familial hypercholesterolemias	germline	germline	GRCh37	NC_000019.9	19	11223944	11223944	G	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	10	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000172	2	226349	19	11223944	G	A	228162	19:11223944:G:A	Likely pathogenic	12/16/16	"subjects mutated among 2600 FH index cases screened = 4 , family member = 2"	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:4	"Centre de Génétique Moléculaire et Chromosomique, Unité de génétique de l'Obésité et des Dyslipidémies,APHP, GH Hôpitaux Universitaires Pitié-Salpêtrière / Charles-Foix"	SCV000503311.1	SCV000503311		LDLR	-	High LDL	3/30/17	46963	0	4	"[0.9999574132827971,4.2586717202904415E-5]"	4	SCV000503311171211	single nucleotide variant	NM_000527.4(LDLR):c.1201C>G (p.Leu401Val)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	11-May-18	146200173	-	RCV000238417;RCV000586642;RCV000148572;RCV000255176	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:C0020443;MedGen:CN517202"	Familial hypercholesterolemia;Familial hypercholesterolemias;Hypercholesterolaemia;not provided	germline	germline	GRCh37	NC_000019.9	19	11223968	11223968	C	G	19p13.2	"criteria provided, conflicting interpretations"	10	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000535,UniProtKB (protein):P01130#VAR_007987"	2	161267	19	11223968	C	G	171211	19:11223968:C:G	Uncertain significance	12/16/16	subject mutated among 2600 FH index cases screened = 1 compound heterozygous on LDL Apheresis /FH-Norvege / Software predictions: Conflicting	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:1	"Centre de Génétique Moléculaire et Chromosomique, Unité de génétique de l'Obésité et des Dyslipidémies,APHP, GH Hôpitaux Universitaires Pitié-Salpêtrière / Charles-Foix"	SCV000503313.1	SCV000503313		LDLR	-	High LDL	5/11/18	46963	0	3	"[0.9999680599620978,3.194003790217831E-5]"	3	SCV000503313228164	single nucleotide variant	NM_000527.4(LDLR):c.1216C>T (p.Arg406Trp)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	30-Mar-17	121908043	-	RCV000211575	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline	germline	GRCh37	NC_000019.9	19	11223983	11223983	C	T	19p13.2	"criteria provided, multiple submitters, no conflicts"	9	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000177,UniProtKB (protein):P01130#VAR_072847"	2	226351	19	11223983	C	T	228164	19:11223983:C:T	Likely pathogenic	12/16/16	"subjects mutated among 2600 FH index cases screened = 11 , family members = 7 with co-segregation / previously described in association with FH/Software predictions: Benign"	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:11	"Centre de Génétique Moléculaire et Chromosomique, Unité de génétique de l'Obésité et des Dyslipidémies,APHP, GH Hôpitaux Universitaires Pitié-Salpêtrière / Charles-Foix"	SCV000503317.1	SCV000503317		LDLR	-	High LDL	3/30/17	46963	0	2	"[0.9999787066413985,2.1293358601452207E-5]"	2	SCV000503317230981	single nucleotide variant	NM_000527.4(LDLR):c.1217G>A (p.Arg406Gln)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	30-Mar-17	552422789	-	RCV000238261;RCV000223047	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN169374"	Familial hypercholesterolemia;not specified	germline	germline	GRCh37	NC_000019.9	19	11223984	11223984	G	A	19p13.2	"criteria provided, conflicting interpretations"	6	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000650,UniProtKB (protein):P01130#VAR_013954"	2	228798	19	11223984	G	A	230981	19:11223984:G:A	Uncertain significance	12/16/16	"subject mutated among 2600 FH index cases screened = 1 , family members = 3 with unclear co-segregation / Software predictions: Damaging"	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:1	"Centre de Génétique Moléculaire et Chromosomique, Unité de génétique de l'Obésité et des Dyslipidémies,APHP, GH Hôpitaux Universitaires Pitié-Salpêtrière / Charles-Foix"	SCV000503318.1	SCV000503318		LDLR	-	High LDL	3/30/17	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV00050331845116	single nucleotide variant	NM_000527.4(LDLR):c.1222G>A (p.Glu408Lys)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	23-Jan-18	137943601	-	RCV000030125;RCV000148564	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443"	Familial hypercholesterolemia;Hypercholesterolaemia	germline;unknown	germline	GRCh37	NC_000019.9	19	11223989	11223989	G	A	19p13.2	"criteria provided, conflicting interpretations"	12	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_001379,UniProtKB (protein):P01130#VAR_005378"	2	36453	19	11223989	G	A	45116	19:11223989:G:A	Likely pathogenic	12/16/16	"subjects mutated among 2600 FH index cases screened = 10 , family members = 5 with co-segregation / FH-AlgÃ©rie-1/Osaka, <2% LDLR Activity / Software predictions: Conflicting"	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:10	"Centre de Génétique Moléculaire et Chromosomique, Unité de génétique de l'Obésité et des Dyslipidémies,APHP, GH Hôpitaux Universitaires Pitié-Salpêtrière / Charles-Foix"	SCV000503319.1	SCV000503319		LDLR	-	High LDL	1/23/18	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV000503319171212	single nucleotide variant	NM_000527.4(LDLR):c.1238C>T (p.Thr413Met)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	23-Oct-17	368562025	-	RCV000211581;RCV000148582;RCV000519267	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202"	Familial hypercholesterolemia;Hypercholesterolaemia;not provided	germline;unknown	germline	GRCh37	NC_000019.9	19	11224005	11224005	C	T	19p13.2	"criteria provided, conflicting interpretations"	9	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000967	2	161276	19	11224005	C	T	171212	19:11224005:C:T	Uncertain significance	12/16/16	subject mutated among 2600 FH index cases screened = 1 / Software predictions: Conflicting	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:1	"Centre de Génétique Moléculaire et Chromosomique, Unité de génétique de l'Obésité et des Dyslipidémies,APHP, GH Hôpitaux Universitaires Pitié-Salpêtrière / Charles-Foix"	SCV000503321.1	SCV000503321		LDLR	-	High LDL	10/23/17	46963	0	3	"[0.9999680599620978,3.194003790217831E-5]"	3	SCV00050332118733	single nucleotide variant	NM_000527.4(LDLR):c.1285G>A (p.Val429Met)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	31-Oct-18	28942078	-	RCV000003882	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline;inherited;unknown	germline	GRCh37	NC_000019.9	19	11224052	11224052	G	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	14	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_001387,OMIM Allelic Variant:606945.0009,UniProtKB (protein):P01130#VAR_005383"	3	3694	19	11224052	G	A	18733	19:11224052:G:A	Likely pathogenic	12/16/16	"subjects mutated among 2600 FH index cases screened = 12 , family members = 6 with co-segregation / FH-Afrikaner-2, < 2% LDLR Activity / Software predictions: Conflicting"	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:12	"Centre de Génétique Moléculaire et Chromosomique, Unité de génétique de l'Obésité et des Dyslipidémies,APHP, GH Hôpitaux Universitaires Pitié-Salpêtrière / Charles-Foix"	SCV000503327.1	SCV000503327		LDLR	-	High LDL	10/31/18	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV00050332718734	single nucleotide variant	NM_000527.4(LDLR):c.1291G>A (p.Ala431Thr)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	30-Mar-17	28942079	-	RCV000003883	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline;unknown	germline	GRCh37	NC_000019.9	19	11224058	11224058	G	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	13	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000184,OMIM Allelic Variant:606945.0010,UniProtKB (protein):P01130#VAR_005384"	3	3695	19	11224058	G	A	18734	19:11224058:G:A	Likely pathogenic	12/16/16	"subjects mutated among 2600 FH index cases screened = 4 , family members = 11 with co-segregation / FH-Algeria-2, 5 to 15% LDLR activity / Software predictions: Damaging"	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:4	"Centre de Génétique Moléculaire et Chromosomique, Unité de génétique de l'Obésité et des Dyslipidémies,APHP, GH Hôpitaux Universitaires Pitié-Salpêtrière / Charles-Foix"	SCV000503329.1	SCV000503329		LDLR	-	High LDL	3/30/17	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV000503329246112	single nucleotide variant	NM_000527.4(LDLR):c.1342C>T (p.Gln448Ter)	3949	LDLR	HGNC:6547	Pathogenic	1	30-Mar-17	879254871	-	RCV000238528	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline	germline	GRCh37	NC_000019.9	19	11224109	11224109	C	T	19p13.2	"criteria provided, multiple submitters, no conflicts"	7	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000730	2	251798	19	11224109	C	T	246112	19:11224109:C:T	Pathogenic	12/16/16	subject mutated among 2600 FH index cases screened = 1	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:1	"Centre de Génétique Moléculaire et Chromosomique, Unité de génétique de l'Obésité et des Dyslipidémies,APHP, GH Hôpitaux Universitaires Pitié-Salpêtrière / Charles-Foix"	SCV000503336.1	SCV000503336		LDLR	-	High LDL	3/30/17	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV000503336172183	single nucleotide variant	NM_000527.4(LDLR):c.1359-1G>A	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	16-Jan-18	139617694	-	RCV000172962;RCV000149884	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443"	Familial hypercholesterolemia;Hypercholesterolaemia	germline	germline	GRCh37	NC_000019.9	19	11224210	11224210	G	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	12	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_001405	2	162499	19	11224210	G	A	172183	19:11224210:G:A	Pathogenic	12/16/16	"subjects mutated among 2600 FH index cases screened = 11 , family members = 2 with co-segregation / previously described in association with FH"	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:11	"Centre de Génétique Moléculaire et Chromosomique, Unité de génétique de l'Obésité et des Dyslipidémies,APHP, GH Hôpitaux Universitaires Pitié-Salpêtrière / Charles-Foix"	SCV000503342.1	SCV000503342		LDLR	-	High LDL	1/16/18	46961	2	1	"[0.9999893528672729,1.0647132727156576E-5]"	1	SCV000503342171213	single nucleotide variant	NM_000527.4(LDLR):c.1432G>A (p.Gly478Arg)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	26-Apr-18	144614838	-	RCV000211688;RCV000148583	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443"	Familial hypercholesterolemia;Hypercholesterolaemia	germline;unknown	germline	GRCh37	NC_000019.9	19	11224284	11224284	G	A	19p13.2	"criteria provided, conflicting interpretations"	13	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000198,UniProtKB (protein):P01130#VAR_005390"	2	161277	19	11224284	G	A	171213	19:11224284:G:A	Uncertain significance	12/16/16	"subjects mutated among 2600 FH index cases screened = 2 / FH-New-York-2, 5 to 15% LDLR activity/Software predictions: Conflicting"	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:2	"Centre de Génétique Moléculaire et Chromosomique, Unité de génétique de l'Obésité et des Dyslipidémies,APHP, GH Hôpitaux Universitaires Pitié-Salpêtrière / Charles-Foix"	SCV000503348.1	SCV000503348		LDLR	-	High LDL	4/26/18	46961	2	3	"[0.9999680586018185,3.194139818146973E-5]"	3	SCV000503348171216	single nucleotide variant	NM_000527.4(LDLR):c.1474G>A (p.Asp492Asn)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	2-Jan-18	373646964	-	RCV000237459;RCV000590270;RCV000148592;RCV000161989	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:C0020443;MedGen:CN517202"	Familial hypercholesterolemia;Familial hypercholesterolemias;Hypercholesterolaemia;not provided	germline;inherited;not applicable	germline	GRCh37	NC_000019.9	19	11224326	11224326	G	A	19p13.2	"criteria provided, conflicting interpretations"	13	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000205,UniProtKB (protein):P01130#VAR_072850"	2	161285	19	11224326	G	A	171216	19:11224326:G:A	Likely pathogenic	12/16/16	"subjects mutated among 2600 FH index cases screened = 10 , family members = 5 with unclear co-segregation / previously described in association with FH/Software predictions: Conflicting"	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:10	"Centre de Génétique Moléculaire et Chromosomique, Unité de génétique de l'Obésité et des Dyslipidémies,APHP, GH Hôpitaux Universitaires Pitié-Salpêtrière / Charles-Foix"	SCV000503353.1	SCV000503353		LDLR	-	High LDL	1/2/18	46963	0	5	"[0.9999467666034964,5.323339650363052E-5]"	3	SCV000503353246223	single nucleotide variant	NM_000527.4(LDLR):c.1586+5G>A	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	25-Apr-17	781362878	-	RCV000237174;RCV000587894	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202"	Familial hypercholesterolemia;not provided	germline	germline	GRCh37	NC_000019.9	19	11224443	11224443	G	A	19p13.2	"criteria provided, conflicting interpretations"	6	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_001463	2	251909	19	11224443	G	A	246223	19:11224443:G:A	Uncertain significance	12/16/16	subjects mutated among 2600 FH index cases screened = 2	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:2	"Centre de Génétique Moléculaire et Chromosomique, Unité de génétique de l'Obésité et des Dyslipidémies,APHP, GH Hôpitaux Universitaires Pitié-Salpêtrière / Charles-Foix"	SCV000503370.1	SCV000503370		LDLR	-	High LDL	4/25/17	46963	0	2	"[0.9999787066413985,2.1293358601452207E-5]"	2	SCV000503370181265	single nucleotide variant	NM_000527.4(LDLR):c.1720C>T (p.Arg574Cys)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	11-Dec-17	185098634	-	RCV000238063;RCV000161998	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202"	Familial hypercholesterolemia;not provided	germline;not applicable	germline	GRCh37	NC_000019.9	19	11227549	11227549	C	T	19p13.2	"criteria provided, conflicting interpretations"	6	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000232,UniProtKB (protein):P01130#VAR_072851"	2	183123	19	11227549	C	T	181265	19:11227549:C:T	Uncertain significance	12/16/16	"subject mutated among 2600 FH index cases screened = 1, family member=1 /FH-Germany/software prediction damaging"	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:1	"Centre de Génétique Moléculaire et Chromosomique, Unité de génétique de l'Obésité et des Dyslipidémies,APHP, GH Hôpitaux Universitaires Pitié-Salpêtrière / Charles-Foix"	SCV000503397.1	SCV000503397		LDLR	-	High LDL	12/11/17	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV000503397362713	single nucleotide variant	NM_000527.4(LDLR):c.1730G>A (p.Trp577Ter)	3949	LDLR	HGNC:6547	Pathogenic	1	30-Mar-17	138947766	-	RCV000417240	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline	germline	GRCh37	NC_000019.9	19	11227559	11227559	G	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	3	"ACMG2013,ACMG2016"	N	-	2	375821	19	11227559	G	A	362713	19:11227559:G:A	Pathogenic	12/16/16	"subjects mutated among 2600 FH index cases screened = 5 , family members = 4 with co-segregation / Other nonsens mutation at same codon with < 2% LDLR Activity"	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:5	"Centre de Génétique Moléculaire et Chromosomique, Unité de génétique de l'Obésité et des Dyslipidémies,APHP, GH Hôpitaux Universitaires Pitié-Salpêtrière / Charles-Foix"	SCV000503401.1	SCV000503401		LDLR	-	High LDL	3/30/17	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV000503401198015	single nucleotide variant	NM_000527.4(LDLR):c.1747C>T (p.His583Tyr)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	23-Jan-18	730882109	-	RCV000211604;RCV000182342	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202"	Familial hypercholesterolemia;not provided	germline;not applicable;unknown	germline	GRCh37	NC_000019.9	19	11227576	11227576	C	T	19p13.2	"criteria provided, conflicting interpretations"	10	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000234	2	200921	19	11227576	C	T	198015	19:11227576:C:T	Likely benign	12/16/16	subject mutated among 2600 FH index cases screened = 1 /previously described in association with FH /Software predictions: Conflicting	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:1	"Centre de Génétique Moléculaire et Chromosomique, Unité de génétique de l'Obésité et des Dyslipidémies,APHP, GH Hôpitaux Universitaires Pitié-Salpêtrière / Charles-Foix"	SCV000503407.1	SCV000503407		LDLR	-	High LDL	1/23/18	46963	0	14	"[0.9998509464897898,1.4905351021016544E-4]"	14	SCV000503407360376	single nucleotide variant	NM_000527.4(LDLR):c.1774G>A (p.Gly592Arg)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	30-Mar-17	763147599	-	RCV000417321	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline	germline	GRCh37	NC_000019.9	19	11227603	11227603	G	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	2	"ACMG2013,ACMG2016"	N	-	2	373769	19	11227603	G	A	360376	19:11227603:G:A	Likely pathogenic	12/16/16	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:2	"Centre de Génétique Moléculaire et Chromosomique, Unité de génétique de l'Obésité et des Dyslipidémies,APHP, GH Hôpitaux Universitaires Pitié-Salpêtrière / Charles-Foix"	SCV000503411.1	SCV000503411		LDLR	-	High LDL	3/30/17	46963	0	2	"[0.9999787066413985,2.1293358601452207E-5]"	2	SCV000503411171217	single nucleotide variant	NM_000527.4(LDLR):c.1775G>A (p.Gly592Glu)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	31-Oct-18	137929307	-	RCV000172964;RCV000587007;RCV000148576;RCV000162001	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:C0020443;MedGen:CN517202"	Familial hypercholesterolemia;Familial hypercholesterolemias;Hypercholesterolaemia;not provided	germline;inherited;not applicable;unknown	germline	GRCh37	NC_000019.9	19	11227604	11227604	G	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	22	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000237,UniProtKB (protein):P01130#VAR_005403"	2	161271	19	11227604	G	A	171217	19:11227604:G:A	Likely pathogenic	12/16/16	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:11	"Centre de Génétique Moléculaire et Chromosomique, Unité de génétique de l'Obésité et des Dyslipidémies,APHP, GH Hôpitaux Universitaires Pitié-Salpêtrière / Charles-Foix"	SCV000503412.1	SCV000503412		LDLR	-	High LDL	10/31/18	46963	0	3	"[0.9999680599620978,3.194003790217831E-5]"	3	SCV000503412171218	single nucleotide variant	NM_000527.4(LDLR):c.1783C>T (p.Arg595Trp)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	24-Oct-17	373371572	-	RCV000237585;RCV000588105;RCV000148597;RCV000518174	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:C0020443;MedGen:CN517202"	Familial hypercholesterolemia;Familial hypercholesterolemias;Hypercholesterolaemia;not provided	germline	germline	GRCh37	NC_000019.9	19	11227612	11227612	C	T	19p13.2	"criteria provided, conflicting interpretations"	11	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000239,UniProtKB (protein):P01130#VAR_072856"	2	161290	19	11227612	C	T	171218	19:11227612:C:T	Likely pathogenic	12/16/16	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:1	"Centre de Génétique Moléculaire et Chromosomique, Unité de génétique de l'Obésité et des Dyslipidémies,APHP, GH Hôpitaux Universitaires Pitié-Salpêtrière / Charles-Foix"	SCV000503414.1	SCV000503414		LDLR	-	High LDL	10/24/17	46963	0	2	"[0.9999787066413985,2.1293358601452207E-5]"	2	SCV000503414171219	single nucleotide variant	NM_000527.4(LDLR):c.1816G>T (p.Ala606Ser)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	25-Oct-17	72658865	-	RCV000211562;RCV000148567;RCV000162003	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202"	Familial hypercholesterolemia;Hypercholesterolaemia;not provided	germline;not applicable	germline	GRCh37	NC_000019.9	19	11227645	11227645	G	T	19p13.2	"criteria provided, conflicting interpretations"	9	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000566	2	161264	19	11227645	G	T	171219	19:11227645:G:T	Uncertain significance	12/16/16	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:3	"Centre de Génétique Moléculaire et Chromosomique, Unité de génétique de l'Obésité et des Dyslipidémies,APHP, GH Hôpitaux Universitaires Pitié-Salpêtrière / Charles-Foix"	SCV000503417.1	SCV000503417		LDLR	-	High LDL	10/25/17	46963	0	5	"[0.9999467666034964,5.323339650363052E-5]"	5	SCV000503417246378	single nucleotide variant	NM_000527.4(LDLR):c.1855T>C (p.Phe619Leu)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	16-Dec-16	747134711	-	RCV000237217	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline	germline	GRCh37	NC_000019.9	19	11230777	11230777	T	C	19p13.2	"criteria provided, conflicting interpretations"	4	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000570	2	252083	19	11230777	T	C	246378	19:11230777:T:C	Uncertain significance	12/16/16	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:1	"Centre de Génétique Moléculaire et Chromosomique, Unité de génétique de l'Obésité et des Dyslipidémies,APHP, GH Hôpitaux Universitaires Pitié-Salpêtrière / Charles-Foix"	SCV000503426.1	SCV000503426		LDLR	-	High LDL	12/16/16	46963	0	3	"[0.9999680599620978,3.194003790217831E-5]"	3	SCV000503426246397	single nucleotide variant	NM_000527.4(LDLR):c.1879G>A (p.Ala627Thr)	3949	LDLR	HGNC:6547	Likely pathogenic	1	30-Mar-17	879255066	-	RCV000237476	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline	germline	GRCh37	NC_000019.9	19	11230801	11230801	G	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	4	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000259	2	252101	19	11230801	G	A	246397	19:11230801:G:A	Likely pathogenic	12/16/16	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:1	"Centre de Génétique Moléculaire et Chromosomique, Unité de génétique de l'Obésité et des Dyslipidémies,APHP, GH Hôpitaux Universitaires Pitié-Salpêtrière / Charles-Foix"	SCV000503429.1	SCV000503429		LDLR	-	High LDL	3/30/17	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV000503429228195	single nucleotide variant	NM_000527.4(LDLR):c.1955T>C (p.Met652Thr)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	28-Mar-18	875989936	-	RCV000211590	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline	germline	GRCh37	NC_000019.9	19	11230877	11230877	T	C	19p13.2	"criteria provided, conflicting interpretations"	5	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000266	2	226382	19	11230877	T	C	228195	19:11230877:T:C	Likely pathogenic	12/16/16	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:2	"Centre de Génétique Moléculaire et Chromosomique, Unité de génétique de l'Obésité et des Dyslipidémies,APHP, GH Hôpitaux Universitaires Pitié-Salpêtrière / Charles-Foix"	SCV000503437.1	SCV000503437		LDLR	-	High LDL	3/28/18	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV000503437246432	single nucleotide variant	NM_000527.4(LDLR):c.1966C>A (p.His656Asn)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	16-Dec-16	762815611	-	RCV000237688	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline	germline	GRCh37	NC_000019.9	19	11230888	11230888	C	A	19p13.2	"criteria provided, conflicting interpretations"	5	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000267	2	252136	19	11230888	C	A	246432	19:11230888:C:A	Likely pathogenic	12/16/16	"subject mutated among 2600 FH index cases screened = 1 , family members = 5 with co-segregation / previously described in association with FH"	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:1	"Centre de Génétique Moléculaire et Chromosomique, Unité de génétique de l'Obésité et des Dyslipidémies,APHP, GH Hôpitaux Universitaires Pitié-Salpêtrière / Charles-Foix"	SCV000503441.1	SCV000503441		LDLR	-	High LDL	12/16/16	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV000503441246458	single nucleotide variant	NM_000527.4(LDLR):c.1999T>C (p.Cys667Arg)	3949	LDLR	HGNC:6547	Likely pathogenic	1	16-Dec-16	150021927	-	RCV000238269	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline;unknown	germline	GRCh37	NC_000019.9	19	11231057	11231057	T	C	19p13.2	"criteria provided, multiple submitters, no conflicts"	7	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000576	2	252163	19	11231057	T	C	246458	19:11231057:T:C	Likely pathogenic	12/16/16	subject mutated among 2600 FH index cases screened = 1/software prediction damaging	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:1	"Centre de Génétique Moléculaire et Chromosomique, Unité de génétique de l'Obésité et des Dyslipidémies,APHP, GH Hôpitaux Universitaires Pitié-Salpêtrière / Charles-Foix"	SCV000503449.1	SCV000503449		LDLR	-	High LDL	12/16/16	46963	0	5	"[0.9999467666034964,5.323339650363052E-5]"	5	SCV00050344918738	single nucleotide variant	NM_000527.4(LDLR):c.2043C>A (p.Cys681Ter)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	31-Oct-18	121908031	-	RCV000003887;RCV000590806;RCV000481771	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:CN517202"	Familial hypercholesterolemia;Familial hypercholesterolemias;not provided	germline;unknown	germline	GRCh37	NC_000019.9	19	11231101	11231101	C	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	18	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_001592,OMIM Allelic Variant:606945.0016"	3	3699	19	11231101	C	A	18738	19:11231101:C:A	Pathogenic	12/16/16	"subjects mutated among 2600 FH index cases screened = 31 (1 homozygote) , family members = 17 with co-segregation / FH-Libanon, < 2% LDLR Activity"	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:31	"Centre de Génétique Moléculaire et Chromosomique, Unité de génétique de l'Obésité et des Dyslipidémies,APHP, GH Hôpitaux Universitaires Pitié-Salpêtrière / Charles-Foix"	SCV000503452.1	SCV000503452		LDLR	-	High LDL	10/31/18	46958	5	1	"[0.9999893521870608,1.0647812939222283E-5]"	1	SCV000503452246486	single nucleotide variant	NM_000527.4(LDLR):c.2050G>A (p.Ala684Thr)	3949	LDLR	HGNC:6547	Likely pathogenic	1	16-Dec-16	774730452	-	RCV000237554	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline	germline	GRCh37	NC_000019.9	19	11231108	11231108	G	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	3	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000754	2	252192	19	11231108	G	A	246486	19:11231108:G:A	Likely pathogenic	12/16/16	subject mutated among 2600 FH index cases screened = 1 / previously described in association with FH (linked to ethnicity ?)/software prediction damaging	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:1	"Centre de Génétique Moléculaire et Chromosomique, Unité de génétique de l'Obésité et des Dyslipidémies,APHP, GH Hôpitaux Universitaires Pitié-Salpêtrière / Charles-Foix"	SCV000503453.1	SCV000503453		LDLR	-	High LDL	12/16/16	46962	1	4	"[0.9999574123759636,4.258762403645501E-5]"	4	SCV00050345318741	single nucleotide variant	NM_000527.4(LDLR):c.2054C>T (p.Pro685Leu)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	31-Oct-18	28942084	-	RCV000003891;RCV000162007	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202"	Familial hypercholesterolemia;not provided	germline;inherited;not applicable;unknown	germline	GRCh37	NC_000019.9	19	11231112	11231112	C	T	19p13.2	"criteria provided, multiple submitters, no conflicts"	16	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000276,OMIM Allelic Variant:606945.0017,UniProtKB (protein):P01130#VAR_005410"	3	3702	19	11231112	C	T	18741	19:11231112:C:T	Likely pathogenic	12/16/16	"subjects mutated among 2600 FH index cases screened = 25 (1 homozygote) , family members = 22 with co-segregation / previously described in association with FH/software prediction damaging"	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:25	"Centre de Génétique Moléculaire et Chromosomique, Unité de génétique de l'Obésité et des Dyslipidémies,APHP, GH Hôpitaux Universitaires Pitié-Salpêtrière / Charles-Foix"	SCV000503454.1	SCV000503454		LDLR	-	High LDL	10/31/18	46963	0	3	"[0.9999680599620978,3.194003790217831E-5]"	3	SCV000503454246513	single nucleotide variant	NM_000527.4(LDLR):c.2096C>T (p.Pro699Leu)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	9-Oct-17	201573863	-	RCV000237906;RCV000589820	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445"	Familial hypercholesterolemia;Familial hypercholesterolemias	germline;unknown	germline	GRCh37	NC_000019.9	19	11231154	11231154	C	T	19p13.2	"criteria provided, conflicting interpretations"	10	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_001600,UniProtKB (protein):P01130#VAR_013955"	2	252219	19	11231154	C	T	246513	19:11231154:C:T	Likely pathogenic	12/16/16	"subject mutated among 2600 FH index cases screened = 1 , family members = 3 with co-segregation / previously described in association with FH/software prediction damaging"	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:1	"Centre de Génétique Moléculaire et Chromosomique, Unité de génétique de l'Obésité et des Dyslipidémies,APHP, GH Hôpitaux Universitaires Pitié-Salpêtrière / Charles-Foix"	SCV000503463.1	SCV000503463		LDLR	-	High LDL	10/9/17	46962	1	6	"[0.9999361185639453,6.388143605468251E-5]"	6	SCV00050346318783	single nucleotide variant	NM_000527.4(LDLR):c.2140+1G>A	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	11-Jun-18	145787161	-	RCV000003942	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline	germline	GRCh37	NC_000019.9	19	11231199	11231199	G	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	8	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000282,OMIM Allelic Variant:606945.0063"	3	3744	19	11231199	G	A	18783	19:11231199:G:A	Pathogenic	12/16/16	subject mutated among 2600 FH index cases screened = 1	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:1	"Centre de Génétique Moléculaire et Chromosomique, Unité de génétique de l'Obésité et des Dyslipidémies,APHP, GH Hôpitaux Universitaires Pitié-Salpêtrière / Charles-Foix"	SCV000503469.1	SCV000503469		LDLR	-	High LDL	6/11/18	46962	1	1	"[0.9999893530939908,1.0646906009113752E-5]"	1	SCV00050346945123	single nucleotide variant	NM_000527.4(LDLR):c.2140+5G>A	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	26-Jan-18	72658867	-	RCV000030133;RCV000614028	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN169374"	Familial hypercholesterolemia;not specified	germline	germline	GRCh37	NC_000019.9	19	11231203	11231203	G	A	19p13.2	"criteria provided, conflicting interpretations"	13	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000283	2	36460	19	11231203	G	A	45123	19:11231203:G:A	Benign	12/16/16	"subject mutated among 2600 FH index cases screened = 1/Polymorphisme cf whitall et al J Med Genet, 2002"	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:1	"Centre de Génétique Moléculaire et Chromosomique, Unité de génétique de l'Obésité et des Dyslipidémies,APHP, GH Hôpitaux Universitaires Pitié-Salpêtrière / Charles-Foix"	SCV000503470.1	SCV000503470		LDLR	-	High LDL	1/26/18	46942	21	472	"[0.9949725192791103,0.005027480720889608]"	464	SCV000503470171222	single nucleotide variant	NM_000527.4(LDLR):c.2282C>T (p.Thr761Met)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	30-Mar-17	138477254	-	RCV000237277;RCV000148565;RCV000162013	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202"	Familial hypercholesterolemia;Hypercholesterolaemia;not provided	germline;not applicable	germline	GRCh37	NC_000019.9	19	11233991	11233991	C	T	19p13.2	"criteria provided, conflicting interpretations"	9	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000907	2	161262	19	11233991	C	T	171222	19:11233991:C:T	Uncertain significance	12/16/16	subjects mutated among 2600 FH index cases screened = 2/Software predictions: Conflicting	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:2	"Centre de Génétique Moléculaire et Chromosomique, Unité de génétique de l'Obésité et des Dyslipidémies,APHP, GH Hôpitaux Universitaires Pitié-Salpêtrière / Charles-Foix"	SCV000503476.1	SCV000503476		LDLR	-	High LDL	3/30/17	46963	0	4	"[0.9999574132827971,4.2586717202904415E-5]"	4	SCV000503476171223	single nucleotide variant	NM_000527.4(LDLR):c.2441G>A (p.Arg814Gln)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	17-Nov-17	5928	-	RCV000237126;RCV000148584;RCV000162024	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202"	Familial hypercholesterolemia;Hypercholesterolaemia;not provided	germline;not applicable	germline	GRCh37	NC_000019.9	19	11240240	11240240	G	A	19p13.2	"criteria provided, conflicting interpretations"	9	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000376,UniProtKB (protein):P01130#VAR_011864"	2	161278	19	11240240	G	A	171223	19:11240240:G:A	Likely benign	12/16/16	"subjects mutated among 2600 FH index cases screened = 3 , family member = 1/previously described in association with FH/Software predictions: Conflicting"	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:3	"Centre de Génétique Moléculaire et Chromosomique, Unité de génétique de l'Obésité et des Dyslipidémies,APHP, GH Hôpitaux Universitaires Pitié-Salpêtrière / Charles-Foix"	SCV000503489.1	SCV000503489		LDLR	-	High LDL	11/17/17	46963	0	50	"[0.9994676660349637,5.323339650363052E-4]"	50	SCV00050348945125	single nucleotide variant	NM_000527.4(LDLR):c.2479G>A (p.Val827Ile)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	2-Nov-17	137853964	-	RCV000030135;RCV000148585;RCV000058923;RCV000436469	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202;MedGen:CN169374"	Familial hypercholesterolemia;Hypercholesterolaemia;not provided;not specified	germline;inherited;not applicable;unknown	germline	GRCh37	NC_000019.9	19	11240278	11240278	G	A	19p13.2	"criteria provided, conflicting interpretations"	16	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_001657,UniProtKB (protein):P01130#VAR_005418"	2	36462	19	11240278	G	A	45125	19:11240278:G:A	Benign	12/16/16	"subjects mutated among 2600 FH index cases screened = 10 , family member = 1/previously described in association with FH/Software predictions: Conflicting"	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:10	"Centre de Génétique Moléculaire et Chromosomique, Unité de génétique de l'Obésité et des Dyslipidémies,APHP, GH Hôpitaux Universitaires Pitié-Salpêtrière / Charles-Foix"	SCV000503493.1	SCV000503493		LDLR	-	High LDL	11/2/17	46963	0	74	"[0.9992121457317462,7.878542682537317E-4]"	74	SCV000503493362654	single nucleotide variant	NM_174936.3(PCSK9):c.385G>A (p.Asp129Asn)	255738	PCSK9	HGNC:20001	Conflicting interpretations of pathogenicity	1	16-Dec-16	778738291	-	RCV000497232;RCV000417258	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C1863551,OMIM:603776"	"Familial hypercholesterolemia;Hypercholesterolemia, autosomal dominant, 3"	germline	germline	GRCh37	NC_000001.10	1	55509693	55509693	G	A	1p32.3	"criteria provided, conflicting interpretations"	3	"ACMG2013,ACMG2016"	N	-	2	375844	1	55509693	G	A	362654	1:55509693:G:A	Likely pathogenic	12/16/16	"subjects mutated among 2600 FH index cases screened = 2, family members = 2, with co-segregation / Software predictions: Conflicting"	OMIM:603776	"C1863551:Hypercholesterolemia, autosomal dominant, 3"	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	"Centre de Génétique Moléculaire et Chromosomique, Unité de génétique de l'Obésité et des Dyslipidémies,APHP, GH Hôpitaux Universitaires Pitié-Salpêtrière / Charles-Foix"	SCV000503504.1	SCV000503504		PCSK9	-	Low LDL	12/16/16	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV000503504260609	single nucleotide variant	NM_174936.3(PCSK9):c.709C>T (p.Arg237Trp)	255738	PCSK9	HGNC:20001	Conflicting interpretations of pathogenicity	1	25-Jul-17	148195424	-	RCV000256274;RCV000417261	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C1863551,OMIM:603776"	"Familial hypercholesterolemia;Hypercholesterolemia, autosomal dominant, 3"	germline	germline	GRCh37	NC_000001.10	1	55518374	55518374	C	T	1p32.3	"criteria provided, conflicting interpretations"	5	"ACMG2013,ACMG2016"	N	UniProtKB (protein):Q8NBP7#VAR_025452	2	265933	1	55518374	C	T	260609	1:55518374:C:T	Uncertain significance	12/16/16	"subjects mutated among 2600 FH index cases screened = 2, family member = 1 / Software predictions: Damaging"	OMIM:603776	"C1863551:Hypercholesterolemia, autosomal dominant, 3"	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	"Centre de Génétique Moléculaire et Chromosomique, Unité de génétique de l'Obésité et des Dyslipidémies,APHP, GH Hôpitaux Universitaires Pitié-Salpêtrière / Charles-Foix"	SCV000503510.1	SCV000503510		PCSK9	-	Low LDL	7/25/17	46949	14	63	"[0.9993290591918891,6.709408081109288E-4]"	63	SCV000503510362650	single nucleotide variant	NM_174936.3(PCSK9):c.103G>T (p.Asp35Tyr)	255738	PCSK9	HGNC:20001	Pathogenic	1	16-Dec-16	764603059	-	RCV000417231	"MedGen:C1863551,OMIM:603776"	"Hypercholesterolemia, autosomal dominant, 3"	germline	germline	GRCh37	NC_000001.10	1	55505613	55505613	G	T	1p32.3	"criteria provided, single submitter"	1	"ACMG2013,ACMG2016"	N	-	2	375848	1	55505613	G	T	362650	1:55505613:G:T	Pathogenic	12/16/16	"subject mutated among 2600 FH index cases screened = 1, family member = 1 / functionnal testing (PMID:22683120) / Software predictions: Conflicting"	OMIM:603776	"C1863551:Hypercholesterolemia, autosomal dominant, 3"	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	"Centre de Génétique Moléculaire et Chromosomique, Unité de génétique de l'Obésité et des Dyslipidémies,APHP, GH Hôpitaux Universitaires Pitié-Salpêtrière / Charles-Foix"	SCV000503512.1	SCV000503512		PCSK9	-	Low LDL	12/16/16	45987	976	1	"[0.9999891273620806,1.0872637919412009E-5]"	1	SCV000503512362653	single nucleotide variant	NM_174936.3(PCSK9):c.323T>G (p.Leu108Arg)	255738	PCSK9	HGNC:20001	Pathogenic/Likely pathogenic	1	23-Feb-17	1057519691	-	RCV000587518;RCV000417273	"MedGen:C0020445;MedGen:C1863551,OMIM:603776"	"Familial hypercholesterolemias;Hypercholesterolemia, autosomal dominant, 3"	germline	germline	GRCh37	NC_000001.10	1	55509631	55509631	T	G	1p32.3	"criteria provided, multiple submitters, no conflicts"	2	"ACMG2013,ACMG2016"	N	-	2	375849	1	55509631	T	G	362653	1:55509631:T:G	Pathogenic	12/16/16	"subject mutated among 2600 FH index cases screened = 1, family member = 1 / functionnal testing (PMID:22683120) / Software predictions: Benign"	OMIM:603776	"C1863551:Hypercholesterolemia, autosomal dominant, 3"	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	"Centre de Génétique Moléculaire et Chromosomique, Unité de génétique de l'Obésité et des Dyslipidémies,APHP, GH Hôpitaux Universitaires Pitié-Salpêtrière / Charles-Foix"	SCV000503513.1	SCV000503513		PCSK9	-	Low LDL	2/23/17	46963	0	2	"[0.9999787066413985,2.1293358601452207E-5]"	2	SCV000503513354066	single nucleotide variant	NM_174936.3(PCSK9):c.1251C>A (p.His417Gln)	255738	PCSK9	HGNC:20001	Conflicting interpretations of pathogenicity	1	16-Dec-16	143275858	-	RCV000408779;RCV000417285	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C1863551,OMIM:603776"	"Familial hypercholesterolemia;Hypercholesterolemia, autosomal dominant, 3"	germline	germline	GRCh37	NC_000001.10	1	55523779	55523779	C	A	1p32.3	"criteria provided, conflicting interpretations"	2	"ACMG2013,ACMG2016"	N	-	2	369875	1	55523779	C	A	354066	1:55523779:C:A	Likely benign	12/16/16	subjects mutated among 2600 FH index cases screened = 2 / One index case is double heterozygote with moderate phenotype / Software predictions: Conflicting	OMIM:603776	"C1863551:Hypercholesterolemia, autosomal dominant, 3"	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	"Centre de Génétique Moléculaire et Chromosomique, Unité de génétique de l'Obésité et des Dyslipidémies,APHP, GH Hôpitaux Universitaires Pitié-Salpêtrière / Charles-Foix"	SCV000503516.1	SCV000503516		PCSK9	-	Low LDL	12/16/16	46963	0	36	"[0.9996167195451738,3.8328045482613975E-4]"	36	SCV00050351629525	single nucleotide variant	NM_170707.3(LMNA):c.1445G>A (p.Arg482Gln)	4000	LMNA	HGNC:6636	Pathogenic	1	31-Oct-18	11575937	-	RCV000763258;RCV000763258;RCV000459624;RCV000763258;RCV000763258;RCV000763258;RCV000190399;RCV000763258;RCV000015575;RCV000763258;RCV000763258;RCV000763258;RCV000041318;RCV000763258;RCV000763258;RCV000754814;RCV000148600;RCV000057299	"MedGen:C0410190,OMIM:181350,Orphanet:ORPHA98853,SNOMED CT:240072005;MedGen:C1854154,OMIM:605588,Orphanet:ORPHA98856;MedGen:C0270914,Orphanet:ORPHA64746;MedGen:C2750785,OMIM:613205,Orphanet:ORPHA157973;MedGen:C1449563,OMIM:115200,Orphanet:ORPHA300751;MedGen:C0796031,OMIM:212112,Orphanet:ORPHA2229;MedGen:C2750035,OMIM:616516,Orphanet:ORPHA98855;MedGen:C2750035,OMIM:616516,Orphanet:ORPHA98855;MedGen:C1720860,OMIM:151660,Orphanet:ORPHA2348;MedGen:C1720860,OMIM:151660,Orphanet:ORPHA2348;MedGen:C1857829,OMIM:610140,Orphanet:ORPHA168796;MedGen:C0033300,OMIM:176670,Orphanet:ORPHA740,SNOMED CT:238870004;MedGen:CN236383,Orphanet:ORPHA98301;MedGen:C0406585,OMIM:275210,Orphanet:ORPHA1662,SNOMED CT:400128006;MedGen:C0432291,OMIM:248370,Orphanet:ORPHA2457,SNOMED CT:109419009;MedGen:C3888631;MedGen:CN221589;MedGen:CN517202"	"Benign scapuloperoneal muscular dystrophy with cardiomyopathy;Charcot-Marie-Tooth disease type 2B1;Charcot-Marie-Tooth disease, type 2;Congenital muscular dystrophy, LMNA-related;Dilated cardiomyopathy 1A;Dilated cardiomyopathy-hypergonadotropic hypogonadism syndrome;Emery-Dreifuss muscular dystrophy 3, autosomal recessive;Emery-Dreifuss muscular dystrophy 3, autosomal recessive;Familial partial lipodystrophy 2;Familial partial lipodystrophy 2;Heart-hand syndrome, Slovenian type;Hutchinson-Gilford syndrome;Laminopathy;Lethal tight skin contracture syndrome;Mandibuloacral dysostosis;Monogenic diabetes;Partial lipodystrophy, Dunnigan;not provided"	de novo;germline;unknown	germline	GRCh37	NC_000001.10	1	156106776	156106776	G	A	1q22	"criteria provided, multiple submitters, no conflicts"	10	"ACMG2013,ACMG2016"	N	"OMIM Allelic Variant:150330.0010,UniProtKB (protein):P02545#VAR_009992"	3	14486	1	156106776	G	A	29525	1:156106776:G:A	Pathogenic	1/4/17	-	not provided	CN517202:not provided	No Information	FALSE	No Information	"criteria provided, single submitter"	clinical testing	de novo:na	"Center for Pediatric Genomic Medicine,Children's Mercy Hospital and Clinics"	SCV000510952.1	SCV000510952		-	-	"Lipodystrophy, MonogenicDM_all"	10/31/18	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV00051095224073	single nucleotide variant	NM_002052.4(GATA4):c.1273G>A (p.Asp425Asn)	2626	GATA4	HGNC:4173	Conflicting interpretations of pathogenicity	1	8-Dec-17	56208331	-	RCV000009600;RCV000549514;RCV000190715;RCV000626818;RCV000626818;RCV000009601;RCV000626818;RCV000431077	"MedGen:C1842778,OMIM:607941;MedGen:C3280781,OMIM:614430;MeSH:D030342,MedGen:C0950123;Human Phenotype Ontology:HP:0010882,MedGen:CN116616;Human Phenotype Ontology:HP:0001642,MedGen:C1956257,OMIM:265500;Human Phenotype Ontology:HP:0001636,MedGen:C0039685,OMIM:187500,Orphanet:ORPHA3303,SNOMED CT:86299006;Human Phenotype Ontology:HP:0005180,MedGen:C0040961;MedGen:CN517202"	Atrial septal defect 2;Atrioventricular septal defect 4;Inborn genetic diseases;Pulmonary valve atresia;Pulmonic stenosis;Tetralogy of Fallot;Tricuspid regurgitation;not provided	germline;unknown	germline	GRCh37	NC_000008.10	8	11615928	11615928	G	A	8p23.1	"criteria provided, conflicting interpretations"	5	NA	N	"OMIM Allelic Variant:600576.0005,UniProtKB (protein):P43694#VAR_067621"	3	9034	8	11615928	G	A	24073	8:11615928:G:A	Benign	9/20/16	-	not provided	CN517202:not provided	No Information	FALSE	No Information	"criteria provided, single submitter"	clinical testing	germline:na	"Center for Pediatric Genomic Medicine,Children's Mercy Hospital and Clinics"	SCV000511051.1	SCV000511051		-	-	"MonogenicDM_all, Neonatal Diabetes"	12/8/17	46963	0	221	"[0.9976470838745395,0.002352916125460469]"	217	SCV000511051376001	single nucleotide variant	NM_000458.3(HNF1B):c.1108G>A (p.Gly370Ser)	6928	HNF1B	HGNC:11630	Conflicting interpretations of pathogenicity	1	5-Jul-18	113042313	-	RCV000429473	MedGen:CN517202	not provided	germline	germline	GRCh37	NC_000017.10	17	36070609	36070609	C	T	17q12	"criteria provided, conflicting interpretations"	2	NA	N	-	2	379811	17	36070609	C	T	376001	17:36070609:C:T	Pathogenic	6/1/15	"The G370S variant in the HNF1B gene has been reported previously in association with maturity-onsetdiabetes of the young type 5/ renal cysts and diabetes syndrome (BellannÃ©-Chantelot et al., 2005; Poitou etal., 2012). The G370S substitution was not observed with any significant frequency in approximately 6,500individuals of European and African American ancestry in the NHLBI Exome Sequencing Project andwas not observed in the homozygous state in any individual within these populations. Although, in silicoanalysis is inconsistent in its predictions as to whether or not the variant is damaging to the proteinstructure/function, the G370S variant is a non-conservative amino acid substitution, which occurs at aposition that is conserved in mammals. Based on the available data, we interpret G370S as pathogenic variant."	Not Provided	CN517202:not provided	"MODY type 5, renal cysts and diabetes syndrome"	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	GeneDx	SCV000517254.3	SCV000517254		HNF1B	-	"MODY, MODY Extended, MonogenicDM_all, Neonatal Diabetes"	7/5/18	46963	0	26	"[0.9997231863381811,2.7681366181887867E-4]"	26	SCV00051725423898	single nucleotide variant	NM_000209.3(PDX1):c.226G>A (p.Asp76Asn)	3651	PDX1	HGNC:6107	"Conflicting interpretations of pathogenicity, risk factor"	1	5-Feb-18	137852783	-	RCV000009409;RCV000626294;RCV000030077;RCV000445407;RCV000246150	"Human Phenotype Ontology:HP:0005978,MedGen:C0011860,OMIM:125853,Orphanet:ORPHA181376,SNOMED CT:44054006;Human Phenotype Ontology:HP:0004904,MedGen:C0342276,OMIM:606391,Orphanet:ORPHA552,SNOMED CT:28453007;MedGen:C1833382,OMIM:606392;MedGen:C3888631;MedGen:CN169374"	"Diabetes mellitus type 2;Maturity onset diabetes mellitus in young;Maturity-onset diabetes of the young, type 4;Monogenic diabetes;not specified"	germline;inherited;unknown	germline	GRCh37	NC_000013.10	13	28494501	28494501	G	A	13q12.2	"criteria provided, conflicting interpretations"	6	NA	N	"OMIM Allelic Variant:600733.0002,UniProtKB (protein):P52945#VAR_009311"	3	8859	13	28494501	G	A	23898	13:28494501:G:A	Likely benign	2/5/18	"This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease."	not specified	CN169374:not specified	No Information	FALSE	No Information	"criteria provided, single submitter"	clinical testing	germline:na	GeneDx	SCV000518497.4	SCV000518497		PDX1	-	"MODY, MODY Extended, MonogenicDM_all"	2/5/18	42422	4541	98	"[0.998844938946773,0.0011550610532270991]"	98	SCV000518497181250	single nucleotide variant	NM_000527.4(LDLR):c.1171G>A (p.Ala391Thr)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	18-Aug-17	11669576	-	RCV000237576;RCV000162023;RCV000241875	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202;MedGen:CN169374"	Familial hypercholesterolemia;not provided;not specified	germline;not applicable;unknown	germline	GRCh37	NC_000019.9	19	11222300	11222300	G	A	19p13.2	"criteria provided, conflicting interpretations"	15	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_001369,UniProtKB (protein):P01130#VAR_024519"	2	183138	19	11222300	G	A	181250	19:11222300:G:A	Benign	1/5/17	"This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease."	not specified	CN169374:not specified	No Information	FALSE	No Information	"criteria provided, single submitter"	clinical testing	germline:na	GeneDx	SCV000520997.4	SCV000520997		LDLR	-	High LDL	8/18/17	46928	35	4469	"[0.9523845039209001,0.0476154960790999]"	3889	SCV000520997246066	single nucleotide variant	NM_000527.4(LDLR):c.1247G>A (p.Arg416Gln)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	13-Dec-16	773658037	-	RCV000237115;RCV000437123	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202"	Familial hypercholesterolemia;not provided	germline	germline	GRCh37	NC_000019.9	19	11224014	11224014	G	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	4	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000379,UniProtKB (protein):P01130#VAR_005380"	2	251752	19	11224014	G	A	246066	19:11224014:G:A	Pathogenic	12/13/16	"The R416Q variant in the LDLR gene has been reported previously in association with familial hypercholesterolemia (Thiart et al., 1998; Fouchier et al., 2001; Hollants et al., 2012; Huijgen et al., 2012). The R416Q variant was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The R416Q variant is a semi-conservative amino acid substitution, which may impact secondary protein structure as these residues differ in some properties. This substitution occurs at a position where amino acids with similar properties to Arginine are tolerated across species. In silico analysis predicts this variant is probably damaging to the protein structure/function. Missense variants in the same codon (R416W, R416P, R416L) have been reported in the Human Gene Mutation Database in association with familial hypercholesterolemia (Stenson et al., 2014), supporting the functional importance of this codon. We interpret R416Q as a pathogenic variant"	Not Provided	CN517202:not provided	familial hypercholesterolemia	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	GeneDx	SCV000520999.3	SCV000520999		LDLR	-	High LDL	12/13/16	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV00052099945125	single nucleotide variant	NM_000527.4(LDLR):c.2479G>A (p.Val827Ile)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	2-Nov-17	137853964	-	RCV000030135;RCV000148585;RCV000058923;RCV000436469	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202;MedGen:CN169374"	Familial hypercholesterolemia;Hypercholesterolaemia;not provided;not specified	germline;inherited;not applicable;unknown	germline	GRCh37	NC_000019.9	19	11240278	11240278	G	A	19p13.2	"criteria provided, conflicting interpretations"	16	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_001657,UniProtKB (protein):P01130#VAR_005418"	2	36462	19	11240278	G	A	45125	19:11240278:G:A	Uncertain significance	11/2/17	"The V827I variant of uncertain significance in the LDLR gene (also reported as FH-New York 5, and as V806I due to alternate nomenclature) has been published multiple times in association with FH; however, there are conflicting reports concerning its pathogenicity (Hobbs et al., 1992; Lombardi et al., 2000; Zakharova et al., 2005; TichÃ½ et al., 2012; Bertolini et al., 2013; Vandrovcova et al., 2013; Norsworthy et al., 2014; Durst et al., 2017). Hobbs et al. (1992) originally reported V827I in an American individual with homozygous FH, who also harbored a second variant in the LDLR gene. Lombardi et al. (2000) identified this variant in a cohort of individuals with FH from the Netherlands but did not provided detailed clinical information. The V827I variant was also identified in a 36-year-old Russian female with FH (LDL-C 321 mg/dl) (Zakharova et al., 2005). Vandrocova et al. (2013) identified V827I in a middle-aged proband with elevated total cholesterol (7.9 mmol/l), but also in the proband's adult daughter with normal cholesterol levels (4.6 mmol/l). More recently, V827I was found in 8 Israeli individuals (7 heterozygotes and 1 compound heterozygote) with a mean cholesterol level of 5.4 mmol/L (Durst et al., 2017). Study participants were also genotyped for 6 common LDL-C raising SNPs, and 6/8 V827I carriers had a 6-SNP score above the top quartile cutoff, suggesting that V827I alone is not sufficient to cause the full FH phenotype (Durst et al., 2017). Via whole exome sequencing, Do et al. (2015) identified V287I in 4 patients experiencing myocardial infarction (MI) at an early age, as well as in 5 control individuals with no history of MI. There are conflicting classifications of V827I in ClinVar by other clinical laboratories, ranging from benign to likely pathogenic (SCV000503493.1, SCV000556789.1, SCV000540872.1, SCV000052790.2, SCV000484685.1, SCV000583958.1; Landrum et al., 2016). The V827I variant is observed in approximately 169/10,152 alleles (1.6%) from individuals of Ashkenazi Jewish ancestry, indicating it may be a rare benign variant in this population. The V827I variant is a conservative amino acid substitution, which is not likely to impact secondary protein structure as these residues share similar properties. However, this substitution occurs at a position that is conserved across species, and in silico analysis predicts this variant is probably damaging to the protein structure/function."	not specified	CN169374:not specified	Familial hypercholesterolemia	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	GeneDx	SCV000521002.3	SCV000521002		LDLR	-	High LDL	11/2/17	46963	0	74	"[0.9992121457317462,7.878542682537317E-4]"	74	SCV00052100245493	single nucleotide variant	NM_000545.6(HNF1A):c.827C>G (p.Ala276Gly)	6927	HNF1A	HGNC:11621	Likely pathogenic	1	26-Oct-16	137853245	-	RCV000030513;RCV000441328	"MedGen:C1838100,OMIM:600496;MedGen:CN517202"	"Maturity-onset diabetes of the young, type 3;not provided"	germline	germline	GRCh37	NC_000012.11	12	121432080	121432080	C	G	12q24.31	"criteria provided, multiple submitters, no conflicts"	2	NA	N	-	2	36832	12	121432080	C	G	45493	12:121432080:C:G	Likely pathogenic	10/26/16	"The A276G variant has been published previously in association with MODY (BellannÃ©-Chantelot et al., 2008; Poitou et al., 2012). However, it has also been observed in an unaffected individual (Flannick et al., 2013). The variant was not observed at any significant frequency in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The variant is a conservative amino acid substitution, which is not likely to impact secondary protein structure as these residues share similar properties. This substitution occurs at a position that is conserved across species; however, in silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. Missense variants in the same residue (A276D) and in nearby residues (R271W/G/Q, R272S/C/H, K273N, K280E, L281P) have been reported in the Human Gene Mutation Database in association with diabetes and MODY (Stenson et al., 2014), supporting the functional importance of this region of the protein. Therefore, this variant is likely pathogenic; however, the possibility that it is benign cannot be excluded."	Not Provided	CN517202:not provided	MODY	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	GeneDx	SCV000521028.3	SCV000521028		HNF1A	-	"MODY, MODY Extended, MonogenicDM_all"	10/26/16	46946	17	1	"[0.9999893494653431,1.0650534656839773E-5]"	1	SCV00052102823901	single nucleotide variant	NM_000209.3(PDX1):c.52T>C (p.Cys18Arg)	3651	PDX1	HGNC:6107	Likely pathogenic	1	10-Oct-16	137852785	-	RCV000009412;RCV000439286	"Human Phenotype Ontology:HP:0005978,MedGen:C0011860,OMIM:125853,Orphanet:ORPHA181376,SNOMED CT:44054006;MedGen:CN517202"	Diabetes mellitus type 2;not provided	germline	germline	GRCh37	NC_000013.10	13	28494327	28494327	T	C	13q12.2	"criteria provided, single submitter"	2	NA	N	"OMIM Allelic Variant:600733.0005,UniProtKB (protein):P52945#VAR_009309"	3	8862	13	28494327	T	C	23901	13:28494327:T:C	Likely pathogenic	10/10/16	"The C18R variant in the PDX1 gene has been reported previously in association with diabetes (Macfarlane et al., 1999; Flannick et al., 2013); however, the variant has been observed in unaffected family members by Macfarlane et al., and in a control subject in another study (Macfarlane et al., 1999; Edghill et al., 2011). The variant was not observed at any significant frequency in approximately 5,600 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. G18R variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is conserved across species, and in silico analysis predicts this variant is probably damaging to the protein structure/function. Additionally, functional studies have shown that G18R results in a moderate reduction in insulin gene activation by the PDX1 protein (Macfarlane et al., 1999). Therefore, this variant is likely pathogenic."	Not Provided	CN517202:not provided	Type 2 diabetes	FALSE	Not trait of interest	"criteria provided, single submitter"	clinical testing	germline:na	GeneDx	SCV000521051.3	SCV000521051		PDX1	-	"MODY, MODY Extended, MonogenicDM_all"	10/10/16	41938	5025	3	"[0.9999642329152558,3.576708474414612E-5]"	3	SCV000521051371260	single nucleotide variant	NM_052968.4(APOA5):c.289C>T (p.Gln97Ter)	116519	APOA5	HGNC:17288	Pathogenic	1	1-Feb-17	201079485	-	RCV000428946	MedGen:CN517202	not provided	germline	germline	GRCh37	NC_000011.9	11	116661656	116661656	G	A	11q23.3	"criteria provided, single submitter"	1	NA	N	-	2	381733	11	116661656	G	A	371260	11:116661656:G:A	Pathogenic	2/1/17	"The Q97X variant in the APOA5 gene has been reported previously in association with hyperchylomicronemia and hypertriglyceridemia, when seen in the heterozygous and homozygous state with homozygous individuals having more severe disease (Priore Oliva et al., 2008; CharriÃ¨re et al., 2009; Dussaillant et al., 2012; Chokshi et al., 2014). Functional studies done with patient cells showed LPL activity level was reduced by about 50% in Q97X heterozygotes and more than 90% in the Q97X homozygote (CharriÃ¨re et al., 2009). This variant is predicted to cause loss of normal protein function through protein truncation. The Q97X variant was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. We interpret Q97X as a pathogenic variant."	Not Provided	CN517202:not provided	hyperchylomicronemia and hypertriglyceridemia	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	GeneDx	SCV000521319.3	SCV000521319		APOA5	-	High triglycerides	2/1/17	46943	20	7	"[0.9999254414928743,7.455850712566304E-5]"	7	SCV000521319380272	single nucleotide variant	NM_000162.3(GCK):c.128G>A (p.Arg43His)	2645	GCK	HGNC:4195	Likely pathogenic	1	21-Dec-17	764232985	-	RCV000445457;RCV000711763	MedGen:C3888631;MedGen:CN517202	Monogenic diabetes;not provided	germline	germline	GRCh37	NC_000007.13	7	44192980	44192980	C	T	7p13	"criteria provided, multiple submitters, no conflicts"	2	NA	N	-	2	393453	7	44192980	C	T	380272	7:44192980:C:T	Likely pathogenic	7/22/16	"The c.128G>A variant in codon 43 (exon 2) of the glucokinase gene, GCK, results in the substitution of Arginine to Histidine. This variant has been reported in the literature in patients with a clinical picture consistent with Maturity-Onset Diabetes of the Young, Type 2 (MODY2, also called GCK-MODY) (22611063, 22493702, 11942313), with evidence of co-segregation with diabetes in two separate families (22611063, 22493702). Different amino acid substitutions at this residue, Arg43Ser and Arg43Cys, have also been reported in patients with MODY2 (17573900, 19358091, 25015100). Functional studies suggest that the Arg43His and Arg43Cys substitutions result proteins with decreased stability compared to wild-type (22611063, 25015100). Additionally, multiple lines of computational evidence (SIFT, Polyphen, MutationTaster, LRT, FATHMM, SVM, LR, CADD, GERP) predict this variant is probably damaging to the protein structure, function, or protein-protein interaction. ACMG Criteria = PS3, PP1, PP3"	Monogenic diabetes	C3888631:Monogenic diabetes	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:2	"Translational Genomics Laboratory,University of Maryland School of Medicine"	SCV000537123.1	SCV000537123		GCK	-	"MODY, MODY Extended, MonogenicDM_all"	12/21/17	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV000537123172489	single nucleotide variant	NM_170707.3(LMNA):c.1634G>A (p.Arg545His)	4000	LMNA	HGNC:6636	Conflicting interpretations of pathogenicity	1	23-Apr-18	142191737	-	RCV000621850;RCV000468904;RCV000491650;RCV000449630;RCV000505801;RCV000150955	"MedGen:CN230736;MedGen:C0270914,Orphanet:ORPHA64746;MedGen:C1834481,OMIM:613426;Human Phenotype Ontology:HP:0009830,MedGen:C0031117,Orphanet:ORPHA98496;MedGen:CN517202;MedGen:CN169374"	"Cardiovascular phenotype;Charcot-Marie-Tooth disease, type 2;Dilated cardiomyopathy 1S;Peripheral neuropathy;not provided;not specified"	germline;maternal	germline	GRCh37	NC_000001.10	1	156107470	156107470	G	A	1q22	"criteria provided, conflicting interpretations"	7	"ACMG2013,ACMG2016"	N	-	2	163878	1	156107470	G	A	172489	1:156107470:G:A	Uncertain significance	8/22/16	-	MedGen:C0031117	C0031117:Peripheral neuropathy	NA	FALSE	Incorrect phenotype	"criteria provided, single submitter"	clinical testing	maternal:na	Claritas Genomics	SCV000537830.1	SCV000537830		LMNA	-	"Lipodystrophy, MonogenicDM_all"	4/23/18	44851	2112	4	"[0.9999554079061782,4.45920938217654E-5]"	4	SCV000537830171207	single nucleotide variant	NM_000527.4(LDLR):c.970G>A (p.Gly324Ser)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	5-Oct-17	72658860	-	RCV000237236;RCV000148566;RCV000162021;RCV000455308	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202;MedGen:CN169374"	Familial hypercholesterolemia;Hypercholesterolaemia;not provided;not specified	germline;not applicable	germline	GRCh37	NC_000019.9	19	11221357	11221357	G	A	19p13.2	"criteria provided, conflicting interpretations"	11	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000640	2	161263	19	11221357	G	A	171207	19:11221357:G:A	Likely benign	1/24/17	"Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: This variant is present in ExAC with a MaxMAF of 1.3% in African chromosomes - disease prevalence is 1/200-1/300, occurs at greater freq than expected for disorder. It is classified in ClinVar with 1 star as both Likely pathogenic and Likely benign. It has been reported in 6 publications in HGMD but most suggest that it is not pathogenic."	not specified	CN169374:not specified	No Information	FALSE	No Information	"criteria provided, single submitter"	clinical testing	germline:na	"Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine"	SCV000539505.1	SCV000539505		LDLR	-	High LDL	10/5/17	46961	2	186	"[0.9980196333127489,0.001980366687251123]"	186	SCV000539505226402	single nucleotide variant	NM_000527.4(LDLR):c.1836C>T (p.Ala612=)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	27-Jun-17	143872778	-	RCV000210239;RCV000586569;RCV000456101	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202;MedGen:CN169374"	Familial hypercholesterolemia;not provided;not specified	germline	germline	GRCh37	NC_000019.9	19	11227665	11227665	C	T	19p13.2	"criteria provided, conflicting interpretations"	9	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000249	2	224618	19	11227665	C	T	226402	19:11227665:C:T	Uncertain significance	1/24/17	Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: This is a silent variant in LDLR. It is classified as DM in HGMD. This variant has been reported in 7 patients with familial hypercholesterolemia in one study (Widhalm 2007). This variant is classified in ClinVar with 1 star as VUS by Mayo Clinic and as Likely Benign by British Heart Foundation. The variant has a Max MAF of 0.03% in ExAC (23 alleles) and 0.03% in gnomAD (43 alleles).	not specified	CN169374:not specified	familial hypercholesterolemia	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	"Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine"	SCV000539509.1	SCV000539509		LDLR	-	High LDL	6/27/17	46963	0	10	"[0.9998935332069927,1.0646679300726103E-4]"	10	SCV000539509181269	single nucleotide variant	NM_000527.4(LDLR):c.1876G>A (p.Glu626Lys)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	27-Sep-17	139791325	-	RCV000211563;RCV000162004;RCV000454999	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202;MedGen:CN169374"	Familial hypercholesterolemia;not provided;not specified	germline;not applicable;unknown	germline	GRCh37	NC_000019.9	19	11230798	11230798	G	A	19p13.2	"criteria provided, conflicting interpretations"	9	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000258	2	183127	19	11230798	G	A	181269	19:11230798:G:A	Uncertain significance	2/3/17	"Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: This variant is present in HGMD in 3 papers but in cases and controls. It is classified in ClinVar with 1 star as Likely benign by British Heart Foundation, VUS by CHOP and Instituto Nacional de Saude Doutor Ricardo Jorge and Pathogenic by PathWest Laboratory Medicine WA - Fiona Stanley Hospital (in 2011). It has a max MAF in ExAC of 0.08% (56 alleles) and in gnomAD of 0.06% (75 alleles)."	not specified	CN169374:not specified	No Information	FALSE	No Information	"criteria provided, single submitter"	clinical testing	germline:na	"Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine"	SCV000539513.1	SCV000539513		LDLR	-	High LDL	9/27/17	46963	0	19	"[0.9997977130932862,2.0228690671379596E-4]"	19	SCV00053951378990	single nucleotide variant	NM_000527.4(LDLR):c.148G>T (p.Ala50Ser)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	30-Nov-17	137853960	-	RCV000210234;RCV000148578;RCV000058916;RCV000455660	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202;MedGen:CN169374"	Familial hypercholesterolemia;Hypercholesterolaemia;not provided;not specified	germline;unknown	germline	GRCh37	NC_000019.9	19	11210979	11210979	G	T	19p13.2	"criteria provided, conflicting interpretations"	13	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000021,UniProtKB (protein):P01130#VAR_007979"	2	68099	19	11210979	G	T	78990	19:11210979:G:T	Uncertain significance	3/31/16	Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: 5 papers describe as VUS/nonpathogenic; ExAC: 0.1% (67/66532) European; ClinVar: 1 VUS	not specified	CN169374:not specified	No Information	FALSE	No Information	"criteria provided, single submitter"	clinical testing	germline:na	"Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine"	SCV000539514.1	SCV000539514		LDLR	-	High LDL	11/30/17	46963	0	43	"[0.9995421927900687,4.5780720993122243E-4]"	43	SCV000539514389422	single nucleotide variant	NM_174936.3(PCSK9):c.1394C>T (p.Ser465Leu)	255738	PCSK9	HGNC:20001	Conflicting interpretations of pathogenicity	1	5-Dec-17	778849441	-	RCV000508822;RCV000460891;RCV000454751	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C1863551,OMIM:603776;MedGen:CN169374"	"Familial hypercholesterolemia;Hypercholesterolemia, autosomal dominant, 3;not specified"	germline	germline	GRCh37	NC_000001.10	1	55524211	55524211	C	T	1p32.3	"criteria provided, conflicting interpretations"	3	"ACMG2013,ACMG2016"	N	-	2	403292	1	55524211	C	T	389422	1:55524211:C:T	Uncertain significance	1/31/17	"Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: 2 papers, not sig diff LDLR"	not specified	CN169374:not specified	No Information	FALSE	No Information	"criteria provided, single submitter"	clinical testing	germline:na	"Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine"	SCV000540002.1	SCV000540002		PCSK9	-	Low LDL	12/5/17	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV00054000245074	single nucleotide variant	NM_000209.3(PDX1):c.725C>T (p.Pro242Leu)	3651	PDX1	HGNC:6107	Conflicting interpretations of pathogenicity	1	28-Mar-16	193922358	-	RCV000030083;RCV000455258	"MedGen:C1833382,OMIM:606392;MedGen:CN169374"	"Maturity-onset diabetes of the young, type 4;not specified"	germline	germline	GRCh37	NC_000013.10	13	28498711	28498711	C	T	13q12.2	"criteria provided, conflicting interpretations"	2	NA	N	-	2	36411	13	28498711	C	T	45074	13:28498711:C:T	Uncertain significance	3/28/16	Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: LP by Labcorp (2011). Low reads. Could not find any publications.	not specified	CN169374:not specified	NA	NA	NA	"criteria provided, single submitter"	clinical testing	germline:na	"Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine"	SCV000540009.1	SCV000540009		PDX1	-	"MODY, MODY Extended, MonogenicDM_all"	3/28/16	41198	5765	24	"[0.9997087237244526,2.9127627554735667E-4]"	24	SCV000540009228117	single nucleotide variant	NM_000527.4(LDLR):c.81C>G (p.Cys27Trp)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	30-Mar-17	2228671	-	RCV000211569;RCV000588365	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445"	Familial hypercholesterolemia;Familial hypercholesterolemias	germline;unknown	germline	GRCh37	NC_000019.9	19	11210912	11210912	C	G	19p13.2	"criteria provided, conflicting interpretations"	10	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000352,UniProtKB (protein):P01130#VAR_005304"	2	226304	19	11210912	C	G	228117	19:11210912:C:G	Likely pathogenic	11/5/16	Disrupt disulfide bridge between Cys27 and Cys39.	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	unknown:2	"Molecular Genetics Laboratory,Centre for Cardiovascular Surgery and Transplantation"	SCV000540716.1	SCV000540716		LDLR	-	High LDL	3/30/17	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV00054071618780	single nucleotide variant	NM_000527.4(LDLR):c.131G>A (p.Trp44Ter)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	14-Nov-17	267607213	-	RCV000003939	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline;inherited	germline	GRCh37	NC_000019.9	19	11210962	11210962	G	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	13	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000019,OMIM Allelic Variant:606945.0060"	3	3741	19	11210962	G	A	18780	19:11210962:G:A	Pathogenic	11/5/16	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	inherited:41	"Molecular Genetics Laboratory,Centre for Cardiovascular Surgery and Transplantation"	SCV000540718.1	SCV000540718		LDLR	-	High LDL	11/14/17	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV00054071818724	single nucleotide variant	NM_000527.4(LDLR):c.259T>G (p.Trp87Gly)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	8-Jun-18	121908025	-	RCV000003870;RCV000622852	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202"	Familial hypercholesterolemia;not provided	germline;inherited	germline	GRCh37	NC_000019.9	19	11213408	11213408	T	G	19p13.2	"criteria provided, multiple submitters, no conflicts"	11	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_001671,OMIM Allelic Variant:606945.0003,UniProtKB (protein):P01130#VAR_005308"	3	3685	19	11213408	T	G	18724	19:11213408:T:G	Likely pathogenic	11/5/16	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	inherited:1	"Molecular Genetics Laboratory,Centre for Cardiovascular Surgery and Transplantation"	SCV000540721.1	SCV000540721		LDLR	-	High LDL	6/8/18	46963	0	3	"[0.9999680599620978,3.194003790217831E-5]"	3	SCV000540721245493	single nucleotide variant	NM_000527.4(LDLR):c.325T>C (p.Cys109Arg)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	30-Mar-17	140807148	-	RCV000237408	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline;inherited	germline	GRCh37	NC_000019.9	19	11215907	11215907	T	C	19p13.2	"criteria provided, multiple submitters, no conflicts"	5	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_001701,UniProtKB (protein):P01130#VAR_005316"	2	251156	19	11215907	T	C	245493	19:11215907:T:C	Likely pathogenic	11/5/16	Disrupt disulfide bridge between Cys109 and Cys121.	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	inherited:14	"Molecular Genetics Laboratory,Centre for Cardiovascular Surgery and Transplantation"	SCV000540726.1	SCV000540726		LDLR	-	High LDL	3/30/17	46961	2	4	"[0.9999574114690913,4.2588530908626306E-5]"	4	SCV000540726181228	single nucleotide variant	NM_000527.4(LDLR):c.502G>A (p.Asp168Asn)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	28-Jun-18	200727689	-	RCV000211669;RCV000162017	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202"	Familial hypercholesterolemia;not provided	germline;not applicable;unknown	germline	GRCh37	NC_000019.9	19	11216084	11216084	G	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	7	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_001749,UniProtKB (protein):P01130#VAR_005322"	2	183136	19	11216084	G	A	181228	19:11216084:G:A	Likely pathogenic	11/5/16	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	unknown:2	"Molecular Genetics Laboratory,Centre for Cardiovascular Surgery and Transplantation"	SCV000540737.1	SCV000540737		LDLR	-	High LDL	6/28/18	46963	0	2	"[0.9999787066413985,2.1293358601452207E-5]"	2	SCV000540737228142	deletion	NM_000527.4(LDLR):c.654_656delTGG (p.Gly219del)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	25-Jun-18	121908027	-	RCV000211647;RCV000589051;RCV000489033	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:CN517202"	Familial hypercholesterolemia;Familial hypercholesterolemias;not provided	germline;inherited;not applicable	germline	GRCh37	NC_000019.9	19	11216236	11216238	TGG	-	19p13.2	"criteria provided, multiple submitters, no conflicts"	14	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000094,OMIM Allelic Variant:606945.0005"	3	226329	19	11216232	ATGG	A	228142	19:11216232:ATGG:A	Likely pathogenic	11/5/16	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	inherited:20	"Molecular Genetics Laboratory,Centre for Cardiovascular Surgery and Transplantation"	SCV000540747.1	SCV000540747		LDLR	-	High LDL	6/25/18	46962	1	1	"[0.9999893530939908,1.0646906009113752E-5]"	1	SCV000540747181233	single nucleotide variant	NM_000527.4(LDLR):c.662A>G (p.Asp221Gly)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	3-Apr-17	373822756	-	RCV000211655;RCV000161962	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202"	Familial hypercholesterolemia;not provided	germline;inherited;not applicable	germline	GRCh37	NC_000019.9	19	11216244	11216244	A	G	19p13.2	"criteria provided, multiple submitters, no conflicts"	14	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000096,UniProtKB (protein):P01130#VAR_005332"	2	183092	19	11216244	A	G	181233	19:11216244:A:G	Likely pathogenic	11/5/16	Asp221 bind structural Ca2+.	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	inherited:45	"Molecular Genetics Laboratory,Centre for Cardiovascular Surgery and Transplantation"	SCV000540749.1	SCV000540749		LDLR	-	High LDL	4/3/17	46959	4	1	"[0.9999893524138078,1.0647586192210225E-5]"	1	SCV000540749245730	single nucleotide variant	NM_000527.4(LDLR):c.682G>C (p.Glu228Gln)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	15-Aug-17	121908029	-	RCV000237530	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline;unknown	germline	GRCh37	NC_000019.9	19	11216264	11216264	G	C	19p13.2	"criteria provided, multiple submitters, no conflicts"	6	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_001817,UniProtKB (protein):P01130#VAR_005340"	2	251393	19	11216264	G	C	245730	19:11216264:G:C	Likely pathogenic	11/5/16	Disrupt SDE motif. SDE bind structural Ca2+.	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	unknown:2	"Molecular Genetics Laboratory,Centre for Cardiovascular Surgery and Transplantation"	SCV000540753.1	SCV000540753		LDLR	-	High LDL	8/15/17	46944	19	4	"[0.9999573960463531,4.2603953646898434E-5]"	4	SCV00054075318730	single nucleotide variant	NM_000527.4(LDLR):c.682G>A (p.Glu228Lys)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	31-Oct-18	121908029	-	RCV000735406;RCV000735406;RCV000735406;RCV000003878;RCV000735406;RCV000735406;RCV000623885	"Human Phenotype Ontology:HP:0002647,MedGen:C0340643;Human Phenotype Ontology:HP:0012158,MedGen:C0338585;Human Phenotype Ontology:HP:0012474,MedGen:C0265101;MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;Human Phenotype Ontology:HP:0012159,MedGen:C0751815;Human Phenotype Ontology:HP:0001297,MedGen:C0038454;MedGen:CN517202"	Aortic dissection;Carotid artery dissection;Carotid artery occlusion;Familial hypercholesterolemia;Internal carotid artery dissection;Stroke;not provided	germline;unknown	germline	GRCh37	NC_000019.9	19	11216264	11216264	G	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	19	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000105,OMIM Allelic Variant:606945.0007,UniProtKB (protein):P01130#VAR_005341"	3	3691	19	11216264	G	A	18730	19:11216264:G:A	Likely pathogenic	11/5/16	Disrupt SDE motif. SDE bind structural Ca2+.	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	unknown:2	"Molecular Genetics Laboratory,Centre for Cardiovascular Surgery and Transplantation"	SCV000540754.1	SCV000540754		LDLR	-	High LDL	10/31/18	46944	19	2	"[0.9999786980231765,2.1301976823449217E-5]"	2	SCV000540754245736	single nucleotide variant	NM_000527.4(LDLR):c.691T>G (p.Cys231Gly)	3949	LDLR	HGNC:6547	Likely pathogenic	1	5-Nov-16	746091400	-	RCV000237108	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline;unknown	germline	GRCh37	NC_000019.9	19	11216273	11216273	T	G	19p13.2	"criteria provided, multiple submitters, no conflicts"	4	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000405,UniProtKB (protein):P01130#VAR_005342"	2	251397	19	11216273	T	G	245736	19:11216273:T:G	Likely pathogenic	11/5/16	Disrupt disulfide bridge between Cys216 and Cys231.	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	unknown:2	"Molecular Genetics Laboratory,Centre for Cardiovascular Surgery and Transplantation"	SCV000540755.1	SCV000540755		LDLR	-	High LDL	11/5/16	46839	124	1	"[0.999989325135037,1.0674864962958219E-5]"	1	SCV000540755228147	single nucleotide variant	NM_000527.4(LDLR):c.796G>A (p.Asp266Asn)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	19-Sep-17	875989907	-	RCV000211615	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline;inherited	germline	GRCh37	NC_000019.9	19	11217342	11217342	G	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	8	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000469	2	226334	19	11217342	G	A	228147	19:11217342:G:A	Likely pathogenic	11/5/16	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	inherited:10	"Molecular Genetics Laboratory,Centre for Cardiovascular Surgery and Transplantation"	SCV000540758.1	SCV000540758		LDLR	-	High LDL	9/19/17	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV000540758171201	single nucleotide variant	NM_000527.4(LDLR):c.798T>A (p.Asp266Glu)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	17-May-18	139043155	-	RCV000172959;RCV000148594;RCV000162020	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202"	Familial hypercholesterolemia;Hypercholesterolaemia;not provided	germline;inherited;not applicable;unknown	germline	GRCh37	NC_000019.9	19	11217344	11217344	T	A	19p13.2	"criteria provided, conflicting interpretations"	16	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000117,UniProtKB (protein):P01130#VAR_005347"	2	161287	19	11217344	T	A	171201	19:11217344:T:A	Likely pathogenic	11/5/16	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	inherited:382	"Molecular Genetics Laboratory,Centre for Cardiovascular Surgery and Transplantation"	SCV000540759.1	SCV000540759		LDLR	-	High LDL	5/17/18	46963	0	2	"[0.9999787066413985,2.1293358601452207E-5]"	2	SCV00054075918731	single nucleotide variant	NM_000527.4(LDLR):c.910G>A (p.Asp304Asn)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	10-Apr-18	121908030	-	RCV000003880;RCV000148569;RCV000622705	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MeSH:D030342,MedGen:C0950123"	Familial hypercholesterolemia;Hypercholesterolaemia;Inborn genetic diseases	germline;inherited;not applicable	germline	GRCh37	NC_000019.9	19	11218160	11218160	G	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	10	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_001861,OMIM Allelic Variant:606945.0008,UniProtKB (protein):P01130#VAR_005355"	3	3692	19	11218160	G	A	18731	19:11218160:G:A	Likely pathogenic	11/5/16	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	inherited:8	"Molecular Genetics Laboratory,Centre for Cardiovascular Surgery and Transplantation"	SCV000540769.1	SCV000540769		LDLR	-	High LDL	4/10/18	46963	0	3	"[0.9999680599620978,3.194003790217831E-5]"	3	SCV000540769228154	single nucleotide variant	NM_000527.4(LDLR):c.986G>A (p.Cys329Tyr)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	16-Dec-16	761954844	-	RCV000211666	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline;not applicable;unknown	germline	GRCh37	NC_000019.9	19	11221373	11221373	G	A	19p13.2	"criteria provided, conflicting interpretations"	7	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000150,UniProtKB (protein):P01130#VAR_005362"	2	226344	19	11221373	G	A	228154	19:11221373:G:A	Likely pathogenic	11/5/16	Disrupt disulfide bridge between Cys318 and Cys329.	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	unknown:2	"Molecular Genetics Laboratory,Centre for Cardiovascular Surgery and Transplantation"	SCV000540780.1	SCV000540780		LDLR	-	High LDL	12/16/16	46963	0	4	"[0.9999574132827971,4.2586717202904415E-5]"	4	SCV000540780228156	single nucleotide variant	NM_000527.4(LDLR):c.1048C>T (p.Arg350Ter)	3949	LDLR	HGNC:6547	Pathogenic	1	8-May-18	769737896	-	RCV000211692;RCV000520229	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202"	Familial hypercholesterolemia;not provided	germline;inherited	germline	GRCh37	NC_000019.9	19	11221435	11221435	C	T	19p13.2	"criteria provided, multiple submitters, no conflicts"	11	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000147	2	226342	19	11221435	C	T	228156	19:11221435:C:T	Pathogenic	11/5/16	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	inherited:10	"Molecular Genetics Laboratory,Centre for Cardiovascular Surgery and Transplantation"	SCV000540784.1	SCV000540784		LDLR	-	High LDL	5/8/18	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV00054078445113	single nucleotide variant	NM_000527.4(LDLR):c.1055G>A (p.Cys352Tyr)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	31-Oct-18	193922566	-	RCV000030122;RCV000722113;RCV000413322	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:CN517202"	Familial hypercholesterolemia;Familial hypercholesterolemias;not provided	germline;unknown	germline	GRCh37	NC_000019.9	19	11221442	11221442	G	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	9	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_001339,UniProtKB (protein):P01130#VAR_005369"	2	36450	19	11221442	G	A	45113	19:11221442:G:A	Likely pathogenic	11/5/16	Disrupt disulfide bridge between Cys340 and Cys352.	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	unknown:2	"Molecular Genetics Laboratory,Centre for Cardiovascular Surgery and Transplantation"	SCV000540786.1	SCV000540786		LDLR	-	High LDL	10/31/18	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV00054078645116	single nucleotide variant	NM_000527.4(LDLR):c.1222G>A (p.Glu408Lys)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	23-Jan-18	137943601	-	RCV000030125;RCV000148564	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443"	Familial hypercholesterolemia;Hypercholesterolaemia	germline;unknown	germline	GRCh37	NC_000019.9	19	11223989	11223989	G	A	19p13.2	"criteria provided, conflicting interpretations"	12	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_001379,UniProtKB (protein):P01130#VAR_005378"	2	36453	19	11223989	G	A	45116	19:11223989:G:A	Likely pathogenic	11/5/16	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	unknown:2	"Molecular Genetics Laboratory,Centre for Cardiovascular Surgery and Transplantation"	SCV000540803.1	SCV000540803		LDLR	-	High LDL	1/23/18	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV00054080318733	single nucleotide variant	NM_000527.4(LDLR):c.1285G>A (p.Val429Met)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	31-Oct-18	28942078	-	RCV000003882	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline;inherited;unknown	germline	GRCh37	NC_000019.9	19	11224052	11224052	G	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	14	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_001387,OMIM Allelic Variant:606945.0009,UniProtKB (protein):P01130#VAR_005383"	3	3694	19	11224052	G	A	18733	19:11224052:G:A	Likely pathogenic	11/5/16	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	inherited:3	"Molecular Genetics Laboratory,Centre for Cardiovascular Surgery and Transplantation"	SCV000540808.1	SCV000540808		LDLR	-	High LDL	10/31/18	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV00054080818734	single nucleotide variant	NM_000527.4(LDLR):c.1291G>A (p.Ala431Thr)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	30-Mar-17	28942079	-	RCV000003883	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline;unknown	germline	GRCh37	NC_000019.9	19	11224058	11224058	G	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	13	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000184,OMIM Allelic Variant:606945.0010,UniProtKB (protein):P01130#VAR_005384"	3	3695	19	11224058	G	A	18734	19:11224058:G:A	Likely pathogenic	11/5/16	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	unknown:6	"Molecular Genetics Laboratory,Centre for Cardiovascular Surgery and Transplantation"	SCV000540810.1	SCV000540810		LDLR	-	High LDL	3/30/17	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV000540810246200	single nucleotide variant	NM_000527.4(LDLR):c.1529C>T (p.Thr510Met)	3949	LDLR	HGNC:6547	Likely pathogenic	1	5-Nov-16	755154048	-	RCV000237591	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline;unknown	germline	GRCh37	NC_000019.9	19	11224381	11224381	C	T	19p13.2	"criteria provided, multiple submitters, no conflicts"	2	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000900	2	251886	19	11224381	C	T	246200	19:11224381:C:T	Likely pathogenic	11/5/16	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	unknown:2	"Molecular Genetics Laboratory,Centre for Cardiovascular Surgery and Transplantation"	SCV000540811.1	SCV000540811		LDLR	-	High LDL	11/5/16	46963	0	2	"[0.9999787066413985,2.1293358601452207E-5]"	2	SCV000540811171213	single nucleotide variant	NM_000527.4(LDLR):c.1432G>A (p.Gly478Arg)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	26-Apr-18	144614838	-	RCV000211688;RCV000148583	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443"	Familial hypercholesterolemia;Hypercholesterolaemia	germline;unknown	germline	GRCh37	NC_000019.9	19	11224284	11224284	G	A	19p13.2	"criteria provided, conflicting interpretations"	13	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000198,UniProtKB (protein):P01130#VAR_005390"	2	161277	19	11224284	G	A	171213	19:11224284:G:A	Likely pathogenic	11/5/16	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	unknown:2	"Molecular Genetics Laboratory,Centre for Cardiovascular Surgery and Transplantation"	SCV000540818.1	SCV000540818		LDLR	-	High LDL	4/26/18	46961	2	3	"[0.9999680586018185,3.194139818146973E-5]"	3	SCV000540818171214	single nucleotide variant	NM_000527.4(LDLR):c.1444G>A (p.Asp482Asn)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	11-May-17	139624145	-	RCV000172963;RCV000148591;RCV000414235	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202"	Familial hypercholesterolemia;Hypercholesterolaemia;not provided	germline;inherited	germline	GRCh37	NC_000019.9	19	11224296	11224296	G	A	19p13.2	"criteria provided, conflicting interpretations"	13	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_001428	2	161284	19	11224296	G	A	171214	19:11224296:G:A	Likely pathogenic	11/5/16	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	inherited:10	"Molecular Genetics Laboratory,Centre for Cardiovascular Surgery and Transplantation"	SCV000540819.1	SCV000540819		LDLR	-	High LDL	5/11/17	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV000540819171216	single nucleotide variant	NM_000527.4(LDLR):c.1474G>A (p.Asp492Asn)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	2-Jan-18	373646964	-	RCV000237459;RCV000590270;RCV000148592;RCV000161989	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:C0020443;MedGen:CN517202"	Familial hypercholesterolemia;Familial hypercholesterolemias;Hypercholesterolaemia;not provided	germline;inherited;not applicable	germline	GRCh37	NC_000019.9	19	11224326	11224326	G	A	19p13.2	"criteria provided, conflicting interpretations"	13	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000205,UniProtKB (protein):P01130#VAR_072850"	2	161285	19	11224326	G	A	171216	19:11224326:G:A	Likely pathogenic	11/5/16	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	inherited:43	"Molecular Genetics Laboratory,Centre for Cardiovascular Surgery and Transplantation"	SCV000540820.1	SCV000540820		LDLR	-	High LDL	1/2/18	46963	0	5	"[0.9999467666034964,5.323339650363052E-5]"	3	SCV000540820243275	single nucleotide variant	NM_000527.4(LDLR):c.1721G>T (p.Arg574Leu)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	5-Nov-16	777188764	-	RCV000228158	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline;inherited	germline	GRCh37	NC_000019.9	19	11227550	11227550	G	T	19p13.2	"criteria provided, conflicting interpretations"	3	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_001502	2	237867	19	11227550	G	T	243275	19:11227550:G:T	Likely pathogenic	11/5/16	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	inherited:8	"Molecular Genetics Laboratory,Centre for Cardiovascular Surgery and Transplantation"	SCV000540833.1	SCV000540833		LDLR	-	High LDL	11/5/16	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV000540833171217	single nucleotide variant	NM_000527.4(LDLR):c.1775G>A (p.Gly592Glu)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	31-Oct-18	137929307	-	RCV000172964;RCV000587007;RCV000148576;RCV000162001	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:C0020443;MedGen:CN517202"	Familial hypercholesterolemia;Familial hypercholesterolemias;Hypercholesterolaemia;not provided	germline;inherited;not applicable;unknown	germline	GRCh37	NC_000019.9	19	11227604	11227604	G	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	22	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000237,UniProtKB (protein):P01130#VAR_005403"	2	161271	19	11227604	G	A	171217	19:11227604:G:A	Likely pathogenic	11/5/16	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	inherited:443	"Molecular Genetics Laboratory,Centre for Cardiovascular Surgery and Transplantation"	SCV000540837.1	SCV000540837		LDLR	-	High LDL	10/31/18	46963	0	3	"[0.9999680599620978,3.194003790217831E-5]"	3	SCV000540837181268	single nucleotide variant	NM_000527.4(LDLR):c.1784G>A (p.Arg595Gln)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	11-Apr-18	201102492	-	RCV000211609;RCV000162002	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202"	Familial hypercholesterolemia;not provided	germline;not applicable;unknown	germline	GRCh37	NC_000019.9	19	11227613	11227613	G	A	19p13.2	"criteria provided, conflicting interpretations"	8	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000563	2	183126	19	11227613	G	A	181268	19:11227613:G:A	Likely pathogenic	11/5/16	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	unknown:2	"Molecular Genetics Laboratory,Centre for Cardiovascular Surgery and Transplantation"	SCV000540838.1	SCV000540838		LDLR	-	High LDL	4/11/18	46963	0	5	"[0.9999467666034964,5.323339650363052E-5]"	5	SCV000540838246513	single nucleotide variant	NM_000527.4(LDLR):c.2096C>T (p.Pro699Leu)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	9-Oct-17	201573863	-	RCV000237906;RCV000589820	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445"	Familial hypercholesterolemia;Familial hypercholesterolemias	germline;unknown	germline	GRCh37	NC_000019.9	19	11231154	11231154	C	T	19p13.2	"criteria provided, conflicting interpretations"	10	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_001600,UniProtKB (protein):P01130#VAR_013955"	2	252219	19	11231154	C	T	246513	19:11231154:C:T	Likely pathogenic	11/5/16	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	unknown:2	"Molecular Genetics Laboratory,Centre for Cardiovascular Surgery and Transplantation"	SCV000540843.1	SCV000540843		LDLR	-	High LDL	10/9/17	46962	1	6	"[0.9999361185639453,6.388143605468251E-5]"	6	SCV000540843246458	single nucleotide variant	NM_000527.4(LDLR):c.1999T>C (p.Cys667Arg)	3949	LDLR	HGNC:6547	Likely pathogenic	1	16-Dec-16	150021927	-	RCV000238269	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline;unknown	germline	GRCh37	NC_000019.9	19	11231057	11231057	T	C	19p13.2	"criteria provided, multiple submitters, no conflicts"	7	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000576	2	252163	19	11231057	T	C	246458	19:11231057:T:C	Likely pathogenic	11/5/16	Disrupt disulfide bridge between Cys667 and Cys681.	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	unknown:2	"Molecular Genetics Laboratory,Centre for Cardiovascular Surgery and Transplantation"	SCV000540851.1	SCV000540851		LDLR	-	High LDL	12/16/16	46963	0	5	"[0.9999467666034964,5.323339650363052E-5]"	5	SCV00054085118738	single nucleotide variant	NM_000527.4(LDLR):c.2043C>A (p.Cys681Ter)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	31-Oct-18	121908031	-	RCV000003887;RCV000590806;RCV000481771	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:CN517202"	Familial hypercholesterolemia;Familial hypercholesterolemias;not provided	germline;unknown	germline	GRCh37	NC_000019.9	19	11231101	11231101	C	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	18	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_001592,OMIM Allelic Variant:606945.0016"	3	3699	19	11231101	C	A	18738	19:11231101:C:A	Pathogenic	11/5/16	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	unknown:2	"Molecular Genetics Laboratory,Centre for Cardiovascular Surgery and Transplantation"	SCV000540853.1	SCV000540853		LDLR	-	High LDL	10/31/18	46958	5	1	"[0.9999893521870608,1.0647812939222283E-5]"	1	SCV00054085318741	single nucleotide variant	NM_000527.4(LDLR):c.2054C>T (p.Pro685Leu)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	31-Oct-18	28942084	-	RCV000003891;RCV000162007	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202"	Familial hypercholesterolemia;not provided	germline;inherited;not applicable;unknown	germline	GRCh37	NC_000019.9	19	11231112	11231112	C	T	19p13.2	"criteria provided, multiple submitters, no conflicts"	16	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000276,OMIM Allelic Variant:606945.0017,UniProtKB (protein):P01130#VAR_005410"	3	3702	19	11231112	C	T	18741	19:11231112:C:T	Likely pathogenic	11/5/16	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	inherited:9	"Molecular Genetics Laboratory,Centre for Cardiovascular Surgery and Transplantation"	SCV000540854.1	SCV000540854		LDLR	-	High LDL	10/31/18	46963	0	3	"[0.9999680599620978,3.194003790217831E-5]"	3	SCV000540854181272	single nucleotide variant	NM_000527.4(LDLR):c.2101G>A (p.Gly701Ser)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	7-Jun-17	368838866	-	RCV000238415;RCV000162008	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202"	Familial hypercholesterolemia;not provided	germline;inherited;not applicable	germline	GRCh37	NC_000019.9	19	11231159	11231159	G	A	19p13.2	"criteria provided, conflicting interpretations"	7	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_001078	2	183130	19	11231159	G	A	181272	19:11231159:G:A	Likely pathogenic	11/5/16	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	inherited:4	"Molecular Genetics Laboratory,Centre for Cardiovascular Surgery and Transplantation"	SCV000540860.1	SCV000540860		LDLR	-	High LDL	6/7/17	46963	0	15	"[0.9998402998104892,1.5970018951089155E-4]"	15	SCV00054086045125	single nucleotide variant	NM_000527.4(LDLR):c.2479G>A (p.Val827Ile)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	2-Nov-17	137853964	-	RCV000030135;RCV000148585;RCV000058923;RCV000436469	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202;MedGen:CN169374"	Familial hypercholesterolemia;Hypercholesterolaemia;not provided;not specified	germline;inherited;not applicable;unknown	germline	GRCh37	NC_000019.9	19	11240278	11240278	G	A	19p13.2	"criteria provided, conflicting interpretations"	16	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_001657,UniProtKB (protein):P01130#VAR_005418"	2	36462	19	11240278	G	A	45125	19:11240278:G:A	Uncertain significance	11/5/16	Probably not pathogenic - position 827 in NPXY signal is variable - PMID: 1968060	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	inherited:11	"Molecular Genetics Laboratory,Centre for Cardiovascular Surgery and Transplantation"	SCV000540872.1	SCV000540872		LDLR	-	High LDL	11/2/17	46963	0	74	"[0.9992121457317462,7.878542682537317E-4]"	74	SCV000540872171212	single nucleotide variant	NM_000527.4(LDLR):c.1238C>T (p.Thr413Met)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	23-Oct-17	368562025	-	RCV000211581;RCV000148582;RCV000519267	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202"	Familial hypercholesterolemia;Hypercholesterolaemia;not provided	germline;unknown	germline	GRCh37	NC_000019.9	19	11224005	11224005	C	T	19p13.2	"criteria provided, conflicting interpretations"	9	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000967	2	161276	19	11224005	C	T	171212	19:11224005:C:T	Likely pathogenic	1/3/17	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	unknown:2	"Molecular Genetics Laboratory,Centre for Cardiovascular Surgery and Transplantation"	SCV000540894.1	SCV000540894		LDLR	-	High LDL	10/23/17	46963	0	3	"[0.9999680599620978,3.194003790217831E-5]"	3	SCV00054089478990	single nucleotide variant	NM_000527.4(LDLR):c.148G>T (p.Ala50Ser)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	30-Nov-17	137853960	-	RCV000210234;RCV000148578;RCV000058916;RCV000455660	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202;MedGen:CN169374"	Familial hypercholesterolemia;Hypercholesterolaemia;not provided;not specified	germline;unknown	germline	GRCh37	NC_000019.9	19	11210979	11210979	G	T	19p13.2	"criteria provided, conflicting interpretations"	13	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000021,UniProtKB (protein):P01130#VAR_007979"	2	68099	19	11210979	G	T	78990	19:11210979:G:T	Benign	3/16/17	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	unknown:20	"Molecular Genetics Laboratory,Centre for Cardiovascular Surgery and Transplantation"	SCV000540896.1	SCV000540896		LDLR	-	High LDL	11/30/17	46963	0	43	"[0.9995421927900687,4.5780720993122243E-4]"	43	SCV000540896181238	single nucleotide variant	NM_000527.4(LDLR):c.829G>A (p.Glu277Lys)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	29-Dec-17	148698650	-	RCV000210246;RCV000495914;RCV000161968;RCV000610848	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202;MedGen:CN169374"	Familial hypercholesterolemia;Familial hypercholesterolemia;not provided;not specified	germline;not applicable;unknown	germline	GRCh37	NC_000019.9	19	11218079	11218079	G	A	19p13.2	"criteria provided, conflicting interpretations"	12	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_001845,UniProtKB (protein):P01130#VAR_005350"	2	183097	19	11218079	G	A	181238	19:11218079:G:A	Uncertain significance	3/20/17	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	unknown:2	"Molecular Genetics Laboratory,Centre for Cardiovascular Surgery and Transplantation"	SCV000540898.1	SCV000540898		LDLR	-	High LDL	12/29/17	46963	0	61	"[0.9993505525626557,6.494474373442923E-4]"	61	SCV000540898181250	single nucleotide variant	NM_000527.4(LDLR):c.1171G>A (p.Ala391Thr)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	18-Aug-17	11669576	-	RCV000237576;RCV000162023;RCV000241875	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202;MedGen:CN169374"	Familial hypercholesterolemia;not provided;not specified	germline;not applicable;unknown	germline	GRCh37	NC_000019.9	19	11222300	11222300	G	A	19p13.2	"criteria provided, conflicting interpretations"	15	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_001369,UniProtKB (protein):P01130#VAR_024519"	2	183138	19	11222300	G	A	181250	19:11222300:G:A	Benign	3/22/17	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	unknown:690	"Molecular Genetics Laboratory,Centre for Cardiovascular Surgery and Transplantation"	SCV000540899.1	SCV000540899		LDLR	-	High LDL	8/18/17	46928	35	4469	"[0.9523845039209001,0.0476154960790999]"	3889	SCV00054089932929	single nucleotide variant	NM_000384.2(APOB):c.10580G>A (p.Arg3527Gln)	338	APOB	HGNC:603	Conflicting interpretations of pathogenicity	1	11-Jul-18	5742904	-	RCV000019479;RCV000284412;RCV000412515;RCV000627797;RCV000499833;RCV000627797;RCV000254882	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C1862596,Orphanet:ORPHA426,SNOMED CT:60193003;MedGen:C1704417,OMIM:144010;MedGen:C1704417,OMIM:144010;MedGen:C0020597,Orphanet:ORPHA31154;MedGen:C4551990,OMIM:615558;MedGen:CN517202"	"Familial hypercholesterolemia;Familial hypobetalipoproteinemia;Hypercholesterolemia, autosomal dominant, type B;Hypercholesterolemia, autosomal dominant, type B;Hypobetalipoproteinemia;Hypobetalipoproteinemia, familial, 1;not provided"	germline;maternal;unknown	germline	GRCh37	NC_000002.11	2	21229160	21229160	C	T	2p24	"criteria provided, conflicting interpretations"	18	"ACMG2013,ACMG2016"	Y	OMIM Allelic Variant:107730.0009	3	17890	2	21229160	C	T	32929	2:21229160:C:T	Pathogenic	6/22/18	"This sequence change replaces arginine with glutamine at codon 3527 of the APOB protein (p.Arg3527Gln). The arginine residue is moderately conserved and there is a small physicochemical difference between arginine and glutamine. This variant is present in population databases (rs5742904, ExAC 0.04%). This variant is a very well known cause of hypercholesterolemia due to APOB deficiency mainly in people of European ancestry (PMID: 24404629). It has been reported to segregate in families affected with hypercholesterolemia (PMID: 2563166, 21868016) and has been reported in multiple affected unrelated individuals (PMID: 9105560, 21059979, 18325181, 18222178, 10388479, 23375686). This variant is also known in the literature as p.Arg3500Gln. ClinVar contains an entry for this variant (Variation ID: 17890). Experimental studies have shown that this missense change disturbs the APOB protein conformation preventing it from binding LDL, therefore disturbing its normal function as inhibitor of the LDL receptor (PMID: 11115503, 15797858). A different missense substitution at this codon (p.Arg3527Trp) is reported to be deleterious (PMID: 7627691). This indicates that the arginine residue is important for APOB protein function. For these reasons, this variant has been classified as Pathogenic."	MedGen:C1704417;MedGen:CN182502	"C1704417:Hypercholesterolemia, autosomal dominant, type B;C4551990:Hypobetalipoproteinemia, familial, 1"	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Invitae	SCV000541940.4	SCV000541940		APOB	-	Low LDL	7/11/18	46963	0	12	"[0.9998722398483912,1.2776015160871325E-4]"	12	SCV000541940389422	single nucleotide variant	NM_174936.3(PCSK9):c.1394C>T (p.Ser465Leu)	255738	PCSK9	HGNC:20001	Conflicting interpretations of pathogenicity	1	5-Dec-17	778849441	-	RCV000508822;RCV000460891;RCV000454751	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C1863551,OMIM:603776;MedGen:CN169374"	"Familial hypercholesterolemia;Hypercholesterolemia, autosomal dominant, 3;not specified"	germline	germline	GRCh37	NC_000001.10	1	55524211	55524211	C	T	1p32.3	"criteria provided, conflicting interpretations"	3	"ACMG2013,ACMG2016"	N	-	2	403292	1	55524211	C	T	389422	1:55524211:C:T	Likely pathogenic	12/5/17	"This sequence change replaces serine with leucine at codon 465 of the PCSK9 protein (p.Ser465Leu). The serine residue is highly conserved and there is a large physicochemical difference between serine and leucine. This variant is not present in population databases (ExAC no frequency). This variant has been reported in multiple unrelated individuals affected with hypercholesterolemia (PMID:Â¬â€ 26374825) and was shown to segregate with hypercholesterolemia in a small family (PMID: 24607922). ClinVar contains an entry for this variant (Variation ID: 403292). Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: ""Deleterious""; PolyPhen-2: ""Benign""; Align-GVGD: ""Class C0""). In summary, this variant has been observed in individuals with hypercholesterolemia and is absent from population databases. In the absence of conclusive segregation evidence, at this time this variant has been classified as Likely Pathogenic."	MedGen:C1863551	"C1863551:Hypercholesterolemia, autosomal dominant, 3"	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Invitae	SCV000543410.3	SCV000543410		PCSK9	-	Low LDL	12/5/17	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV000543410181233	single nucleotide variant	NM_000527.4(LDLR):c.662A>G (p.Asp221Gly)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	3-Apr-17	373822756	-	RCV000211655;RCV000161962	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202"	Familial hypercholesterolemia;not provided	germline;inherited;not applicable	germline	GRCh37	NC_000019.9	19	11216244	11216244	A	G	19p13.2	"criteria provided, multiple submitters, no conflicts"	14	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000096,UniProtKB (protein):P01130#VAR_005332"	2	183092	19	11216244	A	G	181233	19:11216244:A:G	Pathogenic	4/3/17	"This sequence change replaces aspartic acid with glycine at codon 221 of the LDLR protein (p.Asp221Gly). The aspartic acid residue is highly conserved and there is a moderate physicochemical difference between aspartic acid and glycine. This variant is clearly defined as a familial hypercholesterolemia causative allele (PMID: 15523646,23375686). It is a common cause of familial hypercholesterolemia in individuals of Italian ancestry, though it has been observed in individuals in many other countries (PMID: 11196104, 15241806, 220236128, 2698793, 25461735). This variant is also known as p.Asp200Gly in the literature. ClinVar contains an entry for this variant (Variation ID: 183092). Experimental studies have shown that this missense change has a deleterious effect on LDLR activity (PMID: 25647241). For these reasons, this variant has been classified as Pathogenic."	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Invitae	SCV000544638.2	SCV000544638		LDLR	-	High LDL	4/3/17	46959	4	1	"[0.9999893524138078,1.0647586192210225E-5]"	1	SCV000544638228162	single nucleotide variant	NM_000527.4(LDLR):c.1187-10G>A	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	30-Mar-17	765696008	-	RCV000211627;RCV000588170	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445"	Familial hypercholesterolemia;Familial hypercholesterolemias	germline	germline	GRCh37	NC_000019.9	19	11223944	11223944	G	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	10	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000172	2	226349	19	11223944	G	A	228162	19:11223944:G:A	Pathogenic	3/9/17	"This sequence change falls in intron 8 of the LDLR mRNA. It does not directly change the encoded amino acid sequence of the LDLR protein. This variant is present in population databases (rs765696008, ExAC 0.02%). This variant has been reported in several individuals and families affected with familial hypercholesterolemia (PMID: 11668627, 21865347, 12436241, 20145306, 24075752, 20145306), including in an individual with early severe disease that carried two copies of this variant (PMID: 26077743), Â¬â€ and has also been reported by the LDLR-UMD database (PMID:Â¬â€ 12124988 ). ClinVar contains an entry for this variant (Variation ID: 226349). Algorithms developed to predict the effect of sequence changes on mRNA splicing suggest that this variant may alter mRNA splicing, but this prediction has not been confirmed by published transcriptional studies. An experimental study reported reduced LDLR activity in transformed lymphocytesÂ¬â€ (PMID: 21865347). In summary, this is a rare variant that has been previously reported in affected individuals and families and has been shown to affect protein function. For these reasons it has been classified as Pathogenic."	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Invitae	SCV000544644.2	SCV000544644		LDLR	-	High LDL	3/30/17	46963	0	4	"[0.9999574132827971,4.2586717202904415E-5]"	4	SCV00054464418730	single nucleotide variant	NM_000527.4(LDLR):c.682G>A (p.Glu228Lys)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	31-Oct-18	121908029	-	RCV000735406;RCV000735406;RCV000735406;RCV000003878;RCV000735406;RCV000735406;RCV000623885	"Human Phenotype Ontology:HP:0002647,MedGen:C0340643;Human Phenotype Ontology:HP:0012158,MedGen:C0338585;Human Phenotype Ontology:HP:0012474,MedGen:C0265101;MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;Human Phenotype Ontology:HP:0012159,MedGen:C0751815;Human Phenotype Ontology:HP:0001297,MedGen:C0038454;MedGen:CN517202"	Aortic dissection;Carotid artery dissection;Carotid artery occlusion;Familial hypercholesterolemia;Internal carotid artery dissection;Stroke;not provided	germline;unknown	germline	GRCh37	NC_000019.9	19	11216264	11216264	G	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	19	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000105,OMIM Allelic Variant:606945.0007,UniProtKB (protein):P01130#VAR_005341"	3	3691	19	11216264	G	A	18730	19:11216264:G:A	Pathogenic	1/19/18	"This sequence change replaces glutamic acid with lysine at codon 228 of the LDLR protein (p.Glu228Lys). The glutamic acid residue is highly conserved and there is a small physicochemical difference between glutamic acid and lysine. This variant is not present in population databases (rs121908029, ExAC no frequency). This variant has been reported in numerous individuals and families affected with familial hypercholesterolemia (PMID: 2318961, 21475731, 21722902, 22390909, 23375686). This variant is also known as p.Glu207Lys in the literature. ClinVar contains an entry for this variant (Variation ID: 3691). A different missense substitution at this codon (p.Glu228Gln) has been determined to be pathogenic (PMID: 1301956, 8882879, 16250003, 17094996). This suggests that the glutamic acid residue is critical for LDLR protein function and that other missense substitutions at this position may also be pathogenic. Experimental studies have shown that this missense change causes impaired lipoprotein binding (PMID: 18677035). For these reasons, this variant has been classified as Pathogenic."	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Invitae	SCV000544645.3	SCV000544645		LDLR	-	High LDL	10/31/18	46944	19	2	"[0.9999786980231765,2.1301976823449217E-5]"	2	SCV00054464518780	single nucleotide variant	NM_000527.4(LDLR):c.131G>A (p.Trp44Ter)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	14-Nov-17	267607213	-	RCV000003939	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline;inherited	germline	GRCh37	NC_000019.9	19	11210962	11210962	G	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	13	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000019,OMIM Allelic Variant:606945.0060"	3	3741	19	11210962	G	A	18780	19:11210962:G:A	Pathogenic	11/14/17	"This sequence change creates a premature translational stop signal at codon 44 (p.Trp44*) of the LDLR gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in LDLR are known to be pathogenic. This particular variant has been reported in the literature in multiple individuals affected with hypercholesterolemia (PMID: 1301956, 22390909, 21382890, 11668627, 22698793, 20145306, 16542394, 20506408). This variant is also known in the literature as p.W23X. For these reasons, this variant has been classified as Pathogenic."	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Invitae	SCV000544649.3	SCV000544649		LDLR	-	High LDL	11/14/17	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV000544649246513	single nucleotide variant	NM_000527.4(LDLR):c.2096C>T (p.Pro699Leu)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	9-Oct-17	201573863	-	RCV000237906;RCV000589820	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445"	Familial hypercholesterolemia;Familial hypercholesterolemias	germline;unknown	germline	GRCh37	NC_000019.9	19	11231154	11231154	C	T	19p13.2	"criteria provided, conflicting interpretations"	10	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_001600,UniProtKB (protein):P01130#VAR_013955"	2	252219	19	11231154	C	T	246513	19:11231154:C:T	Likely pathogenic	10/9/17	"This sequence change replaces proline with leucine at codon 699 of the LDLR protein (p.Pro699Leu). The proline residue is highly conserved and there is a moderate physicochemical difference between proline and leucine. This variant is present in population databases (rs201573863, ExAC 0.01%) but has not been reported in the literature in individuals with a LDLR-related disease. This variant has been reported in numerous individuals affected with familial hypercholesterolemia (PMID: 21642693, 7489239, 23375686, 22390909, 21310417, 26892515) . This variant is also known as Pro678Leu in the literature. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive, but these predictions have not been confirmed by published functional studies. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic."	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Invitae	SCV000544654.3	SCV000544654		LDLR	-	High LDL	10/9/17	46962	1	6	"[0.9999361185639453,6.388143605468251E-5]"	6	SCV000544654181269	single nucleotide variant	NM_000527.4(LDLR):c.1876G>A (p.Glu626Lys)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	27-Sep-17	139791325	-	RCV000211563;RCV000162004;RCV000454999	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202;MedGen:CN169374"	Familial hypercholesterolemia;not provided;not specified	germline;not applicable;unknown	germline	GRCh37	NC_000019.9	19	11230798	11230798	G	A	19p13.2	"criteria provided, conflicting interpretations"	9	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000258	2	183127	19	11230798	G	A	181269	19:11230798:G:A	Uncertain significance	9/27/17	"This sequence change replaces glutamic acid with lysine at codon 626 of the LDLR protein (p.Glu626Lys). The glutamic acid residue is highly conserved and there is a small physicochemical difference between glutamic acid and lysine. This variant is present in population databases (rs139791325, ExAC 0.08%), and has an allele count higher than expected for a pathogenic variant (PMID: 28166811). This variant has been reported in individuals affected with hypercholesterolemia and myocardial infarction (PMID: 16250003, 20828696, 25487149, 25647241). ClinVar contains an entry for this variant (Variation ID: 183127). Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: ""Deleterious""; PolyPhen-2: ""Benign""; Align-GVGD: ""Class C15""). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance."	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Invitae	SCV000544656.3	SCV000544656		LDLR	-	High LDL	9/27/17	46963	0	19	"[0.9997977130932862,2.0228690671379596E-4]"	19	SCV000544656171198	single nucleotide variant	NM_000527.4(LDLR):c.296C>G (p.Ser99Ter)	3949	LDLR	HGNC:6547	Pathogenic	1	6-May-17	377271627	-	RCV000238369;RCV000148574	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443"	Familial hypercholesterolemia;Hypercholesterolaemia	germline;not applicable	germline	GRCh37	NC_000019.9	19	11213445	11213445	C	G	19p13.2	"criteria provided, multiple submitters, no conflicts"	5	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_001685	2	161269	19	11213445	C	G	171198	19:11213445:C:G	Pathogenic	5/6/17	"This sequence change creates a premature translational stop signal at codon 99 (p.Ser99*) of the LDLR gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in LDLR are known to be pathogenic. This particular variant has been reported in the literature in many individuals with familial hypercholesterolemia (PMID: 7718019, 9259195, 9698020, 11857755, 23375686). This variant is also known as p.Ser78* and FH-Svartor in the literature. ClinVar contains an entry for this variant (Variation ID: 161269). For these reasons, this variant has been classified as Pathogenic."	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Invitae	SCV000544657.2	SCV000544657		LDLR	-	High LDL	5/6/17	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV000544657228138	single nucleotide variant	NM_000527.4(LDLR):c.429C>A (p.Cys143Ter)	3949	LDLR	HGNC:6547	Pathogenic	1	5-Dec-17	199774121	-	RCV000211567	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline	germline	GRCh37	NC_000019.9	19	11216011	11216011	C	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	7	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_001734	2	226325	19	11216011	C	A	228138	19:11216011:C:A	Pathogenic	12/5/17	"This sequence change creates a premature translational stop signal (p.Cys143*) in the LDLR gene. It is expected to result in an absent or disrupted protein product. This variant is present in population databases (rs199774121, ExAC 0.005%). This variant has been reported to segregate with familial hypercholesterolemia in a single family (PMID: 9212177) and has been reported in several individuals with this condition (PMID: 27831900, 165423944, 21382890). This variant is also known as p.Cys122* in the literature. ClinVar contains an entry for this variant (Variation ID: 226325). Loss-of-function variants in LDLR are known to be pathogenic (PMID: 20809525). For these reasons, this variant has been classified as Pathogenic."	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Invitae	SCV000544658.3	SCV000544658		LDLR	-	High LDL	12/5/17	46963	0	2	"[0.9999787066413985,2.1293358601452207E-5]"	2	SCV000544658245730	single nucleotide variant	NM_000527.4(LDLR):c.682G>C (p.Glu228Gln)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	15-Aug-17	121908029	-	RCV000237530	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline;unknown	germline	GRCh37	NC_000019.9	19	11216264	11216264	G	C	19p13.2	"criteria provided, multiple submitters, no conflicts"	6	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_001817,UniProtKB (protein):P01130#VAR_005340"	2	251393	19	11216264	G	C	245730	19:11216264:G:C	Pathogenic	8/15/17	"This sequence change replaces glutamic acid with glutamine at codon 228 of the LDLR protein (p.Glu228Gln). The glutamic acid residue is highly conserved and there is a small physicochemical difference between glutamic acid and glutamine. This variant is present in population databases (rs121908029, ExAC 0.002%). This variant has been reported in several individuals affected with heterozygous familial hypercholesterolemia (PMID: 8882879, 16250003, 17094996), and one individual with homozygous familial hypercholesterolemia (PMID: 1301956). This variant is also known as p.Glu207Gln in the literature and Tulsa-2. ClinVar contains an entry for this variant (Variation ID: 251393). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive, but these predictions have not been confirmed by published functional studies. A different missense substitution at this codon (p.Glu228Lys) is reported to be deleterious (PMID: 1301956, 15359125, 18677035, 20736250). This variant is also known as p.Glu207Lys in the literature. This indicates that the glycine residue is important for LDLR protein function. For these reasons, this variant has been classified as Pathogenic."	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Invitae	SCV000544665.2	SCV000544665		LDLR	-	High LDL	8/15/17	46944	19	4	"[0.9999573960463531,4.2603953646898434E-5]"	4	SCV000544665171217	single nucleotide variant	NM_000527.4(LDLR):c.1775G>A (p.Gly592Glu)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	31-Oct-18	137929307	-	RCV000172964;RCV000587007;RCV000148576;RCV000162001	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:C0020443;MedGen:CN517202"	Familial hypercholesterolemia;Familial hypercholesterolemias;Hypercholesterolaemia;not provided	germline;inherited;not applicable;unknown	germline	GRCh37	NC_000019.9	19	11227604	11227604	G	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	22	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000237,UniProtKB (protein):P01130#VAR_005403"	2	161271	19	11227604	G	A	171217	19:11227604:G:A	Pathogenic	5/22/18	"This sequence change replaces glycine with glutamic acid at codon 592 of the LDLR protein (p.Gly592Glu). The glycine residue is highly conserved and there is a moderate physicochemical difference between glycine and glutamic acid. This variant is present in population databases (rs137929307, ExAC 0.009%). This variant is clearly defined as a familial hypercholesterolemia causative allele (PMID: 15864114,20663204, 21310417), and is a common cause of familial hypercholesterolemia in individuals of European ancestry (PMID: 26238499, 23375686, 21925044), This variant is also known as p.Gly571Glu in the literature. ClinVar contains an entry for this variant (Variation ID: 161271). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive, but these predictions have not been confirmed by published functional studies. For these reasons, this variant has been classified as Pathogenic."	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Invitae	SCV000544669.4	SCV000544669		LDLR	-	High LDL	10/31/18	46963	0	3	"[0.9999680599620978,3.194003790217831E-5]"	3	SCV00054466918731	single nucleotide variant	NM_000527.4(LDLR):c.910G>A (p.Asp304Asn)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	10-Apr-18	121908030	-	RCV000003880;RCV000148569;RCV000622705	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MeSH:D030342,MedGen:C0950123"	Familial hypercholesterolemia;Hypercholesterolaemia;Inborn genetic diseases	germline;inherited;not applicable	germline	GRCh37	NC_000019.9	19	11218160	11218160	G	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	10	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_001861,OMIM Allelic Variant:606945.0008,UniProtKB (protein):P01130#VAR_005355"	3	3692	19	11218160	G	A	18731	19:11218160:G:A	Pathogenic	3/1/17	"This sequence change replaces aspartic acid with asparagine at codon 304 of the LDLR protein (p.Asp304Asn). The aspartic acid residue is highly conserved and there is a small physicochemical difference between aspartic acid and asparagine. This variant is present in population databases (rs121908030, ExAC <0.01%). This variant has been reported in several individuals affected with familial hypercholesterolemia (PMID: 9664576, 11810272, 12436241, 2088165, 21418584, 22698793). This variant is also known as Denver-2 and D283N. ClinVar contains an entry for this variant (Variation ID: 3692). A different missense substitution at this codon (p.Asp304Glu) has been determined to be pathogenic (PMID: 1301956, 17094996). This suggests that the aspartic acid residue is critical for LDLR protein function and that other missense substitutions at this position may also be pathogenic. Experimental studies have shown that this missense change reduces the LDLR receptor activity (PMID: 1301956). For these reasons, this variant has been classified as Pathogenic."	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Invitae	SCV000544684.2	SCV000544684		LDLR	-	High LDL	4/10/18	46963	0	3	"[0.9999680599620978,3.194003790217831E-5]"	3	SCV000544684228156	single nucleotide variant	NM_000527.4(LDLR):c.1048C>T (p.Arg350Ter)	3949	LDLR	HGNC:6547	Pathogenic	1	8-May-18	769737896	-	RCV000211692;RCV000520229	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202"	Familial hypercholesterolemia;not provided	germline;inherited	germline	GRCh37	NC_000019.9	19	11221435	11221435	C	T	19p13.2	"criteria provided, multiple submitters, no conflicts"	11	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000147	2	226342	19	11221435	C	T	228156	19:11221435:C:T	Pathogenic	5/8/18	"This sequence change creates a premature translational stop signal at codon 350 (p.Arg350*) of the LDLR gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in LDLR are known to be pathogenic (PMID: 20809525). This particular variant has been reported in numerous individuals and families affected with familial Â¬â€ hypercholesterolemia (PMID: 7709162, 9039985, 22390909, 21382890, 21310417), and has been reported in an individual affected with myocardial infarction (PMID: 25487149). This variant is also known as Arg329* in the literature. For these reasons, this variant has been classified as Pathogenic."	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Invitae	SCV000544687.3	SCV000544687		LDLR	-	High LDL	5/8/18	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV00054468745113	single nucleotide variant	NM_000527.4(LDLR):c.1055G>A (p.Cys352Tyr)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	31-Oct-18	193922566	-	RCV000030122;RCV000722113;RCV000413322	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:CN517202"	Familial hypercholesterolemia;Familial hypercholesterolemias;not provided	germline;unknown	germline	GRCh37	NC_000019.9	19	11221442	11221442	G	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	9	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_001339,UniProtKB (protein):P01130#VAR_005369"	2	36450	19	11221442	G	A	45113	19:11221442:G:A	Pathogenic	4/11/17	"This sequence change replaces cysteine with tyrosine at codon 352 of the LDLR protein (p.Cys352Tyr). The cysteine residue is highly conserved and there is a large physicochemical difference between cysteine and tyrosine. This variant is present in population databases (rs193922566, ExAC 0.009%). This variant has been reported in the literature segregating with the disease in a family with hypercholesterolemia where the proband was homozygous for this variant (PMID: 25234566), as well as in multiple unrelated individuals affected with hypercholesterolemia (PMID: 1301956, 19717150, 23064986, 22698793, 21722902). This variant is also known as p.Cys331Tyr in the literature. ClinVar contains an entry for this variant (Variation ID: 36450). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive, but these predictions have not been confirmed by published functional studies. In summary, this variant has been reported in the literature segregating with the disease in one family and in multiple unrelated affected individuals. For these reasons, this variant has been classified as Pathogenic."	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Invitae	SCV000544690.2	SCV000544690		LDLR	-	High LDL	10/31/18	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV000544690245782	single nucleotide variant	NM_000527.4(LDLR):c.769C>T (p.Arg257Trp)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	29-Jun-18	200990725	-	RCV000237953	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline	germline	GRCh37	NC_000019.9	19	11217315	11217315	C	T	19p13.2	"criteria provided, conflicting interpretations"	8	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000115,UniProtKB (protein):P01130#VAR_072836"	2	251446	19	11217315	C	T	245782	19:11217315:C:T	Uncertain significance	6/29/18	"This sequence change replaces arginine with tryptophan at codon 257 of the LDLR protein (p.Arg257Trp). The arginine residue is moderately conserved and there is a moderate physicochemical difference between arginine and tryptophan. This variant is present in population databases (rs200990725, ExAC 0.07%)Â¬â€ , and has an allele count higher than expected for a pathogenic variant (PMID: 28166811). This variant has been reported in several individuals affected with familial hypercholesterolemia (PMID: 11462246, 11933210, 25461735, 25962062, 22353362, 20538126, 16250003, 26343872, 27206935). This variant is also known as p.Arg236Trp in the literature. This variant is reportedly found on the same allele as LDLR p.Asp589Asn (PMID: 16250003, 18325082). ClinVar contains an entry for this variant (Variation ID: 251446). Experimental studies have shown that this missense change does not show significant functional differences in LDLR activity, in contrast to established disease-causing variants (PMID: 25545329). In summary, this variant is a rare missense change that is not predicted to affect protein function. It has been reported in both the population and affected individuals, but the available evidence is currently insufficient to determine its role in disease. Therefore, it has been classified as a Variant of Uncertain Significance."	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Invitae	SCV000544695.3	SCV000544695		LDLR	-	High LDL	6/29/18	46963	0	14	"[0.9998509464897898,1.4905351021016544E-4]"	14	SCV000544695171201	single nucleotide variant	NM_000527.4(LDLR):c.798T>A (p.Asp266Glu)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	17-May-18	139043155	-	RCV000172959;RCV000148594;RCV000162020	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202"	Familial hypercholesterolemia;Hypercholesterolaemia;not provided	germline;inherited;not applicable;unknown	germline	GRCh37	NC_000019.9	19	11217344	11217344	T	A	19p13.2	"criteria provided, conflicting interpretations"	16	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000117,UniProtKB (protein):P01130#VAR_005347"	2	161287	19	11217344	T	A	171201	19:11217344:T:A	Pathogenic	5/17/18	"This sequence change replaces aspartic acid with glutamic acid at codon 266 of the LDLR protein (p.Asp266Glu). The aspartic acid residue is highly conserved and there is a small physicochemical difference between aspartic acid and glutamic acid. This variant has been reported in many unrelated individuals affected with hypercholesterolemia (PMID: 1301956, 23375686, 21310417) and is established as a common cause of disease (PMID: 20663204, 22698793, 26238499). Â¬â€ This variant is also known as p.Asp245Glu in the literature. ClinVar contains an entry for this variant (Variation ID: 161287). A different missense substitution at this codon (p.Asp266Tyr) is reported to be deleterious (PMID: 11196104). This indicates that the asparagine residue is important for LDLR protein function. For these reasons, this variant has been classified as Pathogenic."	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Invitae	SCV000544696.4	SCV000544696		LDLR	-	High LDL	5/17/18	46963	0	2	"[0.9999787066413985,2.1293358601452207E-5]"	2	SCV000544696171214	single nucleotide variant	NM_000527.4(LDLR):c.1444G>A (p.Asp482Asn)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	11-May-17	139624145	-	RCV000172963;RCV000148591;RCV000414235	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202"	Familial hypercholesterolemia;Hypercholesterolaemia;not provided	germline;inherited	germline	GRCh37	NC_000019.9	19	11224296	11224296	G	A	19p13.2	"criteria provided, conflicting interpretations"	13	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_001428	2	161284	19	11224296	G	A	171214	19:11224296:G:A	Pathogenic	12/28/16	"This sequence change replaces aspartic acid with asparagine at codon 482 of the LDLR protein (p.Asp482Asn). The aspartic acid residue is highly conserved and there is a small physicochemical difference between aspartic acid and asparagine. This variant is present in population databases (rs139624145, ExAC <0.01%). This variant has been reported in the literature in several unrelated individuals affected with hypercholesterolemia (PMID: 8535447, 23375686, 21310417, 20236128, 16389549). This variant is also known as p.Asp461Asn in the literature. ClinVar contains an entry for this variant (Variation ID: 161284). A different missense substitution at this codon (p.Asp482His) has been determined to be pathogenic (PMID: 21310417, 20236128, 16389549). This suggests that the aspartic acid residue is critical for LDLR protein function and that other missense substitutions at this position may also be pathogenic. For these reasons, this variant has been classified as Pathogenic."	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Invitae	SCV000544697.2	SCV000544697		LDLR	-	High LDL	5/11/17	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV000544697172183	single nucleotide variant	NM_000527.4(LDLR):c.1359-1G>A	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	16-Jan-18	139617694	-	RCV000172962;RCV000149884	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443"	Familial hypercholesterolemia;Hypercholesterolaemia	germline	germline	GRCh37	NC_000019.9	19	11224210	11224210	G	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	12	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_001405	2	162499	19	11224210	G	A	172183	19:11224210:G:A	Pathogenic	1/16/18	"This sequence change affects an acceptor splice site in intron 9 of the LDLR gene. It is expected to disrupt mRNA splicing and results in an absent or disrupted protein product. This variant is not present in population databases (rs139617694, ExAC no frequency). This variant has been reported to segregate with familial hypercholesterolemia in several families (PMID: 9254862, 25154303). It has also been observed in numerous unrelated individuals with familial hypercholesterolemia (PMID: 10735632, 11668640, 11857755, 15241806, 21382890, 21475731, 22390909). ClinVar contains an entry for this variant (Variation ID: 162499). Experimental studies have shown that this intronic change activates a cryptic acceptor splice site and leads to a deletion of seven nucleotides in exon 10 (PMID: 10090473). For these reasons, this variant has been classified as Pathogenic."	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Invitae	SCV000544700.3	SCV000544700		LDLR	-	High LDL	1/16/18	46961	2	1	"[0.9999893528672729,1.0647132727156576E-5]"	1	SCV00054470057209	single nucleotide variant	NM_170707.3(LMNA):c.1567G>A (p.Gly523Arg)	4000	LMNA	HGNC:6636	Conflicting interpretations of pathogenicity	1	16-Aug-18	201583907	-	RCV000245950;RCV000474372;RCV000678714;RCV000057323;RCV000041324	"MedGen:CN230736;MedGen:C0270914,Orphanet:ORPHA64746;Human Phenotype Ontology:HP:0030682,MedGen:C1960469,Orphanet:ORPHA54260,SNOMED CT:427608000;MedGen:CN517202;MedGen:CN169374"	"Cardiovascular phenotype;Charcot-Marie-Tooth disease, type 2;Left ventricular noncompaction;not provided;not specified"	germline	germline	GRCh37	NC_000001.10	1	156106982	156106982	G	A	1q22	"criteria provided, conflicting interpretations"	7	"ACMG2013,ACMG2016"	N	UniProtKB (protein):P02545#VAR_067258	2	48045	1	156106982	G	A	57209	1:156106982:G:A	Uncertain significance	3/9/18	"This sequence change replaces glycine with arginine at codon 523 of the LMNA protein (p.Gly523Arg). The glycine residue is highly conserved and there is a moderate physicochemical difference between glycine and arginine. This variant is present in population databases (rs201583907, ExAC 0.02%). This variant has been reported in the heterozygous state in 2 individuals affected with dilated cardiomyopathy (PMID: 19318026, 24503780) and in an individual affected with limb girdle muscular dystrophy (PMID:Â¬â€ 26404900). ClinVar contains an entry for this variant (Variation ID: 48045). Experimental studies in a yeast two hybrid system show that this missense change leads to the loss of 4 interactions, but the functional significance of these observations is not known (PMID: 24623722). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance."	MedGen:CN043576	"C0270914:Charcot-Marie-Tooth disease, type 2"	NA	FALSE	Incorrect phenotype	"criteria provided, single submitter"	clinical testing	germline:na	Invitae	SCV000548848.4	SCV000548848		LMNA	-	"Lipodystrophy, MonogenicDM_all"	8/16/18	46878	85	4	"[0.9999573360638252,4.2663936174751484E-5]"	4	SCV000548848172489	single nucleotide variant	NM_170707.3(LMNA):c.1634G>A (p.Arg545His)	4000	LMNA	HGNC:6636	Conflicting interpretations of pathogenicity	1	23-Apr-18	142191737	-	RCV000621850;RCV000468904;RCV000491650;RCV000449630;RCV000505801;RCV000150955	"MedGen:CN230736;MedGen:C0270914,Orphanet:ORPHA64746;MedGen:C1834481,OMIM:613426;Human Phenotype Ontology:HP:0009830,MedGen:C0031117,Orphanet:ORPHA98496;MedGen:CN517202;MedGen:CN169374"	"Cardiovascular phenotype;Charcot-Marie-Tooth disease, type 2;Dilated cardiomyopathy 1S;Peripheral neuropathy;not provided;not specified"	germline;maternal	germline	GRCh37	NC_000001.10	1	156107470	156107470	G	A	1q22	"criteria provided, conflicting interpretations"	7	"ACMG2013,ACMG2016"	N	-	2	163878	1	156107470	G	A	172489	1:156107470:G:A	Uncertain significance	4/23/18	"This sequence change replaces arginine with histidine at codon 545 of the LMNA protein (p.Arg545His). The arginine residue is highly conserved and there is a small physicochemical difference between arginine and histidine. This variant is present in population databases (rs142191737, ExAC 0.03%). This variant has been reported in multiple individuals affected with LMNA-related diseases (PMID: 22918509, 23183350, 27919367). ClinVar contains an entry for this variant (Variation ID: 163878). Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: ""Deleterious""; PolyPhen-2: ""Benign""; Align-GVGD: ""Class C25""). The observation of a different missense substitution at this codon (p.Arg545Cys) in an affected individual suggests that this may be a clinically significant residue (PMID: 19589617). In summary, this variant is a rare missense change with uncertain impact on protein function. It has been reported in both the population and affected individuals, but the available evidence is currently insufficient to determine its role in disease. Therefore, it has been classified as a Variant of Uncertain Significance."	MedGen:CN043576	"C0270914:Charcot-Marie-Tooth disease, type 2"	NA	FALSE	Incorrect phenotype	"criteria provided, single submitter"	clinical testing	germline:na	Invitae	SCV000548853.4	SCV000548853		LMNA	-	"Lipodystrophy, MonogenicDM_all"	4/23/18	44851	2112	4	"[0.9999554079061782,4.45920938217654E-5]"	4	SCV00054885329525	single nucleotide variant	NM_170707.3(LMNA):c.1445G>A (p.Arg482Gln)	4000	LMNA	HGNC:6636	Pathogenic	1	31-Oct-18	11575937	-	RCV000763258;RCV000763258;RCV000459624;RCV000763258;RCV000763258;RCV000763258;RCV000190399;RCV000763258;RCV000015575;RCV000763258;RCV000763258;RCV000763258;RCV000041318;RCV000763258;RCV000763258;RCV000754814;RCV000148600;RCV000057299	"MedGen:C0410190,OMIM:181350,Orphanet:ORPHA98853,SNOMED CT:240072005;MedGen:C1854154,OMIM:605588,Orphanet:ORPHA98856;MedGen:C0270914,Orphanet:ORPHA64746;MedGen:C2750785,OMIM:613205,Orphanet:ORPHA157973;MedGen:C1449563,OMIM:115200,Orphanet:ORPHA300751;MedGen:C0796031,OMIM:212112,Orphanet:ORPHA2229;MedGen:C2750035,OMIM:616516,Orphanet:ORPHA98855;MedGen:C2750035,OMIM:616516,Orphanet:ORPHA98855;MedGen:C1720860,OMIM:151660,Orphanet:ORPHA2348;MedGen:C1720860,OMIM:151660,Orphanet:ORPHA2348;MedGen:C1857829,OMIM:610140,Orphanet:ORPHA168796;MedGen:C0033300,OMIM:176670,Orphanet:ORPHA740,SNOMED CT:238870004;MedGen:CN236383,Orphanet:ORPHA98301;MedGen:C0406585,OMIM:275210,Orphanet:ORPHA1662,SNOMED CT:400128006;MedGen:C0432291,OMIM:248370,Orphanet:ORPHA2457,SNOMED CT:109419009;MedGen:C3888631;MedGen:CN221589;MedGen:CN517202"	"Benign scapuloperoneal muscular dystrophy with cardiomyopathy;Charcot-Marie-Tooth disease type 2B1;Charcot-Marie-Tooth disease, type 2;Congenital muscular dystrophy, LMNA-related;Dilated cardiomyopathy 1A;Dilated cardiomyopathy-hypergonadotropic hypogonadism syndrome;Emery-Dreifuss muscular dystrophy 3, autosomal recessive;Emery-Dreifuss muscular dystrophy 3, autosomal recessive;Familial partial lipodystrophy 2;Familial partial lipodystrophy 2;Heart-hand syndrome, Slovenian type;Hutchinson-Gilford syndrome;Laminopathy;Lethal tight skin contracture syndrome;Mandibuloacral dysostosis;Monogenic diabetes;Partial lipodystrophy, Dunnigan;not provided"	de novo;germline;unknown	germline	GRCh37	NC_000001.10	1	156106776	156106776	G	A	1q22	"criteria provided, multiple submitters, no conflicts"	10	"ACMG2013,ACMG2016"	N	"OMIM Allelic Variant:150330.0010,UniProtKB (protein):P02545#VAR_009992"	3	14486	1	156106776	G	A	29525	1:156106776:G:A	Pathogenic	5/7/18	"This sequence change replaces arginine with glutamine at codon 482 of the LMNA protein (p.Arg482Gln). The arginine residue is highly conserved and there is a small physicochemical difference between arginine and glutamine. This variant is present in population databases (rs11575937, ExAC 0.002%). This variant has been reported in many individuals affected with familial lipodystrophy type 2 (FLPD2) and has been observed to segregate with the disease in several families (PMID: 10587585,Â¬â€ 10999791, 19418082, 19859838, 20130076, 20625965,Â¬â€ 26662654). This variant has also been reported in the homozygous state in individuals affected with autosomal recessive Emery-Dreifuss muscular dystrophy (EDMD) (PMID: 23313286). ClinVar contains an entry for this variant (Variation ID: 14486). Experimental studies have shown that this variant recapitulates the FLPD2 phenotype in a mouse model (PMID: 19201734). In addition, in vitro studies in muscle biopsies from individuals carrying this variant detected an imbalance between lipid oxidation and oxidative glucose metabolism (PMID: 20130076). For these reasons, this variant has been classified as Pathogenic."	MedGen:CN043576	"C0270914:Charcot-Marie-Tooth disease, type 2"	NA	FALSE	Incorrect phenotype	"criteria provided, single submitter"	clinical testing	germline:na	Invitae	SCV000548869.4	SCV000548869		LMNA	-	"Lipodystrophy, MonogenicDM_all"	10/31/18	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV000548869226400	single nucleotide variant	NM_000527.4(LDLR):c.1194C>T (p.Ile398=)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	2-Jan-18	13306498	-	RCV000210233	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline	germline	GRCh37	NC_000019.9	19	11223961	11223961	C	T	19p13.2	"criteria provided, conflicting interpretations"	5	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_001231	2	224620	19	11223961	C	T	226400	19:11223961:C:T	Benign	1/2/18	-	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Invitae	SCV000556771.3	SCV000556771		LDLR	-	High LDL	1/2/18	46962	1	134	"[0.9985733145947787,0.0014266854052212426]"	134	SCV000556771181250	single nucleotide variant	NM_000527.4(LDLR):c.1171G>A (p.Ala391Thr)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	18-Aug-17	11669576	-	RCV000237576;RCV000162023;RCV000241875	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202;MedGen:CN169374"	Familial hypercholesterolemia;not provided;not specified	germline;not applicable;unknown	germline	GRCh37	NC_000019.9	19	11222300	11222300	G	A	19p13.2	"criteria provided, conflicting interpretations"	15	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_001369,UniProtKB (protein):P01130#VAR_024519"	2	183138	19	11222300	G	A	181250	19:11222300:G:A	Benign	8/18/17	-	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Invitae	SCV000556774.2	SCV000556774		LDLR	-	High LDL	8/18/17	46928	35	4469	"[0.9523845039209001,0.0476154960790999]"	3889	SCV000556774171207	single nucleotide variant	NM_000527.4(LDLR):c.970G>A (p.Gly324Ser)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	5-Oct-17	72658860	-	RCV000237236;RCV000148566;RCV000162021;RCV000455308	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202;MedGen:CN169374"	Familial hypercholesterolemia;Hypercholesterolaemia;not provided;not specified	germline;not applicable	germline	GRCh37	NC_000019.9	19	11221357	11221357	G	A	19p13.2	"criteria provided, conflicting interpretations"	11	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000640	2	161263	19	11221357	G	A	171207	19:11221357:G:A	Benign	10/5/17	-	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Invitae	SCV000556776.3	SCV000556776		LDLR	-	High LDL	10/5/17	46961	2	186	"[0.9980196333127489,0.001980366687251123]"	186	SCV000556776226399	single nucleotide variant	NM_000527.4(LDLR):c.941-4G>A	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	12-Jan-18	116405216	-	RCV000210248;RCV000736080	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN169374"	Familial hypercholesterolemia;not specified	germline;unknown	germline	GRCh37	NC_000019.9	19	11221324	11221324	G	A	19p13.2	"criteria provided, conflicting interpretations"	10	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000515	2	224619	19	11221324	G	A	226399	19:11221324:G:A	Benign	1/12/18	-	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Invitae	SCV000556777.3	SCV000556777		LDLR	-	High LDL	1/12/18	46963	0	399	"[0.9957519749590102,0.004248025040989715]"	389	SCV00055677745114	single nucleotide variant	NM_000527.4(LDLR):c.1061-8T>C	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	31-May-18	72658861	-	RCV000030123;RCV000759074;RCV000245346	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202;MedGen:CN169374"	Familial hypercholesterolemia;not provided;not specified	germline;unknown	germline	GRCh37	NC_000019.9	19	11222182	11222182	T	C	19p13.2	"criteria provided, conflicting interpretations"	15	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000154	2	36451	19	11222182	T	C	45114	19:11222182:T:C	Benign	1/22/18	-	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Invitae	SCV000556781.3	SCV000556781		LDLR	-	High LDL	5/31/18	46960	3	426	"[0.9954642248722317,0.004535775127768314]"	420	SCV000556781226402	single nucleotide variant	NM_000527.4(LDLR):c.1836C>T (p.Ala612=)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	27-Jun-17	143872778	-	RCV000210239;RCV000586569;RCV000456101	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202;MedGen:CN169374"	Familial hypercholesterolemia;not provided;not specified	germline	germline	GRCh37	NC_000019.9	19	11227665	11227665	C	T	19p13.2	"criteria provided, conflicting interpretations"	9	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000249	2	224618	19	11227665	C	T	226402	19:11227665:C:T	Likely benign	12/25/16	-	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Invitae	SCV000556782.2	SCV000556782		LDLR	-	High LDL	6/27/17	46963	0	10	"[0.9998935332069927,1.0646679300726103E-4]"	10	SCV00055678245125	single nucleotide variant	NM_000527.4(LDLR):c.2479G>A (p.Val827Ile)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	2-Nov-17	137853964	-	RCV000030135;RCV000148585;RCV000058923;RCV000436469	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202;MedGen:CN169374"	Familial hypercholesterolemia;Hypercholesterolaemia;not provided;not specified	germline;inherited;not applicable;unknown	germline	GRCh37	NC_000019.9	19	11240278	11240278	G	A	19p13.2	"criteria provided, conflicting interpretations"	16	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_001657,UniProtKB (protein):P01130#VAR_005418"	2	36462	19	11240278	G	A	45125	19:11240278:G:A	Likely benign	10/30/17	-	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Invitae	SCV000556789.3	SCV000556789		LDLR	-	High LDL	11/2/17	46963	0	74	"[0.9992121457317462,7.878542682537317E-4]"	74	SCV00055678945123	single nucleotide variant	NM_000527.4(LDLR):c.2140+5G>A	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	26-Jan-18	72658867	-	RCV000030133;RCV000614028	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN169374"	Familial hypercholesterolemia;not specified	germline	germline	GRCh37	NC_000019.9	19	11231203	11231203	G	A	19p13.2	"criteria provided, conflicting interpretations"	13	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000283	2	36460	19	11231203	G	A	45123	19:11231203:G:A	Benign	1/26/18	-	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Invitae	SCV000556791.3	SCV000556791		LDLR	-	High LDL	1/26/18	46942	21	472	"[0.9949725192791103,0.005027480720889608]"	464	SCV00055679129566	single nucleotide variant	NM_170707.3(LMNA):c.1930C>T (p.Arg644Cys)	4000	LMNA	HGNC:6636	Conflicting interpretations of pathogenicity	1	21-Nov-18	142000963	-	RCV000245284;RCV000144868;RCV000471403;RCV000755679;RCV000148602;RCV000015626;RCV000057374;RCV000041340	"MedGen:CN230736;MedGen:C0007959,Orphanet:ORPHA166,SNOMED CT:50548001;MedGen:C0270914,Orphanet:ORPHA64746;MedGen:C1449563,OMIM:115200,Orphanet:ORPHA300751;EFO:EFO_0000407,Human Phenotype Ontology:HP:0001644,MedGen:C0007193,Orphanet:ORPHA217604,SNOMED CT:195021004;na;MedGen:CN517202;MedGen:CN169374"	"Cardiovascular phenotype;Charcot-Marie-Tooth disease;Charcot-Marie-Tooth disease, type 2;Dilated cardiomyopathy 1A;Primary dilated cardiomyopathy;Variant of unknown significance;not provided;not specified"	germline;tested-inconclusive;unknown	germline	GRCh37	NC_000001.10	1	156108510	156108510	C	T	1q22	"criteria provided, conflicting interpretations"	13	"ACMG2013,ACMG2016"	N	"OMIM Allelic Variant:150330.0051,UniProtKB (protein):P02545#VAR_039792"	3	14527	1	156108510	C	T	29566	1:156108510:C:T	Likely benign	1/3/18	-	MedGen:CN043576	"C0270914:Charcot-Marie-Tooth disease, type 2"	NA	FALSE	Incorrect phenotype	"criteria provided, single submitter"	clinical testing	germline:na	Invitae	SCV000559827.3	SCV000559827		LMNA	-	"Lipodystrophy, MonogenicDM_all"	11/21/18	46954	9	67	"[0.9992865357584019,7.134642415981599E-4]"	65	SCV00055982718738	single nucleotide variant	NM_000527.4(LDLR):c.2043C>A (p.Cys681Ter)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	31-Oct-18	121908031	-	RCV000003887;RCV000590806;RCV000481771	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:CN517202"	Familial hypercholesterolemia;Familial hypercholesterolemias;not provided	germline;unknown	germline	GRCh37	NC_000019.9	19	11231101	11231101	C	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	18	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_001592,OMIM Allelic Variant:606945.0016"	3	3699	19	11231101	C	A	18738	19:11231101:C:A	Pathogenic	11/2/16	"The C681X pathogenic variant in the LDLR gene (also reported as C660X due to alternate nomenclature) has been reported many times in both the heterozygous state and the homozygous state in individuals with FH (Lehrman et al., 1987; Day et al., 1997; Callis et al., 1998; Xenophontos et al., 2000; Wang et al., 2001; Bodamer et al., 2002; Dedoussis et al., 2004). The C681X variant is considered a Lebanese founder mutation and may account for greater than 80% of FH cases in this population (Abifadel et al., 2009). Furthermore, the C681X pathogenic variant was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project nor was it observed in the Exome Aggregation Consortium (ExAC) data set, indicating it is not a common benign variant in these populations. Located in the middle of a cysteine-rich sequence that is part of the epidermal growth factor precursor homology domain, C681X is predicted to cause loss of normal protein function either by protein truncation or nonsense-mediated mRNA decay (Lehrman et al., 1987). In addition, other nonsense variants in the LDLR gene have been reported in the Human Gene Mutation Database in association with FH (Stenson et al., 2014). In summary, C681X in the LDLR gene is interpreted as a pathogenic variant."	Not Provided	CN517202:not provided	Familial Hypercholesterolemia - based on pubmed	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	GeneDx	SCV000568525.3	SCV000568525		LDLR	-	High LDL	10/31/18	46958	5	1	"[0.9999893521870608,1.0647812939222283E-5]"	1	SCV000568525408541	single nucleotide variant	NM_000545.6(HNF1A):c.685C>T (p.Arg229Ter)	6927	HNF1A	HGNC:11621	Pathogenic	1	13-Mar-17	769086289	-	RCV000483162	MedGen:CN517202	not provided	germline	germline	GRCh37	NC_000012.11	12	121431481	121431481	C	T	12q24.31	"criteria provided, single submitter"	1	NA	N	-	2	420064	12	121431481	C	T	408541	12:121431481:C:T	Pathogenic	3/13/17	"The R229X variant in the HNF1A gene has been reported previously in association with MODY (Kaisaki et al., 1997). This variant has also been reported in an individual with liver adenomatosis and a family history of diabetes (Bacq et al., 2003). The R229X variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. This variant is not observed at a significant frequency in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). We interpret R229X as a pathogenic variant."	Not Provided	CN517202:not provided	MODY	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	GeneDx	SCV000568551.3	SCV000568551		HNF1A	-	"MODY, MODY Extended, MonogenicDM_all"	3/13/17	46962	1	1	"[0.9999893530939908,1.0646906009113752E-5]"	1	SCV00056855145013	single nucleotide variant	NM_000457.4(HNF4A):c.427A>G (p.Ser143Gly)	3172	HNF4A	HGNC:5024	Conflicting interpretations of pathogenicity	1	20-Mar-17	193922472	-	RCV000030019;RCV000484752	"MedGen:C1852093,OMIM:125850;MedGen:CN169374"	"Maturity-onset diabetes of the young,  type 1;not specified"	germline	germline	GRCh37	NC_000020.10	20	43042375	43042375	A	G	20q13.1	"criteria provided, conflicting interpretations"	2	NA	N	-	2	36349	20	43042375	A	G	45013	20:43042375:A:G	Uncertain significance	3/20/17	"The c.361 A>G variant in the HNF4A gene has not been reported previously as a pathogenic variant, nor as a benign variant, to our knowledge. The c.361 A>G variant is observed in 7/65226 (0.01%) alleles from individuals of European Non-Finnish background in the ExAC dataset (Lek et al., 2016). In-silico splice prediction models predict that c.361 A>G may create a cryptic splice donor site in exon 4 that could supplant the natural splice donor site. However, in the absence of RNA/functional studies, the actual effect of the c.361 A>G change in this individual is unknown. If c.361 A>G does not alter splicing, it will result in the S121G missense change. The S121G variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is conserved across species, and in silico analysis predicts this variant is probably damaging to the protein structure/function. We interpret c.361 A>G as a variant of uncertain significance."	not specified	CN169374:not specified	No Information	FALSE	No Information	"criteria provided, single submitter"	clinical testing	germline:na	GeneDx	SCV000574139.3	SCV000574139		HNF4A	-	"MODY, MODY Extended, MonogenicDM_all"	3/20/17	46962	1	1	"[0.9999893530939908,1.0646906009113752E-5]"	1	SCV000574139415104	single nucleotide variant	NM_000162.3(GCK):c.571C>T (p.Arg191Trp)	2645	GCK	HGNC:4195	Pathogenic	1	7-Nov-17	1085307455	-	RCV000754816;RCV000490143	"MedGen:C1841962,OMIM:125851;MedGen:CN517202"	"Maturity-onset diabetes of the young,  type 2;not provided"	germline	germline	GRCh37	NC_000007.13	7	44189576	44189576	G	A	7p13	"criteria provided, multiple submitters, no conflicts"	3	NA	N	-	2	426122	7	44189576	G	A	415104	7:44189576:G:A	Pathogenic	5/2/17	"The R191W variant has been published previously in association with MODY (Vits et al., 2006; Sagen et al., 2008; Caetano et al., 2012). The variant is not observed in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). R191W is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position within the hexokinase small domain that is conserved across species; the small domain is a hotspot for GCK variants (Tinto et al., 2008). In silico analysis predicts this variant is probably damaging to the protein structure/function. Missense variants in the same residue (R191L/Q) and in nearby residues (R186G/Q, D187Y, A188P/T/V, I189T, R192S, G193W/R) have been reported in the Human Gene Mutation Database in association with diabetes and MODY (Stenson et al., 2014), supporting the functional importance of this region of the protein. In summary, we consider this variant to be pathogenic."	Not Provided	CN517202:not provided	MODY	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	GeneDx	SCV000576488.3	SCV000576488		GCK	-	"MODY, MODY Extended, MonogenicDM_all"	11/7/17	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV00057648829966	duplication	NM_000545.6(HNF1A):c.872dupC (p.Gly292Argfs)	6927	HNF1A	HGNC:11621	Pathogenic	1	6-Nov-17	587776825	-	RCV000016063;RCV000117225;RCV000016064;RCV000022617;RCV000016062;RCV000490055	"Human Phenotype Ontology:HP:0006770,MedGen:C0279702,Orphanet:ORPHA319276,SNOMED CT:188251003,SNOMED CT:254915003;MedGen:C0011854,OMIM:222100,Orphanet:ORPHA181371,SNOMED CT:46635009;MedGen:C2675866,OMIM:612520;MedGen:C1840646,OMIM:142330;MedGen:C1838100,OMIM:600496;MedGen:CN517202"	"Clear cell carcinoma of kidney;Diabetes mellitus type 1;Diabetes mellitus, insulin-dependent, 20;Hepatic adenomas, familial;Maturity-onset diabetes of the young, type 3;not provided"	germline;somatic	germline/somatic	GRCh37	NC_000012.11	12	121432125	121432125	C	CC	12q24.31	"criteria provided, multiple submitters, no conflicts"	4	NA	N	OMIM Allelic Variant:142410.0001	3	14927	12	121432117	G	GC	29966	12:121432117:G:GC	Pathogenic	11/6/17	"The c.872dupC variant in the HNF1A gene has been reported previously in association with maturity-onset diabetes of the young (Simms et al., 2011; Yamagata et al., 1996). The c.872dupC variant causes a frameshift starting with codon Glycine 292, changes this amino acid to an Arginine residue, and creates a premature Stop codon at position 25 of the new reading frame, denoted p.Gly292ArgfsX25. This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. The c.872dupC variant is not observed in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). We interpret c.872dupC as a pathogenic variant."	Not Provided	CN517202:not provided	MODY	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	GeneDx	SCV000576668.3	SCV000576668		HNF1A	-	"MODY, MODY Extended, MonogenicDM_all"	11/6/17	46549	414	17	"[0.9998173967217341,1.8260327826591334E-4]"	17	SCV000576668228142	deletion	NM_000527.4(LDLR):c.654_656delTGG (p.Gly219del)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	25-Jun-18	121908027	-	RCV000211647;RCV000589051;RCV000489033	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:CN517202"	Familial hypercholesterolemia;Familial hypercholesterolemias;not provided	germline;inherited;not applicable	germline	GRCh37	NC_000019.9	19	11216236	11216238	TGG	-	19p13.2	"criteria provided, multiple submitters, no conflicts"	14	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000094,OMIM Allelic Variant:606945.0005"	3	226329	19	11216232	ATGG	A	228142	19:11216232:ATGG:A	Pathogenic	7/19/17	"The c.654_656delTGG pathogenic variant in the LDLR gene, also reported as G197del due to alternate nomenclature, has been reported previously in many individuals from various ethnic backgrounds with a diagnosis of FH (Hobbs et al., 1990; Gudnason et al., 1993; Giesel et al., 1995; Heath et al., 1999; Taylor et al., 2007; Junyent et al., 2008; Tichy et al., 2012; Sharifi et al., 2016). Additionally, this variant is considered a Lithuanian Ashkenazi Jewish founder mutation (Meiner et al., 1991; Gorski et al., 1998; Durst et al., 2001). Furthermore, the c.654_656delTGG variant is not observed in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). This variant results in the in-frame deletion of one amino acid, glycine 219, and does not result in a shift in reading frame or a premature stop codon. Nevertheless, functional studies show that the c.654_656delTGG variant results in slow processing and abnormal rate of transport to the Golgi complex likely due to protein mis-folding (Hobbs et al., 1990)."	Not Provided	CN517202:not provided	familial hypercholesterolemia	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	GeneDx	SCV000577590.3	SCV000577590		LDLR	-	High LDL	6/25/18	46962	1	1	"[0.9999893530939908,1.0646906009113752E-5]"	1	SCV000577590228201	deletion	NM_000527.4(LDLR):c.2271delT (p.Leu759Serfs)	3949	LDLR	HGNC:6547	Pathogenic	1	11-May-17	875989940	-	RCV000211650;RCV000493493	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202"	Familial hypercholesterolemia;not provided	germline	germline	GRCh37	NC_000019.9	19	11233980	11233980	T	-	19p13.2	"criteria provided, multiple submitters, no conflicts"	6	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000890	2	226388	19	11233979	CT	C	228201	19:11233979:CT:C	Pathogenic	5/10/17	"The c.2271delT variant in the LDLR gene has been reported previously in association with familial hypercholesterolemia (Vaca et al., 2011). The c.2271delT variant causes a frameshift starting with codon Leucine 759, changes this amino acid to a Serine residue, and creates a premature Stop codon at position 6 of the new reading frame, denoted p.Leu759SerfsX6. This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. The c.2271delT variant is not observed in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). We interpret c.2271delT as a pathogenic variant."	Not Provided	CN517202:not provided	familial hypercholesterolemia	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	GeneDx	SCV000582114.3	SCV000582114		LDLR	-	High LDL	5/11/17	46963	0	2	"[0.9999787066413985,2.1293358601452207E-5]"	2	SCV000582114171217	single nucleotide variant	NM_000527.4(LDLR):c.1775G>A (p.Gly592Glu)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	31-Oct-18	137929307	-	RCV000172964;RCV000587007;RCV000148576;RCV000162001	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:C0020443;MedGen:CN517202"	Familial hypercholesterolemia;Familial hypercholesterolemias;Hypercholesterolaemia;not provided	germline;inherited;not applicable;unknown	germline	GRCh37	NC_000019.9	19	11227604	11227604	G	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	22	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000237,UniProtKB (protein):P01130#VAR_005403"	2	161271	19	11227604	G	A	171217	19:11227604:G:A	Pathogenic	5/4/18	"The G592E variant in the LDLR gene, previously reported as G571E due to alternate nomenclature, has been reported many times in association with heterozygous FH and homozygous FH (Hobbs et al., 1992; Chmara et al., 2010; Goldman et al., 2010; Bertolini et al., 2013; Mollaki et al., 2014; Braenne et al., 2016; Gabcova et al., 2017). The G592E variant is observed in 15/126,710 (0.01%) alleles from individuals of non-Finnish European background in large population cohorts (Lek et al., 2016). The G592E variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. Functional studies demonstrate that this variant would lead to deficient LDLR protein (Susan-Resiga et al., 2017)."	Not Provided	CN517202:not provided	Familial hypercholesterolemia	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	GeneDx	SCV000582282.4	SCV000582282		LDLR	-	High LDL	10/31/18	46963	0	3	"[0.9999680599620978,3.194003790217831E-5]"	3	SCV00058228244846	single nucleotide variant	NM_000162.3(GCK):c.1160C>T (p.Ala387Val)	2645	GCK	HGNC:4195	Likely pathogenic	1	3-Dec-15	193921338	-	RCV000029845;RCV000493278	"MedGen:C1841962,OMIM:125851;MedGen:CN517202"	"Maturity-onset diabetes of the young,  type 2;not provided"	germline	germline	GRCh37	NC_000007.13	7	44185189	44185189	G	A	7p13	"criteria provided, multiple submitters, no conflicts"	2	NA	N	-	2	36182	7	44185189	G	A	44846	7:44185189:G:A	Likely pathogenic	12/3/15	"The A387V variant has been previously published in association with GCK-MODY (Thomson et al., 2003; Pruhova et al., 2010). The variant was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. A387V is a conservative amino acid substitution, which is not likely to impact secondary protein structure as these residues share similar properties. This substitution occurs at a position that is conserved across species within the hexokinase domain; however, in silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. Missense variants in the same residue (A387E/T) and in nearby residues (G385R/W/V, L386V, G388D) have been reported in the Human Gene Mutation Database in association with MODY (Stenson et al., 2014), supporting the functional importance of this region of the protein. Therefore, this variant is likely pathogenic; however, the possibility that it is benign cannot be excluded"	Not Provided	CN517202:not provided	MODY	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	GeneDx	SCV000582616.3	SCV000582616		GCK	-	"MODY, MODY Extended, MonogenicDM_all"	12/3/15	46297	666	1	"[0.9999892001641575,1.0799835842495194E-5]"	1	SCV000582616245448	single nucleotide variant	NM_000527.4(LDLR):c.268G>A (p.Asp90Asn)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	15-Jun-18	749038326	-	RCV000238573;RCV000494304	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202"	Familial hypercholesterolemia;not provided	germline;not applicable	germline	GRCh37	NC_000019.9	19	11213417	11213417	G	A	19p13.2	"criteria provided, conflicting interpretations"	8	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000041,UniProtKB (protein):P01130#VAR_005311"	2	251105	19	11213417	G	A	245448	19:11213417:G:A	Pathogenic	5/3/17	"The D90N variant in the LDLR gene has been reported previously in association with familial hypercholesterolemia (for examples, see Chang et al., 2003; Norsworthy et al., 2014; Xiang et al., 2017). Functional studies show D90N decreases LDLR on the cell surface and decreases LDL binding and internalization (Chang et al., 2003). This variant is not observed at a significant frequency in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). The D90N variant is a semi-conservative amino acid substitution, which may impact secondary protein structure as these residues differ in some properties. This substitution occurs at a position that is conserved across species, and is located in the LDL-receptor class A 2 domain (Uniprot). Missense variants at the same residue (D90Y, D90G, D90A, c.270T>A and c.270T>G D90E) have been reported in association with familial hypercholesterolemia, supporting the functional importance of this region of the protein (Hobbs et al., 1992; Rubinsztein et al., 1993; Marduel et al., 2010; Kolansky et al., 2008; Gabcova et al., 2016). Based on the ACMG recommendations, D90N is interpreted as a known pathogenic sequence change."	Not Provided	CN517202:not provided	familial hypercholesterolemia	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	GeneDx	SCV000582689.3	SCV000582689		LDLR	-	High LDL	6/15/18	46963	0	8	"[0.9999148265655942,8.517343440580883E-5]"	8	SCV00058268948709	single nucleotide variant	NM_000384.2(APOB):c.10579C>T (p.Arg3527Trp)	338	APOB	HGNC:603	Conflicting interpretations of pathogenicity	1	3-Jul-18	144467873	-	RCV000408839;RCV000231844;RCV000627798;RCV000627798;RCV000494148	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C1704417,OMIM:144010;MedGen:C1704417,OMIM:144010;MedGen:C4551990,OMIM:615558;MedGen:CN517202"	"Familial hypercholesterolemia;Hypercholesterolemia, autosomal dominant, type B;Hypercholesterolemia, autosomal dominant, type B;Hypobetalipoproteinemia, familial, 1;not provided"	germline	germline	GRCh37	NC_000002.11	2	21229161	21229161	G	A	2p24	"criteria provided, conflicting interpretations"	8	"ACMG2013,ACMG2016"	Y	-	3	40223	2	21229161	G	A	48709	2:21229161:G:A	Pathogenic	5/24/17	"The R3527W variant in the APOB gene has been reported previously in association with hypercholesterolemia using alternate nomenclature, R3500W (Gaffney et al., 1995; Tai et al., 1998; Fisher et al., 1999). The R3527W variant is observed in 11/8642 (0.1%) alleles from individuals of East Asian background in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). The R3527W variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is conserved in mammals. Functional studies demonstrated the R3500W variant reduced APOB capacity for binding, uptake and degradation of LDL (Fisher et al., 1999). Furthermore, a different missense variant affecting the same residue (R3527Q) has been reported in the Human Gene Mutation Database in association with an APOB-related disorder (Stenson et al., 2014), supporting the functional importance of this region of the protein. We interpret R3527W as a pathogenic variant."	Not Provided	CN517202:not provided	Familial hypercholesterolemia	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	GeneDx	SCV000583115.3	SCV000583115		APOB	-	Low LDL	7/3/18	46963	0	14	"[0.9998509464897898,1.4905351021016544E-4]"	14	SCV000583115243266	single nucleotide variant	NM_000527.4(LDLR):c.12G>A (p.Trp4Ter)	3949	LDLR	HGNC:6547	Pathogenic	1	30-Mar-17	756039188	-	RCV000227275	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline	germline	GRCh37	NC_000019.9	19	11200236	11200236	G	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	5	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000357	2	237860	19	11200236	G	A	243266	19:11200236:G:A	Pathogenic	3/30/17	ACMG Guidelines: Pathogenic (i)	Familial Hypercholesterolemia	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:4	"U4M - Lille University & CHRU Lille,Université Lille 2 - CHRU de Lille"	SCV000583622.1	SCV000583622		LDLR	-	High LDL	3/30/17	46919	44	1	"[0.9999893433363882,1.0656663611756432E-5]"	1	SCV000583622228117	single nucleotide variant	NM_000527.4(LDLR):c.81C>G (p.Cys27Trp)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	30-Mar-17	2228671	-	RCV000211569;RCV000588365	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445"	Familial hypercholesterolemia;Familial hypercholesterolemias	germline;unknown	germline	GRCh37	NC_000019.9	19	11210912	11210912	C	G	19p13.2	"criteria provided, conflicting interpretations"	10	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000352,UniProtKB (protein):P01130#VAR_005304"	2	226304	19	11210912	C	G	228117	19:11210912:C:G	Pathogenic	3/30/17	ACMG Guidelines: Pathogenic (ii)	Familial Hypercholesterolemia	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:8	"U4M - Lille University & CHRU Lille,Université Lille 2 - CHRU de Lille"	SCV000583627.1	SCV000583627		LDLR	-	High LDL	3/30/17	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV000583627424291	single nucleotide variant	NM_000527.4(LDLR):c.82G>A (p.Glu28Lys)	3949	LDLR	HGNC:6547	Likely pathogenic	1	30-Mar-17	551747280	-	RCV000495866	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline	germline	GRCh37	NC_000019.9	19	11210913	11210913	G	A	19p13.2	"criteria provided, single submitter"	2	"ACMG2013,ACMG2016"	N	-	2	430745	19	11210913	G	A	424291	19:11210913:G:A	Likely pathogenic	3/30/17	ACMG Guidelines: Pathogenic (i)	Familial Hypercholesterolemia	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:2	"U4M - Lille University & CHRU Lille,Université Lille 2 - CHRU de Lille"	SCV000583628.1	SCV000583628		LDLR	-	High LDL	3/30/17	46963	0	77	"[0.9991802056938441,8.1979430615591E-4]"	77	SCV00058362818780	single nucleotide variant	NM_000527.4(LDLR):c.131G>A (p.Trp44Ter)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	14-Nov-17	267607213	-	RCV000003939	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline;inherited	germline	GRCh37	NC_000019.9	19	11210962	11210962	G	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	13	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000019,OMIM Allelic Variant:606945.0060"	3	3741	19	11210962	G	A	18780	19:11210962:G:A	Pathogenic	3/30/17	ACMG Guidelines: Pathogenic (ii)	Familial Hypercholesterolemia	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:10	"U4M - Lille University & CHRU Lille,Université Lille 2 - CHRU de Lille"	SCV000583633.1	SCV000583633		LDLR	-	High LDL	11/14/17	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV00058363378990	single nucleotide variant	NM_000527.4(LDLR):c.148G>T (p.Ala50Ser)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	30-Nov-17	137853960	-	RCV000210234;RCV000148578;RCV000058916;RCV000455660	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202;MedGen:CN169374"	Familial hypercholesterolemia;Hypercholesterolaemia;not provided;not specified	germline;unknown	germline	GRCh37	NC_000019.9	19	11210979	11210979	G	T	19p13.2	"criteria provided, conflicting interpretations"	13	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000021,UniProtKB (protein):P01130#VAR_007979"	2	68099	19	11210979	G	T	78990	19:11210979:G:T	Likely benign	3/30/17	ACMG Guidelines: Pathogenic (ii)	Familial Hypercholesterolemia	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:6	"U4M - Lille University & CHRU Lille,Université Lille 2 - CHRU de Lille"	SCV000583635.1	SCV000583635		LDLR	-	High LDL	11/30/17	46963	0	43	"[0.9995421927900687,4.5780720993122243E-4]"	43	SCV00058363518724	single nucleotide variant	NM_000527.4(LDLR):c.259T>G (p.Trp87Gly)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	8-Jun-18	121908025	-	RCV000003870;RCV000622852	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202"	Familial hypercholesterolemia;not provided	germline;inherited	germline	GRCh37	NC_000019.9	19	11213408	11213408	T	G	19p13.2	"criteria provided, multiple submitters, no conflicts"	11	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_001671,OMIM Allelic Variant:606945.0003,UniProtKB (protein):P01130#VAR_005308"	3	3685	19	11213408	T	G	18724	19:11213408:T:G	Pathogenic	3/30/17	-	Familial Hypercholesterolemia	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:16	"U4M - Lille University & CHRU Lille,Université Lille 2 - CHRU de Lille"	SCV000583644.1	SCV000583644		LDLR	-	High LDL	6/8/18	46963	0	3	"[0.9999680599620978,3.194003790217831E-5]"	3	SCV000583644245448	single nucleotide variant	NM_000527.4(LDLR):c.268G>A (p.Asp90Asn)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	15-Jun-18	749038326	-	RCV000238573;RCV000494304	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202"	Familial hypercholesterolemia;not provided	germline;not applicable	germline	GRCh37	NC_000019.9	19	11213417	11213417	G	A	19p13.2	"criteria provided, conflicting interpretations"	8	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000041,UniProtKB (protein):P01130#VAR_005311"	2	251105	19	11213417	G	A	245448	19:11213417:G:A	Pathogenic	3/30/17	-	Familial Hypercholesterolemia	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:3	"U4M - Lille University & CHRU Lille,Université Lille 2 - CHRU de Lille"	SCV000583645.1	SCV000583645		LDLR	-	High LDL	6/15/18	46963	0	8	"[0.9999148265655942,8.517343440580883E-5]"	8	SCV000583645171199	single nucleotide variant	NM_000527.4(LDLR):c.301G>A (p.Glu101Lys)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	31-Oct-18	144172724	-	RCV000211583;RCV000148571;RCV000162016	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202"	Familial hypercholesterolemia;Hypercholesterolaemia;not provided	germline;not applicable;unknown	germline	GRCh37	NC_000019.9	19	11213450	11213450	G	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	15	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000044,UniProtKB (protein):P01130#VAR_005315"	2	161266	19	11213450	G	A	171199	19:11213450:G:A	Pathogenic	3/30/17	-	Familial Hypercholesterolemia	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:10	"U4M - Lille University & CHRU Lille,Université Lille 2 - CHRU de Lille"	SCV000583649.1	SCV000583649		LDLR	-	High LDL	10/31/18	46963	0	3	"[0.9999680599620978,3.194003790217831E-5]"	3	SCV000583649245493	single nucleotide variant	NM_000527.4(LDLR):c.325T>C (p.Cys109Arg)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	30-Mar-17	140807148	-	RCV000237408	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline;inherited	germline	GRCh37	NC_000019.9	19	11215907	11215907	T	C	19p13.2	"criteria provided, multiple submitters, no conflicts"	5	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_001701,UniProtKB (protein):P01130#VAR_005316"	2	251156	19	11215907	T	C	245493	19:11215907:T:C	Pathogenic	3/30/17	-	Familial Hypercholesterolemia	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:16	"U4M - Lille University & CHRU Lille,Université Lille 2 - CHRU de Lille"	SCV000583661.1	SCV000583661		LDLR	-	High LDL	3/30/17	46961	2	4	"[0.9999574114690913,4.2588530908626306E-5]"	4	SCV000583661245500	single nucleotide variant	NM_000527.4(LDLR):c.343C>T (p.Arg115Cys)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	30-Mar-17	774723292	-	RCV000238127	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline	germline	GRCh37	NC_000019.9	19	11215925	11215925	C	T	19p13.2	"criteria provided, conflicting interpretations"	4	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_001036	2	251162	19	11215925	C	T	245500	19:11215925:C:T	Pathogenic	3/30/17	-	Familial Hypercholesterolemia	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:2	"U4M - Lille University & CHRU Lille,Université Lille 2 - CHRU de Lille"	SCV000583664.1	SCV000583664		LDLR	-	High LDL	3/30/17	46962	1	6	"[0.9999361185639453,6.388143605468251E-5]"	6	SCV000583664228138	single nucleotide variant	NM_000527.4(LDLR):c.429C>A (p.Cys143Ter)	3949	LDLR	HGNC:6547	Pathogenic	1	5-Dec-17	199774121	-	RCV000211567	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline	germline	GRCh37	NC_000019.9	19	11216011	11216011	C	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	7	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_001734	2	226325	19	11216011	C	A	228138	19:11216011:C:A	Pathogenic	3/30/17	-	Familial Hypercholesterolemia	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:35	"U4M - Lille University & CHRU Lille,Université Lille 2 - CHRU de Lille"	SCV000583677.1	SCV000583677		LDLR	-	High LDL	12/5/17	46963	0	2	"[0.9999787066413985,2.1293358601452207E-5]"	2	SCV00058367718765	single nucleotide variant	NM_000527.4(LDLR):c.523G>A (p.Asp175Asn)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	2-Jan-18	121908033	-	RCV000003924	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline	germline	GRCh37	NC_000019.9	19	11216105	11216105	G	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	7	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_001755,OMIM Allelic Variant:606945.0044,UniProtKB (protein):P01130#VAR_005326"	3	3726	19	11216105	G	A	18765	19:11216105:G:A	Pathogenic	3/30/17	-	Familial Hypercholesterolemia	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:7	"U4M - Lille University & CHRU Lille,Université Lille 2 - CHRU de Lille"	SCV000583693.1	SCV000583693		LDLR	-	High LDL	1/2/18	46963	0	2	"[0.9999787066413985,2.1293358601452207E-5]"	2	SCV000583693228142	deletion	NM_000527.4(LDLR):c.654_656delTGG (p.Gly219del)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	25-Jun-18	121908027	-	RCV000211647;RCV000589051;RCV000489033	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:CN517202"	Familial hypercholesterolemia;Familial hypercholesterolemias;not provided	germline;inherited;not applicable	germline	GRCh37	NC_000019.9	19	11216236	11216238	TGG	-	19p13.2	"criteria provided, multiple submitters, no conflicts"	14	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000094,OMIM Allelic Variant:606945.0005"	3	226329	19	11216232	ATGG	A	228142	19:11216232:ATGG:A	Pathogenic	3/30/17	-	Familial Hypercholesterolemia	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:2	"U4M - Lille University & CHRU Lille,Université Lille 2 - CHRU de Lille"	SCV000583714.1	SCV000583714		LDLR	-	High LDL	6/25/18	46962	1	1	"[0.9999893530939908,1.0646906009113752E-5]"	1	SCV000583714181233	single nucleotide variant	NM_000527.4(LDLR):c.662A>G (p.Asp221Gly)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	3-Apr-17	373822756	-	RCV000211655;RCV000161962	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202"	Familial hypercholesterolemia;not provided	germline;inherited;not applicable	germline	GRCh37	NC_000019.9	19	11216244	11216244	A	G	19p13.2	"criteria provided, multiple submitters, no conflicts"	14	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000096,UniProtKB (protein):P01130#VAR_005332"	2	183092	19	11216244	A	G	181233	19:11216244:A:G	Pathogenic	3/30/17	-	Familial Hypercholesterolemia	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:27	"U4M - Lille University & CHRU Lille,Université Lille 2 - CHRU de Lille"	SCV000583715.1	SCV000583715		LDLR	-	High LDL	4/3/17	46959	4	1	"[0.9999893524138078,1.0647586192210225E-5]"	1	SCV00058371518729	single nucleotide variant	NM_000527.4(LDLR):c.681C>G (p.Asp227Glu)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	30-Jun-17	121908028	-	RCV000003876	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline;not applicable	germline	GRCh37	NC_000019.9	19	11216263	11216263	C	G	19p13.2	"criteria provided, multiple submitters, no conflicts"	10	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_001815,OMIM Allelic Variant:606945.0006,UniProtKB (protein):P01130#VAR_005338"	3	3690	19	11216263	C	G	18729	19:11216263:C:G	Pathogenic	3/30/17	-	Familial Hypercholesterolemia	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:10	"U4M - Lille University & CHRU Lille,Université Lille 2 - CHRU de Lille"	SCV000583721.1	SCV000583721		LDLR	-	High LDL	6/30/17	46946	17	1	"[0.9999893494653431,1.0650534656839773E-5]"	1	SCV00058372118730	single nucleotide variant	NM_000527.4(LDLR):c.682G>A (p.Glu228Lys)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	31-Oct-18	121908029	-	RCV000735406;RCV000735406;RCV000735406;RCV000003878;RCV000735406;RCV000735406;RCV000623885	"Human Phenotype Ontology:HP:0002647,MedGen:C0340643;Human Phenotype Ontology:HP:0012158,MedGen:C0338585;Human Phenotype Ontology:HP:0012474,MedGen:C0265101;MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;Human Phenotype Ontology:HP:0012159,MedGen:C0751815;Human Phenotype Ontology:HP:0001297,MedGen:C0038454;MedGen:CN517202"	Aortic dissection;Carotid artery dissection;Carotid artery occlusion;Familial hypercholesterolemia;Internal carotid artery dissection;Stroke;not provided	germline;unknown	germline	GRCh37	NC_000019.9	19	11216264	11216264	G	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	19	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000105,OMIM Allelic Variant:606945.0007,UniProtKB (protein):P01130#VAR_005341"	3	3691	19	11216264	G	A	18730	19:11216264:G:A	Pathogenic	3/30/17	-	Familial Hypercholesterolemia	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:20	"U4M - Lille University & CHRU Lille,Université Lille 2 - CHRU de Lille"	SCV000583724.1	SCV000583724		LDLR	-	High LDL	10/31/18	46944	19	2	"[0.9999786980231765,2.1301976823449217E-5]"	2	SCV000583724245730	single nucleotide variant	NM_000527.4(LDLR):c.682G>C (p.Glu228Gln)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	15-Aug-17	121908029	-	RCV000237530	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline;unknown	germline	GRCh37	NC_000019.9	19	11216264	11216264	G	C	19p13.2	"criteria provided, multiple submitters, no conflicts"	6	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_001817,UniProtKB (protein):P01130#VAR_005340"	2	251393	19	11216264	G	C	245730	19:11216264:G:C	Pathogenic	3/30/17	-	Familial Hypercholesterolemia	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:4	"U4M - Lille University & CHRU Lille,Université Lille 2 - CHRU de Lille"	SCV000583725.1	SCV000583725		LDLR	-	High LDL	8/15/17	46944	19	4	"[0.9999573960463531,4.2603953646898434E-5]"	4	SCV000583725228146	single nucleotide variant	NM_000527.4(LDLR):c.682G>T (p.Glu228Ter)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	31-Oct-18	121908029	-	RCV000211631;RCV000589867;RCV000518828	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:CN517202"	Familial hypercholesterolemia;Familial hypercholesterolemias;not provided	germline;not applicable;unknown	germline	GRCh37	NC_000019.9	19	11216264	11216264	G	T	19p13.2	"criteria provided, multiple submitters, no conflicts"	12	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_001818	2	226333	19	11216264	G	T	228146	19:11216264:G:T	Pathogenic	3/30/17	-	Familial Hypercholesterolemia	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:5	"U4M - Lille University & CHRU Lille,Université Lille 2 - CHRU de Lille"	SCV000583726.1	SCV000583726		LDLR	-	High LDL	10/31/18	46944	19	1	"[0.9999893490115883,1.0650988411724608E-5]"	1	SCV000583726198013	single nucleotide variant	NM_000527.4(LDLR):c.718G>A (p.Glu240Lys)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	22-May-18	768563000	-	RCV000211564;RCV000586018;RCV000182341	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:CN517202"	Familial hypercholesterolemia;Familial hypercholesterolemias;not provided	germline	germline	GRCh37	NC_000019.9	19	11217264	11217264	G	A	19p13.2	"criteria provided, conflicting interpretations"	9	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_001828,UniProtKB (protein):P01130#VAR_005343"	2	200920	19	11217264	G	A	198013	19:11217264:G:A	Pathogenic	3/30/17	-	Familial Hypercholesterolemia	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:2	"U4M - Lille University & CHRU Lille,Université Lille 2 - CHRU de Lille"	SCV000583731.1	SCV000583731		LDLR	-	High LDL	5/22/18	46963	0	3	"[0.9999680599620978,3.194003790217831E-5]"	3	SCV000583731171200	single nucleotide variant	NM_000527.4(LDLR):c.757C>T (p.Arg253Trp)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	30-Mar-17	150673992	-	RCV000172958;RCV000148562;RCV000162019	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202"	Familial hypercholesterolemia;Hypercholesterolaemia;not provided	germline;not applicable	germline	GRCh37	NC_000019.9	19	11217303	11217303	C	T	19p13.2	"criteria provided, conflicting interpretations"	8	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000111,UniProtKB (protein):P01130#VAR_013952"	2	161261	19	11217303	C	T	171200	19:11217303:C:T	Pathogenic	3/30/17	-	Familial Hypercholesterolemia	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:2	"U4M - Lille University & CHRU Lille,Université Lille 2 - CHRU de Lille"	SCV000583735.1	SCV000583735		LDLR	-	High LDL	3/30/17	46963	0	28	"[0.9997018929795797,2.981070204203309E-4]"	28	SCV000583735245782	single nucleotide variant	NM_000527.4(LDLR):c.769C>T (p.Arg257Trp)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	29-Jun-18	200990725	-	RCV000237953	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline	germline	GRCh37	NC_000019.9	19	11217315	11217315	C	T	19p13.2	"criteria provided, conflicting interpretations"	8	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000115,UniProtKB (protein):P01130#VAR_072836"	2	251446	19	11217315	C	T	245782	19:11217315:C:T	Pathogenic	3/30/17	-	Familial Hypercholesterolemia	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:2	"U4M - Lille University & CHRU Lille,Université Lille 2 - CHRU de Lille"	SCV000583738.1	SCV000583738		LDLR	-	High LDL	6/29/18	46963	0	14	"[0.9998509464897898,1.4905351021016544E-4]"	14	SCV000583738228147	single nucleotide variant	NM_000527.4(LDLR):c.796G>A (p.Asp266Asn)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	19-Sep-17	875989907	-	RCV000211615	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline;inherited	germline	GRCh37	NC_000019.9	19	11217342	11217342	G	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	8	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000469	2	226334	19	11217342	G	A	228147	19:11217342:G:A	Pathogenic	3/30/17	-	Familial Hypercholesterolemia	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:2	"U4M - Lille University & CHRU Lille,Université Lille 2 - CHRU de Lille"	SCV000583740.1	SCV000583740		LDLR	-	High LDL	9/19/17	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV000583740171201	single nucleotide variant	NM_000527.4(LDLR):c.798T>A (p.Asp266Glu)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	17-May-18	139043155	-	RCV000172959;RCV000148594;RCV000162020	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202"	Familial hypercholesterolemia;Hypercholesterolaemia;not provided	germline;inherited;not applicable;unknown	germline	GRCh37	NC_000019.9	19	11217344	11217344	T	A	19p13.2	"criteria provided, conflicting interpretations"	16	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000117,UniProtKB (protein):P01130#VAR_005347"	2	161287	19	11217344	T	A	171201	19:11217344:T:A	Pathogenic	3/30/17	-	Familial Hypercholesterolemia	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:6	"U4M - Lille University & CHRU Lille,Université Lille 2 - CHRU de Lille"	SCV000583741.1	SCV000583741		LDLR	-	High LDL	5/17/18	46963	0	2	"[0.9999787066413985,2.1293358601452207E-5]"	2	SCV000583741171202	single nucleotide variant	NM_000527.4(LDLR):c.806G>A (p.Gly269Asp)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	17-Oct-17	143992984	-	RCV000210247;RCV000148586;RCV000161966	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202"	Familial hypercholesterolemia;Hypercholesterolaemia;not provided	germline;not applicable	germline	GRCh37	NC_000019.9	19	11217352	11217352	G	A	19p13.2	"criteria provided, conflicting interpretations"	13	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000504	2	161279	19	11217352	G	A	171202	19:11217352:G:A	Likely pathogenic	3/30/17	-	Familial Hypercholesterolemia	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:2	"U4M - Lille University & CHRU Lille,Université Lille 2 - CHRU de Lille"	SCV000583743.1	SCV000583743		LDLR	-	High LDL	10/17/17	46963	0	33	"[0.999648659583076,3.513404169239614E-4]"	33	SCV000583743181238	single nucleotide variant	NM_000527.4(LDLR):c.829G>A (p.Glu277Lys)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	29-Dec-17	148698650	-	RCV000210246;RCV000495914;RCV000161968;RCV000610848	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202;MedGen:CN169374"	Familial hypercholesterolemia;Familial hypercholesterolemia;not provided;not specified	germline;not applicable;unknown	germline	GRCh37	NC_000019.9	19	11218079	11218079	G	A	19p13.2	"criteria provided, conflicting interpretations"	12	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_001845,UniProtKB (protein):P01130#VAR_005350"	2	183097	19	11218079	G	A	181238	19:11218079:G:A	Pathogenic	3/30/17	-	Familial Hypercholesterolemia	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:18	"U4M - Lille University & CHRU Lille,Université Lille 2 - CHRU de Lille"	SCV000583745.1	SCV000583745		LDLR	-	High LDL	12/29/17	46963	0	61	"[0.9993505525626557,6.494474373442923E-4]"	61	SCV000583745171204	single nucleotide variant	NM_000527.4(LDLR):c.862G>A (p.Glu288Lys)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	1-May-18	368657165	-	RCV000234348;RCV000148573	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443"	Familial hypercholesterolemia;Hypercholesterolaemia	germline	germline	GRCh37	NC_000019.9	19	11218112	11218112	G	A	19p13.2	"criteria provided, conflicting interpretations"	11	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000509,UniProtKB (protein):P01130#VAR_007983"	2	161268	19	11218112	G	A	171204	19:11218112:G:A	Pathogenic	3/30/17	-	Familial Hypercholesterolemia	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:5	"U4M - Lille University & CHRU Lille,Université Lille 2 - CHRU de Lille"	SCV000583752.1	SCV000583752		LDLR	-	High LDL	5/1/18	46963	0	8	"[0.9999148265655942,8.517343440580883E-5]"	8	SCV00058375218731	single nucleotide variant	NM_000527.4(LDLR):c.910G>A (p.Asp304Asn)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	10-Apr-18	121908030	-	RCV000003880;RCV000148569;RCV000622705	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MeSH:D030342,MedGen:C0950123"	Familial hypercholesterolemia;Hypercholesterolaemia;Inborn genetic diseases	germline;inherited;not applicable	germline	GRCh37	NC_000019.9	19	11218160	11218160	G	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	10	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_001861,OMIM Allelic Variant:606945.0008,UniProtKB (protein):P01130#VAR_005355"	3	3692	19	11218160	G	A	18731	19:11218160:G:A	Pathogenic	3/30/17	-	Familial Hypercholesterolemia	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:5	"U4M - Lille University & CHRU Lille,Université Lille 2 - CHRU de Lille"	SCV000583757.1	SCV000583757		LDLR	-	High LDL	4/10/18	46963	0	3	"[0.9999680599620978,3.194003790217831E-5]"	3	SCV000583757226399	single nucleotide variant	NM_000527.4(LDLR):c.941-4G>A	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	12-Jan-18	116405216	-	RCV000210248;RCV000736080	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN169374"	Familial hypercholesterolemia;not specified	germline;unknown	germline	GRCh37	NC_000019.9	19	11221324	11221324	G	A	19p13.2	"criteria provided, conflicting interpretations"	10	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000515	2	224619	19	11221324	G	A	226399	19:11221324:G:A	Likely pathogenic	3/30/17	-	Familial Hypercholesterolemia	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:6	"U4M - Lille University & CHRU Lille,Université Lille 2 - CHRU de Lille"	SCV000583767.1	SCV000583767		LDLR	-	High LDL	1/12/18	46963	0	399	"[0.9957519749590102,0.004248025040989715]"	389	SCV000583767245891	single nucleotide variant	NM_000527.4(LDLR):c.949G>A (p.Glu317Lys)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	30-Mar-17	746834464	-	RCV000237913	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline	germline	GRCh37	NC_000019.9	19	11221336	11221336	G	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	3	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000149	2	251567	19	11221336	G	A	245891	19:11221336:G:A	Pathogenic	3/30/17	-	Familial Hypercholesterolemia	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:3	"U4M - Lille University & CHRU Lille,Université Lille 2 - CHRU de Lille"	SCV000583768.1	SCV000583768		LDLR	-	High LDL	3/30/17	46963	0	4	"[0.9999574132827971,4.2586717202904415E-5]"	4	SCV000583768171207	single nucleotide variant	NM_000527.4(LDLR):c.970G>A (p.Gly324Ser)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	5-Oct-17	72658860	-	RCV000237236;RCV000148566;RCV000162021;RCV000455308	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202;MedGen:CN169374"	Familial hypercholesterolemia;Hypercholesterolaemia;not provided;not specified	germline;not applicable	germline	GRCh37	NC_000019.9	19	11221357	11221357	G	A	19p13.2	"criteria provided, conflicting interpretations"	11	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000640	2	161263	19	11221357	G	A	171207	19:11221357:G:A	Pathogenic	3/30/17	-	Familial Hypercholesterolemia	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:5	"U4M - Lille University & CHRU Lille,Université Lille 2 - CHRU de Lille"	SCV000583771.1	SCV000583771		LDLR	-	High LDL	10/5/17	46961	2	186	"[0.9980196333127489,0.001980366687251123]"	186	SCV000583771181247	single nucleotide variant	NM_000527.4(LDLR):c.1027G>A (p.Gly343Ser)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	5-Jul-18	730882096	-	RCV000211596;RCV000587327;RCV000161977	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:CN517202"	Familial hypercholesterolemia;Familial hypercholesterolemias;not provided	germline;not applicable	germline	GRCh37	NC_000019.9	19	11221414	11221414	G	A	19p13.2	"criteria provided, conflicting interpretations"	15	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_001328,UniProtKB (protein):P01130#VAR_005367"	2	183106	19	11221414	G	A	181247	19:11221414:G:A	Pathogenic	3/30/17	-	Familial Hypercholesterolemia	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:12	"U4M - Lille University & CHRU Lille,Université Lille 2 - CHRU de Lille"	SCV000583777.1	SCV000583777		LDLR	-	High LDL	7/5/18	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV000583777245988	single nucleotide variant	NM_000527.4(LDLR):c.1103G>A (p.Cys368Tyr)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	5-Jun-18	768430352	-	RCV000237712	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline	germline	GRCh37	NC_000019.9	19	11222232	11222232	G	A	19p13.2	"criteria provided, conflicting interpretations"	8	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_001357,UniProtKB (protein):P01130#VAR_072844"	2	251665	19	11222232	G	A	245988	19:11222232:G:A	Pathogenic	3/30/17	-	Familial Hypercholesterolemia	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:3	"U4M - Lille University & CHRU Lille,Université Lille 2 - CHRU de Lille"	SCV000583789.1	SCV000583789		LDLR	-	High LDL	6/5/18	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV000583789256754	single nucleotide variant	NM_000527.4(LDLR):c.1167G>A (p.Thr389=)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	30-Mar-17	139066906	-	RCV000495926;RCV000249917	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN169374"	Familial hypercholesterolemia;not specified	germline	germline	GRCh37	NC_000019.9	19	11222296	11222296	G	A	19p13.2	"criteria provided, conflicting interpretations"	2	"ACMG2013,ACMG2016"	N	-	2	256365	19	11222296	G	A	256754	19:11222296:G:A	Likely pathogenic	3/30/17	-	Familial Hypercholesterolemia	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:2	"U4M - Lille University & CHRU Lille,Université Lille 2 - CHRU de Lille"	SCV000583796.1	SCV000583796		LDLR	-	High LDL	3/30/17	46963	0	19	"[0.9997977130932862,2.0228690671379596E-4]"	19	SCV000583796228162	single nucleotide variant	NM_000527.4(LDLR):c.1187-10G>A	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	30-Mar-17	765696008	-	RCV000211627;RCV000588170	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445"	Familial hypercholesterolemia;Familial hypercholesterolemias	germline	germline	GRCh37	NC_000019.9	19	11223944	11223944	G	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	10	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000172	2	226349	19	11223944	G	A	228162	19:11223944:G:A	Pathogenic	3/30/17	-	Familial Hypercholesterolemia	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:5	"U4M - Lille University & CHRU Lille,Université Lille 2 - CHRU de Lille"	SCV000583801.1	SCV000583801		LDLR	-	High LDL	3/30/17	46963	0	4	"[0.9999574132827971,4.2586717202904415E-5]"	4	SCV000583801226400	single nucleotide variant	NM_000527.4(LDLR):c.1194C>T (p.Ile398=)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	2-Jan-18	13306498	-	RCV000210233	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline	germline	GRCh37	NC_000019.9	19	11223961	11223961	C	T	19p13.2	"criteria provided, conflicting interpretations"	5	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_001231	2	224620	19	11223961	C	T	226400	19:11223961:C:T	Likely pathogenic	3/30/17	-	Familial Hypercholesterolemia	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:2	"U4M - Lille University & CHRU Lille,Université Lille 2 - CHRU de Lille"	SCV000583803.1	SCV000583803		LDLR	-	High LDL	1/2/18	46962	1	134	"[0.9985733145947787,0.0014266854052212426]"	134	SCV000583803228164	single nucleotide variant	NM_000527.4(LDLR):c.1216C>T (p.Arg406Trp)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	30-Mar-17	121908043	-	RCV000211575	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline	germline	GRCh37	NC_000019.9	19	11223983	11223983	C	T	19p13.2	"criteria provided, multiple submitters, no conflicts"	9	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000177,UniProtKB (protein):P01130#VAR_072847"	2	226351	19	11223983	C	T	228164	19:11223983:C:T	Pathogenic	3/30/17	-	Familial Hypercholesterolemia	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:3	"U4M - Lille University & CHRU Lille,Université Lille 2 - CHRU de Lille"	SCV000583806.1	SCV000583806		LDLR	-	High LDL	3/30/17	46963	0	2	"[0.9999787066413985,2.1293358601452207E-5]"	2	SCV000583806230981	single nucleotide variant	NM_000527.4(LDLR):c.1217G>A (p.Arg406Gln)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	30-Mar-17	552422789	-	RCV000238261;RCV000223047	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN169374"	Familial hypercholesterolemia;not specified	germline	germline	GRCh37	NC_000019.9	19	11223984	11223984	G	A	19p13.2	"criteria provided, conflicting interpretations"	6	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000650,UniProtKB (protein):P01130#VAR_013954"	2	228798	19	11223984	G	A	230981	19:11223984:G:A	Pathogenic	3/30/17	-	Familial Hypercholesterolemia	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:13	"U4M - Lille University & CHRU Lille,Université Lille 2 - CHRU de Lille"	SCV000583807.1	SCV000583807		LDLR	-	High LDL	3/30/17	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV00058380745116	single nucleotide variant	NM_000527.4(LDLR):c.1222G>A (p.Glu408Lys)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	23-Jan-18	137943601	-	RCV000030125;RCV000148564	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443"	Familial hypercholesterolemia;Hypercholesterolaemia	germline;unknown	germline	GRCh37	NC_000019.9	19	11223989	11223989	G	A	19p13.2	"criteria provided, conflicting interpretations"	12	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_001379,UniProtKB (protein):P01130#VAR_005378"	2	36453	19	11223989	G	A	45116	19:11223989:G:A	Pathogenic	3/30/17	-	Familial Hypercholesterolemia	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:30	"U4M - Lille University & CHRU Lille,Université Lille 2 - CHRU de Lille"	SCV000583809.1	SCV000583809		LDLR	-	High LDL	1/23/18	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV00058380918733	single nucleotide variant	NM_000527.4(LDLR):c.1285G>A (p.Val429Met)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	31-Oct-18	28942078	-	RCV000003882	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline;inherited;unknown	germline	GRCh37	NC_000019.9	19	11224052	11224052	G	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	14	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_001387,OMIM Allelic Variant:606945.0009,UniProtKB (protein):P01130#VAR_005383"	3	3694	19	11224052	G	A	18733	19:11224052:G:A	Pathogenic	3/30/17	-	Familial Hypercholesterolemia	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:17	"U4M - Lille University & CHRU Lille,Université Lille 2 - CHRU de Lille"	SCV000583816.1	SCV000583816		LDLR	-	High LDL	10/31/18	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV00058381618734	single nucleotide variant	NM_000527.4(LDLR):c.1291G>A (p.Ala431Thr)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	30-Mar-17	28942079	-	RCV000003883	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline;unknown	germline	GRCh37	NC_000019.9	19	11224058	11224058	G	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	13	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000184,OMIM Allelic Variant:606945.0010,UniProtKB (protein):P01130#VAR_005384"	3	3695	19	11224058	G	A	18734	19:11224058:G:A	Pathogenic	3/30/17	-	Familial Hypercholesterolemia	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:16	"U4M - Lille University & CHRU Lille,Université Lille 2 - CHRU de Lille"	SCV000583817.1	SCV000583817		LDLR	-	High LDL	3/30/17	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV000583817246112	single nucleotide variant	NM_000527.4(LDLR):c.1342C>T (p.Gln448Ter)	3949	LDLR	HGNC:6547	Pathogenic	1	30-Mar-17	879254871	-	RCV000238528	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline	germline	GRCh37	NC_000019.9	19	11224109	11224109	C	T	19p13.2	"criteria provided, multiple submitters, no conflicts"	7	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000730	2	251798	19	11224109	C	T	246112	19:11224109:C:T	Pathogenic	3/30/17	-	Familial Hypercholesterolemia	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:3	"U4M - Lille University & CHRU Lille,Université Lille 2 - CHRU de Lille"	SCV000583823.1	SCV000583823		LDLR	-	High LDL	3/30/17	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV000583823172183	single nucleotide variant	NM_000527.4(LDLR):c.1359-1G>A	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	16-Jan-18	139617694	-	RCV000172962;RCV000149884	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443"	Familial hypercholesterolemia;Hypercholesterolaemia	germline	germline	GRCh37	NC_000019.9	19	11224210	11224210	G	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	12	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_001405	2	162499	19	11224210	G	A	172183	19:11224210:G:A	Pathogenic	3/30/17	-	Familial Hypercholesterolemia	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:33	"U4M - Lille University & CHRU Lille,Université Lille 2 - CHRU de Lille"	SCV000583825.1	SCV000583825		LDLR	-	High LDL	1/16/18	46961	2	1	"[0.9999893528672729,1.0647132727156576E-5]"	1	SCV000583825171213	single nucleotide variant	NM_000527.4(LDLR):c.1432G>A (p.Gly478Arg)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	26-Apr-18	144614838	-	RCV000211688;RCV000148583	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443"	Familial hypercholesterolemia;Hypercholesterolaemia	germline;unknown	germline	GRCh37	NC_000019.9	19	11224284	11224284	G	A	19p13.2	"criteria provided, conflicting interpretations"	13	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000198,UniProtKB (protein):P01130#VAR_005390"	2	161277	19	11224284	G	A	171213	19:11224284:G:A	Pathogenic	3/30/17	-	Familial Hypercholesterolemia	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:8	"U4M - Lille University & CHRU Lille,Université Lille 2 - CHRU de Lille"	SCV000583830.1	SCV000583830		LDLR	-	High LDL	4/26/18	46961	2	3	"[0.9999680586018185,3.194139818146973E-5]"	3	SCV000583830171214	single nucleotide variant	NM_000527.4(LDLR):c.1444G>A (p.Asp482Asn)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	11-May-17	139624145	-	RCV000172963;RCV000148591;RCV000414235	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202"	Familial hypercholesterolemia;Hypercholesterolaemia;not provided	germline;inherited	germline	GRCh37	NC_000019.9	19	11224296	11224296	G	A	19p13.2	"criteria provided, conflicting interpretations"	13	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_001428	2	161284	19	11224296	G	A	171214	19:11224296:G:A	Pathogenic	3/30/17	-	Familial Hypercholesterolemia	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:9	"U4M - Lille University & CHRU Lille,Université Lille 2 - CHRU de Lille"	SCV000583832.1	SCV000583832		LDLR	-	High LDL	5/11/17	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV000583832171216	single nucleotide variant	NM_000527.4(LDLR):c.1474G>A (p.Asp492Asn)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	2-Jan-18	373646964	-	RCV000237459;RCV000590270;RCV000148592;RCV000161989	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:C0020443;MedGen:CN517202"	Familial hypercholesterolemia;Familial hypercholesterolemias;Hypercholesterolaemia;not provided	germline;inherited;not applicable	germline	GRCh37	NC_000019.9	19	11224326	11224326	G	A	19p13.2	"criteria provided, conflicting interpretations"	13	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000205,UniProtKB (protein):P01130#VAR_072850"	2	161285	19	11224326	G	A	171216	19:11224326:G:A	Pathogenic	3/30/17	-	Familial Hypercholesterolemia	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:14	"U4M - Lille University & CHRU Lille,Université Lille 2 - CHRU de Lille"	SCV000583835.1	SCV000583835		LDLR	-	High LDL	1/2/18	46963	0	5	"[0.9999467666034964,5.323339650363052E-5]"	3	SCV000583835246190	single nucleotide variant	NM_000527.4(LDLR):c.1503G>A (p.Ala501=)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	30-Mar-17	368889457	-	RCV000237830	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline	germline	GRCh37	NC_000019.9	19	11224355	11224355	G	A	19p13.2	"criteria provided, conflicting interpretations"	2	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000208	2	251876	19	11224355	G	A	246190	19:11224355:G:A	Likely pathogenic	3/30/17	-	Familial Hypercholesterolemia	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:6	"U4M - Lille University & CHRU Lille,Université Lille 2 - CHRU de Lille"	SCV000583840.1	SCV000583840		LDLR	-	High LDL	3/30/17	46963	0	5	"[0.9999467666034964,5.323339650363052E-5]"	5	SCV000583840246223	single nucleotide variant	NM_000527.4(LDLR):c.1586+5G>A	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	25-Apr-17	781362878	-	RCV000237174;RCV000587894	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202"	Familial hypercholesterolemia;not provided	germline	germline	GRCh37	NC_000019.9	19	11224443	11224443	G	A	19p13.2	"criteria provided, conflicting interpretations"	6	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_001463	2	251909	19	11224443	G	A	246223	19:11224443:G:A	Likely pathogenic	3/30/17	-	Familial Hypercholesterolemia	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:3	"U4M - Lille University & CHRU Lille,Université Lille 2 - CHRU de Lille"	SCV000583852.1	SCV000583852		LDLR	-	High LDL	4/25/17	46963	0	2	"[0.9999787066413985,2.1293358601452207E-5]"	2	SCV000583852362713	single nucleotide variant	NM_000527.4(LDLR):c.1730G>A (p.Trp577Ter)	3949	LDLR	HGNC:6547	Pathogenic	1	30-Mar-17	138947766	-	RCV000417240	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline	germline	GRCh37	NC_000019.9	19	11227559	11227559	G	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	3	"ACMG2013,ACMG2016"	N	-	2	375821	19	11227559	G	A	362713	19:11227559:G:A	Pathogenic	3/30/17	-	Familial Hypercholesterolemia	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:4	"U4M - Lille University & CHRU Lille,Université Lille 2 - CHRU de Lille"	SCV000583871.1	SCV000583871		LDLR	-	High LDL	3/30/17	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV000583871198015	single nucleotide variant	NM_000527.4(LDLR):c.1747C>T (p.His583Tyr)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	23-Jan-18	730882109	-	RCV000211604;RCV000182342	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202"	Familial hypercholesterolemia;not provided	germline;not applicable;unknown	germline	GRCh37	NC_000019.9	19	11227576	11227576	C	T	19p13.2	"criteria provided, conflicting interpretations"	10	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000234	2	200921	19	11227576	C	T	198015	19:11227576:C:T	Pathogenic	3/30/17	-	Familial Hypercholesterolemia	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:3	"U4M - Lille University & CHRU Lille,Université Lille 2 - CHRU de Lille"	SCV000583880.1	SCV000583880		LDLR	-	High LDL	1/23/18	46963	0	14	"[0.9998509464897898,1.4905351021016544E-4]"	14	SCV000583880360376	single nucleotide variant	NM_000527.4(LDLR):c.1774G>A (p.Gly592Arg)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	30-Mar-17	763147599	-	RCV000417321	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline	germline	GRCh37	NC_000019.9	19	11227603	11227603	G	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	2	"ACMG2013,ACMG2016"	N	-	2	373769	19	11227603	G	A	360376	19:11227603:G:A	Pathogenic	3/30/17	-	Familial Hypercholesterolemia	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:4	"U4M - Lille University & CHRU Lille,Université Lille 2 - CHRU de Lille"	SCV000583882.1	SCV000583882		LDLR	-	High LDL	3/30/17	46963	0	2	"[0.9999787066413985,2.1293358601452207E-5]"	2	SCV000583882171217	single nucleotide variant	NM_000527.4(LDLR):c.1775G>A (p.Gly592Glu)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	31-Oct-18	137929307	-	RCV000172964;RCV000587007;RCV000148576;RCV000162001	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:C0020443;MedGen:CN517202"	Familial hypercholesterolemia;Familial hypercholesterolemias;Hypercholesterolaemia;not provided	germline;inherited;not applicable;unknown	germline	GRCh37	NC_000019.9	19	11227604	11227604	G	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	22	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000237,UniProtKB (protein):P01130#VAR_005403"	2	161271	19	11227604	G	A	171217	19:11227604:G:A	Pathogenic	3/30/17	-	Familial Hypercholesterolemia	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:8	"U4M - Lille University & CHRU Lille,Université Lille 2 - CHRU de Lille"	SCV000583883.1	SCV000583883		LDLR	-	High LDL	10/31/18	46963	0	3	"[0.9999680599620978,3.194003790217831E-5]"	3	SCV000583883226402	single nucleotide variant	NM_000527.4(LDLR):c.1836C>T (p.Ala612=)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	27-Jun-17	143872778	-	RCV000210239;RCV000586569;RCV000456101	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202;MedGen:CN169374"	Familial hypercholesterolemia;not provided;not specified	germline	germline	GRCh37	NC_000019.9	19	11227665	11227665	C	T	19p13.2	"criteria provided, conflicting interpretations"	9	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000249	2	224618	19	11227665	C	T	226402	19:11227665:C:T	Likely pathogenic	3/30/17	-	Familial Hypercholesterolemia	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:5	"U4M - Lille University & CHRU Lille,Université Lille 2 - CHRU de Lille"	SCV000583890.1	SCV000583890		LDLR	-	High LDL	6/27/17	46963	0	10	"[0.9998935332069927,1.0646679300726103E-4]"	10	SCV000583890181269	single nucleotide variant	NM_000527.4(LDLR):c.1876G>A (p.Glu626Lys)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	27-Sep-17	139791325	-	RCV000211563;RCV000162004;RCV000454999	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202;MedGen:CN169374"	Familial hypercholesterolemia;not provided;not specified	germline;not applicable;unknown	germline	GRCh37	NC_000019.9	19	11230798	11230798	G	A	19p13.2	"criteria provided, conflicting interpretations"	9	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000258	2	183127	19	11230798	G	A	181269	19:11230798:G:A	Likely pathogenic	3/30/17	-	Familial Hypercholesterolemia	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:2	"U4M - Lille University & CHRU Lille,Université Lille 2 - CHRU de Lille"	SCV000583902.1	SCV000583902		LDLR	-	High LDL	9/27/17	46963	0	19	"[0.9997977130932862,2.0228690671379596E-4]"	19	SCV000583902246397	single nucleotide variant	NM_000527.4(LDLR):c.1879G>A (p.Ala627Thr)	3949	LDLR	HGNC:6547	Likely pathogenic	1	30-Mar-17	879255066	-	RCV000237476	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline	germline	GRCh37	NC_000019.9	19	11230801	11230801	G	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	4	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000259	2	252101	19	11230801	G	A	246397	19:11230801:G:A	Likely pathogenic	3/30/17	-	Familial Hypercholesterolemia	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:4	"U4M - Lille University & CHRU Lille,Université Lille 2 - CHRU de Lille"	SCV000583903.1	SCV000583903		LDLR	-	High LDL	3/30/17	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV000583903228193	single nucleotide variant	NM_000527.4(LDLR):c.1898G>A (p.Arg633His)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	28-Nov-17	754536745	-	RCV000211621	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline	germline	GRCh37	NC_000019.9	19	11230820	11230820	G	A	19p13.2	"criteria provided, conflicting interpretations"	7	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_001073	2	226380	19	11230820	G	A	228193	19:11230820:G:A	Pathogenic	3/30/17	-	Familial Hypercholesterolemia	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:2	"U4M - Lille University & CHRU Lille,Université Lille 2 - CHRU de Lille"	SCV000583907.1	SCV000583907		LDLR	-	High LDL	11/28/17	46963	0	2	"[0.9999787066413985,2.1293358601452207E-5]"	2	SCV000583907228195	single nucleotide variant	NM_000527.4(LDLR):c.1955T>C (p.Met652Thr)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	28-Mar-18	875989936	-	RCV000211590	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline	germline	GRCh37	NC_000019.9	19	11230877	11230877	T	C	19p13.2	"criteria provided, conflicting interpretations"	5	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000266	2	226382	19	11230877	T	C	228195	19:11230877:T:C	Likely pathogenic	3/30/17	-	Familial Hypercholesterolemia	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:4	"U4M - Lille University & CHRU Lille,Université Lille 2 - CHRU de Lille"	SCV000583911.1	SCV000583911		LDLR	-	High LDL	3/28/18	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV00058391118738	single nucleotide variant	NM_000527.4(LDLR):c.2043C>A (p.Cys681Ter)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	31-Oct-18	121908031	-	RCV000003887;RCV000590806;RCV000481771	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:CN517202"	Familial hypercholesterolemia;Familial hypercholesterolemias;not provided	germline;unknown	germline	GRCh37	NC_000019.9	19	11231101	11231101	C	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	18	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_001592,OMIM Allelic Variant:606945.0016"	3	3699	19	11231101	C	A	18738	19:11231101:C:A	Pathogenic	3/30/17	-	Familial Hypercholesterolemia	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:40	"U4M - Lille University & CHRU Lille,Université Lille 2 - CHRU de Lille"	SCV000583922.1	SCV000583922		LDLR	-	High LDL	10/31/18	46958	5	1	"[0.9999893521870608,1.0647812939222283E-5]"	1	SCV00058392218741	single nucleotide variant	NM_000527.4(LDLR):c.2054C>T (p.Pro685Leu)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	31-Oct-18	28942084	-	RCV000003891;RCV000162007	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202"	Familial hypercholesterolemia;not provided	germline;inherited;not applicable;unknown	germline	GRCh37	NC_000019.9	19	11231112	11231112	C	T	19p13.2	"criteria provided, multiple submitters, no conflicts"	16	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000276,OMIM Allelic Variant:606945.0017,UniProtKB (protein):P01130#VAR_005410"	3	3702	19	11231112	C	T	18741	19:11231112:C:T	Pathogenic	3/30/17	-	Familial Hypercholesterolemia	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:69	"U4M - Lille University & CHRU Lille,Université Lille 2 - CHRU de Lille"	SCV000583924.1	SCV000583924		LDLR	-	High LDL	10/31/18	46963	0	3	"[0.9999680599620978,3.194003790217831E-5]"	3	SCV000583924246513	single nucleotide variant	NM_000527.4(LDLR):c.2096C>T (p.Pro699Leu)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	9-Oct-17	201573863	-	RCV000237906;RCV000589820	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445"	Familial hypercholesterolemia;Familial hypercholesterolemias	germline;unknown	germline	GRCh37	NC_000019.9	19	11231154	11231154	C	T	19p13.2	"criteria provided, conflicting interpretations"	10	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_001600,UniProtKB (protein):P01130#VAR_013955"	2	252219	19	11231154	C	T	246513	19:11231154:C:T	Pathogenic	3/30/17	-	Familial Hypercholesterolemia	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:2	"U4M - Lille University & CHRU Lille,Université Lille 2 - CHRU de Lille"	SCV000583929.1	SCV000583929		LDLR	-	High LDL	10/9/17	46962	1	6	"[0.9999361185639453,6.388143605468251E-5]"	6	SCV000583929424341	single nucleotide variant	NM_000527.4(LDLR):c.2260G>T (p.Gly754Trp)	3949	LDLR	HGNC:6547	Likely pathogenic	1	30-Mar-17	559239150	-	RCV000495862	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline	germline	GRCh37	NC_000019.9	19	11233969	11233969	G	T	19p13.2	"criteria provided, single submitter"	1	"ACMG2013,ACMG2016"	N	-	2	430797	19	11233969	G	T	424341	19:11233969:G:T	Likely pathogenic	3/30/17	-	Familial Hypercholesterolemia	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:4	"U4M - Lille University & CHRU Lille,Université Lille 2 - CHRU de Lille"	SCV000583937.1	SCV000583937		LDLR	-	High LDL	3/30/17	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV000583937228201	deletion	NM_000527.4(LDLR):c.2271delT (p.Leu759Serfs)	3949	LDLR	HGNC:6547	Pathogenic	1	11-May-17	875989940	-	RCV000211650;RCV000493493	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202"	Familial hypercholesterolemia;not provided	germline	germline	GRCh37	NC_000019.9	19	11233980	11233980	T	-	19p13.2	"criteria provided, multiple submitters, no conflicts"	6	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000890	2	226388	19	11233979	CT	C	228201	19:11233979:CT:C	Pathogenic	3/30/17	-	Familial Hypercholesterolemia	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:2	"U4M - Lille University & CHRU Lille,Université Lille 2 - CHRU de Lille"	SCV000583939.1	SCV000583939		LDLR	-	High LDL	5/11/17	46963	0	2	"[0.9999787066413985,2.1293358601452207E-5]"	2	SCV000583939171222	single nucleotide variant	NM_000527.4(LDLR):c.2282C>T (p.Thr761Met)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	30-Mar-17	138477254	-	RCV000237277;RCV000148565;RCV000162013	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202"	Familial hypercholesterolemia;Hypercholesterolaemia;not provided	germline;not applicable	germline	GRCh37	NC_000019.9	19	11233991	11233991	C	T	19p13.2	"criteria provided, conflicting interpretations"	9	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000907	2	161262	19	11233991	C	T	171222	19:11233991:C:T	Pathogenic	3/30/17	-	Familial Hypercholesterolemia	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:2	"U4M - Lille University & CHRU Lille,Université Lille 2 - CHRU de Lille"	SCV000583940.1	SCV000583940		LDLR	-	High LDL	3/30/17	46963	0	4	"[0.9999574132827971,4.2586717202904415E-5]"	4	SCV000583940171223	single nucleotide variant	NM_000527.4(LDLR):c.2441G>A (p.Arg814Gln)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	17-Nov-17	5928	-	RCV000237126;RCV000148584;RCV000162024	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202"	Familial hypercholesterolemia;Hypercholesterolaemia;not provided	germline;not applicable	germline	GRCh37	NC_000019.9	19	11240240	11240240	G	A	19p13.2	"criteria provided, conflicting interpretations"	9	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000376,UniProtKB (protein):P01130#VAR_011864"	2	161278	19	11240240	G	A	171223	19:11240240:G:A	Likely pathogenic	3/30/17	-	Familial Hypercholesterolemia	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:2	"U4M - Lille University & CHRU Lille,Université Lille 2 - CHRU de Lille"	SCV000583953.1	SCV000583953		LDLR	-	High LDL	11/17/17	46963	0	50	"[0.9994676660349637,5.323339650363052E-4]"	50	SCV000583953171224	single nucleotide variant	NM_000527.4(LDLR):c.2475C>G (p.Asn825Lys)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	30-Mar-17	374045590	-	RCV000237920;RCV000148570	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443"	Familial hypercholesterolemia;Hypercholesterolaemia	germline	germline	GRCh37	NC_000019.9	19	11240274	11240274	C	G	19p13.2	"criteria provided, multiple submitters, no conflicts"	5	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_001654,UniProtKB (protein):P01130#VAR_072861"	2	161265	19	11240274	C	G	171224	19:11240274:C:G	Pathogenic	3/30/17	-	Familial Hypercholesterolemia	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:2	"U4M - Lille University & CHRU Lille,Université Lille 2 - CHRU de Lille"	SCV000583956.1	SCV000583956		LDLR	-	High LDL	3/30/17	46963	0	3	"[0.9999680599620978,3.194003790217831E-5]"	3	SCV00058395645125	single nucleotide variant	NM_000527.4(LDLR):c.2479G>A (p.Val827Ile)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	2-Nov-17	137853964	-	RCV000030135;RCV000148585;RCV000058923;RCV000436469	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202;MedGen:CN169374"	Familial hypercholesterolemia;Hypercholesterolaemia;not provided;not specified	germline;inherited;not applicable;unknown	germline	GRCh37	NC_000019.9	19	11240278	11240278	G	A	19p13.2	"criteria provided, conflicting interpretations"	16	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_001657,UniProtKB (protein):P01130#VAR_005418"	2	36462	19	11240278	G	A	45125	19:11240278:G:A	Likely pathogenic	3/30/17	-	Familial Hypercholesterolemia	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:6	"U4M - Lille University & CHRU Lille,Université Lille 2 - CHRU de Lille"	SCV000583958.1	SCV000583958		LDLR	-	High LDL	11/2/17	46963	0	74	"[0.9992121457317462,7.878542682537317E-4]"	74	SCV000583958425956	single nucleotide variant	NM_000545.6(HNF1A):c.1135C>G (p.Pro379Ala)	6927	HNF1A	HGNC:11621	Pathogenic/Likely pathogenic	1	31-Oct-18	754729248	-	RCV000762890;RCV000762890;RCV000762890;RCV000762890;RCV000762890;RCV000762890;RCV000497653	"MedGen:C0011854,OMIM:222100,Orphanet:ORPHA181371,SNOMED CT:46635009;Human Phenotype Ontology:HP:0005978,MedGen:C0011860,OMIM:125853,Orphanet:ORPHA181376,SNOMED CT:44054006;MedGen:C2675866,OMIM:612520;MedGen:C1840646,OMIM:142330;MedGen:C1838100,OMIM:600496;MedGen:C3160732,OMIM:144700;MedGen:CN517202"	"Diabetes mellitus type 1;Diabetes mellitus type 2;Diabetes mellitus, insulin-dependent, 20;Hepatic adenomas, familial;Maturity-onset diabetes of the young, type 3;Renal cell carcinoma, nonpapillary;not provided"	germline;unknown	germline	GRCh37	NC_000012.11	12	121434371	121434371	C	G	12q24.31	"criteria provided, multiple submitters, no conflicts"	2	NA	N	-	2	431970	12	121434371	C	G	425956	12:121434371:C:G	Likely pathogenic	6/23/17	"The P379A variant has been published previously in association with MODY (BellannÃ©-Chantelot et al., 2008; Colclough et al., 2013; Ekholm et al., 2013). The variant is observed in 7/11394 (0.061%) alleles from individuals of Latino background in the ExAC dataset (Lek et al., 2016). P379A is a semi-conservative amino acid substitution, which may impact secondary protein structure as these residues differ in some properties. This substitution occurs at a position that is conserved across species, and in silico analysis predicts this variant is probably damaging to the protein structure/function. Functional studies have shown P379A increases the activation of the CYP7A1 promoter compared to wild-type (Ekholm et al., 2013). In summary, this variant is likely pathogenic; however, the possibility that it is benign cannot be excluded."	Not Provided	CN517202:not provided	MODY	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	GeneDx	SCV000589586.2	SCV000589586		HNF1A	-	"MODY, MODY Extended, MonogenicDM_all"	10/31/18	46953	10	29	"[0.9996911805422444,3.0881945775562794E-4]"	27	SCV00058958631173	single nucleotide variant	NM_000162.3(GCK):c.683C>T (p.Thr228Met)	2645	GCK	HGNC:4195	Pathogenic	1	12-Jun-17	80356655	-	RCV000020167;RCV000030923;RCV000498792	"MedGen:C1841962,OMIM:125851;MedGen:C1833104,OMIM:606176,Orphanet:ORPHA99885;MedGen:CN517202"	"Maturity-onset diabetes of the young,  type 2;Permanent neonatal diabetes mellitus;not provided"	germline	germline	GRCh37	NC_000007.13	7	44187429	44187429	G	A	7p13	"criteria provided, multiple submitters, no conflicts"	4	NA	N	"OMIM Allelic Variant:138079.0003,OMIM Allelic Variant:138079.0011,UniProtKB (protein):P35557#VAR_003705"	3	16134	7	44187429	G	A	31173	7:44187429:G:A	Pathogenic	6/12/17	"The T228M variant has been published previously in association with MODY, including a confirmed de novo occurrence (Stanik et al., 2014; Costantini et al., 2015). The variant has also been observed in the homozygous state in patients with neonatal diabetes mellitus (Stoffel et al., 1992; NjÃ¸lstad et al., 2001). The variant is not observed at a significant frequency in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). T228M is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position within the substrate-binding site that is conserved across species, and in silico analysis predicts this variant is probably damaging to the protein structure/function. Functional studies have shown T228M nearly eliminates the catalytic activity of the GCK protein (NjÃ¸lstad et al., 2001; Molnes et al., 2011). Missense variants in the same residue (T228A/K/R) and in nearby residues (I225F/M, V226E/M, G227R/S/C, G229V/D, N231H/S) have been reported in the Human Gene Mutation Database in association with MODY (Stenson et al., 2014), supporting the functional importance of this region of the protein. In summary, we consider this variant to be pathogenic."	Not Provided	CN517202:not provided	MODY	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	GeneDx	SCV000589594.2	SCV000589594		GCK	-	"MODY, MODY Extended, MonogenicDM_all"	6/12/17	46961	2	1	"[0.9999893528672729,1.0647132727156576E-5]"	1	SCV00058959416569	single nucleotide variant	NM_000237.3(LPL):c.809G>A (p.Arg270His)	4023	LPL	HGNC:6677	Pathogenic	1	29-Jun-17	118204062	-	RCV000001594;RCV000497435	"MedGen:C0023817,OMIM:238600,Orphanet:ORPHA309015,SNOMED CT:238086005,SNOMED CT:275598004;MedGen:CN517202"	"Hyperlipoproteinemia, type I;not provided"	germline	germline	GRCh37	NC_000008.10	8	19813385	19813385	G	A	8p21.3	"criteria provided, single submitter"	2	NA	N	"OMIM Allelic Variant:609708.0011,UniProtKB (protein):P06858#VAR_004233"	3	1530	8	19813385	G	A	16569	8:19813385:G:A	Pathogenic	6/29/17	"The R270H variant in the LPL gene has been reported previously in the homozygous and compound heterozygous states in individuals with LPL deficiency; note that R270H is referred to as R243H using alternate nomenclature by Gotoda et al. (Gotoda et al., 1991; Zahavi et al., 2013. Behar et al., 2013; Zhang et al., 2016). The R270H variant is not observed in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). The R270H variant is a conservative amino acid substitution, which is not likely to impact secondary protein structure as these residues share similar properties. This substitution occurs at a position that is conserved across species. Functional studies of R270H indicate that it leads to decreased levels of LPL mass in media and non-detectable enzymatic activity in transfected cells (Gotoda et al., 1991). Different missense variants in the same residue (R270C, R270L) have been previously reported in association with LPL deficiency; note that R270C is referred to as R243C using alternate nomenclature by Ma et al. (Ma et al., 1994; Murthy et al., 1996). We interpret R270H as a pathogenic variant."	Not Provided	CN517202:not provided	LPL deficiency	FALSE	AR	"criteria provided, single submitter"	clinical testing	germline:na	GeneDx	SCV000589680.2	SCV000589680		LPL	-	High triglycerides	6/29/17	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV000589680143220	single nucleotide variant	NM_002052.4(GATA4):c.909+25G>A	2626	GATA4	HGNC:4173	Conflicting interpretations of pathogenicity	1	7-Jan-17	147860174	-	RCV000498033;RCV000128536	"MedGen:C0152021,SNOMED CT:13213009;MedGen:CN517202"	Congenital heart disease;not provided	unknown	unknown	GRCh37	NC_000008.10	8	11607770	11607770	G	A	8p23.1	no assertion criteria provided	2	NA	N	-	2	139595	8	11607770	G	A	143220	8:11607770:G:A	Pathogenic	1/7/17	-	MedGen:C0152021	C0152021:Congenital heart disease	NA	FALSE	Not trait of interest	no assertion criteria provided	clinical testing	unknown:2	"Central Research Laboratory,Sri Devaraj Urs Academy of Higher Education and Research"	SCV000590808.1	SCV000590808		GATA4	-	"MonogenicDM_all, Neonatal Diabetes"	1/7/17	46958	5	334	"[0.9964436304782998,0.0035563695217002427]"	330	SCV000590808171201	single nucleotide variant	NM_000527.4(LDLR):c.798T>A (p.Asp266Glu)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	17-May-18	139043155	-	RCV000172959;RCV000148594;RCV000162020	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202"	Familial hypercholesterolemia;Hypercholesterolaemia;not provided	germline;inherited;not applicable;unknown	germline	GRCh37	NC_000019.9	19	11217344	11217344	T	A	19p13.2	"criteria provided, conflicting interpretations"	16	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000117,UniProtKB (protein):P01130#VAR_005347"	2	161287	19	11217344	T	A	171201	19:11217344:T:A	Likely pathogenic	9/10/15	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	unknown:1	"Molecular Diagnostics Lab,Nemours Alfred I. duPont Hospital for Children"	SCV000590848.1	SCV000590848		LDLR	-	High LDL	5/17/18	46963	0	2	"[0.9999787066413985,2.1293358601452207E-5]"	2	SCV00059084824144	single nucleotide variant	NM_000352.4(ABCC8):c.4135C>T (p.Arg1379Cys)	6833	ABCC8	HGNC:59	Pathogenic	1	1-Mar-16	137852673	-	RCV000009674;RCV000502425;RCV000009673	"Human Phenotype Ontology:HP:0005978,MedGen:C0011860,OMIM:125853,Orphanet:ORPHA181376,SNOMED CT:44054006;MedGen:C1833104,OMIM:606176,Orphanet:ORPHA99885;MedGen:C1835887,OMIM:610374"	Diabetes mellitus type 2;Permanent neonatal diabetes mellitus;Transient neonatal diabetes mellitus 2	germline	germline	GRCh37	NC_000011.9	11	17417462	17417462	G	A	11p15.1	"criteria provided, single submitter"	2	NA	N	OMIM Allelic Variant:600509.0019	3	9105	11	17417462	G	A	24144	11:17417462:G:A	Pathogenic	3/1/16	-	"Diabetes mellitus, permanent neonatal"	C1833104:Permanent neonatal diabetes mellitus	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	"Genetic Services Laboratory, University of Chicago"	SCV000592981.1	SCV000592981		ABCC8	-	"MODY Extended, MonogenicDM_all, Neonatal Diabetes"	3/1/16	46515	448	1	"[0.9999892507793186,1.0749220681500592E-5]"	1	SCV000592981429205	single nucleotide variant	NM_000352.4(ABCC8):c.2921-9G>A	6833	ABCC8	HGNC:59	Likely pathogenic	1	11-Oct-16	757171524	-	RCV000502550	"MedGen:C2931832,OMIM:256450,SNOMED CT:360339005"	Persistent hyperinsulinemic hypoglycemia of infancy	germline	germline	GRCh37	NC_000011.9	11	17428685	17428685	C	T	11p15.1	"criteria provided, single submitter"	1	NA	N	-	2	434048	11	17428685	C	T	429205	11:17428685:C:T	Likely pathogenic	10/11/16	-	"Hyperinsulinemic hypoglycemia, familial, 1"	C2931832:Persistent hyperinsulinemic hypoglycemia of infancy	NA	FALSE	Not trait of interest	"criteria provided, single submitter"	clinical testing	germline:na	"Genetic Services Laboratory, University of Chicago"	SCV000592984.1	SCV000592984		ABCC8	-	"MODY Extended, MonogenicDM_all, Neonatal Diabetes"	10/11/16	46947	16	3	"[0.9999680490766183,3.1950923381685733E-5]"	3	SCV000592984186811	single nucleotide variant	NM_000352.4(ABCC8):c.4628T>C (p.Leu1543Pro)	6833	ABCC8	HGNC:59	Likely pathogenic	1	9-Nov-15	72559713	-	RCV000169185	"MedGen:C2931832,OMIM:256450,SNOMED CT:360339005"	Persistent hyperinsulinemic hypoglycemia of infancy	germline;unknown	germline	GRCh37	NC_000011.9	11	17414656	17414656	A	G	11p15.1	"criteria provided, multiple submitters, no conflicts"	2	NA	N	UniProtKB (protein):Q09428#VAR_015010	2	188836	11	17414656	A	G	186811	11:17414656:A:G	Likely pathogenic	11/9/15	-	"Hyperinsulinemic hypoglycemia, familial, 1"	C2931832:Persistent hyperinsulinemic hypoglycemia of infancy	NA	FALSE	Not trait of interest	"criteria provided, single submitter"	clinical testing	germline:na	"Genetic Services Laboratory, University of Chicago"	SCV000592989.1	SCV000592989		ABCC8	-	"MODY Extended, MonogenicDM_all, Neonatal Diabetes"	11/9/15	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV000592989186816	single nucleotide variant	NM_001287174.1(ABCC8):c.2509C>T (p.Arg837Ter)	6833	ABCC8	HGNC:59	Pathogenic/Likely pathogenic	1	31-Oct-18	72559722	-	RCV000763234;RCV000763234;RCV000763234;RCV000169276;RCV000763234;RCV000763234;RCV000201895	"Human Phenotype Ontology:HP:0005978,MedGen:C0011860,OMIM:125853,Orphanet:ORPHA181376,SNOMED CT:44054006;MedGen:C0271714,OMIM:240800,SNOMED CT:62151007;MedGen:C1833104,OMIM:606176,Orphanet:ORPHA99885;MedGen:C2931832,OMIM:256450,SNOMED CT:360339005;MedGen:C2931832,OMIM:256450,SNOMED CT:360339005;MedGen:C1835887,OMIM:610374;MedGen:CN517202"	Diabetes mellitus type 2;Leucine-induced hypoglycemia;Permanent neonatal diabetes mellitus;Persistent hyperinsulinemic hypoglycemia of infancy;Persistent hyperinsulinemic hypoglycemia of infancy;Transient neonatal diabetes mellitus 2;not provided	germline;unknown	germline	GRCh37	NC_000011.9	11	17434263	17434263	G	A	11p15.1	"criteria provided, multiple submitters, no conflicts"	5	NA	N	-	2	188915	11	17434263	G	A	186816	11:17434263:G:A	Pathogenic	3/9/16	-	"Hyperinsulinemic hypoglycemia, familial, 1"	C2931832:Persistent hyperinsulinemic hypoglycemia of infancy	NA	FALSE	Not trait of interest	"criteria provided, single submitter"	clinical testing	germline:na	"Genetic Services Laboratory, University of Chicago"	SCV000592993.1	SCV000592993		ABCC8	-	"MODY Extended, MonogenicDM_all, Neonatal Diabetes"	10/31/18	46955	8	12	"[0.9998722180811416,1.2778191885848153E-4]"	12	SCV000592993429210	single nucleotide variant	NM_000352.4(ABCC8):c.1792C>T (p.Arg598Ter)	6833	ABCC8	HGNC:59	Pathogenic	1	7-Mar-17	139328569	-	RCV000500331	"MedGen:C2931832,OMIM:256450,SNOMED CT:360339005"	Persistent hyperinsulinemic hypoglycemia of infancy	germline	germline	GRCh37	NC_000011.9	11	17452386	17452386	G	A	11p15.1	"criteria provided, single submitter"	1	NA	N	-	2	434056	11	17452386	G	A	429210	11:17452386:G:A	Pathogenic	3/7/17	-	"Hyperinsulinemic hypoglycemia, familial, 1"	C2931832:Persistent hyperinsulinemic hypoglycemia of infancy	NA	FALSE	Not trait of interest	"criteria provided, single submitter"	clinical testing	germline:na	"Genetic Services Laboratory, University of Chicago"	SCV000592997.1	SCV000592997		ABCC8	-	"MODY Extended, MonogenicDM_all, Neonatal Diabetes"	3/7/17	46963	0	3	"[0.9999680599620978,3.194003790217831E-5]"	3	SCV00059299732929	single nucleotide variant	NM_000384.2(APOB):c.10580G>A (p.Arg3527Gln)	338	APOB	HGNC:603	Conflicting interpretations of pathogenicity	1	11-Jul-18	5742904	-	RCV000019479;RCV000284412;RCV000412515;RCV000627797;RCV000499833;RCV000627797;RCV000254882	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C1862596,Orphanet:ORPHA426,SNOMED CT:60193003;MedGen:C1704417,OMIM:144010;MedGen:C1704417,OMIM:144010;MedGen:C0020597,Orphanet:ORPHA31154;MedGen:C4551990,OMIM:615558;MedGen:CN517202"	"Familial hypercholesterolemia;Familial hypobetalipoproteinemia;Hypercholesterolemia, autosomal dominant, type B;Hypercholesterolemia, autosomal dominant, type B;Hypobetalipoproteinemia;Hypobetalipoproteinemia, familial, 1;not provided"	germline;maternal;unknown	germline	GRCh37	NC_000002.11	2	21229160	21229160	C	T	2p24	"criteria provided, conflicting interpretations"	18	"ACMG2013,ACMG2016"	Y	OMIM Allelic Variant:107730.0009	3	17890	2	21229160	C	T	32929	2:21229160:C:T	Likely pathogenic	11/30/15	-	Hypobetalipoproteinemia	C0020597:Hypobetalipoproteinemia	NA	FALSE	Not trait of interest and AR	"criteria provided, single submitter"	clinical testing	germline:na	"Genetic Services Laboratory, University of Chicago"	SCV000593263.1	SCV000593263		APOB	-	Low LDL	7/11/18	46963	0	12	"[0.9998722398483912,1.2776015160871325E-4]"	12	SCV000593263427986	deletion	NM_000384.2(APOB):c.10238del (p.Thr3413Metfs)	338	APOB	HGNC:603	Pathogenic	1	29-Apr-16	756209187	-	RCV000501647	"MedGen:C0020597,Orphanet:ORPHA31154"	Hypobetalipoproteinemia	germline	germline	GRCh37	NC_000002.11	2	21229502	21229502	G	-	2p24.1	"criteria provided, single submitter"	1	"ACMG2013,ACMG2016"	N	-	2	434252	2	21229501	AG	A	427986	2:21229501:AG:A	Pathogenic	4/29/16	-	Hypobetalipoproteinemia	C0020597:Hypobetalipoproteinemia	NA	FALSE	Not trait of interest and AR	"criteria provided, single submitter"	clinical testing	germline:na	"Genetic Services Laboratory, University of Chicago"	SCV000593264.1	SCV000593264		APOB	-	Low LDL	4/29/16	46963	0	2	"[0.9999787066413985,2.1293358601452207E-5]"	2	SCV00059326439055	single nucleotide variant	NM_002052.4(GATA4):c.1037C>T (p.Ala346Val)	2626	GATA4	HGNC:4173	Conflicting interpretations of pathogenicity	1	19-Dec-17	115372595	-	RCV000023005;RCV000617346;RCV000503266	"MedGen:C3280781,OMIM:614430;MedGen:CN230736;MedGen:CN169374"	Atrioventricular septal defect 4;Cardiovascular phenotype;not specified	germline	germline	GRCh37	NC_000008.10	8	11614483	11614483	C	T	8p23.1	"criteria provided, conflicting interpretations"	4	NA	N	"OMIM Allelic Variant:600576.0008,UniProtKB (protein):P43694#VAR_067616"	3	30100	8	11614483	C	T	39055	8:11614483:C:T	Likely benign	5/16/16	-	not specified	CN169374:not specified	No Information	FALSE	No Information	"criteria provided, single submitter"	clinical testing	germline:na	"Genetic Services Laboratory, University of Chicago"	SCV000594928.1	SCV000594928		GATA4	-	"MonogenicDM_all, Neonatal Diabetes"	12/19/17	46963	0	104	"[0.9988927453527244,0.0011072546472755147]"	104	SCV00059492844907	single nucleotide variant	NM_000162.5(GCK):c.676G>A (p.Val226Met)	2645	GCK	HGNC:4195	Pathogenic/Likely pathogenic	1	31-Oct-18	148311934	-	RCV000763584;RCV000763584;RCV000029906;RCV000763584;RCV000763584;RCV000255932	"Human Phenotype Ontology:HP:0005978,MedGen:C0011860,OMIM:125853,Orphanet:ORPHA181376,SNOMED CT:44054006;MedGen:C1865290,OMIM:602485,Orphanet:ORPHA79299;MedGen:C1841962,OMIM:125851;MedGen:C1841962,OMIM:125851;MedGen:C1833104,OMIM:606176,Orphanet:ORPHA99885;MedGen:CN517202"	"Diabetes mellitus type 2;Hyperinsulinemic hypoglycemia familial 3;Maturity-onset diabetes of the young,  type 2;Maturity-onset diabetes of the young,  type 2;Permanent neonatal diabetes mellitus;not provided"	germline;unknown	germline	GRCh37	NC_000007.13	7	44189362	44189362	C	T	7p13	"criteria provided, multiple submitters, no conflicts"	6	NA	N	UniProtKB (protein):P35557#VAR_003703	2	36243	7	44189362	C	T	44907	7:44189362:C:T	Pathogenic	7/19/16	-	"MODY, type II"	"C1841962:Maturity-onset diabetes of the young, type 2"	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	"Genetic Services Laboratory, University of Chicago"	SCV000594954.1	SCV000594954		GCK	-	"MODY, MODY Extended, MonogenicDM_all"	10/31/18	46963	0	2	"[0.9999787066413985,2.1293358601452207E-5]"	2	SCV000594954429373	single nucleotide variant	NM_000545.6(HNF1A):c.29C>T (p.Thr10Met)	6927	HNF1A	HGNC:11621	Likely pathogenic	1	13-Feb-15	774637975	-	RCV000500944	"MedGen:C1838100,OMIM:600496"	"Maturity-onset diabetes of the young, type 3"	germline	germline	GRCh37	NC_000012.11	12	121416600	121416600	C	T	12q24.31	"criteria provided, single submitter"	1	NA	N	-	2	435422	12	121416600	C	T	429373	12:121416600:C:T	Likely pathogenic	2/13/15	-	"MODY, type III"	"C1838100:Maturity-onset diabetes of the young, type 3"	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	"Genetic Services Laboratory, University of Chicago"	SCV000595133.1	SCV000595133		HNF1A	-	"MODY, MODY Extended, MonogenicDM_all"	2/13/15	46933	30	7	"[0.9999254256067159,7.457439328404321E-5]"	7	SCV000595133429378	deletion	NM_000545.6(HNF1A):c.864delG (p.Pro291Glnfs)	6927	HNF1A	HGNC:11621	Pathogenic	1	23-Dec-16	762703502	-	RCV000502914;RCV000723679	"MedGen:C1838100,OMIM:600496;MedGen:CN517202"	"Maturity-onset diabetes of the young, type 3;not provided"	germline	germline	GRCh37	NC_000012.11	12	121432117	121432117	G	-	12q24.31	"criteria provided, multiple submitters, no conflicts"	2	NA	N	-	2	435424	12	121432114	CG	C	429378	12:121432114:CG:C	Pathogenic	4/8/16	-	"MODY, type III"	"C1838100:Maturity-onset diabetes of the young, type 3"	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	"Genetic Services Laboratory, University of Chicago"	SCV000595137.1	SCV000595137		HNF1A	-	"MODY, MODY Extended, MonogenicDM_all"	12/23/16	46569	394	7	"[0.9999248427065215,7.515729347849427E-5]"	7	SCV000595137429187	single nucleotide variant	NM_000525.3(KCNJ11):c.868G>A (p.Val290Met)	3767	KCNJ11	HGNC:6257	Likely pathogenic	1	13-Feb-15	750414160	-	RCV000500391	"MedGen:C2931833,OMIM:601820,SNOMED CT:42681006"	Islet cell hyperplasia	germline	germline	GRCh37	NC_000011.9	11	17408771	17408771	C	T	11p15.1	"criteria provided, single submitter"	1	NA	N	-	2	435556	11	17408771	C	T	429187	11:17408771:C:T	Likely pathogenic	2/13/15	-	"Hyperinsulinemic hypoglycemia, familial, 2"	C2931833:Islet cell hyperplasia	NA	FALSE	Not trait of interest	"criteria provided, single submitter"	clinical testing	germline:na	"Genetic Services Laboratory, University of Chicago"	SCV000595310.1	SCV000595310		KCNJ11	-	"MODY Extended, MonogenicDM_all, Neonatal Diabetes"	2/13/15	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV00059531029525	single nucleotide variant	NM_170707.3(LMNA):c.1445G>A (p.Arg482Gln)	4000	LMNA	HGNC:6636	Pathogenic	1	31-Oct-18	11575937	-	RCV000763258;RCV000763258;RCV000459624;RCV000763258;RCV000763258;RCV000763258;RCV000190399;RCV000763258;RCV000015575;RCV000763258;RCV000763258;RCV000763258;RCV000041318;RCV000763258;RCV000763258;RCV000754814;RCV000148600;RCV000057299	"MedGen:C0410190,OMIM:181350,Orphanet:ORPHA98853,SNOMED CT:240072005;MedGen:C1854154,OMIM:605588,Orphanet:ORPHA98856;MedGen:C0270914,Orphanet:ORPHA64746;MedGen:C2750785,OMIM:613205,Orphanet:ORPHA157973;MedGen:C1449563,OMIM:115200,Orphanet:ORPHA300751;MedGen:C0796031,OMIM:212112,Orphanet:ORPHA2229;MedGen:C2750035,OMIM:616516,Orphanet:ORPHA98855;MedGen:C2750035,OMIM:616516,Orphanet:ORPHA98855;MedGen:C1720860,OMIM:151660,Orphanet:ORPHA2348;MedGen:C1720860,OMIM:151660,Orphanet:ORPHA2348;MedGen:C1857829,OMIM:610140,Orphanet:ORPHA168796;MedGen:C0033300,OMIM:176670,Orphanet:ORPHA740,SNOMED CT:238870004;MedGen:CN236383,Orphanet:ORPHA98301;MedGen:C0406585,OMIM:275210,Orphanet:ORPHA1662,SNOMED CT:400128006;MedGen:C0432291,OMIM:248370,Orphanet:ORPHA2457,SNOMED CT:109419009;MedGen:C3888631;MedGen:CN221589;MedGen:CN517202"	"Benign scapuloperoneal muscular dystrophy with cardiomyopathy;Charcot-Marie-Tooth disease type 2B1;Charcot-Marie-Tooth disease, type 2;Congenital muscular dystrophy, LMNA-related;Dilated cardiomyopathy 1A;Dilated cardiomyopathy-hypergonadotropic hypogonadism syndrome;Emery-Dreifuss muscular dystrophy 3, autosomal recessive;Emery-Dreifuss muscular dystrophy 3, autosomal recessive;Familial partial lipodystrophy 2;Familial partial lipodystrophy 2;Heart-hand syndrome, Slovenian type;Hutchinson-Gilford syndrome;Laminopathy;Lethal tight skin contracture syndrome;Mandibuloacral dysostosis;Monogenic diabetes;Partial lipodystrophy, Dunnigan;not provided"	de novo;germline;unknown	germline	GRCh37	NC_000001.10	1	156106776	156106776	G	A	1q22	"criteria provided, multiple submitters, no conflicts"	10	"ACMG2013,ACMG2016"	N	"OMIM Allelic Variant:150330.0010,UniProtKB (protein):P02545#VAR_009992"	3	14486	1	156106776	G	A	29525	1:156106776:G:A	Pathogenic	2/8/13	-	"Lipodystrophy, familial partial, 2"	C1720860:Familial partial lipodystrophy 2	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	"Genetic Services Laboratory, University of Chicago"	SCV000595606.1	SCV000595606		LMNA	-	"Lipodystrophy, MonogenicDM_all"	10/31/18	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV000595606427656	single nucleotide variant	NM_170707.3(LMNA):c.1786G>A (p.Asp596Asn)	4000	LMNA	HGNC:6636	Conflicting interpretations of pathogenicity	1	6-Sep-17	769561386	-	RCV000653834;RCV000503392	"MedGen:C0270914,Orphanet:ORPHA64746;Human Phenotype Ontology:HP:0003560,MeSH:D009136,MedGen:C0026850,Orphanet:ORPHA98473"	"Charcot-Marie-Tooth disease, type 2;Muscular dystrophy"	germline	germline	GRCh37	NC_000001.10	1	156108366	156108366	G	A	1q22	"criteria provided, conflicting interpretations"	2	"ACMG2013,ACMG2016"	N	-	2	435774	1	156108366	G	A	427656	1:156108366:G:A	Pathogenic	2/8/13	-	Orphanet:ORPHA98473	C0026850:Muscular dystrophy	NA	FALSE	Incorrect phenotype	"criteria provided, single submitter"	clinical testing	germline:na	"Genetic Services Laboratory, University of Chicago"	SCV000595638.1	SCV000595638		LMNA	-	"Lipodystrophy, MonogenicDM_all"	9/6/17	46928	35	1	"[0.9999893453801568,1.0654619843163995E-5]"	1	SCV00059563845148	single nucleotide variant	NM_005912.2(MC4R):c.806T>A (p.Ile269Asn)	4160	MC4R	HGNC:6932	Conflicting interpretations of pathogenicity	1	14-Mar-17	79783591	-	RCV000030158;RCV000499660	"Human Phenotype Ontology:HP:0001513,MedGen:C0028754,OMIM:601665,Orphanet:ORPHA71529,SNOMED CT:414916001;MedGen:CN169374"	Obesity;not specified	germline	germline	GRCh37	NC_000018.9	18	58038777	58038777	A	T	18q21.3	"criteria provided, conflicting interpretations"	3	NA	N	-	2	36486	18	58038777	A	T	45148	18:58038777:A:T	Uncertain significance	3/14/17	-	not specified	CN169374:not specified	No Information	FALSE	No Information	"criteria provided, single submitter"	clinical testing	germline:na	"Genetic Services Laboratory, University of Chicago"	SCV000595716.1	SCV000595716		MC4R	-	Obesity	3/14/17	46963	0	241	"[0.997434150288525,0.002565849711474991]"	237	SCV000595716430076	single nucleotide variant	NM_005912.2(MC4R):c.449C>T (p.Thr150Ile)	4160	MC4R	HGNC:6932	Likely pathogenic	1	18-Oct-16	766665118	-	RCV000582643;RCV000503229	"Human Phenotype Ontology:HP:0001513,MedGen:C0028754,OMIM:601665,Orphanet:ORPHA71529,SNOMED CT:414916001;MedGen:CN233047"	"Obesity;Obesity, autosomal dominant"	germline	germline	GRCh37	NC_000018.9	18	58039134	58039134	G	A	18q21.32	"criteria provided, single submitter"	2	NA	N	-	2	435829	18	58039134	G	A	430076	18:58039134:G:A	Likely pathogenic	10/18/16	-	"Obesity, autosomal dominant"	"CN233047:Obesity, autosomal dominant"	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	"Genetic Services Laboratory, University of Chicago"	SCV000595718.1	SCV000595718		MC4R	-	Obesity	10/18/16	46963	0	8	"[0.9999148265655942,8.517343440580883E-5]"	8	SCV000595718430078	single nucleotide variant	NM_005912.2(MC4R):c.181G>A (p.Glu61Lys)	4160	MC4R	HGNC:6932	Pathogenic/Likely pathogenic	1	30-Aug-16	370479598	-	RCV000583759;RCV000501559;RCV000518806	"Human Phenotype Ontology:HP:0001513,MedGen:C0028754,OMIM:601665,Orphanet:ORPHA71529,SNOMED CT:414916001;MedGen:CN233047;MedGen:CN517202"	"Obesity;Obesity, autosomal dominant;not provided"	germline	germline	GRCh37	NC_000018.9	18	58039402	58039402	C	T	18q21.32	"criteria provided, multiple submitters, no conflicts"	3	NA	N	-	2	435831	18	58039402	C	T	430078	18:58039402:C:T	Likely pathogenic	10/26/15	-	"Obesity, autosomal dominant"	"CN233047:Obesity, autosomal dominant"	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	"Genetic Services Laboratory, University of Chicago"	SCV000595720.1	SCV000595720		MC4R	-	Obesity	8/30/16	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV000595720428116	single nucleotide variant	NM_015869.4(PPARG):c.581G>A (p.Arg194Gln)	5468	PPARG	HGNC:9236	Likely pathogenic	1	8-Aug-16	148195788	-	RCV000499572	"MedGen:C1720861,OMIM:604367,Orphanet:ORPHA79083"	Familial partial lipodystrophy 3	germline	germline	GRCh37	NC_000003.11	3	12434213	12434213	G	A	3p25.2	"criteria provided, single submitter"	1	NA	N	-	2	436397	3	12434213	G	A	428116	3:12434213:G:A	Likely pathogenic	8/8/16	-	"Lipodystrophy, familial partial, type 3"	C1720861:Familial partial lipodystrophy 3	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	"Genetic Services Laboratory, University of Chicago"	SCV000596559.1	SCV000596559		PPARG	-	"Lipodystrophy, MonogenicDM_all"	8/8/16	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV000596559428125	deletion	NM_015869.4(PPARG):c.1361del (p.Pro454Leufs)	5468	PPARG	HGNC:9236	Pathogenic	1	22-Jul-16	770557781	-	RCV000503538	"MedGen:C1720861,OMIM:604367,Orphanet:ORPHA79083"	Familial partial lipodystrophy 3	germline	germline	GRCh37	NC_000003.11	3	12475487	12475487	C	-	3p25.2	"criteria provided, single submitter"	1	NA	N	-	2	436405	3	12475484	AC	A	428125	3:12475484:AC:A	Pathogenic	7/22/16	-	"Lipodystrophy, familial partial, type 3"	C1720861:Familial partial lipodystrophy 3	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	"Genetic Services Laboratory, University of Chicago"	SCV000596567.1	SCV000596567		PPARG	-	"Lipodystrophy, MonogenicDM_all"	7/22/16	46963	0	2	"[0.9999787066413985,2.1293358601452207E-5]"	2	SCV000596567441414	deletion	NM_000352.4(ABCC8):c.1634del (p.Phe545Serfs)	6833	ABCC8	HGNC:59	Pathogenic	1	10-May-18	1260178539	-	RCV000668965;RCV000518203	"MedGen:C2931832,OMIM:256450,SNOMED CT:360339005;MedGen:CN517202"	Persistent hyperinsulinemic hypoglycemia of infancy;not provided	germline;unknown	germline	GRCh37	NC_000011.9	11	17453788	17453788	A	-	11p15.1	"criteria provided, multiple submitters, no conflicts"	2	NA	N	-	2	446765	11	17453787	GA	G	441414	11:17453787:GA:G	Pathogenic	5/10/18	-	not provided	CN517202:not provided	congenital hyperinsulinism based on pubmed articles	FALSE	Not trait of interest	"criteria provided, single submitter"	clinical testing	germline:na	Athena Diagnostics Inc	SCV000612201.2	SCV000612201		ABCC8	-	"MODY Extended, MonogenicDM_all, Neonatal Diabetes"	5/10/18	43834	3129	1	"[0.9999885933293791,1.1406670620979149E-5]"	1	SCV000612201186816	single nucleotide variant	NM_001287174.1(ABCC8):c.2509C>T (p.Arg837Ter)	6833	ABCC8	HGNC:59	Pathogenic/Likely pathogenic	1	31-Oct-18	72559722	-	RCV000763234;RCV000763234;RCV000763234;RCV000169276;RCV000763234;RCV000763234;RCV000201895	"Human Phenotype Ontology:HP:0005978,MedGen:C0011860,OMIM:125853,Orphanet:ORPHA181376,SNOMED CT:44054006;MedGen:C0271714,OMIM:240800,SNOMED CT:62151007;MedGen:C1833104,OMIM:606176,Orphanet:ORPHA99885;MedGen:C2931832,OMIM:256450,SNOMED CT:360339005;MedGen:C2931832,OMIM:256450,SNOMED CT:360339005;MedGen:C1835887,OMIM:610374;MedGen:CN517202"	Diabetes mellitus type 2;Leucine-induced hypoglycemia;Permanent neonatal diabetes mellitus;Persistent hyperinsulinemic hypoglycemia of infancy;Persistent hyperinsulinemic hypoglycemia of infancy;Transient neonatal diabetes mellitus 2;not provided	germline;unknown	germline	GRCh37	NC_000011.9	11	17434263	17434263	G	A	11p15.1	"criteria provided, multiple submitters, no conflicts"	5	NA	N	-	2	188915	11	17434263	G	A	186816	11:17434263:G:A	Pathogenic	6/24/16	-	not provided	CN517202:not provided	hyperinsulinism of infancy - based on pubmed articles	FALSE	Not trait of interest	"criteria provided, single submitter"	clinical testing	germline:na	Athena Diagnostics Inc	SCV000612205.1	SCV000612205		ABCC8	-	"MODY Extended, MonogenicDM_all, Neonatal Diabetes"	10/31/18	46955	8	12	"[0.9998722180811416,1.2778191885848153E-4]"	12	SCV00061220524127	single nucleotide variant	NM_001287174.1(ABCC8):c.3992-9G>A	6833	ABCC8	HGNC:59	Pathogenic	1	5-Jun-17	151344623	-	RCV000590487;RCV000009656;RCV000144995	"MedGen:C3888018,Orphanet:ORPHA276525;MedGen:C2931832,OMIM:256450,SNOMED CT:360339005;MedGen:CN517202"	Familial hyperinsulinism;Persistent hyperinsulinemic hypoglycemia of infancy;not provided	germline;unknown	germline	GRCh37	NC_000011.9	11	17418602	17418602	C	T	11p15.1	"criteria provided, multiple submitters, no conflicts"	7	NA	N	OMIM Allelic Variant:600509.0002	3	9088	11	17418602	C	T	24127	11:17418602:C:T	Pathogenic	4/11/17	-	not provided	CN517202:not provided	Familial hyperinsulinism maybe - based on pubmed articles	FALSE	Not trait of interest	"criteria provided, single submitter"	clinical testing	germline:na	Athena Diagnostics Inc	SCV000612213.2	SCV000612213		ABCC8	-	"MODY Extended, MonogenicDM_all, Neonatal Diabetes"	6/5/17	46963	0	15	"[0.9998402998104892,1.5970018951089155E-4]"	15	SCV000612213441404	single nucleotide variant	NM_000352.4(ABCC8):c.4178G>A (p.Arg1393His)	6833	ABCC8	HGNC:59	Conflicting interpretations of pathogenicity	1	14-Dec-17	769279368	-	RCV000671471;RCV000518373	"MedGen:C2931832,OMIM:256450,SNOMED CT:360339005;MedGen:CN517202"	Persistent hyperinsulinemic hypoglycemia of infancy;not provided	germline;unknown	germline	GRCh37	NC_000011.9	11	17417419	17417419	C	T	11p15.1	"criteria provided, conflicting interpretations"	2	NA	N	-	2	446776	11	17417419	C	T	441404	11:17417419:C:T	Likely pathogenic	6/26/17	-	not provided	CN517202:not provided	familial hyperinsulinism or persistent hyperinsulinemic hypoglycemia of infancy based on pubmed articles	FALSE	Not trait of interest	"criteria provided, single submitter"	clinical testing	germline:na	Athena Diagnostics Inc	SCV000612218.2	SCV000612218		ABCC8	-	"MODY Extended, MonogenicDM_all, Neonatal Diabetes"	12/14/17	46650	313	3	"[0.999967845659164,3.215434083601286E-5]"	3	SCV00061221832929	single nucleotide variant	NM_000384.2(APOB):c.10580G>A (p.Arg3527Gln)	338	APOB	HGNC:603	Conflicting interpretations of pathogenicity	1	11-Jul-18	5742904	-	RCV000019479;RCV000284412;RCV000412515;RCV000627797;RCV000499833;RCV000627797;RCV000254882	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C1862596,Orphanet:ORPHA426,SNOMED CT:60193003;MedGen:C1704417,OMIM:144010;MedGen:C1704417,OMIM:144010;MedGen:C0020597,Orphanet:ORPHA31154;MedGen:C4551990,OMIM:615558;MedGen:CN517202"	"Familial hypercholesterolemia;Familial hypobetalipoproteinemia;Hypercholesterolemia, autosomal dominant, type B;Hypercholesterolemia, autosomal dominant, type B;Hypobetalipoproteinemia;Hypobetalipoproteinemia, familial, 1;not provided"	germline;maternal;unknown	germline	GRCh37	NC_000002.11	2	21229160	21229160	C	T	2p24	"criteria provided, conflicting interpretations"	18	"ACMG2013,ACMG2016"	Y	OMIM Allelic Variant:107730.0009	3	17890	2	21229160	C	T	32929	2:21229160:C:T	Pathogenic	4/18/16	-	not provided	CN517202:not provided	hypercholesterolemia - based on pubmed articles	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Athena Diagnostics Inc	SCV000612386.1	SCV000612386		APOB	-	Low LDL	7/11/18	46963	0	12	"[0.9998722398483912,1.2776015160871325E-4]"	12	SCV000612386207484	single nucleotide variant	NM_000162.3(GCK):c.370G>A (p.Asp124Asn)	2645	GCK	HGNC:4195	Conflicting interpretations of pathogenicity	1	1-Jun-17	759072800	-	RCV000193215;RCV000518229	"MedGen:C1841962,OMIM:125851;MedGen:CN169374"	"Maturity-onset diabetes of the young,  type 2;not specified"	germline	germline	GRCh37	NC_000007.13	7	44190668	44190668	C	T	7p13	"criteria provided, conflicting interpretations"	2	NA	N	-	2	211073	7	44190668	C	T	207484	7:44190668:C:T	Uncertain significance	6/1/17	-	not specified	CN169374:not specified	MODY	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Athena Diagnostics Inc	SCV000613426.1	SCV000613426		GCK	-	"MODY, MODY Extended, MonogenicDM_all"	6/1/17	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV000613426415104	single nucleotide variant	NM_000162.3(GCK):c.571C>T (p.Arg191Trp)	2645	GCK	HGNC:4195	Pathogenic	1	7-Nov-17	1085307455	-	RCV000754816;RCV000490143	"MedGen:C1841962,OMIM:125851;MedGen:CN517202"	"Maturity-onset diabetes of the young,  type 2;not provided"	germline	germline	GRCh37	NC_000007.13	7	44189576	44189576	G	A	7p13	"criteria provided, multiple submitters, no conflicts"	3	NA	N	-	2	426122	7	44189576	G	A	415104	7:44189576:G:A	Pathogenic	10/23/17	-	not provided	CN517202:not provided	MODY	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Athena Diagnostics Inc	SCV000613442.2	SCV000613442		GCK	-	"MODY, MODY Extended, MonogenicDM_all"	11/7/17	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV00061344244907	single nucleotide variant	NM_000162.5(GCK):c.676G>A (p.Val226Met)	2645	GCK	HGNC:4195	Pathogenic/Likely pathogenic	1	31-Oct-18	148311934	-	RCV000763584;RCV000763584;RCV000029906;RCV000763584;RCV000763584;RCV000255932	"Human Phenotype Ontology:HP:0005978,MedGen:C0011860,OMIM:125853,Orphanet:ORPHA181376,SNOMED CT:44054006;MedGen:C1865290,OMIM:602485,Orphanet:ORPHA79299;MedGen:C1841962,OMIM:125851;MedGen:C1841962,OMIM:125851;MedGen:C1833104,OMIM:606176,Orphanet:ORPHA99885;MedGen:CN517202"	"Diabetes mellitus type 2;Hyperinsulinemic hypoglycemia familial 3;Maturity-onset diabetes of the young,  type 2;Maturity-onset diabetes of the young,  type 2;Permanent neonatal diabetes mellitus;not provided"	germline;unknown	germline	GRCh37	NC_000007.13	7	44189362	44189362	C	T	7p13	"criteria provided, multiple submitters, no conflicts"	6	NA	N	UniProtKB (protein):P35557#VAR_003703	2	36243	7	44189362	C	T	44907	7:44189362:C:T	Pathogenic	4/17/17	-	not provided	CN517202:not provided	MODY - based on pubmed articles	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Athena Diagnostics Inc	SCV000613449.2	SCV000613449		GCK	-	"MODY, MODY Extended, MonogenicDM_all"	10/31/18	46963	0	2	"[0.9999787066413985,2.1293358601452207E-5]"	2	SCV000613449441107	single nucleotide variant	NM_000162.4(GCK):c.682A>G (p.Thr228Ala)	2645	GCK	HGNC:4195	Likely pathogenic	1	3-Nov-17	1332966015	-	RCV000516688	MedGen:CN517202	not provided	germline	germline	GRCh37	NC_000007.13	7	44187430	44187430	T	C	7p13	"criteria provided, single submitter"	1	NA	N	-	2	447413	7	44187430	T	C	441107	7:44187430:T:C	Likely pathogenic	11/3/17	-	not provided	CN517202:not provided	MODY	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Athena Diagnostics Inc	SCV000613450.2	SCV000613450		GCK	-	"MODY, MODY Extended, MonogenicDM_all"	11/3/17	46961	2	1	"[0.9999893528672729,1.0647132727156576E-5]"	1	SCV00061345031173	single nucleotide variant	NM_000162.3(GCK):c.683C>T (p.Thr228Met)	2645	GCK	HGNC:4195	Pathogenic	1	12-Jun-17	80356655	-	RCV000020167;RCV000030923;RCV000498792	"MedGen:C1841962,OMIM:125851;MedGen:C1833104,OMIM:606176,Orphanet:ORPHA99885;MedGen:CN517202"	"Maturity-onset diabetes of the young,  type 2;Permanent neonatal diabetes mellitus;not provided"	germline	germline	GRCh37	NC_000007.13	7	44187429	44187429	G	A	7p13	"criteria provided, multiple submitters, no conflicts"	4	NA	N	"OMIM Allelic Variant:138079.0003,OMIM Allelic Variant:138079.0011,UniProtKB (protein):P35557#VAR_003705"	3	16134	7	44187429	G	A	31173	7:44187429:G:A	Pathogenic	10/18/13	-	not provided	CN517202:not provided	MODY - based on pubmed articles	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Athena Diagnostics Inc	SCV000613451.1	SCV000613451		GCK	-	"MODY, MODY Extended, MonogenicDM_all"	6/12/17	46961	2	1	"[0.9999893528672729,1.0647132727156576E-5]"	1	SCV00061345129966	duplication	NM_000545.6(HNF1A):c.872dupC (p.Gly292Argfs)	6927	HNF1A	HGNC:11621	Pathogenic	1	6-Nov-17	587776825	-	RCV000016063;RCV000117225;RCV000016064;RCV000022617;RCV000016062;RCV000490055	"Human Phenotype Ontology:HP:0006770,MedGen:C0279702,Orphanet:ORPHA319276,SNOMED CT:188251003,SNOMED CT:254915003;MedGen:C0011854,OMIM:222100,Orphanet:ORPHA181371,SNOMED CT:46635009;MedGen:C2675866,OMIM:612520;MedGen:C1840646,OMIM:142330;MedGen:C1838100,OMIM:600496;MedGen:CN517202"	"Clear cell carcinoma of kidney;Diabetes mellitus type 1;Diabetes mellitus, insulin-dependent, 20;Hepatic adenomas, familial;Maturity-onset diabetes of the young, type 3;not provided"	germline;somatic	germline/somatic	GRCh37	NC_000012.11	12	121432125	121432125	C	CC	12q24.31	"criteria provided, multiple submitters, no conflicts"	4	NA	N	OMIM Allelic Variant:142410.0001	3	14927	12	121432117	G	GC	29966	12:121432117:G:GC	Pathogenic	9/9/15	-	not provided	CN517202:not provided	MODY - from pubmed articles	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Athena Diagnostics Inc	SCV000613637.2	SCV000613637		HNF1A	-	"MODY, MODY Extended, MonogenicDM_all"	11/6/17	46549	414	17	"[0.9998173967217341,1.8260327826591334E-4]"	17	SCV00061363745028	single nucleotide variant	NM_000457.4(HNF4A):c.991C>T (p.Arg331Cys)	3172	HNF4A	HGNC:5024	Conflicting interpretations of pathogenicity	1	21-Dec-16	193922479	-	RCV000193933;RCV000030034;RCV000517103	"Human Phenotype Ontology:HP:0000842,MedGen:C0020459;MedGen:C1852093,OMIM:125850;MedGen:CN169374"	"Hyperinsulinemia;Maturity-onset diabetes of the young,  type 1;not specified"	germline	germline	GRCh37	NC_000020.10	20	43052756	43052756	C	T	20q13.1	"criteria provided, conflicting interpretations"	3	NA	N	-	2	36364	20	43052756	C	T	45028	20:43052756:C:T	Uncertain significance	12/21/16	-	not specified	CN169374:not specified	MODY	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Athena Diagnostics Inc	SCV000613665.1	SCV000613665		HNF4A	-	"MODY, MODY Extended, MonogenicDM_all"	12/21/16	46938	25	1	"[0.9999893476500916,1.065234990838979E-5]"	1	SCV000613665441401	single nucleotide variant	NM_000525.3(KCNJ11):c.160C>T (p.Arg54Cys)	3767	KCNJ11	HGNC:6257	Likely pathogenic	1	22-Dec-17	375848765	-	RCV000516616	MedGen:CN517202	not provided	germline	germline	GRCh37	NC_000011.9	11	17409479	17409479	G	A	11p15.1	"criteria provided, single submitter"	1	NA	N	-	2	447634	11	17409479	G	A	441401	11:17409479:G:A	Likely pathogenic	12/22/17	-	not provided	CN517202:not provided	No Information	FALSE	No Information	"criteria provided, single submitter"	clinical testing	germline:na	Athena Diagnostics Inc	SCV000613862.2	SCV000613862		KCNJ11	-	"MODY Extended, MonogenicDM_all, Neonatal Diabetes"	12/22/17	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV000613862181250	single nucleotide variant	NM_000527.4(LDLR):c.1171G>A (p.Ala391Thr)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	18-Aug-17	11669576	-	RCV000237576;RCV000162023;RCV000241875	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202;MedGen:CN169374"	Familial hypercholesterolemia;not provided;not specified	germline;not applicable;unknown	germline	GRCh37	NC_000019.9	19	11222300	11222300	G	A	19p13.2	"criteria provided, conflicting interpretations"	15	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_001369,UniProtKB (protein):P01130#VAR_024519"	2	183138	19	11222300	G	A	181250	19:11222300:G:A	Likely benign	3/21/17	-	not specified	CN169374:not specified	Familial hypercholesterolemia	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Athena Diagnostics Inc	SCV000614003.1	SCV000614003		LDLR	-	High LDL	8/18/17	46928	35	4469	"[0.9523845039209001,0.0476154960790999]"	3889	SCV000614003171218	single nucleotide variant	NM_000527.4(LDLR):c.1783C>T (p.Arg595Trp)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	24-Oct-17	373371572	-	RCV000237585;RCV000588105;RCV000148597;RCV000518174	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:C0020443;MedGen:CN517202"	Familial hypercholesterolemia;Familial hypercholesterolemias;Hypercholesterolaemia;not provided	germline	germline	GRCh37	NC_000019.9	19	11227612	11227612	C	T	19p13.2	"criteria provided, conflicting interpretations"	11	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000239,UniProtKB (protein):P01130#VAR_072856"	2	161290	19	11227612	C	T	171218	19:11227612:C:T	Likely pathogenic	6/16/17	-	not provided	CN517202:not provided	Familial hypercholesterolemia	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Athena Diagnostics Inc	SCV000614004.1	SCV000614004		LDLR	-	High LDL	10/24/17	46963	0	2	"[0.9999787066413985,2.1293358601452207E-5]"	2	SCV000614004228146	single nucleotide variant	NM_000527.4(LDLR):c.682G>T (p.Glu228Ter)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	31-Oct-18	121908029	-	RCV000211631;RCV000589867;RCV000518828	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:CN517202"	Familial hypercholesterolemia;Familial hypercholesterolemias;not provided	germline;not applicable;unknown	germline	GRCh37	NC_000019.9	19	11216264	11216264	G	T	19p13.2	"criteria provided, multiple submitters, no conflicts"	12	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_001818	2	226333	19	11216264	G	T	228146	19:11216264:G:T	Pathogenic	6/27/13	-	not provided	CN517202:not provided	familial hypercholesterolemia	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Athena Diagnostics Inc	SCV000614010.1	SCV000614010		LDLR	-	High LDL	10/31/18	46944	19	1	"[0.9999893490115883,1.0650988411724608E-5]"	1	SCV000614010430078	single nucleotide variant	NM_005912.2(MC4R):c.181G>A (p.Glu61Lys)	4160	MC4R	HGNC:6932	Pathogenic/Likely pathogenic	1	30-Aug-16	370479598	-	RCV000583759;RCV000501559;RCV000518806	"Human Phenotype Ontology:HP:0001513,MedGen:C0028754,OMIM:601665,Orphanet:ORPHA71529,SNOMED CT:414916001;MedGen:CN233047;MedGen:CN517202"	"Obesity;Obesity, autosomal dominant;not provided"	germline	germline	GRCh37	NC_000018.9	18	58039402	58039402	C	T	18q21.32	"criteria provided, multiple submitters, no conflicts"	3	NA	N	-	2	435831	18	58039402	C	T	430078	18:58039402:C:T	Pathogenic	8/30/16	-	not provided	CN517202:not provided	Obesity	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Athena Diagnostics Inc	SCV000614059.1	SCV000614059		MC4R	-	Obesity	8/30/16	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV000614059226972	single nucleotide variant	NM_000527.4(LDLR):c.190+4A>T	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	23-Oct-17	769446356	-	RCV000211667;RCV000210581;RCV000523458	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MeSH:D030342,MedGen:C0950123;MedGen:CN517202"	Familial hypercholesterolemia;Inborn genetic diseases;not provided	germline;not applicable	germline	GRCh37	NC_000019.9	19	11211025	11211025	A	T	19p13.2	"criteria provided, conflicting interpretations"	8	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000028	2	225097	19	11211025	A	T	226972	19:11211025:A:T	Likely pathogenic	8/24/17	"The c.190+4 A>T likely pathogenic variant in the LDLR gene has been reported in multiple unrelated patients with FH (Fouchier et al., 2005; Punzalan et al., 2005; Al-Khateeb et al., 2011; Wang et al., 2016). The c.190+4 A>T variant is not observed at a significant frequency in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). This substitution occurs at a nucleotide position that is conserved through mammals. The c.190+4 A>T variant is predicted to destroy the canonical splice donor site in intron 2 and cause abnormal gene splicing. Finally, other splice site variants in the LDLR gene have been reported in HGMD in association with FH (Stenson et al., 2014)."	Not Provided	CN517202:not provided	familial hypercholesterolemia	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	GeneDx	SCV000617499.1	SCV000617499		LDLR	-	High LDL	10/23/17	46963	0	2	"[0.9999787066413985,2.1293358601452207E-5]"	2	SCV000617499171199	single nucleotide variant	NM_000527.4(LDLR):c.301G>A (p.Glu101Lys)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	31-Oct-18	144172724	-	RCV000211583;RCV000148571;RCV000162016	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202"	Familial hypercholesterolemia;Hypercholesterolaemia;not provided	germline;not applicable;unknown	germline	GRCh37	NC_000019.9	19	11213450	11213450	G	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	15	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000044,UniProtKB (protein):P01130#VAR_005315"	2	161266	19	11213450	G	A	171199	19:11213450:G:A	Pathogenic	9/7/17	"The E101K (aka E80K, FH Lancashire) pathogenic variant is part of a negatively charged triplet, Ser-Asp-Glu, located at the carboxyl-terminal end of the LDL-receptor A2 repeat domain in the LDLR gene, and is critical for ligand binding (Schneider et al., 2003). E101K has been published numerous times in unrelated patients from different ethnic backgrounds with FH (Webb et al., 1992; Wang et al., 2001; Mozas et al., 2004; Robles-Osorio et al., 2006; Humphries et al., 2006; Al-Khateeb et al., 201; Futema et al., 2013). Patient protein studies and in vitro analysis support alteration to protein processing and intracellular transport, in the presence of E101K (Webb et al., 1992; Thormaehlen et al., 2015). E101K results in a non-conservative amino acid substitution at a position that is conserved across species. Additionally, this variant is classified as pathogenic/likely pathogenic and reported to segregate with disease by other clinical laboratories in ClinVar (ClinVar SCV000285028.2, SCV000484724.1, SCV000503127.1, SCV000583649.1, SCV000268550.1, ; Landrum et al., 2016). Furthermore, the E101K variant is not observed at a significant frequency in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server)."	Not Provided	CN517202:not provided	Familial hypercholesterolemia	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	GeneDx	SCV000617500.1	SCV000617500		LDLR	-	High LDL	10/31/18	46963	0	3	"[0.9999680599620978,3.194003790217831E-5]"	3	SCV000617500181247	single nucleotide variant	NM_000527.4(LDLR):c.1027G>A (p.Gly343Ser)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	5-Jul-18	730882096	-	RCV000211596;RCV000587327;RCV000161977	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:CN517202"	Familial hypercholesterolemia;Familial hypercholesterolemias;not provided	germline;not applicable	germline	GRCh37	NC_000019.9	19	11221414	11221414	G	A	19p13.2	"criteria provided, conflicting interpretations"	15	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_001328,UniProtKB (protein):P01130#VAR_005367"	2	183106	19	11221414	G	A	181247	19:11221414:G:A	Likely pathogenic	10/5/17	"The G343S likely pathogenic variant in the LDLR gene (previously reported as G322S and FH Picardie due to the use of alternate nomenclature) has been reported in association with FH across multiple ethnic groups (Reshef et al., 1996; Thiart et al., 2000; Fouchier et al., 2001; Salazar et al., 2002; Bourbon et al., 2008; Junyent et al., 2008; van der Graaf et al., 2011; Kusters et al., 2013; Medeiros et al., 2014; Jannes et al., 2015; Reiman et al., 2016; Sanchez-Hernandez et al., 2016; Gabcova et al., 2016). This variant is not observed at a significant frequency in large population cohorts (Lek et al., 2016). The G343S variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is conserved across species, and in silico analysis predicts this variant is probably damaging to the protein structure/function. Furthermore, functional studies showed decreased LDL receptor activity (Hobbs et al., 1992). Missense variants in the same residue (G343V, G343D, G343C) have been reported in the Human Gene Mutation Database in association with FH (Stenson et al., 2014); however, the pathogenicity of these variants has not been definitively determined."	Not Provided	CN517202:not provided	Familial hypercholesterolemia	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	GeneDx	SCV000617505.1	SCV000617505		LDLR	-	High LDL	7/5/18	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV000617505228156	single nucleotide variant	NM_000527.4(LDLR):c.1048C>T (p.Arg350Ter)	3949	LDLR	HGNC:6547	Pathogenic	1	8-May-18	769737896	-	RCV000211692;RCV000520229	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202"	Familial hypercholesterolemia;not provided	germline;inherited	germline	GRCh37	NC_000019.9	19	11221435	11221435	C	T	19p13.2	"criteria provided, multiple submitters, no conflicts"	11	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000147	2	226342	19	11221435	C	T	228156	19:11221435:C:T	Pathogenic	8/25/17	"The R350X variant (previously reported as R329X due to the use of alternate nomenclature) in the LDLR gene has been reported in association with FH across multiple ethnic groups (Solberg et al., 1994; Day et al., 1997; Maruyama et al., 2004; Kubalska et al., 2008; Chmara et al., 2010; Futema et al., 2012; Jannes et al., 2015; Fan et al., 2015; Hu et al., 2016). This variant is predicted to cause loss of normal protein function either by protein truncation or nonsense-mediated mRNA decay. Other nonsense variants in the LDLR gene have been reported in Human Gene Mutation Database in association with FH (Stenson et al., 2014). Furthermore, the R350X variant is not observed at a significant frequency in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server)."	Not Provided	CN517202:not provided	familial hypercholesterolemia	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	GeneDx	SCV000617506.1	SCV000617506		LDLR	-	High LDL	5/8/18	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV000617506171212	single nucleotide variant	NM_000527.4(LDLR):c.1238C>T (p.Thr413Met)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	23-Oct-17	368562025	-	RCV000211581;RCV000148582;RCV000519267	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202"	Familial hypercholesterolemia;Hypercholesterolaemia;not provided	germline;unknown	germline	GRCh37	NC_000019.9	19	11224005	11224005	C	T	19p13.2	"criteria provided, conflicting interpretations"	9	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000967	2	161276	19	11224005	C	T	171212	19:11224005:C:T	Likely pathogenic	5/18/17	"The T413M variant in the LDLR gene has been reported previously in at least 5 unrelated individuals from various ethnic backgrounds with familial hypercholesterolemia (Wang et al., 2001; Bunn et al., 2002; Mihaylov et al., 2004; Wang et al., 2005). Additionally, the T413M variant is not observed at a significant frequency in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). The T413M variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. Although this substitution occurs at a position that is not conserved, methionine is not tolerated at this position in any species. In silico analysis predicts this variant is probably damaging to the protein structure/function. Missense variants in nearby residues (E408K, E408V, K411E, L414R, R416W, R416P, R416Q) have been reported in the Human Gene Mutation Database in association with familial hypercholesterolemia (Stenson et al., 2014), supporting the functional importance of this region of the protein. We interpret T413M as a likely pathogenic variant."	Not Provided	CN517202:not provided	Familial hypercholesterolemia	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	GeneDx	SCV000617508.1	SCV000617508		LDLR	-	High LDL	10/23/17	46963	0	3	"[0.9999680599620978,3.194003790217831E-5]"	3	SCV000617508444937	single nucleotide variant	NM_000545.6(HNF1A):c.812G>A (p.Arg271Gln)	6927	HNF1A	HGNC:11621	Pathogenic	1	14-Aug-17	779184183	-	RCV000519064	MedGen:CN517202	not provided	germline	germline	GRCh37	NC_000012.11	12	121432065	121432065	G	A	12q24.31	"criteria provided, single submitter"	1	NA	N	-	2	449403	12	121432065	G	A	444937	12:121432065:G:A	Pathogenic	8/14/17	"The R271Q variant has been reported previously in association with MODY (Tonooka et al., 2002; Bitterman et al., 2016). The variant is not observed at a significant frequency in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). R271Q is a semi-conservative amino acid substitution, which may impact secondary protein structure as these residues differ in some properties. This substitution occurs at a position that is conserved across species, and in silico analysis predicts this variant is probably damaging to the protein structure/function. Functional studies have shown R271Q results in increased DNA binding ability, reduced transactivation activities, and abnormal cytoplasmic distribution (Balamurugan et al.; 2016). Missense variants in the same residue (R271W/G) and in nearby residues (N266S/K, W267R/S, F268L/S, A269P/D, R272S/H, K273N, A276D/G) have been reported in the Human Gene Mutation Database in association with MODY (Stenson et al., 2014), supporting the functional importance of this region of the protein. In summary, we consider this variant to be pathogenic."	Not Provided	CN517202:not provided	MODY	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	GeneDx	SCV000617534.1	SCV000617534		HNF1A	-	"MODY, MODY Extended, MonogenicDM_all"	8/14/17	46959	4	1	"[0.9999893524138078,1.0647586192210225E-5]"	1	SCV00061753429984	single nucleotide variant	NM_000545.6(HNF1A):c.827C>A (p.Ala276Asp)	6927	HNF1A	HGNC:11621	Likely pathogenic	1	7-Jul-17	137853245	-	RCV000016083;RCV000521190	"MedGen:C1838100,OMIM:600496;MedGen:CN517202"	"Maturity-onset diabetes of the young, type 3;not provided"	germline	germline	GRCh37	NC_000012.11	12	121432080	121432080	C	A	12q24.31	"criteria provided, single submitter"	2	NA	N	OMIM Allelic Variant:142410.0019	3	14945	12	121432080	C	A	29984	12:121432080:C:A	Likely pathogenic	7/7/17	"The A276D variant has been reported previously in association with MODY (BjÃ¸rkhaug et al., 2003; BellannÃ©-Chantelot et al., 2008). The variant is observed in 1/8770 (0.01%) alleles from individuals of African background in the ExAC dataset (Lek et al., 2016). A276D is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is conserved across species, and in silico analysis predicts this variant is probably damaging to the protein structure/function. Missense variants in the same residue (A276G) and in nearby residues (R271W/G/Q, R272S/H, K273N, K280E, L281P) have been reported in the Human Gene Mutation Database in association with MODY (Stenson et al., 2014), supporting the functional importance of this region of the protein. In summary, this variant is likely pathogenic."	Not Provided	CN517202:not provided	MODY	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	GeneDx	SCV000617535.1	SCV000617535		HNF1A	-	"MODY, MODY Extended, MonogenicDM_all"	7/7/17	46944	19	2	"[0.9999786980231765,2.1301976823449217E-5]"	2	SCV00061753524251	single nucleotide variant	NM_175914.4(HNF4A):c.340C>T (p.Arg114Trp)	3172	HNF4A	HGNC:5024	Conflicting interpretations of pathogenicity	1	12-Dec-17	137853336	-	RCV000009792;RCV000711955;RCV000520726	"MedGen:C1852093,OMIM:125850;MedGen:CN517202;MedGen:CN169374"	"Maturity-onset diabetes of the young,  type 1;not provided;not specified"	germline	germline	GRCh37	NC_000020.10	20	43042354	43042354	C	T	20q13.1	"criteria provided, conflicting interpretations"	3	NA	N	"OMIM Allelic Variant:600281.0003,UniProtKB (protein):P41235#VAR_004668"	3	9212	20	43042354	C	T	24251	20:43042354:C:T	Uncertain significance	8/15/17	"The R114W variant in the HNF4A gene has been reported previously, using alternate nomenclature R127W, in individuals with diabetes, however it has also been reported in individuals and family members without diabetes, and does not cosegregate in some pedigrees (Furuta et al., 1997; Shankar et al., 2013; Flannick et al., 2013; Delvecchio et al., 2014; Laver et al., 2016). The R114W variant is observed in 7/64396 (0.011%) alleles from individuals of non-Finnish European background, in the ExAC dataset (Lek et al., 2016). The R114W variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is conserved across species. In silico analysis predicts this variant is probably damaging to the protein structure/function. We interpret R114W as a variant of uncertain significance."	not specified	CN169374:not specified	No Information	FALSE	No Information	"criteria provided, single submitter"	clinical testing	germline:na	GeneDx	SCV000617566.1	SCV000617566		HNF4A	-	"MODY, MODY Extended, MonogenicDM_all"	12/12/17	46962	1	5	"[0.9999467654699544,5.3234530045568755E-5]"	5	SCV00061756616561	single nucleotide variant	NM_000237.3(LPL):c.644G>A (p.Gly215Glu)	4023	LPL	HGNC:6677	Pathogenic	1	31-Oct-18	118204057	-	RCV000763181;RCV000001586;RCV000763181;RCV000521241	"Human Phenotype Ontology:HP:0008158,MedGen:C0020474,OMIM:144250;MedGen:C0023817,OMIM:238600,Orphanet:ORPHA309015,SNOMED CT:238086005,SNOMED CT:275598004;MedGen:C0023817,OMIM:238600,Orphanet:ORPHA309015,SNOMED CT:238086005,SNOMED CT:275598004;MedGen:CN517202"	"Hyperapobetalipoproteinemia;Hyperlipoproteinemia, type I;Hyperlipoproteinemia, type I;not provided"	germline;unknown	germline	GRCh37	NC_000008.10	8	19811733	19811733	G	A	8p21.3	"criteria provided, multiple submitters, no conflicts"	3	NA	N	"OMIM Allelic Variant:609708.0002,UniProtKB (protein):P06858#VAR_004225"	3	1522	8	19811733	G	A	16561	8:19811733:G:A	Pathogenic	10/20/17	"The G215E variant in the LPL gene has been reported multiple times in association with autosomalrecessive LPL deficiency when present in the homozygous state or when in trans with another diseasecausingvariant (Emi et al., 1990; Monsalve et al., 1990; Bordugo et al., 2014; Ooi et al., 2012).G215E has also been reported in the heterozygous state in association with hyperlipoproteinemia(Chokshi et al., 2014; Johansen et al., 2014; Rodrigues et al., 2016). Function studies have shown theG215E variant results in a complete loss of catalytic activity (Hata et al., 1992). In silico analysis isinconsistent in its predictions as to whether or not the variant is damaging to the proteinstructure/function. We interpret G215E as a pathogenic variant."	Not Provided	CN517202:not provided	hyperlipoproteinemia	FALSE	AR	"criteria provided, single submitter"	clinical testing	germline:na	GeneDx	SCV000617843.1	SCV000617843		LPL	-	High triglycerides	10/31/18	46963	0	13	"[0.9998615931690905,1.3840683090943933E-4]"	13	SCV000617843171211	single nucleotide variant	NM_000527.4(LDLR):c.1201C>G (p.Leu401Val)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	11-May-18	146200173	-	RCV000238417;RCV000586642;RCV000148572;RCV000255176	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:C0020443;MedGen:CN517202"	Familial hypercholesterolemia;Familial hypercholesterolemias;Hypercholesterolaemia;not provided	germline	germline	GRCh37	NC_000019.9	19	11223968	11223968	C	G	19p13.2	"criteria provided, conflicting interpretations"	10	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000535,UniProtKB (protein):P01130#VAR_007987"	2	161267	19	11223968	C	G	171211	19:11223968:C:G	Likely pathogenic	6/3/17	"This sequence change replaces leucine with valine at codon 401 of the LDLR protein (p.Leu401Val). The leucine residue is highly conserved and there is a small physicochemical difference between leucine and valine. This variant is present in population databases (rs146200173, ExAC 0.02%). This variant has been reported in individuals affected with hypercholesterolemia (PMID: 9104431, 21722902, 25461735). It is also known as p.Leu380Val in the literature. This variant has been reported in individuals in the Universal Mutation Database (PMID: 12124988) and has an entry in ClinVar (Variation ID: 161267). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive, but these predictions have not been confirmed by published functional studies. In summary, this variant is a rare missense change that has been reported in many affected individuals. This evidence indicates that the variant is pathogenic, but additional data is needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic."	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Invitae	SCV000627015.1	SCV000627015		LDLR	-	High LDL	5/11/18	46963	0	3	"[0.9999680599620978,3.194003790217831E-5]"	3	SCV00062701518733	single nucleotide variant	NM_000527.4(LDLR):c.1285G>A (p.Val429Met)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	31-Oct-18	28942078	-	RCV000003882	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline;inherited;unknown	germline	GRCh37	NC_000019.9	19	11224052	11224052	G	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	14	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_001387,OMIM Allelic Variant:606945.0009,UniProtKB (protein):P01130#VAR_005383"	3	3694	19	11224052	G	A	18733	19:11224052:G:A	Pathogenic	4/6/18	"This sequence change replaces valine with methionine at codon 429 of the LDLR protein (p.Val429Met). The valine residue is highly conserved and there is a small physicochemical difference between valine and methionine. This variant is present in population databases (rs28942078, ExAC 0.006%). This variant has been reported in the literature in the homozygous state segregating with disease in a single family (PMID: 21925660) and in several individuals both in the homozygous and heterozygous state affected with familial hypercholesterolemia (PMID: 11668627, 23375686, 2569482, 11196104, 19837725, 15256764, 11139254, 21475731). This variant is also known as p.Val408Met in the literature. ClinVar contains an entry for this variant (Variation ID: 3694). Experimental studies have shown that this missense change causes slower processing of precursor LDLR protein to the mature protein and faster degradation of the protein (PMID: 2569482). For these reasons, this variant has been classified as Pathogenic."	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Invitae	SCV000627017.2	SCV000627017		LDLR	-	High LDL	10/31/18	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV000627017434303	single nucleotide variant	NM_000527.4(LDLR):c.1586+5G>C	3949	LDLR	HGNC:6547	Likely pathogenic	1	30-May-17	781362878	-	RCV000508837;RCV000586202	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445"	Familial hypercholesterolemia;Familial hypercholesterolemias	germline	germline	GRCh37	NC_000019.9	19	11224443	11224443	G	C	19p13.2	"criteria provided, multiple submitters, no conflicts"	3	"ACMG2013,ACMG2016"	N	-	2	440652	19	11224443	G	C	434303	19:11224443:G:C	Likely pathogenic	5/30/17	"This sequence change falls in intron 10 of the LDLR gene. It does not directly change the encoded amino acid sequence of the LDLR protein, but it affects a nucleotide within the consensus splice site of the intron. This variant is not present in population databases (ExAC no frequency). This variant has been reported in individuals affected with hypercholesterolemia (PMID: 17964958, Invitae). This sequence change has been reported in an individual in the Universal Mutation Database (PMID: 12124988). Nucleotide substitutions within the consensus splice site are relatively common causes of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site, but this prediction has not been confirmed by published transcriptional studies. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic."	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Invitae	SCV000627020.1	SCV000627020		LDLR	-	High LDL	5/30/17	46963	0	4	"[0.9999574132827971,4.2586717202904415E-5]"	4	SCV000627020171219	single nucleotide variant	NM_000527.4(LDLR):c.1816G>T (p.Ala606Ser)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	25-Oct-17	72658865	-	RCV000211562;RCV000148567;RCV000162003	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202"	Familial hypercholesterolemia;Hypercholesterolaemia;not provided	germline;not applicable	germline	GRCh37	NC_000019.9	19	11227645	11227645	G	T	19p13.2	"criteria provided, conflicting interpretations"	9	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000566	2	161264	19	11227645	G	T	171219	19:11227645:G:T	Uncertain significance	10/25/17	"This sequence change replaces alanine with serine at codon 606 of the LDLR protein (p.Ala606Ser). The alanine residue is highly conserved and there is a moderate physicochemical difference between alanine and serine. This variant is present in population databases (rs72658865, ExAC 0.01%). This variant has been reported in many individuals with possible or definite hypercholesterolemia. Currently there is insufficient evidence to conclude whether this variant segregates with disease or not (PMID: 9409298, 9544745, 14974088, 15199436, 16250003, 17765246, 18325082, 24956927, 27765764). This variant is also known as p.Arg585Ser in the literature. ClinVar contains an entry for this variant (Variation ID: 161264). Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: ""Tolerated""; PolyPhen-2: ""Possibly Damaging""; Align-GVGD: ""Class C0""). In summary, this variant is a rare missense change with uncertain impact on protein function. While it has been observed in individuals with elevated cholesterol levels, it is also found in the population at an appreciable frequency. In the absence of conclusive segregation or functional evidence, at this time it has been classified as a Variant of Uncertain Significance."	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Invitae	SCV000627022.2	SCV000627022		LDLR	-	High LDL	10/25/17	46963	0	5	"[0.9999467666034964,5.323339650363052E-5]"	5	SCV000627022228195	single nucleotide variant	NM_000527.4(LDLR):c.1955T>C (p.Met652Thr)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	28-Mar-18	875989936	-	RCV000211590	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline	germline	GRCh37	NC_000019.9	19	11230877	11230877	T	C	19p13.2	"criteria provided, conflicting interpretations"	5	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000266	2	226382	19	11230877	T	C	228195	19:11230877:T:C	Uncertain significance	3/28/18	"This sequence change replaces methionine with threonine at codon 652 of the LDLR protein (p.Met652Thr). The methionine residue is weakly conserved and there is a moderate physicochemical difference between methionine and threonine. This variant is not present in population databases (ExAC no frequency). This variant has been reported in several unrelated individuals affected with hypercholesterolemia (PMID: 20236128, 20809525). ClinVar contains an entry for this variant (Variation ID: 226382). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive, but these predictions have not been confirmed by published functional studies. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance."	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Invitae	SCV000627024.2	SCV000627024		LDLR	-	High LDL	3/28/18	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV00062702418741	single nucleotide variant	NM_000527.4(LDLR):c.2054C>T (p.Pro685Leu)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	31-Oct-18	28942084	-	RCV000003891;RCV000162007	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202"	Familial hypercholesterolemia;not provided	germline;inherited;not applicable;unknown	germline	GRCh37	NC_000019.9	19	11231112	11231112	C	T	19p13.2	"criteria provided, multiple submitters, no conflicts"	16	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000276,OMIM Allelic Variant:606945.0017,UniProtKB (protein):P01130#VAR_005410"	3	3702	19	11231112	C	T	18741	19:11231112:C:T	Pathogenic	5/15/18	"This sequence change replaces proline with leucine at codon 685 of the LDLR protein (p.Pro685Leu). The proline residue is highly conserved and there is a moderate physicochemical difference between proline and leucine. This variant is present in population databases (rs28942084, ExAC 0.01%). This variant has been reported in several individuals affected with familial hypercholesterolemia and has been found to segregate with the disease in multiple families (PMID: 11031227, 15359125, 18718593, 21382890, 23155708, 23375686, 23669246, 2726768). This variant is also known as p.Pro664Leu in the literature. This variant has been reported in individuals in the Universal Mutation Database (PMID: 12124988) and has an entry in ClinVar (Variation ID: 3702). Experimental studies have shown that this missense change inhibits LDL-uptake in cultured lymphocytes (PMID: 19013141). For these reasons, this variant has been classified as Pathogenic."	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Invitae	SCV000627025.2	SCV000627025		LDLR	-	High LDL	10/31/18	46963	0	3	"[0.9999680599620978,3.194003790217831E-5]"	3	SCV00062702518783	single nucleotide variant	NM_000527.4(LDLR):c.2140+1G>A	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	11-Jun-18	145787161	-	RCV000003942	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline	germline	GRCh37	NC_000019.9	19	11231199	11231199	G	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	8	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000282,OMIM Allelic Variant:606945.0063"	3	3744	19	11231199	G	A	18783	19:11231199:G:A	Pathogenic	6/11/18	"This sequence change affects a donor splice site in intron 14 of the LDLR gene. It is expected to disrupt RNA splicing and likely results in an absent or disrupted protein product. Loss-of-function variants in LDLR are known to be pathogenic. This particular variant has been reported in individuals affected with familial hypercholesterolemia and to segregate with the disease in a large multigenerational family (PMID: 12522687, 15241806,Â¬â€ 20828696, 23054246). Experimental studies have shown that this splice site variant leads to an aberrant splicing that results in the loss of the protein (PMID: 12522687). For these reasons, this variant has been classified as Pathogenic."	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Invitae	SCV000627027.3	SCV000627027		LDLR	-	High LDL	6/11/18	46962	1	1	"[0.9999893530939908,1.0646906009113752E-5]"	1	SCV000627027228201	deletion	NM_000527.4(LDLR):c.2271delT (p.Leu759Serfs)	3949	LDLR	HGNC:6547	Pathogenic	1	11-May-17	875989940	-	RCV000211650;RCV000493493	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202"	Familial hypercholesterolemia;not provided	germline	germline	GRCh37	NC_000019.9	19	11233980	11233980	T	-	19p13.2	"criteria provided, multiple submitters, no conflicts"	6	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000890	2	226388	19	11233979	CT	C	228201	19:11233979:CT:C	Pathogenic	5/11/17	"This sequence change deletes 1 nucleotide from exon 15 of the LDLR mRNA (c.2271delT), causing a frameshift at codon 759. This creates a premature translational stop signal (p.Leu759Serfs*6) and is expected to result in an absent or disrupted protein product. Loss-of-function variants in LDLR are known to be pathogenic. This particular variant has been reported in the literature in individuals with familial hypercholesterolemia (PMID: 16314194, 22089669). ClinVar contains an entry for this variant (Variation ID: 226388). For these reasons, this variant has been classified as Pathogenic."	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Invitae	SCV000627032.1	SCV000627032		LDLR	-	High LDL	5/11/17	46963	0	2	"[0.9999787066413985,2.1293358601452207E-5]"	2	SCV000627032434210	duplication	NM_000527.4(LDLR):c.337dup (p.Glu113Glyfs)	3949	LDLR	HGNC:6547	Pathogenic	1	6-Feb-17	752191968	-	RCV000508965	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline	germline	GRCh37	NC_000019.9	19	11215919	11215919	na	na	19p13.2	"criteria provided, single submitter"	2	"ACMG2013,ACMG2016"	N	-	2	440560	19	11215918	C	CG	434210	19:11215918:C:CG	Pathogenic	2/6/17	"This sequence change inserts 1 nucleotide in exon 4 of the LDLR mRNA (c.337dupG), causing a frameshift at codon 113. This creates a premature translational stop signal (p.Glu113Glyfs*17) and is expected to result in an absent or disrupted protein product. Loss-of-function variants in LDLR are known to be pathogenic. This particular variant has been reported in the literature in individuals with hypercholesterolemia (PMID: 16314194). This variant is also known as c.338insG in the literature. For these reasons, this variant has been classified as Pathogenic."	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Invitae	SCV000627036.1	SCV000627036		LDLR	-	High LDL	2/6/17	46962	1	1	"[0.9999893530939908,1.0646906009113752E-5]"	1	SCV000627036181228	single nucleotide variant	NM_000527.4(LDLR):c.502G>A (p.Asp168Asn)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	28-Jun-18	200727689	-	RCV000211669;RCV000162017	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202"	Familial hypercholesterolemia;not provided	germline;not applicable;unknown	germline	GRCh37	NC_000019.9	19	11216084	11216084	G	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	7	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_001749,UniProtKB (protein):P01130#VAR_005322"	2	183136	19	11216084	G	A	181228	19:11216084:G:A	Pathogenic	6/28/18	"This sequence change replaces aspartic acid with asparagine at codon 168 of the LDLR protein (p.Asp168Asn). The aspartic acid residue is highly conserved and there is a small physicochemical difference between aspartic acid and asparagine. This variant is present in population databases (rs200727689, ExAC 0.003%). This variant has been reported in numerous unrelated individuals affected with familial hypercholesterolemia (PMID: 9259195, 9678702, 12124988, 15556094, 16205024, 19007590, 22859806, 27784735). This variant is also known as p.Asp147Asn in the literature. ClinVar contains an entry for this variant (Variation ID: 183136). Experimental studies have shown that this missense change causes a significantly reduced affinity to LDL (PMID: 25545329, 25647241). For these reasons, this variant has been classified as Pathogenic."	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Invitae	SCV000627039.3	SCV000627039		LDLR	-	High LDL	6/28/18	46963	0	2	"[0.9999787066413985,2.1293358601452207E-5]"	2	SCV000627039228146	single nucleotide variant	NM_000527.4(LDLR):c.682G>T (p.Glu228Ter)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	31-Oct-18	121908029	-	RCV000211631;RCV000589867;RCV000518828	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:CN517202"	Familial hypercholesterolemia;Familial hypercholesterolemias;not provided	germline;not applicable;unknown	germline	GRCh37	NC_000019.9	19	11216264	11216264	G	T	19p13.2	"criteria provided, multiple submitters, no conflicts"	12	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_001818	2	226333	19	11216264	G	T	228146	19:11216264:G:T	Pathogenic	5/21/18	"This sequence change creates a premature translational stop signal (p.Glu228*) in the LDLR gene. It is expected to result in an absent or disrupted protein product. This variant is present in population databases (rs121908029, ExAC 0.01%). This variant has been reported in multiple unrelated individuals and affected with familial hypercholesterolemia (PMID: 1301956, 11462246, 15359125, 19843101, 21310417,Â¬â€ 23054246). This variant is also known as p.Glu207* in the literature. ClinVar contains an entry for this variant (Variation ID: 226333). Loss-of-function variants in LDLR are known to be pathogenic (PMID: 20809525). For these reasons, this variant has been classified as Pathogenic."	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Invitae	SCV000627046.3	SCV000627046		LDLR	-	High LDL	10/31/18	46944	19	1	"[0.9999893490115883,1.0650988411724608E-5]"	1	SCV00062704639058	single nucleotide variant	NM_002052.4(GATA4):c.1220C>A (p.Pro407Gln)	2626	GATA4	HGNC:4173	Conflicting interpretations of pathogenicity	1	21-Mar-17	115099192	-	RCV000490358;RCV000490358;RCV000526826;RCV000023008;RCV000030949;RCV000490358	"MedGen:C1842778,OMIM:607941;MedGen:C3280781,OMIM:614430;MedGen:C3280781,OMIM:614430;Human Phenotype Ontology:HP:0001636,MedGen:C0039685,OMIM:187500,Orphanet:ORPHA3303,SNOMED CT:86299006;MedGen:C3280777,OMIM:614429;MedGen:C3280777,OMIM:614429"	Atrial septal defect 2;Atrioventricular septal defect 4;Atrioventricular septal defect 4;Tetralogy of Fallot;Ventricular septal defect 1;Ventricular septal defect 1	germline	germline	GRCh37	NC_000008.10	8	11615875	11615875	C	A	8p23.1	"criteria provided, conflicting interpretations"	3	NA	N	"OMIM Allelic Variant:600576.0011,OMIM Allelic Variant:600576.0013,UniProtKB (protein):P43694#VAR_067619"	3	30103	8	11615875	C	A	39058	8:11615875:C:A	Benign	3/21/17	-	MedGen:C3280781	C3280781:Atrioventricular septal defect 4	NA	FALSE	Not trait of interest	"criteria provided, single submitter"	clinical testing	germline:na	Invitae	SCV000651999.1	SCV000651999		GATA4	-	"MonogenicDM_all, Neonatal Diabetes"	3/21/17	46963	0	85	"[0.9990950322594383,9.049677405617188E-4]"	85	SCV00065199924073	single nucleotide variant	NM_002052.4(GATA4):c.1273G>A (p.Asp425Asn)	2626	GATA4	HGNC:4173	Conflicting interpretations of pathogenicity	1	8-Dec-17	56208331	-	RCV000009600;RCV000549514;RCV000190715;RCV000626818;RCV000626818;RCV000009601;RCV000626818;RCV000431077	"MedGen:C1842778,OMIM:607941;MedGen:C3280781,OMIM:614430;MeSH:D030342,MedGen:C0950123;Human Phenotype Ontology:HP:0010882,MedGen:CN116616;Human Phenotype Ontology:HP:0001642,MedGen:C1956257,OMIM:265500;Human Phenotype Ontology:HP:0001636,MedGen:C0039685,OMIM:187500,Orphanet:ORPHA3303,SNOMED CT:86299006;Human Phenotype Ontology:HP:0005180,MedGen:C0040961;MedGen:CN517202"	Atrial septal defect 2;Atrioventricular septal defect 4;Inborn genetic diseases;Pulmonary valve atresia;Pulmonic stenosis;Tetralogy of Fallot;Tricuspid regurgitation;not provided	germline;unknown	germline	GRCh37	NC_000008.10	8	11615928	11615928	G	A	8p23.1	"criteria provided, conflicting interpretations"	5	NA	N	"OMIM Allelic Variant:600576.0005,UniProtKB (protein):P43694#VAR_067621"	3	9034	8	11615928	G	A	24073	8:11615928:G:A	Benign	12/8/17	-	MedGen:C3280781	C3280781:Atrioventricular septal defect 4	NA	FALSE	Not trait of interest	"criteria provided, single submitter"	clinical testing	germline:na	Invitae	SCV000652001.2	SCV000652001		GATA4	-	"MonogenicDM_all, Neonatal Diabetes"	12/8/17	46963	0	221	"[0.9976470838745395,0.002352916125460469]"	217	SCV000652001458160	single nucleotide variant	NM_002052.4(GATA4):c.617-2A>G	2626	GATA4	HGNC:4173	Likely pathogenic	1	14-Nov-17	1405855570	-	RCV000529584	"MedGen:C3280781,OMIM:614430"	Atrioventricular septal defect 4	germline	germline	GRCh37	NC_000008.10	8	11606426	11606426	A	G	8p23.1	"criteria provided, single submitter"	1	NA	N	-	2	472779	8	11606426	A	G	458160	8:11606426:A:G	Likely pathogenic	11/14/17	"This sequence change affects an acceptor splice site in intron 2 of the GATA4 gene. It is expected to disrupt RNA splicing and likely results in an absent or disrupted protein product. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals with GATA4-related disease. Donor and acceptor splice site variants typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in GATA4 are known to be pathogenic (PMID: 12845333, 15235040). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic."	MedGen:C3280781	C3280781:Atrioventricular septal defect 4	NA	FALSE	Not trait of interest	"criteria provided, single submitter"	clinical testing	germline:na	Invitae	SCV000652008.2	SCV000652008		GATA4	-	"MonogenicDM_all, Neonatal Diabetes"	11/14/17	46963	0	2	"[0.9999787066413985,2.1293358601452207E-5]"	2	SCV00065200857199	single nucleotide variant	NM_005572.3(LMNA):c.1201C>T (p.Arg401Cys)	4000	LMNA	HGNC:6636	Conflicting interpretations of pathogenicity	1	17-May-18	61094188	-	RCV000157295;RCV000528639;RCV000172002;RCV000627127;RCV000057258;RCV000041313	"MedGen:C4053736,OMIM:604772;MedGen:C0270914,Orphanet:ORPHA64746;MedGen:C0410189,Orphanet:ORPHA261,SNOMED CT:111508004;MedGen:C0340427,Orphanet:ORPHA217607;MedGen:CN517202;MedGen:CN169374"	"Catecholaminergic polymorphic ventricular tachycardia type 1;Charcot-Marie-Tooth disease, type 2;Emery-Dreifuss muscular dystrophy;Familial dilated cardiomyopathy;not provided;not specified"	germline;unknown	germline	GRCh37	NC_000001.10	1	156106048	156106048	C	T	1q22	"criteria provided, conflicting interpretations"	8	"ACMG2013,ACMG2016"	N	UniProtKB (protein):P02545#VAR_072818	2	48035	1	156106048	C	T	57199	1:156106048:C:T	Uncertain significance	3/30/17	"This sequence change replaces arginine with cysteine at codon 401 of the LMNA protein (p.Arg401Cys). The arginine residue is highly conserved and there is a large physicochemical difference between arginine and cysteine. This variant is present in population databases (rs61094188, ExAC 0.02%). This variant has been reported in an individual affected with muscular dystrophy (PMID: 12376891), as well as several related individuals with dilated cardiomyopathy (PMID: 25448463). However, in the individual with muscular dystrophy, this variant was also observed in their unaffected sister and mother so the clinical significance of this observation is uncertain. ClinVar contains an entry for this variant (Variation ID: 48035). Experimental studies have shown that this missense has varying effects on the binding of known lamin-A interacting proteins (PMID: 14597414, 23977161, 24623722). In summary, this variant is a rare missense change with uncertain impact on protein function. It has been reported in both the population and affected individuals, but the available evidence is currently insufficient to determine its role in disease. Therefore, it has been classified as a Variant of Uncertain Significance."	MedGen:CN043576	"C0270914:Charcot-Marie-Tooth disease, type 2"	NA	FALSE	Incorrect phenotype	"criteria provided, single submitter"	clinical testing	germline:na	Invitae	SCV000657795.1	SCV000657795		LMNA	-	"Lipodystrophy, MonogenicDM_all"	5/17/18	46962	1	6	"[0.9999361185639453,6.388143605468251E-5]"	6	SCV00065779529538	single nucleotide variant	NM_170707.3(LMNA):c.1580G>A (p.Arg527His)	4000	LMNA	HGNC:6636	Pathogenic	1	2-Jul-18	57520892	-	RCV000555364;RCV000015591;RCV000148607;RCV000015592;RCV000057326	"MedGen:C0270914,Orphanet:ORPHA64746;MedGen:C0432291,OMIM:248370,Orphanet:ORPHA2457,SNOMED CT:109419009;MedGen:CN118835;MedGen:CN043412;MedGen:CN517202"	"Charcot-Marie-Tooth disease, type 2;Mandibuloacral dysostosis;Mandibuloacral dysplasia;Mandibuloacral dysplasia with type A lipodystrophy, atypical;not provided"	germline	germline	GRCh37	NC_000001.10	1	156106995	156106995	G	A	1q22	"criteria provided, multiple submitters, no conflicts"	6	"ACMG2013,ACMG2016"	N	"OMIM Allelic Variant:150330.0021,UniProtKB (protein):P02545#VAR_018727"	3	14499	1	156106995	G	A	29538	1:156106995:G:A	Pathogenic	7/2/18	"This sequence change replaces arginine with histidine at codon 527 of the LMNA protein (p.Arg527His). The arginine residue is highly conserved and there is a small physicochemical difference between arginine and histidine. This variant is present in population databases (rs57520892, ExAC 0.05%). This variant has been reported to segregate with autosomal recessive mandibuloacral dysplasia in several families and has been reported in the homozygous state in multiple affected individuals (PMID: 12075506, 14627682). ClinVar contains an entry for this variant (Variation ID: 14499). Experimental studies have shown that this missense variant leads to abnormal nuclear morphology, altered cell cycle regulation and increased sensitivity to ionizing radiation (PMID: 12075506, 18604166 , 25823658, 25324471). A different missense substitution at this codon (p.Arg527Pro) has been determined to cause autosomal dominant Emery-Dreifuss muscular dystrophy (PMID: 10080180, 19084400). This suggests that the arginine residue is critical for LMNA protein function and that other missense substitutions at this position may also be pathogenic. For these reasons, this variant has been classified as Pathogenic."	MedGen:CN043576	"C0270914:Charcot-Marie-Tooth disease, type 2"	NA	FALSE	Incorrect phenotype	"criteria provided, single submitter"	clinical testing	germline:na	Invitae	SCV000657803.3	SCV000657803		LMNA	-	"Lipodystrophy, MonogenicDM_all"	7/2/18	46868	95	8	"[0.9999146539216524,8.534607834769993E-5]"	8	SCV00065780357261	single nucleotide variant	NM_170707.3(LMNA):c.976T>A (p.Ser326Thr)	4000	LMNA	HGNC:6636	Conflicting interpretations of pathogenicity	1	21-Nov-18	56851164	-	RCV000621488;RCV000544253;RCV000755678;RCV000208012;RCV000057494;RCV000212504	"MedGen:CN230736;MedGen:C0270914,Orphanet:ORPHA64746;MedGen:C1449563,OMIM:115200,Orphanet:ORPHA300751;MedGen:C0949658,Orphanet:ORPHA155,SNOMED CT:83978005;MedGen:CN517202;MedGen:CN169374"	"Cardiovascular phenotype;Charcot-Marie-Tooth disease, type 2;Dilated cardiomyopathy 1A;Primary familial hypertrophic cardiomyopathy;not provided;not specified"	germline;unknown	germline	GRCh37	NC_000001.10	1	156105731	156105731	T	A	1q22	"criteria provided, conflicting interpretations"	8	"ACMG2013,ACMG2016"	N	-	2	48097	1	156105731	T	A	57261	1:156105731:T:A	Uncertain significance	1/22/18	"This sequence change replaces serine with threonine at codon 326 of the LMNA protein (p.Ser326Thr). The serine residue is highly conserved and there is a small physicochemical difference between serine and threonine. This variant is present in population databases (rs56851164, ExAC 0.01%). This variant has been reported in individuals affected with Emeryâ€šÃ„Ã¬Dreifuss muscular dystrophy, dilated cardiomyopathy, and late-onset scapular myopathy (PMID: 16585054, 16407522, 24503780). This variant has been reported to segregate with dilated cardiomyopathy in a single family (PMID: 24503780). ClinVar contains an entry for this variant (Variation ID: 48097). A computational modeling study found that this variant was not predicted to affect certain structural properties of the coiled 2B domain in which it occurs (PMID: 23142632). Furthermore, algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated, but these predictions have not been confirmed by published functional studies. In summary, this variant is a rare missense change that is not predicted to affect protein function. It has been reported in both the population and affected individuals, but the available evidence is currently insufficient to determine its role in disease. Therefore, it has been classified as a Variant of Uncertain Significance."	MedGen:CN043576	"C0270914:Charcot-Marie-Tooth disease, type 2"	NA	FALSE	Incorrect phenotype	"criteria provided, single submitter"	clinical testing	germline:na	Invitae	SCV000657831.3	SCV000657831		LMNA	-	"Lipodystrophy, MonogenicDM_all"	11/21/18	46959	4	3	"[0.9999680572414233,3.1942758576630676E-5]"	3	SCV00065783124127	single nucleotide variant	NM_001287174.1(ABCC8):c.3992-9G>A	6833	ABCC8	HGNC:59	Pathogenic	1	5-Jun-17	151344623	-	RCV000590487;RCV000009656;RCV000144995	"MedGen:C3888018,Orphanet:ORPHA276525;MedGen:C2931832,OMIM:256450,SNOMED CT:360339005;MedGen:CN517202"	Familial hyperinsulinism;Persistent hyperinsulinemic hypoglycemia of infancy;not provided	germline;unknown	germline	GRCh37	NC_000011.9	11	17418602	17418602	C	T	11p15.1	"criteria provided, multiple submitters, no conflicts"	7	NA	N	OMIM Allelic Variant:600509.0002	3	9088	11	17418602	C	T	24127	11:17418602:C:T	Pathogenic	11/9/15	-	OMIM:256450	C2931832:Persistent hyperinsulinemic hypoglycemia of infancy	NA	FALSE	Not trait of interest	"criteria provided, single submitter"	clinical testing	unknown:na	Counsyl	SCV000678147.1	SCV000678147		ABCC8	-	"MODY Extended, MonogenicDM_all, Neonatal Diabetes"	6/5/17	46963	0	15	"[0.9998402998104892,1.5970018951089155E-4]"	15	SCV00067814745125	single nucleotide variant	NM_000527.4(LDLR):c.2479G>A (p.Val827Ile)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	2-Nov-17	137853964	-	RCV000030135;RCV000148585;RCV000058923;RCV000436469	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202;MedGen:CN169374"	Familial hypercholesterolemia;Hypercholesterolaemia;not provided;not specified	germline;inherited;not applicable;unknown	germline	GRCh37	NC_000019.9	19	11240278	11240278	G	A	19p13.2	"criteria provided, conflicting interpretations"	16	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_001657,UniProtKB (protein):P01130#VAR_005418"	2	36462	19	11240278	G	A	45125	19:11240278:G:A	Uncertain significance	8/1/17	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:1	"Phosphorus, Inc."	SCV000679811.1	SCV000679811		-	-	High LDL	11/2/17	46963	0	74	"[0.9992121457317462,7.878542682537317E-4]"	74	SCV000679811228146	single nucleotide variant	NM_000527.4(LDLR):c.682G>T (p.Glu228Ter)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	31-Oct-18	121908029	-	RCV000211631;RCV000589867;RCV000518828	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:CN517202"	Familial hypercholesterolemia;Familial hypercholesterolemias;not provided	germline;not applicable;unknown	germline	GRCh37	NC_000019.9	19	11216264	11216264	G	T	19p13.2	"criteria provided, multiple submitters, no conflicts"	12	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_001818	2	226333	19	11216264	G	T	228146	19:11216264:G:T	Pathogenic	2/16/17	"E228X (referred to as Stop207 and FH Morocco) has been reported previously as a novel variant in one individual of Moroccan American ancestry with primary hypercholesterolemia who was homozygous for E228X (Hobbs et al., 1992). E228X is predicted to cause loss of normal protein function either by protein truncation or nonsense-mediated mRNA decay. Furthermore, this particular area of the LDLR gene appears to be a mutation hotspot, and other nonsense variants in the LDLR gene have been reported in Human Gene Mutation Database in association with FH (Stenson et al., 2014). Furthermore, the E228X variant is not observed at a significant frequency in large population cohorts (Lek et al., 2016; Exome Variant Server).In summary, E228X in the LDLR gene is interpreted as a pathogenic variant."	Not Provided	CN517202:not provided	familial hypercholesterolemia	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	GeneDx	SCV000680545.1	SCV000680545		LDLR	-	High LDL	10/31/18	46944	19	1	"[0.9999893490115883,1.0650988411724608E-5]"	1	SCV00068054545114	single nucleotide variant	NM_000527.4(LDLR):c.1061-8T>C	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	31-May-18	72658861	-	RCV000030123;RCV000759074;RCV000245346	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202;MedGen:CN169374"	Familial hypercholesterolemia;not provided;not specified	germline;unknown	germline	GRCh37	NC_000019.9	19	11222182	11222182	T	C	19p13.2	"criteria provided, conflicting interpretations"	15	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000154	2	36451	19	11222182	T	C	45114	19:11222182:T:C	Benign	6/22/17	-	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Color	SCV000689757.1	SCV000689757		LDLR	-	High LDL	5/31/18	46960	3	426	"[0.9954642248722317,0.004535775127768314]"	420	SCV000689757181250	single nucleotide variant	NM_000527.4(LDLR):c.1171G>A (p.Ala391Thr)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	18-Aug-17	11669576	-	RCV000237576;RCV000162023;RCV000241875	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202;MedGen:CN169374"	Familial hypercholesterolemia;not provided;not specified	germline;not applicable;unknown	germline	GRCh37	NC_000019.9	19	11222300	11222300	G	A	19p13.2	"criteria provided, conflicting interpretations"	15	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_001369,UniProtKB (protein):P01130#VAR_024519"	2	183138	19	11222300	G	A	181250	19:11222300:G:A	Benign	6/22/17	-	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Color	SCV000689758.1	SCV000689758		LDLR	-	High LDL	8/18/17	46928	35	4469	"[0.9523845039209001,0.0476154960790999]"	3889	SCV000689758226400	single nucleotide variant	NM_000527.4(LDLR):c.1194C>T (p.Ile398=)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	2-Jan-18	13306498	-	RCV000210233	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline	germline	GRCh37	NC_000019.9	19	11223961	11223961	C	T	19p13.2	"criteria provided, conflicting interpretations"	5	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_001231	2	224620	19	11223961	C	T	226400	19:11223961:C:T	Benign	7/17/17	-	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Color	SCV000689759.1	SCV000689759		LDLR	-	High LDL	1/2/18	46962	1	134	"[0.9985733145947787,0.0014266854052212426]"	134	SCV00068975945123	single nucleotide variant	NM_000527.4(LDLR):c.2140+5G>A	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	26-Jan-18	72658867	-	RCV000030133;RCV000614028	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN169374"	Familial hypercholesterolemia;not specified	germline	germline	GRCh37	NC_000019.9	19	11231203	11231203	G	A	19p13.2	"criteria provided, conflicting interpretations"	13	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000283	2	36460	19	11231203	G	A	45123	19:11231203:G:A	Likely benign	6/22/17	-	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Color	SCV000689773.1	SCV000689773		LDLR	-	High LDL	1/26/18	46942	21	472	"[0.9949725192791103,0.005027480720889608]"	464	SCV00068977345125	single nucleotide variant	NM_000527.4(LDLR):c.2479G>A (p.Val827Ile)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	2-Nov-17	137853964	-	RCV000030135;RCV000148585;RCV000058923;RCV000436469	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202;MedGen:CN169374"	Familial hypercholesterolemia;Hypercholesterolaemia;not provided;not specified	germline;inherited;not applicable;unknown	germline	GRCh37	NC_000019.9	19	11240278	11240278	G	A	19p13.2	"criteria provided, conflicting interpretations"	16	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_001657,UniProtKB (protein):P01130#VAR_005418"	2	36462	19	11240278	G	A	45125	19:11240278:G:A	Benign	8/29/17	-	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Color	SCV000689777.1	SCV000689777		LDLR	-	High LDL	11/2/17	46963	0	74	"[0.9992121457317462,7.878542682537317E-4]"	74	SCV000689777260609	single nucleotide variant	NM_174936.3(PCSK9):c.709C>T (p.Arg237Trp)	255738	PCSK9	HGNC:20001	Conflicting interpretations of pathogenicity	1	25-Jul-17	148195424	-	RCV000256274;RCV000417261	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C1863551,OMIM:603776"	"Familial hypercholesterolemia;Hypercholesterolemia, autosomal dominant, 3"	germline	germline	GRCh37	NC_000001.10	1	55518374	55518374	C	T	1p32.3	"criteria provided, conflicting interpretations"	5	"ACMG2013,ACMG2016"	N	UniProtKB (protein):Q8NBP7#VAR_025452	2	265933	1	55518374	C	T	260609	1:55518374:C:T	Uncertain significance	7/25/17	"Variant of Uncertain Significance due to insufficient evidence: This variant is a missense variant located in the catalytic peptidase domain in the PCSK9 protein. Computational prediction tools and conservation analyses are inconclusive regarding the impact of this variant on the protein function. Computational splicing tools suggest that this variant may not impact the RNA splicing. To our knowledge, functional assays have not been performed for this variant. This variant has been reported in individuals with hypercholesterolemia (PMID 15358785, 16465619, 17765244), as well as in an individual with hypocholesterolemia (PMID 16424354). It has also been identified in 71/118874 chromosomes by the Exome Aggregation Consortium (ExAC) general population database."	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Color	SCV000690989.1	SCV000690989		PCSK9	-	Low LDL	7/25/17	46949	14	63	"[0.9993290591918891,6.709408081109288E-4]"	63	SCV00069098929357	single nucleotide variant	NM_005912.2(MC4R):c.105C>A (p.Tyr35Ter)	4160	MC4R	HGNC:6932	Pathogenic	1	14-Aug-18	13447324	-	RCV000015394;RCV000202583;RCV000255005	"Human Phenotype Ontology:HP:0001513,MedGen:C0028754,OMIM:601665,Orphanet:ORPHA71529,SNOMED CT:414916001;Human Phenotype Ontology:HP:0100753,MedGen:C0036341,OMIM:181500,SNOMED CT:58214004;MedGen:CN517202"	Obesity;Schizophrenia;not provided	germline	germline	GRCh37	NC_000018.9	18	58039478	58039478	G	T	18q21.3	"criteria provided, multiple submitters, no conflicts"	8	NA	N	OMIM Allelic Variant:155541.0003	3	14318	18	58039478	G	T	29357	18:58039478:G:T	Pathogenic	11/6/13	-	MedGen:C0028754	C0028754:Obesity	NA	TRUE	NA	no assertion criteria provided	clinical testing	germline:na	"Clinical Molecular Genetics Laboratory,Johns Hopkins All Children's Hospital"	SCV000692294.1	SCV000692294		MC4R	-	Obesity	8/14/18	46963	0	6	"[0.9999361199241956,6.388007580435663E-5]"	6	SCV000692294485792	single nucleotide variant	NM_005912.2(MC4R):c.161T>C (p.Leu54Pro)	4160	MC4R	HGNC:6932	Pathogenic	1	4-May-17	376439188	-	RCV000582060	"Human Phenotype Ontology:HP:0001513,MedGen:C0028754,OMIM:601665,Orphanet:ORPHA71529,SNOMED CT:414916001"	Obesity	germline	germline	GRCh37	NC_000018.9	18	58039422	58039422	A	G	18q21.32	no assertion criteria provided	1	NA	N	-	2	492861	18	58039422	A	G	485792	18:58039422:A:G	Pathogenic	5/4/17	-	MedGen:C0028754	C0028754:Obesity	NA	TRUE	NA	no assertion criteria provided	clinical testing	germline:na	"Clinical Molecular Genetics Laboratory,Johns Hopkins All Children's Hospital"	SCV000692296.1	SCV000692296		MC4R	-	Obesity	5/4/17	46963	0	2	"[0.9999787066413985,2.1293358601452207E-5]"	2	SCV000692296430078	single nucleotide variant	NM_005912.2(MC4R):c.181G>A (p.Glu61Lys)	4160	MC4R	HGNC:6932	Pathogenic/Likely pathogenic	1	30-Aug-16	370479598	-	RCV000583759;RCV000501559;RCV000518806	"Human Phenotype Ontology:HP:0001513,MedGen:C0028754,OMIM:601665,Orphanet:ORPHA71529,SNOMED CT:414916001;MedGen:CN233047;MedGen:CN517202"	"Obesity;Obesity, autosomal dominant;not provided"	germline	germline	GRCh37	NC_000018.9	18	58039402	58039402	C	T	18q21.32	"criteria provided, multiple submitters, no conflicts"	3	NA	N	-	2	435831	18	58039402	C	T	430078	18:58039402:C:T	Pathogenic	12/19/13	-	MedGen:C0028754	C0028754:Obesity	NA	TRUE	NA	no assertion criteria provided	clinical testing	germline:na	"Clinical Molecular Genetics Laboratory,Johns Hopkins All Children's Hospital"	SCV000692297.1	SCV000692297		MC4R	-	Obesity	8/30/16	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV000692297430076	single nucleotide variant	NM_005912.2(MC4R):c.449C>T (p.Thr150Ile)	4160	MC4R	HGNC:6932	Likely pathogenic	1	18-Oct-16	766665118	-	RCV000582643;RCV000503229	"Human Phenotype Ontology:HP:0001513,MedGen:C0028754,OMIM:601665,Orphanet:ORPHA71529,SNOMED CT:414916001;MedGen:CN233047"	"Obesity;Obesity, autosomal dominant"	germline	germline	GRCh37	NC_000018.9	18	58039134	58039134	G	A	18q21.32	"criteria provided, single submitter"	2	NA	N	-	2	435829	18	58039134	G	A	430076	18:58039134:G:A	Pathogenic	5/13/14	-	MedGen:C0028754	C0028754:Obesity	NA	TRUE	NA	no assertion criteria provided	clinical testing	germline:na	"Clinical Molecular Genetics Laboratory,Johns Hopkins All Children's Hospital"	SCV000692299.1	SCV000692299		MC4R	-	Obesity	10/18/16	46963	0	8	"[0.9999148265655942,8.517343440580883E-5]"	8	SCV00069229929369	single nucleotide variant	NM_005912.2(MC4R):c.523G>A (p.Ala175Thr)	4160	MC4R	HGNC:6932	Pathogenic	1	16-Mar-11	121913563	-	RCV000015406	"Human Phenotype Ontology:HP:0001513,MedGen:C0028754,OMIM:601665,Orphanet:ORPHA71529,SNOMED CT:414916001"	Obesity	germline	germline	GRCh37	NC_000018.9	18	58039060	58039060	C	T	18q21.3	no assertion criteria provided	2	NA	N	"OMIM Allelic Variant:155541.0015,UniProtKB (protein):P32245#VAR_038646"	3	14330	18	58039060	C	T	29369	18:58039060:C:T	Pathogenic	3/16/11	-	MedGen:C0028754	C0028754:Obesity	NA	TRUE	NA	no assertion criteria provided	clinical testing	germline:na	"Clinical Molecular Genetics Laboratory,Johns Hopkins All Children's Hospital"	SCV000692300.1	SCV000692300		MC4R	-	Obesity	3/16/11	46963	0	45	"[0.9995208994314674,4.7910056853267465E-4]"	45	SCV000692300485791	single nucleotide variant	NM_005912.2(MC4R):c.757G>A (p.Val253Ile)	4160	MC4R	HGNC:6932	Pathogenic	1	4-Mar-14	187152753	-	RCV000582762	"Human Phenotype Ontology:HP:0001513,MedGen:C0028754,OMIM:601665,Orphanet:ORPHA71529,SNOMED CT:414916001"	Obesity	germline	germline	GRCh37	NC_000018.9	18	58038826	58038826	C	T	18q21.32	no assertion criteria provided	1	NA	N	-	2	492862	18	58038826	C	T	485791	18:58038826:C:T	Pathogenic	3/4/14	-	MedGen:C0028754	C0028754:Obesity	NA	TRUE	NA	no assertion criteria provided	clinical testing	germline:na	"Clinical Molecular Genetics Laboratory,Johns Hopkins All Children's Hospital"	SCV000692302.1	SCV000692302		MC4R	-	Obesity	3/4/14	46963	0	7	"[0.9999254732448949,7.452675510508272E-5]"	7	SCV00069230245148	single nucleotide variant	NM_005912.2(MC4R):c.806T>A (p.Ile269Asn)	4160	MC4R	HGNC:6932	Conflicting interpretations of pathogenicity	1	14-Mar-17	79783591	-	RCV000030158;RCV000499660	"Human Phenotype Ontology:HP:0001513,MedGen:C0028754,OMIM:601665,Orphanet:ORPHA71529,SNOMED CT:414916001;MedGen:CN169374"	Obesity;not specified	germline	germline	GRCh37	NC_000018.9	18	58038777	58038777	A	T	18q21.3	"criteria provided, conflicting interpretations"	3	NA	N	-	2	36486	18	58038777	A	T	45148	18:58038777:A:T	Pathogenic	5/23/14	-	MedGen:C0028754	C0028754:Obesity	NA	TRUE	NA	no assertion criteria provided	clinical testing	germline:na	"Clinical Molecular Genetics Laboratory,Johns Hopkins All Children's Hospital"	SCV000692303.1	SCV000692303		MC4R	-	Obesity	3/14/17	46963	0	241	"[0.997434150288525,0.002565849711474991]"	237	SCV000692303237314	single nucleotide variant	NM_000352.4(ABCC8):c.3640C>T (p.Arg1214Trp)	6833	ABCC8	HGNC:59	Pathogenic/Likely pathogenic	1	21-Mar-17	139964066	-	RCV000588494;RCV000666191;RCV000223959	"MedGen:C3888018,Orphanet:ORPHA276525;MedGen:C2931832,OMIM:256450,SNOMED CT:360339005;MedGen:CN517202"	Familial hyperinsulinism;Persistent hyperinsulinemic hypoglycemia of infancy;not provided	germline;unknown	germline	GRCh37	NC_000011.9	11	17424218	17424218	G	A	11p15.1	"criteria provided, multiple submitters, no conflicts"	3	NA	N	UniProtKB (protein):Q09428#VAR_031373	2	235633	11	17424218	G	A	237314	11:17424218:G:A	Pathogenic	1/12/17	"Variant summary: The ABCC8 c.3640C>T (p.Arg1214Trp also known as p.Arg1215Trp) variant located in the ABC transporter type 1, transmembrane domain (via InterPro) causes a missense change involving a conserved nucleotide, which 4/4 in silico tools (SNPs&GO not captured due to low reliability index) predict a damaging outcome. The variant of interest was observed in the large, broad control population, ExAC, with an allele frequency of 8/121412 (1/15174), which does not exceed the estimated maximal expected allele frequency for a pathogenic ABCC8 variant of 1/298. Multiple publications cite the variant in affected individuals, who are compound heterozygotes. In addition, multiple clinical diagnostic laboratory classifies this variant as pathogenic. Taken together, this variant is classified as pathogenic."	MedGen:C3888018	C3888018:Familial hyperinsulinism	NA	FALSE	Not trait of interest	"criteria provided, single submitter"	clinical testing	germline:na	Integrated Genetics/Laboratory Corporation of America	SCV000696589.1	SCV000696589		ABCC8	-	"MODY Extended, MonogenicDM_all, Neonatal Diabetes"	3/21/17	46963	0	5	"[0.9999467666034964,5.323339650363052E-5]"	5	SCV00069658924127	single nucleotide variant	NM_001287174.1(ABCC8):c.3992-9G>A	6833	ABCC8	HGNC:59	Pathogenic	1	5-Jun-17	151344623	-	RCV000590487;RCV000009656;RCV000144995	"MedGen:C3888018,Orphanet:ORPHA276525;MedGen:C2931832,OMIM:256450,SNOMED CT:360339005;MedGen:CN517202"	Familial hyperinsulinism;Persistent hyperinsulinemic hypoglycemia of infancy;not provided	germline;unknown	germline	GRCh37	NC_000011.9	11	17418602	17418602	C	T	11p15.1	"criteria provided, multiple submitters, no conflicts"	7	NA	N	OMIM Allelic Variant:600509.0002	3	9088	11	17418602	C	T	24127	11:17418602:C:T	Pathogenic	6/5/17	"Variant summary: The ABCC8 variant, c.3989-9G>A (alternatively also known as 3992-9G>A) involves the alteration of a non-conserved intronic nucleotide in intron 32. Mutation taster predicts a disease-causing outcome for this variant. While Human Splicing Finder predicts this variant to form a cryptic splice acceptor site, other four splice prediction tools predict no significant impact on normal splicing. Functional study shows that this variant leads to aberrant splicing, resulting in a 7-bp addition, a 20-bp deletion, or 30-bp deletion of exon 32 that encodes NBF-2 (nucleotide binding fold 2) of the protein (Thomas_1995). This variant was found in 373/164074 control chromosomes including ExAC at a frequency of 0.0022734, which does not exceed the estimated maximal expected allele frequency of a pathogenic ABCC8 variant (0.0033541). This variant is a known common pathogenic variant causing congenital hyperinsulinism (CH). In Ashkenazi population, c.39899G>A and p.F1387del are the two most common CH-associated ABCC8 mutations (Nestorowicz_1998, Glaser_2011). Carrier rate of this mutation in Ashkenazi general population is 1:60 (Glaser_2011). In GeneReviews, proportion of familial CH attributed to these two mutations is estimated to be nearly 45%. Multiple clinical diagnostic laboratories/reputable databases have classified this variant as pathogenic. Taken together, this variant is classified as pathogenic."	MedGen:C3888018	C3888018:Familial hyperinsulinism	NA	FALSE	Not trait of interest	"criteria provided, single submitter"	clinical testing	germline:na	Integrated Genetics/Laboratory Corporation of America	SCV000696590.1	SCV000696590		ABCC8	-	"MODY Extended, MonogenicDM_all, Neonatal Diabetes"	6/5/17	46963	0	15	"[0.9998402998104892,1.5970018951089155E-4]"	15	SCV000696590186812	single nucleotide variant	NM_000352.4(ABCC8):c.4411G>A (p.Asp1471Asn)	6833	ABCC8	HGNC:59	Pathogenic/Likely pathogenic	1	17-Feb-16	72559716	-	RCV000586940;RCV000169299	"MedGen:C3888018,Orphanet:ORPHA276525;MedGen:C2931832,OMIM:256450,SNOMED CT:360339005"	Familial hyperinsulinism;Persistent hyperinsulinemic hypoglycemia of infancy	germline;unknown	germline	GRCh37	NC_000011.9	11	17416719	17416719	C	T	11p15.1	"criteria provided, multiple submitters, no conflicts"	2	NA	N	-	2	188931	11	17416719	C	T	186812	11:17416719:C:T	Pathogenic	2/17/16	-	MedGen:C3888018	C3888018:Familial hyperinsulinism	NA	FALSE	Not trait of interest	"criteria provided, single submitter"	clinical testing	germline:na	Integrated Genetics/Laboratory Corporation of America	SCV000696591.1	SCV000696591		ABCC8	-	"MODY Extended, MonogenicDM_all, Neonatal Diabetes"	2/17/16	46775	188	2	"[0.9999786210582576,2.1378941742383753E-5]"	2	SCV000696591487472	single nucleotide variant	NM_000352.4(ABCC8):c.62T>A (p.Val21Asp)	6833	ABCC8	HGNC:59	Pathogenic/Likely pathogenic	1	11-Mar-17	200670692	-	RCV000588969;RCV000666072	"MedGen:C3888018,Orphanet:ORPHA276525;MedGen:C2931832,OMIM:256450,SNOMED CT:360339005"	Familial hyperinsulinism;Persistent hyperinsulinemic hypoglycemia of infancy	germline;unknown	germline	GRCh37	NC_000011.9	11	17498262	17498262	A	T	11p15.1	"criteria provided, multiple submitters, no conflicts"	2	NA	N	-	2	495835	11	17498262	A	T	487472	11:17498262:A:T	Pathogenic	2/23/17	"Variant summary: The ABCC8 c.62T>A (p.Val21Asp) variant causes a missense change involving the alteration of a conserved nucleotide. Although the variant is located outside of any known functional domain of the ATP-regulated potassium channels, 5/5 in silico tools predict a deleterious outcome for this variant. This variant was found in 12/88122 control chromosomes at a frequency of 0.0001362, which does not exceed the estimated maximal expected allele frequency of a pathogenic ABCC8 variant (0.0033541). Furthermore, this variant was identified homozygously or in compound heterozygosity in multiple diazoxide-unresponsive comprehensively genotyped neonatal patients with biochemically and histologically confirmed diagnosed diffuse CHI which is inherited in an autosomal recessive manner. Although no in-vitro functional studies supporting a loss of function of the ATP regulated potassium channels have been reported, the available patient characteristics provide in-vivo evidence demonstrating a damaging effect of this variant on channel function. Taken together, the ascertained evidence has been weighted to classify this variant as Pathogenic."	MedGen:C3888018	C3888018:Familial hyperinsulinism	NA	FALSE	Not trait of interest	"criteria provided, single submitter"	clinical testing	germline:na	Integrated Genetics/Laboratory Corporation of America	SCV000696592.1	SCV000696592		ABCC8	-	"MODY Extended, MonogenicDM_all, Neonatal Diabetes"	3/11/17	46850	113	1	"[0.9999893276414088,1.0672358591248667E-5]"	1	SCV000696592181247	single nucleotide variant	NM_000527.4(LDLR):c.1027G>A (p.Gly343Ser)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	5-Jul-18	730882096	-	RCV000211596;RCV000587327;RCV000161977	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:CN517202"	Familial hypercholesterolemia;Familial hypercholesterolemias;not provided	germline;not applicable	germline	GRCh37	NC_000019.9	19	11221414	11221414	G	A	19p13.2	"criteria provided, conflicting interpretations"	15	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_001328,UniProtKB (protein):P01130#VAR_005367"	2	183106	19	11221414	G	A	181247	19:11221414:G:A	Pathogenic	5/9/17	"Variant summary: The LDLR c.1027G>A (p.Gly343Ser) variant involves the alteration of a conserved nucleotide, resulting in a missense substitution that lies within the EGF-like calcium-binding domain, the EGF-like domain, and the Growth factor receptor cysteine-rich domain (InterPro). 5/5 in silico tools predict a damaging outcome for this variant. This variant was found in the large control database ExAC at a frequency of 0.0000246 (3/121826 control chromosomes), which does not exceed the estimated maximal expected allele frequency of a pathogenic LDLR variant (0.0012508). The variant is present in patient cohorts affected with familial hypercholesterolemia (e.g., Bertolini_Arthero_2013; Salazar_HM_2002; Huijgen_HM_2010 amongst others) and is widely considered to be a pathogenic mutation in the literature. A functional study showed that the variant causes a ~50% reduction in LDL receptor protein at the cell surface likely due to protein misfolding, though the receptor that is present at the cell surface is able to bind and release LDL cholesterol properly (Boswell_JBC_2004). In addition, 2 other missense mutations at the Gly343 residue have been identified in patients with familial hypercholesterolemia (p.Gly343Cys [Jelassi_Artherosclerosis_2008] and p.Gly343Asp [Amsellem_HG_2002]), suggesting the residue is a critical amino acid in the development of hypercholesterolemia. Multiple clinical diagnostic laboratories/reputable databases have classified this variant with conflicting interpretations in ClinVar, including uncertain significance, likely pathogenic, and pathogenic. Taken together, this variant is classified as pathogenic."	MedGen:CN118841	C0020445:Familial hypercholesterolemias	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Integrated Genetics/Laboratory Corporation of America	SCV000697181.1	SCV000697181		LDLR	-	High LDL	7/5/18	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV000697181228162	single nucleotide variant	NM_000527.4(LDLR):c.1187-10G>A	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	30-Mar-17	765696008	-	RCV000211627;RCV000588170	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445"	Familial hypercholesterolemia;Familial hypercholesterolemias	germline	germline	GRCh37	NC_000019.9	19	11223944	11223944	G	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	10	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000172	2	226349	19	11223944	G	A	228162	19:11223944:G:A	Pathogenic	3/28/17	"Variant summary: The LDLR c.1187-10G>A variant involves the alteration of a non-conserved intronic nucleotide. One in silico tool predicts a disease-causing outcome for this variant. 5/5 splice prediction tools predict the creation of a cryptic splice site 8bp upstream of the canonical splice site at the exon-intron junction. A functional study that assayed splicing defects via cDNA analysis in a family affected by familial hypercholesterolemia showed that a heterozygous individual expresses both the WT allele as well as the variant allele (which includes the 8bp of retained intronic sequence), and a severely affected homozygous individual who expresses no detectable WT transcript (Sun_Sci Rep_2015). Additionally, another study analyzed residual LDLR activity in B- and T-lymphocytes in FH patients compared to control individuals and found that heterozygous patients have approximately half of LDLR activity of control individuals via flow cytometry experiments (Romano_JLR_2011), which supports the hypothesis that the variant is a null allele. This variant was found in the large control database ExAC at a frequency of 0.0000417 (5/119944 control chromosomes), which does not exceed the estimated maximal expected allele frequency of a pathogenic LDLR variant (0.0012508). In addition, the observations of the variant in the ExAC dataset needs to be cautiously considered due to the cohort containing individuals that could harbor a LDLR phenotype. Furthermore, a publication, Sun_2015, shows the variant to cosegregate with disease in a large FH family, including the proband, who was homozygous for the variant and had a significantly elevated lipid level. Multiple clinical diagnostic laboratories/reputable databases classified this variant as likely pathogenic/pathogenic. Taken together, this variant is classified as pathogenic."	MedGen:CN118841	C0020445:Familial hypercholesterolemias	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Integrated Genetics/Laboratory Corporation of America	SCV000697187.1	SCV000697187		LDLR	-	High LDL	3/30/17	46963	0	4	"[0.9999574132827971,4.2586717202904415E-5]"	4	SCV000697187171211	single nucleotide variant	NM_000527.4(LDLR):c.1201C>G (p.Leu401Val)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	11-May-18	146200173	-	RCV000238417;RCV000586642;RCV000148572;RCV000255176	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:C0020443;MedGen:CN517202"	Familial hypercholesterolemia;Familial hypercholesterolemias;Hypercholesterolaemia;not provided	germline	germline	GRCh37	NC_000019.9	19	11223968	11223968	C	G	19p13.2	"criteria provided, conflicting interpretations"	10	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000535,UniProtKB (protein):P01130#VAR_007987"	2	161267	19	11223968	C	G	171211	19:11223968:C:G	Pathogenic	4/28/16	"Variant summary: The c.1201C>G variant affects a conserved nucleotide, resulting in amino acid change from Leu to Val. 3/4 in-silico tools predict this variant to be damaging (SNPs&GO not captured due to low reliability index). This variant is found in 2/119858 control chromosomes at a frequency of 0.0000167, which does not exceed maximal expected frequency of a pathogenic allele (0.0012508) to exclude pathogenicity. The variant was reported in several FH patients and one study reported the variant to co-segregate with hypercholesterolemia (Leren_JIM_19970) indicating pathogenicity. In addition, a clinical laboratory and a reputable database classify this variant as Likely pathogenic / Disease causing. Taken together, this variant was classified as Pathogenic."	MedGen:CN118841	C0020445:Familial hypercholesterolemias	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Integrated Genetics/Laboratory Corporation of America	SCV000697189.1	SCV000697189		LDLR	-	High LDL	5/11/18	46963	0	3	"[0.9999680599620978,3.194003790217831E-5]"	3	SCV00069718918785	single nucleotide variant	NM_000527.4(LDLR):c.1216C>A (p.Arg406=)	3949	LDLR	HGNC:6547	Pathogenic	1	13-Apr-18	121908043	-	RCV000003944;RCV000588218	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445"	Familial hypercholesterolemia;Familial hypercholesterolemias	germline;not applicable	germline	GRCh37	NC_000019.9	19	11223983	11223983	C	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	6	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000813,OMIM Allelic Variant:606945.0065"	3	3746	19	11223983	C	A	18785	19:11223983:C:A	Pathogenic	7/10/17	"Variant summary: The LDLR c.1216C>A (p.Arg406Arg) variant involves the alteration of a conserved nucleotide, resulting in a synonymous change. One in silico tool predicts a damaging outcome for this variant. 5/5 splice prediction tools predict a significant impact on normal splicing by the introduction of a cryptic splice site and ESE finder predicts that this variant may affect ESE sites at the locus. In support of these predictions, functional studies have shown that the variant splice site is used preferentially over the wild type splice site in patient cell lines and in vitro splicing assays (Tveten_Genet Test Molec Biomarkers_2009; Bourbon_Ather_2007). Additionally, the variant has been cited in numerous patients with hypercholesterolemia and segregates with disease in families (e.g., van der Graaf_Circ_2011; Du_SpringerPlus_2016; Tveten_Genet Test Molec Biomarkers_2009). This variant is absent from the large control database ExAC and control cohorts from the literature (0/120510 control chromosomes). In addition, two reputable databases have classified this variant as pathogenic. Taken together, this variant is classified as pathogenic."	MedGen:CN118841	C0020445:Familial hypercholesterolemias	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Integrated Genetics/Laboratory Corporation of America	SCV000697190.1	SCV000697190		LDLR	-	High LDL	4/13/18	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV000697190171216	single nucleotide variant	NM_000527.4(LDLR):c.1474G>A (p.Asp492Asn)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	2-Jan-18	373646964	-	RCV000237459;RCV000590270;RCV000148592;RCV000161989	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:C0020443;MedGen:CN517202"	Familial hypercholesterolemia;Familial hypercholesterolemias;Hypercholesterolaemia;not provided	germline;inherited;not applicable	germline	GRCh37	NC_000019.9	19	11224326	11224326	G	A	19p13.2	"criteria provided, conflicting interpretations"	13	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000205,UniProtKB (protein):P01130#VAR_072850"	2	161285	19	11224326	G	A	171216	19:11224326:G:A	Pathogenic	6/5/17	"Variant summary: The LDLR c.1474G>A (p.Asp492Asn) variant involves the alteration of a conserved nucleotide. 4/5 in silico tools predict a damaging outcome for this variant. This variant was found in 2/121480 control chromosomes at a frequency of 0.0000165, which does not exceed the estimated maximal expected allele frequency of a pathogenic LDLR variant (0.0012508). This variant has been reported in multiple affected FH patients including heterozygous patients and compound heterozygous patients (Mak_1998, Chiou_2010, Bertolini_2013, Blaha_2015). Variant was shown to segregate with disease in at least one of the reported families (Blaha_2015). Variants involving nearby nucleotides such as c.1474G>C, c.1474delG, c.1475A>G, etc, have been reported in affected individuals suggesting variant of interest is located in a mutiaotn hotspot. In addition, multiple clinical diagnostic laboratories/reputable databases classified this variant as likely pathogenic. Taken together, this variant is classified as pathogenic."	MedGen:CN118841	C0020445:Familial hypercholesterolemias	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Integrated Genetics/Laboratory Corporation of America	SCV000697197.1	SCV000697197		LDLR	-	High LDL	1/2/18	46963	0	5	"[0.9999467666034964,5.323339650363052E-5]"	3	SCV000697197434303	single nucleotide variant	NM_000527.4(LDLR):c.1586+5G>C	3949	LDLR	HGNC:6547	Likely pathogenic	1	30-May-17	781362878	-	RCV000508837;RCV000586202	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445"	Familial hypercholesterolemia;Familial hypercholesterolemias	germline	germline	GRCh37	NC_000019.9	19	11224443	11224443	G	C	19p13.2	"criteria provided, multiple submitters, no conflicts"	3	"ACMG2013,ACMG2016"	N	-	2	440652	19	11224443	G	C	434303	19:11224443:G:C	Likely pathogenic	4/6/16	"Variant summary: c.1586+5G>C affects a conserved nucleotide, resulting in an intronic change. Mutation taster predicts this variant to be disease-causing. 5/5 programs in Alamut predict a loss (or weakening effect) of the canonical splicing donor site and ESE finder predicts changes of binding motifs for RNA splicing enhancers. This variant was not found in 117702 control chromosomes. This variant has been reported in multiple FH pts with evidence of segregation (Yang_JFormosMedAssoc_2008a). Taken together, this variant was classified as Likely Pathogenic until more information becomes available."	MedGen:CN118841	C0020445:Familial hypercholesterolemias	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Integrated Genetics/Laboratory Corporation of America	SCV000697203.1	SCV000697203		LDLR	-	High LDL	5/30/17	46963	0	4	"[0.9999574132827971,4.2586717202904415E-5]"	4	SCV000697203246223	single nucleotide variant	NM_000527.4(LDLR):c.1586+5G>A	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	25-Apr-17	781362878	-	RCV000237174;RCV000587894	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202"	Familial hypercholesterolemia;not provided	germline	germline	GRCh37	NC_000019.9	19	11224443	11224443	G	A	19p13.2	"criteria provided, conflicting interpretations"	6	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_001463	2	251909	19	11224443	G	A	246223	19:11224443:G:A	Uncertain significance	4/25/17	"Variant summary: The LDLR c.1586+5G>A variant involves the alteration of a conserved intronic nucleotide that is 5 nucleotides away from the exon-intron junction. 4/5 splice prediction tools predict a significant impact on normal splicing and ESE finder predicts that the variant may cause an SRp55 ESE site to be introduced at the locus. One functional study has shown that the variant causes two aberrant splicing transcripts in several heterozygous patient cell lines and that the variant segregates with disease within two families, although several family members are discordant. This study also showed that LDL receptor was not properly trafficked to the cell surface in transfected COS7 cells (Jensen_CG_1999). However, a second functional study also detected aberrant splicing, but assessed LDL receptor protein function in heterozygous patient-derived lymphoblast cell lines and found that ~75% or greater of LDLR was at the cell surface and LDL was internalized similarly to controls, suggesting the variant transcripts do not have a significant biological impact (Holla_MGM_2009). Additionally, several studies have cited the variant in hypercholesterolemia patients, though cosegregation data is lacking in most cases. Based on the literature data, the variant may represent a mild mutation and may have a potentiated effect in compound heterozygosity with a truly pathogenic mutation, but have a less severe impact in heterozygous patients. This variant was found in the large control database ExAC at a frequency of 0.000034 (4/117662 control chromosomes), which does not exceed the estimated maximal expected allele frequency of a pathogenic LDLR variant (0.0010005). Multiple clinical diagnostic laboratories/reputable databases have classified this variant with conflicting interpretations, including likely pathogenic and uncertain significance. Taken together, this variant is classified as VUS until more conclusive family segregation data and/or control data can be assessed."	MedGen:CN221809	CN517202:not provided	hypercholesterolemia	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Integrated Genetics/Laboratory Corporation of America	SCV000697204.1	SCV000697204		LDLR	-	High LDL	4/25/17	46963	0	2	"[0.9999787066413985,2.1293358601452207E-5]"	2	SCV000697204171217	single nucleotide variant	NM_000527.4(LDLR):c.1775G>A (p.Gly592Glu)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	31-Oct-18	137929307	-	RCV000172964;RCV000587007;RCV000148576;RCV000162001	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:C0020443;MedGen:CN517202"	Familial hypercholesterolemia;Familial hypercholesterolemias;Hypercholesterolaemia;not provided	germline;inherited;not applicable;unknown	germline	GRCh37	NC_000019.9	19	11227604	11227604	G	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	22	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000237,UniProtKB (protein):P01130#VAR_005403"	2	161271	19	11227604	G	A	171217	19:11227604:G:A	Pathogenic	9/13/16	"Variant summary: The LDLR c.1775G>A (p.Gly592Glu) variant involves the alteration of a conserved nucleotide. Gly592 is highly conserved across species, and 5/5 in silico tools predict a damaging outcome for this variant. This variant was found in 6/121608 control chromosomes at a frequency of 0.0000493, which does not exceed the estimated maximal expected allele frequency of a pathogenic LDLR variant (0.0025031). This variant has been reported in many FH patients in both heterozygous, compound heterozygous, and homozygous states with evidence of co-segregation in some of the families. Functional studies indicate that the variant of interest has defective LDL receptor activity. In addition, multiple clinical diagnostic laboratories/reputable databases classified this variant as pathogenic/likely pathogenic. Taken together, this variant is classified as pathogenic."	MedGen:CN118841	C0020445:Familial hypercholesterolemias	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Integrated Genetics/Laboratory Corporation of America	SCV000697209.1	SCV000697209		LDLR	-	High LDL	10/31/18	46963	0	3	"[0.9999680599620978,3.194003790217831E-5]"	3	SCV000697209171218	single nucleotide variant	NM_000527.4(LDLR):c.1783C>T (p.Arg595Trp)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	24-Oct-17	373371572	-	RCV000237585;RCV000588105;RCV000148597;RCV000518174	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:C0020443;MedGen:CN517202"	Familial hypercholesterolemia;Familial hypercholesterolemias;Hypercholesterolaemia;not provided	germline	germline	GRCh37	NC_000019.9	19	11227612	11227612	C	T	19p13.2	"criteria provided, conflicting interpretations"	11	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000239,UniProtKB (protein):P01130#VAR_072856"	2	161290	19	11227612	C	T	171218	19:11227612:C:T	Pathogenic	6/15/16	"Variant summary: The LDLR c.1783C>T (p.Arg595Trp) variant involves the alteration of a non-conserved nucleotide. 5/5 in silico tools predict a damaging outcome for this variant. This variant was found in 1/121410 control chromosomes at a frequency of 0.0000082, which does not exceed the estimated maximal expected allele frequency of a pathogenic LDLR variant (0.0012508). This variant has been reported in numerous FH patients from multiple ethnic populations. In addition, p.R595Q and p.R595L have been shown to associate with FH, suggesting Arg595 is a mutation hot spot. Taken together, this variant is classified as pathogenic."	MedGen:CN118841	C0020445:Familial hypercholesterolemias	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Integrated Genetics/Laboratory Corporation of America	SCV000697210.1	SCV000697210		LDLR	-	High LDL	10/24/17	46963	0	2	"[0.9999787066413985,2.1293358601452207E-5]"	2	SCV000697210246513	single nucleotide variant	NM_000527.4(LDLR):c.2096C>T (p.Pro699Leu)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	9-Oct-17	201573863	-	RCV000237906;RCV000589820	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445"	Familial hypercholesterolemia;Familial hypercholesterolemias	germline;unknown	germline	GRCh37	NC_000019.9	19	11231154	11231154	C	T	19p13.2	"criteria provided, conflicting interpretations"	10	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_001600,UniProtKB (protein):P01130#VAR_013955"	2	252219	19	11231154	C	T	246513	19:11231154:C:T	Pathogenic	2/26/16	"Variant summary: c.2096C>T affects a conserved nucleotide, resulting in amino acid change from Pro to Leu. 5/5 in-silico tools predict this variant to be damaging. This variant was found in 2/120866 control chromosomes at a frequency of 0.0000165, which does not significantly exceed maximal expected frequency of a pathogenic allele (0.0012508). This variant has been reported in multiple FH patients (including homozygous and heterozygous FH patients). Some of the families showed co-segregation of the variant with disease (Schuster _1995). Taken together, this variant was classified as a Pathogenic."	MedGen:CN118841	C0020445:Familial hypercholesterolemias	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Integrated Genetics/Laboratory Corporation of America	SCV000697211.1	SCV000697211		LDLR	-	High LDL	10/9/17	46962	1	6	"[0.9999361185639453,6.388143605468251E-5]"	6	SCV000697211226402	single nucleotide variant	NM_000527.4(LDLR):c.1836C>T (p.Ala612=)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	27-Jun-17	143872778	-	RCV000210239;RCV000586569;RCV000456101	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202;MedGen:CN169374"	Familial hypercholesterolemia;not provided;not specified	germline	germline	GRCh37	NC_000019.9	19	11227665	11227665	C	T	19p13.2	"criteria provided, conflicting interpretations"	9	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000249	2	224618	19	11227665	C	T	226402	19:11227665:C:T	Uncertain significance	2/29/16	"Variant summary: The c.1836C>T in LDLR gene is a synonymous change that involves a non-conserved nucleotide. 5/5 programs in Alamut predict that this variant does not affect normal splicing, however no functional studies supporting this notion were published at the time of evaluation. The variant is present in the control population dataset of ExAC at frequency of 0.021%. The observed frequency does not exceed the maximum expected allele frequency for a pathogenic LDLR variant of 0.1%, suggesting that it is not a common polymorphism. In addtion, it is unknown whether the control population was cardiographically evaluated or profiled for lipid levels. Therefore, they may or may not represent as true normal population with respect to the silent phenotypes associated with this gene. This variant was found in several affected individuals with premature atherosclerosis and/or hypercholesterolaemia but without strong evidence for casualty. Lastly, the variant of interest has not been reported by reputable databases/clinical laboratories. Taken together, this variant has been classified as a VUS-possibly benign, until more information becomes available."	MedGen:CN221809	CN517202:not provided	premature atherosclerosis and/or hypercholesterolaemia	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Integrated Genetics/Laboratory Corporation of America	SCV000697212.1	SCV000697212		LDLR	-	High LDL	6/27/17	46963	0	10	"[0.9998935332069927,1.0646679300726103E-4]"	10	SCV00069721218738	single nucleotide variant	NM_000527.4(LDLR):c.2043C>A (p.Cys681Ter)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	31-Oct-18	121908031	-	RCV000003887;RCV000590806;RCV000481771	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:CN517202"	Familial hypercholesterolemia;Familial hypercholesterolemias;not provided	germline;unknown	germline	GRCh37	NC_000019.9	19	11231101	11231101	C	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	18	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_001592,OMIM Allelic Variant:606945.0016"	3	3699	19	11231101	C	A	18738	19:11231101:C:A	Pathogenic	10/26/16	"Variant summary: The LDLR c.2043C>A (p.Cys681X) variant results in a premature termination codon, predicted to cause a truncated or absent LDLR protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified in the pathogenic spectrum by our laboratory (e.g. p.Trp813X, p.Ser710fsX2 ). Mutation taster predicts a damaging outcome for this variant. This variant was found in 1/121136 control chromosomes at a frequency of 0.0000083, which does not exceed the estimated maximal expected allele frequency of a pathogenic LDLR variant (0.0025031). It was observed in several FH families and showed co-segregation with the disease indicating causality. Moreover, the variant was shown to result in lack of detectable high affinity binding and uptake of LDL, further supporting pathogenicity. In addition, multiple clinical diagnostic laboratories/reputable databases classified this variant as pathogenic. Taken together, this variant is classified as pathogenic."	MedGen:CN118841	C0020445:Familial hypercholesterolemias	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Integrated Genetics/Laboratory Corporation of America	SCV000697220.1	SCV000697220		LDLR	-	High LDL	10/31/18	46958	5	1	"[0.9999893521870608,1.0647812939222283E-5]"	1	SCV000697220181272	single nucleotide variant	NM_000527.4(LDLR):c.2101G>A (p.Gly701Ser)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	7-Jun-17	368838866	-	RCV000238415;RCV000162008	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202"	Familial hypercholesterolemia;not provided	germline;inherited;not applicable	germline	GRCh37	NC_000019.9	19	11231159	11231159	G	A	19p13.2	"criteria provided, conflicting interpretations"	7	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_001078	2	183130	19	11231159	G	A	181272	19:11231159:G:A	Uncertain significance	6/7/17	"Variant summary: The LDLR c.2101G>A (p.Gly701Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. 4/4 in silico tools predict a damaging outcome for this variant (SNPsandGO not captured due to low reliability index). The variant of interest has been found in a large and broad control population from ExAC in 17/137956 control chromosomes at a frequency of 0.0001232, which does not exceed the estimated maximal expected allele frequency of a pathogenic LDLR variant (0.0012508). This variant has been reported in patients with hypercholesterolemia, coronary artery disease and/or myocardial infarction (Fouchier _2005, Duskova _2011, Thormaehlen_2015, Khera_2016) without strong evidence for causality. In two case-control studies, this variant was not significantly more enriched in patients with coronary artery disease and/or myocardial infarction than in controls (Thormaehlen_2015, Khera_2016). Based on LDLR uptake and complementation assay, one in vitro study has concluded that its pathogenicity or functional outcome is unclear (Thormaehlen _2015). There are conflicting reports of classification on this variant in ClinVar, likely pathogenic as well as likely benign (both in 2016). Taken together, this variant is currently classified as Variant of Unknown Significance."	MedGen:CN221809	CN517202:not provided	Familial hypercholesterolemia	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Integrated Genetics/Laboratory Corporation of America	SCV000697222.1	SCV000697222		LDLR	-	High LDL	6/7/17	46963	0	15	"[0.9998402998104892,1.5970018951089155E-4]"	15	SCV000697222171223	single nucleotide variant	NM_000527.4(LDLR):c.2441G>A (p.Arg814Gln)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	17-Nov-17	5928	-	RCV000237126;RCV000148584;RCV000162024	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202"	Familial hypercholesterolemia;Hypercholesterolaemia;not provided	germline;not applicable	germline	GRCh37	NC_000019.9	19	11240240	11240240	G	A	19p13.2	"criteria provided, conflicting interpretations"	9	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000376,UniProtKB (protein):P01130#VAR_011864"	2	161278	19	11240240	G	A	171223	19:11240240:G:A	Uncertain significance	1/16/17	"Variant summary: The LDLR c.2441G>A (p.Arg814Gln) variant involves the alteration of a conserved nucleotide. 2/4 in silico tools predict a benign outcome for this variant (SNPs&GO not captured due to low reliability index). This variant was found in 34/121530 control chromosomes, predominantly observed in the African subpopulation at a frequency of 0.0031712 (33/10406). This frequency is about 3 times the estimated maximal expected allele frequency of a pathogenic LDLR variant (0.0010005), suggesting this is possibly a benign polymorphism found primarily in the populations of African origin. This variant has been reported in multiple affected individuals (mostly with African ethnicities) without strong evidence for causality. In addition, one clinical diagnostic laboratory/database classified this variant as likely benign and another one classified it as VUS, all without evidence for independent evaluation. In vivo study of LDL metabolism showed this variant with a reduced in vivo activity of LDL-R (80% of WT; Arca_1997 and Arca_1994). Taken together, this variant is classified as VUS."	MedGen:CN221809	CN517202:not provided	Familial hypercholesterolemia	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Integrated Genetics/Laboratory Corporation of America	SCV000697230.1	SCV000697230		LDLR	-	High LDL	11/17/17	46963	0	50	"[0.9994676660349637,5.323339650363052E-4]"	50	SCV00069723045125	single nucleotide variant	NM_000527.4(LDLR):c.2479G>A (p.Val827Ile)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	2-Nov-17	137853964	-	RCV000030135;RCV000148585;RCV000058923;RCV000436469	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202;MedGen:CN169374"	Familial hypercholesterolemia;Hypercholesterolaemia;not provided;not specified	germline;inherited;not applicable;unknown	germline	GRCh37	NC_000019.9	19	11240278	11240278	G	A	19p13.2	"criteria provided, conflicting interpretations"	16	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_001657,UniProtKB (protein):P01130#VAR_005418"	2	36462	19	11240278	G	A	45125	19:11240278:G:A	Uncertain significance	12/9/16	-	MedGen:CN221809	CN517202:not provided	Familial hypercholesterolemia - based on pubmed articles	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Integrated Genetics/Laboratory Corporation of America	SCV000697231.1	SCV000697231		LDLR	-	High LDL	11/2/17	46963	0	74	"[0.9992121457317462,7.878542682537317E-4]"	74	SCV000697231228142	deletion	NM_000527.4(LDLR):c.654_656delTGG (p.Gly219del)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	25-Jun-18	121908027	-	RCV000211647;RCV000589051;RCV000489033	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:CN517202"	Familial hypercholesterolemia;Familial hypercholesterolemias;not provided	germline;inherited;not applicable	germline	GRCh37	NC_000019.9	19	11216236	11216238	TGG	-	19p13.2	"criteria provided, multiple submitters, no conflicts"	14	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000094,OMIM Allelic Variant:606945.0005"	3	226329	19	11216232	ATGG	A	228142	19:11216232:ATGG:A	Pathogenic	3/28/16	"Variant Summary: The LDLR variant of interest causes an in-frame deletion resulting in the loss of a Glycine at codon 219. The variant of interest was observed in the large, broad control population, ExAC, with an allele frequency of 5/119648 (1/23930), which does not exceed the predicted maximum expected allele frequency for a pathogenic LDLR variant of 1/800. The variant of interest has been reported in multiple affected individuals via publications and has been indicated to be a founder mutation. Therefore, taking all available lines of evidence into consideration, the variant of interest is classified as Pathogenic."	MedGen:CN118841	C0020445:Familial hypercholesterolemias	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Integrated Genetics/Laboratory Corporation of America	SCV000697245.1	SCV000697245		LDLR	-	High LDL	6/25/18	46962	1	1	"[0.9999893530939908,1.0646906009113752E-5]"	1	SCV000697245228146	single nucleotide variant	NM_000527.4(LDLR):c.682G>T (p.Glu228Ter)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	31-Oct-18	121908029	-	RCV000211631;RCV000589867;RCV000518828	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:CN517202"	Familial hypercholesterolemia;Familial hypercholesterolemias;not provided	germline;not applicable;unknown	germline	GRCh37	NC_000019.9	19	11216264	11216264	G	T	19p13.2	"criteria provided, multiple submitters, no conflicts"	12	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_001818	2	226333	19	11216264	G	T	228146	19:11216264:G:T	Pathogenic	11/21/16	"Variant summary: The LDLR c.682G>T (p.Glu228X) variant (alternatively also known as E207X) results in a premature termination codon, predicted to cause a truncated or absent LDLR protein due to nonsense mediated decay (NMD), which are commonly known mechanisms for disease. Functional analyses show that this variant results into NMD causing absent LDLR protein (Charng_2006) and/or extremely low LDL receptor activity (Hobbs_1992). Truncations downstream of this position have been classified as pathogenic by our laboratory (e.g. p.Cys276X, p.Val295fsX75). This variant is widely reported in FH patients and is a recurrent pathogenic mutation (Hobbs_1992, Leren_2004, Muller_2004, Charng_2006, Humphries_2006). This variant was found in 2/117006 control chromosomes at a frequency of 0.0000171, which does not exceed the estimated maximal expected allele frequency of a pathogenic LDLR variant (0.0025031). The heterozygotes in ExAC are likely to represent as subclinical cases or reduced penetrance. Multiple clinical lab/research centers have classified this variant as pathogenic. Taken together, this variant is classified as Pathogenic."	MedGen:CN118841	C0020445:Familial hypercholesterolemias	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Integrated Genetics/Laboratory Corporation of America	SCV000697248.1	SCV000697248		LDLR	-	High LDL	10/31/18	46944	19	1	"[0.9999893490115883,1.0650988411724608E-5]"	1	SCV000697248198013	single nucleotide variant	NM_000527.4(LDLR):c.718G>A (p.Glu240Lys)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	22-May-18	768563000	-	RCV000211564;RCV000586018;RCV000182341	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:CN517202"	Familial hypercholesterolemia;Familial hypercholesterolemias;not provided	germline	germline	GRCh37	NC_000019.9	19	11217264	11217264	G	A	19p13.2	"criteria provided, conflicting interpretations"	9	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_001828,UniProtKB (protein):P01130#VAR_005343"	2	200920	19	11217264	G	A	198013	19:11217264:G:A	Pathogenic	6/28/16	"Variant summary: The LDLR c.718G>A (p.Glu240Lys) variant involves the alteration of a conserved nucleotide and results in a replacement of a medium size and acidic Glutamic acid (E) with a large size and basic Lysine (K) located in the ligand binding domain of LDLR. 3/4 in silico tools predict a damaging outcome for this substitution (SNPs&GO not captured due to low reliability index). This variant was found in 2/121994 control chromosomes at a frequency of 0.0000164, which does not exceed the estimated maximal expected allele frequency of a pathogenic LDLR variant (0.0012508). It was reported in several FH patients indicating its pathogenicity. Additionally a functional study of LDLR function in fibroblast monolayers revealed the variant to only have the WT 15-30% LDL receptor activity suggesting the variant to be a partially transport defective allele that impairs transport between ER and Golgi. Furthermore, the variat was found not to fold into a unique disulphide bond structure like the WT does, thus leading to the conclusion that this variant gives rise to a protein folding defect. Moreover, multiple clinical diagnostic laboratories classified this variant as pathogenic. Taken together, this variant is classified as Pathogenic."	MedGen:CN118841	C0020445:Familial hypercholesterolemias	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Integrated Genetics/Laboratory Corporation of America	SCV000697249.1	SCV000697249		LDLR	-	High LDL	5/22/18	46963	0	3	"[0.9999680599620978,3.194003790217831E-5]"	3	SCV000697249171202	single nucleotide variant	NM_000527.4(LDLR):c.806G>A (p.Gly269Asp)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	17-Oct-17	143992984	-	RCV000210247;RCV000148586;RCV000161966	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202"	Familial hypercholesterolemia;Hypercholesterolaemia;not provided	germline;not applicable	germline	GRCh37	NC_000019.9	19	11217352	11217352	G	A	19p13.2	"criteria provided, conflicting interpretations"	13	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000504	2	161279	19	11217352	G	A	171202	19:11217352:G:A	Benign	3/11/16	"Variant summary: c.806G>A affects a non-conserved nucleotide, resulting in amino acid change from Gly to Asp. 2/4 in-silico tools predict this variant to be benign (SNPs&GO not captured due to low reliability index). Functional study showed that the LDL uptake, binding capacity of LDL, and LDLR expression of variant were similar to those observed in control cells (Etxebarria_2012), indicating the neutral effect. This variant was found in 24/131566 control chromosomes at a frequency of 0.0001824. This variant has been reported in multiple FH patients without strong evidence for causality. Among the reported patients, variant was reported to co-occur with a deleterious LDLR variant c.1045delC in cis (Mozas_2004) and there is at least one family reported with lack of co-segregation of this variant with disease (Bourbon_2008). In addition, variant has been detected in early-onset myocardial infarction case with comparable allele frequency as in controls and multiple publications listed variant as nonpathogenic/benign (Do_2015, Etxebarre_2012, and Benito-Vicente_2015). Considering all, this variant is classified as Benign."	MedGen:CN221809	CN517202:not provided	Familial hypercholesterolemia	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Integrated Genetics/Laboratory Corporation of America	SCV000697252.1	SCV000697252		LDLR	-	High LDL	10/17/17	46963	0	33	"[0.999648659583076,3.513404169239614E-4]"	33	SCV000697252228117	single nucleotide variant	NM_000527.4(LDLR):c.81C>G (p.Cys27Trp)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	30-Mar-17	2228671	-	RCV000211569;RCV000588365	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445"	Familial hypercholesterolemia;Familial hypercholesterolemias	germline;unknown	germline	GRCh37	NC_000019.9	19	11210912	11210912	C	G	19p13.2	"criteria provided, conflicting interpretations"	10	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000352,UniProtKB (protein):P01130#VAR_005304"	2	226304	19	11210912	C	G	228117	19:11210912:C:G	Pathogenic	1/12/17	"Variant summary: The LDLR c.81C>G (p.Cys27Trp) variant (alternatively also known as C6W and FH San Francisco) substitutes a Cys residue located in LDL receptor class A repeat which forms ligand binding domain (InterPro, Klancar_2015, Bertolini_2013, Hobbs_1992). The ligand-binding domain contains seven or eight 40-amino acid LDLR class A (cysteine-rich) repeats, each of which contains a coordinated calcium ion and six cysteine residues involved in disulphide bond formation (InterPro, PMID: 6091915). Therefore, this variant is predicted to be deleterious for protein function as it breaks down one of the disulphide bonds. 5/5 in silico tools also predict damaging outcome for this variant. This variant was found in 2/121358 control chromosomes at a frequency of 0.0000165, which does not exceed the estimated maximal expected allele frequency of a pathogenic LDLR variant (0.0012508). In literature, this variant is widely reported as a pathogenic variant found mainly in FH patients of European origin (Klancar_2015, Mollaki_2014,Kolansky_2008, Bertolini_2013, Day_1997, Hobbs_1992). Genotype-phenotype correlation study showed that this variant causes a milder disease (Mollaki_2014). A functional study showed that this variant leads to impaired LDL receptor activity (Hobbs_1992). Multiple reputable databases classified this variant as likely pathogenic/pathogenic. Taken together, this variant is classified as Pathogenic."	MedGen:CN118841	C0020445:Familial hypercholesterolemias	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Integrated Genetics/Laboratory Corporation of America	SCV000697253.1	SCV000697253		LDLR	-	High LDL	3/30/17	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV000697253171207	single nucleotide variant	NM_000527.4(LDLR):c.970G>A (p.Gly324Ser)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	5-Oct-17	72658860	-	RCV000237236;RCV000148566;RCV000162021;RCV000455308	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202;MedGen:CN169374"	Familial hypercholesterolemia;Hypercholesterolaemia;not provided;not specified	germline;not applicable	germline	GRCh37	NC_000019.9	19	11221357	11221357	G	A	19p13.2	"criteria provided, conflicting interpretations"	11	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000640	2	161263	19	11221357	G	A	171207	19:11221357:G:A	Likely benign	7/25/16	"Variant summary: The LDLR c.970G>A (p.Gly324Ser) variant involves the alteration of a conserved nucleotide and results in a replacement of a small size and hydrophobic Glycine (G) with a small size and polar Serine (S) located ) within the first of the three cystein-rich repeats of the epidermal growth factor homology domain that also contributes to ligand binding. 4/4 in silico tools predict a damaging outcome for this variant (SNPs&GO not captured due to low reliability index). This variant was found in 140/120542 control chromosomes, predominantly observed in the African subpopulation at a frequency of 0.0131784 (135/10244). This frequency is about 13 times the estimated maximal expected allele frequency of a pathogenic LDLR variant (0.0010005), suggesting this is likely a benign polymorphism found primarily in the populations of African origin. The variant was reported in several Familial Hypercholesterolemia patients, however without strong evidence for pathogenicity. Moreover, in one FH family, the variant was found to co-occur with pathogenic/likely pathogenic variant and not co-segregate with the disease, indicating neutrality of this variant. In addition, a clinical diagnostic laboratory classified the variant as Likely Benign via ClinVar (without evidence to independently evaluate). Taken together, this variant is classified as likely benign."	MedGen:CN221809	CN517202:not provided	Familial hypercholesterolemia	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Integrated Genetics/Laboratory Corporation of America	SCV000697255.1	SCV000697255		LDLR	-	High LDL	10/5/17	46961	2	186	"[0.9980196333127489,0.001980366687251123]"	186	SCV00069725529566	single nucleotide variant	NM_170707.3(LMNA):c.1930C>T (p.Arg644Cys)	4000	LMNA	HGNC:6636	Conflicting interpretations of pathogenicity	1	21-Nov-18	142000963	-	RCV000245284;RCV000144868;RCV000471403;RCV000755679;RCV000148602;RCV000015626;RCV000057374;RCV000041340	"MedGen:CN230736;MedGen:C0007959,Orphanet:ORPHA166,SNOMED CT:50548001;MedGen:C0270914,Orphanet:ORPHA64746;MedGen:C1449563,OMIM:115200,Orphanet:ORPHA300751;EFO:EFO_0000407,Human Phenotype Ontology:HP:0001644,MedGen:C0007193,Orphanet:ORPHA217604,SNOMED CT:195021004;na;MedGen:CN517202;MedGen:CN169374"	"Cardiovascular phenotype;Charcot-Marie-Tooth disease;Charcot-Marie-Tooth disease, type 2;Dilated cardiomyopathy 1A;Primary dilated cardiomyopathy;Variant of unknown significance;not provided;not specified"	germline;tested-inconclusive;unknown	germline	GRCh37	NC_000001.10	1	156108510	156108510	C	T	1q22	"criteria provided, conflicting interpretations"	13	"ACMG2013,ACMG2016"	N	"OMIM Allelic Variant:150330.0051,UniProtKB (protein):P02545#VAR_039792"	3	14527	1	156108510	C	T	29566	1:156108510:C:T	Uncertain significance	3/13/17	"Variant summary: The LMNA c.1930C>T (p.Arg644Cys) variant involves the alteration of a conserved nucleotide. 4/4 in silico tools predict a damaging outcome for this variant (SNPs&GO not captured due to low reliability index). This variant was found in 145/117680 control chromosomes (1 homozygote) at a frequency of 0.0012322, which is approximately 5 times the estimated maximal expected allele frequency of a pathogenic LMNA variant causing cardiomyopathy (0.00025), suggesting this variant is possibly a benign polymorphism. This variant has been reported in multiple patients with a variety of phenotypes, including lipodystrophy, diabetes, distal motor neuropathy, DCM, scoliosis, hepatic steatosis. Many unaffected relatives of these patients also carry the variant of interest, suggesting this variant has low penetrance or is not associated with phenotype (Cann_2017, Genschel_2000, Rankin_2008, Muntoni_2006, Vasli_2012). Arg644 is located close to ZMPSTE24 cleavage site (codon 646-647) and one study showed that R644C may affect the cleavage efficiency by ZMPSTE24 (Barrowman_2012). Another functional study showed that although this variant did not significantly affect the levels of nuclear abnormalities, it did result in a potential loss of cellular compartmentalization as evidenced by a significant increase in non-lethal ruptures of the nuclear envelope relative to the wild-type LMNA protein (De Vos_2011). However, the results and conclusions drawn from this study are not directly correlated to the mechanisms and presentation of disease associated with Laminopathies attributed to LMNA variants. In addition, multiple clinical diagnostic laboratories/reputable databases provided conflicting classifications including likely pathogenic, VUS, and likely benign. Taken together, this variant is classified as VUS for cardiomyopathy, however, its pathogenicity causing other phenotype with low penetrance can not be ruled out."	MedGen:CN221809	CN517202:not provided	cardiomyopathy	FALSE	Incorrect phenotype	"criteria provided, single submitter"	clinical testing	germline:na	Integrated Genetics/Laboratory Corporation of America	SCV000699968.1	SCV000699968		LMNA	-	"Lipodystrophy, MonogenicDM_all"	11/21/18	46954	9	67	"[0.9992865357584019,7.134642415981599E-4]"	65	SCV000699968362653	single nucleotide variant	NM_174936.3(PCSK9):c.323T>G (p.Leu108Arg)	255738	PCSK9	HGNC:20001	Pathogenic/Likely pathogenic	1	23-Feb-17	1057519691	-	RCV000587518;RCV000417273	"MedGen:C0020445;MedGen:C1863551,OMIM:603776"	"Familial hypercholesterolemias;Hypercholesterolemia, autosomal dominant, 3"	germline	germline	GRCh37	NC_000001.10	1	55509631	55509631	T	G	1p32.3	"criteria provided, multiple submitters, no conflicts"	2	"ACMG2013,ACMG2016"	N	-	2	375849	1	55509631	T	G	362653	1:55509631:T:G	Likely pathogenic	2/23/17	"Variant summary: The PCSK9 c.323T>G (p.Leu108Arg) variant involves the alteration of a non-conserved nucleotide. 3/4 in silico tools predict a damaging outcome for this variant. This variant is absent in 121160 control chromosomes. This variant has been reported in one FH family with unequivocal co-segregation evidence (found in 4 affected members, not found in 3 unaffected members). In vitro study showed that p.L108R had a clear and significant gain-of-function effect. Taken together, this variant is classified as likely pathogenic until additional FH families are reported to carry this variant."	MedGen:CN118841	C0020445:Familial hypercholesterolemias	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Integrated Genetics/Laboratory Corporation of America	SCV000699992.1	SCV000699992		PCSK9	-	Low LDL	2/23/17	46963	0	2	"[0.9999787066413985,2.1293358601452207E-5]"	2	SCV00069999217915	single nucleotide variant	NM_174936.3(PCSK9):c.426C>G (p.Tyr142Ter)	255738	PCSK9	HGNC:20001	Pathogenic	1	31-May-16	67608943	-	RCV000003010;RCV000588335	MedGen:C3276239;MedGen:CN517202	Low density lipoprotein cholesterol level quantitative trait locus 1;not provided	germline	germline	GRCh37	NC_000001.10	1	55512222	55512222	C	G	1p32.3	"criteria provided, single submitter"	2	"ACMG2013,ACMG2016"	N	"OMIM Allelic Variant:607786.0004,OMIM Allelic Variant:607786.0007"	3	2876	1	55512222	C	G	17915	1:55512222:C:G	Pathogenic	5/31/16	"Variant summary: The PCSK9 c.426C>G (p.Tyr142X) variant results in a premature termination codon, predicted to cause a truncated or absent PCSK9 protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Functional studies showed that it leads to the nonsense mediated decay with no detectable protein (Cohen_2005, Zhao_2006). This variant was found in 33/121362 control chromosomes from ExAC, predominantly observed in the African subpopulation at a frequency of 0.0029813 (31/10398). However, it is unknown whether the individuals in ExAC were ruled out to be hypocholesterolemic. This variant is widely known to be a causative mutation for hypocholesterolemia predominantly in Africans including cosegregation data. In a large case-cohort study, this variant was found to be associated with 40% reduction in plasma levels of LDL cholesterol (Cohen_2006). Although this variant is likely to confer protection against coronary artery disease due to its LDLC reducing effect (Peloso_2014), other clinical conditions including cardiovascular effects are likely to manifest as result of the hypocholesterolemia amongst the individuals who carry this variant. Taken together, this variant is classified as Pathogenic."	MedGen:CN221809	CN517202:not provided	Hypercholesterolemia	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Integrated Genetics/Laboratory Corporation of America	SCV000699995.1	SCV000699995		PCSK9	-	Low LDL	5/31/16	46963	0	40	"[0.9995741328279709,4.2586717202904413E-4]"	40	SCV000699995429378	deletion	NM_000545.6(HNF1A):c.864delG (p.Pro291Glnfs)	6927	HNF1A	HGNC:11621	Pathogenic	1	23-Dec-16	762703502	-	RCV000502914;RCV000723679	"MedGen:C1838100,OMIM:600496;MedGen:CN517202"	"Maturity-onset diabetes of the young, type 3;not provided"	germline	germline	GRCh37	NC_000012.11	12	121432117	121432117	G	-	12q24.31	"criteria provided, multiple submitters, no conflicts"	2	NA	N	-	2	435424	12	121432114	CG	C	429378	12:121432114:CG:C	Pathogenic	12/23/16	-	not provided	CN517202:not provided	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:2	"EGL Genetic Diagnostics,Eurofins Clinical Diagnostics"	SCV000700603.2	SCV000700603		HNF1A	-	"MODY, MODY Extended, MonogenicDM_all"	12/23/16	46569	394	7	"[0.9999248427065215,7.515729347849427E-5]"	7	SCV00070060329556	single nucleotide variant	NM_170707.3(LMNA):c.1718C>T (p.Ser573Leu)	4000	LMNA	HGNC:6636	Conflicting interpretations of pathogenicity	1	21-Dec-17	60890628	-	RCV000617932;RCV000653881;RCV000015612;RCV000015614;RCV000015613;RCV000057351;RCV000041329	"MedGen:CN230736;MedGen:C0270914,Orphanet:ORPHA64746;MedGen:C1449563,OMIM:115200,Orphanet:ORPHA300751;MedGen:C1720860,OMIM:151660,Orphanet:ORPHA2348;MedGen:CN043412;MedGen:CN517202;MedGen:CN169374"	"Cardiovascular phenotype;Charcot-Marie-Tooth disease, type 2;Dilated cardiomyopathy 1A;Familial partial lipodystrophy 2;Mandibuloacral dysplasia with type A lipodystrophy, atypical;not provided;not specified"	germline	germline	GRCh37	NC_000001.10	1	156108298	156108298	C	T	1q22	"criteria provided, conflicting interpretations"	7	"ACMG2013,ACMG2016"	N	"OMIM Allelic Variant:150330.0041,UniProtKB (protein):P02545#VAR_039789"	3	14517	1	156108298	C	T	29556	1:156108298:C:T	Uncertain significance	11/14/17	-	not provided	CN517202:not provided	No Information	FALSE	No Information	"criteria provided, single submitter"	clinical testing	germline:3	"EGL Genetic Diagnostics,Eurofins Clinical Diagnostics"	SCV000700905.2	SCV000700905		LMNA	-	"Lipodystrophy, MonogenicDM_all"	12/21/17	46812	151	16	"[0.9998291036486371,1.708963513628984E-4]"	16	SCV00070090529375	single nucleotide variant	NM_005912.2(MC4R):c.380C>T (p.Ser127Leu)	4160	MC4R	HGNC:6932	Conflicting interpretations of pathogenicity	1	25-May-17	13447331	-	RCV000015412;RCV000414065	"Human Phenotype Ontology:HP:0001513,MedGen:C0028754,OMIM:601665,Orphanet:ORPHA71529,SNOMED CT:414916001;MedGen:CN517202"	Obesity;not provided	germline	germline	GRCh37	NC_000018.9	18	58039203	58039203	G	A	18q21.3	"criteria provided, conflicting interpretations"	6	NA	N	"OMIM Allelic Variant:155541.0021,UniProtKB (protein):P32245#VAR_038643"	3	14336	18	58039203	G	A	29375	18:58039203:G:A	Uncertain significance	3/3/17	-	not provided	CN517202:not provided	No Information	FALSE	No Information	"criteria provided, single submitter"	clinical testing	germline:1	"EGL Genetic Diagnostics,Eurofins Clinical Diagnostics"	SCV000705333.2	SCV000705333		MC4R	-	Obesity	5/25/17	46963	0	18	"[0.999808359772587,1.9164022741306988E-4]"	18	SCV00070533357262	single nucleotide variant	NM_170707.3(LMNA):c.992G>A (p.Arg331Gln)	4000	LMNA	HGNC:6636	Conflicting interpretations of pathogenicity	1	28-Jul-17	59301204	-	RCV000182367;RCV000593819	MedGen:CN517202;MedGen:CN169374	not provided;not specified	germline	germline	GRCh37	NC_000001.10	1	156105747	156105747	G	A	1q22	"criteria provided, conflicting interpretations"	3	"ACMG2013,ACMG2016"	N	-	2	48098	1	156105747	G	A	57262	1:156105747:G:A	Uncertain significance	2/6/17	-	not provided	CN517202:not provided	No Information	FALSE	No Information	"criteria provided, single submitter"	clinical testing	germline:1	"EGL Genetic Diagnostics,Eurofins Clinical Diagnostics"	SCV000706057.2	SCV000706057		LMNA	-	"Lipodystrophy, MonogenicDM_all"	7/28/17	46951	12	1	"[0.9999893505995613,1.0649400438755298E-5]"	1	SCV000706057376001	single nucleotide variant	NM_000458.3(HNF1B):c.1108G>A (p.Gly370Ser)	6928	HNF1B	HGNC:11630	Conflicting interpretations of pathogenicity	1	5-Jul-18	113042313	-	RCV000429473	MedGen:CN517202	not provided	germline	germline	GRCh37	NC_000017.10	17	36070609	36070609	C	T	17q12	"criteria provided, conflicting interpretations"	2	NA	N	-	2	379811	17	36070609	C	T	376001	17:36070609:C:T	Uncertain significance	7/5/18	-	not provided	CN517202:not provided	No Information	FALSE	No Information	"criteria provided, single submitter"	clinical testing	germline:5	"EGL Genetic Diagnostics,Eurofins Clinical Diagnostics"	SCV000707876.2	SCV000707876		HNF1B	-	"MODY, MODY Extended, MonogenicDM_all, Neonatal Diabetes"	7/5/18	46963	0	26	"[0.9997231863381811,2.7681366181887867E-4]"	26	SCV000707876171199	single nucleotide variant	NM_000527.4(LDLR):c.301G>A (p.Glu101Lys)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	31-Oct-18	144172724	-	RCV000211583;RCV000148571;RCV000162016	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202"	Familial hypercholesterolemia;Hypercholesterolaemia;not provided	germline;not applicable;unknown	germline	GRCh37	NC_000019.9	19	11213450	11213450	G	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	15	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000044,UniProtKB (protein):P01130#VAR_005315"	2	161266	19	11213450	G	A	171199	19:11213450:G:A	Pathogenic	11/3/17	"The p.Glu101Lys variant in LDLR has been reported in the heterozygous state in >30 individuals with familial hypercholesterolemia (FH), in the compound heterozygous state in 1 individual with homozygous FH (Loux 1992, Webb 1992, GarcÃ­a-GarcÃ­a 2001, Mozas 2004, Humphries 2006, Miyakem2009, Taylor 2010, Futema 2013, Do 2015) and segregated with disease in four affected relatives from two families (Webb 1992, Loux 1992). This variant has also been reported by other clinical laboratories in ClinVar (Variation ID# 161266). In vitro functional studies provide some evidence that the p.Glu101Lys variant may impact protein function (Webb 1992). This variant has also been identified in 3/111700 European chromosomes by the genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP rs144172724). This frequency is low enough to be consistent with the frequency of FH in the general population. Computational prediction tools and conservation analysis suggests that the p.Glu101Lys variant may impact the protein, though this information is not predictive enough to determine pathogenicity. In summary, this variant meets criteria to be classified as pathogenic for familial hypercholesterolemia in an autosomal dominant manner based upon presence in multiple affected individuals, segregation studies, low frequency in the general population and functional evidence."	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:4	"Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine"	SCV000711395.1	SCV000711395		LDLR	-	High LDL	10/31/18	46963	0	3	"[0.9999680599620978,3.194003790217831E-5]"	3	SCV000711395181233	single nucleotide variant	NM_000527.4(LDLR):c.662A>G (p.Asp221Gly)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	3-Apr-17	373822756	-	RCV000211655;RCV000161962	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202"	Familial hypercholesterolemia;not provided	germline;inherited;not applicable	germline	GRCh37	NC_000019.9	19	11216244	11216244	A	G	19p13.2	"criteria provided, multiple submitters, no conflicts"	14	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000096,UniProtKB (protein):P01130#VAR_005332"	2	183092	19	11216244	A	G	181233	19:11216244:A:G	Pathogenic	5/27/16	"The p.Asp221Gly variant in LDLR has been reported in >75 individuals with familial hypercholesterolemia (FH), including in 4 homozygotes who presented with more severe disease (Hobbs 1992, Chmara 2010, Bertolini 2013). However, not all individuals carrying this variant presented with high cholesterol levels (Bertolini 2013, Thormaehlen 2015). This variant has also been identified in 10/65222 European chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs373822756). Please note that this frequency is low enough to be consistent with the frequency of FH in the general population. In vitro functional studies provide some evidence that the p.Asp221Gly variant may impact protein function (Thormaehlen 2015). However, these types of assays may not accurately represent biological function. In summary, this variant meets our criteria to be classified as pathogenic for familial hypercholesterolemia in an autosomal dominant manner based upon presence in affected individuals, low frequency in the general population, and functional data."	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:4	"Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine"	SCV000711396.1	SCV000711396		LDLR	-	High LDL	4/3/17	46959	4	1	"[0.9999893524138078,1.0647586192210225E-5]"	1	SCV000711396171201	single nucleotide variant	NM_000527.4(LDLR):c.798T>A (p.Asp266Glu)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	17-May-18	139043155	-	RCV000172959;RCV000148594;RCV000162020	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202"	Familial hypercholesterolemia;Hypercholesterolaemia;not provided	germline;inherited;not applicable;unknown	germline	GRCh37	NC_000019.9	19	11217344	11217344	T	A	19p13.2	"criteria provided, conflicting interpretations"	16	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000117,UniProtKB (protein):P01130#VAR_005347"	2	161287	19	11217344	T	A	171201	19:11217344:T:A	Pathogenic	11/13/17	"The p.Asp266Glu variant has been reported in over 100 individuals with familial hypercholesterolemia (FH; Bertolini 2013, BrÃ¦nne 2015, Brusgaard 2006, Chmara 2010, Do 2015, Fouchier 2001, Hobbs 1992, Schmidt 2000, Sharifi 2016, TichÃ½ 2012, Weiss 2000). Some publications refer to this variant as p.Asp245Glu (or p.D266E). This variant has also been reported by other clinical laboratories in ClinVar (Variation ID: 161287) and has been identified in 10/126728 European chromosomes by the Genome Aggregation Database (GnomAD, http://gnomad.broadinstitute.org; dbSNP rs139043155). In vitro functional studies provide some evidence that the p.Asp266Glu variant may impact protein function, resulting in 15-30% LDL receptor activity (Hobbs 1992). Computational prediction tools and conservation analysis suggest that the p.Asp266Glu variant may impact the protein. Another likely pathogenic missense change at the same position (p.Asp266Tyr) has been reported in association to FH (reported as p.Asp245Tyr, Weiss 2000). In summary, this variant meets criteria to be classified as pathogenic for familial hypercholesterolemia in an autosomal dominant manner based upon presence in a large number of affected individuals, low frequency in controls, presence of another pathogenic missense change at the same amino acid position, functional evidence and computational evidence. ACMG/AMP Criteria applied: PS4, PM2, PM5, PP3, PS3_supporting (Richards 2015)."	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:28	"Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine"	SCV000711397.1	SCV000711397		LDLR	-	High LDL	5/17/18	46963	0	2	"[0.9999787066413985,2.1293358601452207E-5]"	2	SCV00071139745116	single nucleotide variant	NM_000527.4(LDLR):c.1222G>A (p.Glu408Lys)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	23-Jan-18	137943601	-	RCV000030125;RCV000148564	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443"	Familial hypercholesterolemia;Hypercholesterolaemia	germline;unknown	germline	GRCh37	NC_000019.9	19	11223989	11223989	G	A	19p13.2	"criteria provided, conflicting interpretations"	12	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_001379,UniProtKB (protein):P01130#VAR_005378"	2	36453	19	11223989	G	A	45116	19:11223989:G:A	Likely pathogenic	1/23/18	"The p.Glu408Lys variant in LDLR (also described as p.Glu387Lys in the literature), has been reported in one individual with early myocardial infarction (Do 2015) and at least 7 individuals with familial hypercholesterolemia (FH), including at least 3 heterozygotes, 3 homozygotes and 1 compound heterozygote with a second pathogenic variant in the LDLR gene (Hobbs 1992, Dedoussis 2004, Widhalm 2007, Taylor 2010). Other clinical laboratories have also reported this variant in ClinVar (Variation ID 36453). In vitro functional studies provide some evidence that the p.Glu408Lys variant may impact ligand recycling as it failed to release ligands in the endosome (Hobbs 1992, Strom 2011). This variant has also been identified in 2/111530 European chromosomes by the Genome Aggregation Database (GnomAD, http://gnomad.broadinstitute.org; dbSNP rs137943601). This frequency is low enough to be consistent with the frequency of FH in the general population. Additionally, other amino acid changes at this position have been reported in individuals with FH (Palcoux 2008, Duscova 2011), suggesting that changes at this position may not be tolerated. In summary, although additional studies are required to fully establish its clinical significance, the p.Glu408Lys variant is likely pathogenic. ACMG/AMP Criteria applied: PS4_moderate, PM2, PS3_supporting, PM5_supporting (Richards 2015)."	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:2	"Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine"	SCV000711398.1	SCV000711398		LDLR	-	High LDL	1/23/18	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV000711398181247	single nucleotide variant	NM_000527.4(LDLR):c.1027G>A (p.Gly343Ser)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	5-Jul-18	730882096	-	RCV000211596;RCV000587327;RCV000161977	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:CN517202"	Familial hypercholesterolemia;Familial hypercholesterolemias;not provided	germline;not applicable	germline	GRCh37	NC_000019.9	19	11221414	11221414	G	A	19p13.2	"criteria provided, conflicting interpretations"	15	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_001328,UniProtKB (protein):P01130#VAR_005367"	2	183106	19	11221414	G	A	181247	19:11221414:G:A	Likely pathogenic	12/4/17	"The p.Gly343Ser variant in LDLR has been reported in at least 10 individuals with familial hypercholesterolemia (FH); nine patients were heterozygous (Fouchier 2001, Bourbon 2008, Reshef 1996, Thiart 2000, Guardamagna 2009, Mozas 2004, Van Gaal 2001, Salazar 2002) and one individual carried the variant in the compound heterozygous state (Hobbs 1992). This variant has also been reported by other clinical laboratories in ClinVar (Variation ID 183106). In vitro functional studies provide evidence that the p.Gly343Ser variant may impact protein function (Hobbs 1992). This variant has been identified in 5/126,580 European chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org/, rs730882096). This frequency is low enough to be consistent with the frequency of FH in the general population Computational prediction tools and conservation analysis suggest that the p.Gly343Ser variant may impact the protein, though this information is not predictive enough to determine pathogenicity. In summary, although additional studies are required to fully establish its clinical significance, the p.Gly343Ser variant is likely pathogenic. ACMG/AMP Criteria applied: PS4_Moderate, PM2, PP3, PS3_supporting (Richards 2015)."	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:7	"Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine"	SCV000712222.1	SCV000712222		LDLR	-	High LDL	7/5/18	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV00071222248709	single nucleotide variant	NM_000384.2(APOB):c.10579C>T (p.Arg3527Trp)	338	APOB	HGNC:603	Conflicting interpretations of pathogenicity	1	3-Jul-18	144467873	-	RCV000408839;RCV000231844;RCV000627798;RCV000627798;RCV000494148	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C1704417,OMIM:144010;MedGen:C1704417,OMIM:144010;MedGen:C4551990,OMIM:615558;MedGen:CN517202"	"Familial hypercholesterolemia;Hypercholesterolemia, autosomal dominant, type B;Hypercholesterolemia, autosomal dominant, type B;Hypobetalipoproteinemia, familial, 1;not provided"	germline	germline	GRCh37	NC_000002.11	2	21229161	21229161	G	A	2p24	"criteria provided, conflicting interpretations"	8	"ACMG2013,ACMG2016"	Y	-	3	40223	2	21229161	G	A	48709	2:21229161:G:A	Pathogenic	7/27/17	"The p.Arg3527Trp variant (also referred to in the literature as p.Arg3500Trp) in APOB has been reported in at least 33 individuals with familial hypercholesterolemia, the majority of whom are of East Asian ancestry, and segregated with disease in at least 15 affected relatives from 4 families (Gaffney 1995, Choong 1997, Tai 1998, Fisher 1999, Tai 2001, Yang 2007, Hollandt 2012, Chiou 2010, Chiou 2011, Chiou 2012, Bertolini 2013). This variant has been reported in ClinVar (Variation ID 40223) and has also been identified in 22/18848 East Asian chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP rs144467873). This frequency is low enough to be consistent with the frequency of familial hypercholesterolemia (FH) in the general population. In vitro functional studies provide some evidence that the p.Arg3527Trp variant may impact protein function (Gaffney 1995, Fisher 1999, Tai 2001). Additionally, another variant at this position, p.Arg3527Gln, is a well-established pathogenic variant for FH. In summary, this variant meets criteria to be classified as pathogenic for FH in an autosomal dominant manner based upon segregation studies, increased prevalence in affected individuals, and pathogenicity of other variants at this position. Please note that pathogenic variants in APOB can have reduced penetrance and a less severe phenotype than disease-causing LDLR or PCSK9 variants (Youngblom and Knowles, GeneReviews)."	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:10	"Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine"	SCV000712357.1	SCV000712357		APOB	-	Low LDL	7/3/18	46963	0	14	"[0.9998509464897898,1.4905351021016544E-4]"	14	SCV000712357246373	single nucleotide variant	NM_000527.4(LDLR):c.1846-10G>T	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	29-Aug-17	368243304	-	RCV000237306;RCV000599958	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN169374"	Familial hypercholesterolemia;not specified	germline	germline	GRCh37	NC_000019.9	19	11230758	11230758	G	T	19p13.2	"criteria provided, conflicting interpretations"	3	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000252	2	252072	19	11230758	G	T	246373	19:11230758:G:T	Likely benign	8/29/17	"This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease."	not specified	CN169374:not specified	No Information	FALSE	No Information	"criteria provided, single submitter"	clinical testing	germline:na	GeneDx	SCV000722314.1	SCV000722314		LDLR	-	High LDL	8/29/17	46963	0	3	"[0.9999680599620978,3.194003790217831E-5]"	3	SCV000722314226402	single nucleotide variant	NM_000527.4(LDLR):c.1836C>T (p.Ala612=)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	27-Jun-17	143872778	-	RCV000210239;RCV000586569;RCV000456101	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202;MedGen:CN169374"	Familial hypercholesterolemia;not provided;not specified	germline	germline	GRCh37	NC_000019.9	19	11227665	11227665	C	T	19p13.2	"criteria provided, conflicting interpretations"	9	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000249	2	224618	19	11227665	C	T	226402	19:11227665:C:T	Likely benign	6/27/17	"This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease."	not specified	CN169374:not specified	No Information	FALSE	No Information	"criteria provided, single submitter"	clinical testing	germline:na	GeneDx	SCV000728649.1	SCV000728649		LDLR	-	High LDL	6/27/17	46963	0	10	"[0.9998935332069927,1.0646679300726103E-4]"	10	SCV00072864945123	single nucleotide variant	NM_000527.4(LDLR):c.2140+5G>A	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	26-Jan-18	72658867	-	RCV000030133;RCV000614028	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN169374"	Familial hypercholesterolemia;not specified	germline	germline	GRCh37	NC_000019.9	19	11231203	11231203	G	A	19p13.2	"criteria provided, conflicting interpretations"	13	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000283	2	36460	19	11231203	G	A	45123	19:11231203:G:A	Benign	6/13/17	"This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease."	not specified	CN169374:not specified	No Information	FALSE	No Information	"criteria provided, single submitter"	clinical testing	germline:na	GeneDx	SCV000728650.1	SCV000728650		LDLR	-	High LDL	1/26/18	46942	21	472	"[0.9949725192791103,0.005027480720889608]"	464	SCV000728650181238	single nucleotide variant	NM_000527.4(LDLR):c.829G>A (p.Glu277Lys)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	29-Dec-17	148698650	-	RCV000210246;RCV000495914;RCV000161968;RCV000610848	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202;MedGen:CN169374"	Familial hypercholesterolemia;Familial hypercholesterolemia;not provided;not specified	germline;not applicable;unknown	germline	GRCh37	NC_000019.9	19	11218079	11218079	G	A	19p13.2	"criteria provided, conflicting interpretations"	12	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_001845,UniProtKB (protein):P01130#VAR_005350"	2	183097	19	11218079	G	A	181238	19:11218079:G:A	Likely benign	12/29/17	-	not specified	CN169374:not specified	No Information	FALSE	No Information	"criteria provided, single submitter"	clinical testing	germline:na	GeneDx	SCV000730507.1	SCV000730507		LDLR	-	High LDL	12/29/17	46963	0	61	"[0.9993505525626557,6.494474373442923E-4]"	61	SCV00073050745114	single nucleotide variant	NM_000527.4(LDLR):c.1061-8T>C	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	31-May-18	72658861	-	RCV000030123;RCV000759074;RCV000245346	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202;MedGen:CN169374"	Familial hypercholesterolemia;not provided;not specified	germline;unknown	germline	GRCh37	NC_000019.9	19	11222182	11222182	T	C	19p13.2	"criteria provided, conflicting interpretations"	15	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000154	2	36451	19	11222182	T	C	45114	19:11222182:T:C	Benign	5/11/17	-	not specified	CN169374:not specified	No Information	FALSE	No Information	"criteria provided, single submitter"	clinical testing	germline:na	GeneDx	SCV000730509.1	SCV000730509		LDLR	-	High LDL	5/31/18	46960	3	426	"[0.9954642248722317,0.004535775127768314]"	420	SCV00073050918729	single nucleotide variant	NM_000527.4(LDLR):c.681C>G (p.Asp227Glu)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	30-Jun-17	121908028	-	RCV000003876	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline;not applicable	germline	GRCh37	NC_000019.9	19	11216263	11216263	C	G	19p13.2	"criteria provided, multiple submitters, no conflicts"	10	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_001815,OMIM Allelic Variant:606945.0006,UniProtKB (protein):P01130#VAR_005338"	3	3690	19	11216263	C	G	18729	19:11216263:C:G	Pathogenic	6/30/17	"The p.Asp227Glu variant in LDLR (also known as the FH Afrikaner 1 allele) is a founder variant in the Afrikan population and is thought to account for 65 - 75% of familial hypercholesterolemia in Afrikans (Leitersdorf 1989, Kotze 1990, Kotze 1994). This variant has also been identified in at least 7 Caucasian individuals with familial hypercholesterolemia (Gudnason 1993, Callis 1998, Fouchier 2001, Bertolini 2013, Sharifi 2016) and has been reported in ClinVar (Variation ID 3690). Additionally, in vitro functional studies provide some evidence that the p.Asp227Glu variant may impair receptor activity (Fourie 1988). This variant has been identified in 1/33548 Latino chromosomes by the Genome Aggregation Database (gnomAD; http://gnomad.broadinstitute.org; dbSNP rs121908028). This frequency is low enough to be consistent with the frequency of familial hypercholesterolemia (FH) in the general population. In summary, this variant meets criteria to be classified as pathogenic for FH in an autosomal dominant manner based upon low frequency in controls, functional evidence, and presence in multiple affected individuals."	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:2	"Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine"	SCV000731597.1	SCV000731597		LDLR	-	High LDL	6/30/17	46946	17	1	"[0.9999893494653431,1.0650534656839773E-5]"	1	SCV00073159780399	single nucleotide variant	NM_000384.2(APOB):c.9175C>T (p.Arg3059Cys)	338	APOB	HGNC:603	Conflicting interpretations of pathogenicity	1	16-Oct-17	146377316	-	RCV000497061;RCV000655087;RCV000655087	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C1704417,OMIM:144010;MedGen:C4551990,OMIM:615558"	"Familial hypercholesterolemia;Hypercholesterolemia, autosomal dominant, type B;Hypobetalipoproteinemia, familial, 1"	germline	germline	GRCh37	NC_000002.11	2	21230565	21230565	G	A	2p24	"criteria provided, conflicting interpretations"	4	"ACMG2013,ACMG2016"	N	-	2	69508	2	21230565	G	A	80399	2:21230565:G:A	Likely pathogenic	10/16/17	"The p.Arg3059Cys variant in APOB has been reported in 3 individuals with autosomal dominant hypercholesterolemia, and segregated with disease in 8 affected relatives of one family, though 2 other family members had the variant but only had mildly elevated high cholesterol (Motazacker et al. 2012). In vitro functional studies looking at LDL uptake provide some evidence that the p.Arg3059Cys variant may impact APOB function (Motazacker et al. 2012). The variant has been reported by other clinical laboratories in ClinVar (Variation ID 69508) and has also been identified in 2/245754 chromosomes of the general population in gnomAD (http://gnomad.broadinstitute.org; dbSNP rs146377316). Conservation analysis shows a lack of conservation at this amino acid site, though replacement by a cysteine has not been observed across species. In summary, although additional studies are required to fully establish its clinical significance, the p.Arg3059Cys variant is likely pathogenic. (ACMG/AMP codes applied: PP1_Strong, PS3_Moderate). Please note that pathogenic variants in APOB can have reduced penetrance and a less severe phenotype than disease-causing LDLR or PCSK9 variants (Youngblom and Knowles, GeneReviews)."	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:2	"Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine"	SCV000731607.1	SCV000731607		APOB	-	Low LDL	10/16/17	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV00073160718730	single nucleotide variant	NM_000527.4(LDLR):c.682G>A (p.Glu228Lys)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	31-Oct-18	121908029	-	RCV000735406;RCV000735406;RCV000735406;RCV000003878;RCV000735406;RCV000735406;RCV000623885	"Human Phenotype Ontology:HP:0002647,MedGen:C0340643;Human Phenotype Ontology:HP:0012158,MedGen:C0338585;Human Phenotype Ontology:HP:0012474,MedGen:C0265101;MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;Human Phenotype Ontology:HP:0012159,MedGen:C0751815;Human Phenotype Ontology:HP:0001297,MedGen:C0038454;MedGen:CN517202"	Aortic dissection;Carotid artery dissection;Carotid artery occlusion;Familial hypercholesterolemia;Internal carotid artery dissection;Stroke;not provided	germline;unknown	germline	GRCh37	NC_000019.9	19	11216264	11216264	G	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	19	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000105,OMIM Allelic Variant:606945.0007,UniProtKB (protein):P01130#VAR_005341"	3	3691	19	11216264	G	A	18730	19:11216264:G:A	Pathogenic	9/20/17	"The p.Glu228Lys variant in LDLR is a common pathogenic variant that has been reported in a large number of individuals across several studies (Kusters 2011, Hujgen 2012, Bertolini 2013, Leitersdorf 1990). It is one of the 12 most common LDLR variants in the Dutch (Kusters 2011). This variant has been identified in 2/17176 East Asian chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP rs121908029). In vitro functional studies support that the p.Glu228Lys impacts protein function (Leitersdorf 1990). In addition, several other variants at the same position (p.Glu228Gln, p.Glu228Ala, p.Glu228Gly) have been reported with evidence supporting a disease causing role (ClinVar ID: 251393, 251394, 375796), suggesting that a change at this position is not tolerated. In summary, this variant meets criteria to be classified as pathogenic for familial hypercholesterolemia in an autosomal dominant manner based upon functional studies, presence in multiple affected individuals, low frequency in controls and pathogenicity of other variants at the same amino acid position."	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:2	"Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine"	SCV000731719.1	SCV000731719		LDLR	-	High LDL	10/31/18	46944	19	2	"[0.9999786980231765,2.1301976823449217E-5]"	2	SCV00073171918738	single nucleotide variant	NM_000527.4(LDLR):c.2043C>A (p.Cys681Ter)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	31-Oct-18	121908031	-	RCV000003887;RCV000590806;RCV000481771	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:CN517202"	Familial hypercholesterolemia;Familial hypercholesterolemias;not provided	germline;unknown	germline	GRCh37	NC_000019.9	19	11231101	11231101	C	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	18	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_001592,OMIM Allelic Variant:606945.0016"	3	3699	19	11231101	C	A	18738	19:11231101:C:A	Pathogenic	8/11/17	"The p.Cys681X variant in LDLR has been reported in >80 individuals with hypercholestrolemia across several studies and segregated with disease in >10 affected relatives (Abifadel 2009, Banares 2017, Fahed 2011, Jannes 2015, Lehrman 1987, Tichy 2012, Vandrovcova 2013). This variant is considered to be a founder variant in the Lebanese population (Fahed 2016). This variant has also been reported in Clinvar (Variation ID 3699) and identified in 1/33580 Latino and 1/111664 European chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP rs121908031). This nonsense variant leads to a premature termination codon at position 681, which is predicted to lead to a truncated or absent protein. Heterozygous loss of function of the LDLR gene is an established disease mechanism in familial hypercholestrolemia. In summary, this variant meets criteria to be classified as pathogenic for familial hypercholestrolemia in an autosomal dominant manner based upon frequency in affected individuals and segregation studies."	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:2	"Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine"	SCV000731826.1	SCV000731826		LDLR	-	High LDL	10/31/18	46958	5	1	"[0.9999893521870608,1.0647812939222283E-5]"	1	SCV00073182629357	single nucleotide variant	NM_005912.2(MC4R):c.105C>A (p.Tyr35Ter)	4160	MC4R	HGNC:6932	Pathogenic	1	14-Aug-18	13447324	-	RCV000015394;RCV000202583;RCV000255005	"Human Phenotype Ontology:HP:0001513,MedGen:C0028754,OMIM:601665,Orphanet:ORPHA71529,SNOMED CT:414916001;Human Phenotype Ontology:HP:0100753,MedGen:C0036341,OMIM:181500,SNOMED CT:58214004;MedGen:CN517202"	Obesity;Schizophrenia;not provided	germline	germline	GRCh37	NC_000018.9	18	58039478	58039478	G	T	18q21.3	"criteria provided, multiple submitters, no conflicts"	8	NA	N	OMIM Allelic Variant:155541.0003	3	14318	18	58039478	G	T	29357	18:58039478:G:T	Pathogenic	NA	-	OMIM:601665	C0028754:Obesity	NA	TRUE	NA	no assertion criteria provided	clinical testing	germline:na	"Diagnostic Laboratory, Department of Genetics,University Medical Center Groningen"	SCV000733802.1	SCV000733802		MC4R	-	Obesity	8/14/18	46963	0	6	"[0.9999361199241956,6.388007580435663E-5]"	6	SCV00073380218780	single nucleotide variant	NM_000527.4(LDLR):c.131G>A (p.Trp44Ter)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	14-Nov-17	267607213	-	RCV000003939	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline;inherited	germline	GRCh37	NC_000019.9	19	11210962	11210962	G	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	13	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000019,OMIM Allelic Variant:606945.0060"	3	3741	19	11210962	G	A	18780	19:11210962:G:A	Pathogenic	NA	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	no assertion criteria provided	clinical testing	germline:na	"Diagnostic Laboratory, Department of Genetics,University Medical Center Groningen"	SCV000733811.1	SCV000733811		LDLR	-	High LDL	11/14/17	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV00073381178990	single nucleotide variant	NM_000527.4(LDLR):c.148G>T (p.Ala50Ser)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	30-Nov-17	137853960	-	RCV000210234;RCV000148578;RCV000058916;RCV000455660	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202;MedGen:CN169374"	Familial hypercholesterolemia;Hypercholesterolaemia;not provided;not specified	germline;unknown	germline	GRCh37	NC_000019.9	19	11210979	11210979	G	T	19p13.2	"criteria provided, conflicting interpretations"	13	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000021,UniProtKB (protein):P01130#VAR_007979"	2	68099	19	11210979	G	T	78990	19:11210979:G:T	Benign	NA	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	no assertion criteria provided	clinical testing	germline:na	"Diagnostic Laboratory, Department of Genetics,University Medical Center Groningen"	SCV000733812.1	SCV000733812		LDLR	-	High LDL	11/30/17	46963	0	43	"[0.9995421927900687,4.5780720993122243E-4]"	43	SCV00073381218730	single nucleotide variant	NM_000527.4(LDLR):c.682G>A (p.Glu228Lys)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	31-Oct-18	121908029	-	RCV000735406;RCV000735406;RCV000735406;RCV000003878;RCV000735406;RCV000735406;RCV000623885	"Human Phenotype Ontology:HP:0002647,MedGen:C0340643;Human Phenotype Ontology:HP:0012158,MedGen:C0338585;Human Phenotype Ontology:HP:0012474,MedGen:C0265101;MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;Human Phenotype Ontology:HP:0012159,MedGen:C0751815;Human Phenotype Ontology:HP:0001297,MedGen:C0038454;MedGen:CN517202"	Aortic dissection;Carotid artery dissection;Carotid artery occlusion;Familial hypercholesterolemia;Internal carotid artery dissection;Stroke;not provided	germline;unknown	germline	GRCh37	NC_000019.9	19	11216264	11216264	G	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	19	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000105,OMIM Allelic Variant:606945.0007,UniProtKB (protein):P01130#VAR_005341"	3	3691	19	11216264	G	A	18730	19:11216264:G:A	Pathogenic	NA	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	no assertion criteria provided	clinical testing	germline:na	"Diagnostic Laboratory, Department of Genetics,University Medical Center Groningen"	SCV000733815.1	SCV000733815		LDLR	-	High LDL	10/31/18	46944	19	2	"[0.9999786980231765,2.1301976823449217E-5]"	2	SCV000733815228156	single nucleotide variant	NM_000527.4(LDLR):c.1048C>T (p.Arg350Ter)	3949	LDLR	HGNC:6547	Pathogenic	1	8-May-18	769737896	-	RCV000211692;RCV000520229	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202"	Familial hypercholesterolemia;not provided	germline;inherited	germline	GRCh37	NC_000019.9	19	11221435	11221435	C	T	19p13.2	"criteria provided, multiple submitters, no conflicts"	11	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000147	2	226342	19	11221435	C	T	228156	19:11221435:C:T	Pathogenic	NA	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	no assertion criteria provided	clinical testing	germline:na	"Diagnostic Laboratory, Department of Genetics,University Medical Center Groningen"	SCV000733817.1	SCV000733817		LDLR	-	High LDL	5/8/18	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV00073381745114	single nucleotide variant	NM_000527.4(LDLR):c.1061-8T>C	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	31-May-18	72658861	-	RCV000030123;RCV000759074;RCV000245346	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202;MedGen:CN169374"	Familial hypercholesterolemia;not provided;not specified	germline;unknown	germline	GRCh37	NC_000019.9	19	11222182	11222182	T	C	19p13.2	"criteria provided, conflicting interpretations"	15	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000154	2	36451	19	11222182	T	C	45114	19:11222182:T:C	Benign	NA	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	no assertion criteria provided	clinical testing	germline:na	"Diagnostic Laboratory, Department of Genetics,University Medical Center Groningen"	SCV000733818.1	SCV000733818		LDLR	-	High LDL	5/31/18	46960	3	426	"[0.9954642248722317,0.004535775127768314]"	420	SCV00073381818734	single nucleotide variant	NM_000527.4(LDLR):c.1291G>A (p.Ala431Thr)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	30-Mar-17	28942079	-	RCV000003883	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline;unknown	germline	GRCh37	NC_000019.9	19	11224058	11224058	G	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	13	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000184,OMIM Allelic Variant:606945.0010,UniProtKB (protein):P01130#VAR_005384"	3	3695	19	11224058	G	A	18734	19:11224058:G:A	Pathogenic	NA	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	no assertion criteria provided	clinical testing	germline:na	"Diagnostic Laboratory, Department of Genetics,University Medical Center Groningen"	SCV000733819.1	SCV000733819		LDLR	-	High LDL	3/30/17	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV000733819172183	single nucleotide variant	NM_000527.4(LDLR):c.1359-1G>A	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	16-Jan-18	139617694	-	RCV000172962;RCV000149884	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443"	Familial hypercholesterolemia;Hypercholesterolaemia	germline	germline	GRCh37	NC_000019.9	19	11224210	11224210	G	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	12	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_001405	2	162499	19	11224210	G	A	172183	19:11224210:G:A	Pathogenic	NA	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	no assertion criteria provided	clinical testing	germline:na	"Diagnostic Laboratory, Department of Genetics,University Medical Center Groningen"	SCV000733821.1	SCV000733821		LDLR	-	High LDL	1/16/18	46961	2	1	"[0.9999893528672729,1.0647132727156576E-5]"	1	SCV000733821171217	single nucleotide variant	NM_000527.4(LDLR):c.1775G>A (p.Gly592Glu)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	31-Oct-18	137929307	-	RCV000172964;RCV000587007;RCV000148576;RCV000162001	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:C0020443;MedGen:CN517202"	Familial hypercholesterolemia;Familial hypercholesterolemias;Hypercholesterolaemia;not provided	germline;inherited;not applicable;unknown	germline	GRCh37	NC_000019.9	19	11227604	11227604	G	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	22	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000237,UniProtKB (protein):P01130#VAR_005403"	2	161271	19	11227604	G	A	171217	19:11227604:G:A	Likely pathogenic	NA	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	no assertion criteria provided	clinical testing	germline:na	"Diagnostic Laboratory, Department of Genetics,University Medical Center Groningen"	SCV000733827.1	SCV000733827		LDLR	-	High LDL	10/31/18	46963	0	3	"[0.9999680599620978,3.194003790217831E-5]"	3	SCV000733827181272	single nucleotide variant	NM_000527.4(LDLR):c.2101G>A (p.Gly701Ser)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	7-Jun-17	368838866	-	RCV000238415;RCV000162008	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202"	Familial hypercholesterolemia;not provided	germline;inherited;not applicable	germline	GRCh37	NC_000019.9	19	11231159	11231159	G	A	19p13.2	"criteria provided, conflicting interpretations"	7	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_001078	2	183130	19	11231159	G	A	181272	19:11231159:G:A	Likely benign	NA	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	no assertion criteria provided	clinical testing	germline:na	"Diagnostic Laboratory, Department of Genetics,University Medical Center Groningen"	SCV000733828.1	SCV000733828		LDLR	-	High LDL	6/7/17	46963	0	15	"[0.9998402998104892,1.5970018951089155E-4]"	15	SCV00073382845123	single nucleotide variant	NM_000527.4(LDLR):c.2140+5G>A	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	26-Jan-18	72658867	-	RCV000030133;RCV000614028	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN169374"	Familial hypercholesterolemia;not specified	germline	germline	GRCh37	NC_000019.9	19	11231203	11231203	G	A	19p13.2	"criteria provided, conflicting interpretations"	13	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000283	2	36460	19	11231203	G	A	45123	19:11231203:G:A	Likely benign	NA	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	no assertion criteria provided	clinical testing	germline:na	"Diagnostic Laboratory, Department of Genetics,University Medical Center Groningen"	SCV000733830.1	SCV000733830		LDLR	-	High LDL	1/26/18	46942	21	472	"[0.9949725192791103,0.005027480720889608]"	464	SCV000733830171222	single nucleotide variant	NM_000527.4(LDLR):c.2282C>T (p.Thr761Met)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	30-Mar-17	138477254	-	RCV000237277;RCV000148565;RCV000162013	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202"	Familial hypercholesterolemia;Hypercholesterolaemia;not provided	germline;not applicable	germline	GRCh37	NC_000019.9	19	11233991	11233991	C	T	19p13.2	"criteria provided, conflicting interpretations"	9	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000907	2	161262	19	11233991	C	T	171222	19:11233991:C:T	Likely benign	NA	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	no assertion criteria provided	clinical testing	germline:na	"Diagnostic Laboratory, Department of Genetics,University Medical Center Groningen"	SCV000733832.1	SCV000733832		LDLR	-	High LDL	3/30/17	46963	0	4	"[0.9999574132827971,4.2586717202904415E-5]"	4	SCV00073383253501	single nucleotide variant	NM_002052.4(GATA4):c.1129A>G (p.Ser377Gly)	2626	GATA4	HGNC:4173	Benign	1	13-Dec-16	3729856	-	RCV000620305;RCV000128527;RCV000037322	MedGen:CN230736;MedGen:CN517202;MedGen:CN169374	Cardiovascular phenotype;not provided;not specified	germline	germline	GRCh37	NC_000008.10	8	11614575	11614575	A	G	8p23.1	"criteria provided, multiple submitters, no conflicts"	3	NA	N	UniProtKB (protein):P43694#VAR_038196	2	44334	8	11614575	A	G	53501	8:11614575:A:G	Benign	6/23/15	Lines of evidence used in support of classification: General population or subpopulation frequency is too high to be a pathogenic mutation based on disease/syndrome prevalence and penetrance	cardiovascular phenotype	CN230736:Cardiovascular phenotype	NA	FALSE	Not trait of interest	"criteria provided, single submitter"	clinical testing	germline:1	Ambry Genetics	SCV000735049.2	SCV000735049		GATA4	-	"MonogenicDM_all, Neonatal Diabetes"	12/13/16	46919	44	5733	"[0.9389053475138004,0.06109465248619962]"	5145	SCV00073504939055	single nucleotide variant	NM_002052.4(GATA4):c.1037C>T (p.Ala346Val)	2626	GATA4	HGNC:4173	Conflicting interpretations of pathogenicity	1	19-Dec-17	115372595	-	RCV000023005;RCV000617346;RCV000503266	"MedGen:C3280781,OMIM:614430;MedGen:CN230736;MedGen:CN169374"	Atrioventricular septal defect 4;Cardiovascular phenotype;not specified	germline	germline	GRCh37	NC_000008.10	8	11614483	11614483	C	T	8p23.1	"criteria provided, conflicting interpretations"	4	NA	N	"OMIM Allelic Variant:600576.0008,UniProtKB (protein):P43694#VAR_067616"	3	30100	8	11614483	C	T	39055	8:11614483:C:T	Uncertain significance	2/7/16	"Lines of evidence used in support of classification: Insufficient or conflicting evidence,Detected in individual satisfying established diagnostic critera for classic disease without a clear mutation"	cardiovascular phenotype	CN230736:Cardiovascular phenotype	NA	FALSE	Not trait of interest	"criteria provided, single submitter"	clinical testing	germline:1	Ambry Genetics	SCV000735099.2	SCV000735099		GATA4	-	"MonogenicDM_all, Neonatal Diabetes"	12/19/17	46963	0	104	"[0.9988927453527244,0.0011072546472755147]"	104	SCV000735099172489	single nucleotide variant	NM_170707.3(LMNA):c.1634G>A (p.Arg545His)	4000	LMNA	HGNC:6636	Conflicting interpretations of pathogenicity	1	23-Apr-18	142191737	-	RCV000621850;RCV000468904;RCV000491650;RCV000449630;RCV000505801;RCV000150955	"MedGen:CN230736;MedGen:C0270914,Orphanet:ORPHA64746;MedGen:C1834481,OMIM:613426;Human Phenotype Ontology:HP:0009830,MedGen:C0031117,Orphanet:ORPHA98496;MedGen:CN517202;MedGen:CN169374"	"Cardiovascular phenotype;Charcot-Marie-Tooth disease, type 2;Dilated cardiomyopathy 1S;Peripheral neuropathy;not provided;not specified"	germline;maternal	germline	GRCh37	NC_000001.10	1	156107470	156107470	G	A	1q22	"criteria provided, conflicting interpretations"	7	"ACMG2013,ACMG2016"	N	-	2	163878	1	156107470	G	A	172489	1:156107470:G:A	Uncertain significance	12/12/17	Lines of evidence used in support of classification: Insufficient evidence	cardiovascular phenotype	CN230736:Cardiovascular phenotype	NA	FALSE	Incorrect phenotype	"criteria provided, single submitter"	clinical testing	germline:1	Ambry Genetics	SCV000736172.2	SCV000736172		LMNA	-	"Lipodystrophy, MonogenicDM_all"	4/23/18	44851	2112	4	"[0.9999554079061782,4.45920938217654E-5]"	4	SCV00073617257261	single nucleotide variant	NM_170707.3(LMNA):c.976T>A (p.Ser326Thr)	4000	LMNA	HGNC:6636	Conflicting interpretations of pathogenicity	1	21-Nov-18	56851164	-	RCV000621488;RCV000544253;RCV000755678;RCV000208012;RCV000057494;RCV000212504	"MedGen:CN230736;MedGen:C0270914,Orphanet:ORPHA64746;MedGen:C1449563,OMIM:115200,Orphanet:ORPHA300751;MedGen:C0949658,Orphanet:ORPHA155,SNOMED CT:83978005;MedGen:CN517202;MedGen:CN169374"	"Cardiovascular phenotype;Charcot-Marie-Tooth disease, type 2;Dilated cardiomyopathy 1A;Primary familial hypertrophic cardiomyopathy;not provided;not specified"	germline;unknown	germline	GRCh37	NC_000001.10	1	156105731	156105731	T	A	1q22	"criteria provided, conflicting interpretations"	8	"ACMG2013,ACMG2016"	N	-	2	48097	1	156105731	T	A	57261	1:156105731:T:A	Uncertain significance	9/15/17	Lines of evidence used in support of classification: Insufficient evidence	cardiovascular phenotype	CN230736:Cardiovascular phenotype	NA	FALSE	Incorrect phenotype	"criteria provided, single submitter"	clinical testing	germline:1	Ambry Genetics	SCV000736913.2	SCV000736913		LMNA	-	"Lipodystrophy, MonogenicDM_all"	11/21/18	46959	4	3	"[0.9999680572414233,3.1942758576630676E-5]"	3	SCV00073691329556	single nucleotide variant	NM_170707.3(LMNA):c.1718C>T (p.Ser573Leu)	4000	LMNA	HGNC:6636	Conflicting interpretations of pathogenicity	1	21-Dec-17	60890628	-	RCV000617932;RCV000653881;RCV000015612;RCV000015614;RCV000015613;RCV000057351;RCV000041329	"MedGen:CN230736;MedGen:C0270914,Orphanet:ORPHA64746;MedGen:C1449563,OMIM:115200,Orphanet:ORPHA300751;MedGen:C1720860,OMIM:151660,Orphanet:ORPHA2348;MedGen:CN043412;MedGen:CN517202;MedGen:CN169374"	"Cardiovascular phenotype;Charcot-Marie-Tooth disease, type 2;Dilated cardiomyopathy 1A;Familial partial lipodystrophy 2;Mandibuloacral dysplasia with type A lipodystrophy, atypical;not provided;not specified"	germline	germline	GRCh37	NC_000001.10	1	156108298	156108298	C	T	1q22	"criteria provided, conflicting interpretations"	7	"ACMG2013,ACMG2016"	N	"OMIM Allelic Variant:150330.0041,UniProtKB (protein):P02545#VAR_039789"	3	14517	1	156108298	C	T	29556	1:156108298:C:T	Uncertain significance	5/24/17	Lines of evidence used in support of classification: Insufficient evidence	cardiovascular phenotype	CN230736:Cardiovascular phenotype	NA	FALSE	Incorrect phenotype	"criteria provided, single submitter"	clinical testing	germline:1	Ambry Genetics	SCV000738025.2	SCV000738025		LMNA	-	"Lipodystrophy, MonogenicDM_all"	12/21/17	46812	151	16	"[0.9998291036486371,1.708963513628984E-4]"	16	SCV00073802518724	single nucleotide variant	NM_000527.4(LDLR):c.259T>G (p.Trp87Gly)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	8-Jun-18	121908025	-	RCV000003870;RCV000622852	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202"	Familial hypercholesterolemia;not provided	germline;inherited	germline	GRCh37	NC_000019.9	19	11213408	11213408	T	G	19p13.2	"criteria provided, multiple submitters, no conflicts"	11	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_001671,OMIM Allelic Variant:606945.0003,UniProtKB (protein):P01130#VAR_005308"	3	3685	19	11213408	T	G	18724	19:11213408:T:G	Likely pathogenic	7/11/17	-	not provided	CN517202:not provided	No Information	FALSE	No Information	"criteria provided, single submitter"	clinical testing	germline:na	"Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease,Montreal Heart Institute"	SCV000740415.1	SCV000740415		LDLR	-	High LDL	6/8/18	46963	0	3	"[0.9999680599620978,3.194003790217831E-5]"	3	SCV00074041518730	single nucleotide variant	NM_000527.4(LDLR):c.682G>A (p.Glu228Lys)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	31-Oct-18	121908029	-	RCV000735406;RCV000735406;RCV000735406;RCV000003878;RCV000735406;RCV000735406;RCV000623885	"Human Phenotype Ontology:HP:0002647,MedGen:C0340643;Human Phenotype Ontology:HP:0012158,MedGen:C0338585;Human Phenotype Ontology:HP:0012474,MedGen:C0265101;MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;Human Phenotype Ontology:HP:0012159,MedGen:C0751815;Human Phenotype Ontology:HP:0001297,MedGen:C0038454;MedGen:CN517202"	Aortic dissection;Carotid artery dissection;Carotid artery occlusion;Familial hypercholesterolemia;Internal carotid artery dissection;Stroke;not provided	germline;unknown	germline	GRCh37	NC_000019.9	19	11216264	11216264	G	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	19	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000105,OMIM Allelic Variant:606945.0007,UniProtKB (protein):P01130#VAR_005341"	3	3691	19	11216264	G	A	18730	19:11216264:G:A	Likely pathogenic	7/20/17	-	not provided	CN517202:not provided	No Information	FALSE	No Information	"criteria provided, single submitter"	clinical testing	germline:na	"Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease,Montreal Heart Institute"	SCV000740416.1	SCV000740416		LDLR	-	High LDL	10/31/18	46944	19	2	"[0.9999786980231765,2.1301976823449217E-5]"	2	SCV00074041618731	single nucleotide variant	NM_000527.4(LDLR):c.910G>A (p.Asp304Asn)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	10-Apr-18	121908030	-	RCV000003880;RCV000148569;RCV000622705	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MeSH:D030342,MedGen:C0950123"	Familial hypercholesterolemia;Hypercholesterolaemia;Inborn genetic diseases	germline;inherited;not applicable	germline	GRCh37	NC_000019.9	19	11218160	11218160	G	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	10	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_001861,OMIM Allelic Variant:606945.0008,UniProtKB (protein):P01130#VAR_005355"	3	3692	19	11218160	G	A	18731	19:11218160:G:A	Likely pathogenic	3/3/17	Lines of evidence used in support of classification: LIKELY POSITIVE: Relevant Alteration(s) Detected	MeSH:D030342	C0950123:Inborn genetic diseases	Familial Hypercholesterolemia	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:1	Ambry Genetics	SCV000741389.1	SCV000741389		LDLR	-	High LDL	4/10/18	46963	0	3	"[0.9999680599620978,3.194003790217831E-5]"	3	SCV000741389511752	single nucleotide variant	NM_000237.3(LPL):c.590G>A (p.Arg197His)	4023	LPL	HGNC:6677	Pathogenic	1	26-Apr-16	372668179	-	RCV000623537	"MeSH:D030342,MedGen:C0950123"	Inborn genetic diseases	germline	germline	GRCh37	NC_000008.10	8	19811679	19811679	G	A	8p21.3	"criteria provided, single submitter"	1	NA	N	-	2	521082	8	19811679	G	A	511752	8:19811679:G:A	Pathogenic	4/26/16	Lines of evidence used in support of classification: POSITIVE: Relevant Alteration(s) Detected	MeSH:D030342	C0950123:Inborn genetic diseases	NA	TRUE	Kept because pubmed articles referenced are all relevant to phenotype	"criteria provided, single submitter"	clinical testing	germline:1	Ambry Genetics	SCV000741513.1	SCV000741513		LPL	-	High triglycerides	4/26/16	46963	0	12	"[0.9998722398483912,1.2776015160871325E-4]"	12	SCV00074151318730	single nucleotide variant	NM_000527.4(LDLR):c.682G>A (p.Glu228Lys)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	31-Oct-18	121908029	-	RCV000735406;RCV000735406;RCV000735406;RCV000003878;RCV000735406;RCV000735406;RCV000623885	"Human Phenotype Ontology:HP:0002647,MedGen:C0340643;Human Phenotype Ontology:HP:0012158,MedGen:C0338585;Human Phenotype Ontology:HP:0012474,MedGen:C0265101;MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;Human Phenotype Ontology:HP:0012159,MedGen:C0751815;Human Phenotype Ontology:HP:0001297,MedGen:C0038454;MedGen:CN517202"	Aortic dissection;Carotid artery dissection;Carotid artery occlusion;Familial hypercholesterolemia;Internal carotid artery dissection;Stroke;not provided	germline;unknown	germline	GRCh37	NC_000019.9	19	11216264	11216264	G	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	19	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000105,OMIM Allelic Variant:606945.0007,UniProtKB (protein):P01130#VAR_005341"	3	3691	19	11216264	G	A	18730	19:11216264:G:A	Pathogenic	7/28/17	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	"Genome Diagnostics Laboratory,University Medical Center Utrecht"	SCV000743851.1	SCV000743851		LDLR	-	High LDL	10/31/18	46944	19	2	"[0.9999786980231765,2.1301976823449217E-5]"	2	SCV000743851226399	single nucleotide variant	NM_000527.4(LDLR):c.941-4G>A	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	12-Jan-18	116405216	-	RCV000210248;RCV000736080	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN169374"	Familial hypercholesterolemia;not specified	germline;unknown	germline	GRCh37	NC_000019.9	19	11221324	11221324	G	A	19p13.2	"criteria provided, conflicting interpretations"	10	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000515	2	224619	19	11221324	G	A	226399	19:11221324:G:A	Benign	7/28/17	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	"Genome Diagnostics Laboratory,University Medical Center Utrecht"	SCV000743852.1	SCV000743852		LDLR	-	High LDL	1/12/18	46963	0	399	"[0.9957519749590102,0.004248025040989715]"	389	SCV00074385216589	single nucleotide variant	NM_000237.3(LPL):c.953A>G (p.Asn318Ser)	4023	LPL	HGNC:6677	Pathogenic	1	3-Dec-17	268	-	RCV000001615	"Human Phenotype Ontology:HP:0008158,MedGen:C0020474,OMIM:144250"	Hyperapobetalipoproteinemia	germline;inherited	germline	GRCh37	NC_000008.10	8	19813529	19813529	A	G	8p21.3	"criteria provided, single submitter"	2	NA	N	"OMIM Allelic Variant:609708.0033,UniProtKB (protein):P06858#VAR_004239"	3	1550	8	19813529	A	G	16589	8:19813529:A:G	Pathogenic	12/3/17	-	MedGen:C0020474	C0020474:Hyperapobetalipoproteinemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	inherited:na	"Genomic Research Center,Shahid Beheshti University of Medical Sciences"	SCV000746401.1	SCV000746401		-	-	High triglycerides	12/3/17	46963	0	727	"[0.9922598641483721,0.007740135851627877]"	721	SCV00074640139054	single nucleotide variant	NM_002052.4(GATA4):c.487C>T (p.Pro163Ser)	2626	GATA4	HGNC:4173	Conflicting interpretations of pathogenicity	1	9-Jan-18	387906769	-	RCV000023002;RCV000023004;RCV000023003	"MedGen:C3280781,OMIM:614430;Human Phenotype Ontology:HP:0001636,MedGen:C0039685,OMIM:187500,Orphanet:ORPHA3303,SNOMED CT:86299006;MedGen:C3280777,OMIM:614429"	Atrioventricular septal defect 4;Tetralogy of Fallot;Ventricular septal defect 1	germline;inherited	germline	GRCh37	NC_000008.10	8	11566308	11566308	C	T	8p23.1	"criteria provided, conflicting interpretations"	3	NA	N	"OMIM Allelic Variant:600576.0007,UniProtKB (protein):P43694#VAR_067610"	3	30099	8	11566308	C	T	39054	8:11566308:C:T	Pathogenic	12/18/17	-	MedGen:C0039685	C0039685:Tetralogy of Fallot	NA	FALSE	Not trait of interest	"criteria provided, single submitter"	clinical testing	inherited:na	"Genomic Research Center,Shahid Beheshti University of Medical Sciences"	SCV000746750.1	SCV000746750		-	-	"MonogenicDM_all, Neonatal Diabetes"	1/9/18	25928	21035	2	"[0.999961431656896,3.856834310398025E-5]"	2	SCV00074675023898	single nucleotide variant	NM_000209.3(PDX1):c.226G>A (p.Asp76Asn)	3651	PDX1	HGNC:6107	"Conflicting interpretations of pathogenicity, risk factor"	1	5-Feb-18	137852783	-	RCV000009409;RCV000626294;RCV000030077;RCV000445407;RCV000246150	"Human Phenotype Ontology:HP:0005978,MedGen:C0011860,OMIM:125853,Orphanet:ORPHA181376,SNOMED CT:44054006;Human Phenotype Ontology:HP:0004904,MedGen:C0342276,OMIM:606391,Orphanet:ORPHA552,SNOMED CT:28453007;MedGen:C1833382,OMIM:606392;MedGen:C3888631;MedGen:CN169374"	"Diabetes mellitus type 2;Maturity onset diabetes mellitus in young;Maturity-onset diabetes of the young, type 4;Monogenic diabetes;not specified"	germline;inherited;unknown	germline	GRCh37	NC_000013.10	13	28494501	28494501	G	A	13q12.2	"criteria provided, conflicting interpretations"	6	NA	N	"OMIM Allelic Variant:600733.0002,UniProtKB (protein):P52945#VAR_009311"	3	8859	13	28494501	G	A	23898	13:28494501:G:A	Uncertain significance	12/18/17	-	MedGen:C0011860	C0011860:Diabetes mellitus type 2	NA	FALSE	Not trait of interest	"criteria provided, single submitter"	clinical testing	inherited:na	"Genomic Research Center,Shahid Beheshti University of Medical Sciences"	SCV000746931.1	SCV000746931		-	-	"MODY, MODY Extended, MonogenicDM_all"	2/5/18	42422	4541	98	"[0.998844938946773,0.0011550610532270991]"	98	SCV00074693123898	single nucleotide variant	NM_000209.3(PDX1):c.226G>A (p.Asp76Asn)	3651	PDX1	HGNC:6107	"Conflicting interpretations of pathogenicity, risk factor"	1	5-Feb-18	137852783	-	RCV000009409;RCV000626294;RCV000030077;RCV000445407;RCV000246150	"Human Phenotype Ontology:HP:0005978,MedGen:C0011860,OMIM:125853,Orphanet:ORPHA181376,SNOMED CT:44054006;Human Phenotype Ontology:HP:0004904,MedGen:C0342276,OMIM:606391,Orphanet:ORPHA552,SNOMED CT:28453007;MedGen:C1833382,OMIM:606392;MedGen:C3888631;MedGen:CN169374"	"Diabetes mellitus type 2;Maturity onset diabetes mellitus in young;Maturity-onset diabetes of the young, type 4;Monogenic diabetes;not specified"	germline;inherited;unknown	germline	GRCh37	NC_000013.10	13	28494501	28494501	G	A	13q12.2	"criteria provided, conflicting interpretations"	6	NA	N	"OMIM Allelic Variant:600733.0002,UniProtKB (protein):P52945#VAR_009311"	3	8859	13	28494501	G	A	23898	13:28494501:G:A	Likely pathogenic	12/18/17	-	MedGen:C0342276	C0342276:Maturity onset diabetes mellitus in young	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	inherited:na	"Genomic Research Center,Shahid Beheshti University of Medical Sciences"	SCV000746953.1	SCV000746953		-	-	"MODY, MODY Extended, MonogenicDM_all"	2/5/18	42422	4541	98	"[0.998844938946773,0.0011550610532270991]"	98	SCV00074695344274	single nucleotide variant	NM_000352.4(ABCC8):c.3517G>A (p.Val1173Met)	6833	ABCC8	HGNC:59	Likely pathogenic	1	1-Jan-17	141322087	-	RCV000626670;RCV000626670;RCV000626670;RCV000626670;RCV000626670;RCV000626670;RCV000626670;RCV000626670;RCV000626670;RCV000029255;RCV000626670;RCV000626670;RCV000626670	"Human Phenotype Ontology:HP:0001631,MedGen:C0018817,Orphanet:ORPHA1478;Human Phenotype Ontology:HP:0001693,MedGen:C0232180;Human Phenotype Ontology:HP:0001635,MedGen:C0018802;Human Phenotype Ontology:HP:0011968,MedGen:C0232466;Human Phenotype Ontology:HP:0002020,MedGen:C4317146;Human Phenotype Ontology:HP:0001510,MedGen:C0456070;Human Phenotype Ontology:HP:0001943,MedGen:C0020615;Human Phenotype Ontology:HP:0000256,MedGen:C2243051;Human Phenotype Ontology:HP:0000400,MedGen:C0152421;MedGen:C0158981,Orphanet:ORPHA224,SNOMED CT:49817004;Human Phenotype Ontology:HP:0002643,MedGen:C4281993;Human Phenotype Ontology:HP:0004322,MedGen:C0349588;Human Phenotype Ontology:HP:0001518,MedGen:C0235991"	Atrial septal defect;Cardiac shunt;Congestive heart failure;Feeding difficulties;Gastroesophageal reflux;Growth delay;Hypoglycemia;Macrocephalus;Macrotia;Neonatal diabetes mellitus;Neonatal respiratory distress;Short stature;Small for gestational age	germline;unknown	germline	GRCh37	NC_000011.9	11	17426099	17426099	C	T	11p15.1	"criteria provided, multiple submitters, no conflicts"	2	NA	N	-	2	35609	11	17426099	C	T	44274	11:17426099:C:T	Likely pathogenic	1/1/17	-	Human Phenotype Ontology:HP:0000256;Human Phenotype Ontology:HP:0000400;Human Phenotype Ontology:HP:0001510;Human Phenotype Ontology:HP:0001518;Human Phenotype Ontology:HP:0001631;Human Phenotype Ontology:HP:0001635;Human Phenotype Ontology:HP:0001693;Human Phenotype Ontology:HP:0001943;Human Phenotype Ontology:HP:0002020;Human Phenotype Ontology:HP:0002643;Human Phenotype Ontology:HP:0004322;Human Phenotype Ontology:HP:0011968	C0018802:Congestive heart failure;C0018817:Atrial septal defect;C0020615:Hypoglycemia;C0152421:Macrotia;C0232180:Cardiac shunt;C0232466:Feeding difficulties;C0235991:Small for gestational age;C0349588:Short stature;C0456070:Growth delay;C2243051:Macrocephalus;C4281993:Neonatal respiratory distress;C4317146:Gastroesophageal reflux	NA	FALSE	Not trait of interest	"criteria provided, single submitter"	clinical testing	unknown:na	"Centre for Mendelian Genomics,University Medical Centre Ljubljana"	SCV000747372.1	SCV000747372		ABCC8	-	"MODY Extended, MonogenicDM_all, Neonatal Diabetes"	1/1/17	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV00074737224073	single nucleotide variant	NM_002052.4(GATA4):c.1273G>A (p.Asp425Asn)	2626	GATA4	HGNC:4173	Conflicting interpretations of pathogenicity	1	8-Dec-17	56208331	-	RCV000009600;RCV000549514;RCV000190715;RCV000626818;RCV000626818;RCV000009601;RCV000626818;RCV000431077	"MedGen:C1842778,OMIM:607941;MedGen:C3280781,OMIM:614430;MeSH:D030342,MedGen:C0950123;Human Phenotype Ontology:HP:0010882,MedGen:CN116616;Human Phenotype Ontology:HP:0001642,MedGen:C1956257,OMIM:265500;Human Phenotype Ontology:HP:0001636,MedGen:C0039685,OMIM:187500,Orphanet:ORPHA3303,SNOMED CT:86299006;Human Phenotype Ontology:HP:0005180,MedGen:C0040961;MedGen:CN517202"	Atrial septal defect 2;Atrioventricular septal defect 4;Inborn genetic diseases;Pulmonary valve atresia;Pulmonic stenosis;Tetralogy of Fallot;Tricuspid regurgitation;not provided	germline;unknown	germline	GRCh37	NC_000008.10	8	11615928	11615928	G	A	8p23.1	"criteria provided, conflicting interpretations"	5	NA	N	"OMIM Allelic Variant:600576.0005,UniProtKB (protein):P43694#VAR_067621"	3	9034	8	11615928	G	A	24073	8:11615928:G:A	Uncertain significance	1/1/17	-	Human Phenotype Ontology:HP:0001642;Human Phenotype Ontology:HP:0005180;Human Phenotype Ontology:HP:0010882	C0040961:Tricuspid regurgitation;C1956257:Pulmonic stenosis;CN116616:Pulmonary valve atresia	NA	FALSE	Not trait of interest	"criteria provided, single submitter"	clinical testing	unknown:na	"Centre for Mendelian Genomics,University Medical Centre Ljubljana"	SCV000747521.1	SCV000747521		GATA4	-	"MonogenicDM_all, Neonatal Diabetes"	12/8/17	46963	0	221	"[0.9976470838745395,0.002352916125460469]"	217	SCV00074752129566	single nucleotide variant	NM_170707.3(LMNA):c.1930C>T (p.Arg644Cys)	4000	LMNA	HGNC:6636	Conflicting interpretations of pathogenicity	1	21-Nov-18	142000963	-	RCV000245284;RCV000144868;RCV000471403;RCV000755679;RCV000148602;RCV000015626;RCV000057374;RCV000041340	"MedGen:CN230736;MedGen:C0007959,Orphanet:ORPHA166,SNOMED CT:50548001;MedGen:C0270914,Orphanet:ORPHA64746;MedGen:C1449563,OMIM:115200,Orphanet:ORPHA300751;EFO:EFO_0000407,Human Phenotype Ontology:HP:0001644,MedGen:C0007193,Orphanet:ORPHA217604,SNOMED CT:195021004;na;MedGen:CN517202;MedGen:CN169374"	"Cardiovascular phenotype;Charcot-Marie-Tooth disease;Charcot-Marie-Tooth disease, type 2;Dilated cardiomyopathy 1A;Primary dilated cardiomyopathy;Variant of unknown significance;not provided;not specified"	germline;tested-inconclusive;unknown	germline	GRCh37	NC_000001.10	1	156108510	156108510	C	T	1q22	"criteria provided, conflicting interpretations"	13	"ACMG2013,ACMG2016"	N	"OMIM Allelic Variant:150330.0051,UniProtKB (protein):P02545#VAR_039792"	3	14527	1	156108510	C	T	29566	1:156108510:C:T	Uncertain significance	3/31/17	-	not specified	CN169374:not specified	No Information	FALSE	No Information	"criteria provided, single submitter"	clinical testing	germline:na	"Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease,Montreal Heart Institute"	SCV000747924.1	SCV000747924		LMNA	-	"Lipodystrophy, MonogenicDM_all"	11/21/18	46954	9	67	"[0.9992865357584019,7.134642415981599E-4]"	65	SCV00074792457199	single nucleotide variant	NM_005572.3(LMNA):c.1201C>T (p.Arg401Cys)	4000	LMNA	HGNC:6636	Conflicting interpretations of pathogenicity	1	17-May-18	61094188	-	RCV000157295;RCV000528639;RCV000172002;RCV000627127;RCV000057258;RCV000041313	"MedGen:C4053736,OMIM:604772;MedGen:C0270914,Orphanet:ORPHA64746;MedGen:C0410189,Orphanet:ORPHA261,SNOMED CT:111508004;MedGen:C0340427,Orphanet:ORPHA217607;MedGen:CN517202;MedGen:CN169374"	"Catecholaminergic polymorphic ventricular tachycardia type 1;Charcot-Marie-Tooth disease, type 2;Emery-Dreifuss muscular dystrophy;Familial dilated cardiomyopathy;not provided;not specified"	germline;unknown	germline	GRCh37	NC_000001.10	1	156106048	156106048	C	T	1q22	"criteria provided, conflicting interpretations"	8	"ACMG2013,ACMG2016"	N	UniProtKB (protein):P02545#VAR_072818	2	48035	1	156106048	C	T	57199	1:156106048:C:T	Likely pathogenic	2/17/17	-	OMIM:PS115200	C0340427:Familial dilated cardiomyopathy	NA	FALSE	Incorrect phenotype	"criteria provided, single submitter"	clinical testing	germline:na	"Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease,Montreal Heart Institute"	SCV000747935.1	SCV000747935		LMNA	-	"Lipodystrophy, MonogenicDM_all"	5/17/18	46962	1	6	"[0.9999361185639453,6.388143605468251E-5]"	6	SCV000747935245672	single nucleotide variant	NM_000527.4(LDLR):c.631C>T (p.His211Tyr)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	25-Apr-18	771917370	-	RCV000237464	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline;not applicable	germline	GRCh37	NC_000019.9	19	11216213	11216213	C	T	19p13.2	"criteria provided, multiple submitters, no conflicts"	4	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000711	2	251335	19	11216213	C	T	245672	19:11216213:C:T	Pathogenic	4/25/18	"This sequence change replaces histidine with tyrosine at codon 211 of the LDLR protein (p.His211Tyr). The histidine residue is highly conserved and there is a moderate physicochemical difference between histidine and tyrosine. This variant is present in population databases (rs771917370, ExAC 0.009%). This variant has been reported to segregate with familial hypercholesterolemia in a single family (PMID: 1057090) and has also been reported in an independent individual affected with this condition (PMID: 23064986). This variant is also known as p.His190Tyr in the literature. ClinVar contains an entry for this variant (Variation ID: 251335). Experimental studies have shown that this missense change impairs LDLR protein function in vitro (PMID: 21511053). Two different missense substitutions at this codon (p.His221Leu and p.His221Asp) have been reported in individuals affected with familial hypercholesterolemia (PMID: 17347910, 27784735). This suggests that the histidine residue is critical for LDLR protein function. For these reasons, this variant has been classified as Pathogenic."	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Invitae	SCV000752404.2	SCV000752404		LDLR	-	High LDL	4/25/18	46963	0	2	"[0.9999787066413985,2.1293358601452207E-5]"	2	SCV000752404181265	single nucleotide variant	NM_000527.4(LDLR):c.1720C>T (p.Arg574Cys)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	11-Dec-17	185098634	-	RCV000238063;RCV000161998	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202"	Familial hypercholesterolemia;not provided	germline;not applicable	germline	GRCh37	NC_000019.9	19	11227549	11227549	C	T	19p13.2	"criteria provided, conflicting interpretations"	6	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000232,UniProtKB (protein):P01130#VAR_072851"	2	183123	19	11227549	C	T	181265	19:11227549:C:T	Likely pathogenic	12/11/17	"This sequence change replaces arginine with cysteine at codon 574 of the LDLR protein (p.Arg574Cys). The arginine residue is highly conserved and there is a large physicochemical difference between arginine and cysteine. This variant is present in population databases (rs185098634, ExAC 0.02%). This variant has been reported in several individuals affected with hypercholesterolemia (PMID: 11462246, 19446849, 26892515), probable hypercholesterolemia (PMID: 23375686, 20145306), and myocardial infarction (PMID: 25487149). ClinVar contains an entry for this variant (Variation ID: 183123). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. Different missense substitutions at this codon (p.Arg574His, p.Arg574Ser, p.Arg574Leu) have been reported in several individuals affected with hypercholesterolemia (PMID: 28028493, 20018285, 22698793). This suggests that the arginine residue is critical for LDLR protein function. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic."	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Invitae	SCV000752408.1	SCV000752408		LDLR	-	High LDL	12/11/17	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV000752408171218	single nucleotide variant	NM_000527.4(LDLR):c.1783C>T (p.Arg595Trp)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	24-Oct-17	373371572	-	RCV000237585;RCV000588105;RCV000148597;RCV000518174	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:C0020443;MedGen:CN517202"	Familial hypercholesterolemia;Familial hypercholesterolemias;Hypercholesterolaemia;not provided	germline	germline	GRCh37	NC_000019.9	19	11227612	11227612	C	T	19p13.2	"criteria provided, conflicting interpretations"	11	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000239,UniProtKB (protein):P01130#VAR_072856"	2	161290	19	11227612	C	T	171218	19:11227612:C:T	Likely pathogenic	10/24/17	"This sequence change replaces arginine with tryptophan at codon 595 of the LDLR protein (p.Arg595Trp). The arginine residue is highly conserved and there is a moderate physicochemical difference between arginine and tryptophan. This variant is present in population databases (rs373371572, ExAC 0.001%). This variant has been reported in several individuals affected with hypercholesterolemia (PMID: 11737238, 25461735, 27784735, 16250003, 20538126). ClinVar contains an entry for this variant (Variation ID: 161290). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic."	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Invitae	SCV000752411.1	SCV000752411		LDLR	-	High LDL	10/24/17	46963	0	2	"[0.9999787066413985,2.1293358601452207E-5]"	2	SCV000752411181268	single nucleotide variant	NM_000527.4(LDLR):c.1784G>A (p.Arg595Gln)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	11-Apr-18	201102492	-	RCV000211609;RCV000162002	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202"	Familial hypercholesterolemia;not provided	germline;not applicable;unknown	germline	GRCh37	NC_000019.9	19	11227613	11227613	G	A	19p13.2	"criteria provided, conflicting interpretations"	8	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000563	2	183126	19	11227613	G	A	181268	19:11227613:G:A	Pathogenic	4/11/18	"This sequence change replaces arginine with glutamine at codon 595 of the LDLR protein (p.Arg595Gln). The arginine residue is highly conserved and there is a small physicochemical difference between arginine and glutamine. This variant is present in population databases (rs201102492, ExAC 0.03%). This variant has been reported in several individuals affected with familial hypercholesterolemia (FH) and myocardial infarction and has been described as a common cause of FH in Finland (PMID: 15359125, 15256764, 16250003, 18718593, 25437892,Â¬â€ 25487149, 27497240). This variant is also known as p.Arg574Gln and FH-Pogosta in the literature. ClinVar contains an entry for this variant (Variation ID: 183126). Experimental studies have shown that this missense change does not affect LDL uptake in vitro (PMID: 25647241). A different missense substitution at this codon (p.Arg595Trp) has been determined to be pathogenic (PMID: 11737238, 25461735, 27784735, 16250003, 20538126). This suggests that the arginine residue is critical for LDLR protein function and that other missense substitutions at this position may also be pathogenic. For these reasons, this variant has been classified as Pathogenic."	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Invitae	SCV000752415.2	SCV000752415		LDLR	-	High LDL	4/11/18	46963	0	5	"[0.9999467666034964,5.323339650363052E-5]"	5	SCV000752415198015	single nucleotide variant	NM_000527.4(LDLR):c.1747C>T (p.His583Tyr)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	23-Jan-18	730882109	-	RCV000211604;RCV000182342	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202"	Familial hypercholesterolemia;not provided	germline;not applicable;unknown	germline	GRCh37	NC_000019.9	19	11227576	11227576	C	T	19p13.2	"criteria provided, conflicting interpretations"	10	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000234	2	200921	19	11227576	C	T	198015	19:11227576:C:T	Pathogenic	11/10/17	"This sequence change replaces histidine with tyrosine at codon 583 of the LDLR protein (p.His583Tyr). The histidine residue is highly conserved and there is a moderate physicochemical difference between histidine and tyrosine. This variant is present in population databases (rs730882109, ExAC 0.09%), and has an allele count higher than expected for a pathogenic variant (PMID: 28166811). This variant is a known familial hypercholesterolemia founder variant in China and it has been reported in multiple unrelated affected individuals and segregating with disease in a family in China and Southeast Asia (PMID: 7903864, 23155708, 27206935, 21376320, 22353362, 28028493, 16205024). This variant is also known as p.His562Tyr in the literature. ClinVar contains an entry for this variant (Variation ID: 200921). Experimental studies have shown that this missense change impairs lipoprotein uptake by reducing the number of surface receptors (PMID: 7903864, 21511053). Different missense substitution at this codon (p.His583Gln, p.His583Asp, His583Arg) have been reported in several individuals affected with hypercholesterolemia (PMID: 23375686, 19318025, 22698793). This suggests that the histidine residue is critical for LDLR protein function and that other missense substitutions at this position may be deleterious. For these reasons, this variant has been classified as Pathogenic."	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Invitae	SCV000752419.1	SCV000752419		LDLR	-	High LDL	1/23/18	46963	0	14	"[0.9998509464897898,1.4905351021016544E-4]"	14	SCV000752419226972	single nucleotide variant	NM_000527.4(LDLR):c.190+4A>T	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	23-Oct-17	769446356	-	RCV000211667;RCV000210581;RCV000523458	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MeSH:D030342,MedGen:C0950123;MedGen:CN517202"	Familial hypercholesterolemia;Inborn genetic diseases;not provided	germline;not applicable	germline	GRCh37	NC_000019.9	19	11211025	11211025	A	T	19p13.2	"criteria provided, conflicting interpretations"	8	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000028	2	225097	19	11211025	A	T	226972	19:11211025:A:T	Pathogenic	10/23/17	"This sequence change falls in intron 2 of the LDLR gene. It does not directly change the encoded amino acid sequence of the LDLR protein, but it affects a nucleotide within the consensus splice site of the intron. This variant is present in population databases (rs769446356, ExAC 0.02%). This variant has been reported in several individuals affected with familial hypercholesterolemia (PMID: 16250003, 27765764, 15199436, 16205024, 21418584). ClinVar contains an entry for this variant (Variation ID: 225097). Nucleotide substitutions within the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Experimental studies have shown that this intronic change results in a reduction in transcripts with this variant compared to wild type and it reduces the amount of surface LDLR and LDL internalization (PMID: 19208450). For these reasons, this variant has been classified as Pathogenic."	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Invitae	SCV000752427.1	SCV000752427		LDLR	-	High LDL	10/23/17	46963	0	2	"[0.9999787066413985,2.1293358601452207E-5]"	2	SCV000752427245980	single nucleotide variant	NM_000527.4(LDLR):c.1090T>C (p.Cys364Arg)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	1-Jun-18	879254787	-	RCV000238003	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline	germline	GRCh37	NC_000019.9	19	11222219	11222219	T	C	19p13.2	"criteria provided, conflicting interpretations"	5	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_001355,UniProtKB (protein):P01130#VAR_005373"	2	251657	19	11222219	T	C	245980	19:11222219:T:C	Pathogenic	6/1/18	"This sequence change replaces cysteine with arginine at codon 364 of the LDLR protein (p.Cys364Arg). The cysteine residue is highly conserved and there is a large physicochemical difference between cysteine and arginine. This variant is not present in population databases (ExAC no frequency). This variant has been reported in multiple individuals affected with hypercholesterolemia (PMID: 1301956, 23375686, 26723464, 21722902, 25461735, 16314194, 10978268, 15556094). This variant is also known in the literature as Cys343Arg and FH Mexico-3. ClinVar contains an entry for this variant (Variation ID: 251657). This variant affects a cysteine residue located within an epidermal-growth-factor (EGF)â€šÃ„Ã¬like domain of the LDLR protein. Cysteine residues in these domains have been shown to be involved in the formation of disulfide bridges, which are critical for protein structure and stability (PMID: 3495735, 4750422). In addition, missense substitutions within the LDLR EGF-like domains affecting cysteine residues are overrepresented among patients with hypercholesterolemia (PMID: 18325082). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. Several different missense substitution at this codon (p.Cys364Phe, p.Cys364Ser, p.Cys364Tyr) have been reported in individuals affected with hypercholesterolemia (PMID: 11196104, 21310417, 28379029). This suggests that the cysteine residue is critical for LDLR protein function. For these reasons, this variant has been classified as Pathogenic."	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Invitae	SCV000752428.2	SCV000752428		LDLR	-	High LDL	6/1/18	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV00075242878990	single nucleotide variant	NM_000527.4(LDLR):c.148G>T (p.Ala50Ser)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	30-Nov-17	137853960	-	RCV000210234;RCV000148578;RCV000058916;RCV000455660	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202;MedGen:CN169374"	Familial hypercholesterolemia;Hypercholesterolaemia;not provided;not specified	germline;unknown	germline	GRCh37	NC_000019.9	19	11210979	11210979	G	T	19p13.2	"criteria provided, conflicting interpretations"	13	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000021,UniProtKB (protein):P01130#VAR_007979"	2	68099	19	11210979	G	T	78990	19:11210979:G:T	Likely benign	11/30/17	-	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Invitae	SCV000752432.1	SCV000752432		LDLR	-	High LDL	11/30/17	46963	0	43	"[0.9995421927900687,4.5780720993122243E-4]"	43	SCV000752432171223	single nucleotide variant	NM_000527.4(LDLR):c.2441G>A (p.Arg814Gln)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	17-Nov-17	5928	-	RCV000237126;RCV000148584;RCV000162024	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202"	Familial hypercholesterolemia;Hypercholesterolaemia;not provided	germline;not applicable	germline	GRCh37	NC_000019.9	19	11240240	11240240	G	A	19p13.2	"criteria provided, conflicting interpretations"	9	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000376,UniProtKB (protein):P01130#VAR_011864"	2	161278	19	11240240	G	A	171223	19:11240240:G:A	Likely benign	11/17/17	-	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Invitae	SCV000752439.1	SCV000752439		LDLR	-	High LDL	11/17/17	46963	0	50	"[0.9994676660349637,5.323339650363052E-4]"	50	SCV000752439171202	single nucleotide variant	NM_000527.4(LDLR):c.806G>A (p.Gly269Asp)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	17-Oct-17	143992984	-	RCV000210247;RCV000148586;RCV000161966	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202"	Familial hypercholesterolemia;Hypercholesterolaemia;not provided	germline;not applicable	germline	GRCh37	NC_000019.9	19	11217352	11217352	G	A	19p13.2	"criteria provided, conflicting interpretations"	13	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000504	2	161279	19	11217352	G	A	171202	19:11217352:G:A	Likely benign	10/17/17	-	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Invitae	SCV000752451.1	SCV000752451		LDLR	-	High LDL	10/17/17	46963	0	33	"[0.999648659583076,3.513404169239614E-4]"	33	SCV000752451427656	single nucleotide variant	NM_170707.3(LMNA):c.1786G>A (p.Asp596Asn)	4000	LMNA	HGNC:6636	Conflicting interpretations of pathogenicity	1	6-Sep-17	769561386	-	RCV000653834;RCV000503392	"MedGen:C0270914,Orphanet:ORPHA64746;Human Phenotype Ontology:HP:0003560,MeSH:D009136,MedGen:C0026850,Orphanet:ORPHA98473"	"Charcot-Marie-Tooth disease, type 2;Muscular dystrophy"	germline	germline	GRCh37	NC_000001.10	1	156108366	156108366	G	A	1q22	"criteria provided, conflicting interpretations"	2	"ACMG2013,ACMG2016"	N	-	2	435774	1	156108366	G	A	427656	1:156108366:G:A	Uncertain significance	9/6/17	"This sequence change replaces aspartic acid with asparagine at codon 596 of the LMNA protein (p.Asp596Asn). The aspartic acid residue is moderately conserved and there is a small physicochemical difference between aspartic acid and asparagine. This variant is present in population databases (rs769561386, ExAC 0.01%). This variant has been reported in an individual affected with limb-girdle muscular dystrophy and dilated cardiomyopathy (PMID: 18035816). This variant has been reported in an individual with Emery-Dreifuss muscular dystrophy (EDMD) in the Leiden Open-source Variation Database (PMID: 21520333). Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: ""Deleterious""; PolyPhen-2: ""Benign""; Align-GVGD: ""Class C0""). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance."	MedGen:CN043576	"C0270914:Charcot-Marie-Tooth disease, type 2"	NA	FALSE	Incorrect phenotype	"criteria provided, single submitter"	clinical testing	germline:na	Invitae	SCV000775724.1	SCV000775724		LMNA	-	"Lipodystrophy, MonogenicDM_all"	9/6/17	46928	35	1	"[0.9999893453801568,1.0654619843163995E-5]"	1	SCV00077572429556	single nucleotide variant	NM_170707.3(LMNA):c.1718C>T (p.Ser573Leu)	4000	LMNA	HGNC:6636	Conflicting interpretations of pathogenicity	1	21-Dec-17	60890628	-	RCV000617932;RCV000653881;RCV000015612;RCV000015614;RCV000015613;RCV000057351;RCV000041329	"MedGen:CN230736;MedGen:C0270914,Orphanet:ORPHA64746;MedGen:C1449563,OMIM:115200,Orphanet:ORPHA300751;MedGen:C1720860,OMIM:151660,Orphanet:ORPHA2348;MedGen:CN043412;MedGen:CN517202;MedGen:CN169374"	"Cardiovascular phenotype;Charcot-Marie-Tooth disease, type 2;Dilated cardiomyopathy 1A;Familial partial lipodystrophy 2;Mandibuloacral dysplasia with type A lipodystrophy, atypical;not provided;not specified"	germline	germline	GRCh37	NC_000001.10	1	156108298	156108298	C	T	1q22	"criteria provided, conflicting interpretations"	7	"ACMG2013,ACMG2016"	N	"OMIM Allelic Variant:150330.0041,UniProtKB (protein):P02545#VAR_039789"	3	14517	1	156108298	C	T	29556	1:156108298:C:T	Uncertain significance	12/21/17	"This sequence change replaces serine with leucine at codon 573 of the LMNA protein (p.Ser573Leu). The serine residue is highly conserved and there is a large physicochemical difference between serine and leucine. This variant is present in population databases (rs60890628, ExAC 0.02%), and has an allele count higher than expected for a pathogenic variant (PMID: 28166811). This variant has been reported as homozygous in an individual with an arthropathy syndrome, tendinous calcinosis, and progeroid features (PMID: 16278265), heterozygous in an individual affected with cardiac arrythmias (PMID: 28341588), in individuals affected with dilated cardiomyopathy (PMID: 12628721, 18926329, 28416588), in an individual with lipodystrophy (PMID: 17250669), in an individual affected with limb-girdle muscular dystrophy (PMID: 17377071), and in an individual with a complex phenotype including dyslipedemia, hypertrophic cardiomyopathy and left ventricular outflow tract obstruction (PMID: 28874324). This variant is also known as p.Ser543Leu in the literature. ClinVar contains an entry for this variant (Variation ID: 14517). Experimental studies have shown that this missense change can restore LMNA protein function in LMNA-deficient fibroblasts (PMID: 16809772). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance."	MedGen:CN043576	"C0270914:Charcot-Marie-Tooth disease, type 2"	NA	FALSE	Incorrect phenotype	"criteria provided, single submitter"	clinical testing	germline:na	Invitae	SCV000775771.1	SCV000775771		LMNA	-	"Lipodystrophy, MonogenicDM_all"	12/21/17	46812	151	16	"[0.9998291036486371,1.708963513628984E-4]"	16	SCV00077577157227	single nucleotide variant	NM_170707.3(LMNA):c.350A>G (p.Lys117Arg)	4000	LMNA	HGNC:6636	Conflicting interpretations of pathogenicity	1	15-Jun-18	397517901	-	RCV000653882;RCV000324940;RCV000041346	"MedGen:C0270914,Orphanet:ORPHA64746;MedGen:CN517202;MedGen:CN169374"	"Charcot-Marie-Tooth disease, type 2;not provided;not specified"	germline	germline	GRCh37	NC_000001.10	1	156085059	156085059	A	G	1q22	"criteria provided, conflicting interpretations"	3	"ACMG2013,ACMG2016"	N	-	2	48063	1	156085059	A	G	57227	1:156085059:A:G	Uncertain significance	6/15/18	"This sequence change replaces lysine with arginine at codon 117 of the LMNA protein (p.Lys117Arg). The lysine residue is highly conserved and there is a small physicochemical difference between lysine and arginine. This variant is present in population databases (rs397517901, ExAC 0.03%). This variant has been reported in several individuals affected with dilated cardiomyopathy (PMID:Â¬â€ 23183350,Â¬â€ 23328570, 26752647, 27532257). This variant has been reported in individuals in the Universal Mutation Database (PMID: 10612827).Â¬â€ ClinVar contains an entry for this variant (Variation ID: 48063). Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: ""Deleterious""; PolyPhen-2: ""Benign""; Align-GVGD: ""Class C25""). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance."	MedGen:CN043576	"C0270914:Charcot-Marie-Tooth disease, type 2"	NA	FALSE	Incorrect phenotype	"criteria provided, single submitter"	clinical testing	germline:na	Invitae	SCV000775772.2	SCV000775772		LMNA	-	"Lipodystrophy, MonogenicDM_all"	6/15/18	46729	234	3	"[0.99996790001926,3.2099980740011554E-5]"	3	SCV00077577229537	single nucleotide variant	NM_170707.3(LMNA):c.892C>T (p.Arg298Cys)	4000	LMNA	HGNC:6636	Pathogenic	1	8-Jun-18	59885338	-	RCV000192238;RCV000015590;RCV000653885;RCV000057479	"MedGen:C0007959,Orphanet:ORPHA166,SNOMED CT:50548001;MedGen:C1854154,OMIM:605588,Orphanet:ORPHA98856;MedGen:C0270914,Orphanet:ORPHA64746;MedGen:CN517202"	"Charcot-Marie-Tooth disease;Charcot-Marie-Tooth disease type 2B1;Charcot-Marie-Tooth disease, type 2;not provided"	germline	germline	GRCh37	NC_000001.10	1	156105059	156105059	C	T	1q22	"criteria provided, multiple submitters, no conflicts"	5	"ACMG2013,ACMG2016"	N	"OMIM Allelic Variant:150330.0020,UniProtKB (protein):P02545#VAR_017661"	3	14498	1	156105059	C	T	29537	1:156105059:C:T	Pathogenic	6/8/18	"This sequence change replaces arginine with cysteine at codon 298 of the LMNA protein (p.Arg298Cys). The arginine residue is highly conserved and there is a large physicochemical difference between arginine and cysteine. This variant is present in population databases (rs59885338, ExAC 0.009%). This variant is a well known pathogenic founder mutation in North African countries and it has been reported to segregate with Charcot-Marie-Tooth type 2 in several affected familes (PMID: 18549403, 14607793, 17347251). ClinVar contains an entry for this variant (Variation ID: 14498). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. For these reasons, this variant has been classified as Pathogenic."	MedGen:CN043576	"C0270914:Charcot-Marie-Tooth disease, type 2"	NA	FALSE	Incorrect phenotype	"criteria provided, single submitter"	clinical testing	germline:na	Invitae	SCV000775775.2	SCV000775775		LMNA	-	"Lipodystrophy, MonogenicDM_all"	6/8/18	46953	10	2	"[0.9999787021063616,2.129789363831917E-5]"	2	SCV00077577577699	single nucleotide variant	NM_170707.3(LMNA):c.1303C>T (p.Arg435Cys)	4000	LMNA	HGNC:6636	Conflicting interpretations of pathogenicity	1	12-Nov-17	150840924	-	RCV000653929;RCV000150953;RCV000148606;RCV000057265	"MedGen:C0270914,Orphanet:ORPHA64746;MedGen:C0033300,OMIM:176670,Orphanet:ORPHA740,SNOMED CT:238870004;EFO:EFO_0000407,Human Phenotype Ontology:HP:0001644,MedGen:C0007193,Orphanet:ORPHA217604,SNOMED CT:195021004;MedGen:CN517202"	"Charcot-Marie-Tooth disease, type 2;Hutchinson-Gilford syndrome;Primary dilated cardiomyopathy;not provided"	germline	germline	GRCh37	NC_000001.10	1	156106150	156106150	C	T	1q22	"criteria provided, conflicting interpretations"	5	"ACMG2013,ACMG2016"	N	UniProtKB (protein):P02545#VAR_039779	3	66802	1	156106150	C	T	77699	1:156106150:C:T	Pathogenic	11/12/17	"This sequence change replaces arginine with cysteine at codon 435 of the LMNA protein (p.Arg435Cys). The arginine residue is highly conserved and there is a large physicochemical difference between arginine and cysteine. This variant is present in population databases (rs150840924, ExAC 0.002%). This variant has been reported as homozygous in individuals affected with autosomal recessive progeroid restrictive dermopathy and to segregate with disease in these families (PMID: 19842191, 20662858, 23804595). This variant has been reported as heterozygous in one individual affected with dilated cardiomyopathy, and as heterozygous in several individuals without cardiac disease (PMID: 14684700, 19842191, 20662858, 23804595). ClinVar contains an entry for this variant (Variation ID: 66802). Experimental studies have shown that this missense change results in progressive loss or absence of lamin A levels in-vivo as well as impaired protein interactions (PMID: 23804595, 24623722). For these reasons, this variant has been classified as Pathogenic."	MedGen:CN043576	"C0270914:Charcot-Marie-Tooth disease, type 2"	NA	FALSE	Incorrect phenotype	"criteria provided, single submitter"	clinical testing	germline:na	Invitae	SCV000775819.1	SCV000775819		LMNA	-	"Lipodystrophy, MonogenicDM_all"	11/12/17	46956	7	1	"[0.9999893517335378,1.064826646221995E-5]"	1	SCV00077581929558	single nucleotide variant	NM_170707.3(LMNA):c.1195C>T (p.Arg399Cys)	4000	LMNA	HGNC:6636	Uncertain significance	1	15-Nov-17	58672172	-	RCV000653937;RCV000015616;RCV000057255;RCV000212505	"MedGen:C0270914,Orphanet:ORPHA64746;MedGen:C1720860,OMIM:151660,Orphanet:ORPHA2348;MedGen:CN517202;MedGen:CN169374"	"Charcot-Marie-Tooth disease, type 2;Familial partial lipodystrophy 2;not provided;not specified"	germline	germline	GRCh37	NC_000001.10	1	156106042	156106042	C	T	1q22	"criteria provided, multiple submitters, no conflicts"	4	"ACMG2013,ACMG2016"	N	"OMIM Allelic Variant:150330.0043,UniProtKB (protein):P02545#VAR_039778"	3	14519	1	156106042	C	T	29558	1:156106042:C:T	Uncertain significance	11/15/17	"This sequence change replaces arginine with cysteine at codon 399 of the LMNA protein (p.Arg399Cys). The arginine residue is highly conserved and there is a large physicochemical difference between arginine and cysteine. This variant is present in population databases (rs58672172, ExAC 0.002%). This variant has been reported in an individual affected with lipodystrophy (PMID: 17250699) This variant has also been reported in an individual affected with dilated cardiomyopathy, however, it did not segregate with disease in this family (PMID: 20160190). ClinVar contains an entry for this variant (Variation ID: 14519). Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: ""Deleterious""; PolyPhen-2: ""Benign""; Align-GVGD: ""Class C15""). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance."	MedGen:CN043576	"C0270914:Charcot-Marie-Tooth disease, type 2"	NA	FALSE	Incorrect phenotype	"criteria provided, single submitter"	clinical testing	germline:na	Invitae	SCV000775827.1	SCV000775827		LMNA	-	"Lipodystrophy, MonogenicDM_all"	11/15/17	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV00077582780399	single nucleotide variant	NM_000384.2(APOB):c.9175C>T (p.Arg3059Cys)	338	APOB	HGNC:603	Conflicting interpretations of pathogenicity	1	16-Oct-17	146377316	-	RCV000497061;RCV000655087;RCV000655087	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C1704417,OMIM:144010;MedGen:C4551990,OMIM:615558"	"Familial hypercholesterolemia;Hypercholesterolemia, autosomal dominant, type B;Hypobetalipoproteinemia, familial, 1"	germline	germline	GRCh37	NC_000002.11	2	21230565	21230565	G	A	2p24	"criteria provided, conflicting interpretations"	4	"ACMG2013,ACMG2016"	N	-	2	69508	2	21230565	G	A	80399	2:21230565:G:A	Uncertain significance	8/30/17	"This sequence change replaces arginine with cysteine at codon 3059 of the APOB protein (p.Arg3059Cys). The arginine residue is weakly conserved and there is a large physicochemical difference between arginine and cysteine. This variant is present in population databases (rs146377316, ExAC 0.01%). This variant has been reported to segregate with hypercholesterolemia in a single family (PMID: 22408029). Experimental studies have shown that this missense change causes a large reduction in low density lipoprotein (LDL) uptake (PMID: 22408029). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance."	MedGen:C1704417;MedGen:CN182502	"C1704417:Hypercholesterolemia, autosomal dominant, type B;C4551990:Hypobetalipoproteinemia, familial, 1"	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Invitae	SCV000777012.1	SCV000777012		APOB	-	Low LDL	10/16/17	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV000777012245935	single nucleotide variant	NM_000527.4(LDLR):c.1045C>T (p.Gln349Ter)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	2-Jan-18	748300548	-	RCV000237544	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline	germline	GRCh37	NC_000019.9	19	11221432	11221432	C	T	19p13.2	"criteria provided, conflicting interpretations"	4	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000964	2	251611	19	11221432	C	T	245935	19:11221432:C:T	Pathogenic	1/2/18	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	"Robarts Research Institute,Western University"	SCV000782905.1	SCV000782905		LDLR	-	High LDL	1/2/18	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV000782905245949	single nucleotide variant	NM_000527.4(LDLR):c.1060+10G>A	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	2-Jan-18	12710260	-	RCV000238168	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline	germline	GRCh37	NC_000019.9	19	11221457	11221457	G	A	19p13.2	"criteria provided, conflicting interpretations"	5	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000880	2	251625	19	11221457	G	A	245949	19:11221457:G:A	Uncertain significance	1/2/18	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	"Robarts Research Institute,Western University"	SCV000782906.1	SCV000782906		LDLR	-	High LDL	1/2/18	46962	1	1	"[0.9999893530939908,1.0646906009113752E-5]"	1	SCV000782906171216	single nucleotide variant	NM_000527.4(LDLR):c.1474G>A (p.Asp492Asn)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	2-Jan-18	373646964	-	RCV000237459;RCV000590270;RCV000148592;RCV000161989	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:C0020443;MedGen:CN517202"	Familial hypercholesterolemia;Familial hypercholesterolemias;Hypercholesterolaemia;not provided	germline;inherited;not applicable	germline	GRCh37	NC_000019.9	19	11224326	11224326	G	A	19p13.2	"criteria provided, conflicting interpretations"	13	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000205,UniProtKB (protein):P01130#VAR_072850"	2	161285	19	11224326	G	A	171216	19:11224326:G:A	Uncertain significance	1/2/18	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	"Robarts Research Institute,Western University"	SCV000782916.1	SCV000782916		LDLR	-	High LDL	1/2/18	46963	0	5	"[0.9999467666034964,5.323339650363052E-5]"	3	SCV000782916431955	single nucleotide variant	NM_000527.4(LDLR):c.1723C>T (p.Leu575Phe)	3949	LDLR	HGNC:6547	Likely pathogenic	1	2-Jan-18	1205480064	-	RCV000505222	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline;not applicable	germline	GRCh37	NC_000019.9	19	11227552	11227552	C	T	19p13.2	"criteria provided, multiple submitters, no conflicts"	2	"ACMG2013,ACMG2016"	N	-	2	438324	19	11227552	C	T	431955	19:11227552:C:T	Likely pathogenic	1/2/18	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	"Robarts Research Institute,Western University"	SCV000782924.1	SCV000782924		LDLR	-	High LDL	1/2/18	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV00078292418765	single nucleotide variant	NM_000527.4(LDLR):c.523G>A (p.Asp175Asn)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	2-Jan-18	121908033	-	RCV000003924	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline	germline	GRCh37	NC_000019.9	19	11216105	11216105	G	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	7	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_001755,OMIM Allelic Variant:606945.0044,UniProtKB (protein):P01130#VAR_005326"	3	3726	19	11216105	G	A	18765	19:11216105:G:A	Likely pathogenic	1/2/18	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	"Robarts Research Institute,Western University"	SCV000782949.1	SCV000782949		LDLR	-	High LDL	1/2/18	46963	0	2	"[0.9999787066413985,2.1293358601452207E-5]"	2	SCV000782949228142	deletion	NM_000527.4(LDLR):c.654_656delTGG (p.Gly219del)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	25-Jun-18	121908027	-	RCV000211647;RCV000589051;RCV000489033	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:CN517202"	Familial hypercholesterolemia;Familial hypercholesterolemias;not provided	germline;inherited;not applicable	germline	GRCh37	NC_000019.9	19	11216236	11216238	TGG	-	19p13.2	"criteria provided, multiple submitters, no conflicts"	14	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000094,OMIM Allelic Variant:606945.0005"	3	226329	19	11216232	ATGG	A	228142	19:11216232:ATGG:A	Likely pathogenic	1/2/18	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	"Robarts Research Institute,Western University"	SCV000782951.1	SCV000782951		LDLR	-	High LDL	6/25/18	46962	1	1	"[0.9999893530939908,1.0646906009113752E-5]"	1	SCV000782951198013	single nucleotide variant	NM_000527.4(LDLR):c.718G>A (p.Glu240Lys)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	22-May-18	768563000	-	RCV000211564;RCV000586018;RCV000182341	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:CN517202"	Familial hypercholesterolemia;Familial hypercholesterolemias;not provided	germline	germline	GRCh37	NC_000019.9	19	11217264	11217264	G	A	19p13.2	"criteria provided, conflicting interpretations"	9	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_001828,UniProtKB (protein):P01130#VAR_005343"	2	200920	19	11217264	G	A	198013	19:11217264:G:A	Uncertain significance	1/2/18	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	"Robarts Research Institute,Western University"	SCV000782952.1	SCV000782952		LDLR	-	High LDL	5/22/18	46963	0	3	"[0.9999680599620978,3.194003790217831E-5]"	3	SCV000782952245782	single nucleotide variant	NM_000527.4(LDLR):c.769C>T (p.Arg257Trp)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	29-Jun-18	200990725	-	RCV000237953	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline	germline	GRCh37	NC_000019.9	19	11217315	11217315	C	T	19p13.2	"criteria provided, conflicting interpretations"	8	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000115,UniProtKB (protein):P01130#VAR_072836"	2	251446	19	11217315	C	T	245782	19:11217315:C:T	Uncertain significance	1/2/18	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	"Robarts Research Institute,Western University"	SCV000782953.1	SCV000782953		LDLR	-	High LDL	6/29/18	46963	0	14	"[0.9998509464897898,1.4905351021016544E-4]"	14	SCV000782953487472	single nucleotide variant	NM_000352.4(ABCC8):c.62T>A (p.Val21Asp)	6833	ABCC8	HGNC:59	Pathogenic/Likely pathogenic	1	11-Mar-17	200670692	-	RCV000588969;RCV000666072	"MedGen:C3888018,Orphanet:ORPHA276525;MedGen:C2931832,OMIM:256450,SNOMED CT:360339005"	Familial hyperinsulinism;Persistent hyperinsulinemic hypoglycemia of infancy	germline;unknown	germline	GRCh37	NC_000011.9	11	17498262	17498262	A	T	11p15.1	"criteria provided, multiple submitters, no conflicts"	2	NA	N	-	2	495835	11	17498262	A	T	487472	11:17498262:A:T	Likely pathogenic	3/11/17	-	OMIM:256450	C2931832:Persistent hyperinsulinemic hypoglycemia of infancy	NA	FALSE	Not trait of interest	"criteria provided, single submitter"	clinical testing	unknown:na	Counsyl	SCV000790310.1	SCV000790310		ABCC8	-	"MODY Extended, MonogenicDM_all, Neonatal Diabetes"	3/11/17	46850	113	1	"[0.9999893276414088,1.0672358591248667E-5]"	1	SCV000790310237314	single nucleotide variant	NM_000352.4(ABCC8):c.3640C>T (p.Arg1214Trp)	6833	ABCC8	HGNC:59	Pathogenic/Likely pathogenic	1	21-Mar-17	139964066	-	RCV000588494;RCV000666191;RCV000223959	"MedGen:C3888018,Orphanet:ORPHA276525;MedGen:C2931832,OMIM:256450,SNOMED CT:360339005;MedGen:CN517202"	Familial hyperinsulinism;Persistent hyperinsulinemic hypoglycemia of infancy;not provided	germline;unknown	germline	GRCh37	NC_000011.9	11	17424218	17424218	G	A	11p15.1	"criteria provided, multiple submitters, no conflicts"	3	NA	N	UniProtKB (protein):Q09428#VAR_031373	2	235633	11	17424218	G	A	237314	11:17424218:G:A	Likely pathogenic	3/21/17	-	OMIM:256450	C2931832:Persistent hyperinsulinemic hypoglycemia of infancy	NA	FALSE	Not trait of interest	"criteria provided, single submitter"	clinical testing	unknown:na	Counsyl	SCV000790442.1	SCV000790442		ABCC8	-	"MODY Extended, MonogenicDM_all, Neonatal Diabetes"	3/21/17	46963	0	5	"[0.9999467666034964,5.323339650363052E-5]"	5	SCV000790442546211	single nucleotide variant	NM_000352.4(ABCC8):c.3868-1G>A	6833	ABCC8	HGNC:59	Pathogenic	1	26-Jun-17	766431403	-	RCV000667948	"MedGen:C2931832,OMIM:256450,SNOMED CT:360339005"	Persistent hyperinsulinemic hypoglycemia of infancy	unknown	unknown	GRCh37	NC_000011.9	11	17418861	17418861	C	T	11p15.1	"criteria provided, single submitter"	1	NA	N	-	2	552652	11	17418861	C	T	546211	11:17418861:C:T	Pathogenic	6/26/17	-	OMIM:256450	C2931832:Persistent hyperinsulinemic hypoglycemia of infancy	NA	FALSE	Not trait of interest	"criteria provided, single submitter"	clinical testing	unknown:na	Counsyl	SCV000792477.1	SCV000792477		ABCC8	-	"MODY Extended, MonogenicDM_all, Neonatal Diabetes"	6/26/17	46963	0	2	"[0.9999787066413985,2.1293358601452207E-5]"	2	SCV000792477207832	single nucleotide variant	NM_000525.3(KCNJ11):c.881C>T (p.Thr294Met)	3767	KCNJ11	HGNC:6257	Pathogenic/Likely pathogenic	1	18-Aug-17	780957825	-	RCV000192330;RCV000668887;RCV000668887;RCV000668887	"MedGen:C2931833,OMIM:601820,SNOMED CT:42681006;MedGen:C2931833,OMIM:601820,SNOMED CT:42681006;MedGen:C1833104,OMIM:606176,Orphanet:ORPHA99885;MedGen:C1864623,OMIM:610582"	Islet cell hyperplasia;Islet cell hyperplasia;Permanent neonatal diabetes mellitus;Transient neonatal diabetes mellitus 3	germline;unknown	germline	GRCh37	NC_000011.9	11	17408758	17408758	G	A	11p15.1	"criteria provided, multiple submitters, no conflicts"	2	NA	N	-	2	211230	11	17408758	G	A	207832	11:17408758:G:A	Likely pathogenic	8/18/17	-	OMIM:601820;OMIM:606176;OMIM:610582	C1833104:Permanent neonatal diabetes mellitus;C1864623:Transient neonatal diabetes mellitus 3;C2931833:Islet cell hyperplasia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	unknown:na	Counsyl	SCV000793561.1	SCV000793561		KCNJ11	-	"MODY Extended, MonogenicDM_all, Neonatal Diabetes"	8/18/17	46963	0	7	"[0.9999254732448949,7.452675510508272E-5]"	7	SCV000793561441414	deletion	NM_000352.4(ABCC8):c.1634del (p.Phe545Serfs)	6833	ABCC8	HGNC:59	Pathogenic	1	10-May-18	1260178539	-	RCV000668965;RCV000518203	"MedGen:C2931832,OMIM:256450,SNOMED CT:360339005;MedGen:CN517202"	Persistent hyperinsulinemic hypoglycemia of infancy;not provided	germline;unknown	germline	GRCh37	NC_000011.9	11	17453788	17453788	A	-	11p15.1	"criteria provided, multiple submitters, no conflicts"	2	NA	N	-	2	446765	11	17453787	GA	G	441414	11:17453787:GA:G	Pathogenic	8/22/17	-	OMIM:256450	C2931832:Persistent hyperinsulinemic hypoglycemia of infancy	NA	FALSE	Not trait of interest	"criteria provided, single submitter"	clinical testing	unknown:na	Counsyl	SCV000793650.1	SCV000793650		ABCC8	-	"MODY Extended, MonogenicDM_all, Neonatal Diabetes"	5/10/18	43834	3129	1	"[0.9999885933293791,1.1406670620979149E-5]"	1	SCV000793650546279	single nucleotide variant	NM_000352.4(ABCC8):c.2041-21G>A	6833	ABCC8	HGNC:59	Likely pathogenic	1	20-Sep-17	746714109	-	RCV000669471	"MedGen:C2931832,OMIM:256450,SNOMED CT:360339005"	Persistent hyperinsulinemic hypoglycemia of infancy	unknown	unknown	GRCh37	NC_000011.9	11	17449510	17449510	C	T	11p15.1	"criteria provided, single submitter"	1	NA	N	-	2	553929	11	17449510	C	T	546279	11:17449510:C:T	Likely pathogenic	9/20/17	-	OMIM:256450	C2931832:Persistent hyperinsulinemic hypoglycemia of infancy	NA	FALSE	Not trait of interest	"criteria provided, single submitter"	clinical testing	unknown:na	Counsyl	SCV000794228.1	SCV000794228		ABCC8	-	"MODY Extended, MonogenicDM_all, Neonatal Diabetes"	9/20/17	46955	8	3	"[0.9999680545202854,3.194547971462038E-5]"	3	SCV000794228546170	duplication	NM_000525.3(KCNJ11):c.1064dup (p.Leu356Thrfs)	3767	KCNJ11	HGNC:6257	Likely pathogenic	1	27-Nov-17	1337406718	-	RCV000671033;RCV000671033;RCV000671033	"MedGen:C2931833,OMIM:601820,SNOMED CT:42681006;MedGen:C1833104,OMIM:606176,Orphanet:ORPHA99885;MedGen:C1864623,OMIM:610582"	Islet cell hyperplasia;Permanent neonatal diabetes mellitus;Transient neonatal diabetes mellitus 3	unknown	unknown	GRCh37	NC_000011.9	11	17408574	17408574	T	TA	11p15.1	"criteria provided, single submitter"	1	NA	N	-	2	555247	11	17408574	T	TA	546170	11:17408574:T:TA	Likely pathogenic	11/27/17	-	OMIM:601820;OMIM:606176;OMIM:610582	C1833104:Permanent neonatal diabetes mellitus;C1864623:Transient neonatal diabetes mellitus 3;C2931833:Islet cell hyperplasia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	unknown:na	Counsyl	SCV000795972.1	SCV000795972		KCNJ11	-	"MODY Extended, MonogenicDM_all, Neonatal Diabetes"	11/27/17	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV000795972545939	single nucleotide variant	NM_000352.4(ABCC8):c.579+2T>A	6833	ABCC8	HGNC:59	Likely pathogenic	1	30-Nov-17	1449198328	-	RCV000671080	"MedGen:C2931832,OMIM:256450,SNOMED CT:360339005"	Persistent hyperinsulinemic hypoglycemia of infancy	unknown	unknown	GRCh37	NC_000011.9	11	17484983	17484983	A	T	11p15.1	"criteria provided, single submitter"	1	NA	N	-	2	555287	11	17484983	A	T	545939	11:17484983:A:T	Likely pathogenic	11/30/17	-	OMIM:256450	C2931832:Persistent hyperinsulinemic hypoglycemia of infancy	NA	FALSE	Not trait of interest	"criteria provided, single submitter"	clinical testing	unknown:na	Counsyl	SCV000796022.1	SCV000796022		ABCC8	-	"MODY Extended, MonogenicDM_all, Neonatal Diabetes"	11/30/17	46927	36	1	"[0.9999893451531101,1.0654846889850193E-5]"	1	SCV00079602223722	single nucleotide variant	NM_000525.3(KCNJ11):c.902G>A (p.Arg301His)	3767	KCNJ11	HGNC:6257	Likely pathogenic	1	11-Dec-17	74339576	-	RCV000009220;RCV000671339;RCV000671339;RCV000671339	"MedGen:C2931833,OMIM:601820,SNOMED CT:42681006;MedGen:C2931833,OMIM:601820,SNOMED CT:42681006;MedGen:C1833104,OMIM:606176,Orphanet:ORPHA99885;MedGen:C1864623,OMIM:610582"	Islet cell hyperplasia;Islet cell hyperplasia;Permanent neonatal diabetes mellitus;Transient neonatal diabetes mellitus 3	germline;unknown	germline	GRCh37	NC_000011.9	11	17408737	17408737	C	T	11p15.1	"criteria provided, single submitter"	2	NA	N	OMIM Allelic Variant:600937.0019	3	8683	11	17408737	C	T	23722	11:17408737:C:T	Likely pathogenic	12/11/17	-	OMIM:601820;OMIM:606176;OMIM:610582	C1833104:Permanent neonatal diabetes mellitus;C1864623:Transient neonatal diabetes mellitus 3;C2931833:Islet cell hyperplasia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	unknown:na	Counsyl	SCV000796303.1	SCV000796303		KCNJ11	-	"MODY Extended, MonogenicDM_all, Neonatal Diabetes"	12/11/17	46963	0	2	"[0.9999787066413985,2.1293358601452207E-5]"	2	SCV000796303441404	single nucleotide variant	NM_000352.4(ABCC8):c.4178G>A (p.Arg1393His)	6833	ABCC8	HGNC:59	Conflicting interpretations of pathogenicity	1	14-Dec-17	769279368	-	RCV000671471;RCV000518373	"MedGen:C2931832,OMIM:256450,SNOMED CT:360339005;MedGen:CN517202"	Persistent hyperinsulinemic hypoglycemia of infancy;not provided	germline;unknown	germline	GRCh37	NC_000011.9	11	17417419	17417419	C	T	11p15.1	"criteria provided, conflicting interpretations"	2	NA	N	-	2	446776	11	17417419	C	T	441404	11:17417419:C:T	Uncertain significance	12/14/17	-	OMIM:256450	C2931832:Persistent hyperinsulinemic hypoglycemia of infancy	NA	FALSE	Not trait of interest	"criteria provided, single submitter"	clinical testing	unknown:na	Counsyl	SCV000796447.1	SCV000796447		ABCC8	-	"MODY Extended, MonogenicDM_all, Neonatal Diabetes"	12/14/17	46650	313	3	"[0.999967845659164,3.215434083601286E-5]"	3	SCV000796447545934	single nucleotide variant	NM_000352.4(ABCC8):c.1501G>A (p.Glu501Lys)	6833	ABCC8	HGNC:59	Likely pathogenic	1	10-May-18	372307320	-	RCV000674549	"MedGen:C2931832,OMIM:256450,SNOMED CT:360339005"	Persistent hyperinsulinemic hypoglycemia of infancy	unknown	unknown	GRCh37	NC_000011.9	11	17464396	17464396	C	T	11p15.1	"criteria provided, single submitter"	1	NA	N	-	2	558304	11	17464396	C	T	545934	11:17464396:C:T	Likely pathogenic	5/10/18	-	OMIM:256450	C2931832:Persistent hyperinsulinemic hypoglycemia of infancy	NA	FALSE	Not trait of interest	"criteria provided, single submitter"	clinical testing	unknown:na	Counsyl	SCV000799904.1	SCV000799904		ABCC8	-	"MODY Extended, MonogenicDM_all, Neonatal Diabetes"	5/10/18	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV000799904207840	single nucleotide variant	NM_000525.3(KCNJ11):c.79C>T (p.Arg27Cys)	3767	KCNJ11	HGNC:6257	Conflicting interpretations of pathogenicity	1	26-May-17	752507753	-	RCV000193401;RCV000675066;RCV000675066;RCV000675066	"MedGen:C2931833,OMIM:601820,SNOMED CT:42681006;MedGen:C2931833,OMIM:601820,SNOMED CT:42681006;MedGen:C1833104,OMIM:606176,Orphanet:ORPHA99885;MedGen:C1864623,OMIM:610582"	Islet cell hyperplasia;Islet cell hyperplasia;Permanent neonatal diabetes mellitus;Transient neonatal diabetes mellitus 3	germline;unknown	germline	GRCh37	NC_000011.9	11	17409560	17409560	G	A	11p15.1	"criteria provided, conflicting interpretations"	2	NA	N	-	2	211226	11	17409560	G	A	207840	11:17409560:G:A	Uncertain significance	5/26/17	-	OMIM:601820;OMIM:606176;OMIM:610582	C1833104:Permanent neonatal diabetes mellitus;C1864623:Transient neonatal diabetes mellitus 3;C2931833:Islet cell hyperplasia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	unknown:na	Counsyl	SCV000800538.1	SCV000800538		KCNJ11	-	"MODY Extended, MonogenicDM_all, Neonatal Diabetes"	5/26/17	46963	0	2	"[0.9999787066413985,2.1293358601452207E-5]"	2	SCV00080053844289	single nucleotide variant	NM_000352.4(ABCC8):c.886G>A (p.Gly296Arg)	6833	ABCC8	HGNC:59	Conflicting interpretations of pathogenicity	1	9-Nov-17	148529020	-	RCV000029271;RCV000675093	"MedGen:C0158981,Orphanet:ORPHA224,SNOMED CT:49817004;MedGen:C2931832,OMIM:256450,SNOMED CT:360339005"	Neonatal diabetes mellitus;Persistent hyperinsulinemic hypoglycemia of infancy	germline;unknown	germline	GRCh37	NC_000011.9	11	17482160	17482160	C	T	11p15.1	"criteria provided, conflicting interpretations"	2	NA	N	-	2	35624	11	17482160	C	T	44289	11:17482160:C:T	Uncertain significance	11/9/17	-	OMIM:256450	C2931832:Persistent hyperinsulinemic hypoglycemia of infancy	NA	FALSE	Not trait of interest	"criteria provided, single submitter"	clinical testing	unknown:na	Counsyl	SCV000800622.1	SCV000800622		ABCC8	-	"MODY Extended, MonogenicDM_all, Neonatal Diabetes"	11/9/17	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV00080062244279	single nucleotide variant	NM_000352.4(ABCC8):c.4135C>A (p.Arg1379Ser)	6833	ABCC8	HGNC:59	Conflicting interpretations of pathogenicity	1	9-May-18	137852673	-	RCV000029261;RCV000675131	"MedGen:C0158981,Orphanet:ORPHA224,SNOMED CT:49817004;MedGen:C2931832,OMIM:256450,SNOMED CT:360339005"	Neonatal diabetes mellitus;Persistent hyperinsulinemic hypoglycemia of infancy	germline;unknown	germline	GRCh37	NC_000011.9	11	17417462	17417462	G	T	11p15.1	"criteria provided, conflicting interpretations"	2	NA	N	-	2	35614	11	17417462	G	T	44279	11:17417462:G:T	Uncertain significance	5/9/18	-	OMIM:256450	C2931832:Persistent hyperinsulinemic hypoglycemia of infancy	NA	FALSE	Not trait of interest	"criteria provided, single submitter"	clinical testing	unknown:na	Counsyl	SCV000800706.1	SCV000800706		ABCC8	-	"MODY Extended, MonogenicDM_all, Neonatal Diabetes"	5/9/18	46517	446	3	"[0.9999677537244448,3.2246275555173374E-5]"	3	SCV00080070648709	single nucleotide variant	NM_000384.2(APOB):c.10579C>T (p.Arg3527Trp)	338	APOB	HGNC:603	Conflicting interpretations of pathogenicity	1	3-Jul-18	144467873	-	RCV000408839;RCV000231844;RCV000627798;RCV000627798;RCV000494148	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C1704417,OMIM:144010;MedGen:C1704417,OMIM:144010;MedGen:C4551990,OMIM:615558;MedGen:CN517202"	"Familial hypercholesterolemia;Hypercholesterolemia, autosomal dominant, type B;Hypercholesterolemia, autosomal dominant, type B;Hypobetalipoproteinemia, familial, 1;not provided"	germline	germline	GRCh37	NC_000002.11	2	21229161	21229161	G	A	2p24	"criteria provided, conflicting interpretations"	8	"ACMG2013,ACMG2016"	Y	-	3	40223	2	21229161	G	A	48709	2:21229161:G:A	Pathogenic	5/3/18	-	not provided	CN517202:not provided	No Information	FALSE	No Information	no assertion criteria provided	clinical testing	germline:na	"Molecular Genetics Laboratory,BC Children's and BC Women's Hospitals"	SCV000803730.1	SCV000803730		-	-	Low LDL	7/3/18	46963	0	14	"[0.9998509464897898,1.4905351021016544E-4]"	14	SCV00080373057209	single nucleotide variant	NM_170707.3(LMNA):c.1567G>A (p.Gly523Arg)	4000	LMNA	HGNC:6636	Conflicting interpretations of pathogenicity	1	16-Aug-18	201583907	-	RCV000245950;RCV000474372;RCV000678714;RCV000057323;RCV000041324	"MedGen:CN230736;MedGen:C0270914,Orphanet:ORPHA64746;Human Phenotype Ontology:HP:0030682,MedGen:C1960469,Orphanet:ORPHA54260,SNOMED CT:427608000;MedGen:CN517202;MedGen:CN169374"	"Cardiovascular phenotype;Charcot-Marie-Tooth disease, type 2;Left ventricular noncompaction;not provided;not specified"	germline	germline	GRCh37	NC_000001.10	1	156106982	156106982	G	A	1q22	"criteria provided, conflicting interpretations"	7	"ACMG2013,ACMG2016"	N	UniProtKB (protein):P02545#VAR_067258	2	48045	1	156106982	G	A	57209	1:156106982:G:A	Likely pathogenic	4/19/17	-	MedGen:C1960469	C1960469:Left ventricular noncompaction	NA	FALSE	Incorrect phenotype	"criteria provided, single submitter"	clinical testing	germline:na	"Clinical Molecular Genetics Laboratory,Johns Hopkins All Children's Hospital"	SCV000804881.1	SCV000804881		LMNA	-	"Lipodystrophy, MonogenicDM_all"	8/16/18	46878	85	4	"[0.9999573360638252,4.2663936174751484E-5]"	4	SCV000804881245448	single nucleotide variant	NM_000527.4(LDLR):c.268G>A (p.Asp90Asn)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	15-Jun-18	749038326	-	RCV000238573;RCV000494304	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202"	Familial hypercholesterolemia;not provided	germline;not applicable	germline	GRCh37	NC_000019.9	19	11213417	11213417	G	A	19p13.2	"criteria provided, conflicting interpretations"	8	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000041,UniProtKB (protein):P01130#VAR_005311"	2	251105	19	11213417	G	A	245448	19:11213417:G:A	Pathogenic	6/15/18	"This sequence change replaces aspartic acid with asparagine at codon 90 of the LDLR protein (p.Asp90Asn). The aspartic acid residue is highly conserved and there is a small physicochemical difference between aspartic acid and asparagine. This variant is present in population databases (rs749038326, ExAC 0.07%). This variant has been reported in many individuals affected with familial hypercholesterolemia (PMID: 23375686, 16343504, 27206935, 25962062, 21376320, 12436241, 27765764, 15823276, 9763532, 12837857, 9259195, 22390909). This variant is also known as p.Asp69Asn in the literature. ClinVar contains an entry for this variant (Variation ID: 251105). Experimental studies have shown that this missense change affects LDLR subcellular localization and reduces LDLR activity (PMID: 12837857). Several different missense substitutions at this codon (p.Asp90Gly, p.Asp90Ala, p.Asp90Tyr) have been reported in individuals with familial hypercholesterolemia (PMID: 1301956, 19026292, 8347689). This suggests that the aspartic acid residue is critical for LDLR protein function and that other missense substitutions at this position may also be pathogenic. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic."	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Invitae	SCV000816377.1	SCV000816377		LDLR	-	High LDL	6/15/18	46963	0	8	"[0.9999148265655942,8.517343440580883E-5]"	8	SCV000816377181247	single nucleotide variant	NM_000527.4(LDLR):c.1027G>A (p.Gly343Ser)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	5-Jul-18	730882096	-	RCV000211596;RCV000587327;RCV000161977	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:CN517202"	Familial hypercholesterolemia;Familial hypercholesterolemias;not provided	germline;not applicable	germline	GRCh37	NC_000019.9	19	11221414	11221414	G	A	19p13.2	"criteria provided, conflicting interpretations"	15	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_001328,UniProtKB (protein):P01130#VAR_005367"	2	183106	19	11221414	G	A	181247	19:11221414:G:A	Pathogenic	7/5/18	"This sequence change replaces glycine with serine at codon 343 of the LDLR protein (p.Gly343Ser). The glycine residue is highly conserved and there is a small physicochemical difference between glycine and serine. This variant is present in population databases (rs730882096, ExAC 0.005%). This variant has been reported in numerous individuals affected with familial hypercholesterolemia (PMID: 1301956, 11040093, 11933210, 20506408, 23375686, 22294733, 18096825, 17765246, 15241806, 25461735, 27765764). This variant is also known as G322S or FH-Picardie in the literature. ClinVar contains an entry for this variant (Variation ID: 183106). Experimental studies have shown that this missense change affects protein folding and expression in the cell surface in vitro (PMID: 15100232). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site, but this prediction has not been confirmed by published transcriptional studies. Different missense substitutions at this codon (p.Gly343Asp, p.Gly343Val) have been reported in individuals affected with hypercholesterolemia (PMID: 12436241, 18718593). These variants are also known in the literature as p.Gly322Asp and p.Gly322Val. For these reasons, this variant has been classified as Pathogenic."	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Invitae	SCV000821038.1	SCV000821038		LDLR	-	High LDL	7/5/18	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV000821038245988	single nucleotide variant	NM_000527.4(LDLR):c.1103G>A (p.Cys368Tyr)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	5-Jun-18	768430352	-	RCV000237712	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline	germline	GRCh37	NC_000019.9	19	11222232	11222232	G	A	19p13.2	"criteria provided, conflicting interpretations"	8	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_001357,UniProtKB (protein):P01130#VAR_072844"	2	251665	19	11222232	G	A	245988	19:11222232:G:A	Pathogenic	6/5/18	"This sequence change replaces cysteine with tyrosine at codon 368 of the LDLR protein (p.Cys368Tyr). The cysteine residue is highly conserved and there is a large physicochemical difference between cysteine and tyrosine. This variant is present in population databases (rs768430352, ExAC 0.002%). This variant has been observed in several individuals affected with familial hypercholesterolemia (PMID: 1310940, 23064986, 21722902, 25461735,Â¬â€ 26081744). This variant is also known as p.Cys347Tyr in the literature. ClinVar contains an entry for this variant (Variation ID: 251665). This variant affects a cysteine residue located within an epidermal-growth-factor (EGF)â€šÃ„Ã¬like domain of the LDLR protein. Cysteine residues in these domains have been shown to be involved in the formation of disulfide bridges, which are critical for protein structure and stability (PMID: 3495735, 4750422). In addition, missense substitutions within the LDLR EGF-like domains affecting cysteine residues are overrepresented among patients with hypercholesterolemia (PMID: 18325082). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. The p.Cys368 amino acid residue in LDLR has been determined to be clinically significant (PMID:Â¬â€ 9452094, 27765764). This suggests that variants that disrupt this residue are likely to be causative of disease. For these reasons, this variant has been classified as Pathogenic."	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Invitae	SCV000824206.1	SCV000824206		LDLR	-	High LDL	6/5/18	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV00082420639054	single nucleotide variant	NM_002052.4(GATA4):c.487C>T (p.Pro163Ser)	2626	GATA4	HGNC:4173	Conflicting interpretations of pathogenicity	1	9-Jan-18	387906769	-	RCV000023002;RCV000023004;RCV000023003	"MedGen:C3280781,OMIM:614430;Human Phenotype Ontology:HP:0001636,MedGen:C0039685,OMIM:187500,Orphanet:ORPHA3303,SNOMED CT:86299006;MedGen:C3280777,OMIM:614429"	Atrioventricular septal defect 4;Tetralogy of Fallot;Ventricular septal defect 1	germline;inherited	germline	GRCh37	NC_000008.10	8	11566308	11566308	C	T	8p23.1	"criteria provided, conflicting interpretations"	3	NA	N	"OMIM Allelic Variant:600576.0007,UniProtKB (protein):P43694#VAR_067610"	3	30099	8	11566308	C	T	39054	8:11566308:C:T	Uncertain significance	1/9/18	"This sequence change replaces proline with serine at codon 163 of the GATA4 protein (p.Pro163Ser). The proline residue is moderately conserved and there is a moderate physicochemical difference between proline and serine. This variant is present in population databases (rs387906769, ExAC 0.02%). This variant has been reported in individuals affected with congenital heart disease (PMID: 17643447, 18672102, 21110066, 23626780, 27139165, 28161810) and in control individuals (PMID: 23626780). In addition, this variant has been observed in a family with congenital heart disease (PMID: 27130165). However, in the same family, a different variant identified in ACTC1 was reported to segregate with disease in all affected family members, which suggests that this c.487C>T variant in GATA4 was not the primary cause of disease. ClinVar contains an entry for this variant (Variation ID: 30099). Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: ""Tolerated""; PolyPhen-2: ""Possibly Damaging""; Align-GVGD: ""Class C0""). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance."	MedGen:C3280781	C3280781:Atrioventricular septal defect 4	NA	FALSE	Incorrect phenotype	"criteria provided, single submitter"	clinical testing	germline:na	Invitae	SCV000825496.1	SCV000825496		GATA4	-	"MonogenicDM_all, Neonatal Diabetes"	1/9/18	25928	21035	2	"[0.999961431656896,3.856834310398025E-5]"	2	SCV000825496560798	single nucleotide variant	NM_000384.2(APOB):c.4503T>G (p.Tyr1501Ter)	338	APOB	HGNC:603	Pathogenic	1	10-May-18	-1	-	RCV000700300;RCV000700300	"MedGen:C1704417,OMIM:144010;MedGen:C4551990,OMIM:615558"	"Hypercholesterolemia, autosomal dominant, type B;Hypobetalipoproteinemia, familial, 1"	germline	germline	GRCh37	NC_000002.11	2	21235237	21235237	A	C	2p24.1	"criteria provided, single submitter"	1	"ACMG2013,ACMG2016"	N	-	2	577519	2	21235237	A	C	560798	2:21235237:A:C	Pathogenic	5/10/18	"This sequence change creates a premature translational stop signal (p.Tyr1501*) in the APOB gene. It is expected to result in an absent or disrupted protein product. This variant is present in population databases (rs368825685, ExAC 0.001%). This variant has been observed in individuals affected withÂ¬â€ hypobetalipoproteinemiaÂ¬â€ (PMID: 8468533, 24507775). Loss-of-function variants in APOB are known to be pathogenic (PMID: 20032471). For these reasons, this variant has been classified as Pathogenic."	MedGen:C1704417;MedGen:CN182502	"C1704417:Hypercholesterolemia, autosomal dominant, type B;C4551990:Hypobetalipoproteinemia, familial, 1"	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Invitae	SCV000829049.1	SCV000829049		APOB	-	Low LDL	5/10/18	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV000829049226401	single nucleotide variant	NM_000527.4(LDLR):c.1691A>G (p.Asn564Ser)	3949	LDLR	HGNC:6547	Likely pathogenic	1	24-Apr-18	758194385	-	RCV000210237	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline	germline	GRCh37	NC_000019.9	19	11226874	11226874	A	G	19p13.2	"criteria provided, multiple submitters, no conflicts"	5	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000225,UniProtKB (protein):P01130#VAR_005400"	2	224616	19	11226874	A	G	226401	19:11226874:A:G	Likely pathogenic	4/24/18	"This sequence change replaces asparagine with serine at codon 564 of the LDLR protein (p.Asn564Ser). The asparagine residue is highly conserved and there is a small physicochemical difference between asparagine and serine. This variant is present in population databases (rs758194385, ExAC 0.01%). This variant has been reported in several individuals affected with hypercholesterolemia (PMID: 9654205, 18718593, 20538126, 23375686,Â¬â€ 28145427).Â¬â€ This variant is also known as N543S in the literature. ClinVar contains an entry for this variant (Variation ID: 224616). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic."	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Invitae	SCV000831365.1	SCV000831365		LDLR	-	High LDL	4/24/18	46963	0	5	"[0.9999467666034964,5.323339650363052E-5]"	5	SCV000831365171213	single nucleotide variant	NM_000527.4(LDLR):c.1432G>A (p.Gly478Arg)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	26-Apr-18	144614838	-	RCV000211688;RCV000148583	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443"	Familial hypercholesterolemia;Hypercholesterolaemia	germline;unknown	germline	GRCh37	NC_000019.9	19	11224284	11224284	G	A	19p13.2	"criteria provided, conflicting interpretations"	13	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000198,UniProtKB (protein):P01130#VAR_005390"	2	161277	19	11224284	G	A	171213	19:11224284:G:A	Likely pathogenic	4/26/18	"This sequence change replaces glycine with arginine at codon 478 of the LDLR protein (p.Gly478Arg). The glycine residue is highly conserved and there is a moderate physicochemical difference between glycine and arginine. This variant is present in population databases (rs144614838, ExAC 0.01%). This variant has been reported in several individuals affected with familial hypercholesterolemia (PMID: 27206935, 17087781, 23064986, 21376320, 17765246, 17765246, Â¬â€ 11810272, 17765246). This variant is also known as p.Gly457Arg in the literature. ClinVar contains an entry for this variant (Variation ID: 161277). Different missense substitutions at this codon (p.Gly478Glu and p.Gly478Arg) have been reported in an individuals affected with familial hypercholesterolemia (PMID: 27824480, 28126585). Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: ""Deleterious""; PolyPhen-2: ""Probably Damaging""; Align-GVGD: ""Class C15""). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic."	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Invitae	SCV000832839.1	SCV000832839		LDLR	-	High LDL	4/26/18	46961	2	3	"[0.9999680586018185,3.194139818146973E-5]"	3	SCV00083283918785	single nucleotide variant	NM_000527.4(LDLR):c.1216C>A (p.Arg406=)	3949	LDLR	HGNC:6547	Pathogenic	1	13-Apr-18	121908043	-	RCV000003944;RCV000588218	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445"	Familial hypercholesterolemia;Familial hypercholesterolemias	germline;not applicable	germline	GRCh37	NC_000019.9	19	11223983	11223983	C	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	6	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000813,OMIM Allelic Variant:606945.0065"	3	3746	19	11223983	C	A	18785	19:11223983:C:A	Pathogenic	4/13/18	"This sequence change affects codon 406 of the LDLR mRNA. It is a 'silent' change, meaning that it does not change the encoded amino acid sequence of the LDLR protein. This variant is not present in population databases (ExAC no frequency). This variant has been reported in individuals affected with familial hypercholesterolemia (PMID: 17335829, 19371225, 17094996, 21382890, 18400033) including an individual compound heterozygous with another LDLR variant affected with autosomal recessive hypercholesterolemia (PMID:Â¬â€ 28028493). ClinVar contains an entry for this variant (Variation ID: 3746). Experimental studies have shown that this silent change causes aberrantly spliced transcripts that are degraded via nonsense-mediated decay (PMID: 17335829, 19371225). For these reasons, this variant has been classified as Pathogenic."	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Invitae	SCV000833922.1	SCV000833922		LDLR	-	High LDL	4/13/18	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV00083392229524	single nucleotide variant	NM_005572.3(LMNA):c.1711C>A (p.Arg571Ser)	4000	LMNA	HGNC:6636	Uncertain significance	1	1-Feb-18	80338938	-	RCV000705473;RCV000015574;RCV000057044	"MedGen:C0270914,Orphanet:ORPHA64746;MedGen:C1449563,OMIM:115200,Orphanet:ORPHA300751;MedGen:CN517202"	"Charcot-Marie-Tooth disease, type 2;Dilated cardiomyopathy 1A;not provided"	germline	germline	GRCh37	NC_000001.10	1	156107547	156107547	C	A	1q22	"criteria provided, single submitter"	4	"ACMG2013,ACMG2016"	N	OMIM Allelic Variant:150330.0009	3	14485	1	156107547	C	A	29524	1:156107547:C:A	Uncertain significance	2/1/18	"This sequence change replaces arginine with serine at codon 639 of the LMN A/C protein (p.Phe639Leu). The arginine residue is weakly conserved and there is a moderate physicochemical difference between arginine and serine. The LMNA gene has two clinically relevant isoforms. The p.Phe639Leu variant occurs in alternate transcript NM_005572.3 (lamin C) which corresponds to position c.1698+13C>A in NM_170707.3, that is the primary transcript listed in the Methods. This variant is present in population databases (rs80338938, ExAC 0.2%). This variant has been reported to segregate with dilated cardiomyopathy and conduction defects in a large multigenerational family (PMID: 10580070). ClinVar contains an entry for this variant (Variation ID: 14485). A different variant (c.1711_1712delinsTC ) giving rise to the same protein effect observed here (p.Arg571Ser) has been reported in an individual affected withÂ¬â€  lipodystrophy (PMID: 28686329), indicating that this residue may be critical for protein function. A different missense substitution at this codon (p.Arg571Cys) has been reported in an individual affected with muscular dystrophy and peripheral neuropathy (PMID: 15965218). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance."	MedGen:CN043576	"C0270914:Charcot-Marie-Tooth disease, type 2"	NA	FALSE	Incorrect phenotype	"criteria provided, single submitter"	clinical testing	germline:na	Invitae	SCV000834472.1	SCV000834472		LMNA	-	"Lipodystrophy, MonogenicDM_all"	2/1/18	37533	9430	2	"[0.9999733567793675,2.6643220632510057E-5]"	2	SCV000834472246297	single nucleotide variant	NM_000527.4(LDLR):c.1721G>A (p.Arg574His)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	3-Jul-18	777188764	-	RCV000237135	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline	germline	GRCh37	NC_000019.9	19	11227550	11227550	G	A	19p13.2	"criteria provided, conflicting interpretations"	4	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000233,UniProtKB (protein):P01130#VAR_072852"	2	251996	19	11227550	G	A	246297	19:11227550:G:A	Likely pathogenic	7/3/18	"This sequence change replaces arginine with histidine at codon 574 of the LDLR protein (p.Arg574His). The arginine residue is highly conserved and there is a small physicochemical difference between arginine and histidine. This variant is present in population databases (rs777188764, ExAC 0.01%). This variant has been observed in individuals affected with familial hypercholesterolemia (PMID: 20018285, 25461735, Invitae). ClinVar contains an entry for this variant (Variation ID: 251996). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. Variants that disrupt the p.Arg574 amino acid residue in LDLR have been observed in affected individuals (PMID:Â¬â€ 11462246, 19446849, 26892515, 20018285, 25461735, Invitae). This suggests that it is a clinically significant residue, and that other variants that disrupt this residue are likely to be causative of disease. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic."	MedGen:C0020445	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Invitae	SCV000836468.1	SCV000836468		LDLR	-	High LDL	7/3/18	46963	0	3	"[0.9999680599620978,3.194003790217831E-5]"	3	SCV00083646832929	single nucleotide variant	NM_000384.2(APOB):c.10580G>A (p.Arg3527Gln)	338	APOB	HGNC:603	Conflicting interpretations of pathogenicity	1	11-Jul-18	5742904	-	RCV000019479;RCV000284412;RCV000412515;RCV000627797;RCV000499833;RCV000627797;RCV000254882	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C1862596,Orphanet:ORPHA426,SNOMED CT:60193003;MedGen:C1704417,OMIM:144010;MedGen:C1704417,OMIM:144010;MedGen:C0020597,Orphanet:ORPHA31154;MedGen:C4551990,OMIM:615558;MedGen:CN517202"	"Familial hypercholesterolemia;Familial hypobetalipoproteinemia;Hypercholesterolemia, autosomal dominant, type B;Hypercholesterolemia, autosomal dominant, type B;Hypobetalipoproteinemia;Hypobetalipoproteinemia, familial, 1;not provided"	germline;maternal;unknown	germline	GRCh37	NC_000002.11	2	21229160	21229160	C	T	2p24	"criteria provided, conflicting interpretations"	18	"ACMG2013,ACMG2016"	Y	OMIM Allelic Variant:107730.0009	3	17890	2	21229160	C	T	32929	2:21229160:C:T	Pathogenic	5/25/17	"This c.10580G>A (p.Arg3527Gln) variant in the APOB gene has previously been reported in multiple patients with hypercholesterolemia [PMID 2563166, 23375686, 18325181, 27497240, 24956927, 21059979, 9603795 among others, reported as p.Arg3500Gln]. This variant is the most common cause of hypercholesterolemia due to an APOB variant and is common among Northern European populations. This change disrupts the binding of low density lipoproteins (LDL) onto the LDL receptor. The receptor mediated catabolism is thus disrupted and LDL accumulates in the plasma. The disorder caused by this specific variant is sometimes referred as hypercholesterolemia, due to ligand-defective apo B [MIM 144010]. This variant has been observed in 28 heterozygous individuals from the ExAC database (http://exac.broadinstitute.org/variant/2-21229160-C-T). Arginine at position 3527 of the APOB protein is highly conserved within mammals. While not validated for clinical use, the computer-based algorithms predict this p.Arg3527Gln change to be deleterious. It is thus interpreted as a pathogenic variant."	OMIM:144010	"C1704417:Hypercholesterolemia, autosomal dominant, type B"	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	"Human Genome Sequencing Center Clinical Lab,Baylor College of Medicine"	SCV000839879.1	SCV000839879		APOB	-	Low LDL	7/11/18	46963	0	12	"[0.9998722398483912,1.2776015160871325E-4]"	12	SCV00083987918780	single nucleotide variant	NM_000527.4(LDLR):c.131G>A (p.Trp44Ter)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	14-Nov-17	267607213	-	RCV000003939	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline;inherited	germline	GRCh37	NC_000019.9	19	11210962	11210962	G	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	13	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000019,OMIM Allelic Variant:606945.0060"	3	3741	19	11210962	G	A	18780	19:11210962:G:A	Pathogenic	9/19/17	"This c.131G>A (p.Trp44*) variant in the LDLR gene is predicted to is predicted to introduce a premature translation termination codon. This variant has been reported in multiple patients with familial hypercholesterolemia (PMID: 1301956, 8850176). The c.131G>A (p.Trp44*) variant in the LDLR gene is classified as pathogenic."	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	"Human Genome Sequencing Center Clinical Lab,Baylor College of Medicine"	SCV000839974.1	SCV000839974		LDLR	-	High LDL	11/14/17	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV000839974171201	single nucleotide variant	NM_000527.4(LDLR):c.798T>A (p.Asp266Glu)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	17-May-18	139043155	-	RCV000172959;RCV000148594;RCV000162020	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202"	Familial hypercholesterolemia;Hypercholesterolaemia;not provided	germline;inherited;not applicable;unknown	germline	GRCh37	NC_000019.9	19	11217344	11217344	T	A	19p13.2	"criteria provided, conflicting interpretations"	16	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000117,UniProtKB (protein):P01130#VAR_005347"	2	161287	19	11217344	T	A	171201	19:11217344:T:A	Likely pathogenic	7/6/17	"This c.798T>A (p.Asp266Glu) variant has previously been detected in multiple patients with familial hypercholesterolemia [PMID 1301956, 11196104, 25637381, 25487149, 11810272, 16542394, 21310417, also reported as FH Cincinnati-1 (legacy: 245)]. Additional patients with hypercholesterolemia have been reported with variants located at the same amino acid position (p.Asp266Asn, p.Asp266Gly, p.Asp266Tyr and p.Asp266Val). This variant was observed in ten heterozygous individuals in the gnomAD database (http://gnomad.broadinstitute.org/variant/19-11217344-T-A This variant is highly conserved in mammals and computer-based algorithms predict this p.Asp266Glu change to be deleterious. It is thus classified as likely pathogenic."	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	"Human Genome Sequencing Center Clinical Lab,Baylor College of Medicine"	SCV000839980.1	SCV000839980		LDLR	-	High LDL	5/17/18	46963	0	2	"[0.9999787066413985,2.1293358601452207E-5]"	2	SCV000839980171214	single nucleotide variant	NM_000527.4(LDLR):c.1444G>A (p.Asp482Asn)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	11-May-17	139624145	-	RCV000172963;RCV000148591;RCV000414235	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202"	Familial hypercholesterolemia;Hypercholesterolaemia;not provided	germline;inherited	germline	GRCh37	NC_000019.9	19	11224296	11224296	G	A	19p13.2	"criteria provided, conflicting interpretations"	13	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_001428	2	161284	19	11224296	G	A	171214	19:11224296:G:A	Likely pathogenic	5/11/17	"The c.1444G>A (p.Asp482Asn) variant in the LDLR gene has been reported in patients with hypercholesterolemia [PMID 8535447, 23375686, 20236128, 16159606, 21326404; legacy name 461]. This variant was observed in five heterozygous individuals in the ExAC population database (http://exac.broadinstitute.org/variant/19-11224296-G-A). Aspartate at position 482 of the LDLR protein is conserved in mammals and while not clinically validated, computer-based algorithms (SIFT and Polyphen-2) predict this p.Asp482Asn change to be deleterious. This c.1444G>A (p.Asp482Asn) variant is thus classified as likely pathogenic."	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	"Human Genome Sequencing Center Clinical Lab,Baylor College of Medicine"	SCV000839981.1	SCV000839981		LDLR	-	High LDL	5/11/17	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV000839981171216	single nucleotide variant	NM_000527.4(LDLR):c.1474G>A (p.Asp492Asn)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	2-Jan-18	373646964	-	RCV000237459;RCV000590270;RCV000148592;RCV000161989	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:C0020443;MedGen:CN517202"	Familial hypercholesterolemia;Familial hypercholesterolemias;Hypercholesterolaemia;not provided	germline;inherited;not applicable	germline	GRCh37	NC_000019.9	19	11224326	11224326	G	A	19p13.2	"criteria provided, conflicting interpretations"	13	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000205,UniProtKB (protein):P01130#VAR_072850"	2	161285	19	11224326	G	A	171216	19:11224326:G:A	Likely pathogenic	4/26/17	"This c.1474G>A (p.Asp492Asn) variant has been reported in a 42 year old male patient with familial hypercholesterolemia from a cohort of 30 patients [reported as D471N, FH Graz-1 in PMID 9763532]. This variant was also reported in a patient presenting with a total cholesterol level of 23 mmol/L and xanthomas [PMID 25936317]; this patient also carried a second allele (p.Gly592Glu), which is classified as pathogenic by our laboratory . This variant was further detected in a patient from a cohort of 2,078 patients from Italy [PMID 23375686]; this patient also carried a p.Cys698Trp variant, classified as a variant of unknown significance by our laboratory at this time. Additional variants affecting the same amino acid at position 492 (p.Asp492Gly and p.Asp492His) have been reported in patients with familial hypercholesterolemia [PMID 16250003, 10208479].This variant was reported in 2 heterozygous individuals in the ExAC database (http://exac.broadinstitute.org/variant/19-11224326-G-A). Asparagine at amino acid position 492 of the LDLR protein is highly conserved in mammals. While not validated for clinical use, the computer-based algorithms predict this p.Asp492Asn change to be deleterious. This variant is thus classified as likely pathogenic."	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	"Human Genome Sequencing Center Clinical Lab,Baylor College of Medicine"	SCV000839982.1	SCV000839982		LDLR	-	High LDL	1/2/18	46963	0	5	"[0.9999467666034964,5.323339650363052E-5]"	3	SCV000839982228147	single nucleotide variant	NM_000527.4(LDLR):c.796G>A (p.Asp266Asn)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	19-Sep-17	875989907	-	RCV000211615	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline;inherited	germline	GRCh37	NC_000019.9	19	11217342	11217342	G	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	8	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000469	2	226334	19	11217342	G	A	228147	19:11217342:G:A	Likely pathogenic	9/19/17	"This c.796G>A (p.Asp266Asn) variant in the LDLR gene has been reported in multiple patients with familial hypercholesterolemia (PMID: 11810272, 23375686). Multiple different amino acid substitutions affecting aspartic acid at position 266 of the LDLR protein have also been reported in patients with familial hypercholesterolemia (PMID: 1301956, 12417285, 28235710). The c.796G>A variant is extremely rare in the general population and aspartic acid at position 266 of the LDLR protein is highly evolutionarily conserved. The c.796G>A (p.Asp266Asn) variant in the LDLR gene is classified as likely pathogenic."	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	"Human Genome Sequencing Center Clinical Lab,Baylor College of Medicine"	SCV000839983.1	SCV000839983		LDLR	-	High LDL	9/19/17	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV000839983171213	single nucleotide variant	NM_000527.4(LDLR):c.1432G>A (p.Gly478Arg)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	26-Apr-18	144614838	-	RCV000211688;RCV000148583	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443"	Familial hypercholesterolemia;Hypercholesterolaemia	germline;unknown	germline	GRCh37	NC_000019.9	19	11224284	11224284	G	A	19p13.2	"criteria provided, conflicting interpretations"	13	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000198,UniProtKB (protein):P01130#VAR_005390"	2	161277	19	11224284	G	A	171213	19:11224284:G:A	Likely pathogenic	9/19/17	"This c.1432G>A (p.Gly478Arg) variant in the LDLR gene has been reported in multiple patients with familial hypercholesterolemia (PMID: 1301956, 7573037, 9763532, 11810272). Functional studies have indicated that the p.Gly478Arg variant LDLR protein has 2-5% receptor activity compared to wild-type LDLR protein (PMID: 1301956). The c.1432G>A variant is extremely rare in the general population and glycine at position 478 of the LDLR protein is highly evolutionarily conserved. The c.1432G>A (p.Gly478Arg) variant in the LDLR gene is classified as likely pathogenic."	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	"Human Genome Sequencing Center Clinical Lab,Baylor College of Medicine"	SCV000839985.1	SCV000839985		LDLR	-	High LDL	4/26/18	46961	2	3	"[0.9999680586018185,3.194139818146973E-5]"	3	SCV00083998518779	single nucleotide variant	NM_000527.4(LDLR):c.782G>T (p.Cys261Phe)	3949	LDLR	HGNC:6547	Likely pathogenic	1	12-Apr-17	121908040	-	RCV000003938;RCV000148568	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443"	Familial hypercholesterolemia;Hypercholesterolaemia	germline	germline	GRCh37	NC_000019.9	19	11217328	11217328	G	T	19p13.2	"criteria provided, multiple submitters, no conflicts"	5	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000647,OMIM Allelic Variant:606945.0059,UniProtKB (protein):P01130#VAR_013953"	3	3740	19	11217328	G	T	18779	19:11217328:G:T	Likely pathogenic	4/12/17	"This c.782G>T (p.Cys261Phe) variant has previously been detected in several patients with familial hypercholesterolemia [legacy: 240 in PMID 9767373, 16542394]. The variant was also detected in a 13 y/o female, compound heterozygous for this variant and a loss of function variant [PMID 10422803]. Two siblings carried the same c.782G>T (p.Cys261Phe) heterozygous variant with only one clinically presenting hypercholesterolemia. In vitro assays showed that although the cells produced a detectable protein, cells expressing the mutant protein were unable to mediate uptake and degradation of LDL [PMID 10422803]. This variant has been reported in only one heterozygous individual from the ExAC database (http://exac.broadinstitute.org/variant/19-11217328-G-T). This variant is conserved in mammals and while not clinically validated, computer-based algorithms (SIFT and Polyphen-2) predict this p.Cys261Phe change to be deleterious. This variant is thus classified as likely pathogenic."	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	"Human Genome Sequencing Center Clinical Lab,Baylor College of Medicine"	SCV000839987.1	SCV000839987		LDLR	-	High LDL	4/12/17	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV000839987171204	single nucleotide variant	NM_000527.4(LDLR):c.862G>A (p.Glu288Lys)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	1-May-18	368657165	-	RCV000234348;RCV000148573	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443"	Familial hypercholesterolemia;Hypercholesterolaemia	germline	germline	GRCh37	NC_000019.9	19	11218112	11218112	G	A	19p13.2	"criteria provided, conflicting interpretations"	11	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000509,UniProtKB (protein):P01130#VAR_007983"	2	161268	19	11218112	G	A	171204	19:11218112:G:A	Likely pathogenic	8/21/17	"This c.862G>C (p.Glu288Lys) variant in the LDLR gene has been reported in multiple patients with familial hypercholesterolemia (PMID: 21990180, 26927322). Glutamate at position 288 of the LDLR protein is highly evolutionarily conserved. Functional studies have shown that this variant disrupts normal LDLR function by decreasing its internalization and ligand binding capacity (PMID: 21990180). This variant is classified as likely pathogenic."	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	"Human Genome Sequencing Center Clinical Lab,Baylor College of Medicine"	SCV000839988.1	SCV000839988		LDLR	-	High LDL	5/1/18	46963	0	8	"[0.9999148265655942,8.517343440580883E-5]"	8	SCV000839988228142	deletion	NM_000527.4(LDLR):c.654_656delTGG (p.Gly219del)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	25-Jun-18	121908027	-	RCV000211647;RCV000589051;RCV000489033	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:CN517202"	Familial hypercholesterolemia;Familial hypercholesterolemias;not provided	germline;inherited;not applicable	germline	GRCh37	NC_000019.9	19	11216236	11216238	TGG	-	19p13.2	"criteria provided, multiple submitters, no conflicts"	14	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000094,OMIM Allelic Variant:606945.0005"	3	226329	19	11216232	ATGG	A	228142	19:11216232:ATGG:A	Pathogenic	5/25/17	"The c.654_656del (p.Gly219del) variant in the LDLR gene has been detected in multiple cohorts of patients with hypercholesterolemia [PMID 22698793, 18096825, sometimes referred as G197del]. This variant is a founder mutation in the Ashkenazi Jewish population and traces its ancestry to Lithuania [PMID 1867200, 11309683, 9744476]. This variant leads to the deletion of one single amino acid and preserves the reading frame. This variant has been observed in only 5 individuals in the ExAC database (http://exac.broadinstitute.org/variant/19-11216232-ATGG-A). This variant thus classified as pathogenic."	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	"Human Genome Sequencing Center Clinical Lab,Baylor College of Medicine"	SCV000839990.1	SCV000839990		LDLR	-	High LDL	6/25/18	46962	1	1	"[0.9999893530939908,1.0646906009113752E-5]"	1	SCV000839990171212	single nucleotide variant	NM_000527.4(LDLR):c.1238C>T (p.Thr413Met)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	23-Oct-17	368562025	-	RCV000211581;RCV000148582;RCV000519267	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202"	Familial hypercholesterolemia;Hypercholesterolaemia;not provided	germline;unknown	germline	GRCh37	NC_000019.9	19	11224005	11224005	C	T	19p13.2	"criteria provided, conflicting interpretations"	9	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000967	2	161276	19	11224005	C	T	171212	19:11224005:C:T	Likely pathogenic	10/23/17	"This c.1238C>T (p.Thr413Met) variant in the LDLR gene has been reported in multiple individuals with familial hypercholesterolemia (PMID: 11857755, 17539906, 19843101, 11668627, 15015036, 25682026) or myocardial infarction (PMID: 25487149). The p.Thr413Met variant occurs within the low-density lipoprotein receptor repeat class B domain of the LDLR protein (https://www.ncbi.nlm.nih.gov/Structure/cdd/wrpsb.cgi?seqinput=NP_001182729.1 ). The c.1238C>T variant is rare in the general population and threonine at position 413 of the LDLR protein is highly evolutionarily conserved. The c.1238C>T (p.Thr413Met) variant in the LDLR gene is classified as likely pathogenic."	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	"Human Genome Sequencing Center Clinical Lab,Baylor College of Medicine"	SCV000839993.1	SCV000839993		LDLR	-	High LDL	10/23/17	46963	0	3	"[0.9999680599620978,3.194003790217831E-5]"	3	SCV000839993171211	single nucleotide variant	NM_000527.4(LDLR):c.1201C>G (p.Leu401Val)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	11-May-18	146200173	-	RCV000238417;RCV000586642;RCV000148572;RCV000255176	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:C0020443;MedGen:CN517202"	Familial hypercholesterolemia;Familial hypercholesterolemias;Hypercholesterolaemia;not provided	germline	germline	GRCh37	NC_000019.9	19	11223968	11223968	C	G	19p13.2	"criteria provided, conflicting interpretations"	10	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000535,UniProtKB (protein):P01130#VAR_007987"	2	161267	19	11223968	C	G	171211	19:11223968:C:G	Likely pathogenic	5/11/18	"The c.1201C>G (p.Leu401Val) variant in the LDLR gene has been observed in multiple individuals with familial hypercholesteromeia (PMID: 9104431, 21722902, 25461735). In addition, a missense variant at the same residue, p.Leu401His, has been previously reported in other affected individuals (PMID: 7573037, 11810272,15701167). Therefore, this variant in the LDLR gene is classified as likely pathogenic."	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	"Human Genome Sequencing Center Clinical Lab,Baylor College of Medicine"	SCV000839994.1	SCV000839994		LDLR	-	High LDL	5/11/18	46963	0	3	"[0.9999680599620978,3.194003790217831E-5]"	3	SCV000839994228193	single nucleotide variant	NM_000527.4(LDLR):c.1898G>A (p.Arg633His)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	28-Nov-17	754536745	-	RCV000211621	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline	germline	GRCh37	NC_000019.9	19	11230820	11230820	G	A	19p13.2	"criteria provided, conflicting interpretations"	7	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_001073	2	226380	19	11230820	G	A	228193	19:11230820:G:A	Likely pathogenic	11/28/17	"The c.1898G>A (p.Arg633His) variant is extremely rare in general population (3 in 246014 by gnomad) and observed in multiple familial hypercholesterolaemia (FH) patients (PMID: 15823288,16250003,19318025). It is predicted to be deleterious by multiple in silica prediction software. The Arg633 is well conserved during evolution. It has been also observed in other clinical labs and reported as pathogenic. At the same position, Arg633Cys variant was observed in multiple FH patient cohort. Based on the above evidences, we interpret this variant as ikely pathogenic."	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	"Human Genome Sequencing Center Clinical Lab,Baylor College of Medicine"	SCV000839996.1	SCV000839996		LDLR	-	High LDL	11/28/17	46963	0	2	"[0.9999787066413985,2.1293358601452207E-5]"	2	SCV00083999618731	single nucleotide variant	NM_000527.4(LDLR):c.910G>A (p.Asp304Asn)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	10-Apr-18	121908030	-	RCV000003880;RCV000148569;RCV000622705	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MeSH:D030342,MedGen:C0950123"	Familial hypercholesterolemia;Hypercholesterolaemia;Inborn genetic diseases	germline;inherited;not applicable	germline	GRCh37	NC_000019.9	19	11218160	11218160	G	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	10	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_001861,OMIM Allelic Variant:606945.0008,UniProtKB (protein):P01130#VAR_005355"	3	3692	19	11218160	G	A	18731	19:11218160:G:A	Pathogenic	4/10/18	"This c.910G>A (p.Asp304Asn) variant in the LDLR gene has been reported in multiple unrelated individuals with familial hypercholesterolemia (PMID: 1301956, 9664576, 11810272, 12436241, 21418584, 21310417) and is extremely rare in the general population. Functional studies have shown that the mutant LDLR protein retains only 5-15% of receptor activity compared with wildtype LDLR protein (PMID: 1301956). This c.910G>A (p.Asp304Asn) variant in the LDLR gene is classified as pathogenic."	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	"Human Genome Sequencing Center Clinical Lab,Baylor College of Medicine"	SCV000840002.1	SCV000840002		LDLR	-	High LDL	4/10/18	46963	0	3	"[0.9999680599620978,3.194003790217831E-5]"	3	SCV000840002540034	single nucleotide variant	NM_005912.2(MC4R):c.749T>A (p.Leu250Gln)	4160	MC4R	HGNC:6932	Conflicting interpretations of pathogenicity	1	10-Mar-17	772393451	-	RCV000664153;RCV000709739	"MedGen:C3888631;Human Phenotype Ontology:HP:0001513,MedGen:C0028754,OMIM:601665,Orphanet:ORPHA71529,SNOMED CT:414916001"	Monogenic diabetes;Obesity	germline;unknown	germline	GRCh37	NC_000018.9	18	58038834	58038834	A	T	18q21.32	"criteria provided, conflicting interpretations"	2	NA	N	-	2	549551	18	58038834	A	T	540034	18:58038834:A:T	Likely pathogenic	3/10/17	"This c.749T>A (p.Leu250Gln) has previously been reported in multiple patients presenting with obesity [PMID 10903341, 16507637, 18559663, 12690102]. Functional assays showed that the receptor displayed high constitutive activity [PMID 12690102, 16611215, 16507637, 23791567]. However, cell surface expression level of the p.Leu250Gln mutant was decreased by about half of wild type [PMID 12690102, 16507637]. Thus the mechanism of pathogenicity of this variant in unclear at this time. This variant is conserved in mammals. This variant has been observed in one heterozygous individual from the ExAC database (http://exac.broadinstitute.org/variant/18-58038834-A-T). While not validated for clinical use, the computer-based algorithms predict this p.Leu250Gln change to be deleterious. It is thus interpreted as a likely pathogenic variant."	OMIM:601665	C0028754:Obesity	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	"Human Genome Sequencing Center Clinical Lab,Baylor College of Medicine"	SCV000840006.1	SCV000840006		MC4R	-	Obesity	3/10/17	46962	1	1	"[0.9999893530939908,1.0646906009113752E-5]"	1	SCV00084000629375	single nucleotide variant	NM_005912.2(MC4R):c.380C>T (p.Ser127Leu)	4160	MC4R	HGNC:6932	Conflicting interpretations of pathogenicity	1	25-May-17	13447331	-	RCV000015412;RCV000414065	"Human Phenotype Ontology:HP:0001513,MedGen:C0028754,OMIM:601665,Orphanet:ORPHA71529,SNOMED CT:414916001;MedGen:CN517202"	Obesity;not provided	germline	germline	GRCh37	NC_000018.9	18	58039203	58039203	G	A	18q21.3	"criteria provided, conflicting interpretations"	6	NA	N	"OMIM Allelic Variant:155541.0021,UniProtKB (protein):P32245#VAR_038643"	3	14336	18	58039203	G	A	29375	18:58039203:G:A	Likely pathogenic	5/25/17	"This c.380C>T (p.Ser127Leu) variant in the MC4R gene has previously been reported in multiple patients presenting with obesity [PMID 12499395, 24385306, 18559663, 14764818, 26047380]. The variant was also detected in one lean individual, the mother of the obese proband, indicating possible incomplete penetrance [PMID 26047380]. Functional assays showed that the receptor displayed high constitutive activity [PMID 19298524, 12970296]. However, cell surface expression level of the p.Ser127Leu mutant was decreased by about half of wild type [PMID 19298524, 24385306]. Thus, the mechanism of pathogenicity for this variant in unclear at this time. Serine at amino acid position 127 of the MC4R protein is highly conserved in mammals. This variant has been observed in 20 heterozygous individuals from the ExAC database (http://exac.broadinstitute.org/variant/18-58039203-G-A). While not validated for clinical use, the computer-based algorithms SIFT and Polyphen2 predict this p.Ser127Leu change to be deleterious. It is thus interpreted as a likely pathogenic variant."	OMIM:601665	C0028754:Obesity	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	"Human Genome Sequencing Center Clinical Lab,Baylor College of Medicine"	SCV000840007.1	SCV000840007		MC4R	-	Obesity	5/25/17	46963	0	18	"[0.999808359772587,1.9164022741306988E-4]"	18	SCV000840007577178	single nucleotide variant	NM_000352.4(ABCC8):c.4136G>A (p.Arg1379His)	6833	ABCC8	HGNC:59	Likely pathogenic	1	28-Sep-17	-1	-	RCV000710386	MedGen:CN517202	not provided	germline	germline	GRCh37	NC_000011.9	11	17417461	17417461	C	T	11p15.1	"criteria provided, single submitter"	1	NA	N	-	2	585346	11	17417461	C	T	577178	11:17417461:C:T	Likely pathogenic	9/28/17	-	not provided	CN517202:not provided	neonatal diabetes - based on pubmed articles	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Athena Diagnostics Inc	SCV000840596.1	SCV000840596		ABCC8	-	"MODY Extended, MonogenicDM_all, Neonatal Diabetes"	9/28/17	46495	468	1	"[0.9999892461555006,1.075384449940854E-5]"	1	SCV00084059624135	single nucleotide variant	NM_000352.4(ABCC8):c.4477C>T (p.Arg1493Trp)	6833	ABCC8	HGNC:59	Pathogenic/Likely pathogenic	1	29-Aug-17	28936371	-	RCV000009664;RCV000710390	"MedGen:C2931832,OMIM:256450,SNOMED CT:360339005;MedGen:CN517202"	Persistent hyperinsulinemic hypoglycemia of infancy;not provided	germline;unknown	germline	GRCh37	NC_000011.9	11	17415881	17415881	G	A	11p15.1	"criteria provided, multiple submitters, no conflicts"	3	NA	N	"OMIM Allelic Variant:600509.0010,UniProtKB (protein):Q09428#VAR_008540"	3	9096	11	17415881	G	A	24135	11:17415881:G:A	Pathogenic	8/29/17	-	not provided	CN517202:not provided	familial hyperinsulinism or persistent hyperinsulinemic hypoglycemia of infancy based on pubmed articles	FALSE	Not trait of interest	"criteria provided, single submitter"	clinical testing	germline:na	Athena Diagnostics Inc	SCV000840600.1	SCV000840600		ABCC8	-	"MODY Extended, MonogenicDM_all, Neonatal Diabetes"	8/29/17	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV000840600577184	single nucleotide variant	NM_000352.4(ABCC8):c.742C>T (p.Arg248Ter)	6833	ABCC8	HGNC:59	Pathogenic	1	29-Aug-17	-1	-	RCV000710396	MedGen:CN517202	not provided	germline	germline	GRCh37	NC_000011.9	11	17483210	17483210	G	A	11p15.1	"criteria provided, single submitter"	1	NA	N	-	2	585351	11	17483210	G	A	577184	11:17483210:G:A	Pathogenic	8/29/17	-	not provided	CN517202:not provided	Hyperinsulinism of Infancy - based on pubmed articles	FALSE	Not trait of interest	"criteria provided, single submitter"	clinical testing	germline:na	Athena Diagnostics Inc	SCV000840608.1	SCV000840608		ABCC8	-	"MODY Extended, MonogenicDM_all, Neonatal Diabetes"	8/29/17	46963	0	4	"[0.9999574132827971,4.2586717202904415E-5]"	4	SCV000840608577183	single nucleotide variant	NM_000352.4(ABCC8):c.928G>A (p.Asp310Asn)	6833	ABCC8	HGNC:59	Likely pathogenic	1	20-Apr-18	-1	-	RCV000710397	MedGen:CN517202	not provided	germline	germline	GRCh37	NC_000011.9	11	17482118	17482118	C	T	11p15.1	"criteria provided, single submitter"	1	NA	N	-	2	585352	11	17482118	C	T	577183	11:17482118:C:T	Likely pathogenic	4/20/18	-	not provided	CN517202:not provided	congenital hyperinsulinism - based on pubmed articles	FALSE	Not trait of interest	"criteria provided, single submitter"	clinical testing	germline:na	Athena Diagnostics Inc	SCV000840609.1	SCV000840609		ABCC8	-	"MODY Extended, MonogenicDM_all, Neonatal Diabetes"	4/20/18	46963	0	2	"[0.9999787066413985,2.1293358601452207E-5]"	2	SCV00084060944852	single nucleotide variant	NM_000162.3(GCK):c.1240A>G (p.Lys414Glu)	2645	GCK	HGNC:4195	Likely pathogenic	1	22-May-18	193922272	-	RCV000029851;RCV000711759	"MedGen:C1841962,OMIM:125851;MedGen:CN517202"	"Maturity-onset diabetes of the young,  type 2;not provided"	germline	germline	GRCh37	NC_000007.13	7	44185109	44185109	T	C	7p13	"criteria provided, multiple submitters, no conflicts"	2	NA	N	UniProtKB (protein):P35557#VAR_003714	2	36188	7	44185109	T	C	44852	7:44185109:T:C	Likely pathogenic	5/22/18	-	not provided	CN517202:not provided	No Information	FALSE	No Information	"criteria provided, single submitter"	clinical testing	germline:na	Athena Diagnostics Inc	SCV000842153.1	SCV000842153		GCK	-	"MODY, MODY Extended, MonogenicDM_all"	5/22/18	46861	102	1	"[0.9999893301466037,1.0669853396214336E-5]"	1	SCV000842153380272	single nucleotide variant	NM_000162.3(GCK):c.128G>A (p.Arg43His)	2645	GCK	HGNC:4195	Likely pathogenic	1	21-Dec-17	764232985	-	RCV000445457;RCV000711763	MedGen:C3888631;MedGen:CN517202	Monogenic diabetes;not provided	germline	germline	GRCh37	NC_000007.13	7	44192980	44192980	C	T	7p13	"criteria provided, multiple submitters, no conflicts"	2	NA	N	-	2	393453	7	44192980	C	T	380272	7:44192980:C:T	Likely pathogenic	12/21/17	-	not provided	CN517202:not provided	MODY - based on pubmed articles	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Athena Diagnostics Inc	SCV000842157.1	SCV000842157		GCK	-	"MODY, MODY Extended, MonogenicDM_all"	12/21/17	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV00084215744873	single nucleotide variant	NM_000162.3(GCK):c.214G>A (p.Gly72Arg)	2645	GCK	HGNC:4195	Pathogenic	1	12-Jul-18	193922289	-	RCV000029872;RCV000255585	"MedGen:C1841962,OMIM:125851;MedGen:CN517202"	"Maturity-onset diabetes of the young,  type 2;not provided"	germline	germline	GRCh37	NC_000007.13	7	44192019	44192019	C	T	7p13	"criteria provided, multiple submitters, no conflicts"	3	NA	N	-	2	36209	7	44192019	C	T	44873	7:44192019:C:T	Pathogenic	7/12/18	-	not provided	CN517202:not provided	MODY - based on pubmed articles	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Athena Diagnostics Inc	SCV000842164.1	SCV000842164		GCK	-	"MODY, MODY Extended, MonogenicDM_all"	7/12/18	46963	0	2	"[0.9999787066413985,2.1293358601452207E-5]"	2	SCV00084216424251	single nucleotide variant	NM_175914.4(HNF4A):c.340C>T (p.Arg114Trp)	3172	HNF4A	HGNC:5024	Conflicting interpretations of pathogenicity	1	12-Dec-17	137853336	-	RCV000009792;RCV000711955;RCV000520726	"MedGen:C1852093,OMIM:125850;MedGen:CN517202;MedGen:CN169374"	"Maturity-onset diabetes of the young,  type 1;not provided;not specified"	germline	germline	GRCh37	NC_000020.10	20	43042354	43042354	C	T	20q13.1	"criteria provided, conflicting interpretations"	3	NA	N	"OMIM Allelic Variant:600281.0003,UniProtKB (protein):P41235#VAR_004668"	3	9212	20	43042354	C	T	24251	20:43042354:C:T	Pathogenic	12/12/17	-	not provided	CN517202:not provided	MODY - based on pubmed articles	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Athena Diagnostics Inc	SCV000842366.1	SCV000842366		HNF4A	-	"MODY, MODY Extended, MonogenicDM_all"	12/12/17	46962	1	5	"[0.9999467654699544,5.3234530045568755E-5]"	5	SCV000842366577863	single nucleotide variant	NM_000457.4(HNF4A):c.998G>A (p.Arg333His)	3172	HNF4A	HGNC:5024	Conflicting interpretations of pathogenicity	1	22-Nov-17	1375557127	-	RCV000754815;RCV000711966	"MedGen:C1852093,OMIM:125850;MedGen:CN517202"	"Maturity-onset diabetes of the young,  type 1;not provided"	germline	germline	GRCh37	NC_000020.10	20	43052763	43052763	G	A	20q13.12	"criteria provided, conflicting interpretations"	2	NA	N	-	2	586023	20	43052763	G	A	577863	20:43052763:G:A	Uncertain significance	11/22/17	-	not provided	CN517202:not provided	MODY - based on pubmed articles	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Athena Diagnostics Inc	SCV000842377.1	SCV000842377		HNF4A	-	"MODY, MODY Extended, MonogenicDM_all"	11/22/17	46948	15	1	"[0.9999893499190594,1.0650080940615148E-5]"	1	SCV00084237729375	single nucleotide variant	NM_005912.2(MC4R):c.380C>T (p.Ser127Leu)	4160	MC4R	HGNC:6932	Conflicting interpretations of pathogenicity	1	25-May-17	13447331	-	RCV000015412;RCV000414065	"Human Phenotype Ontology:HP:0001513,MedGen:C0028754,OMIM:601665,Orphanet:ORPHA71529,SNOMED CT:414916001;MedGen:CN517202"	Obesity;not provided	germline	germline	GRCh37	NC_000018.9	18	58039203	58039203	G	A	18q21.3	"criteria provided, conflicting interpretations"	6	NA	N	"OMIM Allelic Variant:155541.0021,UniProtKB (protein):P32245#VAR_038643"	3	14336	18	58039203	G	A	29375	18:58039203:G:A	Pathogenic	6/18/13	-	not provided	CN517202:not provided	Obesity	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Athena Diagnostics Inc	SCV000842715.1	SCV000842715		MC4R	-	Obesity	5/25/17	46963	0	18	"[0.999808359772587,1.9164022741306988E-4]"	18	SCV000842715577690	single nucleotide variant	NM_005912.2(MC4R):c.913C>T (p.Arg305Trp)	4160	MC4R	HGNC:6932	Likely pathogenic	1	8-Sep-17	-1	-	RCV000712270	MedGen:CN517202	not provided	germline	germline	GRCh37	NC_000018.9	18	58038670	58038670	G	A	18q21.32	"criteria provided, single submitter"	1	NA	N	-	2	586138	18	58038670	G	A	577690	18:58038670:G:A	Likely pathogenic	9/8/17	-	not provided	CN517202:not provided	Obesity	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Athena Diagnostics Inc	SCV000842720.1	SCV000842720		MC4R	-	Obesity	9/8/17	46963	0	2	"[0.9999787066413985,2.1293358601452207E-5]"	2	SCV000842720577689	single nucleotide variant	NM_005912.2(MC4R):c.983T>A (p.Leu328Ter)	4160	MC4R	HGNC:6932	Pathogenic	1	13-Nov-17	-1	-	RCV000712271	MedGen:CN517202	not provided	germline	germline	GRCh37	NC_000018.9	18	58038600	58038600	A	T	18q21.32	"criteria provided, single submitter"	1	NA	N	-	2	586139	18	58038600	A	T	577689	18:58038600:A:T	Pathogenic	11/13/17	-	not provided	CN517202:not provided	No Information	FALSE	No Information	"criteria provided, single submitter"	clinical testing	germline:na	Athena Diagnostics Inc	SCV000842721.1	SCV000842721		MC4R	-	Obesity	11/13/17	46963	0	2	"[0.9999787066413985,2.1293358601452207E-5]"	2	SCV000842721260011	single nucleotide variant	NM_000545.6(HNF1A):c.779C>T (p.Thr260Met)	6927	HNF1A	HGNC:11621	Pathogenic	1	16-Feb-18	886039544	-	RCV000255526	MedGen:CN517202	not provided	germline	germline	GRCh37	NC_000012.11	12	121432032	121432032	C	T	12q24.31	"criteria provided, multiple submitters, no conflicts"	2	NA	N	-	2	265436	12	121432032	C	T	260011	12:121432032:C:T	Pathogenic	2/16/18	-	not provided	CN517202:not provided	MODY - based on pubmed articles	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	Athena Diagnostics Inc	SCV000844429.1	SCV000844429		HNF1A	-	"MODY, MODY Extended, MonogenicDM_all"	2/16/18	46957	6	1	"[0.9999893519603041,1.0648039695891987E-5]"	1	SCV000844429578489	single nucleotide variant	NM_000352.4(ABCC8):c.4051G>A (p.Val1351Met)	6833	ABCC8	HGNC:59	Likely pathogenic	1	7-Aug-18	-1	-	RCV000714711	"MedGen:C3888018,Orphanet:ORPHA276525"	Familial hyperinsulinism	inherited	germline	GRCh37	NC_000011.9	11	17418531	17418531	C	T	11p15.1	"criteria provided, single submitter"	1	NA	N	-	2	587515	11	17418531	C	T	578489	11:17418531:C:T	Likely pathogenic	8/7/18	-	MedGen:C3888018	C3888018:Familial hyperinsulinism	NA	FALSE	NA	"criteria provided, single submitter"	clinical testing	inherited:1	"Genomic Research Center,Shahid Beheshti University of Medical Sciences"	SCV000845437.1	SCV000845437		ABCC8	-	"MODY Extended, MonogenicDM_all, Neonatal Diabetes"	8/7/18	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV000845437167531	single nucleotide variant	NM_000352.4(ABCC8):c.1562G>A (p.Arg521Gln)	6833	ABCC8	HGNC:59	Conflicting interpretations of pathogenicity	1	1-Jan-17	368114790	-	RCV000144978;RCV000722048	"Human Phenotype Ontology:HP:0000819,MedGen:C0011849,SNOMED CT:73211009;MedGen:C3888018,Orphanet:ORPHA276525"	Diabetes mellitus;Familial hyperinsulinism	germline	germline	GRCh37	NC_000011.9	11	17464335	17464335	C	T	11p15.1	"criteria provided, conflicting interpretations"	2	NA	N	-	2	157683	11	17464335	C	T	167531	11:17464335:C:T	Likely pathogenic	1/1/17	-	MedGen:C3888018	C3888018:Familial hyperinsulinism	NA	FALSE	NA	"criteria provided, single submitter"	research	germline:na	"Snyder Lab, Genetics Department,Stanford University"	SCV000853091.1	SCV000853091		ABCC8	-	"MODY Extended, MonogenicDM_all, Neonatal Diabetes"	1/1/17	46963	0	4	"[0.9999574132827971,4.2586717202904415E-5]"	4	SCV00085309118730	single nucleotide variant	NM_000527.4(LDLR):c.682G>A (p.Glu228Lys)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	31-Oct-18	121908029	-	RCV000735406;RCV000735406;RCV000735406;RCV000003878;RCV000735406;RCV000735406;RCV000623885	"Human Phenotype Ontology:HP:0002647,MedGen:C0340643;Human Phenotype Ontology:HP:0012158,MedGen:C0338585;Human Phenotype Ontology:HP:0012474,MedGen:C0265101;MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;Human Phenotype Ontology:HP:0012159,MedGen:C0751815;Human Phenotype Ontology:HP:0001297,MedGen:C0038454;MedGen:CN517202"	Aortic dissection;Carotid artery dissection;Carotid artery occlusion;Familial hypercholesterolemia;Internal carotid artery dissection;Stroke;not provided	germline;unknown	germline	GRCh37	NC_000019.9	19	11216264	11216264	G	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	19	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000105,OMIM Allelic Variant:606945.0007,UniProtKB (protein):P01130#VAR_005341"	3	3691	19	11216264	G	A	18730	19:11216264:G:A	Pathogenic	NA	-	Human Phenotype Ontology:HP:0001297;Human Phenotype Ontology:HP:0002647;Human Phenotype Ontology:HP:0012158;Human Phenotype Ontology:HP:0012159;Human Phenotype Ontology:HP:0012474	C0038454:Stroke;C0265101:Carotid artery occlusion;C0338585:Carotid artery dissection;C0340643:Aortic dissection;C0751815:Internal carotid artery dissection	NA	FALSE	NA	"criteria provided, single submitter"	clinical testing	germline:na	"CHLA Center for Personalized Medicine,Children's Hospital, Los Angeles"	SCV000854561.2	SCV000854561		LDLR	-	High LDL	10/31/18	46944	19	2	"[0.9999786980231765,2.1301976823449217E-5]"	2	SCV00085456145501	single nucleotide variant	NM_000458.3(HNF1B):c.140C>T (p.Pro47Leu)	6928	HNF1B	HGNC:11630	Conflicting interpretations of pathogenicity	1	27-Nov-17	193922483	-	RCV000030521;RCV000730643	"MedGen:C0431693,OMIM:137920,SNOMED CT:253864004;MedGen:CN517202"	"Familial hypoplastic, glomerulocystic kidney;not provided"	germline	germline	GRCh37	NC_000017.10	17	36104736	36104736	G	A	17q12	"criteria provided, conflicting interpretations"	2	NA	N	-	2	36840	17	36104736	G	A	45501	17:36104736:G:A	Uncertain significance	11/27/17	-	not provided	CN517202:not provided	No Information	FALSE	No Information	"criteria provided, single submitter"	clinical testing	germline:1	"EGL Genetic Diagnostics,Eurofins Clinical Diagnostics"	SCV000858394.1	SCV000858394		HNF1B	-	"MODY, MODY Extended, MonogenicDM_all, Neonatal Diabetes"	11/27/17	46962	1	6	"[0.9999361185639453,6.388143605468251E-5]"	6	SCV00085839429357	single nucleotide variant	NM_005912.2(MC4R):c.105C>A (p.Tyr35Ter)	4160	MC4R	HGNC:6932	Pathogenic	1	14-Aug-18	13447324	-	RCV000015394;RCV000202583;RCV000255005	"Human Phenotype Ontology:HP:0001513,MedGen:C0028754,OMIM:601665,Orphanet:ORPHA71529,SNOMED CT:414916001;Human Phenotype Ontology:HP:0100753,MedGen:C0036341,OMIM:181500,SNOMED CT:58214004;MedGen:CN517202"	Obesity;Schizophrenia;not provided	germline	germline	GRCh37	NC_000018.9	18	58039478	58039478	G	T	18q21.3	"criteria provided, multiple submitters, no conflicts"	8	NA	N	OMIM Allelic Variant:155541.0003	3	14318	18	58039478	G	T	29357	18:58039478:G:T	Pathogenic	8/14/18	-	not provided	CN517202:not provided	Pubmed articles mention obesity	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:1	"EGL Genetic Diagnostics,Eurofins Clinical Diagnostics"	SCV000862775.1	SCV000862775		MC4R	-	Obesity	8/14/18	46963	0	6	"[0.9999361199241956,6.388007580435663E-5]"	6	SCV000862775226399	single nucleotide variant	NM_000527.4(LDLR):c.941-4G>A	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	12-Jan-18	116405216	-	RCV000210248;RCV000736080	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN169374"	Familial hypercholesterolemia;not specified	germline;unknown	germline	GRCh37	NC_000019.9	19	11221324	11221324	G	A	19p13.2	"criteria provided, conflicting interpretations"	10	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000515	2	224619	19	11221324	G	A	226399	19:11221324:G:A	Likely benign	5/17/17	"BS1, BP4; This alteration has an allele frequency that is greater than expected for the associated disease, and is predicted to be tolerated by multiple functional prediction tools."	Not Specified	CN169374:not specified	No Information	FALSE	No Information	"criteria provided, single submitter"	clinical testing	germline:na	"Institute for Genomic Medicine (IGM) Clinical Laboratory,Nationwide Children's Hospital"	SCV000864320.1	SCV000864320		LDLR	-	High LDL	1/12/18	46963	0	399	"[0.9957519749590102,0.004248025040989715]"	389	SCV00086432029525	single nucleotide variant	NM_170707.3(LMNA):c.1445G>A (p.Arg482Gln)	4000	LMNA	HGNC:6636	Pathogenic	1	31-Oct-18	11575937	-	RCV000763258;RCV000763258;RCV000459624;RCV000763258;RCV000763258;RCV000763258;RCV000190399;RCV000763258;RCV000015575;RCV000763258;RCV000763258;RCV000763258;RCV000041318;RCV000763258;RCV000763258;RCV000754814;RCV000148600;RCV000057299	"MedGen:C0410190,OMIM:181350,Orphanet:ORPHA98853,SNOMED CT:240072005;MedGen:C1854154,OMIM:605588,Orphanet:ORPHA98856;MedGen:C0270914,Orphanet:ORPHA64746;MedGen:C2750785,OMIM:613205,Orphanet:ORPHA157973;MedGen:C1449563,OMIM:115200,Orphanet:ORPHA300751;MedGen:C0796031,OMIM:212112,Orphanet:ORPHA2229;MedGen:C2750035,OMIM:616516,Orphanet:ORPHA98855;MedGen:C2750035,OMIM:616516,Orphanet:ORPHA98855;MedGen:C1720860,OMIM:151660,Orphanet:ORPHA2348;MedGen:C1720860,OMIM:151660,Orphanet:ORPHA2348;MedGen:C1857829,OMIM:610140,Orphanet:ORPHA168796;MedGen:C0033300,OMIM:176670,Orphanet:ORPHA740,SNOMED CT:238870004;MedGen:CN236383,Orphanet:ORPHA98301;MedGen:C0406585,OMIM:275210,Orphanet:ORPHA1662,SNOMED CT:400128006;MedGen:C0432291,OMIM:248370,Orphanet:ORPHA2457,SNOMED CT:109419009;MedGen:C3888631;MedGen:CN221589;MedGen:CN517202"	"Benign scapuloperoneal muscular dystrophy with cardiomyopathy;Charcot-Marie-Tooth disease type 2B1;Charcot-Marie-Tooth disease, type 2;Congenital muscular dystrophy, LMNA-related;Dilated cardiomyopathy 1A;Dilated cardiomyopathy-hypergonadotropic hypogonadism syndrome;Emery-Dreifuss muscular dystrophy 3, autosomal recessive;Emery-Dreifuss muscular dystrophy 3, autosomal recessive;Familial partial lipodystrophy 2;Familial partial lipodystrophy 2;Heart-hand syndrome, Slovenian type;Hutchinson-Gilford syndrome;Laminopathy;Lethal tight skin contracture syndrome;Mandibuloacral dysostosis;Monogenic diabetes;Partial lipodystrophy, Dunnigan;not provided"	de novo;germline;unknown	germline	GRCh37	NC_000001.10	1	156106776	156106776	G	A	1q22	"criteria provided, multiple submitters, no conflicts"	10	"ACMG2013,ACMG2016"	N	"OMIM Allelic Variant:150330.0010,UniProtKB (protein):P02545#VAR_009992"	3	14486	1	156106776	G	A	29525	1:156106776:G:A	Pathogenic	12/7/17	"The c.1445G>A variant in codon 482 (exon 8 of the RefSeq gene) of the Lamin A/C gene, LMNA, results in the substitution of Arginine to Glutamine. Mutations in the LMNA gene have been found to cause multiple disorders, collectively known as A-type laminopathies, that have overlapping signs and symptoms (23853504, 20074070, OMIM, 16364671). A-type laminopathies include familial partial lipodystrophy type 2 (FPLD2, also called familial partial lipodystrophy, Dunnigan type), Limb-Girdle muscular dystrophy type 1B, Emery-Dreifuss muscular dystrophy (EDMD), Charcot-Marie-Tooth type 2B1 disease, Hutchinson-Gilford progeria, Heart-hand syndrome, Slovenian type, mandibuloacral dysplasia, Malouf syndrome, and familial dilated cardiomyopathy (23853504, 20074070, OMIM). To date, no clear genotype-phenotype correlations have been identified (23853504, 20074070). The c.1445G>A variant has been identified in multiple individuals over multiple generations in families with clinical diagnoses of FPLD2 (22700598, 10868844, 10999845, 10587585, 10739751, 10655060). This variant was also found in the homozygous state in an individual with FPLD2 and autosomal recessive-EDMD (23313286). A different amino acid change at codon 482, Arg482Trp, has also been shown to segregate with FPLD2 (23853504, 22700598, 10999845, 10739751, 10655060). Approximately 75% of patients with FPLD2 have a mutation at Arg482, making it a mutational hotspot for FPLD2 (16364671). Multiple lines of computational evidence (SIFT, LRT, MutationTaster, FATHMM, MetaSVM, MetalR, GERP, CADD) predict the c.1445G>A variant is probably damaging to the protein structure, function, or protein-protein interaction. Indeed, functional studies of the Arg482Gln mutant protein, as well as the Arg482Trp protein, demonstrated a failure of adipocyte cell differentiation (16415042). A transgenic mouse harboring the Arg482Gln mutation recapitulates the FPLD2 phenotype and studies confirmed a lack of adipocyte renewal (19201734). ACMG criteria = PS3, PS4, PP1-strong, PM1, PM5, PP3"	MedGen:C3888631	C3888631:Monogenic diabetes	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	"Translational Genomics Laboratory,University of Maryland School of Medicine"	SCV000882464.1	SCV000882464		LMNA	-	"Lipodystrophy, MonogenicDM_all"	10/31/18	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV000882464577863	single nucleotide variant	NM_000457.4(HNF4A):c.998G>A (p.Arg333His)	3172	HNF4A	HGNC:5024	Conflicting interpretations of pathogenicity	1	22-Nov-17	1375557127	-	RCV000754815;RCV000711966	"MedGen:C1852093,OMIM:125850;MedGen:CN517202"	"Maturity-onset diabetes of the young,  type 1;not provided"	germline	germline	GRCh37	NC_000020.10	20	43052763	43052763	G	A	20q13.12	"criteria provided, conflicting interpretations"	2	NA	N	-	2	586023	20	43052763	G	A	577863	20:43052763:G:A	Pathogenic	10/19/17	"The c.923G>A variant in codon 308 (exon 10) of the Hepatocyte Nuclear Factor 4-Alpha gene, HNF4A, results in the substitution of Arginine to Histidine. Missense mutations in the HNF4A gene, including ones in exon 10, have been reported previously in patients with a clinical picture consistent with Maturity-Onset Diabetes of the Young, Type 1 (MODY1) (23348805). The c.923G>A variant was not observed in the NHLBI Exome Sequencing Project, 1000 Genomes Project, or Exome Aggregation Consortium databases; however, the c.923G>A variant has been previously identified in multiple individuals with a diagnosis of MODY1 (10768098, 24947580, 26059258), with evidence of co-segregation in three families (24947580, K. Colclough, personal communication, January 3rd, 2017). Different amino acid substitutions at Arg308 (Arg308Cys and Arg308Ser) have been identified in patients with a strong MODY1 phenotype and have shown co-segregation in one family (K. Colclough, personal communication, January 3rd, 2017). Additionally, multiple lines of computational evidence (SIFT, Polyphen, MutationTaster, FATHMM, MetaSVM, MetalR, Provean, GERP, CADD) predict this variant is probably damaging to the protein structure, function, or protein-protein interaction. The c.923G>A variant is located in the ligand-binding domain of the protein, a region of the protein that has minimal benign variation among individuals in population databases and in the literature (23485969, 16917892). ACMG criteria = PP1-strong, PM1, PM2, PM5, PP3"	MedGen:C1852093	"C1852093:Maturity-onset diabetes of the young, type 1"	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	"Translational Genomics Laboratory,University of Maryland School of Medicine"	SCV000882465.1	SCV000882465		HNF4A	-	"MODY, MODY Extended, MonogenicDM_all"	11/22/17	46948	15	1	"[0.9999893499190594,1.0650080940615148E-5]"	1	SCV000882465415104	single nucleotide variant	NM_000162.3(GCK):c.571C>T (p.Arg191Trp)	2645	GCK	HGNC:4195	Pathogenic	1	7-Nov-17	1085307455	-	RCV000754816;RCV000490143	"MedGen:C1841962,OMIM:125851;MedGen:CN517202"	"Maturity-onset diabetes of the young,  type 2;not provided"	germline	germline	GRCh37	NC_000007.13	7	44189576	44189576	G	A	7p13	"criteria provided, multiple submitters, no conflicts"	3	NA	N	-	2	426122	7	44189576	G	A	415104	7:44189576:G:A	Pathogenic	11/7/17	"The c.571C>T variant in codon 191 (exon 6) of the glucokinase gene, GCK, results in the substitution of Arginine to Tryptophan. Missense mutations in GCK, including ones in exon 6, have been reported in patients with Maturity-Onset Diabetes of the Young, Type 2 (MODY2, also called GCK-MODY) (19790256). The c.571C>T variant was not observed in the NHLBI Exome Sequencing Project, 1000 Genomes Project, or Exome Aggregation Consortium databases; however, the c.571C>T variant was previously identified in individuals with a MODY2 phenotype of Korean, Norwegian, Belgian, Brazilian, French, Japanese, Italian, and British descent (16632067, 18399931, 16965331, 23295292, 18411240, 22060211, 11508276, 10753050) . Other amino acid substitutions at this residue, p.Arg191Gln and p.Arg191Leu, have been found in individuals with a MODY2 phenotype (19790256, 11508276, 16444761, 19309449). Additionally, multiple lines of computational evidence (LRT, MutationTaster, FATHMM, MetaSVM, MetalR, Provean, GERP, CADD) predict this variant is probably damaging to the protein structure, function, or protein-protein interaction. The c.571C>T variant is located within the small domain of the protein, a region considered to be a mutational hotspot (18382660). ACMG criteria = PS4, PM1, PM2, PP1-mod, PP3"	MedGen:C1841962	"C1841962:Maturity-onset diabetes of the young, type 2"	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	"Translational Genomics Laboratory,University of Maryland School of Medicine"	SCV000882466.1	SCV000882466		GCK	-	"MODY, MODY Extended, MonogenicDM_all"	11/7/17	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV00088246657261	single nucleotide variant	NM_170707.3(LMNA):c.976T>A (p.Ser326Thr)	4000	LMNA	HGNC:6636	Conflicting interpretations of pathogenicity	1	21-Nov-18	56851164	-	RCV000621488;RCV000544253;RCV000755678;RCV000208012;RCV000057494;RCV000212504	"MedGen:CN230736;MedGen:C0270914,Orphanet:ORPHA64746;MedGen:C1449563,OMIM:115200,Orphanet:ORPHA300751;MedGen:C0949658,Orphanet:ORPHA155,SNOMED CT:83978005;MedGen:CN517202;MedGen:CN169374"	"Cardiovascular phenotype;Charcot-Marie-Tooth disease, type 2;Dilated cardiomyopathy 1A;Primary familial hypertrophic cardiomyopathy;not provided;not specified"	germline;unknown	germline	GRCh37	NC_000001.10	1	156105731	156105731	T	A	1q22	"criteria provided, conflicting interpretations"	8	"ACMG2013,ACMG2016"	N	-	2	48097	1	156105731	T	A	57261	1:156105731:T:A	Uncertain significance	11/21/18	-	OMIM:115200	C1449563:Dilated cardiomyopathy 1A	NA	FALSE	NA	"criteria provided, single submitter"	clinical testing	unknown:na	"Equipe Genetique des Anomalies du Developpement,Université de Bourgogne"	SCV000883086.1	SCV000883086		LMNA	-	"Lipodystrophy, MonogenicDM_all"	11/21/18	46959	4	3	"[0.9999680572414233,3.1942758576630676E-5]"	3	SCV00088308629566	single nucleotide variant	NM_170707.3(LMNA):c.1930C>T (p.Arg644Cys)	4000	LMNA	HGNC:6636	Conflicting interpretations of pathogenicity	1	21-Nov-18	142000963	-	RCV000245284;RCV000144868;RCV000471403;RCV000755679;RCV000148602;RCV000015626;RCV000057374;RCV000041340	"MedGen:CN230736;MedGen:C0007959,Orphanet:ORPHA166,SNOMED CT:50548001;MedGen:C0270914,Orphanet:ORPHA64746;MedGen:C1449563,OMIM:115200,Orphanet:ORPHA300751;EFO:EFO_0000407,Human Phenotype Ontology:HP:0001644,MedGen:C0007193,Orphanet:ORPHA217604,SNOMED CT:195021004;na;MedGen:CN517202;MedGen:CN169374"	"Cardiovascular phenotype;Charcot-Marie-Tooth disease;Charcot-Marie-Tooth disease, type 2;Dilated cardiomyopathy 1A;Primary dilated cardiomyopathy;Variant of unknown significance;not provided;not specified"	germline;tested-inconclusive;unknown	germline	GRCh37	NC_000001.10	1	156108510	156108510	C	T	1q22	"criteria provided, conflicting interpretations"	13	"ACMG2013,ACMG2016"	N	"OMIM Allelic Variant:150330.0051,UniProtKB (protein):P02545#VAR_039792"	3	14527	1	156108510	C	T	29566	1:156108510:C:T	Uncertain significance	11/21/18	-	OMIM:115200	C1449563:Dilated cardiomyopathy 1A	NA	FALSE	NA	"criteria provided, single submitter"	clinical testing	unknown:na	"Equipe Genetique des Anomalies du Developpement,Université de Bourgogne"	SCV000883087.1	SCV000883087		LMNA	-	"Lipodystrophy, MonogenicDM_all"	11/21/18	46954	9	67	"[0.9992865357584019,7.134642415981599E-4]"	65	SCV00088308729525	single nucleotide variant	NM_170707.3(LMNA):c.1445G>A (p.Arg482Gln)	4000	LMNA	HGNC:6636	Pathogenic	1	31-Oct-18	11575937	-	RCV000763258;RCV000763258;RCV000459624;RCV000763258;RCV000763258;RCV000763258;RCV000190399;RCV000763258;RCV000015575;RCV000763258;RCV000763258;RCV000763258;RCV000041318;RCV000763258;RCV000763258;RCV000754814;RCV000148600;RCV000057299	"MedGen:C0410190,OMIM:181350,Orphanet:ORPHA98853,SNOMED CT:240072005;MedGen:C1854154,OMIM:605588,Orphanet:ORPHA98856;MedGen:C0270914,Orphanet:ORPHA64746;MedGen:C2750785,OMIM:613205,Orphanet:ORPHA157973;MedGen:C1449563,OMIM:115200,Orphanet:ORPHA300751;MedGen:C0796031,OMIM:212112,Orphanet:ORPHA2229;MedGen:C2750035,OMIM:616516,Orphanet:ORPHA98855;MedGen:C2750035,OMIM:616516,Orphanet:ORPHA98855;MedGen:C1720860,OMIM:151660,Orphanet:ORPHA2348;MedGen:C1720860,OMIM:151660,Orphanet:ORPHA2348;MedGen:C1857829,OMIM:610140,Orphanet:ORPHA168796;MedGen:C0033300,OMIM:176670,Orphanet:ORPHA740,SNOMED CT:238870004;MedGen:CN236383,Orphanet:ORPHA98301;MedGen:C0406585,OMIM:275210,Orphanet:ORPHA1662,SNOMED CT:400128006;MedGen:C0432291,OMIM:248370,Orphanet:ORPHA2457,SNOMED CT:109419009;MedGen:C3888631;MedGen:CN221589;MedGen:CN517202"	"Benign scapuloperoneal muscular dystrophy with cardiomyopathy;Charcot-Marie-Tooth disease type 2B1;Charcot-Marie-Tooth disease, type 2;Congenital muscular dystrophy, LMNA-related;Dilated cardiomyopathy 1A;Dilated cardiomyopathy-hypergonadotropic hypogonadism syndrome;Emery-Dreifuss muscular dystrophy 3, autosomal recessive;Emery-Dreifuss muscular dystrophy 3, autosomal recessive;Familial partial lipodystrophy 2;Familial partial lipodystrophy 2;Heart-hand syndrome, Slovenian type;Hutchinson-Gilford syndrome;Laminopathy;Lethal tight skin contracture syndrome;Mandibuloacral dysostosis;Monogenic diabetes;Partial lipodystrophy, Dunnigan;not provided"	de novo;germline;unknown	germline	GRCh37	NC_000001.10	1	156106776	156106776	G	A	1q22	"criteria provided, multiple submitters, no conflicts"	10	"ACMG2013,ACMG2016"	N	"OMIM Allelic Variant:150330.0010,UniProtKB (protein):P02545#VAR_009992"	3	14486	1	156106776	G	A	29525	1:156106776:G:A	Pathogenic	8/11/17	"The LMNA c.1445G>A, p.Arg482Gln variant (rs11575937) has been reported in multiple families with familial partial lipodystrophy (Dunnigan-type) (Cao 2000, Drac 2010, Gamberini 2008, Hegele 2000, Hegele 2000b, Imachi 2009, Ludtke 2005, Shackleton 2000, Speckman 2000, Vigouroux 2000), and co-segregated with affected individuals (Cao 2000, Hegele 2000, Speckman 2000). Other missense variants at this position (p.Arg482Trp and p.Arg482Leu) have also been implicated in familial partial lipodystrophy (Hegele 2000b, Shackleton 2000, Speckman 2000, Vigouroux 2000). The variant protein appears to have no significant impact on the structural integrity of the nucleus, but appears to decrease Lamin B2 expression (Zwerger 2013). Transgenic mice expressing the human variant protein shows increase blood insulin levels, reduced insulin sensitivity, and impaired adipocyte differentiation, consistent with the clinical phenotypes in patients (Wojtanik 2009). The p.Arg482Gln variant is listed as pathogenic in ClinVar (Variation ID: 14486), and observed once in the Exome Variant Server (1/13006 alleles) and Genome Aggregation Database (1/246132 alleles). Based on the above information, the variant is classified as pathogenic. References: Cao H et al. Nuclear lamin A/C R482Q mutation in canadian kindreds with Dunnigan-type familial partial lipodystrophy. Hum Mol Genet. 2000; 9(1):109-12. Gambineri A et al. Monogenic polycystic ovary syndrome due to a mutation in the lamin A/C gene is sensitive to thiazolidinediones but not to metformin. Eur J Endocrinol. 2008; 159(3):347-53. Hegele R et al. Association between nuclear lamin A/C R482Q mutation and partial lipodystrophy with hyperinsulinemia, dyslipidemia, hypertension, and diabetes. Genome Res. 2000; 10(5):652-8. Hegele R et al. Heterogeneity of nuclear lamin A mutations in Dunnigan-type familial partial lipodystrophy. J Clin Endocrinol Metab. 2000b; 85(9):3431-5. Imachi H et al. A case of Dunnigan-type familial partial lipodystrophy (FPLD) due to lamin A/C (LMNA) mutations complicated by end-stage renal disease. Endocrine. 2009; 35(1):18-21. Ludtke A et al. Hepatic steatosis in Dunnigan-type familial partial lipodystrophy. Am J Gastroenterol. 2005; 100(10):2218-24. Shackleton S et al. LMNA, encoding lamin A/C, is mutated in partial lipodystrophy. Nat Genet. 2000; 24(2):153-6. Speckman R et al. Mutational and haplotype analyses of families with familial partial lipodystrophy (Dunnigan variety) reveal recurrent missense mutations in the globular C-terminal domain of lamin A/C. Am J Hum Genet. 2000; 66(4):1192-8. Vigouroux C et al. Lamin A/C gene: sex-determined expression of mutations in Dunnigan-type familial partial lipodystrophy and absence of coding mutations in congenital and acquired generalized lipoatrophy. Diabetes. 2000; 49(11):1958-62. Wojtanik K et al. The role of LMNA in adipose: a novel mouse model of lipodystrophy based on the Dunnigan-type familial partial lipodystrophy mutation. J Lipid Res. 2009; 50(6):1068-79. Zwerger M et al. Myopathic lamin mutations impair nuclear stability in cells and tissue and disrupt nucleo-cytoskeletal coupling. Hum Mol Genet. 2013; 22(12):2335-49."	Not Provided	CN517202:not provided	familial partial lipodystrophy (Dunnigan-type) 	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:na	"ARUP Laboratories, Molecular Genetics and Genomics,ARUP Laboratories"	SCV000885655.1	SCV000885655		-	-	"Lipodystrophy, MonogenicDM_all"	10/31/18	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV00088565532929	single nucleotide variant	NM_000384.2(APOB):c.10580G>A (p.Arg3527Gln)	338	APOB	HGNC:603	Conflicting interpretations of pathogenicity	1	11-Jul-18	5742904	-	RCV000019479;RCV000284412;RCV000412515;RCV000627797;RCV000499833;RCV000627797;RCV000254882	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C1862596,Orphanet:ORPHA426,SNOMED CT:60193003;MedGen:C1704417,OMIM:144010;MedGen:C1704417,OMIM:144010;MedGen:C0020597,Orphanet:ORPHA31154;MedGen:C4551990,OMIM:615558;MedGen:CN517202"	"Familial hypercholesterolemia;Familial hypobetalipoproteinemia;Hypercholesterolemia, autosomal dominant, type B;Hypercholesterolemia, autosomal dominant, type B;Hypobetalipoproteinemia;Hypobetalipoproteinemia, familial, 1;not provided"	germline;maternal;unknown	germline	GRCh37	NC_000002.11	2	21229160	21229160	C	T	2p24	"criteria provided, conflicting interpretations"	18	"ACMG2013,ACMG2016"	Y	OMIM Allelic Variant:107730.0009	3	17890	2	21229160	C	T	32929	2:21229160:C:T	Pathogenic	7/11/18	-	not provided	CN517202:not provided	No Information	FALSE	No Information	"criteria provided, single submitter"	clinical testing	germline:na	Quest Diagnostics Nichols Institute San Juan Capistrano	SCV000887561.1	SCV000887561		APOB	-	Low LDL	7/11/18	46963	0	12	"[0.9998722398483912,1.2776015160871325E-4]"	12	SCV00088756145114	single nucleotide variant	NM_000527.4(LDLR):c.1061-8T>C	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	31-May-18	72658861	-	RCV000030123;RCV000759074;RCV000245346	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202;MedGen:CN169374"	Familial hypercholesterolemia;not provided;not specified	germline;unknown	germline	GRCh37	NC_000019.9	19	11222182	11222182	T	C	19p13.2	"criteria provided, conflicting interpretations"	15	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_000154	2	36451	19	11222182	T	C	45114	19:11222182:T:C	Benign	5/31/18	-	not provided	CN517202:not provided	No Information	FALSE	No Information	"criteria provided, single submitter"	clinical testing	germline:na	Quest Diagnostics Nichols Institute San Juan Capistrano	SCV000888160.1	SCV000888160		LDLR	-	High LDL	5/31/18	46960	3	426	"[0.9954642248722317,0.004535775127768314]"	420	SCV000888160171217	single nucleotide variant	NM_000527.4(LDLR):c.1775G>A (p.Gly592Glu)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	31-Oct-18	137929307	-	RCV000172964;RCV000587007;RCV000148576;RCV000162001	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:C0020443;MedGen:CN517202"	Familial hypercholesterolemia;Familial hypercholesterolemias;Hypercholesterolaemia;not provided	germline;inherited;not applicable;unknown	germline	GRCh37	NC_000019.9	19	11227604	11227604	G	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	22	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000237,UniProtKB (protein):P01130#VAR_005403"	2	161271	19	11227604	G	A	171217	19:11227604:G:A	Pathogenic	8/24/18	-	not provided	CN517202:not provided	No Information	FALSE	No Information	"criteria provided, single submitter"	clinical testing	germline:na	Quest Diagnostics Nichols Institute San Juan Capistrano	SCV000888163.1	SCV000888163		LDLR	-	High LDL	10/31/18	46963	0	3	"[0.9999680599620978,3.194003790217831E-5]"	3	SCV000888163198013	single nucleotide variant	NM_000527.4(LDLR):c.718G>A (p.Glu240Lys)	3949	LDLR	HGNC:6547	Conflicting interpretations of pathogenicity	1	22-May-18	768563000	-	RCV000211564;RCV000586018;RCV000182341	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:CN517202"	Familial hypercholesterolemia;Familial hypercholesterolemias;not provided	germline	germline	GRCh37	NC_000019.9	19	11217264	11217264	G	A	19p13.2	"criteria provided, conflicting interpretations"	9	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_001828,UniProtKB (protein):P01130#VAR_005343"	2	200920	19	11217264	G	A	198013	19:11217264:G:A	Pathogenic	5/22/18	-	not provided	CN517202:not provided	No Information	FALSE	No Information	"criteria provided, single submitter"	clinical testing	germline:na	Quest Diagnostics Nichols Institute San Juan Capistrano	SCV000888167.1	SCV000888167		LDLR	-	High LDL	5/22/18	46963	0	3	"[0.9999680599620978,3.194003790217831E-5]"	3	SCV000888167611361	single nucleotide variant	NM_000162.5(GCK):c.45+1G>T	2645	GCK	HGNC:4195	Pathogenic	1	17-Aug-17	-1	-	RCV000760157	"MedGen:C1841962,OMIM:125851"	"Maturity-onset diabetes of the young,  type 2"	germline	germline	GRCh37	NC_000007.13	7	44228507	44228507	C	A	7p13	"criteria provided, single submitter"	1	NA	N	-	2	619964	7	44228507	C	A	611361	7:44228507:C:A	Pathogenic	8/17/17	-	OMIM:125851	"C1841962:Maturity-onset diabetes of the young, type 2"	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:1	"Molecular Diagnostics Laboratory,M Health: University of Minnesota"	SCV000889974.1	SCV000889974		GCK	-	"MODY, MODY Extended, MonogenicDM_all"	8/17/17	46962	1	1	"[0.9999893530939908,1.0646906009113752E-5]"	1	SCV00088997444907	single nucleotide variant	NM_000162.5(GCK):c.676G>A (p.Val226Met)	2645	GCK	HGNC:4195	Pathogenic/Likely pathogenic	1	31-Oct-18	148311934	-	RCV000763584;RCV000763584;RCV000029906;RCV000763584;RCV000763584;RCV000255932	"Human Phenotype Ontology:HP:0005978,MedGen:C0011860,OMIM:125853,Orphanet:ORPHA181376,SNOMED CT:44054006;MedGen:C1865290,OMIM:602485,Orphanet:ORPHA79299;MedGen:C1841962,OMIM:125851;MedGen:C1841962,OMIM:125851;MedGen:C1833104,OMIM:606176,Orphanet:ORPHA99885;MedGen:CN517202"	"Diabetes mellitus type 2;Hyperinsulinemic hypoglycemia familial 3;Maturity-onset diabetes of the young,  type 2;Maturity-onset diabetes of the young,  type 2;Permanent neonatal diabetes mellitus;not provided"	germline;unknown	germline	GRCh37	NC_000007.13	7	44189362	44189362	C	T	7p13	"criteria provided, multiple submitters, no conflicts"	6	NA	N	UniProtKB (protein):P35557#VAR_003703	2	36243	7	44189362	C	T	44907	7:44189362:C:T	Likely pathogenic	10/4/16	-	OMIM:125851	"C1841962:Maturity-onset diabetes of the young, type 2"	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	germline:1	"Molecular Diagnostics Laboratory,M Health: University of Minnesota"	SCV000891242.1	SCV000891242		GCK	-	"MODY, MODY Extended, MonogenicDM_all"	10/31/18	46963	0	2	"[0.9999787066413985,2.1293358601452207E-5]"	2	SCV000891242425956	single nucleotide variant	NM_000545.6(HNF1A):c.1135C>G (p.Pro379Ala)	6927	HNF1A	HGNC:11621	Pathogenic/Likely pathogenic	1	31-Oct-18	754729248	-	RCV000762890;RCV000762890;RCV000762890;RCV000762890;RCV000762890;RCV000762890;RCV000497653	"MedGen:C0011854,OMIM:222100,Orphanet:ORPHA181371,SNOMED CT:46635009;Human Phenotype Ontology:HP:0005978,MedGen:C0011860,OMIM:125853,Orphanet:ORPHA181376,SNOMED CT:44054006;MedGen:C2675866,OMIM:612520;MedGen:C1840646,OMIM:142330;MedGen:C1838100,OMIM:600496;MedGen:C3160732,OMIM:144700;MedGen:CN517202"	"Diabetes mellitus type 1;Diabetes mellitus type 2;Diabetes mellitus, insulin-dependent, 20;Hepatic adenomas, familial;Maturity-onset diabetes of the young, type 3;Renal cell carcinoma, nonpapillary;not provided"	germline;unknown	germline	GRCh37	NC_000012.11	12	121434371	121434371	C	G	12q24.31	"criteria provided, multiple submitters, no conflicts"	2	NA	N	-	2	431970	12	121434371	C	G	425956	12:121434371:C:G	Pathogenic	10/31/18	-	OMIM:125853;OMIM:142330;OMIM:144700;OMIM:222100;OMIM:600496;OMIM:612520	"C0011854:Diabetes mellitus type 1;C0011860:Diabetes mellitus type 2;C1838100:Maturity-onset diabetes of the young, type 3;C1840646:Hepatic adenomas, familial;C2675866:Diabetes mellitus, insulin-dependent, 20;C3160732:Renal cell carcinoma, nonpapillary"	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	unknown:na	"Fulgent Genetics,Fulgent Genetics"	SCV000893280.1	SCV000893280		-	-	"MODY, MODY Extended, MonogenicDM_all"	10/31/18	46953	10	29	"[0.9996911805422444,3.0881945775562794E-4]"	27	SCV00089328016561	single nucleotide variant	NM_000237.3(LPL):c.644G>A (p.Gly215Glu)	4023	LPL	HGNC:6677	Pathogenic	1	31-Oct-18	118204057	-	RCV000763181;RCV000001586;RCV000763181;RCV000521241	"Human Phenotype Ontology:HP:0008158,MedGen:C0020474,OMIM:144250;MedGen:C0023817,OMIM:238600,Orphanet:ORPHA309015,SNOMED CT:238086005,SNOMED CT:275598004;MedGen:C0023817,OMIM:238600,Orphanet:ORPHA309015,SNOMED CT:238086005,SNOMED CT:275598004;MedGen:CN517202"	"Hyperapobetalipoproteinemia;Hyperlipoproteinemia, type I;Hyperlipoproteinemia, type I;not provided"	germline;unknown	germline	GRCh37	NC_000008.10	8	19811733	19811733	G	A	8p21.3	"criteria provided, multiple submitters, no conflicts"	3	NA	N	"OMIM Allelic Variant:609708.0002,UniProtKB (protein):P06858#VAR_004225"	3	1522	8	19811733	G	A	16561	8:19811733:G:A	Pathogenic	10/31/18	-	OMIM:144250;OMIM:238600	"C0020474:Hyperapobetalipoproteinemia;C0023817:Hyperlipoproteinemia, type I"		???This gene is only in our list for High LDL??		"criteria provided, single submitter"	clinical testing	unknown:na	"Fulgent Genetics,Fulgent Genetics"	SCV000893780.1	SCV000893780		-	-	High triglycerides	10/31/18	46963	0	13	"[0.9998615931690905,1.3840683090943933E-4]"	13	SCV00089378023725	single nucleotide variant	NM_000525.3(KCNJ11):c.844G>A (p.Glu282Lys)	3767	KCNJ11	HGNC:6257	Pathogenic/Likely pathogenic	1	31-Oct-18	267607196	-	RCV000763231;RCV000009223;RCV000763231;RCV000763231;RCV000763231;RCV000763231	"Human Phenotype Ontology:HP:0005978,MedGen:C0011860,OMIM:125853,Orphanet:ORPHA181376,SNOMED CT:44054006;MedGen:C2931833,OMIM:601820,SNOMED CT:42681006;MedGen:C2931833,OMIM:601820,SNOMED CT:42681006;MedGen:C4225365,OMIM:616329;MedGen:C1833104,OMIM:606176,Orphanet:ORPHA99885;MedGen:C1864623,OMIM:610582"	"Diabetes mellitus type 2;Islet cell hyperplasia;Islet cell hyperplasia;Maturity-onset diabetes of the young, type 13;Permanent neonatal diabetes mellitus;Transient neonatal diabetes mellitus 3"	germline;unknown	germline	GRCh37	NC_000011.9	11	17408795	17408795	C	T	11p15.1	"criteria provided, multiple submitters, no conflicts"	3	NA	N	OMIM Allelic Variant:600937.0022	3	8686	11	17408795	C	T	23725	11:17408795:C:T	Likely pathogenic	10/31/18	-	OMIM:125853;OMIM:601820;OMIM:606176;OMIM:610582;OMIM:616329	"C0011860:Diabetes mellitus type 2;C1833104:Permanent neonatal diabetes mellitus;C1864623:Transient neonatal diabetes mellitus 3;C2931833:Islet cell hyperplasia;C4225365:Maturity-onset diabetes of the young, type 13"	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	unknown:na	"Fulgent Genetics,Fulgent Genetics"	SCV000893864.1	SCV000893864		-	-	"MODY Extended, MonogenicDM_all, Neonatal Diabetes"	10/31/18	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV000893864186816	single nucleotide variant	NM_001287174.1(ABCC8):c.2509C>T (p.Arg837Ter)	6833	ABCC8	HGNC:59	Pathogenic/Likely pathogenic	1	31-Oct-18	72559722	-	RCV000763234;RCV000763234;RCV000763234;RCV000169276;RCV000763234;RCV000763234;RCV000201895	"Human Phenotype Ontology:HP:0005978,MedGen:C0011860,OMIM:125853,Orphanet:ORPHA181376,SNOMED CT:44054006;MedGen:C0271714,OMIM:240800,SNOMED CT:62151007;MedGen:C1833104,OMIM:606176,Orphanet:ORPHA99885;MedGen:C2931832,OMIM:256450,SNOMED CT:360339005;MedGen:C2931832,OMIM:256450,SNOMED CT:360339005;MedGen:C1835887,OMIM:610374;MedGen:CN517202"	Diabetes mellitus type 2;Leucine-induced hypoglycemia;Permanent neonatal diabetes mellitus;Persistent hyperinsulinemic hypoglycemia of infancy;Persistent hyperinsulinemic hypoglycemia of infancy;Transient neonatal diabetes mellitus 2;not provided	germline;unknown	germline	GRCh37	NC_000011.9	11	17434263	17434263	G	A	11p15.1	"criteria provided, multiple submitters, no conflicts"	5	NA	N	-	2	188915	11	17434263	G	A	186816	11:17434263:G:A	Pathogenic	10/31/18	-	OMIM:125853;OMIM:240800;OMIM:256450;OMIM:606176;OMIM:610374	C0011860:Diabetes mellitus type 2;C0271714:Leucine-induced hypoglycemia;C1833104:Permanent neonatal diabetes mellitus;C1835887:Transient neonatal diabetes mellitus 2;C2931832:Persistent hyperinsulinemic hypoglycemia of infancy	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	unknown:na	"Fulgent Genetics,Fulgent Genetics"	SCV000893867.1	SCV000893867		-	-	"MODY Extended, MonogenicDM_all, Neonatal Diabetes"	10/31/18	46955	8	12	"[0.9998722180811416,1.2778191885848153E-4]"	12	SCV00089386729525	single nucleotide variant	NM_170707.3(LMNA):c.1445G>A (p.Arg482Gln)	4000	LMNA	HGNC:6636	Pathogenic	1	31-Oct-18	11575937	-	RCV000763258;RCV000763258;RCV000459624;RCV000763258;RCV000763258;RCV000763258;RCV000190399;RCV000763258;RCV000015575;RCV000763258;RCV000763258;RCV000763258;RCV000041318;RCV000763258;RCV000763258;RCV000754814;RCV000148600;RCV000057299	"MedGen:C0410190,OMIM:181350,Orphanet:ORPHA98853,SNOMED CT:240072005;MedGen:C1854154,OMIM:605588,Orphanet:ORPHA98856;MedGen:C0270914,Orphanet:ORPHA64746;MedGen:C2750785,OMIM:613205,Orphanet:ORPHA157973;MedGen:C1449563,OMIM:115200,Orphanet:ORPHA300751;MedGen:C0796031,OMIM:212112,Orphanet:ORPHA2229;MedGen:C2750035,OMIM:616516,Orphanet:ORPHA98855;MedGen:C2750035,OMIM:616516,Orphanet:ORPHA98855;MedGen:C1720860,OMIM:151660,Orphanet:ORPHA2348;MedGen:C1720860,OMIM:151660,Orphanet:ORPHA2348;MedGen:C1857829,OMIM:610140,Orphanet:ORPHA168796;MedGen:C0033300,OMIM:176670,Orphanet:ORPHA740,SNOMED CT:238870004;MedGen:CN236383,Orphanet:ORPHA98301;MedGen:C0406585,OMIM:275210,Orphanet:ORPHA1662,SNOMED CT:400128006;MedGen:C0432291,OMIM:248370,Orphanet:ORPHA2457,SNOMED CT:109419009;MedGen:C3888631;MedGen:CN221589;MedGen:CN517202"	"Benign scapuloperoneal muscular dystrophy with cardiomyopathy;Charcot-Marie-Tooth disease type 2B1;Charcot-Marie-Tooth disease, type 2;Congenital muscular dystrophy, LMNA-related;Dilated cardiomyopathy 1A;Dilated cardiomyopathy-hypergonadotropic hypogonadism syndrome;Emery-Dreifuss muscular dystrophy 3, autosomal recessive;Emery-Dreifuss muscular dystrophy 3, autosomal recessive;Familial partial lipodystrophy 2;Familial partial lipodystrophy 2;Heart-hand syndrome, Slovenian type;Hutchinson-Gilford syndrome;Laminopathy;Lethal tight skin contracture syndrome;Mandibuloacral dysostosis;Monogenic diabetes;Partial lipodystrophy, Dunnigan;not provided"	de novo;germline;unknown	germline	GRCh37	NC_000001.10	1	156106776	156106776	G	A	1q22	"criteria provided, multiple submitters, no conflicts"	10	"ACMG2013,ACMG2016"	N	"OMIM Allelic Variant:150330.0010,UniProtKB (protein):P02545#VAR_009992"	3	14486	1	156106776	G	A	29525	1:156106776:G:A	Pathogenic	10/31/18	-	OMIM:115200;OMIM:151660;OMIM:176670;OMIM:181350;OMIM:212112;OMIM:248370;OMIM:275210;OMIM:605588;OMIM:610140;OMIM:613205;OMIM:616516	"C0033300:Hutchinson-Gilford syndrome;C0406585:Lethal tight skin contracture syndrome;C0410190:Benign scapuloperoneal muscular dystrophy with cardiomyopathy;C0432291:Mandibuloacral dysostosis;C0796031:Dilated cardiomyopathy-hypergonadotropic hypogonadism syndrome;C1449563:Dilated cardiomyopathy 1A;C1720860:Familial partial lipodystrophy 2;C1854154:Charcot-Marie-Tooth disease type 2B1;C1857829:Heart-hand syndrome, Slovenian type;C2750035:Emery-Dreifuss muscular dystrophy 3, autosomal recessive;C2750785:Congenital muscular dystrophy, LMNA-related"	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	unknown:na	"Fulgent Genetics,Fulgent Genetics"	SCV000893895.1	SCV000893895		-	-	"Lipodystrophy, MonogenicDM_all"	10/31/18	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV000893895171199	single nucleotide variant	NM_000527.4(LDLR):c.301G>A (p.Glu101Lys)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	31-Oct-18	144172724	-	RCV000211583;RCV000148571;RCV000162016	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020443;MedGen:CN517202"	Familial hypercholesterolemia;Hypercholesterolaemia;not provided	germline;not applicable;unknown	germline	GRCh37	NC_000019.9	19	11213450	11213450	G	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	15	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000044,UniProtKB (protein):P01130#VAR_005315"	2	161266	19	11213450	G	A	171199	19:11213450:G:A	Pathogenic	10/31/18	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	unknown:na	"Fulgent Genetics,Fulgent Genetics"	SCV000894165.1	SCV000894165		-	-	High LDL	10/31/18	46963	0	3	"[0.9999680599620978,3.194003790217831E-5]"	3	SCV000894165245646	single nucleotide variant	NM_000527.4(LDLR):c.590G>T (p.Cys197Phe)	3949	LDLR	HGNC:6547	Likely pathogenic	1	31-Oct-18	376459828	-	RCV000238173	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline;unknown	germline	GRCh37	NC_000019.9	19	11216172	11216172	G	T	19p13.2	"criteria provided, multiple submitters, no conflicts"	4	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000082,UniProtKB (protein):P01130#VAR_005328"	2	251309	19	11216172	G	T	245646	19:11216172:G:T	Likely pathogenic	10/31/18	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	unknown:na	"Fulgent Genetics,Fulgent Genetics"	SCV000894169.1	SCV000894169		-	-	High LDL	10/31/18	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV00089416918730	single nucleotide variant	NM_000527.4(LDLR):c.682G>A (p.Glu228Lys)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	31-Oct-18	121908029	-	RCV000735406;RCV000735406;RCV000735406;RCV000003878;RCV000735406;RCV000735406;RCV000623885	"Human Phenotype Ontology:HP:0002647,MedGen:C0340643;Human Phenotype Ontology:HP:0012158,MedGen:C0338585;Human Phenotype Ontology:HP:0012474,MedGen:C0265101;MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;Human Phenotype Ontology:HP:0012159,MedGen:C0751815;Human Phenotype Ontology:HP:0001297,MedGen:C0038454;MedGen:CN517202"	Aortic dissection;Carotid artery dissection;Carotid artery occlusion;Familial hypercholesterolemia;Internal carotid artery dissection;Stroke;not provided	germline;unknown	germline	GRCh37	NC_000019.9	19	11216264	11216264	G	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	19	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000105,OMIM Allelic Variant:606945.0007,UniProtKB (protein):P01130#VAR_005341"	3	3691	19	11216264	G	A	18730	19:11216264:G:A	Pathogenic	10/31/18	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	unknown:na	"Fulgent Genetics,Fulgent Genetics"	SCV000894170.1	SCV000894170		-	-	High LDL	10/31/18	46944	19	2	"[0.9999786980231765,2.1301976823449217E-5]"	2	SCV000894170228146	single nucleotide variant	NM_000527.4(LDLR):c.682G>T (p.Glu228Ter)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	31-Oct-18	121908029	-	RCV000211631;RCV000589867;RCV000518828	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:CN517202"	Familial hypercholesterolemia;Familial hypercholesterolemias;not provided	germline;not applicable;unknown	germline	GRCh37	NC_000019.9	19	11216264	11216264	G	T	19p13.2	"criteria provided, multiple submitters, no conflicts"	12	"ACMG2013,ACMG2016"	N	LDLR @ LOVD:LDLR_001818	2	226333	19	11216264	G	T	228146	19:11216264:G:T	Pathogenic	10/31/18	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	unknown:na	"Fulgent Genetics,Fulgent Genetics"	SCV000894171.1	SCV000894171		-	-	High LDL	10/31/18	46944	19	1	"[0.9999893490115883,1.0650988411724608E-5]"	1	SCV00089417145113	single nucleotide variant	NM_000527.4(LDLR):c.1055G>A (p.Cys352Tyr)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	31-Oct-18	193922566	-	RCV000030122;RCV000722113;RCV000413322	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:CN517202"	Familial hypercholesterolemia;Familial hypercholesterolemias;not provided	germline;unknown	germline	GRCh37	NC_000019.9	19	11221442	11221442	G	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	9	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_001339,UniProtKB (protein):P01130#VAR_005369"	2	36450	19	11221442	G	A	45113	19:11221442:G:A	Pathogenic	10/31/18	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	unknown:na	"Fulgent Genetics,Fulgent Genetics"	SCV000894172.1	SCV000894172		-	-	High LDL	10/31/18	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV00089417218733	single nucleotide variant	NM_000527.4(LDLR):c.1285G>A (p.Val429Met)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	31-Oct-18	28942078	-	RCV000003882	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000"	Familial hypercholesterolemia	germline;inherited;unknown	germline	GRCh37	NC_000019.9	19	11224052	11224052	G	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	14	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_001387,OMIM Allelic Variant:606945.0009,UniProtKB (protein):P01130#VAR_005383"	3	3694	19	11224052	G	A	18733	19:11224052:G:A	Pathogenic	10/31/18	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	unknown:na	"Fulgent Genetics,Fulgent Genetics"	SCV000894174.1	SCV000894174		-	-	High LDL	10/31/18	46963	0	1	"[0.9999893533206993,1.0646679300726104E-5]"	1	SCV000894174171217	single nucleotide variant	NM_000527.4(LDLR):c.1775G>A (p.Gly592Glu)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	31-Oct-18	137929307	-	RCV000172964;RCV000587007;RCV000148576;RCV000162001	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:C0020443;MedGen:CN517202"	Familial hypercholesterolemia;Familial hypercholesterolemias;Hypercholesterolaemia;not provided	germline;inherited;not applicable;unknown	germline	GRCh37	NC_000019.9	19	11227604	11227604	G	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	22	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000237,UniProtKB (protein):P01130#VAR_005403"	2	161271	19	11227604	G	A	171217	19:11227604:G:A	Pathogenic	10/31/18	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	unknown:na	"Fulgent Genetics,Fulgent Genetics"	SCV000894177.1	SCV000894177		-	-	High LDL	10/31/18	46963	0	3	"[0.9999680599620978,3.194003790217831E-5]"	3	SCV00089417718738	single nucleotide variant	NM_000527.4(LDLR):c.2043C>A (p.Cys681Ter)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	31-Oct-18	121908031	-	RCV000003887;RCV000590806;RCV000481771	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:C0020445;MedGen:CN517202"	Familial hypercholesterolemia;Familial hypercholesterolemias;not provided	germline;unknown	germline	GRCh37	NC_000019.9	19	11231101	11231101	C	A	19p13.2	"criteria provided, multiple submitters, no conflicts"	18	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_001592,OMIM Allelic Variant:606945.0016"	3	3699	19	11231101	C	A	18738	19:11231101:C:A	Pathogenic	10/31/18	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	unknown:na	"Fulgent Genetics,Fulgent Genetics"	SCV000894178.1	SCV000894178		-	-	High LDL	10/31/18	46958	5	1	"[0.9999893521870608,1.0647812939222283E-5]"	1	SCV00089417818741	single nucleotide variant	NM_000527.4(LDLR):c.2054C>T (p.Pro685Leu)	3949	LDLR	HGNC:6547	Pathogenic/Likely pathogenic	1	31-Oct-18	28942084	-	RCV000003891;RCV000162007	"MedGen:C0745103,OMIM:143890,SNOMED CT:397915002,SNOMED CT:398036000;MedGen:CN517202"	Familial hypercholesterolemia;not provided	germline;inherited;not applicable;unknown	germline	GRCh37	NC_000019.9	19	11231112	11231112	C	T	19p13.2	"criteria provided, multiple submitters, no conflicts"	16	"ACMG2013,ACMG2016"	N	"LDLR @ LOVD:LDLR_000276,OMIM Allelic Variant:606945.0017,UniProtKB (protein):P01130#VAR_005410"	3	3702	19	11231112	C	T	18741	19:11231112:C:T	Pathogenic	10/31/18	-	OMIM:143890	C0745103:Familial hypercholesterolemia	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	unknown:na	"Fulgent Genetics,Fulgent Genetics"	SCV000894179.1	SCV000894179		-	-	High LDL	10/31/18	46963	0	3	"[0.9999680599620978,3.194003790217831E-5]"	3	SCV00089417944907	single nucleotide variant	NM_000162.5(GCK):c.676G>A (p.Val226Met)	2645	GCK	HGNC:4195	Pathogenic/Likely pathogenic	1	31-Oct-18	148311934	-	RCV000763584;RCV000763584;RCV000029906;RCV000763584;RCV000763584;RCV000255932	"Human Phenotype Ontology:HP:0005978,MedGen:C0011860,OMIM:125853,Orphanet:ORPHA181376,SNOMED CT:44054006;MedGen:C1865290,OMIM:602485,Orphanet:ORPHA79299;MedGen:C1841962,OMIM:125851;MedGen:C1841962,OMIM:125851;MedGen:C1833104,OMIM:606176,Orphanet:ORPHA99885;MedGen:CN517202"	"Diabetes mellitus type 2;Hyperinsulinemic hypoglycemia familial 3;Maturity-onset diabetes of the young,  type 2;Maturity-onset diabetes of the young,  type 2;Permanent neonatal diabetes mellitus;not provided"	germline;unknown	germline	GRCh37	NC_000007.13	7	44189362	44189362	C	T	7p13	"criteria provided, multiple submitters, no conflicts"	6	NA	N	UniProtKB (protein):P35557#VAR_003703	2	36243	7	44189362	C	T	44907	7:44189362:C:T	Pathogenic	10/31/18	-	OMIM:125851;OMIM:125853;OMIM:602485;OMIM:606176	"C0011860:Diabetes mellitus type 2;C1833104:Permanent neonatal diabetes mellitus;C1841962:Maturity-onset diabetes of the young, type 2;C1865290:Hyperinsulinemic hypoglycemia familial 3"	NA	TRUE	NA	"criteria provided, single submitter"	clinical testing	unknown:na	"Fulgent Genetics,Fulgent Genetics"	SCV000894423.1	SCV000894423		-	-	"MODY, MODY Extended, MonogenicDM_all"	10/31/18	46963	0	2	"[0.9999787066413985,2.1293358601452207E-5]"	2	SCV000894423